data_2c06_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2c06 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptp . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.925 0.393 . . . . 1.45 110.532 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -116.78 172.11 7.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.226 -0.443 . . . . 2.01 111.077 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -73.19 131.06 41.54 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.196 -0.456 . . . . 2.16 111.031 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.67 1.22 58.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.878 -0.677 . . . . 0.87 113.116 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -84.61 146.86 27.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 0.99 111.255 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.2 mt -106.52 118.91 55.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.862 -0.608 . . . . 1.16 110.265 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -118.05 128.65 54.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.91 111.124 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.9 tp -80.07 130.03 34.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.366 -0.379 . . . . 0.9 110.621 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.0 p -158.28 165.17 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.415 -0.357 . . . . 1.04 110.389 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 m -104.95 139.86 39.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.848 0.356 . . . . 1.32 110.898 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 25.3 mt -98.43 -9.17 25.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.003 0.43 . . . . 1.29 110.58 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.1 165.55 49.7 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.533 -0.758 . . . . 1.54 110.672 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.95 139.25 60.46 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.83 -1.321 . . . . 1.69 113.073 0.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 p -111.27 157.1 20.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.502 -0.772 . . . . 1.53 110.175 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -136.3 148.93 48.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.34 . . . . 1.7 111.075 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.88 -86.62 1.07 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.94 -0.648 . . . . 1.18 112.176 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -160.44 45.13 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.158 0.504 . . . . 3.12 111.258 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -79.43 176.63 9.52 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.737 -0.468 . . . . 1.14 109.737 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -78.94 90.35 4.75 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.434 -0.58 . . . . 2.09 109.434 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -89.94 158.63 17.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.783 -0.644 . . . . 2.44 112.059 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.9 127.72 6.18 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.684 -0.689 . . . . 1.07 112.805 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.9 m -63.14 129.92 42.37 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.77 0.319 . . . . 1.46 110.336 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.43 155.49 29.86 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.175 -0.466 . . . . 2.01 110.283 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.53 131.6 17.69 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.314 2.009 . . . . 1.01 110.824 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.9 m -107.38 154.12 8.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.439 -0.346 . . . . 0.76 110.288 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.7 tp -100.87 133.03 45.96 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.372 -0.377 . . . . 0.7 111.061 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.9 mm -76.51 108.96 10.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.92 110.117 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.42 -39.59 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.95 112.039 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.35 146.76 81.74 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 112.142 0.423 . . . . 1.12 112.142 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.28 158.08 59.08 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.795 2.33 . . . . 1.3 112.107 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.9 -39.7 74.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.932 -0.577 . . . . 1.39 112.065 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.73 -42.1 83.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 1.61 111.385 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -70.39 -46.51 63.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.945 -0.57 . . . . 1.77 110.402 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -61.9 -30.31 70.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 1.48 111.197 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -68.39 -44.96 73.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.277 -0.419 . . . . 3.04 112.101 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -86.72 -40.97 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 113.907 1.077 . . . . 1.86 113.907 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.8 m -84.78 -33.3 23.03 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.767 0.284 . . . . 2.06 111.767 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 65.46 20.42 11.73 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.058 0.456 . . . . 4.87 111.673 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.1 mt -134.01 91.78 23.43 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.668 -0.697 . . . . 1.81 109.181 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -84.41 135.43 6.12 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.516 2.144 . . . . 1.05 113.339 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -79.17 124.8 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.922 -1.14 . . . . 1.03 107.922 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.4 m -124.33 153.74 31.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.627 0.602 . . . . 0.79 112.627 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.42 140.74 27.74 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.352 -0.84 . . . . 0.72 109.695 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.27 147.65 16.29 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.801 2.334 . . . . 1.03 113.897 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.0 t -103.76 119.74 52.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.485 -0.779 . . . . 1.28 109.269 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.319 -0.76 0 N-CA-C 109.506 -0.553 . . . . 2.5 109.506 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 111.939 -0.464 . . . . 1.69 111.939 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -87.94 -9.65 52.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.235 0.54 . . . . 1.56 110.28 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.86 134.21 34.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.466 -0.788 . . . . 1.25 108.981 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.2 m -94.97 165.68 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.062 0.458 . . . . 1.68 111.912 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.1 m -71.97 143.25 49.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.842 -0.617 . . . . 2.25 111.041 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.9 mt -136.49 -52.92 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.135 0.42 . . . . 1.35 112.135 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -66.22 116.07 6.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.129 0.49 . . . . 2.21 111.788 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.59 -27.86 0.85 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.633 -0.712 . . . . 1.18 111.848 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.5 m -89.56 -10.48 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.36 0.504 . . . . 1.21 112.36 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.72 73.02 1.06 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.802 -0.713 . . . . 1.08 112.606 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.9 pt -116.63 172.3 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.804 0.335 . . . . 1.07 111.011 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.0 ttm-85 -92.68 -28.35 16.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.226 0.536 . . . . 4.33 109.922 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.8 m -77.22 109.55 11.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.651 -0.704 . . . . 1.51 111.068 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 m -93.45 110.69 22.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.231 0.539 . . . . 1.79 110.898 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 171.18 -169.02 42.14 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.119 -0.792 . . . . 1.18 111.119 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.7 t -129.24 124.87 61.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 110.192 -0.299 . . . . 1.56 110.192 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.2 t -73.97 121.12 24.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.692 -0.485 . . . . 1.29 109.692 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -114.94 135.97 53.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.914 0.388 . . . . 2.85 110.721 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.1 m -113.89 32.51 5.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.907 -0.588 . . . . 1.47 109.697 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -88.97 -49.63 6.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.467 -0.788 . . . . 0.89 111.73 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -117.3 74.58 8.03 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.7 -0.227 . . . . 2.65 111.587 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -96.34 163.6 1.22 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.943 2.429 . . . . 0.8 112.495 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -170.24 146.11 2.87 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.297 -0.411 . . . . 2.42 110.802 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.4 m -84.68 93.87 8.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.051 0.453 . . . . 1.79 109.915 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.5 pt -84.36 -174.19 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.483 0.659 . . . . 1.15 112.718 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -89.54 132.06 35.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.047 -0.979 . . . . 1.03 110.554 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 51.8 tpp -127.26 26.39 6.03 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.472 -0.936 . . . . 1.29 108.472 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -112.33 -45.92 3.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.518 -0.765 . . . . 3.09 111.093 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.27 -26.09 16.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.179 -0.464 . . . . 1.12 111.409 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -80.06 -43.77 21.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.236 -0.438 . . . . 1.17 111.626 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.99 127.67 2.05 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.831 -0.7 . . . . 1.12 112.759 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -104.05 136.74 13.17 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.849 -0.691 . . . . 1.16 112.077 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -109.47 117.04 32.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.945 -0.391 . . . . 2.87 109.945 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.8 ttp85 -74.55 126.27 30.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.751 0.31 . . . . 2.93 110.943 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.25 -73.36 0.68 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.073 0.463 . . . . 1.29 110.801 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -146.57 -164.52 2.0 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.638 -0.71 . . . . 1.15 109.522 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -143.18 150.66 39.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.755 0.312 . . . . 1.57 110.746 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -102.5 151.96 38.29 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.217 -0.447 . . . . 0.75 110.465 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -66.16 167.22 18.74 Favored 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 122.636 2.224 . . . . 0.95 111.644 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -60.73 -21.4 62.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.977 -0.556 . . . . 1.51 111.537 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -42.24 94.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.928 -0.578 . . . . 1.62 110.599 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.7 mm -76.19 -33.88 24.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.841 -0.618 . . . . 1.31 110.823 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.4 tpt -59.9 -41.36 91.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 1.6 110.99 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -65.64 -35.08 79.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 2.52 110.648 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -60.52 -48.35 82.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.934 -0.576 . . . . 1.64 111.295 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.67 -40.78 90.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.952 -0.567 . . . . 1.03 111.226 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.2 mt -68.54 1.05 3.39 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.225 0.824 . . . . 1.22 113.225 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.12 -1.18 26.8 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.121 -1.038 . . . . 1.03 112.945 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -104.82 -20.56 13.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.9 0.381 . . . . 2.16 111.771 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.5 mt -73.73 -24.82 59.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.001 0.429 . . . . 1.02 111.707 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -28.86 62.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.839 0.352 . . . . 1.11 111.544 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.85 -17.28 61.08 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.055 0.761 . . . . 1.95 113.055 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.1 pt -93.51 -13.62 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 111.978 0.362 . . . . 1.15 111.978 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.408 ' C ' ' HG1' ' A' ' 110' ' ' THR . 93.2 mt -86.39 86.8 7.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.928 0.394 . . . . 0.98 110.939 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.408 ' HG1' ' C ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 116.367 -0.379 . . . . 1.35 111.037 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.404 ' SD ' ' N ' ' B' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.366 0.603 . . . . 2.03 112.577 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . 0.404 ' N ' ' SD ' ' B' ' 1' ' ' MET . 30.4 mt-10 -95.62 -7.47 37.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.431 -0.804 . . . . 2.82 109.608 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? 73.42 120.71 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.22 1.193 . . . . 2.66 114.22 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.51 43.54 44.38 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 115.008 0.763 . . . . 1.28 115.008 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -117.55 93.74 4.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.26 0.53 . . . . 1.53 112.377 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 57.2 mt -100.05 102.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.442 -0.947 . . . . 0.75 108.442 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -105.79 145.84 30.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.272 0.558 . . . . 0.82 112.4 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 22.9 tp -102.77 119.73 39.35 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.471 -0.937 . . . . 1.05 108.471 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.93 159.29 4.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.865 0.364 . . . . 0.72 110.788 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.68 121.22 25.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.155 -0.475 . . . . 1.68 110.519 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 88.5 mt -79.69 -20.62 46.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.147 -0.479 . . . . 0.83 110.728 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.07 153.89 90.9 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.639 . . . . 1.62 110.574 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -88.98 162.26 39.68 Favored 'Cis proline' 0 C--O 1.236 0.394 0 C-N-CA 123.438 -1.484 . . . . 1.28 112.053 -0.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.24 160.73 43.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 1.7 110.587 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.29 142.97 37.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.783 0.325 . . . . 1.22 110.61 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.24 -155.62 34.66 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.949 -0.643 . . . . 1.01 112.433 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -85.53 50.43 1.96 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.197 0.443 . . . . 2.62 112.197 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -112.76 163.71 14.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.19 -0.459 . . . . 1.28 109.847 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -73.17 138.28 45.6 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.164 0.802 . . . . 1.98 113.164 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -146.65 -179.73 6.98 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.58 -0.736 . . . . 1.86 110.419 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.24 150.88 21.57 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.125 -0.56 . . . . 0.9 112.549 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 45.2 m -86.34 106.04 17.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.953 0.406 . . . . 1.11 109.925 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.65 159.95 35.11 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.159 -0.473 . . . . 2.0 109.759 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.72 139.8 82.59 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.347 2.031 . . . . 0.65 111.21 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.12 152.33 27.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.39 -0.368 . . . . 0.57 110.509 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 22.9 tp -103.05 121.66 43.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.113 -0.494 . . . . 1.17 109.722 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 10.5 mt -74.31 148.63 8.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.432 -0.349 . . . . 0.66 110.703 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 21.9 t -114.78 -34.18 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.014 0.435 . . . . 0.93 110.988 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.29 138.43 91.85 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.059 -0.519 . . . . 1.1 112.208 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.41 170.27 19.69 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.888 2.392 . . . . 0.78 112.638 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.79 -30.31 71.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.852 -0.613 . . . . 1.03 110.61 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.03 -0.75 8.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.665 -0.698 . . . . 1.4 112.3 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -135.14 -40.53 0.74 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.952 0.406 . . . . 1.57 111.0 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -59.54 -33.05 70.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.834 -0.621 . . . . 1.92 111.471 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -97.41 11.69 35.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.365 -0.379 . . . . 2.93 110.993 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 97.7 t -110.57 -67.03 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 1.09 111.493 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 14.5 p -84.07 -22.83 31.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.764 0.316 . . . . 1.64 110.979 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? 70.35 12.87 7.57 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.596 -0.729 . . . . 2.01 111.689 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 17.1 mt -119.7 90.18 42.78 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.401 -0.962 . . . . 1.16 108.401 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -92.45 161.78 2.98 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.737 2.291 . . . . 0.57 114.134 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.88 130.75 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.173 -1.047 . . . . 1.08 108.173 177.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 23.5 m -120.76 145.48 27.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 112.68 0.622 . . . . 0.64 112.68 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 53.5 t -97.73 118.53 63.97 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.874 -1.057 . . . . 1.1 108.451 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.67 124.27 11.75 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.861 2.374 . . . . 0.73 113.259 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 46.1 t -87.31 139.79 16.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.161 -0.681 . . . . 0.9 109.161 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -120.95 116.09 24.44 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.561 -0.533 . . . . 1.24 109.561 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 C--O 1.237 0.407 0 CA-C-N 115.934 -0.576 . . . . 2.43 112.168 -179.587 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.227 0 CA-C-O 120.739 0.304 . . . . 1.96 111.074 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.79 -110.23 3.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.136 -0.554 . . . . 1.14 112.534 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -93.46 -14.38 26.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.976 0.417 . . . . 3.57 110.788 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.55 110.08 10.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 1.08 110.864 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 85.7 t -87.97 131.48 35.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.941 -0.572 . . . . 1.34 109.501 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 9.3 t -88.3 119.05 28.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.409 -0.359 . . . . 1.71 111.131 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 60.3 mt -87.9 -18.11 29.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.723 -0.843 . . . . 1.02 108.723 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -86.46 142.92 28.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.201 -0.909 . . . . 1.79 110.469 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.9 -55.12 0.76 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 121.034 -0.603 . . . . 1.15 111.68 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 13.9 p -73.9 -27.61 22.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.949 0.404 . . . . 1.17 111.638 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.66 68.94 0.33 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.871 -0.681 . . . . 1.05 111.977 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -125.42 148.27 29.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.087 -0.709 . . . . 1.61 109.087 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.32 -50.41 63.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.958 0.409 . . . . 2.65 109.963 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 7.2 m -67.77 94.75 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.851 -0.613 . . . . 0.93 110.501 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 4.5 m -87.15 90.71 8.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.924 -0.58 . . . . 1.62 110.82 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.81 -170.01 35.29 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.376 -0.916 . . . . 0.79 112.383 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 15.6 m -123.12 145.33 30.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.791 0.329 . . . . 0.93 110.667 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.3 m -91.43 136.32 24.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.821 0.343 . . . . 1.38 111.198 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -86.32 82.73 7.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 1.52 110.611 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 2.5 m -79.81 45.93 0.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.017 0.436 . . . . 1.55 110.838 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -135.6 -32.91 0.89 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.927 -0.578 . . . . 1.1 110.949 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -125.69 79.47 67.85 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 112.455 0.539 . . . . 2.83 112.455 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -89.16 143.47 4.76 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.555 2.17 . . . . 0.96 110.647 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -124.53 141.48 52.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.801 0.334 . . . . 2.32 111.765 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.75 121.23 26.62 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.482 -0.932 . . . . 1.21 108.482 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 15.9 pt -126.96 -164.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.045 0.45 . . . . 1.28 111.41 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -115.7 143.87 44.75 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.903 -0.777 . . . . 1.28 108.903 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 11.6 ttp -126.32 31.71 5.34 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.734 0.272 . . . . 2.7 111.734 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -137.65 -42.5 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.181 0.437 . . . . 2.62 112.181 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.21 -29.63 15.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.816 0.341 . . . . 1.06 110.246 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -72.65 -35.73 67.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 1.47 110.628 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.22 106.74 0.99 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.922 -0.656 . . . . 0.92 112.757 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.18 159.91 21.89 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.68 -0.772 . . . . 0.92 112.084 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -151.59 136.12 16.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.026 -0.361 . . . . 2.24 110.026 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -76.93 126.13 30.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.652 0.263 . . . . 2.99 110.583 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 80.1 mt -82.4 -64.17 1.23 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.242 -0.435 . . . . 0.76 110.868 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -139.85 174.17 10.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 1.07 110.311 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -112.34 115.11 28.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.234 0.54 . . . . 2.71 110.903 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.33 133.07 87.48 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.465 -0.789 . . . . 1.45 110.801 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.66 147.56 39.31 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 122.94 2.427 . . . . 1.03 111.999 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.02 -33.37 67.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.996 -0.547 . . . . 2.14 111.021 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.61 -48.97 79.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.862 -0.608 . . . . 2.06 110.799 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 21.2 mm -72.05 -34.48 50.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.771 -0.65 . . . . 1.33 110.48 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 11.8 tpt -59.64 -38.63 81.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 2.34 110.477 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -65.77 -35.83 81.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.889 -0.596 . . . . 2.09 110.853 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -63.55 -46.59 85.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 1.76 109.965 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 24.5 t -58.74 -48.68 85.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.116 -0.493 . . . . 1.01 110.915 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.95 -35.49 76.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.99 -0.55 . . . . 1.29 111.243 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.74 -36.43 92.27 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.259 -0.736 . . . . 1.02 111.259 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -73.45 -34.07 65.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.04 0.448 . . . . 2.34 110.258 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 78.7 mt -71.03 -11.41 60.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.893 -0.594 . . . . 1.94 111.335 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.7 m -77.71 -8.57 58.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.88 0.371 . . . . 1.16 111.488 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.3 m -74.22 -16.17 60.98 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.898 0.333 . . . . 1.85 111.898 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 31.5 pt -79.69 -1.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 111.885 0.328 . . . . 1.98 111.885 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 88.8 mt -102.05 15.99 27.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.246 0.546 . . . . 1.36 110.6 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.252 1.188 0 CA-C-N 115.769 -0.65 . . . . 2.71 110.061 179.691 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 ptp . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.857 0.361 . . . . 1.45 110.481 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -107.66 167.0 10.27 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.103 -0.499 . . . . 2.01 111.095 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -74.03 131.58 41.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.842 -0.617 . . . . 2.16 109.718 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.15 -1.54 43.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 0.87 112.986 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -93.42 149.8 20.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.95 0.375 . . . . 0.99 110.695 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.7 pt -113.07 112.82 42.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.352 0.596 . . . . 1.16 110.402 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.8 m95 -105.48 118.23 36.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.696 -0.683 . . . . 0.91 110.779 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.8 tp -67.02 117.76 9.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.36 -0.382 . . . . 0.9 110.332 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.2 p -156.84 157.14 3.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.939 0.399 . . . . 1.04 111.073 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 t -92.43 124.17 36.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.659 -0.497 . . . . 1.32 109.659 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 mt -76.51 -12.55 60.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.772 -0.649 . . . . 1.29 110.533 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.28 164.24 62.63 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.202 -0.908 . . . . 1.54 111.314 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.92 145.77 54.13 Favored 'Cis proline' 0 C--N 1.353 0.776 0 C-N-CA 124.337 -1.11 . . . . 1.69 112.82 0.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.3 p -120.72 162.57 19.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.142 -0.481 . . . . 1.53 111.829 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.41 146.21 31.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.605 -0.725 . . . . 1.7 109.378 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.15 -129.77 32.16 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.656 -0.783 . . . . 1.18 111.998 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -107.61 14.35 25.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.773 0.32 . . . . 3.12 111.236 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -61.6 128.93 38.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.881 -0.414 . . . . 1.14 109.881 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -49.09 125.77 11.27 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.052 -0.522 . . . . 2.09 112.217 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -123.12 176.56 5.99 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.458 -0.792 . . . . 2.44 111.486 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.15 140.27 8.9 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.705 -0.759 . . . . 1.07 114.116 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 m -81.8 89.44 6.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.035 -1.098 . . . . 1.46 108.035 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -135.26 160.42 68.15 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.822 -0.626 . . . . 2.01 110.419 -177.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.87 125.33 14.05 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.233 1.955 . . . . 1.01 111.387 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.8 m -101.42 132.03 48.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.088 -0.506 . . . . 0.76 110.525 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -81.98 121.24 26.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.928 -0.578 . . . . 0.7 110.879 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.3 mm -70.55 110.04 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.256 -0.429 . . . . 0.92 110.438 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.5 t -89.16 -34.52 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.98 0.419 . . . . 0.95 111.166 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.09 146.25 84.5 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.244 -0.434 . . . . 1.12 111.57 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.1 158.88 49.54 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.55 2.167 . . . . 1.3 111.812 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.39 -41.52 72.76 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.984 -0.553 . . . . 1.39 112.333 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.49 97.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.297 -0.41 . . . . 1.61 111.413 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -64.86 -43.9 91.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.289 -0.414 . . . . 1.77 110.834 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -59.8 -30.55 68.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.589 . . . . 1.48 110.949 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -86.74 -35.29 19.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.564 -0.744 . . . . 3.04 112.426 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.7 p -83.01 -45.19 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 113.274 0.842 . . . . 1.86 113.274 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -84.17 -27.16 28.27 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.185 -0.322 . . . . 2.06 111.071 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 64.75 19.64 11.89 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.02 -0.536 . . . . 4.87 111.304 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.2 tp -143.75 101.08 5.03 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 108.319 -0.993 . . . . 1.81 108.319 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -90.67 150.5 4.18 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.807 2.338 . . . . 1.05 114.183 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.7 t -98.96 116.73 42.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 106.704 -1.591 . . . . 1.03 106.704 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.9 m -125.46 155.38 34.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 113.386 0.884 . . . . 0.79 113.386 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.8 m -120.3 116.23 32.41 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.069 -0.969 . . . . 0.72 109.443 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.26 136.28 31.28 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.837 2.358 . . . . 1.03 113.301 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.3 t -64.8 136.63 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.684 -0.689 . . . . 1.28 110.234 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.661 0 CA-C-N 116.029 -0.532 . . . . 2.5 110.806 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 N-CA-C 111.091 -0.804 . . . . 1.69 111.091 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -82.26 42.44 0.74 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.491 0.662 . . . . 1.56 110.187 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -135.33 107.8 7.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.321 -0.854 . . . . 1.25 109.815 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.5 t -97.35 128.17 48.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.141 -0.481 . . . . 1.68 110.26 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.64 137.38 38.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.154 -0.475 . . . . 2.25 111.389 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 74.2 mt -94.56 17.24 13.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.29 0.567 . . . . 1.35 110.903 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -81.5 137.58 35.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.626 -0.716 . . . . 2.21 110.407 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.25 -26.52 11.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.618 -0.801 . . . . 1.18 113.066 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.8 m -93.17 -24.18 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.106 0.41 . . . . 1.21 112.106 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 68.66 63.37 3.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.795 -0.717 . . . . 1.08 113.284 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.3 pt -108.93 -172.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 O-C-N 122.646 -0.326 . . . . 1.07 110.569 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -93.2 -39.1 11.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.849 0.357 . . . . 4.33 111.432 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 m -64.89 111.7 2.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.302 0.572 . . . . 1.51 111.732 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.28 79.76 2.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.804 -0.634 . . . . 1.79 110.502 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.36 -167.12 14.9 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.783 -0.722 . . . . 1.18 112.144 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 t -118.99 139.11 47.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 110.069 -0.345 . . . . 1.56 110.069 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.0 t -79.72 133.14 30.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.775 0.322 . . . . 1.29 111.136 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.81 154.5 17.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.119 -0.491 . . . . 2.85 110.512 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 58.8 m -141.0 2.57 1.74 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.955 0.407 . . . . 1.47 110.768 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -121.77 5.09 9.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.043 -0.526 . . . . 0.89 111.163 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -122.03 74.76 38.62 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 112.964 0.727 . . . . 2.65 112.964 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.86 119.11 3.53 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.65 2.233 . . . . 0.8 109.908 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -117.72 107.24 13.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.068 0.461 . . . . 2.42 111.747 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.6 90.27 6.09 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.98 -0.748 . . . . 1.79 108.98 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.9 pt -125.75 150.5 31.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.25 -0.432 . . . . 1.15 111.275 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -75.85 124.4 27.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.854 0.359 . . . . 1.03 110.553 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 52.0 tpp -81.61 -20.77 39.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.706 -0.679 . . . . 1.29 112.062 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -65.67 -32.68 74.38 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.767 0.654 . . . . 3.09 112.767 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.86 9.18 40.18 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.115 0.413 . . . . 1.12 112.115 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 40.7 mtt-85 -127.86 -44.46 1.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.27 0.47 . . . . 1.17 112.27 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.91 97.47 0.32 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.815 -0.707 . . . . 1.12 112.38 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -97.75 150.64 19.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.815 -0.707 . . . . 1.16 112.296 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -113.38 113.77 25.68 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.015 -0.365 . . . . 2.87 110.015 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -71.07 118.4 13.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.603 0.24 . . . . 2.93 111.324 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -86.76 -68.56 0.74 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.43 -0.581 . . . . 1.29 109.43 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -151.95 -167.43 2.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.347 -0.842 . . . . 1.15 109.433 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.9 ptm85 -132.81 142.87 49.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.788 0.327 . . . . 1.57 110.702 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.2 m -91.08 158.76 41.07 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.191 -0.459 . . . . 0.75 110.697 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.92 147.33 90.0 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.539 2.16 . . . . 0.95 111.029 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -55.54 -29.32 58.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.057 -0.52 . . . . 1.51 111.945 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.66 -33.3 73.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.909 0.385 . . . . 1.62 111.174 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.7 mm -70.67 -41.22 77.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.213 0.53 . . . . 1.31 109.759 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.6 tpt -66.87 -37.98 85.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.56 -0.745 . . . . 1.6 110.259 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -61.73 -34.87 76.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.905 -0.589 . . . . 2.52 110.477 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.47 -45.52 90.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.008 -0.542 . . . . 1.64 110.787 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.2 t -62.48 -44.12 98.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.044 -0.525 . . . . 1.03 110.581 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.98 -38.02 81.35 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.016 -0.538 . . . . 1.22 111.084 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.86 -41.65 98.7 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.846 -0.692 . . . . 1.03 112.072 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -67.84 -32.85 73.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.933 0.397 . . . . 2.16 110.73 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.03 -25.57 62.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.98 -0.555 . . . . 1.02 110.844 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -74.67 -28.46 60.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.981 0.42 . . . . 1.11 111.276 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.87 -22.22 58.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.382 0.512 . . . . 1.95 112.382 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 pt -89.84 1.83 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.739 0.644 . . . . 1.15 112.739 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.3 mt -86.67 80.85 8.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.544 0.211 . . . . 0.98 110.959 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 111.86 0.318 . . . . 1.35 111.86 -179.879 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.403 ' CG ' ' H ' ' B' ' 2' ' ' GLU . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 121.006 0.432 . . . . 2.03 111.633 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . 0.403 ' H ' ' CG ' ' B' ' 1' ' ' MET . 10.3 mt-10 -83.94 -14.59 50.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.816 -0.439 . . . . 2.82 109.816 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 71.95 113.72 0.06 Allowed 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.827 1.047 . . . . 2.66 113.827 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.04 -34.64 4.67 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.726 -0.67 . . . . 1.28 114.71 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.49 106.24 0.62 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.868 0.692 . . . . 1.53 112.868 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 61.3 mt -98.17 128.37 49.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 109.349 -0.611 . . . . 0.75 109.349 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -111.68 153.66 26.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.085 0.469 . . . . 0.82 111.536 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 23.5 tp -113.35 123.57 50.42 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.366 -0.605 . . . . 1.05 109.366 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 p -153.92 156.85 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.54 -0.3 . . . . 0.72 110.535 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 6.8 m -89.47 129.29 35.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.497 -0.32 . . . . 1.68 110.612 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 78.0 mt -81.13 -18.27 47.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.24 0.543 . . . . 0.83 110.308 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.25 153.59 81.27 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.215 -0.902 . . . . 1.62 110.381 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -93.29 92.1 0.14 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.639 -1.4 . . . . 1.28 112.34 -0.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.25 173.82 12.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.182 -0.463 . . . . 1.7 110.144 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.75 168.22 23.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.577 0.227 . . . . 1.22 111.114 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.98 -130.25 30.13 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.932 -0.652 . . . . 1.01 112.024 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -90.28 -1.84 57.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.833 0.349 . . . . 2.62 110.973 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -67.33 123.63 20.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.071 -0.715 . . . . 1.28 109.071 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -52.3 131.38 32.87 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.168 0.803 . . . . 1.98 113.168 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -113.43 139.01 49.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.579 -0.737 . . . . 1.86 109.623 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.32 147.6 8.11 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.835 -0.698 . . . . 0.9 112.93 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 26.9 m -76.69 124.47 27.7 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.06 -0.348 . . . . 1.11 110.06 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.42 158.71 33.36 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.801 -0.444 . . . . 2.0 109.801 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.23 131.55 32.71 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.219 1.946 . . . . 0.65 110.267 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.79 142.47 41.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.134 0.492 . . . . 0.57 111.45 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 18.7 tp -101.51 126.98 48.4 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.223 -0.658 . . . . 1.17 109.223 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 27.7 mt -86.4 144.53 9.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.576 -0.284 . . . . 0.66 110.339 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 45.4 t -108.38 -36.09 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.981 0.419 . . . . 0.93 110.943 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.64 143.79 98.69 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 1.1 112.328 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -66.81 159.4 51.64 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.097 2.531 . . . . 0.78 111.785 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.59 -37.6 73.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.98 -0.555 . . . . 1.03 111.403 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.65 -48.6 81.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 1.4 111.066 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -64.18 -40.3 95.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.046 0.451 . . . . 1.57 110.673 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -67.09 -19.88 65.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.924 -0.58 . . . . 1.92 111.257 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -95.32 -33.64 12.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.271 -0.422 . . . . 2.93 111.943 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 99.1 t -82.39 -71.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.612 0.244 . . . . 1.09 111.367 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.3 -30.04 66.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.781 0.324 . . . . 1.64 110.444 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? 66.96 17.42 10.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.607 -0.724 . . . . 2.01 112.257 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.23 92.85 43.81 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.278 -0.638 . . . . 1.16 109.278 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -90.57 147.38 4.13 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.813 2.342 . . . . 0.57 113.572 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 5.0 m -93.9 118.02 38.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.488 -0.93 . . . . 1.08 108.488 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 35.7 m -108.83 145.79 15.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 112.597 0.592 . . . . 0.64 112.597 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 90.5 t -111.03 115.73 52.52 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.955 -1.02 . . . . 1.1 108.851 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -72.71 123.17 8.8 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.946 2.43 . . . . 0.73 113.287 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.31 138.86 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.824 -0.806 . . . . 0.9 108.824 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.79 168.92 9.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.544 -0.298 . . . . 1.24 110.727 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.45 -0.341 . . . . 2.43 111.227 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 109.893 -0.41 . . . . 1.96 109.893 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.69 -98.25 2.38 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.994 -0.622 . . . . 1.14 112.673 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -120.54 5.25 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.016 0.436 . . . . 3.57 111.28 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.61 107.17 18.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.921 -0.581 . . . . 1.08 111.203 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 61.0 t -89.81 122.28 40.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.864 -0.607 . . . . 1.34 109.796 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -82.56 123.91 29.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.298 -0.41 . . . . 1.71 110.829 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 97.2 mt -91.16 -14.13 31.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.2 -0.455 . . . . 1.02 111.328 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -81.84 142.88 32.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.07 -0.514 . . . . 1.79 111.439 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.51 -19.33 12.88 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.919 -0.658 . . . . 1.15 112.672 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -109.62 -12.32 11.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.86 0.362 . . . . 1.17 111.703 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.47 60.58 0.78 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.451 -0.88 . . . . 1.05 112.53 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 78.1 mt -121.12 134.79 63.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.772 -0.455 . . . . 1.61 109.772 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -63.16 -39.28 94.21 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.073 0.463 . . . . 2.65 109.826 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 7.2 m -77.55 73.74 4.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.731 -0.668 . . . . 0.93 109.839 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 13.3 m -73.74 105.3 4.98 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.665 -0.698 . . . . 1.62 110.758 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -177.45 -161.21 25.51 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.784 -0.722 . . . . 0.79 112.118 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 m -124.27 136.33 60.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.962 0.411 . . . . 0.93 110.967 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 32.3 t -88.93 122.76 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.863 -0.608 . . . . 1.38 110.346 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 21.9 mmm-85 -92.57 81.48 4.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.926 0.393 . . . . 1.52 110.336 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.77 1.33 10.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.942 -0.572 . . . . 1.55 112.089 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.09 -7.89 59.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.334 -0.394 . . . . 1.1 111.463 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -142.53 84.34 11.18 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 113.459 0.911 . . . . 2.83 113.459 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.46 132.93 4.42 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.049 2.499 . . . . 0.96 110.277 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.48 127.06 45.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.244 0.461 . . . . 2.32 112.244 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.06 123.24 31.14 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.006 -0.739 . . . . 1.21 109.006 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 35.9 pt -134.61 154.11 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.545 0.212 . . . . 1.28 111.269 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.45 109.59 5.52 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.262 -0.426 . . . . 1.28 110.428 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 51.7 tpp -78.44 -13.07 60.01 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.572 0.582 . . . . 2.7 112.572 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -81.64 -44.06 17.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.96 0.409 . . . . 2.62 111.188 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.66 -23.58 56.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.132 -0.485 . . . . 1.06 111.73 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 55.8 mtt-85 -96.16 -47.96 5.84 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.365 0.505 . . . . 1.47 112.365 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.3 101.05 0.6 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.623 -0.799 . . . . 0.92 112.398 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -97.76 142.08 15.94 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.816 -0.707 . . . . 0.92 112.291 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -123.33 128.69 50.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.384 -0.228 . . . . 2.24 110.384 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -69.56 132.61 46.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.767 0.318 . . . . 2.99 111.005 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 93.7 mt -100.29 -69.52 0.77 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.76 111.338 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -142.4 -176.36 4.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.146 -0.479 . . . . 1.07 110.259 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -125.9 118.0 24.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.79 0.329 . . . . 2.71 111.291 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 2.5 p -80.11 131.36 63.09 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 1.45 110.503 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -50.2 145.47 20.32 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.239 2.626 . . . . 1.03 112.312 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -58.49 -27.51 64.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 2.14 112.504 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.32 -38.81 84.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.193 0.52 . . . . 2.06 110.352 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 19.8 mm -86.05 -33.65 7.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.804 -0.635 . . . . 1.33 109.72 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 11.5 tpt -63.01 -33.22 74.95 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.201 0.524 . . . . 2.34 110.225 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -61.13 -38.47 86.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.499 -0.773 . . . . 2.09 110.188 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -60.18 -41.17 92.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.916 -0.584 . . . . 1.76 110.684 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 34.2 t -60.44 -46.87 94.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.978 -0.555 . . . . 1.01 109.963 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 71.2 mt -62.49 -36.3 82.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.97 -0.559 . . . . 1.29 110.274 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.08 -43.49 97.2 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.6 -0.727 . . . . 1.02 111.801 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -66.23 -32.21 73.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.055 0.455 . . . . 2.34 110.451 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 79.8 mt -71.18 -13.85 62.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.976 -0.556 . . . . 1.94 111.232 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 10.8 m -84.04 -24.44 30.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.122 0.487 . . . . 1.16 110.395 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.33 -29.18 63.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 1.85 111.571 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 49.8 pt -80.39 -3.58 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.727 0.299 . . . . 1.98 111.657 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 96.4 mt -86.04 12.8 8.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.197 0.523 . . . . 1.36 110.669 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.246 0.901 0 N-CA-C 109.301 -0.629 . . . . 2.71 109.301 179.766 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 ptp . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.901 0.382 . . . . 1.45 110.779 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.444 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 43.8 mt-10 -123.16 -173.63 2.76 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.685 -0.689 . . . . 2.01 110.376 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -89.16 133.39 34.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.996 -0.547 . . . . 2.16 110.898 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.23 13.88 52.95 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.791 -0.719 . . . . 0.87 112.997 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 83.3 mt-10 -98.67 153.21 18.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.717 0.294 . . . . 0.99 110.571 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pt -118.46 110.17 29.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.134 -0.485 . . . . 1.16 109.917 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -102.53 122.47 44.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.885 -0.598 . . . . 0.91 110.831 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.8 tp -82.7 131.89 35.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.116 -0.493 . . . . 0.9 111.364 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.4 p -172.59 159.65 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.201 -0.454 . . . . 1.04 110.245 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.7 m -82.74 141.47 32.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.616 0.246 . . . . 1.32 110.767 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.3 mt -95.32 -11.44 27.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.113 0.482 . . . . 1.29 110.86 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.49 174.46 5.1 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.707 -0.679 . . . . 1.54 110.95 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -73.12 142.47 74.87 Favored 'Cis proline' 0 C--N 1.354 0.851 0 C-N-CA 124.609 -0.996 . . . . 1.69 112.386 -0.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.7 p -122.44 175.55 6.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 1.53 110.993 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.01 103.49 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 1.7 110.319 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.59 -151.84 18.13 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.838 -0.696 . . . . 1.18 111.658 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -105.98 37.15 2.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.531 0.682 . . . . 3.12 110.374 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -79.86 -170.37 2.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.615 . . . . 1.14 109.691 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -77.06 87.11 3.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.271 0.557 . . . . 2.09 110.678 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -107.07 172.9 6.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.238 -0.892 . . . . 2.44 111.289 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.3 177.61 28.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.977 -0.63 . . . . 1.07 113.74 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.3 m -114.12 129.49 56.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.623 -0.51 . . . . 1.46 109.623 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.78 160.44 11.48 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.142 -0.318 . . . . 2.01 110.142 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -73.5 135.6 22.4 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.302 2.001 . . . . 1.01 110.869 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.7 m -108.38 136.39 44.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.219 -0.446 . . . . 0.76 110.28 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.8 tp -86.6 125.67 33.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.363 -0.381 . . . . 0.7 111.045 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.1 mm -74.83 117.24 18.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.318 -0.401 . . . . 0.92 110.371 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -92.16 -37.8 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.057 -0.52 . . . . 0.95 111.236 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.75 150.96 82.18 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.619 0.6 . . . . 1.12 112.619 -179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.88 158.71 42.47 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.75 2.3 . . . . 1.3 111.934 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.57 -39.85 65.13 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.563 0.579 . . . . 1.39 112.563 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.92 99.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.356 . . . . 1.61 111.196 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -69.17 -40.93 77.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.014 -0.539 . . . . 1.77 110.419 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -64.36 -26.13 68.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 1.48 110.773 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -78.26 -25.46 46.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.986 -0.552 . . . . 3.04 111.873 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -96.34 -43.88 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.535 0.569 . . . . 1.86 112.535 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 m -81.28 -25.74 36.3 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.87 0.322 . . . . 2.06 111.87 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 71.69 -2.8 2.35 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.039 0.536 . . . . 4.87 112.217 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 mt -131.33 114.47 15.96 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.379 -0.6 . . . . 1.81 109.379 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -89.14 131.56 2.17 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.802 2.335 . . . . 1.05 113.137 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.78 121.09 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.873 -1.158 . . . . 1.03 107.873 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.4 m -128.24 153.2 37.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 113.485 0.92 . . . . 0.79 113.485 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -114.27 131.1 23.42 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 114.685 -1.143 . . . . 0.72 108.788 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.83 114.1 3.95 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.793 2.329 . . . . 1.03 113.973 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.3 t -79.72 99.54 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.089 -0.708 . . . . 1.28 109.089 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 116.422 -0.354 . . . . 2.5 111.394 -178.641 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.418 -0.273 . . . . 1.69 112.418 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -95.1 -8.38 36.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.907 0.384 . . . . 1.56 110.956 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.56 142.85 32.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.208 -0.664 . . . . 1.25 109.208 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.4 m -94.82 156.14 3.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.174 0.511 . . . . 1.68 112.133 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.26 106.05 17.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.573 -0.74 . . . . 2.25 111.394 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.1 mt -91.51 -32.13 15.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.179 0.514 . . . . 1.35 110.751 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -75.19 112.37 11.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.072 -0.513 . . . . 2.21 110.628 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.46 -23.01 0.75 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.599 -0.6 . . . . 1.18 111.599 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.7 m -100.99 1.84 10.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 111.82 0.304 . . . . 1.21 111.82 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.59 47.41 34.4 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.958 -0.639 . . . . 1.08 113.147 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pp -84.79 173.71 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.673 0.273 . . . . 1.07 111.348 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.2 ttm105 -98.54 -55.66 2.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.556 -0.293 . . . . 4.33 110.739 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.0 m -62.01 101.62 0.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.187 0.518 . . . . 1.51 110.822 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.73 83.27 5.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.86 -0.609 . . . . 1.79 111.339 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -143.1 158.25 27.15 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.783 -0.722 . . . . 1.18 111.674 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.3 t -105.82 107.11 21.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.954 -0.388 . . . . 1.56 109.954 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.44 116.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.39 . . . . 1.29 110.628 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -102.78 119.34 38.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.084 -0.507 . . . . 2.85 111.686 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.8 m -103.52 5.88 37.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.429 0.633 . . . . 1.47 109.515 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.59 -33.79 31.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.454 -0.794 . . . . 0.89 111.574 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -130.38 64.02 71.41 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.677 -0.238 . . . . 2.65 110.951 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.56 164.85 20.88 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.092 1.861 . . . . 0.8 112.237 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -166.7 118.02 0.95 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 2.42 110.999 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 78.3 m -72.72 109.66 6.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.383 -0.371 . . . . 1.79 110.295 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.0 pt -103.08 165.95 2.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.704 -0.68 . . . . 1.15 111.225 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -82.78 136.99 34.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.644 -0.707 . . . . 1.03 109.896 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 27.6 tpp -111.46 1.59 17.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.273 -0.421 . . . . 1.29 111.216 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -91.28 -56.42 3.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.564 -0.289 . . . . 3.09 111.768 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.84 -29.98 44.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.378 . . . . 1.12 111.14 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 72.3 mtt-85 -76.35 -39.74 53.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.31 -0.405 . . . . 1.17 110.8 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.29 82.19 0.15 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.952 -0.642 . . . . 1.12 112.914 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -81.93 168.0 48.55 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.807 -0.711 . . . . 1.16 112.848 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -121.53 121.94 38.59 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.18 -0.304 . . . . 2.87 110.18 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.38 120.66 23.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.82 0.343 . . . . 2.93 111.194 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -86.71 -67.17 0.83 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.139 -0.482 . . . . 1.29 110.511 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -153.57 -174.05 4.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.946 -0.57 . . . . 1.15 109.58 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -130.58 140.15 50.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.056 0.455 . . . . 1.57 110.355 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.0 m -94.15 152.03 40.03 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.865 -0.607 . . . . 0.75 110.801 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.38 162.57 17.09 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.889 2.393 . . . . 0.95 111.947 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -62.86 -24.23 67.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 1.51 111.066 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.66 -35.46 80.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 1.62 110.702 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.4 mm -69.95 -31.02 46.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.397 -0.594 . . . . 1.31 109.397 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.7 tpt -64.89 -34.16 77.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.721 -0.672 . . . . 1.6 109.641 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -63.12 -40.39 97.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.675 -0.693 . . . . 2.52 109.404 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -58.66 -49.35 77.86 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.543 -0.753 . . . . 1.64 109.857 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.9 t -62.29 -49.11 85.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.573 -0.74 . . . . 1.03 110.901 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.5 mt -56.74 -43.31 80.57 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.271 -0.422 . . . . 1.22 111.194 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.36 -40.85 98.08 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.115 -0.564 . . . . 1.03 112.524 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -71.05 -43.07 68.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.896 0.379 . . . . 2.16 110.914 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.89 -31.4 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 1.02 111.676 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.1 m -69.03 -16.51 63.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.409 -0.359 . . . . 1.11 111.521 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.4 m -93.85 -24.45 17.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.693 0.257 . . . . 1.95 111.693 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.7 pt -84.06 -20.9 8.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 112.08 0.4 . . . . 1.15 112.08 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 97.3 mt -77.01 79.23 3.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.013 0.435 . . . . 0.98 111.603 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.929 -0.578 . . . . 1.35 110.364 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.288 0 N-CA-C 112.756 0.65 . . . . 2.03 112.756 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -71.13 -22.42 62.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.629 -0.714 . . . . 2.82 110.848 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? 78.82 123.73 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.951 0.722 . . . . 2.66 112.951 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.09 49.22 6.07 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.478 -0.783 . . . . 1.28 113.683 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -125.37 90.38 3.21 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.473 0.546 . . . . 1.53 112.473 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 64.0 mt -99.86 104.39 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.184 -1.043 . . . . 0.75 108.184 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -103.79 166.49 10.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.925 -0.579 . . . . 0.82 111.59 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 55.4 tp -118.39 112.34 19.87 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.196 -0.668 . . . . 1.05 109.196 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 p -136.61 156.17 35.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.301 -0.409 . . . . 0.72 110.362 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 5.8 t -90.28 127.22 36.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.402 -0.592 . . . . 1.68 109.402 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 20.5 mt -94.67 -25.88 16.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.192 0.52 . . . . 0.83 110.49 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.83 147.24 98.86 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.754 . . . . 1.62 110.85 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.513 ' C ' ' HG1' ' B' ' 14' ' ' THR . 10.1 Cg_endo -87.97 160.66 45.16 Favored 'Cis proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.601 -1.416 . . . . 1.28 111.978 0.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.513 ' HG1' ' C ' ' B' ' 13' ' ' PRO . 14.0 m -156.74 124.74 5.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.377 -0.374 . . . . 1.7 110.219 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.78 164.75 14.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.388 -0.369 . . . . 1.22 110.802 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.06 -164.33 35.23 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.795 -0.717 . . . . 1.01 112.511 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -99.23 31.34 3.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.871 0.367 . . . . 2.62 110.641 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.38 -167.7 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 1.28 111.206 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -98.85 101.21 12.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.32 -0.4 . . . . 1.98 110.832 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -102.59 -178.47 3.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.129 -0.487 . . . . 1.86 110.148 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.53 130.64 5.33 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.89 -0.671 . . . . 0.9 112.363 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 56.4 m -76.68 94.74 3.84 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.423 -0.584 . . . . 1.11 109.423 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.3 165.96 32.85 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.498 -0.774 . . . . 2.0 110.19 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.79 145.54 82.71 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.714 2.276 . . . . 0.65 112.016 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 10.5 m -135.47 145.92 30.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.898 -0.592 . . . . 0.57 111.138 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 48.2 tp -103.62 125.96 50.46 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.009 -0.541 . . . . 1.17 109.573 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 23.5 mt -78.47 140.75 16.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.58 0.228 . . . . 0.66 111.148 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.85 -31.95 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.9 0.381 . . . . 0.93 111.621 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.42 130.15 91.04 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.502 -0.317 . . . . 1.1 111.728 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.74 162.29 41.58 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.013 2.475 . . . . 0.78 112.725 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.54 -31.2 63.93 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.79 -0.641 . . . . 1.03 112.614 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.43 -18.56 40.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 1.4 112.077 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -122.4 -33.04 3.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.994 0.426 . . . . 1.57 110.187 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -56.12 -41.49 75.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.52 -0.764 . . . . 1.92 111.781 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -85.73 6.1 29.32 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.804 0.668 . . . . 2.93 112.804 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.05 -65.39 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.173 0.511 . . . . 1.09 110.354 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 13.2 p -81.35 -23.83 37.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.868 -0.606 . . . . 1.64 110.834 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 67.33 16.93 10.16 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.632 -0.713 . . . . 2.01 111.432 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 13.3 mt -128.18 94.71 35.56 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.19 -1.041 . . . . 1.16 108.19 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -91.54 159.66 3.59 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.582 2.188 . . . . 0.57 113.585 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 15.2 m -94.37 131.92 39.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.236 -1.024 . . . . 1.08 108.236 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.0 153.18 29.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 113.066 0.765 . . . . 0.64 113.066 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 42.7 t -106.63 114.2 62.16 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 114.647 -1.16 . . . . 1.1 108.411 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.62 123.39 10.71 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.69 2.26 . . . . 0.73 112.555 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 48.9 t -77.65 123.38 34.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.348 -0.612 . . . . 0.9 109.348 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.75 102.49 15.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.311 -0.404 . . . . 1.24 110.44 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 116.066 -0.516 . . . . 2.43 110.573 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.734 0.302 . . . . 1.96 111.47 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.22 -73.46 1.78 Allowed Glycine 0 CA--C 1.516 0.149 0 C-N-CA 121.005 -0.617 . . . . 1.14 112.831 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -88.18 -11.08 47.84 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.195 0.521 . . . . 3.57 110.924 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.98 116.81 30.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.975 -0.557 . . . . 1.08 110.211 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 49.5 t -90.71 135.04 27.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.295 -0.411 . . . . 1.34 110.102 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 19.0 t -87.7 138.5 31.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.965 0.412 . . . . 1.71 111.23 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 69.0 mt -101.63 5.34 41.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.05 -0.722 . . . . 1.02 109.05 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.09 157.41 18.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.07 -0.968 . . . . 1.79 110.638 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.51 -62.94 0.3 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.702 -0.761 . . . . 1.15 112.92 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.96 -31.72 51.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.865 0.364 . . . . 1.17 111.95 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.12 79.75 1.15 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.554 -0.831 . . . . 1.05 113.067 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 45.9 mt -123.71 152.79 29.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.737 -0.838 . . . . 1.61 108.737 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -63.48 -48.69 76.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.625 0.25 . . . . 2.65 111.433 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 12.1 m -78.83 99.87 6.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.237 0.541 . . . . 0.93 111.685 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.8 88.61 6.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.718 -0.674 . . . . 1.62 110.751 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -163.16 -170.64 28.34 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.298 -0.953 . . . . 0.79 112.669 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.5 m -124.67 136.92 59.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.849 0.357 . . . . 0.93 110.333 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 16.1 m -86.55 133.23 30.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.313 -0.403 . . . . 1.38 111.404 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -88.75 85.74 6.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.565 -0.531 . . . . 1.52 109.565 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 1.1 m -65.68 -15.26 62.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.355 0.598 . . . . 1.55 111.116 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.28 -12.74 51.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.501 -0.772 . . . . 1.1 111.12 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -126.38 66.23 61.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 114.233 1.197 . . . . 2.83 114.233 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.76 142.43 15.95 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.786 1.657 . . . . 0.96 109.159 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -138.36 144.01 40.11 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.747 -0.381 . . . . 2.32 111.882 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.76 140.38 33.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.788 -0.642 . . . . 1.21 109.714 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.96 157.8 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.935 0.397 . . . . 1.28 111.426 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -85.39 110.82 19.4 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.813 -0.81 . . . . 1.28 108.813 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 13.7 ttp -78.62 -3.52 44.32 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.44 0.904 . . . . 2.7 113.44 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 10.3 pttt -117.63 -45.08 2.71 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.002 0.742 . . . . 2.62 113.002 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.37 -38.75 41.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.793 0.33 . . . . 1.06 111.67 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -79.89 -25.28 40.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.525 -0.307 . . . . 1.47 111.055 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.84 132.02 1.74 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.661 -0.78 . . . . 0.92 111.849 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.39 148.15 14.42 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.157 -1.02 . . . . 0.92 113.16 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -146.49 157.43 43.75 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.786 -0.45 . . . . 2.24 109.786 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -82.45 126.0 31.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.696 0.284 . . . . 2.99 110.601 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 50.4 mt -89.68 -51.43 5.52 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 0.76 110.7 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -150.16 170.55 18.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.968 -0.56 . . . . 1.07 111.812 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -115.5 115.27 26.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.742 -0.663 . . . . 2.71 110.361 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 11.9 p -74.08 134.5 77.53 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.966 -0.561 . . . . 1.45 110.629 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.03 148.3 48.77 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.822 2.348 . . . . 1.03 112.195 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -55.39 -34.05 64.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.805 -0.634 . . . . 2.14 111.601 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.87 -49.03 79.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.219 0.533 . . . . 2.06 110.942 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 21.1 mm -74.19 -39.88 50.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.878 -0.601 . . . . 1.33 110.491 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 8.3 tpt -58.54 -42.36 87.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.985 0.421 . . . . 2.34 110.545 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -63.5 -35.36 80.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.939 -0.573 . . . . 2.09 110.478 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -62.82 -42.46 99.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.023 -0.535 . . . . 1.76 110.388 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 39.9 t -61.53 -45.14 99.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.976 -0.556 . . . . 1.01 110.525 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.46 -38.41 87.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.017 -0.538 . . . . 1.29 110.586 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.14 -42.86 94.19 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.692 -0.686 . . . . 1.02 111.579 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -69.33 -29.5 67.34 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.806 0.336 . . . . 2.34 110.72 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 11.3 mt -66.64 -23.17 66.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 1.94 110.535 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 24.2 m -82.76 -8.61 59.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.347 -0.388 . . . . 1.16 111.767 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.84 -15.87 61.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 1.85 111.778 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 37.2 pt -88.18 -1.11 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.807 0.337 . . . . 1.98 111.111 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 58.8 mt -87.42 -4.94 59.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.034 -0.53 . . . . 1.36 111.048 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.687 -0.673 . . . . 2.71 109.81 179.618 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptp . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.89 0.376 . . . . 1.45 110.783 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -123.22 168.12 12.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.886 -0.597 . . . . 2.01 110.828 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -63.52 128.73 37.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.973 -0.558 . . . . 2.16 110.642 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.74 -20.84 17.25 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.756 -0.735 . . . . 0.87 113.112 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -83.49 145.49 28.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.794 0.297 . . . . 0.99 111.309 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.2 pt -112.91 130.49 66.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.879 0.371 . . . . 1.16 110.746 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.4 m95 -116.22 117.58 30.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.152 -0.476 . . . . 0.91 111.098 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.7 tp -76.07 113.44 13.59 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.791 -0.448 . . . . 0.9 109.791 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 p -150.66 159.92 4.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.61 -0.268 . . . . 1.04 110.738 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 t -97.25 132.4 43.04 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.499 -0.556 . . . . 1.32 109.499 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.4 mt -86.29 -11.65 51.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.403 -0.362 . . . . 1.29 111.509 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.18 164.59 17.44 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.803 -0.635 . . . . 1.54 112.649 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -83.34 111.63 2.28 Favored 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 123.553 -1.436 . . . . 1.69 112.572 0.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.49 150.49 26.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.106 -0.497 . . . . 1.53 111.298 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -130.02 167.21 18.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.002 -0.545 . . . . 1.7 110.533 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.8 -150.55 48.05 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.893 -0.883 . . . . 1.18 110.893 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -85.62 4.14 37.62 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.093 0.446 . . . . 3.12 111.338 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -65.33 134.38 53.45 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.134 -0.321 . . . . 1.14 110.134 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -54.77 124.45 16.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.951 -0.568 . . . . 2.09 112.098 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.85 -178.81 4.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.722 -0.672 . . . . 2.44 110.195 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.26 164.52 39.32 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.861 -0.685 . . . . 1.07 113.917 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 m -91.96 124.76 36.31 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.078 -0.712 . . . . 1.46 109.078 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.88 158.06 26.4 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 110.466 -0.198 . . . . 2.01 110.466 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.86 121.04 5.69 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.957 1.771 . . . . 1.01 111.335 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.4 m -95.59 131.07 43.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.082 -0.508 . . . . 0.76 110.532 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.8 tp -87.91 122.64 31.78 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.788 -0.642 . . . . 0.7 110.825 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.0 mm -71.11 111.45 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.794 -0.446 . . . . 0.92 109.794 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -92.32 -37.12 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.275 -0.42 . . . . 0.95 111.724 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.85 148.85 82.5 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 111.719 0.266 . . . . 1.12 111.719 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.69 161.2 45.94 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.598 2.199 . . . . 1.3 111.879 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.11 -35.79 74.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.026 -0.534 . . . . 1.39 111.567 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.64 -43.56 89.81 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.241 -0.436 . . . . 1.61 111.672 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -71.94 -48.39 45.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.889 -0.596 . . . . 1.77 110.786 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -59.25 -32.68 70.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.024 -0.534 . . . . 1.48 111.123 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -64.85 -30.08 71.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.852 -0.613 . . . . 3.04 112.136 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 p -96.32 -47.28 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 113.575 0.954 . . . . 1.86 113.575 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.1 p -78.34 -28.61 47.26 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.72 0.637 . . . . 2.06 112.72 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 74.04 -1.09 3.17 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.585 0.553 . . . . 4.87 111.567 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.9 mt -126.05 107.3 25.02 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.317 -0.624 . . . . 1.81 109.317 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -89.09 139.78 3.76 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.73 2.287 . . . . 1.05 113.018 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.8 t -79.79 113.66 19.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.015 -1.476 . . . . 1.03 107.015 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.46 165.33 19.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 112.711 0.634 . . . . 0.79 112.711 -177.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.54 125.92 24.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.711 -1.131 . . . . 0.72 108.797 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.42 131.59 8.6 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.691 2.26 . . . . 1.03 113.667 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.1 t -78.77 128.63 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.942 -0.762 . . . . 1.28 108.942 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 C--N 1.325 -0.46 0 C-N-CA 121.217 -0.193 . . . . 2.5 111.388 -179.287 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.753 0 N-CA-C 111.43 -0.668 . . . . 1.69 111.43 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -103.37 15.12 29.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.178 0.513 . . . . 1.56 110.995 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.44 153.5 19.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.741 -0.663 . . . . 1.25 109.439 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.13 163.11 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.874 0.369 . . . . 1.68 111.755 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.9 m -82.53 133.74 35.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.794 -0.639 . . . . 2.25 110.78 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 18.3 mt -103.48 -32.15 9.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.191 0.52 . . . . 1.35 110.775 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.78 97.9 1.87 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.369 0.604 . . . . 2.21 110.814 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.82 -8.29 4.87 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.803 -0.713 . . . . 1.18 112.605 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.5 m -94.33 -1.9 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.851 0.325 . . . . 1.21 111.701 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.08 54.44 5.25 Favored Glycine 0 C--O 1.236 0.228 0 C-N-CA 121.16 -0.543 . . . . 1.08 113.937 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.6 pt -129.67 171.92 16.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 122.823 -0.222 . . . . 1.07 110.666 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -104.82 -23.74 12.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.895 -0.409 . . . . 4.33 109.895 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.1 m -52.74 107.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.468 -0.787 . . . . 1.51 111.378 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.73 90.71 8.34 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.589 -0.732 . . . . 1.79 111.126 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.71 -151.47 10.43 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.941 -0.864 . . . . 1.18 110.941 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.83 131.13 37.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.986 0.422 . . . . 1.56 110.797 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.1 t -97.96 142.88 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.27 -0.423 . . . . 1.29 109.922 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.39 163.9 37.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.381 -0.372 . . . . 2.85 110.311 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.32 13.94 20.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.757 0.313 . . . . 1.47 111.383 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -86.95 -3.18 59.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 0.89 112.075 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -129.96 64.65 72.99 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.758 -0.201 . . . . 2.65 111.42 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -94.82 131.49 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.619 2.213 . . . . 0.8 113.003 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -161.43 154.91 21.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.951 0.405 . . . . 2.42 111.594 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.85 130.02 36.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.186 -0.672 . . . . 1.79 109.186 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.7 pt -131.1 157.28 43.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.961 0.41 . . . . 1.15 111.111 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -87.84 133.19 33.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.854 -0.612 . . . . 1.03 110.596 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 43.7 tpp -120.09 21.76 11.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.128 -0.487 . . . . 1.29 110.286 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -107.31 -38.58 5.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.096 -0.502 . . . . 3.09 110.794 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.71 -26.18 15.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.994 -0.548 . . . . 1.12 111.203 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -76.47 -59.76 2.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.852 0.358 . . . . 1.17 111.154 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.29 89.7 1.39 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.84 -0.695 . . . . 1.12 111.478 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -95.97 172.29 29.42 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.666 -0.778 . . . . 1.16 112.561 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -121.36 109.39 14.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.764 -0.458 . . . . 2.87 109.764 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.16 128.18 34.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.501 0.191 . . . . 2.93 110.795 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.56 -89.04 0.37 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.589 -0.278 . . . . 1.29 110.881 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -122.09 -172.78 2.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.51 -0.314 . . . . 1.15 110.409 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -140.57 133.88 29.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.94 0.4 . . . . 1.57 110.449 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.42 155.21 66.25 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.113 -0.494 . . . . 0.75 111.411 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.54 149.38 89.98 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.47 2.114 . . . . 0.95 111.941 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -60.77 -23.21 64.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.892 -0.595 . . . . 1.51 111.488 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -38.07 89.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.243 -0.435 . . . . 1.62 109.851 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.7 mm -71.6 -37.92 65.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.916 -0.584 . . . . 1.31 109.5 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 84.6 mmm -62.06 -36.9 83.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.616 -0.72 . . . . 1.6 110.234 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -62.52 -35.98 81.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.752 -0.658 . . . . 2.52 110.548 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -63.84 -46.63 84.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.5 -0.556 . . . . 1.64 109.5 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.73 -47.27 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.688 -0.687 . . . . 1.03 110.446 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.3 mt -61.86 -33.84 74.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 1.22 111.121 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.95 -17.57 75.55 Favored Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.904 -0.589 . . . . 1.03 113.091 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -97.86 -24.98 15.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.973 0.416 . . . . 2.16 110.786 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 90.6 mt -68.42 -25.45 65.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.139 -0.482 . . . . 1.02 111.398 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -16.53 64.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.835 0.35 . . . . 1.11 111.568 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.76 -16.5 32.02 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.193 0.442 . . . . 1.95 112.193 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.3 pt -91.9 -9.34 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.641 0.608 . . . . 1.15 112.641 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.7 mt -87.73 82.91 7.24 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.915 -0.402 . . . . 0.98 109.915 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 N-CA-C 113.006 0.743 . . . . 1.35 113.006 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.326 0 N-CA-C 109.61 -0.515 . . . . 2.03 109.61 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -77.97 -5.42 51.19 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.719 -0.474 . . . . 2.82 109.719 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 60.69 80.19 0.22 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.099 -0.955 . . . . 2.66 112.968 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.69 -32.69 2.35 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.092 -1.052 . . . . 1.28 113.826 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -64.63 109.62 2.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.062 0.458 . . . . 1.53 112.169 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 51.4 mt -98.8 130.7 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.371 -0.603 . . . . 0.75 109.371 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -115.44 178.32 4.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.037 0.446 . . . . 0.82 111.316 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 tt -146.22 133.7 20.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.086 -0.506 . . . . 1.05 110.032 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -167.16 164.75 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.504 -0.316 . . . . 0.72 110.182 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 6.0 t -88.83 140.56 29.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.636 0.255 . . . . 1.68 110.661 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 32.1 mt -96.45 -12.25 24.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.369 0.604 . . . . 0.83 110.15 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.97 153.59 84.77 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.507 -0.769 . . . . 1.62 110.083 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.584 ' C ' ' HG1' ' B' ' 14' ' ' THR . 86.6 Cg_endo -96.23 161.73 14.48 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.823 -1.324 . . . . 1.28 112.154 -0.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.584 ' HG1' ' C ' ' B' ' 13' ' ' PRO . 0.2 OUTLIER -157.93 -164.65 1.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.172 -0.677 . . . . 1.7 109.172 179.108 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.41 161.57 40.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.075 -0.342 . . . . 1.22 110.075 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.47 -143.23 25.66 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.891 -0.671 . . . . 1.01 112.244 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -92.83 2.05 56.97 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.875 0.324 . . . . 2.62 111.875 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.44 136.0 57.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.648 0.261 . . . . 1.28 110.758 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -60.31 128.33 36.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 1.98 112.097 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -129.55 -167.37 1.79 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.466 -0.788 . . . . 1.86 110.874 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.22 175.7 50.89 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.962 -0.563 . . . . 0.9 112.765 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 18.4 m -111.0 108.79 18.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.01 0.433 . . . . 1.11 110.591 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.48 164.81 20.1 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.004 -0.544 . . . . 2.0 109.764 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.08 147.28 91.1 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.406 2.071 . . . . 0.65 111.078 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 9.8 m -134.99 137.2 50.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.138 0.494 . . . . 0.57 111.753 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 33.5 tp -101.83 129.13 47.98 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.186 -0.672 . . . . 1.17 109.186 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 55.3 mt -89.22 133.65 30.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.605 0.24 . . . . 0.66 110.369 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.5 -34.84 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.379 -0.373 . . . . 0.93 111.913 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.54 138.99 93.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 111.956 0.354 . . . . 1.1 111.956 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.34 162.26 41.26 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.003 2.469 . . . . 0.78 113.02 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.06 67.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.536 -0.756 . . . . 1.03 112.208 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.07 -46.18 79.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.035 0.445 . . . . 1.4 110.961 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -66.05 -48.13 72.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.031 -0.531 . . . . 1.57 110.599 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -61.16 -26.88 68.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 1.92 111.937 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -82.52 -33.98 28.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.484 -0.325 . . . . 2.93 111.262 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 89.0 t -82.99 -55.75 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.372 0.508 . . . . 1.09 112.372 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 58.0 p -74.43 -27.81 60.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.7 0.286 . . . . 1.64 111.33 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? 62.84 26.22 15.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.897 -0.592 . . . . 2.01 110.061 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 30.4 mt -145.67 96.67 4.73 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.115 -0.948 . . . . 1.16 109.57 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -87.43 146.99 7.4 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.861 2.374 . . . . 0.57 112.711 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 4.9 m -85.52 110.68 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.327 -0.62 . . . . 1.08 109.327 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 34.6 m -95.73 138.26 21.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.9 -0.591 . . . . 0.64 112.035 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 41.2 t -107.52 116.38 57.84 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.022 -0.99 . . . . 1.1 108.91 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -67.85 124.62 12.09 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.984 2.456 . . . . 0.73 114.221 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -95.24 142.07 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.588 -0.893 . . . . 0.9 108.588 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -112.63 100.56 8.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.951 0.405 . . . . 1.24 111.181 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.774 -0.648 . . . . 2.43 110.722 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.946 0.403 . . . . 1.96 110.988 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.34 -77.09 0.74 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.745 -0.661 . . . . 1.14 112.869 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -104.4 -14.42 15.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.512 0.196 . . . . 3.57 111.153 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.87 95.96 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.419 -0.355 . . . . 1.08 110.566 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 45.0 t -85.14 125.19 40.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.11 -0.496 . . . . 1.34 111.173 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.01 126.41 31.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.147 -0.479 . . . . 1.71 110.993 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 75.9 mt -96.01 87.63 4.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 1.02 111.461 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -161.95 179.21 8.2 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.704 -0.48 . . . . 1.79 109.704 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.22 -42.47 3.16 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 121.242 -0.504 . . . . 1.15 112.452 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 14.2 p -80.18 -27.28 11.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.091 0.472 . . . . 1.17 111.111 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.65 89.51 1.07 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.717 -0.754 . . . . 1.05 112.62 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 4.9 pt -141.28 177.39 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.925 -0.769 . . . . 1.61 108.925 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -83.13 -53.49 5.75 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.982 0.42 . . . . 2.65 110.307 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 7.2 m -64.89 112.53 3.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.889 -0.596 . . . . 0.93 109.743 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.4 131.58 53.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.888 0.375 . . . . 1.62 111.438 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.89 -174.42 32.41 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.941 -0.647 . . . . 0.79 111.899 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 m -102.7 124.04 56.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.045 0.45 . . . . 0.93 111.437 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.0 t -86.53 118.35 32.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.801 -0.636 . . . . 1.38 110.661 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' B' ' 75' ' ' ASP . 9.3 mmm180 -87.3 83.9 7.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.937 0.399 . . . . 1.52 110.315 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 2.5 m -71.17 22.97 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.233 0.827 . . . . 1.55 113.233 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' B' ' 73' ' ' ARG . 13.3 p-10 -112.64 -4.16 14.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.661 0.267 . . . . 1.1 110.701 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -121.26 86.22 42.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 112.497 0.554 . . . . 2.83 112.497 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -92.8 104.38 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.88 2.387 . . . . 0.96 110.588 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -111.37 125.81 54.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.938 0.399 . . . . 2.32 111.949 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.04 114.11 21.5 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.427 -0.583 . . . . 1.21 109.427 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 45.0 pt -133.8 171.79 17.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.008 0.432 . . . . 1.28 111.023 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -77.47 141.87 39.46 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.643 -0.708 . . . . 1.28 109.678 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 49.0 tpp -115.19 -18.02 11.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.996 0.426 . . . . 2.7 111.472 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -92.11 -42.9 9.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.373 -0.376 . . . . 2.62 111.617 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.38 -25.43 33.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.103 0.478 . . . . 1.06 111.391 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -81.4 -13.99 57.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.263 -0.426 . . . . 1.47 111.411 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.71 43.49 35.56 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.862 -0.685 . . . . 0.92 112.628 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.33 144.77 48.97 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.049 -0.596 . . . . 0.92 112.426 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.35 146.73 51.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.455 -0.202 . . . . 2.24 110.455 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -91.71 134.18 34.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.276 -0.42 . . . . 2.99 110.108 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 94.9 mt -89.97 -63.84 1.22 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.438 -0.346 . . . . 0.76 111.598 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -161.32 -173.84 4.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.55 -0.296 . . . . 1.07 110.387 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 43.2 ttt85 -121.04 115.67 23.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.391 -0.368 . . . . 2.71 110.705 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.03 136.69 72.91 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.939 -0.573 . . . . 1.45 109.61 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -47.92 144.58 11.53 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.071 2.514 . . . . 1.03 112.922 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -33.32 68.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.66 -0.7 . . . . 2.14 111.96 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -26.84 68.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.122 0.487 . . . . 2.06 111.128 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 30.0 mm -89.34 -37.03 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 1.33 109.647 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 18.3 tpt -65.74 -30.34 70.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 2.34 110.564 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -59.08 -34.14 71.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.794 -0.639 . . . . 2.09 110.221 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.71 -44.48 90.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.939 -0.573 . . . . 1.76 109.687 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 34.9 t -59.55 -44.88 94.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.492 -0.776 . . . . 1.01 110.816 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.3 -40.35 85.93 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.117 0.484 . . . . 1.29 110.596 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.36 -39.13 94.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.934 -0.65 . . . . 1.02 111.886 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -67.55 -36.9 81.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.897 0.379 . . . . 2.34 110.363 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 68.5 mt -65.59 -21.59 66.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.935 -0.575 . . . . 1.94 111.27 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 24.7 m -76.51 -14.32 60.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.008 0.433 . . . . 1.16 111.168 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 3.0 m -93.3 -7.81 43.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.305 -0.407 . . . . 1.85 112.051 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 13.1 pt -81.64 -21.01 10.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.959 0.409 . . . . 1.98 110.866 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 94.6 mt -94.07 47.5 1.21 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 1.36 110.711 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.255 1.372 0 CA-C-O 118.267 -0.873 . . . . 2.71 110.235 -179.618 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptp . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 121.337 0.589 . . . . 1.45 111.149 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -106.73 177.86 4.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.417 -0.81 . . . . 2.01 111.039 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -80.93 124.33 29.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.829 -0.623 . . . . 2.16 109.986 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.73 7.04 42.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.685 -0.769 . . . . 0.87 112.803 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -94.74 151.18 19.47 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.614 -0.345 . . . . 0.99 111.114 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.3 pt -110.35 113.92 45.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.111 0.481 . . . . 1.16 110.191 178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -106.82 118.43 36.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.924 -0.58 . . . . 0.91 111.779 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.2 tp -72.89 104.54 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.954 -0.566 . . . . 0.9 110.47 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -144.63 161.13 14.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.304 -0.407 . . . . 1.04 110.865 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 t -96.96 130.02 44.34 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.887 -0.782 . . . . 1.32 108.887 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.17 4.51 52.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.813 0.34 . . . . 1.29 111.17 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -79.8 162.87 60.99 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.845 -0.616 . . . . 1.54 110.957 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.48 144.58 68.15 Favored 'Cis proline' 0 C--N 1.351 0.7 0 C-N-CA 124.264 -1.14 . . . . 1.69 112.588 0.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 p -109.81 135.94 49.91 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.886 -0.597 . . . . 1.53 112.045 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.64 117.45 31.94 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.044 -0.525 . . . . 1.7 110.2 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.99 -120.99 7.51 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.721 -0.752 . . . . 1.18 112.543 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -109.73 36.52 2.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.734 0.302 . . . . 3.12 111.393 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -68.54 173.68 4.83 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.69 -0.485 . . . . 1.14 109.69 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -71.1 91.36 0.9 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.978 0.418 . . . . 2.09 111.399 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.12 152.74 18.53 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.658 -0.701 . . . . 2.44 111.489 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.04 168.85 16.51 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.957 -0.639 . . . . 1.07 113.234 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.7 m -111.85 112.07 23.47 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.755 -0.461 . . . . 1.46 109.755 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.37 159.97 37.83 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.265 -0.425 . . . . 2.01 110.348 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.34 99.27 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.496 2.13 . . . . 1.01 110.916 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.0 m -80.12 142.28 14.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.232 -0.44 . . . . 0.76 110.345 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.6 tp -84.98 126.02 33.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.252 -0.431 . . . . 0.7 111.17 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.7 mm -78.86 114.98 20.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.382 -0.599 . . . . 0.92 109.382 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.8 t -92.47 -22.85 5.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.935 0.398 . . . . 0.95 111.659 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.87 152.03 68.33 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 111.791 0.293 . . . . 1.12 111.791 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.28 160.86 45.66 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.805 2.337 . . . . 1.3 111.736 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.45 -38.54 66.46 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.608 0.596 . . . . 1.39 112.608 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.55 -44.55 82.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.415 -0.357 . . . . 1.61 111.569 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -60.42 -37.7 81.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.039 0.447 . . . . 1.77 111.055 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 52.5 m-20 -67.49 -9.87 46.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.669 -0.696 . . . . 1.48 111.386 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -112.08 -51.77 2.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.298 -0.41 . . . . 3.04 111.588 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.23 -47.74 86.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.294 0.479 . . . . 1.86 112.294 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -88.62 -29.87 19.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.637 0.256 . . . . 2.06 110.94 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 73.96 -10.74 1.06 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.802 -0.636 . . . . 4.87 111.962 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.3 mt -108.51 99.03 31.1 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.286 -0.415 . . . . 1.81 110.261 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -87.63 135.68 3.61 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.004 2.469 . . . . 1.05 112.785 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.2 t -80.49 113.4 19.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.018 -1.475 . . . . 1.03 107.018 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.1 m -116.91 152.82 18.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 112.909 0.707 . . . . 0.79 112.909 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.2 m -115.94 131.08 23.91 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 114.91 -1.041 . . . . 0.72 108.441 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.46 172.81 13.48 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.753 2.302 . . . . 1.03 114.449 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.3 t -137.43 135.35 46.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.665 -1.152 . . . . 1.28 108.135 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 C--N 1.326 -0.436 0 N-CA-C 111.552 0.204 . . . . 2.5 111.552 -179.528 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.319 0 N-CA-C 112.772 -0.131 . . . . 1.69 112.772 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -103.22 -13.53 16.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.968 0.413 . . . . 1.56 111.022 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.84 109.71 19.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.2 -0.455 . . . . 1.25 109.81 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 m -101.19 139.34 22.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.058 0.456 . . . . 1.68 111.592 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 p -86.78 144.39 27.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.192 -0.458 . . . . 2.25 110.544 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.0 mt -84.88 -8.82 58.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 1.35 110.872 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -67.56 131.64 46.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.821 -0.627 . . . . 2.21 109.928 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.99 -39.28 1.93 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.662 -0.575 . . . . 1.18 111.662 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -93.7 -8.13 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.758 0.313 . . . . 1.21 111.03 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.89 98.26 0.24 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.855 -0.688 . . . . 1.08 112.765 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 13.3 pt -122.26 165.69 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.815 0.34 . . . . 1.07 111.143 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -91.94 -44.1 9.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.093 -0.503 . . . . 4.33 110.398 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.04 -164.1 0.42 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.136 -0.483 . . . . 1.51 112.019 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.5 m -153.0 143.37 22.53 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.18 -0.304 . . . . 1.79 110.18 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.98 166.67 11.77 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.065 -0.588 . . . . 1.18 111.777 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.9 139.73 26.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.558 0.179 . . . . 1.56 110.569 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -72.38 126.84 33.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.752 0.31 . . . . 1.29 110.316 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.8 mmm-85 -104.91 92.62 4.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.078 -0.51 . . . . 2.85 111.63 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.8 m -88.18 4.89 43.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.993 -0.549 . . . . 1.47 110.087 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.15 -14.44 38.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.624 -0.716 . . . . 0.89 111.967 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -129.42 64.24 70.63 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 113.295 0.85 . . . . 2.65 113.295 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.43 134.76 23.15 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.201 1.934 . . . . 0.8 110.035 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 ptm85 -154.74 145.68 22.6 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.109 0.781 . . . . 2.42 113.109 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.41 115.02 26.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.37 -0.832 . . . . 1.79 109.502 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.78 138.85 49.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.995 -0.372 . . . . 1.15 109.995 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.08 118.38 11.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.99 0.424 . . . . 1.03 111.212 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 57.7 tpp -87.47 -13.64 42.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.861 -0.608 . . . . 1.29 111.148 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -71.18 -53.37 14.71 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.162 0.43 . . . . 3.09 112.162 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.17 -25.12 59.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.929 0.395 . . . . 1.12 111.888 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 65.7 mtt-85 -82.35 -48.91 10.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.226 -0.443 . . . . 1.17 111.799 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.74 114.8 0.21 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.623 -0.798 . . . . 1.12 112.474 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -129.61 163.25 22.74 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.812 -0.709 . . . . 1.16 112.189 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -103.92 129.15 51.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.164 -0.31 . . . . 2.87 110.164 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -85.64 115.18 23.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.738 0.304 . . . . 2.93 110.765 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -86.14 -71.84 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.415 -0.357 . . . . 1.29 110.719 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -149.29 -169.32 3.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.137 -0.483 . . . . 1.15 109.724 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -135.04 143.01 46.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.749 0.309 . . . . 1.57 110.444 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.3 m -83.45 153.65 65.45 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.267 -0.424 . . . . 0.75 111.305 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.39 157.94 33.7 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.753 2.302 . . . . 0.95 111.467 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.79 -27.16 67.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.689 0.28 . . . . 1.51 111.621 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.24 -45.97 85.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.282 -0.417 . . . . 1.62 110.575 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.8 mm -66.32 -40.75 87.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.953 -0.567 . . . . 1.31 110.007 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 9.5 tpt -62.29 -38.82 90.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.863 -0.608 . . . . 1.6 110.486 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -64.56 -34.22 77.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.968 -0.56 . . . . 2.52 111.193 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.12 -48.87 74.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.908 -0.587 . . . . 1.64 110.386 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.6 t -59.28 -43.23 89.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.157 -0.474 . . . . 1.03 110.609 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.78 -34.59 78.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.846 -0.616 . . . . 1.22 111.429 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.94 -27.6 66.37 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.245 -0.502 . . . . 1.03 113.077 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -77.04 -33.29 57.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.125 0.488 . . . . 2.16 110.553 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.9 mt -66.19 -30.91 71.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.935 -0.575 . . . . 1.02 111.69 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -27.95 68.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.873 0.368 . . . . 1.11 111.299 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 m -72.85 -31.0 64.44 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.086 0.402 . . . . 1.95 112.086 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.4 pt -86.07 -3.32 8.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.464 0.542 . . . . 1.15 112.464 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.04 69.88 10.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.859 0.362 . . . . 0.98 110.159 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.373 -0.376 . . . . 1.35 111.935 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 121.213 0.53 . . . . 2.03 112.147 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -85.46 9.69 15.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.086 0.47 . . . . 2.82 110.198 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 81.76 58.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.118 -0.946 . . . . 2.66 113.207 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.94 57.64 6.89 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.593 -0.731 . . . . 1.28 114.321 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.46 ' CD ' HH21 ' B' ' 92' ' ' ARG . 5.5 mm-40 -115.98 117.45 30.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.863 0.331 . . . . 1.53 111.674 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 66.6 mt -99.78 120.06 48.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 0.75 109.798 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -114.74 144.77 42.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.428 -0.351 . . . . 0.82 110.693 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 38.0 tp -105.8 117.1 33.16 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.221 -0.445 . . . . 1.05 110.0 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 9.5 p -158.89 167.54 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.72 110.244 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 7.0 m -88.88 137.64 32.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.851 0.358 . . . . 1.68 110.54 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 55.7 mt -85.09 -21.36 29.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.323 -0.399 . . . . 0.83 110.999 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -60.19 153.29 58.25 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.862 -0.608 . . . . 1.62 110.829 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.02 120.64 5.84 Favored 'Cis proline' 0 C--O 1.235 0.341 0 C-N-CA 123.534 -1.444 . . . . 1.28 113.741 0.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.11 146.68 46.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.297 -0.865 . . . . 1.7 108.95 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.07 -177.79 5.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.913 0.387 . . . . 1.22 111.979 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.79 -106.03 0.98 Allowed Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.006 -0.543 . . . . 1.01 113.34 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -115.89 8.49 14.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.845 0.355 . . . . 2.62 110.365 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -71.04 148.92 47.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 1.28 110.132 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -77.73 107.24 10.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.48 -0.327 . . . . 1.98 111.013 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -83.31 164.97 19.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.012 -0.54 . . . . 1.86 111.675 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.72 -169.75 28.84 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.01 -0.615 . . . . 0.9 113.625 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 35.8 m -108.24 119.99 41.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.654 -0.498 . . . . 1.11 109.654 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.63 154.34 48.13 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.192 -0.458 . . . . 2.0 110.487 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -63.28 135.91 52.8 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.46 2.107 . . . . 0.65 110.72 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.85 151.56 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.174 0.512 . . . . 0.57 111.425 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 mp -109.42 122.35 47.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.682 -0.69 . . . . 1.17 109.918 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 43.8 mt -70.08 120.23 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.697 0.284 . . . . 0.66 110.827 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 18.4 t -79.33 -40.93 22.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.051 -0.522 . . . . 0.93 111.519 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.9 146.19 95.07 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.973 -0.558 . . . . 1.1 111.455 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.79 164.16 34.17 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.752 2.302 . . . . 0.78 112.591 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.46 -40.57 71.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.496 -0.775 . . . . 1.03 111.807 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.01 0.84 4.02 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.702 0.63 . . . . 1.4 112.702 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -119.31 -40.9 2.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.208 0.528 . . . . 1.57 109.736 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.17 -32.97 70.38 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.517 -0.765 . . . . 1.92 111.863 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.52 2.84 55.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.132 -0.485 . . . . 2.93 112.261 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 64.2 t -113.27 -46.13 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.924 0.392 . . . . 1.09 110.421 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 10.3 m -87.09 -24.26 24.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.349 0.595 . . . . 1.64 110.1 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.412 ' CA ' ' HE ' ' B' ' 38' ' ' ARG . 0.6 OUTLIER 75.16 -38.1 0.36 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.848 1.055 . . . . 2.01 113.848 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 89.7 mt -99.59 101.84 14.75 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.978 -0.379 . . . . 1.16 109.978 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -94.12 163.69 2.08 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.907 2.404 . . . . 0.57 113.889 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 1.8 m -96.13 138.35 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.782 -0.821 . . . . 1.08 108.782 178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 17.8 m -126.09 150.12 31.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 113.205 0.817 . . . . 0.64 113.205 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 24.4 t -97.62 111.74 59.51 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.022 -0.99 . . . . 1.1 108.835 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.93 127.83 14.17 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.9 2.4 . . . . 0.73 112.722 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 61.8 t -99.98 133.45 42.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.055 -0.521 . . . . 0.9 109.887 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -98.17 92.1 5.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.34 -0.391 . . . . 1.24 110.489 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 116.011 -0.541 . . . . 2.43 110.602 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.891 0.377 . . . . 1.96 110.411 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.64 -88.3 0.36 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.124 -0.56 . . . . 1.14 112.732 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -104.95 -17.06 14.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.969 0.414 . . . . 3.57 110.045 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.64 120.0 25.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.862 -0.608 . . . . 1.08 111.566 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 t -119.8 134.55 62.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.069 -0.715 . . . . 1.34 109.069 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 37.5 p -76.26 135.79 39.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.667 0.27 . . . . 1.71 111.234 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 77.9 mt -89.72 -0.96 57.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.157 0.503 . . . . 1.02 110.626 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.65 148.2 28.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.958 -0.565 . . . . 1.79 111.152 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.4 -38.1 3.47 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.913 -0.66 . . . . 1.15 112.336 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 10.8 p -81.36 -26.28 10.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.749 0.278 . . . . 1.17 111.749 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.05 22.93 3.4 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.435 -0.888 . . . . 1.05 113.362 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 61.4 mt -90.61 138.51 19.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.541 -0.54 . . . . 1.61 109.541 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 28.0 ttt85 -68.31 -42.48 79.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.004 0.43 . . . . 2.65 110.704 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 16.5 m -68.12 97.47 0.7 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.536 -0.756 . . . . 0.93 110.957 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.6 97.61 10.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.923 -0.581 . . . . 1.62 111.432 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.65 -179.75 46.35 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.739 -0.744 . . . . 0.79 111.702 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 m -105.81 136.49 39.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.705 0.288 . . . . 0.93 110.8 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 10.0 m -84.27 137.28 21.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.961 0.41 . . . . 1.38 111.478 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 32.9 mmm-85 -113.32 85.97 2.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.191 -0.459 . . . . 1.52 110.114 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 5.2 m -82.12 6.3 16.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.184 -0.462 . . . . 1.55 111.266 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -87.43 -10.47 51.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.863 -0.608 . . . . 1.1 111.56 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -135.29 78.34 52.13 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 112.896 0.702 . . . . 2.83 112.896 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.89 98.99 0.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.737 2.291 . . . . 0.96 111.729 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -102.64 140.68 36.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.381 -0.372 . . . . 2.32 111.497 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.03 125.74 29.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 1.21 109.67 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 26.8 pt -131.32 -179.7 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.454 -0.339 . . . . 1.28 110.189 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -97.52 139.86 32.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.368 . . . . 1.28 110.867 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 35.6 tpp -126.03 29.74 5.81 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.395 -0.594 . . . . 2.7 109.395 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -121.14 -55.93 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.703 -0.68 . . . . 2.62 111.352 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.53 -33.96 15.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.133 -0.485 . . . . 1.06 110.653 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -63.94 -23.05 67.19 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.863 -0.608 . . . . 1.47 111.428 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.0 90.38 0.83 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.94 -0.648 . . . . 0.92 112.623 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.89 133.13 11.27 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.532 -0.842 . . . . 0.92 112.253 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -139.04 130.29 26.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.6 0.238 . . . . 2.24 110.818 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -83.08 127.93 34.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.471 -0.332 . . . . 2.99 110.268 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 94.3 mt -91.14 -72.62 0.57 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.188 -0.46 . . . . 0.76 111.557 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -133.42 169.93 16.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.094 -0.503 . . . . 1.07 110.722 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.46 HH21 ' CD ' ' B' ' 5' ' ' GLU . 15.2 ttm180 -104.48 141.62 36.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.183 -0.462 . . . . 2.71 110.193 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.1 132.38 50.76 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.906 -0.588 . . . . 1.45 110.68 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.64 155.74 57.06 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.601 2.2 . . . . 1.03 110.758 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.28 -38.92 74.69 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.321 0.489 . . . . 2.14 112.321 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.95 -39.21 88.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.974 0.416 . . . . 2.06 111.12 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 30.0 mm -82.47 -32.02 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.158 -0.474 . . . . 1.33 110.434 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 12.7 tpt -58.66 -45.04 90.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 2.34 110.239 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -64.57 -35.07 79.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.998 -0.546 . . . . 2.09 110.302 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -60.06 -44.47 94.69 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.771 -0.649 . . . . 1.76 109.959 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.99 -44.85 99.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.039 -0.528 . . . . 1.01 110.197 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.44 -42.0 90.92 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.048 -0.524 . . . . 1.29 110.559 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.79 -42.8 98.41 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.433 -0.667 . . . . 1.02 111.433 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -63.97 -32.74 74.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.038 0.447 . . . . 2.34 110.793 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 93.8 mt -68.91 -20.91 64.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.021 -0.536 . . . . 1.94 110.815 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 5.7 m -86.06 -24.73 26.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.159 -0.473 . . . . 1.16 109.944 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.1 m -68.29 -37.41 80.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 1.85 111.214 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 39.2 pt -76.43 0.23 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.333 -0.394 . . . . 1.98 112.036 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 96.3 mt -91.26 10.26 27.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.922 0.391 . . . . 1.36 110.967 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.792 -0.623 . . . . 2.71 110.219 179.903 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 120.814 0.34 . . . . 1.45 110.883 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -124.96 169.72 11.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.106 -0.497 . . . . 2.01 110.612 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -71.52 128.01 34.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.909 -0.587 . . . . 2.16 109.671 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.11 -6.04 46.51 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.622 -0.799 . . . . 0.87 112.492 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -79.92 147.68 31.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.877 0.37 . . . . 0.99 110.782 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.5 mt -109.88 119.91 59.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.178 -0.465 . . . . 1.16 109.86 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 21.2 m95 -114.93 149.9 36.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.012 -0.54 . . . . 0.91 110.782 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.0 tp -106.01 118.39 36.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.776 -0.193 . . . . 0.9 110.491 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 p -166.14 148.95 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 120.948 0.404 . . . . 1.04 110.814 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.17 141.66 40.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.356 -0.384 . . . . 1.32 110.607 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.2 mt -97.58 4.11 50.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.157 0.503 . . . . 1.29 111.252 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.08 179.9 0.92 Allowed Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.642 -0.708 . . . . 1.54 110.302 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.65 134.89 32.76 Favored 'Cis proline' 0 C--N 1.354 0.822 0 CA-C-N 119.736 0.942 . . . . 1.69 112.62 0.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.2 p -108.14 155.41 20.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.663 -0.699 . . . . 1.53 111.144 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.2 102.56 5.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.138 -0.69 . . . . 1.7 109.138 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.37 -116.21 3.87 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.505 -1.438 . . . . 1.18 109.505 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -134.06 78.55 1.77 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.065 0.459 . . . . 3.12 111.75 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -110.59 -149.32 0.44 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.791 -0.818 . . . . 1.14 108.791 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -82.58 53.77 2.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.312 0.577 . . . . 2.09 110.007 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.31 128.77 37.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.294 -0.866 . . . . 2.44 112.006 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.99 146.84 9.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.83 -0.7 . . . . 1.07 113.445 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.2 m -79.31 121.1 24.68 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.715 -0.476 . . . . 1.46 109.715 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.48 161.51 40.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.437 -0.347 . . . . 2.01 110.354 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.32 145.75 60.67 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.104 1.87 . . . . 1.01 110.289 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.1 m -128.75 140.12 50.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.42 -0.354 . . . . 0.76 110.55 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.1 tp -95.04 128.64 42.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.034 -0.53 . . . . 0.7 110.822 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.13 109.34 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.801 -0.444 . . . . 0.92 109.801 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.95 -27.91 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 120.997 0.427 . . . . 0.95 111.413 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.85 145.41 74.28 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.294 -0.412 . . . . 1.12 111.411 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.69 158.91 52.34 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.646 2.231 . . . . 1.3 112.173 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.25 -40.04 64.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.993 -0.549 . . . . 1.39 112.206 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.31 -50.18 74.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.331 -0.395 . . . . 1.61 111.767 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -63.93 -38.41 90.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.115 0.483 . . . . 1.77 110.885 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -67.53 -20.84 65.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.732 -0.667 . . . . 1.48 111.051 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -91.33 -35.03 14.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.197 -0.456 . . . . 3.04 112.003 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.57 -50.3 15.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.693 0.627 . . . . 1.86 112.693 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 m -87.38 -31.61 20.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.855 0.359 . . . . 2.06 110.95 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 66.46 23.38 10.54 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.795 -0.639 . . . . 4.87 111.543 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.7 mt -132.35 100.43 15.31 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.442 -0.799 . . . . 1.81 109.053 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -89.69 140.45 3.58 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.629 2.219 . . . . 1.05 114.163 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.1 t -90.36 124.37 42.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.221 -1.4 . . . . 1.03 107.221 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.43 163.97 21.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 113.542 0.942 . . . . 0.79 113.542 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.93 134.56 25.13 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 114.307 -1.315 . . . . 0.72 108.686 178.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.11 128.86 10.91 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.927 2.418 . . . . 1.03 114.674 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.0 t -88.6 118.44 34.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.021 -0.733 . . . . 1.28 109.021 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.478 0 N-CA-C 110.163 -0.31 . . . . 2.5 110.163 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 CA-C-O 120.706 0.059 . . . . 1.69 113.048 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -106.34 17.07 23.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.906 0.384 . . . . 1.56 111.778 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.68 137.39 35.42 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.226 -0.657 . . . . 1.25 109.226 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.5 m -88.44 161.16 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.047 0.451 . . . . 1.68 111.731 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -84.67 93.5 8.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.988 -0.551 . . . . 2.25 111.641 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.2 mt -87.11 -33.79 19.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.341 -0.39 . . . . 1.35 111.923 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -68.71 114.79 7.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.023 0.439 . . . . 2.21 111.788 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.47 -10.78 5.53 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.652 -0.785 . . . . 1.18 113.004 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.6 m -90.61 -16.11 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 117.224 0.512 . . . . 1.21 111.49 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.88 51.77 7.56 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 121.066 -0.588 . . . . 1.08 113.461 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.1 pt -103.72 -171.73 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.718 0.294 . . . . 1.07 111.155 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 54.7 ttm-85 -102.23 -33.65 9.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.103 -0.499 . . . . 4.33 110.28 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.8 m -55.85 117.55 3.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.412 -0.813 . . . . 1.51 111.132 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.19 109.6 21.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.973 -0.558 . . . . 1.79 110.558 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.72 -165.43 28.41 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.629 -0.795 . . . . 1.18 112.115 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 81.6 t -132.69 129.63 58.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.797 0.332 . . . . 1.56 110.742 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 69.9 t -72.18 110.96 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.874 -0.788 . . . . 1.29 108.874 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.1 mtm-85 -99.68 121.57 41.43 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.326 -0.397 . . . . 2.85 110.516 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 14.4 m -98.57 34.7 1.97 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.274 -0.421 . . . . 1.47 110.784 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.53 -60.96 2.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.232 -0.44 . . . . 0.89 110.868 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -115.51 80.63 8.12 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.291 -0.413 . . . . 2.65 111.4 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -84.3 156.16 12.69 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.639 2.226 . . . . 0.8 111.118 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -168.32 166.4 12.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.056 0.455 . . . . 2.42 111.265 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.2 m -92.53 145.49 24.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.625 -0.716 . . . . 1.79 109.174 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 26.6 pt -135.3 150.79 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.684 0.278 . . . . 1.15 110.529 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.94 142.7 47.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.043 -0.526 . . . . 1.03 110.051 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 35.4 tpp -121.55 5.61 10.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.186 0.517 . . . . 1.29 110.78 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -93.43 -46.54 7.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.2 -0.454 . . . . 3.09 111.043 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.02 -40.6 10.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.389 -0.369 . . . . 1.12 110.47 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -62.31 -57.6 10.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.389 -0.368 . . . . 1.17 110.304 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.24 84.94 0.19 Allowed Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.909 -0.662 . . . . 1.12 113.505 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.34 172.56 47.22 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.704 -0.76 . . . . 1.16 111.867 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -122.29 122.45 39.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.064 -0.346 . . . . 2.87 110.064 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.88 137.39 38.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.631 0.253 . . . . 2.93 110.937 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -112.64 -81.05 0.59 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.227 -0.442 . . . . 1.29 110.291 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -131.05 -163.71 1.35 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.221 -0.445 . . . . 1.15 110.738 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -147.63 155.19 41.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.564 0.221 . . . . 1.57 110.56 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.6 m -103.58 156.36 35.64 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.289 -0.414 . . . . 0.75 111.399 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -69.28 166.88 25.48 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.762 2.308 . . . . 0.95 111.73 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -58.82 -24.11 61.47 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.437 -0.347 . . . . 1.51 111.769 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -40.74 87.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.285 -0.416 . . . . 1.62 110.825 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.5 mm -71.04 -37.78 69.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 1.31 110.186 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.7 tpt -62.0 -37.21 83.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 1.6 110.472 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -64.16 -35.59 81.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.071 0.462 . . . . 2.52 110.085 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -44.99 88.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.763 -0.653 . . . . 1.64 109.62 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.5 t -64.23 -41.26 91.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.714 -0.675 . . . . 1.03 110.597 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.9 mt -55.56 -43.01 75.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.107 -0.497 . . . . 1.22 110.742 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.6 -41.95 98.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.909 -0.662 . . . . 1.03 111.897 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -62.05 -45.89 91.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.761 0.315 . . . . 2.16 110.529 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.9 mt -62.65 -40.65 97.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.037 -0.529 . . . . 1.02 111.104 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.1 m -70.78 -3.06 16.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 1.11 111.596 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.7 m -105.11 -34.11 8.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.789 0.328 . . . . 1.95 110.806 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.2 pt -79.97 -23.31 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 111.996 0.369 . . . . 1.15 111.996 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.0 mt -76.21 81.84 3.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.98 111.023 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.755 -0.657 . . . . 1.35 109.835 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.434 ' SD ' ' N ' ' B' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.133 0 CA-C-O 121.616 0.722 . . . . 2.03 112.736 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . 0.434 ' N ' ' SD ' ' B' ' 1' ' ' MET . 37.3 mt-10 -86.59 -19.57 29.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.259 -0.882 . . . . 2.82 109.315 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? 77.82 115.18 0.06 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.913 -1.039 . . . . 2.66 112.759 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.23 49.48 4.95 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.879 -0.6 . . . . 1.28 114.128 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -126.58 88.33 2.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.58 0.585 . . . . 1.53 112.58 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 60.8 mt -102.21 107.45 21.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.88 -0.785 . . . . 0.75 108.88 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -108.03 160.36 15.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.91 -0.587 . . . . 0.82 111.198 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 42.0 tp -111.84 121.47 45.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.914 -0.772 . . . . 1.05 108.914 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 p -152.17 157.32 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 120.787 0.327 . . . . 0.72 110.536 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 47.6 m -83.13 119.25 24.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.246 -0.433 . . . . 1.68 110.083 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.42 -26.31 61.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.161 -0.472 . . . . 0.83 111.071 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.26 149.78 86.34 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.88 -0.6 . . . . 1.62 110.497 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.07 140.78 30.95 Favored 'Cis proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.58 -1.425 . . . . 1.28 112.561 0.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.72 129.4 36.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.981 -0.554 . . . . 1.7 109.655 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.88 173.6 6.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.367 -0.379 . . . . 1.22 111.497 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.41 -134.27 24.42 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.643 -0.708 . . . . 1.01 113.271 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -114.28 29.21 8.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.974 0.416 . . . . 2.62 110.305 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -83.02 168.53 16.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.752 -0.658 . . . . 1.28 110.664 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -74.15 133.26 42.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.22 0.533 . . . . 1.98 111.962 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -125.02 -178.28 4.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.762 -0.654 . . . . 1.86 110.809 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.71 166.92 42.75 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.235 -0.507 . . . . 0.9 113.583 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.9 m -96.52 110.15 22.6 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.996 -0.742 . . . . 1.11 108.996 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.85 162.97 27.7 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.466 -0.334 . . . . 2.0 110.246 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.87 141.57 98.18 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.447 2.098 . . . . 0.65 111.209 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 9.7 m -135.11 139.76 46.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.103 -0.498 . . . . 0.57 110.654 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 61.3 tp -99.98 121.98 42.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.127 -0.488 . . . . 1.17 109.837 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 16.7 mt -72.26 145.5 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.425 -0.352 . . . . 0.66 110.073 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 19.2 t -112.36 -27.72 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 120.8 0.333 . . . . 0.93 111.525 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.77 148.16 96.48 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.503 -0.317 . . . . 1.1 111.84 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.62 176.17 10.37 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.962 2.441 . . . . 0.78 113.54 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.422 ' C ' ' H ' ' B' ' 33' ' ' PHE . . . -66.93 -31.3 71.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.476 -0.784 . . . . 1.03 110.736 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.24 18.37 0.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.944 -0.571 . . . . 1.4 110.946 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . 0.422 ' H ' ' C ' ' B' ' 31' ' ' ALA . 2.2 t80 -137.16 -53.62 0.69 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.033 -0.53 . . . . 1.57 110.023 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -57.12 -39.61 75.47 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.99 -0.55 . . . . 1.92 111.953 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -92.67 8.27 39.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.23 -0.441 . . . . 2.93 111.59 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 62.7 t -116.01 -64.04 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.284 -0.416 . . . . 1.09 111.157 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 37.1 p -78.52 -16.23 57.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.335 0.588 . . . . 1.64 110.493 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.62 29.77 19.25 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.365 -0.834 . . . . 2.01 110.684 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 30.5 mt -143.24 102.74 5.14 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.35 -0.841 . . . . 1.16 109.282 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -97.18 149.35 0.94 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.778 2.319 . . . . 0.57 113.571 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 16.2 m -97.44 133.68 38.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.58 -1.267 . . . . 1.08 107.58 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 24.9 m -127.18 153.78 36.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 113.981 1.104 . . . . 0.64 113.981 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 54.4 t -103.61 119.36 55.0 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 114.43 -1.259 . . . . 1.1 108.216 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.51 126.23 13.88 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.889 2.393 . . . . 0.73 113.217 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 87.8 t -88.89 135.98 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.826 -0.625 . . . . 0.9 109.353 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -114.21 96.62 5.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.502 -0.317 . . . . 1.24 110.378 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.026 -0.534 . . . . 2.43 110.827 179.578 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.747 0.308 . . . . 1.96 110.469 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.78 -98.43 0.29 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.118 -0.563 . . . . 1.14 113.099 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -86.55 -16.21 37.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.825 0.345 . . . . 3.57 111.398 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.51 131.45 34.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.311 -0.404 . . . . 1.08 110.523 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -113.17 144.24 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 1.34 110.143 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -80.62 113.19 18.63 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.06 0.393 . . . . 1.71 112.06 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 97.9 mt -88.55 -7.17 56.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.654 0.74 . . . . 1.02 109.016 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -98.07 141.24 31.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.143 -0.935 . . . . 1.79 109.767 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.91 -58.06 0.7 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.723 -0.751 . . . . 1.15 112.125 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 p -75.7 -26.85 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.076 0.465 . . . . 1.17 111.294 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.93 57.83 0.42 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.473 -0.87 . . . . 1.05 113.287 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 84.9 mt -104.09 143.2 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.919 -0.771 . . . . 1.61 108.919 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -65.23 -53.43 44.5 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.81 0.338 . . . . 2.65 110.495 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 8.8 m -71.13 101.27 2.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.18 0.514 . . . . 0.93 110.033 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -91.85 108.8 20.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.082 -0.508 . . . . 1.62 110.997 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.55 -160.22 25.98 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.004 -0.617 . . . . 0.79 111.997 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 10.7 m -125.87 139.44 51.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.791 0.329 . . . . 0.93 110.877 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.57 143.12 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.364 -0.38 . . . . 1.38 110.887 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 35.5 mmm-85 -97.86 84.87 3.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.149 0.499 . . . . 1.52 110.614 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.2 m -73.96 -5.87 43.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 1.55 111.296 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -88.7 -16.15 33.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.058 -0.519 . . . . 1.1 111.409 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -130.82 60.49 53.38 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 113.04 0.756 . . . . 2.83 113.04 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.93 141.08 23.67 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.085 1.857 . . . . 0.96 110.223 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -132.61 143.61 49.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.862 0.363 . . . . 2.32 111.34 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.39 135.06 37.36 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.389 -0.967 . . . . 1.21 108.389 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 9.3 pt -118.99 154.21 21.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.93 0.395 . . . . 1.28 110.948 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -86.03 139.89 30.77 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.853 -0.612 . . . . 1.28 109.42 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 2.6 ttp -130.9 26.73 4.94 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.603 0.716 . . . . 2.7 109.505 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -109.86 -44.05 3.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.033 -0.985 . . . . 2.62 109.399 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.38 -28.42 8.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.421 -0.809 . . . . 1.06 110.074 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -80.97 151.94 28.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.963 -0.562 . . . . 1.47 110.384 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.92 131.88 10.82 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.215 -0.754 . . . . 0.92 111.215 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.25 148.25 18.5 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.954 -0.641 . . . . 0.92 111.679 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -139.89 137.69 35.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.489 0.185 . . . . 2.24 110.904 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -78.55 131.2 36.69 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.235 -0.284 . . . . 2.99 110.235 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 82.4 mt -98.33 -58.06 2.06 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.434 0.531 . . . . 0.76 112.434 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -149.07 158.22 44.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.412 -0.358 . . . . 1.07 110.278 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -101.02 112.07 24.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.772 0.32 . . . . 2.71 110.155 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.28 133.77 94.58 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.776 -0.647 . . . . 1.45 110.854 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.69 146.4 77.0 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.673 2.249 . . . . 1.03 111.11 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -55.06 -32.66 62.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 2.14 111.891 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -48.39 78.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.93 -0.577 . . . . 2.06 110.953 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 40.4 mm -80.29 -34.48 14.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 1.33 110.593 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 6.9 tpt -56.58 -47.39 79.65 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.007 -0.542 . . . . 2.34 110.854 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -67.06 -33.71 76.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 2.09 110.914 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -46.06 91.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 1.76 110.872 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 50.2 t -59.33 -44.09 91.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.946 0.403 . . . . 1.01 110.495 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -62.9 -36.37 83.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 1.29 110.264 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.63 -34.13 86.58 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.802 -0.635 . . . . 1.02 111.852 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 19.6 mmt85 -70.74 -28.74 64.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.035 0.445 . . . . 2.34 110.661 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 36.5 mt -76.93 -18.54 58.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 1.94 110.774 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 24.6 m -76.94 -6.92 54.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.212 -0.449 . . . . 1.16 111.694 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 3.7 m -66.73 -25.04 66.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 1.85 111.366 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 46.7 pt -92.07 7.21 5.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.829 0.347 . . . . 1.98 111.675 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 59.2 mt -87.0 13.33 9.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.155 0.502 . . . . 1.36 111.246 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.654 -0.703 . . . . 2.71 109.436 179.806 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 120.658 0.266 . . . . 1.45 110.988 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -123.26 168.04 12.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.288 -0.415 . . . . 2.01 110.442 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.429 HH22 ' C ' ' B' ' 110' ' ' THR . 36.3 ttm180 -67.64 124.67 23.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.986 -0.552 . . . . 2.16 110.692 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.58 -2.86 32.4 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.822 -0.704 . . . . 0.87 113.31 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -93.79 152.25 19.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.472 -0.428 . . . . 0.99 110.979 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.5 pt -115.87 117.11 54.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.147 0.499 . . . . 1.16 110.345 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -108.43 125.41 51.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.658 -0.701 . . . . 0.91 111.097 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.3 tp -74.52 117.78 16.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.19 -0.459 . . . . 0.9 110.633 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 p -162.24 153.9 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.413 -0.358 . . . . 1.04 110.122 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 t -84.01 140.14 32.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.961 0.41 . . . . 1.32 110.509 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -100.15 13.25 34.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.018 -0.537 . . . . 1.29 111.103 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.12 171.47 10.79 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.618 -0.719 . . . . 1.54 110.325 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.82 133.2 27.77 Favored 'Cis proline' 0 C--N 1.352 0.743 0 C-N-CA 124.419 -1.075 . . . . 1.69 112.198 -0.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.7 p -102.25 138.52 39.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.705 -0.679 . . . . 1.53 111.295 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -106.93 140.46 39.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.437 -0.579 . . . . 1.7 109.437 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.35 -113.27 5.23 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.645 -0.788 . . . . 1.18 111.472 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -130.54 46.32 2.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.808 0.337 . . . . 3.12 111.283 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -65.84 -174.86 0.25 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.971 -0.559 . . . . 1.14 110.437 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -78.51 69.2 4.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.333 0.587 . . . . 2.09 110.234 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -76.13 144.61 40.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.402 -0.817 . . . . 2.44 111.241 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.92 143.03 5.73 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.64 -0.791 . . . . 1.07 112.843 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 m -92.9 107.17 19.01 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.263 -0.643 . . . . 1.46 109.263 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.31 163.39 28.34 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.429 -0.35 . . . . 2.01 110.582 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.02 119.47 6.45 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.498 2.132 . . . . 1.01 111.393 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 m -97.26 142.46 14.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.126 -0.488 . . . . 0.76 110.38 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.6 tp -83.86 121.9 27.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.44 -0.346 . . . . 0.7 111.282 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.8 mm -71.84 112.67 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.92 109.713 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.38 -37.51 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.346 -0.388 . . . . 0.95 111.889 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.86 150.55 75.49 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 112.387 0.514 . . . . 1.12 112.387 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.1 155.91 63.7 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.766 2.311 . . . . 1.3 112.323 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.92 -38.0 64.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.843 -0.617 . . . . 1.39 112.05 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.38 -41.4 89.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.027 0.441 . . . . 1.61 111.227 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -73.22 -41.95 63.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.091 -0.504 . . . . 1.77 110.777 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -62.81 -21.13 65.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.898 -0.592 . . . . 1.48 111.345 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -93.37 -25.52 17.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 3.04 111.93 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 p -82.78 -49.24 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 112.93 0.715 . . . . 1.86 112.93 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.5 p -94.9 -23.86 17.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 2.06 110.783 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 68.78 18.04 8.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.478 -0.783 . . . . 4.87 111.607 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 75.8 mt -129.11 93.28 36.91 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.349 -0.842 . . . . 1.81 108.897 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.92 132.53 9.64 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.567 2.178 . . . . 1.05 113.521 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.03 116.64 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.833 -1.543 . . . . 1.03 106.833 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 m -124.71 156.91 33.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 113.478 0.918 . . . . 0.79 113.478 -177.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.37 118.57 33.83 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 114.806 -1.088 . . . . 0.72 108.646 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.47 156.59 63.67 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.076 2.518 . . . . 1.03 113.507 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.2 t -114.1 127.12 71.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.085 -0.962 . . . . 1.28 108.638 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.2 p . . . . . 0 C--N 1.324 -0.516 0 C-N-CA 121.105 -0.238 . . . . 2.5 111.25 -179.619 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.177 0 CA-C-O 120.702 0.057 . . . . 1.69 112.97 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -91.32 -32.75 15.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.893 0.378 . . . . 1.56 110.971 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.47 120.9 25.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.083 -0.508 . . . . 1.25 110.097 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.4 m -93.85 153.64 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.913 0.387 . . . . 1.68 111.707 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.86 142.98 34.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.969 -0.559 . . . . 2.25 111.615 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 mt -109.94 0.57 18.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 1.35 110.927 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -91.55 -173.68 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 2.21 109.914 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.7 -47.68 3.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 1.18 112.151 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.0 m -74.6 -28.7 22.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.889 0.376 . . . . 1.21 110.754 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.77 67.88 1.53 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.743 -0.742 . . . . 1.08 113.619 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.8 pt -102.97 174.69 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.624 -0.51 . . . . 1.07 109.624 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -80.68 -44.84 18.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.956 0.407 . . . . 4.33 110.46 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.51 149.2 49.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.8 -0.636 . . . . 1.51 111.46 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.08 91.96 3.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.836 -0.62 . . . . 1.79 110.795 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -164.85 -162.42 15.85 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.17 -0.772 . . . . 1.18 111.17 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.34 138.63 53.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.092 -0.336 . . . . 1.56 110.092 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.7 t -75.3 131.1 35.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.817 0.341 . . . . 1.29 110.456 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.8 mmm-85 -100.35 91.4 4.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.127 -0.488 . . . . 2.85 112.259 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.8 m -82.67 -10.14 59.06 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.901 -0.777 . . . . 1.47 108.901 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -86.85 -12.52 47.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.121 -0.945 . . . . 0.89 110.943 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -129.42 62.93 65.71 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 112.195 0.443 . . . . 2.65 112.195 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.95 144.61 21.64 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.667 2.245 . . . . 0.8 111.024 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.1 ptm85 -163.92 124.61 2.2 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.072 0.397 . . . . 2.42 112.072 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.6 m -82.19 123.52 29.08 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.847 -0.615 . . . . 1.79 109.597 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 24.3 pt -126.1 161.95 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.025 0.44 . . . . 1.15 111.183 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -76.61 145.37 38.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.62 -0.718 . . . . 1.03 110.686 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 38.2 tpp -131.91 24.66 4.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.23 0.538 . . . . 1.29 109.786 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.12 -40.42 3.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.158 -0.474 . . . . 3.09 110.778 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.88 -35.38 10.51 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.362 -0.607 . . . . 1.12 109.362 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -68.72 -57.56 5.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.471 -0.786 . . . . 1.17 110.704 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.82 120.52 2.03 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.787 -0.72 . . . . 1.12 113.193 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.0 171.16 21.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.939 -0.648 . . . . 1.16 111.796 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -132.79 123.13 25.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.834 0.35 . . . . 2.87 111.482 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -75.41 120.39 20.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.226 -0.443 . . . . 2.93 110.897 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.95 -53.86 4.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.925 0.393 . . . . 1.29 110.328 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -160.14 -168.44 2.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.709 -0.678 . . . . 1.15 109.38 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -143.29 139.76 30.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.757 0.313 . . . . 1.57 110.33 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.54 158.25 43.21 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.136 -0.484 . . . . 0.75 111.461 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.0 160.72 48.48 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.712 2.275 . . . . 0.95 111.564 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -60.87 -23.04 64.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 1.51 111.93 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -37.08 74.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.483 . . . . 1.62 110.585 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.2 mm -88.55 -40.78 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.747 -0.661 . . . . 1.31 109.99 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.7 tpt -56.63 -50.83 70.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.696 -0.683 . . . . 1.6 112.107 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -65.18 -32.19 73.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 2.52 111.268 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -61.5 -45.14 95.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.862 -0.608 . . . . 1.64 110.366 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 50.0 t -59.88 -44.85 95.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.036 -0.529 . . . . 1.03 110.013 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.6 mt -59.92 -40.88 90.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.732 -0.667 . . . . 1.22 111.051 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.87 -41.42 98.77 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.901 -0.666 . . . . 1.03 112.016 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -68.2 -38.52 82.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 2.16 110.555 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 62.6 mt -63.78 -24.24 67.68 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.03 -0.532 . . . . 1.02 112.111 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 57.0 m -72.12 -6.27 41.41 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.934 0.716 . . . . 1.11 112.934 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 74.5 p -92.49 -11.34 34.89 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.193 0.442 . . . . 1.95 112.193 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.8 pt -107.48 16.25 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.914 0.388 . . . . 1.15 111.897 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 83.4 mt -97.42 25.87 5.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.131 0.491 . . . . 0.98 110.784 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.957 -0.565 . . . . 1.35 111.405 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 112.007 0.373 . . . . 2.03 112.007 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -91.01 2.97 55.9 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.168 -0.332 . . . . 2.82 110.804 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 84.86 61.24 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.933 1.086 . . . . 2.66 113.933 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.25 22.98 74.82 Favored Glycine 0 CA--C 1.519 0.313 0 N-CA-C 115.006 0.762 . . . . 1.28 115.006 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -83.19 116.55 22.42 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 117.498 0.649 . . . . 1.53 110.892 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.9 mt -96.07 123.26 48.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.75 110.184 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -112.92 127.47 56.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.008 0.432 . . . . 0.82 111.477 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 40.1 tp -90.13 120.35 31.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.056 -0.52 . . . . 1.05 109.748 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 5.9 p -158.63 169.55 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.505 -0.316 . . . . 0.72 110.379 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.45 133.27 34.49 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.899 -0.408 . . . . 1.68 109.899 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 18.9 mt -81.29 -29.09 34.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.485 -0.325 . . . . 0.83 111.437 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.7 154.58 35.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.051 -0.522 . . . . 1.62 111.629 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.65 116.52 4.58 Favored 'Cis proline' 0 C--O 1.237 0.432 0 C-N-CA 123.607 -1.414 . . . . 1.28 113.364 0.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.41 147.88 46.68 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.812 -0.81 . . . . 1.7 108.812 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.65 177.88 8.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.319 0.581 . . . . 1.22 112.117 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.57 -108.53 2.45 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.888 -0.672 . . . . 1.01 112.585 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -108.31 3.29 23.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.727 0.299 . . . . 2.62 111.147 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -72.4 140.21 48.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.297 -0.411 . . . . 1.28 110.05 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -68.28 142.16 55.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.669 -0.493 . . . . 1.98 109.669 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -120.1 165.85 14.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.726 0.639 . . . . 1.86 112.726 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.7 -173.11 36.45 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.44 -0.8 . . . . 0.9 112.327 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 15.6 m -96.04 123.36 39.61 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.973 -0.751 . . . . 1.11 108.973 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -157.45 155.0 26.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.705 -0.225 . . . . 2.0 110.84 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.63 133.8 35.65 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.608 2.206 . . . . 0.65 111.841 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.61 156.92 37.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.074 -0.512 . . . . 0.57 110.693 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tp -106.24 119.32 38.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.118 -0.492 . . . . 1.17 110.71 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 27.8 mt -78.36 116.83 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.317 . . . . 0.66 110.607 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 37.5 t -77.61 -37.55 24.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.025 -0.534 . . . . 0.93 111.839 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.19 142.47 87.26 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.436 -0.347 . . . . 1.1 111.74 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.68 156.09 61.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.83 2.353 . . . . 0.78 112.407 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.3 77.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.861 -0.609 . . . . 1.03 111.704 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.98 -36.74 73.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.92 0.39 . . . . 1.4 111.55 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -81.39 -40.88 22.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.112 0.482 . . . . 1.57 110.519 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -59.43 -24.84 63.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.682 -0.69 . . . . 1.92 111.899 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -89.42 -2.61 58.46 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.399 0.518 . . . . 2.93 112.399 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -108.12 -52.08 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.977 0.418 . . . . 1.09 110.282 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 1.5 m -80.87 -31.84 35.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.818 -0.628 . . . . 1.64 111.14 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? 71.01 -0.22 3.14 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.53 0.937 . . . . 2.01 113.53 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 98.4 mt -121.45 94.32 48.61 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.577 -0.527 . . . . 1.16 109.577 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.37 154.18 14.09 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.867 2.378 . . . . 0.57 113.992 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 8.8 t -95.45 123.53 47.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.901 -1.148 . . . . 1.08 107.901 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 32.3 m -113.93 147.31 17.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 113.434 0.902 . . . . 0.64 113.434 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 t -106.09 118.97 53.66 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 114.63 -1.168 . . . . 1.1 108.386 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.38 134.79 19.41 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.728 2.285 . . . . 0.73 112.557 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 44.0 t -99.01 123.62 51.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.88 -0.6 . . . . 0.9 110.46 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.44 89.89 8.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.887 -0.597 . . . . 1.24 109.579 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 115.855 -0.612 . . . . 2.43 111.342 -179.682 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.023 0.44 . . . . 1.96 110.339 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.51 -87.68 0.26 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.796 -0.638 . . . . 1.14 112.676 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -109.68 -6.69 15.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.879 0.371 . . . . 3.57 110.86 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -93.04 115.13 27.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.049 -0.523 . . . . 1.08 110.845 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 23.7 t -117.05 135.99 55.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.101 -0.5 . . . . 1.34 110.013 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 88.3 p -79.42 141.59 36.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.801 0.334 . . . . 1.71 111.605 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 72.8 mt -88.76 -16.76 31.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.181 0.515 . . . . 1.02 110.751 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -73.63 147.0 44.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.718 -0.673 . . . . 1.79 111.003 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.03 -40.14 2.5 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.056 -0.593 . . . . 1.15 112.461 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 p -90.21 -17.69 7.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.111 0.412 . . . . 1.17 112.111 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.24 20.91 4.24 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.499 -0.858 . . . . 1.05 113.599 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 81.4 mt -86.64 141.31 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.772 -0.455 . . . . 1.61 109.772 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -70.9 -47.84 56.94 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.623 0.249 . . . . 2.65 110.923 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 12.2 m -60.97 99.14 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.368 0.604 . . . . 0.93 110.334 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.69 91.49 8.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.946 -0.57 . . . . 1.62 111.746 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.45 -174.0 38.81 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.709 -0.758 . . . . 0.79 111.7 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.5 m -113.71 136.31 50.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 110.211 -0.292 . . . . 0.93 110.211 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 m -80.34 135.59 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.556 -0.293 . . . . 1.38 110.92 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 16.1 mmm-85 -101.99 82.97 2.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.112 0.482 . . . . 1.52 110.829 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 2.3 m -69.32 -9.04 51.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.758 -0.655 . . . . 1.55 111.047 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -88.45 -6.21 57.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.589 -0.732 . . . . 1.1 111.771 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -126.13 55.77 14.2 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 113.0 0.741 . . . . 2.83 113.0 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.96 126.4 5.74 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.771 1.647 . . . . 0.96 112.271 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -130.38 140.39 50.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.917 0.389 . . . . 2.32 111.218 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.72 125.87 30.21 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.189 -0.671 . . . . 1.21 109.189 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 41.4 pt -128.51 151.48 35.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.521 -0.471 . . . . 1.28 111.653 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.439 ' CG ' ' HZ1' ' B' ' 83' ' ' LYS . 4.8 t70 -77.83 83.95 4.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.858 -0.61 . . . . 1.28 109.994 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 59.7 tpp -61.69 -31.66 71.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.691 -0.686 . . . . 2.7 112.274 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . 0.439 ' HZ1' ' CG ' ' B' ' 81' ' ' ASP . 1.4 pttp -67.22 -38.91 86.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.397 0.517 . . . . 2.62 112.397 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.98 -30.18 28.41 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.108 0.41 . . . . 1.06 112.108 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -82.22 -42.46 18.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.174 0.435 . . . . 1.47 112.174 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.4 99.94 1.52 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.92 112.597 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -99.3 153.71 19.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.677 -0.773 . . . . 0.92 112.588 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.15 128.15 16.5 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.284 -0.265 . . . . 2.24 110.284 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -78.91 121.04 24.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.963 0.411 . . . . 2.99 111.339 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 89.8 mt -90.8 -68.62 0.78 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.136 -0.484 . . . . 0.76 110.666 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.61 -176.88 4.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.935 -0.575 . . . . 1.07 110.028 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.81 137.98 53.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.959 0.409 . . . . 2.71 111.198 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 53.7 t -82.86 126.72 72.2 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.854 -0.612 . . . . 1.45 109.993 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -59.59 152.5 61.86 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.656 2.237 . . . . 1.03 111.11 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -54.26 -29.69 47.78 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.461 0.541 . . . . 2.14 112.461 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.7 p -59.46 -53.83 53.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.991 0.424 . . . . 2.06 111.219 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 32.5 mm -74.84 -34.04 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.202 -0.453 . . . . 1.33 110.0 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 5.1 tpt -55.33 -45.26 76.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.706 -0.679 . . . . 2.34 110.972 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -67.55 -35.34 78.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.098 -0.501 . . . . 2.09 110.996 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.53 -44.86 89.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.97 -0.559 . . . . 1.76 111.0 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 73.9 t -60.29 -48.61 87.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.306 -0.406 . . . . 1.01 110.425 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 82.9 mt -59.68 -34.93 73.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.555 . . . . 1.29 111.048 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.45 -41.28 96.46 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.578 -0.609 . . . . 1.02 111.578 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -67.35 -33.59 75.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.898 0.38 . . . . 2.34 110.315 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 46.4 mt -65.98 -25.5 67.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.912 -0.586 . . . . 1.94 110.513 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 13.0 m -87.68 -13.94 41.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.008 -0.542 . . . . 1.16 111.161 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.13 -31.65 61.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.898 0.38 . . . . 1.85 111.361 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 14.0 pt -84.91 0.82 5.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.442 -0.345 . . . . 1.98 111.558 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.49 4.66 53.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.342 -0.39 . . . . 1.36 111.859 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.429 ' C ' HH22 ' A' ' 3' ' ' ARG . 7.0 t . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.825 -0.607 . . . . 2.71 110.206 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptp . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.782 0.325 . . . . 1.45 110.75 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -135.28 175.01 9.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.02 -0.536 . . . . 2.01 111.053 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.2 ttp85 -79.27 136.22 36.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.048 -0.523 . . . . 2.16 109.955 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.44 8.27 59.91 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.87 112.476 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -95.27 142.22 27.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.949 0.404 . . . . 0.99 111.138 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.7 mt -99.0 115.93 40.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.814 -0.81 . . . . 1.16 108.814 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -114.12 137.33 51.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.401 -0.363 . . . . 0.91 111.083 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.3 tp -88.81 120.76 30.51 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.392 -0.595 . . . . 0.9 109.392 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 p -147.49 169.19 4.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 120.867 0.365 . . . . 1.04 110.708 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.2 t -103.75 129.83 51.18 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.001 -0.74 . . . . 1.32 109.001 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.3 mt -88.32 -12.57 43.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.461 -0.336 . . . . 1.29 111.377 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.93 164.15 43.67 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.94 -0.573 . . . . 1.54 111.162 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.74 139.09 49.57 Favored 'Cis proline' 0 C--N 1.353 0.79 0 C-N-CA 124.324 -1.115 . . . . 1.69 112.485 -0.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 p -121.9 171.95 8.54 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.085 -0.507 . . . . 1.53 111.319 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.79 164.34 26.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 1.7 110.063 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.4 -136.87 32.34 Favored Glycine 0 CA--C 1.516 0.123 0 C-N-CA 121.16 -0.543 . . . . 1.18 113.409 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -103.74 25.46 9.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.022 -0.362 . . . . 3.12 110.022 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -76.47 175.75 8.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.212 -0.449 . . . . 1.14 111.427 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -74.23 77.38 1.81 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.607 -0.724 . . . . 2.09 110.506 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -78.03 122.89 26.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.835 -0.62 . . . . 2.44 111.726 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.71 163.45 12.27 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.272 -0.966 . . . . 1.07 113.502 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.62 148.38 25.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.743 -0.229 . . . . 1.46 110.505 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -172.71 159.87 3.83 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 110.247 -0.279 . . . . 2.01 110.247 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.65 130.3 15.72 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.448 2.099 . . . . 1.01 110.713 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 m -116.37 137.21 50.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.335 -0.393 . . . . 0.76 110.569 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.1 tp -92.32 124.39 36.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.154 -0.475 . . . . 0.7 110.948 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.6 mt -80.07 111.03 16.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.92 110.148 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 t -90.18 -27.2 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.218 -0.446 . . . . 0.95 111.75 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 p -77.6 142.25 66.08 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.603 0.594 . . . . 1.12 112.603 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.79 151.74 83.78 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.217 2.611 . . . . 1.3 111.798 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.18 -38.81 77.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.085 -0.507 . . . . 1.39 112.036 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.17 -38.3 82.81 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.024 0.44 . . . . 1.61 110.777 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -72.34 -38.73 68.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.032 -0.531 . . . . 1.77 110.166 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -64.78 -15.81 62.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.676 -0.693 . . . . 1.48 111.199 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -87.8 -24.12 23.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.562 -0.29 . . . . 3.04 110.724 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.6 t -83.1 -65.12 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 1.86 111.489 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.1 m -78.82 -33.99 45.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.337 -0.392 . . . . 2.06 110.862 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 75.14 12.64 3.35 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.724 -0.671 . . . . 4.87 111.738 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.8 mt -124.92 93.04 46.61 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.544 -0.753 . . . . 1.81 109.404 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.06 137.26 26.15 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.502 2.135 . . . . 1.05 112.798 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.8 t -83.64 111.65 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 107.972 -1.122 . . . . 1.03 107.972 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.8 m -114.54 158.74 14.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.24 0.543 . . . . 0.79 112.282 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.89 122.08 33.08 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.236 -0.893 . . . . 0.72 109.775 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.99 94.75 1.06 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.867 2.378 . . . . 1.03 112.761 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.0 m -78.68 155.86 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 1.28 110.407 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 112.345 0.498 . . . . 2.5 112.345 179.106 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.195 0 N-CA-C 112.538 -0.225 . . . . 1.69 112.538 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -96.08 -16.77 21.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.628 0.252 . . . . 1.56 111.03 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.02 87.37 2.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.587 -0.523 . . . . 1.25 109.587 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.3 t -66.13 121.86 16.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.276 -0.42 . . . . 1.68 110.726 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.1 t -77.56 125.94 30.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.896 0.379 . . . . 2.25 111.539 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 91.9 mt -88.35 -5.93 58.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.45 0.643 . . . . 1.35 109.427 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -80.5 108.96 14.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.264 -0.88 . . . . 2.21 109.84 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.85 -34.56 1.23 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.873 -0.679 . . . . 1.18 112.017 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.5 m -78.36 -30.7 15.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.729 0.3 . . . . 1.21 111.6 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.59 65.1 0.93 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.638 -0.791 . . . . 1.08 112.671 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.4 pt -125.24 -171.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.354 -0.609 . . . . 1.07 109.354 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -101.22 -27.66 13.09 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.739 -0.384 . . . . 4.33 111.477 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.7 m -81.41 80.71 7.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.268 0.556 . . . . 1.51 110.388 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 m -80.21 94.54 6.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.63 -0.714 . . . . 1.79 111.256 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -162.52 -178.31 36.27 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.828 -0.624 . . . . 1.18 112.137 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.3 m -105.0 138.99 27.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.821 0.31 . . . . 1.56 110.963 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.9 t -73.81 126.93 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.808 -0.633 . . . . 1.29 110.258 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.75 85.23 7.02 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.584 0.587 . . . . 2.85 112.584 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 11.0 m -83.44 -8.19 59.42 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.81 -0.811 . . . . 1.47 108.81 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -87.55 -27.97 22.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.801 -1.091 . . . . 0.89 111.14 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -130.84 64.53 73.91 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 113.984 1.105 . . . . 2.65 113.984 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -77.52 133.96 13.44 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 121.872 1.715 . . . . 0.8 109.204 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -135.19 143.06 46.22 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.683 0.623 . . . . 2.42 112.683 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.85 127.88 34.15 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.814 -1.18 . . . . 1.79 107.814 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.5 pt -126.1 173.18 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.967 0.413 . . . . 1.15 111.091 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -101.65 133.48 46.29 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.64 -0.709 . . . . 1.03 109.138 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.2 mmt -126.19 27.98 6.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.971 0.415 . . . . 1.29 111.266 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -125.3 -42.98 1.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 3.09 110.8 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.46 -37.54 9.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.728 -0.669 . . . . 1.12 109.505 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -68.69 -49.28 60.25 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.006 -0.543 . . . . 1.17 110.453 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.33 143.55 4.59 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.909 -0.587 . . . . 1.12 112.278 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.77 176.77 32.39 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.766 -0.73 . . . . 1.16 111.958 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -128.31 126.31 40.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.586 0.232 . . . . 2.87 111.171 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -74.3 132.99 42.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 2.93 110.451 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 83.1 mt -103.71 -73.23 0.68 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.362 -0.381 . . . . 1.29 110.639 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -144.83 175.4 10.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.214 -0.448 . . . . 1.15 110.626 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.6 ttp85 -120.03 144.64 47.44 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.428 -0.582 . . . . 1.57 109.428 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.9 m -103.32 145.26 30.26 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.704 0.288 . . . . 0.75 111.298 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.77 155.09 45.17 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.742 2.295 . . . . 0.95 111.751 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -67.59 -21.09 65.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.06 -0.518 . . . . 1.51 111.276 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.97 -57.46 12.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 1.62 110.994 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 pt -69.83 -23.04 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 1.31 111.509 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 40.0 mmm -67.75 -34.9 77.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 1.6 109.813 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -67.04 -30.71 70.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.583 . . . . 2.52 110.083 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -62.57 -31.16 71.92 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.781 -0.645 . . . . 1.64 110.481 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.54 -48.97 23.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.506 -0.77 . . . . 1.03 109.76 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.42 -37.08 79.73 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.966 -0.561 . . . . 1.22 111.351 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.88 -40.01 97.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.908 -0.663 . . . . 1.03 111.928 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.0 mtt85 -75.77 -38.7 58.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.947 0.403 . . . . 2.16 110.739 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 82.8 mt -59.37 -41.82 90.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.906 -0.588 . . . . 1.02 111.109 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.2 m -63.83 -20.86 66.12 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.23 0.455 . . . . 1.11 112.23 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -90.89 -35.63 14.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.812 0.339 . . . . 1.95 111.508 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.9 pt -78.04 -14.7 14.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 113.114 0.783 . . . . 1.15 113.114 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 61.8 mt -78.32 65.3 3.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.086 0.47 . . . . 0.98 110.932 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.758 -0.655 . . . . 1.35 110.632 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 121.098 0.475 . . . . 2.03 111.335 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -76.33 -34.99 58.99 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.232 -1.025 . . . . 2.82 108.232 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 68.35 140.45 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.613 -1.176 . . . . 2.66 112.853 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.53 -10.48 74.4 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.814 -0.708 . . . . 1.28 112.54 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -76.84 99.14 5.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.875 0.369 . . . . 1.53 111.536 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 20.6 mt -89.02 122.42 40.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.907 -0.588 . . . . 0.75 110.816 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -122.32 134.34 54.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.088 -0.505 . . . . 0.82 109.877 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 tt -95.14 123.06 38.43 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.66 -0.246 . . . . 1.05 110.587 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.18 154.73 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.72 110.76 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 67.8 m -76.63 126.08 30.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.439 -0.346 . . . . 1.68 111.215 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.53 -21.28 25.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.83 112.003 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.06 162.9 62.68 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.544 -0.298 . . . . 1.62 111.007 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.18 152.96 98.91 Favored 'Cis proline' 0 C--N 1.352 0.712 0 C-N-CA 123.82 -1.325 . . . . 1.28 113.214 0.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 6.2 p -123.93 145.04 49.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.576 -0.738 . . . . 1.7 110.406 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -132.79 108.32 8.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.923 0.392 . . . . 1.22 110.665 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.28 -133.96 11.73 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.897 -0.668 . . . . 1.01 111.79 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -101.32 23.79 10.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.658 0.266 . . . . 2.62 111.504 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -71.39 150.48 44.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.039 -0.528 . . . . 1.28 110.799 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -69.39 116.0 9.31 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.642 -0.503 . . . . 1.98 109.642 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -103.23 173.11 6.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.12 -0.491 . . . . 1.86 112.203 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.66 138.31 4.05 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.759 -0.655 . . . . 0.9 113.332 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 91.7 m -70.01 130.65 42.73 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.351 -0.611 . . . . 1.11 109.351 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -159.74 160.94 27.41 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.503 -0.317 . . . . 2.0 110.374 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -66.02 131.97 28.66 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.629 2.219 . . . . 0.65 110.836 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 18.4 m -125.43 157.81 34.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.388 -0.369 . . . . 0.57 110.938 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -103.88 133.18 49.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.954 -0.566 . . . . 1.17 109.942 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 54.6 mt -85.81 123.37 39.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.741 0.305 . . . . 0.66 110.958 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.69 49.44 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.496 0.665 . . . . 0.93 110.081 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 8.1 m -143.34 122.75 7.53 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.918 -0.583 . . . . 1.1 109.879 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -48.62 128.1 17.59 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.078 2.518 . . . . 0.78 112.405 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.72 -30.66 67.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.962 -0.563 . . . . 1.03 111.536 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.9 -32.83 71.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 1.4 111.211 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -94.57 -21.42 18.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.174 0.511 . . . . 1.57 110.266 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -58.71 -35.6 72.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.748 -0.66 . . . . 1.92 110.649 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.8 -20.33 65.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.265 -0.425 . . . . 2.93 111.73 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.06 -58.97 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.793 0.664 . . . . 1.09 112.793 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 1.2 p -86.51 -33.81 20.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.569 0.581 . . . . 1.64 112.569 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 67.43 24.51 8.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.309 0.576 . . . . 2.01 111.197 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.63 88.69 16.2 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.517 -0.765 . . . . 1.16 109.301 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -85.98 149.29 9.51 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.678 2.252 . . . . 0.57 113.384 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 6.1 t -86.53 124.55 40.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.555 -0.906 . . . . 1.08 108.555 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.65 154.58 22.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.237 0.458 . . . . 0.64 112.237 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 m -118.06 127.6 26.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.494 -0.775 . . . . 1.1 109.444 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.12 160.56 23.58 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.934 2.422 . . . . 0.73 113.031 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 31.5 m -115.55 145.52 21.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.943 -0.571 . . . . 0.9 110.519 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 27.9 m -95.39 124.2 39.31 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.534 -0.543 . . . . 1.24 109.534 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 N-CA-C 112.569 0.581 . . . . 2.43 112.569 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.378 0 CA-C-O 121.061 0.457 . . . . 1.96 111.487 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.0 -114.39 6.08 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.814 -0.63 . . . . 1.14 112.497 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -116.09 16.12 16.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.925 0.393 . . . . 3.57 110.457 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.07 111.28 23.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.087 -0.506 . . . . 1.08 110.674 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 t -95.66 124.18 48.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.284 -0.416 . . . . 1.34 110.195 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.7 m -77.4 123.09 26.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.733 0.642 . . . . 1.71 112.733 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 88.2 mt -89.75 -15.62 32.05 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.185 -1.043 . . . . 1.02 108.185 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -71.48 150.42 44.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.362 -1.29 . . . . 1.79 110.499 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.79 -44.5 3.25 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.802 -0.713 . . . . 1.15 113.469 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 p -70.1 -18.82 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.949 0.404 . . . . 1.17 111.926 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.21 59.74 0.5 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.567 -0.825 . . . . 1.05 112.91 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 31.5 mm -128.61 137.24 57.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.131 -0.692 . . . . 1.61 109.131 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -65.44 -36.55 84.26 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.293 0.568 . . . . 2.65 109.874 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 11.8 m -80.0 82.17 6.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.634 -0.712 . . . . 0.93 109.946 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 23.2 p -68.48 97.52 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.861 -0.609 . . . . 1.62 111.313 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.12 -171.53 37.87 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.637 -0.792 . . . . 0.79 112.46 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 m -118.16 132.67 67.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.555 0.217 . . . . 0.93 111.24 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 30.4 t -74.78 128.78 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.434 -0.348 . . . . 1.38 110.459 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 14.0 mmm-85 -96.95 84.78 3.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.061 0.457 . . . . 1.52 110.319 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.22 -13.03 61.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.793 -0.639 . . . . 1.55 110.538 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -87.53 7.16 30.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.769 -0.65 . . . . 1.1 111.899 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -132.56 61.77 58.86 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 111.803 0.298 . . . . 2.83 111.803 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.98 119.99 4.89 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.482 2.121 . . . . 0.96 110.83 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -136.9 122.23 19.36 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 111.944 0.35 . . . . 2.32 111.944 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -84.03 139.9 32.21 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.218 -0.66 . . . . 1.21 109.218 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 8.3 pt -148.86 162.69 5.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.484 -0.325 . . . . 1.28 110.374 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -77.98 94.6 4.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.201 0.524 . . . . 1.28 110.679 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 53.0 tpp -61.11 -24.76 66.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.302 -0.863 . . . . 2.7 112.263 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.18 -49.25 11.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.76 0.314 . . . . 2.62 111.633 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.94 -41.46 82.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.379 -0.373 . . . . 1.06 111.077 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -75.68 -31.83 59.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 1.47 111.334 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.57 101.83 0.88 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.86 -0.686 . . . . 0.92 112.822 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -112.35 150.61 18.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.871 -0.68 . . . . 0.92 112.49 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -140.58 136.68 33.05 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.403 -0.221 . . . . 2.24 110.403 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -75.69 135.89 40.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.799 0.333 . . . . 2.99 110.853 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 82.7 mt -108.14 -77.99 0.59 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.301 0.482 . . . . 0.76 112.301 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.1 -178.18 4.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.495 -0.32 . . . . 1.07 111.635 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -121.5 122.67 40.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 2.71 110.778 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 57.7 t -82.91 136.19 44.57 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.934 -0.575 . . . . 1.45 110.559 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -53.66 144.57 52.57 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.837 2.358 . . . . 1.03 111.999 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -55.9 -39.95 72.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.668 -0.696 . . . . 2.14 111.916 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 14.2 t -57.53 -33.95 68.61 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.625 0.602 . . . . 2.06 112.625 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 48.2 mm -82.3 -36.57 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.218 0.532 . . . . 1.33 110.206 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 30.0 mmt -66.22 -33.27 75.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 2.34 111.047 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -60.24 -36.23 77.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.19 0.519 . . . . 2.09 110.414 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -67.67 -41.05 84.35 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.724 -0.671 . . . . 1.76 110.442 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 93.8 t -57.54 -48.3 83.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.156 -0.475 . . . . 1.01 110.248 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.79 -40.6 97.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.744 -0.662 . . . . 1.29 110.175 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.14 -46.94 89.73 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.81 -0.632 . . . . 1.02 112.342 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -60.8 -41.12 95.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.858 0.361 . . . . 2.34 110.936 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 31.8 tp -66.1 -30.67 71.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.193 -0.458 . . . . 1.94 110.714 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 49.1 m -66.33 -34.78 78.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.175 -0.466 . . . . 1.16 111.308 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -15.92 62.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.04 0.385 . . . . 1.85 112.04 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 60.2 mt -79.03 -23.16 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.297 0.57 . . . . 1.98 110.375 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 74.9 mt -93.8 48.02 1.25 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.757 -0.656 . . . . 1.36 110.779 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.661 -0.685 . . . . 2.71 110.56 179.691 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ptp . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.958 0.408 . . . . 1.45 110.742 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -108.66 167.15 10.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.674 -0.694 . . . . 2.01 110.231 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -69.01 129.27 39.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.287 -0.415 . . . . 2.16 109.99 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.35 -7.46 34.67 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.558 -0.83 . . . . 0.87 112.828 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -81.42 147.36 29.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.826 0.313 . . . . 0.99 111.271 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.6 mt -111.45 121.67 64.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 1.16 110.751 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -118.43 147.48 43.54 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.91 110.145 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 tp -102.91 130.09 49.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.939 -0.119 . . . . 0.9 110.717 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -169.74 154.62 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.237 0.336 . . . . 1.04 110.421 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.0 m -80.97 141.25 34.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.714 0.292 . . . . 1.32 110.435 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 53.8 mt -82.85 -7.79 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 1.29 111.03 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.45 162.45 41.79 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.412 -0.813 . . . . 1.54 110.153 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.57 141.35 64.03 Favored 'Cis proline' 0 C--O 1.236 0.385 0 C-N-CA 123.716 -1.368 . . . . 1.69 111.726 -0.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.0 p -117.58 171.77 7.79 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.224 -0.444 . . . . 1.53 110.536 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.28 137.57 39.14 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.434 -0.58 . . . . 1.7 109.434 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.54 -116.02 5.27 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.71 -0.757 . . . . 1.18 112.995 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -113.05 17.4 18.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.531 0.205 . . . . 3.12 111.136 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -59.26 137.45 57.97 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.251 -0.431 . . . . 1.14 110.004 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.76 118.39 4.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.492 -0.322 . . . . 2.09 111.204 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -124.42 164.01 20.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.169 -0.469 . . . . 2.44 110.674 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.05 150.36 11.32 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.608 -0.806 . . . . 1.07 113.595 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.47 113.9 10.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.875 0.369 . . . . 1.46 110.124 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.96 160.51 52.61 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.372 -0.376 . . . . 2.01 110.173 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.31 134.18 24.24 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.468 2.112 . . . . 1.01 111.056 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.3 m -119.28 136.08 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 110.005 -0.368 . . . . 0.76 110.005 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.8 tp -94.35 128.72 41.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.083 -0.508 . . . . 0.7 111.437 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.2 mm -73.32 114.56 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.345 -0.389 . . . . 0.92 110.127 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.2 t -90.33 -41.82 13.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.002 0.43 . . . . 0.95 111.953 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.69 147.18 96.36 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 112.04 0.385 . . . . 1.12 112.04 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.45 159.12 54.76 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.767 2.311 . . . . 1.3 111.986 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.61 70.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.982 -0.554 . . . . 1.39 112.348 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.29 94.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.846 0.355 . . . . 1.61 110.948 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -66.48 -41.2 89.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.039 -0.528 . . . . 1.77 110.482 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -67.54 -11.82 58.92 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.034 -0.53 . . . . 1.48 110.886 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.8 ttp-105 -94.79 -31.96 13.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.175 -0.466 . . . . 3.04 111.212 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.41 -49.08 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.824 0.676 . . . . 1.86 112.824 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 p -95.27 -27.05 15.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.953 0.406 . . . . 2.06 110.564 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 67.13 21.25 10.15 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.367 -0.833 . . . . 4.87 111.395 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.0 mt -125.65 98.98 33.37 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.393 -0.821 . . . . 1.81 109.027 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -88.55 134.54 2.85 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.806 2.337 . . . . 1.05 113.775 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.9 t -79.21 114.37 19.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.193 -1.41 . . . . 1.03 107.193 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.5 m -115.66 150.61 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 113.44 0.904 . . . . 0.79 113.44 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 m -117.97 129.03 25.62 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.931 -1.031 . . . . 0.72 108.96 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.35 145.44 53.77 Favored 'Trans proline' 0 CA--C 1.527 0.17 0 C-N-CA 123.186 2.591 . . . . 1.03 113.871 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.8 t -107.49 119.9 57.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.509 -0.923 . . . . 1.28 108.509 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.4 m . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 120.521 0.201 . . . . 2.5 111.172 -179.258 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 112.338 -0.305 . . . . 1.69 112.338 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -106.06 69.07 0.79 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.127 0.489 . . . . 1.56 111.328 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.19 138.45 29.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.9 -0.591 . . . . 1.25 110.03 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.7 t -116.25 118.24 58.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.601 -0.272 . . . . 1.68 110.882 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.7 118.87 20.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.609 -0.269 . . . . 2.25 111.117 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.87 -18.61 39.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.233 0.54 . . . . 1.35 110.58 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -67.37 117.04 8.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.566 -0.743 . . . . 2.21 109.954 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.78 -31.4 2.21 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.381 -0.688 . . . . 1.18 111.381 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.7 m -83.18 -17.26 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.835 0.35 . . . . 1.21 111.502 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.58 83.07 0.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.849 -0.691 . . . . 1.08 112.68 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.7 pt -138.44 169.67 17.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.838 -0.43 . . . . 1.07 109.838 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -76.5 -51.73 11.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.79 0.329 . . . . 4.33 110.586 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.9 m -85.34 75.88 10.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.269 0.557 . . . . 1.51 110.948 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.02 158.47 29.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.759 -0.655 . . . . 1.79 111.322 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 156.42 -157.34 27.83 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 121.069 -0.586 . . . . 1.18 111.744 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.6 t -130.04 126.39 61.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 110.178 -0.305 . . . . 1.56 110.178 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.7 t -72.56 118.94 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.318 -0.623 . . . . 1.29 109.318 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -92.89 96.03 9.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.241 -0.436 . . . . 2.85 110.971 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.16 -6.04 57.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.538 0.685 . . . . 1.47 109.373 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -78.98 -16.2 57.24 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.902 -1.045 . . . . 0.89 112.689 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -136.83 68.71 58.47 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 114.138 1.162 . . . . 2.65 114.138 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.79 140.73 32.63 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.289 1.993 . . . . 0.8 109.914 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.1 ptm85 -156.21 114.15 3.31 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.823 0.675 . . . . 2.42 112.823 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.8 m -82.76 109.94 17.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.154 -0.476 . . . . 1.79 110.089 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.0 pt -120.96 155.18 24.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.038 -0.528 . . . . 1.15 109.641 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.53 125.77 26.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.976 0.417 . . . . 1.03 111.5 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 40.3 tpp -103.08 9.24 38.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.094 0.473 . . . . 1.29 110.718 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -92.94 -64.21 1.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.173 -0.467 . . . . 3.09 111.854 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.58 -27.96 63.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.293 -0.412 . . . . 1.12 111.305 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -73.81 -29.86 62.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.253 -0.431 . . . . 1.17 110.502 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.32 66.94 2.09 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.896 -0.669 . . . . 1.12 112.355 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.14 151.94 51.67 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.713 -0.756 . . . . 1.16 112.27 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -113.43 122.12 46.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.31 -0.255 . . . . 2.87 110.31 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -82.18 135.28 35.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.655 0.264 . . . . 2.93 111.224 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -104.27 -64.68 1.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.134 0.492 . . . . 1.29 110.616 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -162.95 -169.07 1.93 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.791 -0.64 . . . . 1.15 109.346 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -130.77 156.48 44.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.684 0.278 . . . . 1.57 110.579 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.8 m -97.33 156.59 36.05 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.39 -0.368 . . . . 0.75 111.085 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -64.19 145.52 89.09 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.721 2.281 . . . . 0.95 111.129 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -61.19 -25.7 67.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 1.51 111.662 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -38.43 87.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.877 0.37 . . . . 1.62 110.577 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.7 mm -73.56 -46.48 48.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.96 -0.564 . . . . 1.31 109.921 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 9.8 tpt -63.03 -26.05 68.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.953 -0.567 . . . . 1.6 110.99 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.15 -48.22 79.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.673 -0.694 . . . . 2.52 111.634 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -28.41 60.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.543 -0.299 . . . . 1.64 111.55 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.2 -46.93 95.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.699 -0.482 . . . . 1.03 109.699 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 77.7 mt -61.34 -36.38 80.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.614 -0.721 . . . . 1.22 110.185 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.31 -46.18 94.95 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.479 -0.782 . . . . 1.03 112.453 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.5 mtt180 -65.4 -37.84 88.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 2.16 110.77 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.61 -18.27 65.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.757 -0.656 . . . . 1.02 112.253 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.1 m -78.82 -24.96 44.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.938 0.399 . . . . 1.11 111.164 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.75 -22.25 50.56 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.124 0.416 . . . . 1.95 112.124 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.0 pt -84.23 -9.22 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 111.96 0.356 . . . . 1.15 111.96 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.3 mt -84.2 73.03 10.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.897 0.379 . . . . 0.98 110.092 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 116.361 -0.381 . . . . 1.35 111.666 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.743 0.306 . . . . 2.03 110.881 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -82.27 -21.53 36.18 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.328 -0.619 . . . . 2.82 109.328 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 72.14 120.9 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.946 -1.024 . . . . 2.66 112.903 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.47 -26.76 21.66 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.741 -0.663 . . . . 1.28 113.679 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -71.08 97.84 1.55 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.848 0.685 . . . . 1.53 112.848 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 64.5 mt -95.26 125.91 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.851 -0.796 . . . . 0.75 108.851 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -105.78 164.78 11.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.986 0.422 . . . . 0.82 112.007 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 45.8 tp -128.87 120.04 25.51 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.05 -0.523 . . . . 1.05 109.949 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 p -159.69 169.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.251 -0.431 . . . . 0.72 110.122 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.77 135.54 39.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.779 0.323 . . . . 1.68 110.472 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 35.3 mt -86.28 -18.26 32.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.234 -0.439 . . . . 0.83 111.189 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.96 154.24 89.81 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.915 -0.584 . . . . 1.62 111.116 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.47 124.28 9.38 Favored 'Cis proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.266 -1.556 . . . . 1.28 113.041 0.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.93 166.85 13.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.554 -0.748 . . . . 1.7 109.918 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.87 -171.24 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.582 0.23 . . . . 1.22 111.069 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.96 -104.92 1.18 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 116.081 -0.508 . . . . 1.01 112.702 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -132.43 14.52 4.54 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.293 0.568 . . . . 2.62 110.285 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -78.07 143.95 36.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.735 -0.666 . . . . 1.28 110.061 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.08 105.47 2.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.763 0.316 . . . . 1.98 111.224 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -83.89 -174.73 5.45 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.112 -0.495 . . . . 1.86 110.913 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.05 -167.11 49.25 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.95 -0.568 . . . . 0.9 112.752 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 20.1 m -113.89 122.27 46.49 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.428 -0.582 . . . . 1.11 109.428 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -151.61 159.99 32.42 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.681 -0.488 . . . . 2.0 109.681 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -59.47 137.76 79.86 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.192 1.928 . . . . 0.65 110.671 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 m -128.09 128.13 68.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.989 0.424 . . . . 0.57 111.126 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 46.7 tp -94.44 121.2 35.74 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.961 -0.563 . . . . 1.17 109.605 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 51.5 mt -80.86 137.82 20.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.956 -0.387 . . . . 0.66 109.956 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.87 -29.39 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.821 0.344 . . . . 0.93 111.051 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.06 137.31 75.89 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.258 -0.428 . . . . 1.1 111.615 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.2 161.42 42.99 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.009 2.473 . . . . 0.78 112.045 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.77 -37.08 73.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.169 -0.468 . . . . 1.03 111.677 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.51 -29.99 71.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.114 0.483 . . . . 1.4 111.176 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -81.13 -40.01 24.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.033 0.444 . . . . 1.57 110.135 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -66.52 -22.32 66.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.63 -0.713 . . . . 1.92 110.725 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -79.75 -34.83 39.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 2.93 110.948 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 58.0 t -85.4 -64.21 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.156 -0.475 . . . . 1.09 111.987 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 1.3 m -67.51 -30.77 70.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.385 -0.37 . . . . 1.64 111.014 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 71.69 -9.84 0.9 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.534 0.568 . . . . 2.01 112.534 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 60.4 mt -118.62 100.93 51.09 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.681 -0.489 . . . . 1.16 109.681 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.68 158.96 9.14 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.742 2.295 . . . . 0.57 113.322 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 6.4 m -92.95 127.2 45.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 109.202 -0.666 . . . . 1.08 109.202 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.68 146.78 18.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.252 0.549 . . . . 0.64 112.148 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 43.1 t -109.84 112.91 57.87 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.944 -1.026 . . . . 1.1 109.279 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.06 119.42 6.16 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.69 2.26 . . . . 0.73 112.567 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 91.6 t -77.49 136.44 24.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.812 -0.631 . . . . 0.9 110.202 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 3.9 m -105.07 112.01 24.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.129 -0.487 . . . . 1.24 110.097 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 CA-C-N 116.184 -0.462 . . . . 2.43 110.64 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.138 0.494 . . . . 1.96 109.995 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.95 -94.24 0.78 Allowed Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.77 -0.65 . . . . 1.14 112.464 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -87.72 -6.64 58.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.921 0.391 . . . . 3.57 111.096 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.36 113.91 22.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.36 -0.382 . . . . 1.08 110.392 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 t -77.79 141.29 15.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.03 -0.532 . . . . 1.34 110.335 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -90.2 124.94 35.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.54 -0.3 . . . . 1.71 110.709 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 72.4 mt -89.97 -35.68 15.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.267 -0.424 . . . . 1.02 110.868 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -82.87 -173.22 4.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 1.79 111.321 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.92 -38.46 3.17 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.162 -0.775 . . . . 1.15 111.162 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 7.0 p -94.85 -3.35 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.953 0.406 . . . . 1.17 110.679 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.88 84.29 1.68 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.789 -0.719 . . . . 1.05 112.597 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 12.0 tt -135.3 160.58 40.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.798 -0.445 . . . . 1.61 109.798 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -83.5 -45.13 13.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.864 0.364 . . . . 2.65 110.705 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 17.1 m -85.46 90.52 7.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.154 0.502 . . . . 0.93 111.643 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 52.7 m -71.46 98.1 1.77 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.804 -0.634 . . . . 1.62 111.016 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -165.05 -171.2 31.0 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.793 -0.717 . . . . 0.79 112.152 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 15.1 m -117.58 151.97 19.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.862 0.363 . . . . 0.93 111.131 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 47.3 t -87.92 121.96 39.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.904 -0.589 . . . . 1.38 110.219 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 33.3 mmm-85 -97.25 84.93 3.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.953 0.406 . . . . 1.52 111.138 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 29.6 m -73.67 -0.75 16.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.189 -0.459 . . . . 1.55 111.228 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -96.06 -2.8 45.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.977 -0.556 . . . . 1.1 111.939 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -130.16 52.45 9.42 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.538 0.94 . . . . 2.83 113.538 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.87 119.4 2.18 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.269 1.979 . . . . 0.96 111.49 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -125.61 140.34 52.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.705 0.288 . . . . 2.32 111.453 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.18 126.98 31.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.679 -0.86 . . . . 1.21 108.679 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 31.5 pt -133.8 149.54 30.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.389 0.514 . . . . 1.28 112.389 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -76.41 91.71 3.32 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.277 -0.638 . . . . 1.28 109.277 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 48.5 tpp -67.76 -16.71 64.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.976 -0.556 . . . . 2.7 111.869 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -75.91 -45.58 34.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.282 -0.417 . . . . 2.62 111.111 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.98 -31.69 25.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.236 -0.438 . . . . 1.06 111.88 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -72.61 -36.01 67.98 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.943 0.349 . . . . 1.47 111.943 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.64 80.1 1.44 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.351 -0.928 . . . . 0.92 112.108 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.55 162.0 28.93 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.746 -0.74 . . . . 0.92 112.749 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -155.96 155.37 32.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.661 -0.866 . . . . 2.24 108.661 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -99.35 142.26 31.06 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 121.083 -0.247 . . . . 2.99 111.144 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 53.5 mt -108.39 -97.06 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.95 0.352 . . . . 0.76 111.95 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -106.89 169.86 8.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.466 -0.334 . . . . 1.07 111.153 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -110.72 106.06 15.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.373 -0.376 . . . . 2.71 110.417 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 14.4 p -69.37 133.05 89.36 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.405 -0.361 . . . . 1.45 110.851 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.8 147.11 33.09 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.002 2.468 . . . . 1.03 112.52 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -60.67 -28.32 68.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.852 -0.613 . . . . 2.14 110.937 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -47.16 86.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.762 -0.654 . . . . 2.06 110.768 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 51.6 mm -74.66 -40.07 47.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.545 . . . . 1.33 110.199 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 8.8 tpt -58.56 -38.01 76.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.9 -0.591 . . . . 2.34 110.981 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -60.94 -39.35 89.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.917 0.389 . . . . 2.09 110.701 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -67.14 -27.63 67.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 1.76 111.257 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 63.3 t -70.94 -51.27 36.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.414 -0.587 . . . . 1.01 109.414 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.23 -36.59 81.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.585 -0.734 . . . . 1.29 110.821 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.23 -50.88 63.07 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.936 -0.575 . . . . 1.02 112.079 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 77.2 mtt85 -62.95 -35.89 81.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.72 0.295 . . . . 2.34 110.893 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 35.4 mt -66.03 -31.2 71.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.247 0.546 . . . . 1.94 110.115 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -80.81 -18.73 46.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.793 -0.64 . . . . 1.16 110.858 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 7.8 m -74.13 -38.88 63.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.296 -0.411 . . . . 1.85 110.841 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 34.6 pt -76.29 2.25 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 111.982 0.364 . . . . 1.98 111.982 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 86.2 mt -82.97 -13.84 55.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.345 -0.389 . . . . 1.36 111.138 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.802 -0.618 . . . . 2.71 110.273 179.65 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptp . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.887 0.375 . . . . 1.45 110.474 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -129.23 158.4 39.14 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.971 -0.559 . . . . 2.01 110.55 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -61.64 122.61 15.73 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 110.037 -0.357 . . . . 2.16 110.037 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 111.09 -8.85 29.22 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.914 -0.66 . . . . 0.87 112.055 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -85.8 145.35 27.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.88 0.371 . . . . 0.99 111.365 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.12 110.75 33.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.259 -0.645 . . . . 1.16 109.259 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -104.67 135.22 46.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.934 0.397 . . . . 0.91 111.294 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.6 tp -95.51 122.3 38.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.26 -0.427 . . . . 0.9 110.822 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 p -160.87 157.24 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 1.04 109.936 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.17 130.01 35.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.841 -0.429 . . . . 1.32 109.841 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.6 mt -78.96 -10.51 59.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.252 -0.431 . . . . 1.29 110.952 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.23 164.47 60.78 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.707 -0.679 . . . . 1.54 110.922 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.99 141.12 65.08 Favored 'Cis proline' 0 C--N 1.347 0.49 0 C-N-CA 123.815 -1.327 . . . . 1.69 112.533 0.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.0 p -120.35 151.81 38.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.296 -0.411 . . . . 1.53 111.276 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.85 125.47 11.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.931 -0.577 . . . . 1.7 109.689 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.38 -124.54 6.76 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.206 -0.758 . . . . 1.18 111.206 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -139.99 75.54 1.51 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.148 0.499 . . . . 3.12 110.948 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.86 166.79 23.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.567 -0.742 . . . . 1.14 109.414 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -63.2 128.03 34.0 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.406 0.441 . . . . 2.09 110.634 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -131.22 178.62 6.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.064 -0.516 . . . . 2.44 110.106 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.1 162.62 38.24 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.804 -0.712 . . . . 1.07 113.844 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.6 m -85.95 102.44 13.76 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.975 -0.75 . . . . 1.46 108.975 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.99 156.12 75.92 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.268 -0.423 . . . . 2.01 110.622 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.13 123.69 9.43 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.564 2.176 . . . . 1.01 110.795 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.9 m -108.93 134.22 51.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.959 0.409 . . . . 0.76 110.156 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.8 tp -86.31 122.61 30.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.849 -0.614 . . . . 0.7 111.268 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.4 mm -74.76 115.23 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.92 109.854 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.9 t -96.75 -38.78 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 112.07 0.396 . . . . 0.95 112.07 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.08 147.22 76.48 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 112.186 0.439 . . . . 1.12 112.186 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.02 156.25 65.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.853 2.368 . . . . 1.3 112.03 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.19 61.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.816 -0.629 . . . . 1.39 112.561 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.09 -46.3 90.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.745 0.307 . . . . 1.61 111.453 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -67.62 -41.2 84.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.12 0.486 . . . . 1.77 110.416 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -66.5 -18.61 65.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.712 -0.676 . . . . 1.48 111.362 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -88.99 -42.22 11.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.393 -0.367 . . . . 3.04 111.966 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 p -81.13 -44.42 20.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.032 0.753 . . . . 1.86 113.032 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 m -90.72 -24.2 20.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.83 0.348 . . . . 2.06 111.395 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? 64.25 15.79 9.64 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.915 -0.584 . . . . 4.87 111.851 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.57 87.74 55.8 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 1.81 111.045 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.66 132.12 14.24 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.207 1.938 . . . . 1.05 112.248 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.8 t -77.62 118.9 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.097 -1.445 . . . . 1.03 107.097 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.1 m -127.68 161.3 35.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.617 0.723 . . . . 0.79 112.87 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -125.06 130.74 24.09 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 114.547 -1.206 . . . . 0.72 108.292 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.7 141.73 27.98 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.528 2.152 . . . . 1.03 113.68 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 90.0 t -107.12 111.04 33.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.996 -0.742 . . . . 1.28 108.996 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 116.36 -0.382 . . . . 2.5 110.431 -179.642 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.683 0 N-CA-C 111.711 -0.556 . . . . 1.69 111.711 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -108.81 15.2 23.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.154 0.502 . . . . 1.56 111.252 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -132.23 77.86 1.78 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.814 -0.63 . . . . 1.25 110.2 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.6 m -85.26 133.62 28.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.837 -0.62 . . . . 1.68 111.285 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.69 148.16 24.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.778 -0.646 . . . . 2.25 110.802 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.1 mt -91.64 -16.84 26.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.245 0.545 . . . . 1.35 110.175 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.21 124.95 25.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.668 -0.696 . . . . 2.21 110.614 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.4 -27.94 2.94 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.45 -0.66 . . . . 1.18 111.45 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.5 m -96.01 -13.2 8.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.667 0.27 . . . . 1.21 111.266 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.96 72.8 0.97 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.957 -0.639 . . . . 1.08 113.108 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 15.6 pt -123.25 -167.86 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.613 0.244 . . . . 1.07 111.043 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -102.95 -43.78 5.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.147 0.499 . . . . 4.33 109.781 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.2 m -64.75 109.34 2.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.514 -0.766 . . . . 1.51 111.327 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 m -102.21 127.28 49.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.06 -0.518 . . . . 1.79 111.101 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 162.31 -166.84 36.65 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.499 -1.04 . . . . 1.18 110.499 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.81 131.89 72.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.24 -0.652 . . . . 1.56 109.24 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.2 t -78.23 117.56 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.835 0.35 . . . . 1.29 110.83 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -82.85 103.39 12.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.639 -0.504 . . . . 2.85 109.639 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.19 1.96 55.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.135 0.493 . . . . 1.47 110.943 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -89.67 -16.32 30.7 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.586 -0.734 . . . . 0.89 111.341 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -125.61 72.73 68.23 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 113.49 0.922 . . . . 2.65 113.49 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -90.97 115.18 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.888 2.392 . . . . 0.8 110.014 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -138.07 165.88 25.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.163 0.506 . . . . 2.42 111.735 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.18 133.02 42.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.343 -0.984 . . . . 1.79 108.343 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.2 pt -132.21 148.35 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.788 0.328 . . . . 1.15 111.304 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -82.08 102.42 11.02 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.882 -0.414 . . . . 1.03 109.882 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.3 tpp -89.76 -10.12 46.75 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.235 -0.439 . . . . 1.29 111.108 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.1 tptp -79.69 -41.25 27.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.798 0.332 . . . . 3.09 111.274 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.09 -26.82 42.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.421 -0.354 . . . . 1.12 111.388 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 33.1 mtt-85 -84.06 -59.47 2.39 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.385 0.513 . . . . 1.17 112.385 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.78 109.29 0.3 Allowed Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.889 -0.672 . . . . 1.12 111.85 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.03 -168.66 12.5 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.649 -0.786 . . . . 1.16 112.79 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -131.36 138.97 49.4 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.063 -0.347 . . . . 2.87 110.063 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -86.2 139.8 30.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.753 0.311 . . . . 2.93 111.137 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -89.04 -55.37 3.71 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.049 -0.722 . . . . 1.29 109.049 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -170.37 -160.61 0.22 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.183 -0.917 . . . . 1.15 108.688 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -134.58 149.97 50.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.688 0.28 . . . . 1.57 110.456 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.4 m -97.73 159.82 30.07 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.26 -0.427 . . . . 0.75 111.092 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -64.87 155.87 65.28 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.713 2.276 . . . . 0.95 111.398 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -63.59 -26.94 68.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 1.51 110.753 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.34 -37.59 78.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.542 . . . . 1.62 110.573 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.5 mm -70.06 -43.69 78.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.022 -0.535 . . . . 1.31 110.12 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.7 tpt -63.7 -45.87 88.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 1.6 110.459 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -61.58 -36.69 81.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.024 -0.535 . . . . 2.52 110.716 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -63.08 -47.64 82.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.072 -0.513 . . . . 1.64 110.589 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.64 -46.02 97.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.939 -0.573 . . . . 1.03 110.336 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.55 -39.14 83.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.099 -0.501 . . . . 1.22 110.689 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.42 -43.37 99.15 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.783 -0.644 . . . . 1.03 111.644 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -65.14 -37.76 88.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 2.16 110.49 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.43 -25.06 65.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.56 . . . . 1.02 111.691 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.2 m -71.89 -11.53 60.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 1.11 111.067 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.26 -13.65 26.31 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.316 0.487 . . . . 1.95 112.316 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.1 pt -100.75 -1.24 9.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.827 0.677 . . . . 1.15 112.827 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.8 mt -81.65 73.7 8.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.753 0.311 . . . . 0.98 110.222 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.545 -0.298 . . . . 1.35 111.596 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 120.708 0.289 . . . . 2.03 110.432 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -77.39 -25.95 51.33 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.922 -0.77 . . . . 2.82 108.922 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 73.03 142.84 0.06 Allowed 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 114.96 -1.018 . . . . 2.66 111.457 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.46 -50.03 4.16 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.898 -0.668 . . . . 1.28 113.62 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -57.66 107.41 0.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.838 0.681 . . . . 1.53 112.838 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 80.6 mt -98.66 127.28 51.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.374 -0.602 . . . . 0.75 109.374 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -107.68 168.82 8.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.201 0.524 . . . . 0.82 111.805 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 33.5 tp -141.53 132.17 25.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.697 -0.683 . . . . 1.05 109.941 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 p -169.26 165.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.532 -0.544 . . . . 0.72 109.532 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 22.9 t -88.76 139.36 30.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.677 -0.49 . . . . 1.68 109.677 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 31.7 mt -87.72 -16.82 33.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.201 0.524 . . . . 0.83 110.349 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.83 162.08 75.72 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.76 -0.655 . . . . 1.62 111.283 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.28 135.56 33.92 Favored 'Cis proline' 0 C--N 1.344 0.299 0 C-N-CA 123.359 -1.517 . . . . 1.28 113.259 0.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.02 170.51 15.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.345 -0.843 . . . . 1.7 109.575 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.46 165.09 28.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.575 0.226 . . . . 1.22 110.551 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.34 -146.23 34.23 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.122 -0.561 . . . . 1.01 112.266 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -90.15 -1.72 57.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.384 -0.228 . . . . 2.62 110.384 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -57.78 154.25 12.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.906 -0.588 . . . . 1.28 112.201 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -60.94 127.35 31.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.686 -0.688 . . . . 1.98 111.383 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -142.06 -176.6 4.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.893 -0.594 . . . . 1.86 110.533 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.59 174.82 50.62 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.993 -0.622 . . . . 0.9 112.697 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 22.9 m -105.65 103.62 13.16 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.828 -0.434 . . . . 1.11 109.828 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -141.55 157.98 64.25 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.241 -0.436 . . . . 2.0 110.332 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.02 141.36 79.27 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.495 2.13 . . . . 0.65 111.411 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.4 m -131.75 131.49 62.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.379 0.609 . . . . 0.57 111.56 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 36.6 tp -101.72 123.85 46.39 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.669 -0.696 . . . . 1.17 109.527 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 34.4 mt -78.89 138.16 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.58 -0.282 . . . . 0.66 110.362 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.54 -34.92 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.406 -0.361 . . . . 0.93 110.945 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.53 140.96 68.78 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.215 -0.448 . . . . 1.1 111.634 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.76 159.83 27.93 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.767 2.311 . . . . 0.78 112.009 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.18 -29.7 58.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.212 -0.449 . . . . 1.03 111.954 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.38 -40.73 75.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.292 -0.413 . . . . 1.4 110.871 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -89.33 -37.76 14.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.058 -0.519 . . . . 1.57 110.63 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -61.69 -18.22 58.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.704 -0.68 . . . . 1.92 112.302 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -88.13 -25.88 22.76 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.694 0.257 . . . . 2.93 111.694 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -82.02 -61.84 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.963 0.411 . . . . 1.09 111.645 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.79 -28.21 36.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.186 -0.461 . . . . 1.64 111.201 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 69.9 8.23 6.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.809 -0.632 . . . . 2.01 111.819 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.64 98.06 48.28 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.968 -0.56 . . . . 1.16 109.537 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -90.62 155.23 4.28 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.789 2.326 . . . . 0.57 113.112 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 m -94.74 124.93 47.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.105 -0.702 . . . . 1.08 109.105 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.2 147.19 15.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 112.802 0.667 . . . . 0.64 112.802 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.41 118.29 49.38 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 114.752 -1.113 . . . . 1.1 108.757 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.14 142.45 30.8 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.628 2.219 . . . . 0.73 113.041 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 44.0 t -95.62 116.72 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.798 -0.637 . . . . 0.9 109.809 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.88 145.0 26.87 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.193 -0.458 . . . . 1.24 110.79 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 C--N 1.321 -0.672 0 CA-C-O 120.73 0.3 . . . . 2.43 110.745 179.728 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 110.53 -0.174 . . . . 1.96 110.53 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.39 -61.33 5.48 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.253 -0.498 . . . . 1.14 112.54 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -114.65 0.38 13.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.283 0.563 . . . . 3.57 110.54 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -100.16 106.23 17.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.614 -0.721 . . . . 1.08 110.573 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 57.0 t -87.92 129.31 39.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.675 -0.693 . . . . 1.34 109.895 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.4 t -85.08 138.21 32.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.224 -0.444 . . . . 1.71 111.467 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 37.8 mt -106.11 5.81 30.47 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.719 -0.845 . . . . 1.02 108.719 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -101.19 144.48 30.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.239 -0.891 . . . . 1.79 110.864 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.14 -23.33 11.5 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 116.102 -0.499 . . . . 1.15 111.96 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 p -100.14 -20.52 5.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.173 0.511 . . . . 1.17 111.54 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.96 51.62 0.88 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.601 -0.809 . . . . 1.05 112.708 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 82.6 mt -109.13 147.42 13.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.446 -0.575 . . . . 1.61 109.446 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -65.53 -49.53 68.61 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.869 0.366 . . . . 2.65 110.133 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 17.8 m -67.89 101.8 1.15 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.915 -0.584 . . . . 0.93 109.866 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.17 113.97 25.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.138 -0.483 . . . . 1.62 111.253 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.98 -170.25 39.18 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.439 -0.886 . . . . 0.79 112.681 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 6.0 m -123.86 133.97 67.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.972 -0.381 . . . . 0.93 109.972 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 19.3 m -82.34 138.11 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.464 -0.334 . . . . 1.38 111.445 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 mmm-85 -94.82 85.09 4.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.376 -0.374 . . . . 1.52 110.101 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.4 m -67.85 -9.21 42.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 1.55 111.617 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -92.24 -1.86 56.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.471 . . . . 1.1 111.833 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -128.27 83.24 66.71 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 112.02 0.378 . . . . 2.83 112.02 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -92.01 144.87 2.92 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.01 2.473 . . . . 0.96 112.181 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -148.42 131.46 16.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.453 -0.34 . . . . 2.32 111.01 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.07 126.52 34.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.549 . . . . 1.21 109.567 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 23.9 pt -140.47 151.33 20.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 1.28 111.315 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -80.67 100.43 8.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 1.28 109.852 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 48.5 tpp -66.62 -16.77 64.43 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.674 0.62 . . . . 2.7 112.674 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -80.29 -54.34 5.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.931 0.396 . . . . 2.62 110.887 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.65 -28.16 67.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.125 -0.489 . . . . 1.06 111.34 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -85.44 -11.39 54.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.295 -0.411 . . . . 1.47 111.501 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.96 57.49 18.47 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 121.096 -0.573 . . . . 0.92 112.754 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.24 148.86 51.15 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.934 -0.65 . . . . 0.92 112.793 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.11 164.45 21.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.49 -0.189 . . . . 2.24 110.49 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -105.23 137.22 43.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.771 0.319 . . . . 2.99 110.399 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 23.5 mt -98.55 -69.26 0.77 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.233 -0.439 . . . . 0.76 111.908 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -154.02 -171.13 3.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.069 -0.514 . . . . 1.07 110.705 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -128.03 119.92 26.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.032 0.444 . . . . 2.71 111.262 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 2.6 p -84.58 135.06 41.2 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.687 -0.688 . . . . 1.45 109.637 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.45 145.78 27.48 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.954 2.436 . . . . 1.03 113.097 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -56.76 -29.15 62.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.757 -0.656 . . . . 2.14 111.517 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -39.14 77.53 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.326 -0.397 . . . . 2.06 111.362 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 31.5 mm -79.26 -29.8 13.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.276 0.56 . . . . 1.33 109.516 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 11.2 mmt -62.89 -32.31 73.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.59 -0.732 . . . . 2.34 110.566 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.15 -41.85 93.64 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.922 -0.581 . . . . 2.09 110.253 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -62.57 -45.04 94.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.814 -0.63 . . . . 1.76 110.024 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 38.4 t -62.66 -49.86 82.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.649 -0.705 . . . . 1.01 111.05 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 86.7 mt -55.85 -38.57 70.25 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.343 -0.389 . . . . 1.29 111.512 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.58 -44.78 97.05 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.655 -0.783 . . . . 1.02 111.34 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -68.34 -33.36 74.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.059 0.456 . . . . 2.34 110.472 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.35 -24.87 67.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.882 -0.599 . . . . 1.94 110.854 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 23.2 m -85.17 -24.16 28.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.152 -0.476 . . . . 1.16 110.882 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.35 -28.57 62.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.259 -0.428 . . . . 1.85 112.068 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 40.7 pt -68.5 -19.67 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.548 0.573 . . . . 1.98 112.548 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.31 59.45 5.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.271 0.558 . . . . 1.36 111.457 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-N 115.954 -0.566 . . . . 2.71 109.699 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptp . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.925 0.393 . . . . 1.45 110.532 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -116.78 172.11 7.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.226 -0.443 . . . . 2.01 111.077 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -73.19 131.06 41.54 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.196 -0.456 . . . . 2.16 111.031 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.67 1.22 58.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.878 -0.677 . . . . 0.87 113.116 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -84.61 146.86 27.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 0.99 111.255 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.2 mt -106.52 118.91 55.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.862 -0.608 . . . . 1.16 110.265 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -118.05 128.65 54.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.91 111.124 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.9 tp -80.07 130.03 34.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.366 -0.379 . . . . 0.9 110.621 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.0 p -158.28 165.17 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.415 -0.357 . . . . 1.04 110.389 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 m -104.95 139.86 39.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.848 0.356 . . . . 1.32 110.898 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 25.3 mt -98.43 -9.17 25.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.003 0.43 . . . . 1.29 110.58 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.1 165.55 49.7 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.533 -0.758 . . . . 1.54 110.672 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.95 139.25 60.46 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.83 -1.321 . . . . 1.69 113.073 0.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 p -111.27 157.1 20.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.502 -0.772 . . . . 1.53 110.175 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -136.3 148.93 48.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.34 . . . . 1.7 111.075 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.88 -86.62 1.07 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.94 -0.648 . . . . 1.18 112.176 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -160.44 45.13 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.158 0.504 . . . . 3.12 111.258 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -79.43 176.63 9.52 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.737 -0.468 . . . . 1.14 109.737 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -78.94 90.35 4.75 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.434 -0.58 . . . . 2.09 109.434 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -89.94 158.63 17.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.783 -0.644 . . . . 2.44 112.059 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.9 127.72 6.18 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.684 -0.689 . . . . 1.07 112.805 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.9 m -63.14 129.92 42.37 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.77 0.319 . . . . 1.46 110.336 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.43 155.49 29.86 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.175 -0.466 . . . . 2.01 110.283 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.53 131.6 17.69 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.314 2.009 . . . . 1.01 110.824 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.9 m -107.38 154.12 8.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.439 -0.346 . . . . 0.76 110.288 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.7 tp -100.87 133.03 45.96 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.372 -0.377 . . . . 0.7 111.061 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.9 mm -76.51 108.96 10.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.92 110.117 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.42 -39.59 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.95 112.039 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.35 146.76 81.74 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 112.142 0.423 . . . . 1.12 112.142 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.28 158.08 59.08 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.795 2.33 . . . . 1.3 112.107 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.9 -39.7 74.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.932 -0.577 . . . . 1.39 112.065 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.73 -42.1 83.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 1.61 111.385 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -70.39 -46.51 63.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.945 -0.57 . . . . 1.77 110.402 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -61.9 -30.31 70.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 1.48 111.197 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -68.39 -44.96 73.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.277 -0.419 . . . . 3.04 112.101 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -86.72 -40.97 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 113.907 1.077 . . . . 1.86 113.907 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.8 m -84.78 -33.3 23.03 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.767 0.284 . . . . 2.06 111.767 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 65.46 20.42 11.73 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.058 0.456 . . . . 4.87 111.673 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.1 mt -134.01 91.78 23.43 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.668 -0.697 . . . . 1.81 109.181 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -84.41 135.43 6.12 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.516 2.144 . . . . 1.05 113.339 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -79.17 124.8 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.922 -1.14 . . . . 1.03 107.922 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.4 m -124.33 153.74 31.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.627 0.602 . . . . 0.79 112.627 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.42 140.74 27.74 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.352 -0.84 . . . . 0.72 109.695 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.27 147.65 16.29 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.801 2.334 . . . . 1.03 113.897 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.0 t -103.76 119.74 52.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.485 -0.779 . . . . 1.28 109.269 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.61 -158.06 0.86 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.506 -0.553 . . . . 2.5 109.506 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.72 -178.8 6.16 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.785 -0.45 . . . . 2.82 109.785 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -131.92 -69.21 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.407 -0.901 . . . . 3.36 110.973 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.02 -99.13 0.12 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 111.553 -0.619 . . . . 3.83 111.553 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -86.83 -45.1 11.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.857 0.361 . . . . 5.09 111.349 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -132.54 161.48 33.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.009 -0.541 . . . . 6.24 110.301 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.89 65.56 3.36 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.322 0.582 . . . . 2.61 110.815 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 ptm85 -136.37 -168.67 2.29 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.632 -0.713 . . . . 5.23 110.656 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.9 121.51 10.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.045 -0.525 . . . . 2.69 111.904 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -137.04 70.25 1.4 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.279 0.561 . . . . 3.17 109.803 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.99 -97.17 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.797 -0.638 . . . . 1.69 111.939 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -87.94 -9.65 52.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.235 0.54 . . . . 1.56 110.28 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.86 134.21 34.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.466 -0.788 . . . . 1.25 108.981 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.2 m -94.97 165.68 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.062 0.458 . . . . 1.68 111.912 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.1 m -71.97 143.25 49.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.842 -0.617 . . . . 2.25 111.041 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.9 mt -136.49 -52.92 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.135 0.42 . . . . 1.35 112.135 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -66.22 116.07 6.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.129 0.49 . . . . 2.21 111.788 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.59 -27.86 0.85 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.633 -0.712 . . . . 1.18 111.848 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.5 m -89.56 -10.48 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.36 0.504 . . . . 1.21 112.36 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.72 73.02 1.06 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.802 -0.713 . . . . 1.08 112.606 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.9 pt -116.63 172.3 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.804 0.335 . . . . 1.07 111.011 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.0 ttm-85 -92.68 -28.35 16.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.226 0.536 . . . . 4.33 109.922 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.8 m -77.22 109.55 11.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.651 -0.704 . . . . 1.51 111.068 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 m -93.45 110.69 22.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.231 0.539 . . . . 1.79 110.898 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 171.18 -169.02 42.14 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.119 -0.792 . . . . 1.18 111.119 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.7 t -129.24 124.87 61.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 110.192 -0.299 . . . . 1.56 110.192 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.2 t -73.97 121.12 24.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.692 -0.485 . . . . 1.29 109.692 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.474 ' NH1' ' C2 ' ' C' ' 3' ' ' ' A' . 19.8 mtm180 -114.94 135.97 53.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.914 0.388 . . . . 2.85 110.721 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.1 m -113.89 32.51 5.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.907 -0.588 . . . . 1.47 109.697 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -88.97 -49.63 6.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.467 -0.788 . . . . 0.89 111.73 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -117.3 74.58 8.03 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.7 -0.227 . . . . 2.65 111.587 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -96.34 163.6 1.22 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.943 2.429 . . . . 0.8 112.495 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -170.24 146.11 2.87 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.297 -0.411 . . . . 2.42 110.802 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.4 m -84.68 93.87 8.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.051 0.453 . . . . 1.79 109.915 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.5 pt -84.36 -174.19 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.483 0.659 . . . . 1.15 112.718 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -89.54 132.06 35.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.047 -0.979 . . . . 1.03 110.554 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 51.8 tpp -127.26 26.39 6.03 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.472 -0.936 . . . . 1.29 108.472 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -112.33 -45.92 3.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.518 -0.765 . . . . 3.09 111.093 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.27 -26.09 16.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.179 -0.464 . . . . 1.12 111.409 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -80.06 -43.77 21.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.236 -0.438 . . . . 1.17 111.626 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.99 127.67 2.05 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.831 -0.7 . . . . 1.12 112.759 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -104.05 136.74 13.17 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.849 -0.691 . . . . 1.16 112.077 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -109.47 117.04 32.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.945 -0.391 . . . . 2.87 109.945 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.8 ttp85 -74.55 126.27 30.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.751 0.31 . . . . 2.93 110.943 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.25 -73.36 0.68 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.073 0.463 . . . . 1.29 110.801 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -146.57 -164.52 2.0 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.638 -0.71 . . . . 1.15 109.522 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -143.18 150.66 39.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.755 0.312 . . . . 1.57 110.746 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -102.5 151.96 38.29 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.217 -0.447 . . . . 0.75 110.465 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -66.16 167.22 18.74 Favored 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 122.636 2.224 . . . . 0.95 111.644 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -60.73 -21.4 62.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.977 -0.556 . . . . 1.51 111.537 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -42.24 94.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.928 -0.578 . . . . 1.62 110.599 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.7 mm -76.19 -33.88 24.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.841 -0.618 . . . . 1.31 110.823 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.4 tpt -59.9 -41.36 91.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 1.6 110.99 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -65.64 -35.08 79.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 2.52 110.648 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -60.52 -48.35 82.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.934 -0.576 . . . . 1.64 111.295 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.67 -40.78 90.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.952 -0.567 . . . . 1.03 111.226 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.2 mt -68.54 1.05 3.39 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.225 0.824 . . . . 1.22 113.225 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.12 -1.18 26.8 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.121 -1.038 . . . . 1.03 112.945 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -104.82 -20.56 13.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.9 0.381 . . . . 2.16 111.771 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.5 mt -73.73 -24.82 59.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.001 0.429 . . . . 1.02 111.707 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -28.86 62.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.839 0.352 . . . . 1.11 111.544 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.85 -17.28 61.08 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.055 0.761 . . . . 1.95 113.055 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.1 pt -93.51 -13.62 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 111.978 0.362 . . . . 1.15 111.978 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.408 ' C ' ' HG1' ' A' ' 110' ' ' THR . 93.2 mt -86.39 86.8 7.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.928 0.394 . . . . 0.98 110.939 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.408 ' HG1' ' C ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 116.367 -0.379 . . . . 1.35 111.037 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.404 ' SD ' ' N ' ' B' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.366 0.603 . . . . 2.03 112.577 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 0.404 ' N ' ' SD ' ' B' ' 1' ' ' MET . 30.4 mt-10 -95.62 -7.47 37.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.431 -0.804 . . . . 2.82 109.608 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? 73.42 120.71 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.22 1.193 . . . . 2.66 114.22 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.51 43.54 44.38 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 115.008 0.763 . . . . 1.28 115.008 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -117.55 93.74 4.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.26 0.53 . . . . 1.53 112.377 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 57.2 mt -100.05 102.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.442 -0.947 . . . . 0.75 108.442 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -105.79 145.84 30.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.272 0.558 . . . . 0.82 112.4 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 22.9 tp -102.77 119.73 39.35 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.471 -0.937 . . . . 1.05 108.471 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.93 159.29 4.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.865 0.364 . . . . 0.72 110.788 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.68 121.22 25.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.155 -0.475 . . . . 1.68 110.519 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 88.5 mt -79.69 -20.62 46.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.147 -0.479 . . . . 0.83 110.728 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.07 153.89 90.9 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.639 . . . . 1.62 110.574 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -88.98 162.26 39.68 Favored 'Cis proline' 0 C--O 1.236 0.394 0 C-N-CA 123.438 -1.484 . . . . 1.28 112.053 -0.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.24 160.73 43.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 1.7 110.587 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.29 142.97 37.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.783 0.325 . . . . 1.22 110.61 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.24 -155.62 34.66 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.949 -0.643 . . . . 1.01 112.433 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -85.53 50.43 1.96 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.197 0.443 . . . . 2.62 112.197 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -112.76 163.71 14.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.19 -0.459 . . . . 1.28 109.847 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -73.17 138.28 45.6 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.164 0.802 . . . . 1.98 113.164 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -146.65 -179.73 6.98 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.58 -0.736 . . . . 1.86 110.419 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.24 150.88 21.57 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.125 -0.56 . . . . 0.9 112.549 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 45.2 m -86.34 106.04 17.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.953 0.406 . . . . 1.11 109.925 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.65 159.95 35.11 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.159 -0.473 . . . . 2.0 109.759 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.72 139.8 82.59 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.347 2.031 . . . . 0.65 111.21 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.12 152.33 27.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.39 -0.368 . . . . 0.57 110.509 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 22.9 tp -103.05 121.66 43.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.113 -0.494 . . . . 1.17 109.722 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 10.5 mt -74.31 148.63 8.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.432 -0.349 . . . . 0.66 110.703 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 21.9 t -114.78 -34.18 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.014 0.435 . . . . 0.93 110.988 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.29 138.43 91.85 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.059 -0.519 . . . . 1.1 112.208 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.41 170.27 19.69 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.888 2.392 . . . . 0.78 112.638 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.79 -30.31 71.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.852 -0.613 . . . . 1.03 110.61 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.03 -0.75 8.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.665 -0.698 . . . . 1.4 112.3 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -135.14 -40.53 0.74 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.952 0.406 . . . . 1.57 111.0 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -59.54 -33.05 70.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.834 -0.621 . . . . 1.92 111.471 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -97.41 11.69 35.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.365 -0.379 . . . . 2.93 110.993 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 97.7 t -110.57 -67.03 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 1.09 111.493 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 14.5 p -84.07 -22.83 31.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.764 0.316 . . . . 1.64 110.979 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? 70.35 12.87 7.57 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.596 -0.729 . . . . 2.01 111.689 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 17.1 mt -119.7 90.18 42.78 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.401 -0.962 . . . . 1.16 108.401 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -92.45 161.78 2.98 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.737 2.291 . . . . 0.57 114.134 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.88 130.75 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.173 -1.047 . . . . 1.08 108.173 177.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 23.5 m -120.76 145.48 27.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 112.68 0.622 . . . . 0.64 112.68 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 53.5 t -97.73 118.53 63.97 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.874 -1.057 . . . . 1.1 108.451 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.67 124.27 11.75 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.861 2.374 . . . . 0.73 113.259 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 46.1 t -87.31 139.79 16.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.161 -0.681 . . . . 0.9 109.161 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -120.95 116.09 24.44 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.561 -0.533 . . . . 1.24 109.561 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 9.5 m -56.33 139.06 49.66 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.934 -0.576 . . . . 2.43 112.168 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.17 -4.0 53.95 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.744 -0.662 . . . . 2.22 111.599 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.37 -102.13 2.79 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.003 -0.618 . . . . 3.43 111.916 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -107.66 -19.68 13.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.554 0.216 . . . . 4.91 111.31 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -150.75 147.36 27.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.479 -0.328 . . . . 6.27 110.255 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.93 156.45 46.14 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.441 -0.345 . . . . 4.39 110.257 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -140.85 146.0 36.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.577 -0.283 . . . . 4.51 110.305 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 3.9 t -78.47 137.46 37.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.385 -0.371 . . . . 3.23 110.089 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.33 115.97 2.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.497 -0.32 . . . . 1.96 111.074 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.79 -110.23 3.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.136 -0.554 . . . . 1.14 112.534 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -93.46 -14.38 26.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.976 0.417 . . . . 3.57 110.788 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.55 110.08 10.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 1.08 110.864 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 85.7 t -87.97 131.48 35.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.941 -0.572 . . . . 1.34 109.501 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 9.3 t -88.3 119.05 28.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.409 -0.359 . . . . 1.71 111.131 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 60.3 mt -87.9 -18.11 29.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.723 -0.843 . . . . 1.02 108.723 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -86.46 142.92 28.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.201 -0.909 . . . . 1.79 110.469 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.9 -55.12 0.76 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 121.034 -0.603 . . . . 1.15 111.68 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 13.9 p -73.9 -27.61 22.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.949 0.404 . . . . 1.17 111.638 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.66 68.94 0.33 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.871 -0.681 . . . . 1.05 111.977 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -125.42 148.27 29.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.087 -0.709 . . . . 1.61 109.087 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.32 -50.41 63.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.958 0.409 . . . . 2.65 109.963 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 7.2 m -67.77 94.75 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.851 -0.613 . . . . 0.93 110.501 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 4.5 m -87.15 90.71 8.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.924 -0.58 . . . . 1.62 110.82 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.81 -170.01 35.29 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.376 -0.916 . . . . 0.79 112.383 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 15.6 m -123.12 145.33 30.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.791 0.329 . . . . 0.93 110.667 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.3 m -91.43 136.32 24.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.821 0.343 . . . . 1.38 111.198 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -86.32 82.73 7.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 1.52 110.611 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 2.5 m -79.81 45.93 0.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.017 0.436 . . . . 1.55 110.838 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -135.6 -32.91 0.89 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.927 -0.578 . . . . 1.1 110.949 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -125.69 79.47 67.85 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 112.455 0.539 . . . . 2.83 112.455 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -89.16 143.47 4.76 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.555 2.17 . . . . 0.96 110.647 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -124.53 141.48 52.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.801 0.334 . . . . 2.32 111.765 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.75 121.23 26.62 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.482 -0.932 . . . . 1.21 108.482 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 15.9 pt -126.96 -164.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.045 0.45 . . . . 1.28 111.41 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -115.7 143.87 44.75 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.903 -0.777 . . . . 1.28 108.903 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 11.6 ttp -126.32 31.71 5.34 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.734 0.272 . . . . 2.7 111.734 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -137.65 -42.5 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.181 0.437 . . . . 2.62 112.181 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.21 -29.63 15.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.816 0.341 . . . . 1.06 110.246 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -72.65 -35.73 67.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 1.47 110.628 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.22 106.74 0.99 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.922 -0.656 . . . . 0.92 112.757 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.18 159.91 21.89 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.68 -0.772 . . . . 0.92 112.084 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -151.59 136.12 16.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.026 -0.361 . . . . 2.24 110.026 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -76.93 126.13 30.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.652 0.263 . . . . 2.99 110.583 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 80.1 mt -82.4 -64.17 1.23 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.242 -0.435 . . . . 0.76 110.868 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -139.85 174.17 10.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 1.07 110.311 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -112.34 115.11 28.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.234 0.54 . . . . 2.71 110.903 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.33 133.07 87.48 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.465 -0.789 . . . . 1.45 110.801 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.66 147.56 39.31 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 122.94 2.427 . . . . 1.03 111.999 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.02 -33.37 67.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.996 -0.547 . . . . 2.14 111.021 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.61 -48.97 79.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.862 -0.608 . . . . 2.06 110.799 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 21.2 mm -72.05 -34.48 50.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.771 -0.65 . . . . 1.33 110.48 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 11.8 tpt -59.64 -38.63 81.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 2.34 110.477 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -65.77 -35.83 81.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.889 -0.596 . . . . 2.09 110.853 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -63.55 -46.59 85.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 1.76 109.965 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 24.5 t -58.74 -48.68 85.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.116 -0.493 . . . . 1.01 110.915 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.95 -35.49 76.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.99 -0.55 . . . . 1.29 111.243 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.74 -36.43 92.27 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.259 -0.736 . . . . 1.02 111.259 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -73.45 -34.07 65.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.04 0.448 . . . . 2.34 110.258 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 78.7 mt -71.03 -11.41 60.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.893 -0.594 . . . . 1.94 111.335 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.7 m -77.71 -8.57 58.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.88 0.371 . . . . 1.16 111.488 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.3 m -74.22 -16.17 60.98 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.898 0.333 . . . . 1.85 111.898 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 31.5 pt -79.69 -1.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 111.885 0.328 . . . . 1.98 111.885 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 88.8 mt -102.05 15.99 27.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.246 0.546 . . . . 1.36 110.6 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.252 1.188 0 CA-C-N 115.769 -0.65 . . . . 2.71 110.061 179.691 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.431 -0.553 0 O4'-C1'-C2' 107.707 0.934 . 0.0 '__' . 6.89 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.423 -1.058 0 C4'-C3'-C2' 105.187 2.487 OUTLIER-DELTA 0.0 OUTLIER . 3.15 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' ' A' . . . . . 0.663 ' N3 ' " H2'" ' C' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.429 -0.658 0 C1'-C2'-O2' 108.498 -0.701 . 0.0 OUTLIER gamma 2.89 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C3'--C2' 1.541 1.475 0 C4'-C3'-C2' 105.209 2.509 . 0.0 OUTLIER . 2.51 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' ' A' . . . . . 0.457 H5'' ' N3 ' ' C' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.886 0 O4'-C1'-C2' 107.82 1.014 . 0.0 OUTLIER . 5.55 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 ptp . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.857 0.361 . . . . 1.45 110.481 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -107.66 167.0 10.27 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.103 -0.499 . . . . 2.01 111.095 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -74.03 131.58 41.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.842 -0.617 . . . . 2.16 109.718 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.15 -1.54 43.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 0.87 112.986 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -93.42 149.8 20.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.95 0.375 . . . . 0.99 110.695 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.7 pt -113.07 112.82 42.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.352 0.596 . . . . 1.16 110.402 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.8 m95 -105.48 118.23 36.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.696 -0.683 . . . . 0.91 110.779 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.8 tp -67.02 117.76 9.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.36 -0.382 . . . . 0.9 110.332 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.2 p -156.84 157.14 3.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.939 0.399 . . . . 1.04 111.073 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 t -92.43 124.17 36.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.659 -0.497 . . . . 1.32 109.659 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 mt -76.51 -12.55 60.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.772 -0.649 . . . . 1.29 110.533 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.28 164.24 62.63 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.202 -0.908 . . . . 1.54 111.314 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.92 145.77 54.13 Favored 'Cis proline' 0 C--N 1.353 0.776 0 C-N-CA 124.337 -1.11 . . . . 1.69 112.82 0.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.3 p -120.72 162.57 19.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.142 -0.481 . . . . 1.53 111.829 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.41 146.21 31.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.605 -0.725 . . . . 1.7 109.378 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.15 -129.77 32.16 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.656 -0.783 . . . . 1.18 111.998 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -107.61 14.35 25.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.773 0.32 . . . . 3.12 111.236 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -61.6 128.93 38.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.881 -0.414 . . . . 1.14 109.881 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -49.09 125.77 11.27 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.052 -0.522 . . . . 2.09 112.217 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -123.12 176.56 5.99 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.458 -0.792 . . . . 2.44 111.486 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.15 140.27 8.9 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.705 -0.759 . . . . 1.07 114.116 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 m -81.8 89.44 6.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.035 -1.098 . . . . 1.46 108.035 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -135.26 160.42 68.15 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.822 -0.626 . . . . 2.01 110.419 -177.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.87 125.33 14.05 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.233 1.955 . . . . 1.01 111.387 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.8 m -101.42 132.03 48.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.088 -0.506 . . . . 0.76 110.525 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -81.98 121.24 26.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.928 -0.578 . . . . 0.7 110.879 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.3 mm -70.55 110.04 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.256 -0.429 . . . . 0.92 110.438 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.5 t -89.16 -34.52 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.98 0.419 . . . . 0.95 111.166 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.09 146.25 84.5 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.244 -0.434 . . . . 1.12 111.57 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.1 158.88 49.54 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.55 2.167 . . . . 1.3 111.812 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.39 -41.52 72.76 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.984 -0.553 . . . . 1.39 112.333 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.49 97.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.297 -0.41 . . . . 1.61 111.413 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -64.86 -43.9 91.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.289 -0.414 . . . . 1.77 110.834 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -59.8 -30.55 68.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.589 . . . . 1.48 110.949 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -86.74 -35.29 19.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.564 -0.744 . . . . 3.04 112.426 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.7 p -83.01 -45.19 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 113.274 0.842 . . . . 1.86 113.274 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -84.17 -27.16 28.27 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.185 -0.322 . . . . 2.06 111.071 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 64.75 19.64 11.89 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.02 -0.536 . . . . 4.87 111.304 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.2 tp -143.75 101.08 5.03 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 108.319 -0.993 . . . . 1.81 108.319 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -90.67 150.5 4.18 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.807 2.338 . . . . 1.05 114.183 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.7 t -98.96 116.73 42.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 106.704 -1.591 . . . . 1.03 106.704 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.9 m -125.46 155.38 34.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 113.386 0.884 . . . . 0.79 113.386 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.8 m -120.3 116.23 32.41 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.069 -0.969 . . . . 0.72 109.443 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.26 136.28 31.28 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.837 2.358 . . . . 1.03 113.301 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.3 t -64.8 136.63 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.684 -0.689 . . . . 1.28 110.234 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.99 171.45 8.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.029 -0.532 . . . . 2.5 110.806 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.98 135.58 41.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.165 -0.47 . . . . 2.82 110.007 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.89 -11.4 43.45 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.483 -0.865 . . . . 3.36 112.298 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.72 -152.64 50.71 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.874 -0.679 . . . . 3.83 111.966 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -84.46 -39.52 18.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.044 0.45 . . . . 5.09 110.409 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -113.24 96.29 5.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.986 -0.552 . . . . 6.24 109.933 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.32 97.75 2.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.988 -0.551 . . . . 2.61 110.808 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -128.39 167.59 16.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.054 -0.521 . . . . 5.23 110.198 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.53 140.55 48.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.428 -0.351 . . . . 2.69 111.017 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.53 74.02 0.87 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.114 -0.493 . . . . 3.17 110.012 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.35 -116.9 6.02 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.091 -0.804 . . . . 1.69 111.091 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -82.26 42.44 0.74 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.491 0.662 . . . . 1.56 110.187 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -135.33 107.8 7.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.321 -0.854 . . . . 1.25 109.815 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.5 t -97.35 128.17 48.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.141 -0.481 . . . . 1.68 110.26 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.64 137.38 38.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.154 -0.475 . . . . 2.25 111.389 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 74.2 mt -94.56 17.24 13.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.29 0.567 . . . . 1.35 110.903 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -81.5 137.58 35.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.626 -0.716 . . . . 2.21 110.407 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.25 -26.52 11.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.618 -0.801 . . . . 1.18 113.066 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.8 m -93.17 -24.18 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.106 0.41 . . . . 1.21 112.106 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 68.66 63.37 3.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.795 -0.717 . . . . 1.08 113.284 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.3 pt -108.93 -172.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 O-C-N 122.646 -0.326 . . . . 1.07 110.569 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -93.2 -39.1 11.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.849 0.357 . . . . 4.33 111.432 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 m -64.89 111.7 2.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.302 0.572 . . . . 1.51 111.732 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.28 79.76 2.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.804 -0.634 . . . . 1.79 110.502 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.36 -167.12 14.9 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.783 -0.722 . . . . 1.18 112.144 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 t -118.99 139.11 47.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 110.069 -0.345 . . . . 1.56 110.069 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.0 t -79.72 133.14 30.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.775 0.322 . . . . 1.29 111.136 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.81 154.5 17.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.119 -0.491 . . . . 2.85 110.512 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 58.8 m -141.0 2.57 1.74 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.955 0.407 . . . . 1.47 110.768 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -121.77 5.09 9.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.043 -0.526 . . . . 0.89 111.163 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -122.03 74.76 38.62 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 112.964 0.727 . . . . 2.65 112.964 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.86 119.11 3.53 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.65 2.233 . . . . 0.8 109.908 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -117.72 107.24 13.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.068 0.461 . . . . 2.42 111.747 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.6 90.27 6.09 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.98 -0.748 . . . . 1.79 108.98 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.9 pt -125.75 150.5 31.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.25 -0.432 . . . . 1.15 111.275 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -75.85 124.4 27.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.854 0.359 . . . . 1.03 110.553 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 52.0 tpp -81.61 -20.77 39.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.706 -0.679 . . . . 1.29 112.062 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -65.67 -32.68 74.38 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.767 0.654 . . . . 3.09 112.767 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.86 9.18 40.18 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.115 0.413 . . . . 1.12 112.115 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 40.7 mtt-85 -127.86 -44.46 1.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.27 0.47 . . . . 1.17 112.27 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.91 97.47 0.32 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.815 -0.707 . . . . 1.12 112.38 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -97.75 150.64 19.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.815 -0.707 . . . . 1.16 112.296 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -113.38 113.77 25.68 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.015 -0.365 . . . . 2.87 110.015 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -71.07 118.4 13.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.603 0.24 . . . . 2.93 111.324 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -86.76 -68.56 0.74 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.43 -0.581 . . . . 1.29 109.43 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -151.95 -167.43 2.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.347 -0.842 . . . . 1.15 109.433 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.9 ptm85 -132.81 142.87 49.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.788 0.327 . . . . 1.57 110.702 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.2 m -91.08 158.76 41.07 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.191 -0.459 . . . . 0.75 110.697 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.92 147.33 90.0 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.539 2.16 . . . . 0.95 111.029 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -55.54 -29.32 58.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.057 -0.52 . . . . 1.51 111.945 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.66 -33.3 73.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.909 0.385 . . . . 1.62 111.174 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.7 mm -70.67 -41.22 77.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.213 0.53 . . . . 1.31 109.759 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.6 tpt -66.87 -37.98 85.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.56 -0.745 . . . . 1.6 110.259 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -61.73 -34.87 76.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.905 -0.589 . . . . 2.52 110.477 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.47 -45.52 90.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.008 -0.542 . . . . 1.64 110.787 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.2 t -62.48 -44.12 98.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.044 -0.525 . . . . 1.03 110.581 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.98 -38.02 81.35 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.016 -0.538 . . . . 1.22 111.084 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.86 -41.65 98.7 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.846 -0.692 . . . . 1.03 112.072 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -67.84 -32.85 73.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.933 0.397 . . . . 2.16 110.73 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.03 -25.57 62.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.98 -0.555 . . . . 1.02 110.844 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -74.67 -28.46 60.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.981 0.42 . . . . 1.11 111.276 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.87 -22.22 58.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.382 0.512 . . . . 1.95 112.382 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 pt -89.84 1.83 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.739 0.644 . . . . 1.15 112.739 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.3 mt -86.67 80.85 8.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.544 0.211 . . . . 0.98 110.959 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 111.86 0.318 . . . . 1.35 111.86 -179.879 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.403 ' CG ' ' H ' ' B' ' 2' ' ' GLU . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 121.006 0.432 . . . . 2.03 111.633 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 0.403 ' H ' ' CG ' ' B' ' 1' ' ' MET . 10.3 mt-10 -83.94 -14.59 50.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.816 -0.439 . . . . 2.82 109.816 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 71.95 113.72 0.06 Allowed 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.827 1.047 . . . . 2.66 113.827 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.04 -34.64 4.67 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.726 -0.67 . . . . 1.28 114.71 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.49 106.24 0.62 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.868 0.692 . . . . 1.53 112.868 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 61.3 mt -98.17 128.37 49.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 109.349 -0.611 . . . . 0.75 109.349 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -111.68 153.66 26.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.085 0.469 . . . . 0.82 111.536 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 23.5 tp -113.35 123.57 50.42 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.366 -0.605 . . . . 1.05 109.366 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 p -153.92 156.85 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.54 -0.3 . . . . 0.72 110.535 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 6.8 m -89.47 129.29 35.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.497 -0.32 . . . . 1.68 110.612 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 78.0 mt -81.13 -18.27 47.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.24 0.543 . . . . 0.83 110.308 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.25 153.59 81.27 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.215 -0.902 . . . . 1.62 110.381 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -93.29 92.1 0.14 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.639 -1.4 . . . . 1.28 112.34 -0.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.25 173.82 12.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.182 -0.463 . . . . 1.7 110.144 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.75 168.22 23.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.577 0.227 . . . . 1.22 111.114 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.98 -130.25 30.13 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.932 -0.652 . . . . 1.01 112.024 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -90.28 -1.84 57.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.833 0.349 . . . . 2.62 110.973 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -67.33 123.63 20.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.071 -0.715 . . . . 1.28 109.071 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -52.3 131.38 32.87 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.168 0.803 . . . . 1.98 113.168 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -113.43 139.01 49.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.579 -0.737 . . . . 1.86 109.623 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.32 147.6 8.11 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.835 -0.698 . . . . 0.9 112.93 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 26.9 m -76.69 124.47 27.7 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.06 -0.348 . . . . 1.11 110.06 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.42 158.71 33.36 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.801 -0.444 . . . . 2.0 109.801 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.23 131.55 32.71 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.219 1.946 . . . . 0.65 110.267 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.79 142.47 41.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.134 0.492 . . . . 0.57 111.45 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 18.7 tp -101.51 126.98 48.4 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.223 -0.658 . . . . 1.17 109.223 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 27.7 mt -86.4 144.53 9.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.576 -0.284 . . . . 0.66 110.339 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 45.4 t -108.38 -36.09 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.981 0.419 . . . . 0.93 110.943 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.64 143.79 98.69 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 1.1 112.328 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -66.81 159.4 51.64 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.097 2.531 . . . . 0.78 111.785 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.59 -37.6 73.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.98 -0.555 . . . . 1.03 111.403 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.65 -48.6 81.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 1.4 111.066 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -64.18 -40.3 95.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.046 0.451 . . . . 1.57 110.673 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -67.09 -19.88 65.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.924 -0.58 . . . . 1.92 111.257 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -95.32 -33.64 12.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.271 -0.422 . . . . 2.93 111.943 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 99.1 t -82.39 -71.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.612 0.244 . . . . 1.09 111.367 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.3 -30.04 66.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.781 0.324 . . . . 1.64 110.444 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? 66.96 17.42 10.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.607 -0.724 . . . . 2.01 112.257 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.23 92.85 43.81 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.278 -0.638 . . . . 1.16 109.278 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -90.57 147.38 4.13 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.813 2.342 . . . . 0.57 113.572 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 5.0 m -93.9 118.02 38.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.488 -0.93 . . . . 1.08 108.488 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 35.7 m -108.83 145.79 15.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 112.597 0.592 . . . . 0.64 112.597 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 90.5 t -111.03 115.73 52.52 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.955 -1.02 . . . . 1.1 108.851 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -72.71 123.17 8.8 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.946 2.43 . . . . 0.73 113.287 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.31 138.86 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.824 -0.806 . . . . 0.9 108.824 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.79 168.92 9.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.544 -0.298 . . . . 1.24 110.727 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.41 159.01 25.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.45 -0.341 . . . . 2.43 111.227 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.0 72.63 2.25 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.838 -0.696 . . . . 2.22 112.142 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.68 58.59 4.89 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.075 -0.583 . . . . 3.43 112.367 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -98.79 95.27 7.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.936 0.398 . . . . 4.91 110.191 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -79.46 -34.82 41.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.068 -0.515 . . . . 6.27 110.633 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -130.93 -71.84 0.57 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.061 -0.518 . . . . 4.39 110.188 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -168.25 106.97 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 4.51 110.98 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.7 t -100.11 157.6 16.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.287 -0.415 . . . . 3.23 110.566 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.13 -155.15 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 1.96 109.893 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.69 -98.25 2.38 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.994 -0.622 . . . . 1.14 112.673 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -120.54 5.25 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.016 0.436 . . . . 3.57 111.28 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.61 107.17 18.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.921 -0.581 . . . . 1.08 111.203 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 61.0 t -89.81 122.28 40.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.864 -0.607 . . . . 1.34 109.796 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -82.56 123.91 29.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.298 -0.41 . . . . 1.71 110.829 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 97.2 mt -91.16 -14.13 31.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.2 -0.455 . . . . 1.02 111.328 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -81.84 142.88 32.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.07 -0.514 . . . . 1.79 111.439 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.51 -19.33 12.88 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.919 -0.658 . . . . 1.15 112.672 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -109.62 -12.32 11.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.86 0.362 . . . . 1.17 111.703 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.47 60.58 0.78 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.451 -0.88 . . . . 1.05 112.53 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 78.1 mt -121.12 134.79 63.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.772 -0.455 . . . . 1.61 109.772 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -63.16 -39.28 94.21 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.073 0.463 . . . . 2.65 109.826 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 7.2 m -77.55 73.74 4.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.731 -0.668 . . . . 0.93 109.839 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 13.3 m -73.74 105.3 4.98 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.665 -0.698 . . . . 1.62 110.758 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -177.45 -161.21 25.51 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.784 -0.722 . . . . 0.79 112.118 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 m -124.27 136.33 60.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.962 0.411 . . . . 0.93 110.967 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 32.3 t -88.93 122.76 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.863 -0.608 . . . . 1.38 110.346 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 21.9 mmm-85 -92.57 81.48 4.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.926 0.393 . . . . 1.52 110.336 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.77 1.33 10.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.942 -0.572 . . . . 1.55 112.089 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.09 -7.89 59.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.334 -0.394 . . . . 1.1 111.463 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -142.53 84.34 11.18 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 113.459 0.911 . . . . 2.83 113.459 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.46 132.93 4.42 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.049 2.499 . . . . 0.96 110.277 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.48 127.06 45.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.244 0.461 . . . . 2.32 112.244 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.06 123.24 31.14 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.006 -0.739 . . . . 1.21 109.006 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 35.9 pt -134.61 154.11 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.545 0.212 . . . . 1.28 111.269 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.45 109.59 5.52 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.262 -0.426 . . . . 1.28 110.428 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 51.7 tpp -78.44 -13.07 60.01 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.572 0.582 . . . . 2.7 112.572 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -81.64 -44.06 17.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.96 0.409 . . . . 2.62 111.188 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.66 -23.58 56.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.132 -0.485 . . . . 1.06 111.73 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 55.8 mtt-85 -96.16 -47.96 5.84 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.365 0.505 . . . . 1.47 112.365 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.3 101.05 0.6 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.623 -0.799 . . . . 0.92 112.398 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -97.76 142.08 15.94 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.816 -0.707 . . . . 0.92 112.291 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -123.33 128.69 50.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.384 -0.228 . . . . 2.24 110.384 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -69.56 132.61 46.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.767 0.318 . . . . 2.99 111.005 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 93.7 mt -100.29 -69.52 0.77 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.76 111.338 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -142.4 -176.36 4.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.146 -0.479 . . . . 1.07 110.259 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -125.9 118.0 24.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.79 0.329 . . . . 2.71 111.291 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 2.5 p -80.11 131.36 63.09 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 1.45 110.503 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -50.2 145.47 20.32 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.239 2.626 . . . . 1.03 112.312 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -58.49 -27.51 64.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 2.14 112.504 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.32 -38.81 84.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.193 0.52 . . . . 2.06 110.352 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 19.8 mm -86.05 -33.65 7.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.804 -0.635 . . . . 1.33 109.72 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 11.5 tpt -63.01 -33.22 74.95 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.201 0.524 . . . . 2.34 110.225 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -61.13 -38.47 86.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.499 -0.773 . . . . 2.09 110.188 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -60.18 -41.17 92.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.916 -0.584 . . . . 1.76 110.684 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 34.2 t -60.44 -46.87 94.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.978 -0.555 . . . . 1.01 109.963 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 71.2 mt -62.49 -36.3 82.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.97 -0.559 . . . . 1.29 110.274 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.08 -43.49 97.2 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.6 -0.727 . . . . 1.02 111.801 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -66.23 -32.21 73.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.055 0.455 . . . . 2.34 110.451 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 79.8 mt -71.18 -13.85 62.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.976 -0.556 . . . . 1.94 111.232 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 10.8 m -84.04 -24.44 30.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.122 0.487 . . . . 1.16 110.395 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.33 -29.18 63.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 1.85 111.571 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 49.8 pt -80.39 -3.58 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.727 0.299 . . . . 1.98 111.657 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 96.4 mt -86.04 12.8 8.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.197 0.523 . . . . 1.36 110.669 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.246 0.901 0 N-CA-C 109.301 -0.629 . . . . 2.71 109.301 179.766 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.761 0 C1'-C2'-O2' 108.38 -0.74 . 0.0 '__' . 6.89 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' ' U' . . . . . 0.402 " O2'" ' OP2' ' C' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.95 0 C3'-C2'-C1' 100.579 -1.023 . 0.0 OUTLIER beta 3.15 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' ' A' . . . . . 0.712 ' N3 ' " H2'" ' C' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.856 0 C4'-C3'-C2' 103.618 0.918 . 0.0 OUTLIER gamma 2.89 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.908 0 N19-C1'-C2' 115.268 1.167 . 0.0 OUTLIER . 2.51 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.786 0 C4'-C3'-C2' 103.759 1.059 . 0.0 OUTLIER gamma 5.55 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 ptp . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.901 0.382 . . . . 1.45 110.779 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.444 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 43.8 mt-10 -123.16 -173.63 2.76 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.685 -0.689 . . . . 2.01 110.376 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -89.16 133.39 34.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.996 -0.547 . . . . 2.16 110.898 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.23 13.88 52.95 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.791 -0.719 . . . . 0.87 112.997 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 83.3 mt-10 -98.67 153.21 18.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.717 0.294 . . . . 0.99 110.571 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pt -118.46 110.17 29.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.134 -0.485 . . . . 1.16 109.917 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -102.53 122.47 44.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.885 -0.598 . . . . 0.91 110.831 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.8 tp -82.7 131.89 35.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.116 -0.493 . . . . 0.9 111.364 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.4 p -172.59 159.65 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.201 -0.454 . . . . 1.04 110.245 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.7 m -82.74 141.47 32.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.616 0.246 . . . . 1.32 110.767 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.3 mt -95.32 -11.44 27.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.113 0.482 . . . . 1.29 110.86 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.49 174.46 5.1 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.707 -0.679 . . . . 1.54 110.95 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -73.12 142.47 74.87 Favored 'Cis proline' 0 C--N 1.354 0.851 0 C-N-CA 124.609 -0.996 . . . . 1.69 112.386 -0.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.7 p -122.44 175.55 6.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 1.53 110.993 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.01 103.49 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 1.7 110.319 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.59 -151.84 18.13 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.838 -0.696 . . . . 1.18 111.658 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -105.98 37.15 2.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.531 0.682 . . . . 3.12 110.374 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -79.86 -170.37 2.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.615 . . . . 1.14 109.691 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -77.06 87.11 3.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.271 0.557 . . . . 2.09 110.678 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -107.07 172.9 6.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.238 -0.892 . . . . 2.44 111.289 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.3 177.61 28.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.977 -0.63 . . . . 1.07 113.74 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.3 m -114.12 129.49 56.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.623 -0.51 . . . . 1.46 109.623 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.78 160.44 11.48 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.142 -0.318 . . . . 2.01 110.142 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -73.5 135.6 22.4 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.302 2.001 . . . . 1.01 110.869 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.7 m -108.38 136.39 44.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.219 -0.446 . . . . 0.76 110.28 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.8 tp -86.6 125.67 33.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.363 -0.381 . . . . 0.7 111.045 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.1 mm -74.83 117.24 18.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.318 -0.401 . . . . 0.92 110.371 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -92.16 -37.8 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.057 -0.52 . . . . 0.95 111.236 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.75 150.96 82.18 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.619 0.6 . . . . 1.12 112.619 -179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.88 158.71 42.47 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.75 2.3 . . . . 1.3 111.934 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.57 -39.85 65.13 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.563 0.579 . . . . 1.39 112.563 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.92 99.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.356 . . . . 1.61 111.196 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -69.17 -40.93 77.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.014 -0.539 . . . . 1.77 110.419 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -64.36 -26.13 68.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 1.48 110.773 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -78.26 -25.46 46.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.986 -0.552 . . . . 3.04 111.873 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -96.34 -43.88 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.535 0.569 . . . . 1.86 112.535 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 m -81.28 -25.74 36.3 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.87 0.322 . . . . 2.06 111.87 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 71.69 -2.8 2.35 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.039 0.536 . . . . 4.87 112.217 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 mt -131.33 114.47 15.96 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.379 -0.6 . . . . 1.81 109.379 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -89.14 131.56 2.17 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.802 2.335 . . . . 1.05 113.137 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.78 121.09 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.873 -1.158 . . . . 1.03 107.873 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.4 m -128.24 153.2 37.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 113.485 0.92 . . . . 0.79 113.485 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -114.27 131.1 23.42 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 114.685 -1.143 . . . . 0.72 108.788 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.83 114.1 3.95 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.793 2.329 . . . . 1.03 113.973 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.3 t -79.72 99.54 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.089 -0.708 . . . . 1.28 109.089 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 m -120.38 -115.78 0.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.422 -0.354 . . . . 2.5 111.394 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.94 164.73 28.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.5 0.191 . . . . 2.82 110.927 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.97 74.74 0.41 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.288 -0.725 . . . . 3.36 111.288 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.02 -71.1 3.01 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.793 -0.718 . . . . 3.83 111.365 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -163.65 -50.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.819 0.342 . . . . 5.09 111.081 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -86.43 143.82 27.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.328 -0.396 . . . . 6.24 111.043 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.47 65.1 8.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.145 0.498 . . . . 2.61 110.932 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -123.07 -169.29 1.9 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.706 -0.679 . . . . 5.23 109.951 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.69 78.22 2.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.052 0.453 . . . . 2.69 110.758 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.01 82.29 7.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.066 -0.515 . . . . 3.17 110.706 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.55 -96.4 0.35 Allowed Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.898 -0.592 . . . . 1.69 112.418 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -95.1 -8.38 36.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.907 0.384 . . . . 1.56 110.956 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.56 142.85 32.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.208 -0.664 . . . . 1.25 109.208 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.4 m -94.82 156.14 3.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.174 0.511 . . . . 1.68 112.133 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.26 106.05 17.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.573 -0.74 . . . . 2.25 111.394 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.1 mt -91.51 -32.13 15.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.179 0.514 . . . . 1.35 110.751 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -75.19 112.37 11.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.072 -0.513 . . . . 2.21 110.628 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.46 -23.01 0.75 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.599 -0.6 . . . . 1.18 111.599 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.7 m -100.99 1.84 10.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 111.82 0.304 . . . . 1.21 111.82 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.59 47.41 34.4 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.958 -0.639 . . . . 1.08 113.147 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pp -84.79 173.71 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.673 0.273 . . . . 1.07 111.348 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.2 ttm105 -98.54 -55.66 2.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.556 -0.293 . . . . 4.33 110.739 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.0 m -62.01 101.62 0.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.187 0.518 . . . . 1.51 110.822 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.73 83.27 5.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.86 -0.609 . . . . 1.79 111.339 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -143.1 158.25 27.15 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.783 -0.722 . . . . 1.18 111.674 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.3 t -105.82 107.11 21.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.954 -0.388 . . . . 1.56 109.954 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.44 116.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.39 . . . . 1.29 110.628 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.435 ' NH2' " O2'" ' C' ' 2' ' ' ' U' . 74.8 mtp180 -102.78 119.34 38.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.084 -0.507 . . . . 2.85 111.686 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.8 m -103.52 5.88 37.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.429 0.633 . . . . 1.47 109.515 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.59 -33.79 31.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.454 -0.794 . . . . 0.89 111.574 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -130.38 64.02 71.41 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.677 -0.238 . . . . 2.65 110.951 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.56 164.85 20.88 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.092 1.861 . . . . 0.8 112.237 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -166.7 118.02 0.95 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 2.42 110.999 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 78.3 m -72.72 109.66 6.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.383 -0.371 . . . . 1.79 110.295 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.0 pt -103.08 165.95 2.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.704 -0.68 . . . . 1.15 111.225 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -82.78 136.99 34.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.644 -0.707 . . . . 1.03 109.896 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 27.6 tpp -111.46 1.59 17.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.273 -0.421 . . . . 1.29 111.216 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -91.28 -56.42 3.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.564 -0.289 . . . . 3.09 111.768 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.84 -29.98 44.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.378 . . . . 1.12 111.14 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 72.3 mtt-85 -76.35 -39.74 53.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.31 -0.405 . . . . 1.17 110.8 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.29 82.19 0.15 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.952 -0.642 . . . . 1.12 112.914 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -81.93 168.0 48.55 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.807 -0.711 . . . . 1.16 112.848 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -121.53 121.94 38.59 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.18 -0.304 . . . . 2.87 110.18 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.38 120.66 23.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.82 0.343 . . . . 2.93 111.194 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -86.71 -67.17 0.83 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.139 -0.482 . . . . 1.29 110.511 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -153.57 -174.05 4.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.946 -0.57 . . . . 1.15 109.58 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -130.58 140.15 50.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.056 0.455 . . . . 1.57 110.355 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.0 m -94.15 152.03 40.03 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.865 -0.607 . . . . 0.75 110.801 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.38 162.57 17.09 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.889 2.393 . . . . 0.95 111.947 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -62.86 -24.23 67.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 1.51 111.066 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.66 -35.46 80.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 1.62 110.702 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.4 mm -69.95 -31.02 46.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.397 -0.594 . . . . 1.31 109.397 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.7 tpt -64.89 -34.16 77.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.721 -0.672 . . . . 1.6 109.641 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -63.12 -40.39 97.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.675 -0.693 . . . . 2.52 109.404 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -58.66 -49.35 77.86 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.543 -0.753 . . . . 1.64 109.857 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.9 t -62.29 -49.11 85.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.573 -0.74 . . . . 1.03 110.901 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.5 mt -56.74 -43.31 80.57 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.271 -0.422 . . . . 1.22 111.194 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.36 -40.85 98.08 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.115 -0.564 . . . . 1.03 112.524 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -71.05 -43.07 68.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.896 0.379 . . . . 2.16 110.914 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.89 -31.4 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 1.02 111.676 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.1 m -69.03 -16.51 63.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.409 -0.359 . . . . 1.11 111.521 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.4 m -93.85 -24.45 17.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.693 0.257 . . . . 1.95 111.693 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.7 pt -84.06 -20.9 8.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 112.08 0.4 . . . . 1.15 112.08 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 97.3 mt -77.01 79.23 3.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.013 0.435 . . . . 0.98 111.603 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.929 -0.578 . . . . 1.35 110.364 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.288 0 N-CA-C 112.756 0.65 . . . . 2.03 112.756 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -71.13 -22.42 62.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.629 -0.714 . . . . 2.82 110.848 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? 78.82 123.73 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.951 0.722 . . . . 2.66 112.951 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.09 49.22 6.07 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.478 -0.783 . . . . 1.28 113.683 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -125.37 90.38 3.21 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.473 0.546 . . . . 1.53 112.473 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 64.0 mt -99.86 104.39 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.184 -1.043 . . . . 0.75 108.184 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -103.79 166.49 10.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.925 -0.579 . . . . 0.82 111.59 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 55.4 tp -118.39 112.34 19.87 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.196 -0.668 . . . . 1.05 109.196 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 p -136.61 156.17 35.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.301 -0.409 . . . . 0.72 110.362 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 5.8 t -90.28 127.22 36.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.402 -0.592 . . . . 1.68 109.402 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 20.5 mt -94.67 -25.88 16.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.192 0.52 . . . . 0.83 110.49 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.83 147.24 98.86 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.754 . . . . 1.62 110.85 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.513 ' C ' ' HG1' ' B' ' 14' ' ' THR . 10.1 Cg_endo -87.97 160.66 45.16 Favored 'Cis proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.601 -1.416 . . . . 1.28 111.978 0.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.513 ' HG1' ' C ' ' B' ' 13' ' ' PRO . 14.0 m -156.74 124.74 5.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.377 -0.374 . . . . 1.7 110.219 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.78 164.75 14.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.388 -0.369 . . . . 1.22 110.802 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.06 -164.33 35.23 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.795 -0.717 . . . . 1.01 112.511 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -99.23 31.34 3.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.871 0.367 . . . . 2.62 110.641 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.38 -167.7 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 1.28 111.206 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -98.85 101.21 12.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.32 -0.4 . . . . 1.98 110.832 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -102.59 -178.47 3.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.129 -0.487 . . . . 1.86 110.148 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.53 130.64 5.33 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.89 -0.671 . . . . 0.9 112.363 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 56.4 m -76.68 94.74 3.84 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.423 -0.584 . . . . 1.11 109.423 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.3 165.96 32.85 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.498 -0.774 . . . . 2.0 110.19 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.79 145.54 82.71 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.714 2.276 . . . . 0.65 112.016 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 10.5 m -135.47 145.92 30.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.898 -0.592 . . . . 0.57 111.138 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 48.2 tp -103.62 125.96 50.46 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.009 -0.541 . . . . 1.17 109.573 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 23.5 mt -78.47 140.75 16.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.58 0.228 . . . . 0.66 111.148 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.85 -31.95 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.9 0.381 . . . . 0.93 111.621 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.42 130.15 91.04 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.502 -0.317 . . . . 1.1 111.728 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.74 162.29 41.58 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.013 2.475 . . . . 0.78 112.725 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.54 -31.2 63.93 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.79 -0.641 . . . . 1.03 112.614 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.43 -18.56 40.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 1.4 112.077 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -122.4 -33.04 3.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.994 0.426 . . . . 1.57 110.187 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -56.12 -41.49 75.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.52 -0.764 . . . . 1.92 111.781 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -85.73 6.1 29.32 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.804 0.668 . . . . 2.93 112.804 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.05 -65.39 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.173 0.511 . . . . 1.09 110.354 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 13.2 p -81.35 -23.83 37.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.868 -0.606 . . . . 1.64 110.834 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 67.33 16.93 10.16 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.632 -0.713 . . . . 2.01 111.432 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 13.3 mt -128.18 94.71 35.56 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.19 -1.041 . . . . 1.16 108.19 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -91.54 159.66 3.59 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.582 2.188 . . . . 0.57 113.585 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 15.2 m -94.37 131.92 39.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.236 -1.024 . . . . 1.08 108.236 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.0 153.18 29.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 113.066 0.765 . . . . 0.64 113.066 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 42.7 t -106.63 114.2 62.16 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 114.647 -1.16 . . . . 1.1 108.411 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.62 123.39 10.71 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.69 2.26 . . . . 0.73 112.555 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 48.9 t -77.65 123.38 34.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.348 -0.612 . . . . 0.9 109.348 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.75 102.49 15.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.311 -0.404 . . . . 1.24 110.44 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.47 89.73 0.95 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.066 -0.516 . . . . 2.43 110.573 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.8 -14.42 77.69 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.766 -0.73 . . . . 2.22 112.104 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.92 -84.65 0.16 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.022 -0.609 . . . . 3.43 111.597 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.62 -39.23 17.54 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.268 0.556 . . . . 4.91 109.507 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -90.09 88.2 7.18 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.791 -0.64 . . . . 6.27 110.806 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.59 81.49 1.88 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.554 -0.748 . . . . 4.39 109.972 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.17 150.59 49.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.935 -0.575 . . . . 4.51 110.386 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.19 127.54 31.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.227 -0.442 . . . . 3.23 110.433 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -127.16 46.09 2.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.47 -0.332 . . . . 1.96 111.47 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.22 -73.46 1.78 Allowed Glycine 0 CA--C 1.516 0.149 0 C-N-CA 121.005 -0.617 . . . . 1.14 112.831 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -88.18 -11.08 47.84 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.195 0.521 . . . . 3.57 110.924 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.98 116.81 30.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.975 -0.557 . . . . 1.08 110.211 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 49.5 t -90.71 135.04 27.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.295 -0.411 . . . . 1.34 110.102 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 19.0 t -87.7 138.5 31.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.965 0.412 . . . . 1.71 111.23 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 69.0 mt -101.63 5.34 41.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.05 -0.722 . . . . 1.02 109.05 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.09 157.41 18.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.07 -0.968 . . . . 1.79 110.638 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.51 -62.94 0.3 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.702 -0.761 . . . . 1.15 112.92 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.96 -31.72 51.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.865 0.364 . . . . 1.17 111.95 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.12 79.75 1.15 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.554 -0.831 . . . . 1.05 113.067 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 45.9 mt -123.71 152.79 29.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.737 -0.838 . . . . 1.61 108.737 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -63.48 -48.69 76.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.625 0.25 . . . . 2.65 111.433 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 12.1 m -78.83 99.87 6.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.237 0.541 . . . . 0.93 111.685 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.8 88.61 6.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.718 -0.674 . . . . 1.62 110.751 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -163.16 -170.64 28.34 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.298 -0.953 . . . . 0.79 112.669 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.5 m -124.67 136.92 59.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.849 0.357 . . . . 0.93 110.333 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 16.1 m -86.55 133.23 30.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.313 -0.403 . . . . 1.38 111.404 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -88.75 85.74 6.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.565 -0.531 . . . . 1.52 109.565 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 1.1 m -65.68 -15.26 62.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.355 0.598 . . . . 1.55 111.116 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.28 -12.74 51.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.501 -0.772 . . . . 1.1 111.12 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -126.38 66.23 61.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 114.233 1.197 . . . . 2.83 114.233 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.76 142.43 15.95 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.786 1.657 . . . . 0.96 109.159 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -138.36 144.01 40.11 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.747 -0.381 . . . . 2.32 111.882 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.76 140.38 33.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.788 -0.642 . . . . 1.21 109.714 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.96 157.8 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.935 0.397 . . . . 1.28 111.426 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -85.39 110.82 19.4 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.813 -0.81 . . . . 1.28 108.813 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 13.7 ttp -78.62 -3.52 44.32 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.44 0.904 . . . . 2.7 113.44 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 10.3 pttt -117.63 -45.08 2.71 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.002 0.742 . . . . 2.62 113.002 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.37 -38.75 41.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.793 0.33 . . . . 1.06 111.67 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -79.89 -25.28 40.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.525 -0.307 . . . . 1.47 111.055 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.84 132.02 1.74 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.661 -0.78 . . . . 0.92 111.849 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.39 148.15 14.42 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.157 -1.02 . . . . 0.92 113.16 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -146.49 157.43 43.75 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.786 -0.45 . . . . 2.24 109.786 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -82.45 126.0 31.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.696 0.284 . . . . 2.99 110.601 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 50.4 mt -89.68 -51.43 5.52 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 0.76 110.7 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -150.16 170.55 18.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.968 -0.56 . . . . 1.07 111.812 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -115.5 115.27 26.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.742 -0.663 . . . . 2.71 110.361 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 11.9 p -74.08 134.5 77.53 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.966 -0.561 . . . . 1.45 110.629 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.03 148.3 48.77 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.822 2.348 . . . . 1.03 112.195 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -55.39 -34.05 64.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.805 -0.634 . . . . 2.14 111.601 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.87 -49.03 79.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.219 0.533 . . . . 2.06 110.942 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 21.1 mm -74.19 -39.88 50.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.878 -0.601 . . . . 1.33 110.491 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 8.3 tpt -58.54 -42.36 87.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.985 0.421 . . . . 2.34 110.545 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -63.5 -35.36 80.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.939 -0.573 . . . . 2.09 110.478 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -62.82 -42.46 99.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.023 -0.535 . . . . 1.76 110.388 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 39.9 t -61.53 -45.14 99.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.976 -0.556 . . . . 1.01 110.525 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.46 -38.41 87.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.017 -0.538 . . . . 1.29 110.586 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.14 -42.86 94.19 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.692 -0.686 . . . . 1.02 111.579 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -69.33 -29.5 67.34 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.806 0.336 . . . . 2.34 110.72 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 11.3 mt -66.64 -23.17 66.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 1.94 110.535 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 24.2 m -82.76 -8.61 59.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.347 -0.388 . . . . 1.16 111.767 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.84 -15.87 61.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 1.85 111.778 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 37.2 pt -88.18 -1.11 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.807 0.337 . . . . 1.98 111.111 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 58.8 mt -87.42 -4.94 59.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.034 -0.53 . . . . 1.36 111.048 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.687 -0.673 . . . . 2.71 109.81 179.618 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.603 0 C3'-C2'-C1' 100.881 -0.687 . 0.0 '__' . 6.89 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' ' U' . . . . . 0.75 " H4'" ' N7 ' ' C' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.401 -1.076 0 C4'-C3'-C2' 105.283 2.583 OUTLIER-DELTA 0.0 OUTLIER delta 3.15 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' ' A' . . . . . 0.75 ' N7 ' " H4'" ' C' ' 2' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.845 0 C1'-C2'-O2' 108.292 -0.769 . 0.0 OUTLIER delta-1 2.89 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' ' C' . . . . . 0.573 H5'' " O2'" ' C' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.755 0 O4'-C4'-C3' 102.527 -2.123 . 0.0 OUTLIER . 2.51 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' ' A' . . . . . 0.558 ' N3 ' " H2'" ' C' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.985 0 C5'-C4'-O4' 108.054 -0.818 . 0.0 OUTLIER . 5.55 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptp . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.89 0.376 . . . . 1.45 110.783 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -123.22 168.12 12.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.886 -0.597 . . . . 2.01 110.828 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -63.52 128.73 37.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.973 -0.558 . . . . 2.16 110.642 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.74 -20.84 17.25 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.756 -0.735 . . . . 0.87 113.112 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -83.49 145.49 28.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.794 0.297 . . . . 0.99 111.309 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.2 pt -112.91 130.49 66.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.879 0.371 . . . . 1.16 110.746 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.4 m95 -116.22 117.58 30.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.152 -0.476 . . . . 0.91 111.098 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.7 tp -76.07 113.44 13.59 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.791 -0.448 . . . . 0.9 109.791 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 p -150.66 159.92 4.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.61 -0.268 . . . . 1.04 110.738 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 t -97.25 132.4 43.04 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.499 -0.556 . . . . 1.32 109.499 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.4 mt -86.29 -11.65 51.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.403 -0.362 . . . . 1.29 111.509 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.18 164.59 17.44 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.803 -0.635 . . . . 1.54 112.649 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -83.34 111.63 2.28 Favored 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 123.553 -1.436 . . . . 1.69 112.572 0.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.49 150.49 26.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.106 -0.497 . . . . 1.53 111.298 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -130.02 167.21 18.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.002 -0.545 . . . . 1.7 110.533 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.8 -150.55 48.05 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.893 -0.883 . . . . 1.18 110.893 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -85.62 4.14 37.62 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.093 0.446 . . . . 3.12 111.338 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -65.33 134.38 53.45 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.134 -0.321 . . . . 1.14 110.134 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -54.77 124.45 16.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.951 -0.568 . . . . 2.09 112.098 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.85 -178.81 4.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.722 -0.672 . . . . 2.44 110.195 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.26 164.52 39.32 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.861 -0.685 . . . . 1.07 113.917 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 m -91.96 124.76 36.31 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.078 -0.712 . . . . 1.46 109.078 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.88 158.06 26.4 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 110.466 -0.198 . . . . 2.01 110.466 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.86 121.04 5.69 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.957 1.771 . . . . 1.01 111.335 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.4 m -95.59 131.07 43.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.082 -0.508 . . . . 0.76 110.532 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.8 tp -87.91 122.64 31.78 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.788 -0.642 . . . . 0.7 110.825 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.0 mm -71.11 111.45 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.794 -0.446 . . . . 0.92 109.794 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -92.32 -37.12 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.275 -0.42 . . . . 0.95 111.724 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.85 148.85 82.5 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 111.719 0.266 . . . . 1.12 111.719 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.69 161.2 45.94 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.598 2.199 . . . . 1.3 111.879 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.11 -35.79 74.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.026 -0.534 . . . . 1.39 111.567 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.64 -43.56 89.81 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.241 -0.436 . . . . 1.61 111.672 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -71.94 -48.39 45.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.889 -0.596 . . . . 1.77 110.786 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -59.25 -32.68 70.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.024 -0.534 . . . . 1.48 111.123 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -64.85 -30.08 71.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.852 -0.613 . . . . 3.04 112.136 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 p -96.32 -47.28 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 113.575 0.954 . . . . 1.86 113.575 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.1 p -78.34 -28.61 47.26 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.72 0.637 . . . . 2.06 112.72 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 74.04 -1.09 3.17 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.585 0.553 . . . . 4.87 111.567 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.9 mt -126.05 107.3 25.02 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.317 -0.624 . . . . 1.81 109.317 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -89.09 139.78 3.76 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.73 2.287 . . . . 1.05 113.018 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.8 t -79.79 113.66 19.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.015 -1.476 . . . . 1.03 107.015 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.46 165.33 19.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 112.711 0.634 . . . . 0.79 112.711 -177.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.54 125.92 24.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.711 -1.131 . . . . 0.72 108.797 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.42 131.59 8.6 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.691 2.26 . . . . 1.03 113.667 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.1 t -78.77 128.63 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.942 -0.762 . . . . 1.28 108.942 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.5 p -115.9 -160.44 0.75 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.217 -0.193 . . . . 2.5 111.388 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.1 m -111.01 153.41 25.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.769 0.318 . . . . 2.82 111.202 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.23 19.82 3.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.491 -0.862 . . . . 3.36 112.525 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.12 -112.75 4.34 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.597 -0.811 . . . . 3.83 111.987 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -104.38 -52.11 2.98 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.733 -0.469 . . . . 5.09 109.733 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -121.33 158.54 27.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.675 -0.693 . . . . 6.24 109.623 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -92.52 174.1 7.45 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.209 -0.293 . . . . 2.61 110.209 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.9 ptt85 -169.69 167.11 9.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.203 -0.453 . . . . 5.23 109.994 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.03 67.65 1.75 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.991 0.424 . . . . 2.69 111.72 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.54 73.22 5.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.353 0.597 . . . . 3.17 110.13 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.04 -98.27 1.83 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.355 -0.839 . . . . 1.69 111.43 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -103.37 15.12 29.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.178 0.513 . . . . 1.56 110.995 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.44 153.5 19.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.741 -0.663 . . . . 1.25 109.439 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.13 163.11 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.874 0.369 . . . . 1.68 111.755 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.9 m -82.53 133.74 35.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.794 -0.639 . . . . 2.25 110.78 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 18.3 mt -103.48 -32.15 9.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.191 0.52 . . . . 1.35 110.775 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.78 97.9 1.87 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.369 0.604 . . . . 2.21 110.814 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.82 -8.29 4.87 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.803 -0.713 . . . . 1.18 112.605 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.5 m -94.33 -1.9 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.851 0.325 . . . . 1.21 111.701 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.08 54.44 5.25 Favored Glycine 0 C--O 1.236 0.228 0 C-N-CA 121.16 -0.543 . . . . 1.08 113.937 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.6 pt -129.67 171.92 16.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 122.823 -0.222 . . . . 1.07 110.666 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -104.82 -23.74 12.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.895 -0.409 . . . . 4.33 109.895 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.1 m -52.74 107.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.468 -0.787 . . . . 1.51 111.378 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.73 90.71 8.34 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.589 -0.732 . . . . 1.79 111.126 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.71 -151.47 10.43 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.941 -0.864 . . . . 1.18 110.941 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.83 131.13 37.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.986 0.422 . . . . 1.56 110.797 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.1 t -97.96 142.88 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.27 -0.423 . . . . 1.29 109.922 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.446 ' NH1' ' C2 ' ' C' ' 3' ' ' ' A' . 0.0 OUTLIER -150.39 163.9 37.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.381 -0.372 . . . . 2.85 110.311 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.32 13.94 20.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.757 0.313 . . . . 1.47 111.383 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -86.95 -3.18 59.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 0.89 112.075 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -129.96 64.65 72.99 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.758 -0.201 . . . . 2.65 111.42 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -94.82 131.49 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.619 2.213 . . . . 0.8 113.003 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -161.43 154.91 21.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.951 0.405 . . . . 2.42 111.594 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.85 130.02 36.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.186 -0.672 . . . . 1.79 109.186 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.7 pt -131.1 157.28 43.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.961 0.41 . . . . 1.15 111.111 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -87.84 133.19 33.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.854 -0.612 . . . . 1.03 110.596 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 43.7 tpp -120.09 21.76 11.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.128 -0.487 . . . . 1.29 110.286 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -107.31 -38.58 5.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.096 -0.502 . . . . 3.09 110.794 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.71 -26.18 15.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.994 -0.548 . . . . 1.12 111.203 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -76.47 -59.76 2.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.852 0.358 . . . . 1.17 111.154 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.29 89.7 1.39 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.84 -0.695 . . . . 1.12 111.478 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -95.97 172.29 29.42 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.666 -0.778 . . . . 1.16 112.561 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -121.36 109.39 14.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.764 -0.458 . . . . 2.87 109.764 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.16 128.18 34.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.501 0.191 . . . . 2.93 110.795 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.56 -89.04 0.37 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.589 -0.278 . . . . 1.29 110.881 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -122.09 -172.78 2.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.51 -0.314 . . . . 1.15 110.409 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -140.57 133.88 29.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.94 0.4 . . . . 1.57 110.449 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.42 155.21 66.25 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.113 -0.494 . . . . 0.75 111.411 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.54 149.38 89.98 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.47 2.114 . . . . 0.95 111.941 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -60.77 -23.21 64.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.892 -0.595 . . . . 1.51 111.488 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -38.07 89.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.243 -0.435 . . . . 1.62 109.851 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.7 mm -71.6 -37.92 65.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.916 -0.584 . . . . 1.31 109.5 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 84.6 mmm -62.06 -36.9 83.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.616 -0.72 . . . . 1.6 110.234 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -62.52 -35.98 81.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.752 -0.658 . . . . 2.52 110.548 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -63.84 -46.63 84.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.5 -0.556 . . . . 1.64 109.5 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.73 -47.27 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.688 -0.687 . . . . 1.03 110.446 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.3 mt -61.86 -33.84 74.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 1.22 111.121 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.95 -17.57 75.55 Favored Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.904 -0.589 . . . . 1.03 113.091 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -97.86 -24.98 15.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.973 0.416 . . . . 2.16 110.786 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 90.6 mt -68.42 -25.45 65.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.139 -0.482 . . . . 1.02 111.398 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -16.53 64.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.835 0.35 . . . . 1.11 111.568 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.76 -16.5 32.02 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.193 0.442 . . . . 1.95 112.193 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.3 pt -91.9 -9.34 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.641 0.608 . . . . 1.15 112.641 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.7 mt -87.73 82.91 7.24 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.915 -0.402 . . . . 0.98 109.915 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 N-CA-C 113.006 0.743 . . . . 1.35 113.006 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.326 0 N-CA-C 109.61 -0.515 . . . . 2.03 109.61 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -77.97 -5.42 51.19 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.719 -0.474 . . . . 2.82 109.719 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 60.69 80.19 0.22 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.099 -0.955 . . . . 2.66 112.968 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.69 -32.69 2.35 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.092 -1.052 . . . . 1.28 113.826 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -64.63 109.62 2.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.062 0.458 . . . . 1.53 112.169 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 51.4 mt -98.8 130.7 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.371 -0.603 . . . . 0.75 109.371 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -115.44 178.32 4.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.037 0.446 . . . . 0.82 111.316 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 tt -146.22 133.7 20.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.086 -0.506 . . . . 1.05 110.032 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -167.16 164.75 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.504 -0.316 . . . . 0.72 110.182 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 6.0 t -88.83 140.56 29.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.636 0.255 . . . . 1.68 110.661 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 32.1 mt -96.45 -12.25 24.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.369 0.604 . . . . 0.83 110.15 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.97 153.59 84.77 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.507 -0.769 . . . . 1.62 110.083 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.584 ' C ' ' HG1' ' B' ' 14' ' ' THR . 86.6 Cg_endo -96.23 161.73 14.48 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.823 -1.324 . . . . 1.28 112.154 -0.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.584 ' HG1' ' C ' ' B' ' 13' ' ' PRO . 0.2 OUTLIER -157.93 -164.65 1.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.172 -0.677 . . . . 1.7 109.172 179.108 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.41 161.57 40.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.075 -0.342 . . . . 1.22 110.075 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.47 -143.23 25.66 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.891 -0.671 . . . . 1.01 112.244 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -92.83 2.05 56.97 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.875 0.324 . . . . 2.62 111.875 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.44 136.0 57.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.648 0.261 . . . . 1.28 110.758 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -60.31 128.33 36.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 1.98 112.097 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -129.55 -167.37 1.79 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.466 -0.788 . . . . 1.86 110.874 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.22 175.7 50.89 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.962 -0.563 . . . . 0.9 112.765 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 18.4 m -111.0 108.79 18.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.01 0.433 . . . . 1.11 110.591 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.48 164.81 20.1 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.004 -0.544 . . . . 2.0 109.764 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.08 147.28 91.1 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.406 2.071 . . . . 0.65 111.078 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 9.8 m -134.99 137.2 50.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.138 0.494 . . . . 0.57 111.753 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 33.5 tp -101.83 129.13 47.98 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.186 -0.672 . . . . 1.17 109.186 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 55.3 mt -89.22 133.65 30.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.605 0.24 . . . . 0.66 110.369 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.5 -34.84 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.379 -0.373 . . . . 0.93 111.913 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.54 138.99 93.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 111.956 0.354 . . . . 1.1 111.956 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.34 162.26 41.26 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.003 2.469 . . . . 0.78 113.02 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.06 67.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.536 -0.756 . . . . 1.03 112.208 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.07 -46.18 79.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.035 0.445 . . . . 1.4 110.961 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -66.05 -48.13 72.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.031 -0.531 . . . . 1.57 110.599 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -61.16 -26.88 68.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 1.92 111.937 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -82.52 -33.98 28.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.484 -0.325 . . . . 2.93 111.262 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 89.0 t -82.99 -55.75 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.372 0.508 . . . . 1.09 112.372 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 58.0 p -74.43 -27.81 60.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.7 0.286 . . . . 1.64 111.33 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? 62.84 26.22 15.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.897 -0.592 . . . . 2.01 110.061 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 30.4 mt -145.67 96.67 4.73 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.115 -0.948 . . . . 1.16 109.57 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -87.43 146.99 7.4 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.861 2.374 . . . . 0.57 112.711 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 4.9 m -85.52 110.68 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.327 -0.62 . . . . 1.08 109.327 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 34.6 m -95.73 138.26 21.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.9 -0.591 . . . . 0.64 112.035 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 41.2 t -107.52 116.38 57.84 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.022 -0.99 . . . . 1.1 108.91 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -67.85 124.62 12.09 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.984 2.456 . . . . 0.73 114.221 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -95.24 142.07 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.588 -0.893 . . . . 0.9 108.588 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -112.63 100.56 8.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.951 0.405 . . . . 1.24 111.181 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.57 157.72 26.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.774 -0.648 . . . . 2.43 110.722 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.26 -21.98 27.87 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.476 -0.649 . . . . 2.22 111.476 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.53 84.55 0.49 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.764 -0.732 . . . . 3.43 111.933 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -78.03 -78.7 0.13 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.089 0.471 . . . . 4.91 110.648 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -92.67 28.38 2.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 6.27 110.92 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.95 148.78 45.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.724 -0.671 . . . . 4.39 110.182 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -70.35 137.48 50.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.106 -0.331 . . . . 4.51 110.106 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 10.4 t -64.55 120.87 13.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.47 0.652 . . . . 3.23 110.74 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.43 68.04 6.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.724 -0.671 . . . . 1.96 110.988 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.34 -77.09 0.74 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.745 -0.661 . . . . 1.14 112.869 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -104.4 -14.42 15.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.512 0.196 . . . . 3.57 111.153 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.87 95.96 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.419 -0.355 . . . . 1.08 110.566 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 45.0 t -85.14 125.19 40.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.11 -0.496 . . . . 1.34 111.173 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.01 126.41 31.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.147 -0.479 . . . . 1.71 110.993 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 75.9 mt -96.01 87.63 4.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 1.02 111.461 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -161.95 179.21 8.2 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.704 -0.48 . . . . 1.79 109.704 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.22 -42.47 3.16 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 121.242 -0.504 . . . . 1.15 112.452 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 14.2 p -80.18 -27.28 11.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.091 0.472 . . . . 1.17 111.111 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.65 89.51 1.07 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.717 -0.754 . . . . 1.05 112.62 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 4.9 pt -141.28 177.39 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.925 -0.769 . . . . 1.61 108.925 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -83.13 -53.49 5.75 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.982 0.42 . . . . 2.65 110.307 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 7.2 m -64.89 112.53 3.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.889 -0.596 . . . . 0.93 109.743 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.4 131.58 53.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.888 0.375 . . . . 1.62 111.438 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.89 -174.42 32.41 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.941 -0.647 . . . . 0.79 111.899 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 m -102.7 124.04 56.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.045 0.45 . . . . 0.93 111.437 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.0 t -86.53 118.35 32.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.801 -0.636 . . . . 1.38 110.661 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' B' ' 75' ' ' ASP . 9.3 mmm180 -87.3 83.9 7.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.937 0.399 . . . . 1.52 110.315 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 2.5 m -71.17 22.97 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.233 0.827 . . . . 1.55 113.233 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' B' ' 73' ' ' ARG . 13.3 p-10 -112.64 -4.16 14.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.661 0.267 . . . . 1.1 110.701 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -121.26 86.22 42.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 112.497 0.554 . . . . 2.83 112.497 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -92.8 104.38 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.88 2.387 . . . . 0.96 110.588 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -111.37 125.81 54.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.938 0.399 . . . . 2.32 111.949 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.04 114.11 21.5 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.427 -0.583 . . . . 1.21 109.427 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 45.0 pt -133.8 171.79 17.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.008 0.432 . . . . 1.28 111.023 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -77.47 141.87 39.46 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.643 -0.708 . . . . 1.28 109.678 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 49.0 tpp -115.19 -18.02 11.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.996 0.426 . . . . 2.7 111.472 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -92.11 -42.9 9.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.373 -0.376 . . . . 2.62 111.617 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.38 -25.43 33.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.103 0.478 . . . . 1.06 111.391 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -81.4 -13.99 57.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.263 -0.426 . . . . 1.47 111.411 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.71 43.49 35.56 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.862 -0.685 . . . . 0.92 112.628 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.33 144.77 48.97 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.049 -0.596 . . . . 0.92 112.426 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.35 146.73 51.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.455 -0.202 . . . . 2.24 110.455 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -91.71 134.18 34.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.276 -0.42 . . . . 2.99 110.108 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 94.9 mt -89.97 -63.84 1.22 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.438 -0.346 . . . . 0.76 111.598 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -161.32 -173.84 4.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.55 -0.296 . . . . 1.07 110.387 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 43.2 ttt85 -121.04 115.67 23.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.391 -0.368 . . . . 2.71 110.705 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.03 136.69 72.91 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.939 -0.573 . . . . 1.45 109.61 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -47.92 144.58 11.53 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.071 2.514 . . . . 1.03 112.922 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -33.32 68.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.66 -0.7 . . . . 2.14 111.96 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -26.84 68.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.122 0.487 . . . . 2.06 111.128 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 30.0 mm -89.34 -37.03 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 1.33 109.647 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 18.3 tpt -65.74 -30.34 70.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 2.34 110.564 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -59.08 -34.14 71.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.794 -0.639 . . . . 2.09 110.221 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.71 -44.48 90.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.939 -0.573 . . . . 1.76 109.687 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 34.9 t -59.55 -44.88 94.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.492 -0.776 . . . . 1.01 110.816 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.3 -40.35 85.93 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.117 0.484 . . . . 1.29 110.596 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.36 -39.13 94.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.934 -0.65 . . . . 1.02 111.886 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -67.55 -36.9 81.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.897 0.379 . . . . 2.34 110.363 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 68.5 mt -65.59 -21.59 66.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.935 -0.575 . . . . 1.94 111.27 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 24.7 m -76.51 -14.32 60.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.008 0.433 . . . . 1.16 111.168 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 3.0 m -93.3 -7.81 43.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.305 -0.407 . . . . 1.85 112.051 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 13.1 pt -81.64 -21.01 10.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.959 0.409 . . . . 1.98 110.866 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 94.6 mt -94.07 47.5 1.21 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 1.36 110.711 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.255 1.372 0 CA-C-O 118.267 -0.873 . . . . 2.71 110.235 -179.618 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.614 0 C3'-C2'-C1' 100.817 -0.759 . 0.0 '__' . 6.89 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' ' U' . . . . . 0.593 " H1'" ' N7 ' ' C' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.402 -0.967 0 C4'-C3'-C2' 104.761 2.061 OUTLIER-DELTA 0.0 OUTLIER . 3.15 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' ' A' . . . . . 0.593 ' N7 ' " H1'" ' C' ' 2' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.428 -0.765 0 C4'-C3'-C2' 104.444 1.744 . 0.0 OUTLIER . 2.89 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' ' C' . . . . . 0.78 ' O2 ' " H2'" ' C' ' 4' ' ' ' C' . . . . . . . . 0 O4'--C1' 1.405 -0.787 0 C4'-C3'-C2' 104.943 2.243 OUTLIER-DELTA 0.0 OUTLIER . 2.51 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' ' A' . . . . . 0.718 ' H2 ' " O2'" ' C' ' 4' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.81 0 C4'-C3'-C2' 103.57 0.87 . 0.0 OUTLIER . 5.55 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptp . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 121.337 0.589 . . . . 1.45 111.149 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -106.73 177.86 4.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.417 -0.81 . . . . 2.01 111.039 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -80.93 124.33 29.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.829 -0.623 . . . . 2.16 109.986 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.73 7.04 42.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.685 -0.769 . . . . 0.87 112.803 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -94.74 151.18 19.47 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.614 -0.345 . . . . 0.99 111.114 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.3 pt -110.35 113.92 45.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.111 0.481 . . . . 1.16 110.191 178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -106.82 118.43 36.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.924 -0.58 . . . . 0.91 111.779 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.2 tp -72.89 104.54 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.954 -0.566 . . . . 0.9 110.47 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -144.63 161.13 14.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.304 -0.407 . . . . 1.04 110.865 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 t -96.96 130.02 44.34 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.887 -0.782 . . . . 1.32 108.887 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.17 4.51 52.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.813 0.34 . . . . 1.29 111.17 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -79.8 162.87 60.99 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.845 -0.616 . . . . 1.54 110.957 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.48 144.58 68.15 Favored 'Cis proline' 0 C--N 1.351 0.7 0 C-N-CA 124.264 -1.14 . . . . 1.69 112.588 0.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 p -109.81 135.94 49.91 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.886 -0.597 . . . . 1.53 112.045 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.64 117.45 31.94 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.044 -0.525 . . . . 1.7 110.2 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.99 -120.99 7.51 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.721 -0.752 . . . . 1.18 112.543 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -109.73 36.52 2.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.734 0.302 . . . . 3.12 111.393 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -68.54 173.68 4.83 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.69 -0.485 . . . . 1.14 109.69 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -71.1 91.36 0.9 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.978 0.418 . . . . 2.09 111.399 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.12 152.74 18.53 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.658 -0.701 . . . . 2.44 111.489 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.04 168.85 16.51 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.957 -0.639 . . . . 1.07 113.234 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.7 m -111.85 112.07 23.47 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.755 -0.461 . . . . 1.46 109.755 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.37 159.97 37.83 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.265 -0.425 . . . . 2.01 110.348 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.34 99.27 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.496 2.13 . . . . 1.01 110.916 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.0 m -80.12 142.28 14.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.232 -0.44 . . . . 0.76 110.345 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.6 tp -84.98 126.02 33.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.252 -0.431 . . . . 0.7 111.17 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.7 mm -78.86 114.98 20.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.382 -0.599 . . . . 0.92 109.382 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.8 t -92.47 -22.85 5.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.935 0.398 . . . . 0.95 111.659 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.87 152.03 68.33 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 111.791 0.293 . . . . 1.12 111.791 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.28 160.86 45.66 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.805 2.337 . . . . 1.3 111.736 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.45 -38.54 66.46 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.608 0.596 . . . . 1.39 112.608 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.55 -44.55 82.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.415 -0.357 . . . . 1.61 111.569 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -60.42 -37.7 81.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.039 0.447 . . . . 1.77 111.055 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 52.5 m-20 -67.49 -9.87 46.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.669 -0.696 . . . . 1.48 111.386 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -112.08 -51.77 2.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.298 -0.41 . . . . 3.04 111.588 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.23 -47.74 86.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.294 0.479 . . . . 1.86 112.294 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -88.62 -29.87 19.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.637 0.256 . . . . 2.06 110.94 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 73.96 -10.74 1.06 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.802 -0.636 . . . . 4.87 111.962 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.3 mt -108.51 99.03 31.1 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.286 -0.415 . . . . 1.81 110.261 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -87.63 135.68 3.61 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.004 2.469 . . . . 1.05 112.785 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.2 t -80.49 113.4 19.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.018 -1.475 . . . . 1.03 107.018 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.1 m -116.91 152.82 18.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 112.909 0.707 . . . . 0.79 112.909 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.2 m -115.94 131.08 23.91 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 114.91 -1.041 . . . . 0.72 108.441 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.46 172.81 13.48 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.753 2.302 . . . . 1.03 114.449 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.3 t -137.43 135.35 46.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.665 -1.152 . . . . 1.28 108.135 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.1 p -138.02 179.72 6.27 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.552 0.204 . . . . 2.5 111.552 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.5 t -79.21 -85.02 0.08 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.254 -0.43 . . . . 2.82 111.453 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.41 4.42 43.62 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.88 -0.888 . . . . 3.36 110.88 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.47 -113.78 5.3 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.152 -0.546 . . . . 3.83 112.342 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -96.43 -2.18 45.99 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.722 0.296 . . . . 5.09 111.221 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -91.05 45.53 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.008 0.432 . . . . 6.24 111.414 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.06 61.76 5.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.293 0.568 . . . . 2.61 110.591 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.05 175.85 13.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.672 -0.694 . . . . 5.23 110.38 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.6 m -67.62 122.34 17.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.931 0.396 . . . . 2.69 111.351 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.98 101.4 3.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.733 -0.667 . . . . 3.17 110.253 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.82 -100.91 0.73 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.052 -0.594 . . . . 1.69 112.772 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -103.22 -13.53 16.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.968 0.413 . . . . 1.56 111.022 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.84 109.71 19.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.2 -0.455 . . . . 1.25 109.81 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 m -101.19 139.34 22.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.058 0.456 . . . . 1.68 111.592 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 p -86.78 144.39 27.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.192 -0.458 . . . . 2.25 110.544 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.0 mt -84.88 -8.82 58.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 1.35 110.872 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -67.56 131.64 46.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.821 -0.627 . . . . 2.21 109.928 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.99 -39.28 1.93 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.662 -0.575 . . . . 1.18 111.662 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -93.7 -8.13 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.758 0.313 . . . . 1.21 111.03 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.89 98.26 0.24 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.855 -0.688 . . . . 1.08 112.765 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 13.3 pt -122.26 165.69 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.815 0.34 . . . . 1.07 111.143 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -91.94 -44.1 9.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.093 -0.503 . . . . 4.33 110.398 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.04 -164.1 0.42 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.136 -0.483 . . . . 1.51 112.019 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.5 m -153.0 143.37 22.53 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.18 -0.304 . . . . 1.79 110.18 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.98 166.67 11.77 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.065 -0.588 . . . . 1.18 111.777 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.9 139.73 26.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.558 0.179 . . . . 1.56 110.569 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -72.38 126.84 33.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.752 0.31 . . . . 1.29 110.316 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.503 HH12 " H5'" ' C' ' 3' ' ' ' A' . 55.8 mmm-85 -104.91 92.62 4.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.078 -0.51 . . . . 2.85 111.63 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.8 m -88.18 4.89 43.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.993 -0.549 . . . . 1.47 110.087 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.15 -14.44 38.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.624 -0.716 . . . . 0.89 111.967 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -129.42 64.24 70.63 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 113.295 0.85 . . . . 2.65 113.295 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.43 134.76 23.15 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.201 1.934 . . . . 0.8 110.035 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 ptm85 -154.74 145.68 22.6 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.109 0.781 . . . . 2.42 113.109 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.41 115.02 26.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.37 -0.832 . . . . 1.79 109.502 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.78 138.85 49.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.995 -0.372 . . . . 1.15 109.995 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.08 118.38 11.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.99 0.424 . . . . 1.03 111.212 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 57.7 tpp -87.47 -13.64 42.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.861 -0.608 . . . . 1.29 111.148 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -71.18 -53.37 14.71 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.162 0.43 . . . . 3.09 112.162 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.17 -25.12 59.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.929 0.395 . . . . 1.12 111.888 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 65.7 mtt-85 -82.35 -48.91 10.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.226 -0.443 . . . . 1.17 111.799 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.74 114.8 0.21 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.623 -0.798 . . . . 1.12 112.474 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -129.61 163.25 22.74 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.812 -0.709 . . . . 1.16 112.189 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -103.92 129.15 51.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.164 -0.31 . . . . 2.87 110.164 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -85.64 115.18 23.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.738 0.304 . . . . 2.93 110.765 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -86.14 -71.84 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.415 -0.357 . . . . 1.29 110.719 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -149.29 -169.32 3.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.137 -0.483 . . . . 1.15 109.724 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -135.04 143.01 46.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.749 0.309 . . . . 1.57 110.444 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.3 m -83.45 153.65 65.45 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.267 -0.424 . . . . 0.75 111.305 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.39 157.94 33.7 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.753 2.302 . . . . 0.95 111.467 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.79 -27.16 67.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.689 0.28 . . . . 1.51 111.621 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.24 -45.97 85.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.282 -0.417 . . . . 1.62 110.575 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.8 mm -66.32 -40.75 87.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.953 -0.567 . . . . 1.31 110.007 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 9.5 tpt -62.29 -38.82 90.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.863 -0.608 . . . . 1.6 110.486 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -64.56 -34.22 77.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.968 -0.56 . . . . 2.52 111.193 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.12 -48.87 74.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.908 -0.587 . . . . 1.64 110.386 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.6 t -59.28 -43.23 89.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.157 -0.474 . . . . 1.03 110.609 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.78 -34.59 78.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.846 -0.616 . . . . 1.22 111.429 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.94 -27.6 66.37 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.245 -0.502 . . . . 1.03 113.077 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -77.04 -33.29 57.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.125 0.488 . . . . 2.16 110.553 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.9 mt -66.19 -30.91 71.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.935 -0.575 . . . . 1.02 111.69 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -27.95 68.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.873 0.368 . . . . 1.11 111.299 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 m -72.85 -31.0 64.44 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.086 0.402 . . . . 1.95 112.086 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.4 pt -86.07 -3.32 8.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.464 0.542 . . . . 1.15 112.464 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.04 69.88 10.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.859 0.362 . . . . 0.98 110.159 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.373 -0.376 . . . . 1.35 111.935 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 121.213 0.53 . . . . 2.03 112.147 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -85.46 9.69 15.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.086 0.47 . . . . 2.82 110.198 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 81.76 58.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.118 -0.946 . . . . 2.66 113.207 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.94 57.64 6.89 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.593 -0.731 . . . . 1.28 114.321 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.46 ' CD ' HH21 ' B' ' 92' ' ' ARG . 5.5 mm-40 -115.98 117.45 30.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.863 0.331 . . . . 1.53 111.674 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 66.6 mt -99.78 120.06 48.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 0.75 109.798 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -114.74 144.77 42.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.428 -0.351 . . . . 0.82 110.693 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 38.0 tp -105.8 117.1 33.16 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.221 -0.445 . . . . 1.05 110.0 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 9.5 p -158.89 167.54 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.72 110.244 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 7.0 m -88.88 137.64 32.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.851 0.358 . . . . 1.68 110.54 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 55.7 mt -85.09 -21.36 29.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.323 -0.399 . . . . 0.83 110.999 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -60.19 153.29 58.25 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.862 -0.608 . . . . 1.62 110.829 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.02 120.64 5.84 Favored 'Cis proline' 0 C--O 1.235 0.341 0 C-N-CA 123.534 -1.444 . . . . 1.28 113.741 0.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.11 146.68 46.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.297 -0.865 . . . . 1.7 108.95 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.07 -177.79 5.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.913 0.387 . . . . 1.22 111.979 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.79 -106.03 0.98 Allowed Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.006 -0.543 . . . . 1.01 113.34 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -115.89 8.49 14.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.845 0.355 . . . . 2.62 110.365 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -71.04 148.92 47.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 1.28 110.132 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -77.73 107.24 10.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.48 -0.327 . . . . 1.98 111.013 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -83.31 164.97 19.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.012 -0.54 . . . . 1.86 111.675 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.72 -169.75 28.84 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.01 -0.615 . . . . 0.9 113.625 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 35.8 m -108.24 119.99 41.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.654 -0.498 . . . . 1.11 109.654 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.63 154.34 48.13 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.192 -0.458 . . . . 2.0 110.487 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -63.28 135.91 52.8 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.46 2.107 . . . . 0.65 110.72 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.85 151.56 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.174 0.512 . . . . 0.57 111.425 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 mp -109.42 122.35 47.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.682 -0.69 . . . . 1.17 109.918 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 43.8 mt -70.08 120.23 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.697 0.284 . . . . 0.66 110.827 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 18.4 t -79.33 -40.93 22.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.051 -0.522 . . . . 0.93 111.519 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.9 146.19 95.07 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.973 -0.558 . . . . 1.1 111.455 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.79 164.16 34.17 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.752 2.302 . . . . 0.78 112.591 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.46 -40.57 71.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.496 -0.775 . . . . 1.03 111.807 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.01 0.84 4.02 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.702 0.63 . . . . 1.4 112.702 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -119.31 -40.9 2.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.208 0.528 . . . . 1.57 109.736 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.17 -32.97 70.38 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.517 -0.765 . . . . 1.92 111.863 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.52 2.84 55.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.132 -0.485 . . . . 2.93 112.261 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 64.2 t -113.27 -46.13 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.924 0.392 . . . . 1.09 110.421 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 10.3 m -87.09 -24.26 24.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.349 0.595 . . . . 1.64 110.1 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.412 ' CA ' ' HE ' ' B' ' 38' ' ' ARG . 0.6 OUTLIER 75.16 -38.1 0.36 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.848 1.055 . . . . 2.01 113.848 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 89.7 mt -99.59 101.84 14.75 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.978 -0.379 . . . . 1.16 109.978 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -94.12 163.69 2.08 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.907 2.404 . . . . 0.57 113.889 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 1.8 m -96.13 138.35 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.782 -0.821 . . . . 1.08 108.782 178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 17.8 m -126.09 150.12 31.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 113.205 0.817 . . . . 0.64 113.205 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 24.4 t -97.62 111.74 59.51 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.022 -0.99 . . . . 1.1 108.835 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.93 127.83 14.17 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.9 2.4 . . . . 0.73 112.722 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 61.8 t -99.98 133.45 42.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.055 -0.521 . . . . 0.9 109.887 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -98.17 92.1 5.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.34 -0.391 . . . . 1.24 110.489 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.77 152.94 26.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.011 -0.541 . . . . 2.43 110.602 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 160.99 -59.36 0.3 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.483 -0.865 . . . . 2.22 111.82 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.19 168.94 30.21 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.552 -0.832 . . . . 3.43 111.692 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -111.24 26.15 10.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.128 0.489 . . . . 4.91 110.521 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -72.92 -43.0 62.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.798 -0.637 . . . . 6.27 110.074 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.4 113.98 24.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.873 -0.603 . . . . 4.39 109.539 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.08 -42.32 11.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.133 0.492 . . . . 4.51 110.875 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 1.5 t -148.47 120.95 8.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.365 0.602 . . . . 3.23 111.549 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.87 78.53 1.77 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.691 -0.686 . . . . 1.96 110.411 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.64 -88.3 0.36 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.124 -0.56 . . . . 1.14 112.732 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -104.95 -17.06 14.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.969 0.414 . . . . 3.57 110.045 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.64 120.0 25.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.862 -0.608 . . . . 1.08 111.566 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 t -119.8 134.55 62.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.069 -0.715 . . . . 1.34 109.069 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 37.5 p -76.26 135.79 39.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.667 0.27 . . . . 1.71 111.234 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 77.9 mt -89.72 -0.96 57.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.157 0.503 . . . . 1.02 110.626 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.65 148.2 28.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.958 -0.565 . . . . 1.79 111.152 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.4 -38.1 3.47 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.913 -0.66 . . . . 1.15 112.336 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 10.8 p -81.36 -26.28 10.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.749 0.278 . . . . 1.17 111.749 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.05 22.93 3.4 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.435 -0.888 . . . . 1.05 113.362 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 61.4 mt -90.61 138.51 19.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.541 -0.54 . . . . 1.61 109.541 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 28.0 ttt85 -68.31 -42.48 79.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.004 0.43 . . . . 2.65 110.704 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 16.5 m -68.12 97.47 0.7 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.536 -0.756 . . . . 0.93 110.957 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.6 97.61 10.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.923 -0.581 . . . . 1.62 111.432 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.65 -179.75 46.35 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.739 -0.744 . . . . 0.79 111.702 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 m -105.81 136.49 39.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.705 0.288 . . . . 0.93 110.8 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 10.0 m -84.27 137.28 21.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.961 0.41 . . . . 1.38 111.478 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 32.9 mmm-85 -113.32 85.97 2.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.191 -0.459 . . . . 1.52 110.114 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 5.2 m -82.12 6.3 16.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.184 -0.462 . . . . 1.55 111.266 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -87.43 -10.47 51.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.863 -0.608 . . . . 1.1 111.56 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -135.29 78.34 52.13 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 112.896 0.702 . . . . 2.83 112.896 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.89 98.99 0.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.737 2.291 . . . . 0.96 111.729 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -102.64 140.68 36.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.381 -0.372 . . . . 2.32 111.497 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.03 125.74 29.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 1.21 109.67 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 26.8 pt -131.32 -179.7 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.454 -0.339 . . . . 1.28 110.189 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -97.52 139.86 32.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.368 . . . . 1.28 110.867 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 35.6 tpp -126.03 29.74 5.81 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.395 -0.594 . . . . 2.7 109.395 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -121.14 -55.93 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.703 -0.68 . . . . 2.62 111.352 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.53 -33.96 15.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.133 -0.485 . . . . 1.06 110.653 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -63.94 -23.05 67.19 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.863 -0.608 . . . . 1.47 111.428 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.0 90.38 0.83 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.94 -0.648 . . . . 0.92 112.623 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.89 133.13 11.27 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.532 -0.842 . . . . 0.92 112.253 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -139.04 130.29 26.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.6 0.238 . . . . 2.24 110.818 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -83.08 127.93 34.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.471 -0.332 . . . . 2.99 110.268 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 94.3 mt -91.14 -72.62 0.57 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.188 -0.46 . . . . 0.76 111.557 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -133.42 169.93 16.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.094 -0.503 . . . . 1.07 110.722 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.46 HH21 ' CD ' ' B' ' 5' ' ' GLU . 15.2 ttm180 -104.48 141.62 36.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.183 -0.462 . . . . 2.71 110.193 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.1 132.38 50.76 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.906 -0.588 . . . . 1.45 110.68 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.64 155.74 57.06 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.601 2.2 . . . . 1.03 110.758 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.28 -38.92 74.69 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.321 0.489 . . . . 2.14 112.321 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.95 -39.21 88.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.974 0.416 . . . . 2.06 111.12 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 30.0 mm -82.47 -32.02 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.158 -0.474 . . . . 1.33 110.434 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 12.7 tpt -58.66 -45.04 90.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 2.34 110.239 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -64.57 -35.07 79.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.998 -0.546 . . . . 2.09 110.302 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -60.06 -44.47 94.69 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.771 -0.649 . . . . 1.76 109.959 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.99 -44.85 99.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.039 -0.528 . . . . 1.01 110.197 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.44 -42.0 90.92 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.048 -0.524 . . . . 1.29 110.559 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.79 -42.8 98.41 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.433 -0.667 . . . . 1.02 111.433 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -63.97 -32.74 74.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.038 0.447 . . . . 2.34 110.793 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 93.8 mt -68.91 -20.91 64.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.021 -0.536 . . . . 1.94 110.815 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 5.7 m -86.06 -24.73 26.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.159 -0.473 . . . . 1.16 109.944 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.1 m -68.29 -37.41 80.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 1.85 111.214 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 39.2 pt -76.43 0.23 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.333 -0.394 . . . . 1.98 112.036 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 96.3 mt -91.26 10.26 27.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.922 0.391 . . . . 1.36 110.967 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.792 -0.623 . . . . 2.71 110.219 179.903 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.699 0 C1'-C2'-O2' 108.616 -0.661 . 0.0 '__' . 6.89 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.884 0 C4'-C3'-C2' 104.484 1.784 . 0.0 OUTLIER . 3.15 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' ' A' . . . . . 0.726 ' N3 ' " H2'" ' C' ' 3' ' ' ' A' . . . . . . . . 0 C3'--C2' 1.538 1.201 0 C4'-C3'-C2' 105.703 3.003 OUTLIER-DELTA 0.0 OUTLIER . 2.89 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.778 0 N19-C1'-C2' 114.955 0.972 . 0.0 OUTLIER zeta-1 2.51 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' ' A' . . . . . 0.402 ' N3 ' " C2'" ' C' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.402 -0.985 0 C4'-C3'-C2' 104.965 2.265 . 0.0 OUTLIER gamma 5.55 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 120.814 0.34 . . . . 1.45 110.883 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -124.96 169.72 11.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.106 -0.497 . . . . 2.01 110.612 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -71.52 128.01 34.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.909 -0.587 . . . . 2.16 109.671 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.11 -6.04 46.51 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.622 -0.799 . . . . 0.87 112.492 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -79.92 147.68 31.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.877 0.37 . . . . 0.99 110.782 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.5 mt -109.88 119.91 59.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.178 -0.465 . . . . 1.16 109.86 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 21.2 m95 -114.93 149.9 36.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.012 -0.54 . . . . 0.91 110.782 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.0 tp -106.01 118.39 36.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.776 -0.193 . . . . 0.9 110.491 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 p -166.14 148.95 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 120.948 0.404 . . . . 1.04 110.814 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.17 141.66 40.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.356 -0.384 . . . . 1.32 110.607 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.2 mt -97.58 4.11 50.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.157 0.503 . . . . 1.29 111.252 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.08 179.9 0.92 Allowed Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.642 -0.708 . . . . 1.54 110.302 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.65 134.89 32.76 Favored 'Cis proline' 0 C--N 1.354 0.822 0 CA-C-N 119.736 0.942 . . . . 1.69 112.62 0.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.2 p -108.14 155.41 20.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.663 -0.699 . . . . 1.53 111.144 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.2 102.56 5.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.138 -0.69 . . . . 1.7 109.138 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.37 -116.21 3.87 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.505 -1.438 . . . . 1.18 109.505 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -134.06 78.55 1.77 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.065 0.459 . . . . 3.12 111.75 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -110.59 -149.32 0.44 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.791 -0.818 . . . . 1.14 108.791 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -82.58 53.77 2.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.312 0.577 . . . . 2.09 110.007 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.31 128.77 37.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.294 -0.866 . . . . 2.44 112.006 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.99 146.84 9.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.83 -0.7 . . . . 1.07 113.445 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.2 m -79.31 121.1 24.68 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.715 -0.476 . . . . 1.46 109.715 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.469 HH22 " H3'" ' C' ' 3' ' ' ' A' . 0.0 OUTLIER -145.48 161.51 40.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.437 -0.347 . . . . 2.01 110.354 -179.224 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.32 145.75 60.67 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.104 1.87 . . . . 1.01 110.289 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.1 m -128.75 140.12 50.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.42 -0.354 . . . . 0.76 110.55 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.1 tp -95.04 128.64 42.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.034 -0.53 . . . . 0.7 110.822 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.13 109.34 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.801 -0.444 . . . . 0.92 109.801 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.95 -27.91 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 120.997 0.427 . . . . 0.95 111.413 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.85 145.41 74.28 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.294 -0.412 . . . . 1.12 111.411 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.69 158.91 52.34 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.646 2.231 . . . . 1.3 112.173 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.25 -40.04 64.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.993 -0.549 . . . . 1.39 112.206 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.31 -50.18 74.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.331 -0.395 . . . . 1.61 111.767 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -63.93 -38.41 90.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.115 0.483 . . . . 1.77 110.885 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -67.53 -20.84 65.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.732 -0.667 . . . . 1.48 111.051 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -91.33 -35.03 14.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.197 -0.456 . . . . 3.04 112.003 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.57 -50.3 15.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.693 0.627 . . . . 1.86 112.693 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 m -87.38 -31.61 20.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.855 0.359 . . . . 2.06 110.95 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 66.46 23.38 10.54 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.795 -0.639 . . . . 4.87 111.543 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.7 mt -132.35 100.43 15.31 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.442 -0.799 . . . . 1.81 109.053 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -89.69 140.45 3.58 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.629 2.219 . . . . 1.05 114.163 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.1 t -90.36 124.37 42.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.221 -1.4 . . . . 1.03 107.221 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.43 163.97 21.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 113.542 0.942 . . . . 0.79 113.542 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.93 134.56 25.13 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 114.307 -1.315 . . . . 0.72 108.686 178.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.11 128.86 10.91 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.927 2.418 . . . . 1.03 114.674 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.0 t -88.6 118.44 34.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.021 -0.733 . . . . 1.28 109.021 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.44 -167.75 2.87 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.163 -0.31 . . . . 2.5 110.163 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.97 156.0 26.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.47 0.176 . . . . 2.82 110.648 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.55 69.67 0.26 Allowed Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.168 -0.773 . . . . 3.36 111.168 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.34 -111.09 3.93 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.352 -1.099 . . . . 3.83 110.352 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -106.84 -10.17 16.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.233 0.539 . . . . 5.09 109.993 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -133.31 -169.25 2.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.831 -0.622 . . . . 6.24 110.11 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.59 65.35 0.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.369 0.604 . . . . 2.61 109.466 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 ptt85 -130.52 -177.8 4.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.712 -0.676 . . . . 5.23 111.365 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.3 103.21 1.9 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.593 -0.731 . . . . 2.69 110.915 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -116.75 90.28 3.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.93 0.395 . . . . 3.17 111.007 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.57 -99.33 1.6 Allowed Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.911 -0.586 . . . . 1.69 113.048 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -106.34 17.07 23.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.906 0.384 . . . . 1.56 111.778 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.68 137.39 35.42 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.226 -0.657 . . . . 1.25 109.226 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.5 m -88.44 161.16 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.047 0.451 . . . . 1.68 111.731 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -84.67 93.5 8.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.988 -0.551 . . . . 2.25 111.641 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.2 mt -87.11 -33.79 19.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.341 -0.39 . . . . 1.35 111.923 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -68.71 114.79 7.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.023 0.439 . . . . 2.21 111.788 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.47 -10.78 5.53 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.652 -0.785 . . . . 1.18 113.004 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.6 m -90.61 -16.11 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 117.224 0.512 . . . . 1.21 111.49 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.88 51.77 7.56 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 121.066 -0.588 . . . . 1.08 113.461 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.1 pt -103.72 -171.73 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.718 0.294 . . . . 1.07 111.155 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 54.7 ttm-85 -102.23 -33.65 9.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.103 -0.499 . . . . 4.33 110.28 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.8 m -55.85 117.55 3.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.412 -0.813 . . . . 1.51 111.132 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.19 109.6 21.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.973 -0.558 . . . . 1.79 110.558 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.511 ' CA ' ' H41' ' C' ' 4' ' ' ' C' . . . 146.72 -165.43 28.41 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.629 -0.795 . . . . 1.18 112.115 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 81.6 t -132.69 129.63 58.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.797 0.332 . . . . 1.56 110.742 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 69.9 t -72.18 110.96 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.874 -0.788 . . . . 1.29 108.874 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.1 mtm-85 -99.68 121.57 41.43 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.326 -0.397 . . . . 2.85 110.516 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 14.4 m -98.57 34.7 1.97 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.274 -0.421 . . . . 1.47 110.784 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.53 -60.96 2.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.232 -0.44 . . . . 0.89 110.868 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -115.51 80.63 8.12 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.291 -0.413 . . . . 2.65 111.4 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -84.3 156.16 12.69 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.639 2.226 . . . . 0.8 111.118 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -168.32 166.4 12.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.056 0.455 . . . . 2.42 111.265 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.2 m -92.53 145.49 24.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.625 -0.716 . . . . 1.79 109.174 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 26.6 pt -135.3 150.79 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.684 0.278 . . . . 1.15 110.529 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.94 142.7 47.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.043 -0.526 . . . . 1.03 110.051 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 35.4 tpp -121.55 5.61 10.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.186 0.517 . . . . 1.29 110.78 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -93.43 -46.54 7.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.2 -0.454 . . . . 3.09 111.043 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.02 -40.6 10.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.389 -0.369 . . . . 1.12 110.47 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -62.31 -57.6 10.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.389 -0.368 . . . . 1.17 110.304 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.24 84.94 0.19 Allowed Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.909 -0.662 . . . . 1.12 113.505 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.34 172.56 47.22 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.704 -0.76 . . . . 1.16 111.867 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -122.29 122.45 39.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.064 -0.346 . . . . 2.87 110.064 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.88 137.39 38.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.631 0.253 . . . . 2.93 110.937 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -112.64 -81.05 0.59 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.227 -0.442 . . . . 1.29 110.291 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -131.05 -163.71 1.35 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.221 -0.445 . . . . 1.15 110.738 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -147.63 155.19 41.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.564 0.221 . . . . 1.57 110.56 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.6 m -103.58 156.36 35.64 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.289 -0.414 . . . . 0.75 111.399 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -69.28 166.88 25.48 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.762 2.308 . . . . 0.95 111.73 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -58.82 -24.11 61.47 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.437 -0.347 . . . . 1.51 111.769 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -40.74 87.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.285 -0.416 . . . . 1.62 110.825 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.5 mm -71.04 -37.78 69.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 1.31 110.186 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.7 tpt -62.0 -37.21 83.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 1.6 110.472 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -64.16 -35.59 81.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.071 0.462 . . . . 2.52 110.085 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -44.99 88.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.763 -0.653 . . . . 1.64 109.62 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.5 t -64.23 -41.26 91.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.714 -0.675 . . . . 1.03 110.597 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.9 mt -55.56 -43.01 75.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.107 -0.497 . . . . 1.22 110.742 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.6 -41.95 98.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.909 -0.662 . . . . 1.03 111.897 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -62.05 -45.89 91.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.761 0.315 . . . . 2.16 110.529 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.9 mt -62.65 -40.65 97.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.037 -0.529 . . . . 1.02 111.104 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.1 m -70.78 -3.06 16.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 1.11 111.596 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.7 m -105.11 -34.11 8.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.789 0.328 . . . . 1.95 110.806 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.2 pt -79.97 -23.31 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 111.996 0.369 . . . . 1.15 111.996 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.0 mt -76.21 81.84 3.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.98 111.023 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.755 -0.657 . . . . 1.35 109.835 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.434 ' SD ' ' N ' ' B' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.133 0 CA-C-O 121.616 0.722 . . . . 2.03 112.736 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 0.434 ' N ' ' SD ' ' B' ' 1' ' ' MET . 37.3 mt-10 -86.59 -19.57 29.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.259 -0.882 . . . . 2.82 109.315 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? 77.82 115.18 0.06 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.913 -1.039 . . . . 2.66 112.759 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.23 49.48 4.95 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.879 -0.6 . . . . 1.28 114.128 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -126.58 88.33 2.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.58 0.585 . . . . 1.53 112.58 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 60.8 mt -102.21 107.45 21.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.88 -0.785 . . . . 0.75 108.88 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -108.03 160.36 15.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.91 -0.587 . . . . 0.82 111.198 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 42.0 tp -111.84 121.47 45.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.914 -0.772 . . . . 1.05 108.914 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 p -152.17 157.32 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 120.787 0.327 . . . . 0.72 110.536 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 47.6 m -83.13 119.25 24.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.246 -0.433 . . . . 1.68 110.083 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.42 -26.31 61.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.161 -0.472 . . . . 0.83 111.071 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.26 149.78 86.34 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.88 -0.6 . . . . 1.62 110.497 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.07 140.78 30.95 Favored 'Cis proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.58 -1.425 . . . . 1.28 112.561 0.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.72 129.4 36.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.981 -0.554 . . . . 1.7 109.655 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.88 173.6 6.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.367 -0.379 . . . . 1.22 111.497 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.41 -134.27 24.42 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.643 -0.708 . . . . 1.01 113.271 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -114.28 29.21 8.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.974 0.416 . . . . 2.62 110.305 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -83.02 168.53 16.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.752 -0.658 . . . . 1.28 110.664 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -74.15 133.26 42.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.22 0.533 . . . . 1.98 111.962 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -125.02 -178.28 4.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.762 -0.654 . . . . 1.86 110.809 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.71 166.92 42.75 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.235 -0.507 . . . . 0.9 113.583 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.9 m -96.52 110.15 22.6 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.996 -0.742 . . . . 1.11 108.996 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.85 162.97 27.7 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.466 -0.334 . . . . 2.0 110.246 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.87 141.57 98.18 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.447 2.098 . . . . 0.65 111.209 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 9.7 m -135.11 139.76 46.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.103 -0.498 . . . . 0.57 110.654 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 61.3 tp -99.98 121.98 42.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.127 -0.488 . . . . 1.17 109.837 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 16.7 mt -72.26 145.5 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.425 -0.352 . . . . 0.66 110.073 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 19.2 t -112.36 -27.72 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 120.8 0.333 . . . . 0.93 111.525 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.77 148.16 96.48 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.503 -0.317 . . . . 1.1 111.84 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.62 176.17 10.37 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.962 2.441 . . . . 0.78 113.54 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.422 ' C ' ' H ' ' B' ' 33' ' ' PHE . . . -66.93 -31.3 71.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.476 -0.784 . . . . 1.03 110.736 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.24 18.37 0.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.944 -0.571 . . . . 1.4 110.946 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . 0.422 ' H ' ' C ' ' B' ' 31' ' ' ALA . 2.2 t80 -137.16 -53.62 0.69 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.033 -0.53 . . . . 1.57 110.023 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -57.12 -39.61 75.47 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.99 -0.55 . . . . 1.92 111.953 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -92.67 8.27 39.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.23 -0.441 . . . . 2.93 111.59 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 62.7 t -116.01 -64.04 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.284 -0.416 . . . . 1.09 111.157 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 37.1 p -78.52 -16.23 57.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.335 0.588 . . . . 1.64 110.493 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.62 29.77 19.25 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.365 -0.834 . . . . 2.01 110.684 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 30.5 mt -143.24 102.74 5.14 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.35 -0.841 . . . . 1.16 109.282 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -97.18 149.35 0.94 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.778 2.319 . . . . 0.57 113.571 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 16.2 m -97.44 133.68 38.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.58 -1.267 . . . . 1.08 107.58 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 24.9 m -127.18 153.78 36.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 113.981 1.104 . . . . 0.64 113.981 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 54.4 t -103.61 119.36 55.0 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 114.43 -1.259 . . . . 1.1 108.216 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.51 126.23 13.88 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.889 2.393 . . . . 0.73 113.217 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 87.8 t -88.89 135.98 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.826 -0.625 . . . . 0.9 109.353 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -114.21 96.62 5.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.502 -0.317 . . . . 1.24 110.378 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.1 m -68.47 119.87 13.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.026 -0.534 . . . . 2.43 110.827 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -110.61 40.88 2.4 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.058 -0.817 . . . . 2.22 111.058 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.31 -91.27 0.38 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.019 -0.61 . . . . 3.43 111.676 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -131.34 6.84 4.52 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.27 0.557 . . . . 4.91 110.611 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -100.87 119.57 38.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.656 -0.702 . . . . 6.27 110.073 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.47 92.45 1.77 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.201 -0.454 . . . . 4.39 110.817 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.22 136.78 53.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.307 -0.406 . . . . 4.51 110.931 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 2.4 t -72.35 134.29 45.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.67 -0.695 . . . . 3.23 111.872 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.42 97.79 1.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.764 -0.653 . . . . 1.96 110.469 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.78 -98.43 0.29 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.118 -0.563 . . . . 1.14 113.099 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -86.55 -16.21 37.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.825 0.345 . . . . 3.57 111.398 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.51 131.45 34.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.311 -0.404 . . . . 1.08 110.523 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -113.17 144.24 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 1.34 110.143 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -80.62 113.19 18.63 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.06 0.393 . . . . 1.71 112.06 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 97.9 mt -88.55 -7.17 56.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.654 0.74 . . . . 1.02 109.016 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -98.07 141.24 31.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.143 -0.935 . . . . 1.79 109.767 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.91 -58.06 0.7 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.723 -0.751 . . . . 1.15 112.125 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 p -75.7 -26.85 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.076 0.465 . . . . 1.17 111.294 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.93 57.83 0.42 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.473 -0.87 . . . . 1.05 113.287 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 84.9 mt -104.09 143.2 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.919 -0.771 . . . . 1.61 108.919 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -65.23 -53.43 44.5 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.81 0.338 . . . . 2.65 110.495 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 8.8 m -71.13 101.27 2.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.18 0.514 . . . . 0.93 110.033 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -91.85 108.8 20.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.082 -0.508 . . . . 1.62 110.997 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.55 -160.22 25.98 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.004 -0.617 . . . . 0.79 111.997 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 10.7 m -125.87 139.44 51.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.791 0.329 . . . . 0.93 110.877 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.57 143.12 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.364 -0.38 . . . . 1.38 110.887 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 35.5 mmm-85 -97.86 84.87 3.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.149 0.499 . . . . 1.52 110.614 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.2 m -73.96 -5.87 43.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 1.55 111.296 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -88.7 -16.15 33.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.058 -0.519 . . . . 1.1 111.409 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -130.82 60.49 53.38 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 113.04 0.756 . . . . 2.83 113.04 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.93 141.08 23.67 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.085 1.857 . . . . 0.96 110.223 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -132.61 143.61 49.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.862 0.363 . . . . 2.32 111.34 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.39 135.06 37.36 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.389 -0.967 . . . . 1.21 108.389 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 9.3 pt -118.99 154.21 21.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.93 0.395 . . . . 1.28 110.948 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -86.03 139.89 30.77 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.853 -0.612 . . . . 1.28 109.42 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 2.6 ttp -130.9 26.73 4.94 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.603 0.716 . . . . 2.7 109.505 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -109.86 -44.05 3.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.033 -0.985 . . . . 2.62 109.399 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.38 -28.42 8.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.421 -0.809 . . . . 1.06 110.074 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -80.97 151.94 28.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.963 -0.562 . . . . 1.47 110.384 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.92 131.88 10.82 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.215 -0.754 . . . . 0.92 111.215 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.25 148.25 18.5 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.954 -0.641 . . . . 0.92 111.679 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -139.89 137.69 35.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.489 0.185 . . . . 2.24 110.904 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -78.55 131.2 36.69 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.235 -0.284 . . . . 2.99 110.235 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 82.4 mt -98.33 -58.06 2.06 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.434 0.531 . . . . 0.76 112.434 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -149.07 158.22 44.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.412 -0.358 . . . . 1.07 110.278 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -101.02 112.07 24.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.772 0.32 . . . . 2.71 110.155 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.28 133.77 94.58 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.776 -0.647 . . . . 1.45 110.854 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.69 146.4 77.0 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.673 2.249 . . . . 1.03 111.11 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -55.06 -32.66 62.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 2.14 111.891 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -48.39 78.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.93 -0.577 . . . . 2.06 110.953 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 40.4 mm -80.29 -34.48 14.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 1.33 110.593 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 6.9 tpt -56.58 -47.39 79.65 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.007 -0.542 . . . . 2.34 110.854 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -67.06 -33.71 76.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 2.09 110.914 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -46.06 91.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 1.76 110.872 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 50.2 t -59.33 -44.09 91.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.946 0.403 . . . . 1.01 110.495 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -62.9 -36.37 83.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 1.29 110.264 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.63 -34.13 86.58 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.802 -0.635 . . . . 1.02 111.852 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 19.6 mmt85 -70.74 -28.74 64.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.035 0.445 . . . . 2.34 110.661 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 36.5 mt -76.93 -18.54 58.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 1.94 110.774 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 24.6 m -76.94 -6.92 54.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.212 -0.449 . . . . 1.16 111.694 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 3.7 m -66.73 -25.04 66.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 1.85 111.366 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 46.7 pt -92.07 7.21 5.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.829 0.347 . . . . 1.98 111.675 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 59.2 mt -87.0 13.33 9.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.155 0.502 . . . . 1.36 111.246 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.654 -0.703 . . . . 2.71 109.436 179.806 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.432 -0.477 0 C3'-C2'-C1' 100.763 -0.818 . 0.0 '__' . 6.89 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.848 0 C4'-C3'-C2' 103.853 1.153 . 0.0 OUTLIER gamma 3.15 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' ' A' . . . . . 0.469 " H3'" HH22 ' A' ' 23' ' ' ARG . . . . . . . . 0 O5'--C5' 1.429 -0.708 0 C3'-C2'-O2' 111.095 -0.76 . 0.0 OUTLIER gamma 2.89 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' ' C' . . . . . 0.511 ' H41' ' CA ' ' A' ' 70' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.917 0 O4'-C4'-C3' 103.064 -1.74 . 0.0 OUTLIER zeta-1 2.51 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.984 0 C1'-C2'-O2' 108.393 -0.736 . 0.0 OUTLIER . 5.55 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 120.658 0.266 . . . . 1.45 110.988 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -123.26 168.04 12.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.288 -0.415 . . . . 2.01 110.442 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.429 HH22 ' C ' ' B' ' 110' ' ' THR . 36.3 ttm180 -67.64 124.67 23.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.986 -0.552 . . . . 2.16 110.692 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.58 -2.86 32.4 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.822 -0.704 . . . . 0.87 113.31 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -93.79 152.25 19.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.472 -0.428 . . . . 0.99 110.979 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.5 pt -115.87 117.11 54.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.147 0.499 . . . . 1.16 110.345 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -108.43 125.41 51.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.658 -0.701 . . . . 0.91 111.097 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.3 tp -74.52 117.78 16.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.19 -0.459 . . . . 0.9 110.633 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 p -162.24 153.9 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.413 -0.358 . . . . 1.04 110.122 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 t -84.01 140.14 32.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.961 0.41 . . . . 1.32 110.509 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -100.15 13.25 34.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.018 -0.537 . . . . 1.29 111.103 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.12 171.47 10.79 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.618 -0.719 . . . . 1.54 110.325 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.82 133.2 27.77 Favored 'Cis proline' 0 C--N 1.352 0.743 0 C-N-CA 124.419 -1.075 . . . . 1.69 112.198 -0.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.7 p -102.25 138.52 39.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.705 -0.679 . . . . 1.53 111.295 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -106.93 140.46 39.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.437 -0.579 . . . . 1.7 109.437 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.35 -113.27 5.23 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.645 -0.788 . . . . 1.18 111.472 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -130.54 46.32 2.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.808 0.337 . . . . 3.12 111.283 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -65.84 -174.86 0.25 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.971 -0.559 . . . . 1.14 110.437 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -78.51 69.2 4.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.333 0.587 . . . . 2.09 110.234 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -76.13 144.61 40.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.402 -0.817 . . . . 2.44 111.241 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.92 143.03 5.73 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.64 -0.791 . . . . 1.07 112.843 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 m -92.9 107.17 19.01 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.263 -0.643 . . . . 1.46 109.263 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.31 163.39 28.34 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.429 -0.35 . . . . 2.01 110.582 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.02 119.47 6.45 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.498 2.132 . . . . 1.01 111.393 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 m -97.26 142.46 14.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.126 -0.488 . . . . 0.76 110.38 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.6 tp -83.86 121.9 27.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.44 -0.346 . . . . 0.7 111.282 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.8 mm -71.84 112.67 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.92 109.713 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.38 -37.51 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.346 -0.388 . . . . 0.95 111.889 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.86 150.55 75.49 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 112.387 0.514 . . . . 1.12 112.387 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.1 155.91 63.7 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.766 2.311 . . . . 1.3 112.323 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.92 -38.0 64.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.843 -0.617 . . . . 1.39 112.05 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.38 -41.4 89.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.027 0.441 . . . . 1.61 111.227 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -73.22 -41.95 63.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.091 -0.504 . . . . 1.77 110.777 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -62.81 -21.13 65.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.898 -0.592 . . . . 1.48 111.345 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -93.37 -25.52 17.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 3.04 111.93 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 p -82.78 -49.24 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 112.93 0.715 . . . . 1.86 112.93 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.5 p -94.9 -23.86 17.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 2.06 110.783 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 68.78 18.04 8.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.478 -0.783 . . . . 4.87 111.607 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 75.8 mt -129.11 93.28 36.91 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.349 -0.842 . . . . 1.81 108.897 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.92 132.53 9.64 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.567 2.178 . . . . 1.05 113.521 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.03 116.64 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.833 -1.543 . . . . 1.03 106.833 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 m -124.71 156.91 33.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 113.478 0.918 . . . . 0.79 113.478 -177.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.37 118.57 33.83 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 114.806 -1.088 . . . . 0.72 108.646 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.47 156.59 63.67 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.076 2.518 . . . . 1.03 113.507 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.2 t -114.1 127.12 71.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.085 -0.962 . . . . 1.28 108.638 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.2 p -114.95 -171.71 1.99 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.105 -0.238 . . . . 2.5 111.25 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.26 139.7 54.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.319 -0.4 . . . . 2.82 111.384 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.26 19.04 32.57 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.638 -0.791 . . . . 3.36 111.932 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.32 -131.87 35.61 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.841 -0.695 . . . . 3.83 111.533 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -91.77 -43.01 9.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.042 0.448 . . . . 5.09 109.874 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -130.43 127.81 40.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.92 -0.582 . . . . 6.24 109.901 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.01 89.95 1.14 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 2.61 111.128 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -108.09 153.51 23.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.864 -0.607 . . . . 5.23 110.9 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -72.1 132.4 44.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.143 -0.48 . . . . 2.69 110.021 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.01 69.8 1.48 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.352 -0.386 . . . . 3.17 111.174 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.94 -83.41 0.31 Allowed Glycine 0 C--O 1.229 -0.177 0 CA-C-N 116.008 -0.542 . . . . 1.69 112.97 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -91.32 -32.75 15.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.893 0.378 . . . . 1.56 110.971 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.47 120.9 25.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.083 -0.508 . . . . 1.25 110.097 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.4 m -93.85 153.64 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.913 0.387 . . . . 1.68 111.707 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.86 142.98 34.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.969 -0.559 . . . . 2.25 111.615 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 mt -109.94 0.57 18.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 1.35 110.927 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -91.55 -173.68 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 2.21 109.914 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.7 -47.68 3.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 1.18 112.151 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.0 m -74.6 -28.7 22.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.889 0.376 . . . . 1.21 110.754 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.77 67.88 1.53 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.743 -0.742 . . . . 1.08 113.619 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.8 pt -102.97 174.69 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.624 -0.51 . . . . 1.07 109.624 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -80.68 -44.84 18.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.956 0.407 . . . . 4.33 110.46 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.51 149.2 49.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.8 -0.636 . . . . 1.51 111.46 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.08 91.96 3.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.836 -0.62 . . . . 1.79 110.795 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -164.85 -162.42 15.85 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.17 -0.772 . . . . 1.18 111.17 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.34 138.63 53.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.092 -0.336 . . . . 1.56 110.092 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.7 t -75.3 131.1 35.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.817 0.341 . . . . 1.29 110.456 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.41 ' NH1' ' C5 ' ' C' ' 3' ' ' ' A' . 55.8 mmm-85 -100.35 91.4 4.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.127 -0.488 . . . . 2.85 112.259 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.8 m -82.67 -10.14 59.06 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.901 -0.777 . . . . 1.47 108.901 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -86.85 -12.52 47.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.121 -0.945 . . . . 0.89 110.943 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -129.42 62.93 65.71 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 112.195 0.443 . . . . 2.65 112.195 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.95 144.61 21.64 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.667 2.245 . . . . 0.8 111.024 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.1 ptm85 -163.92 124.61 2.2 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.072 0.397 . . . . 2.42 112.072 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.6 m -82.19 123.52 29.08 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.847 -0.615 . . . . 1.79 109.597 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 24.3 pt -126.1 161.95 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.025 0.44 . . . . 1.15 111.183 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -76.61 145.37 38.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.62 -0.718 . . . . 1.03 110.686 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 38.2 tpp -131.91 24.66 4.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.23 0.538 . . . . 1.29 109.786 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.12 -40.42 3.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.158 -0.474 . . . . 3.09 110.778 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.88 -35.38 10.51 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.362 -0.607 . . . . 1.12 109.362 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -68.72 -57.56 5.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.471 -0.786 . . . . 1.17 110.704 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.82 120.52 2.03 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.787 -0.72 . . . . 1.12 113.193 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.0 171.16 21.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.939 -0.648 . . . . 1.16 111.796 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -132.79 123.13 25.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.834 0.35 . . . . 2.87 111.482 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -75.41 120.39 20.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.226 -0.443 . . . . 2.93 110.897 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.95 -53.86 4.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.925 0.393 . . . . 1.29 110.328 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -160.14 -168.44 2.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.709 -0.678 . . . . 1.15 109.38 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -143.29 139.76 30.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.757 0.313 . . . . 1.57 110.33 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.54 158.25 43.21 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.136 -0.484 . . . . 0.75 111.461 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.0 160.72 48.48 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.712 2.275 . . . . 0.95 111.564 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -60.87 -23.04 64.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 1.51 111.93 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -37.08 74.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.483 . . . . 1.62 110.585 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.2 mm -88.55 -40.78 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.747 -0.661 . . . . 1.31 109.99 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.7 tpt -56.63 -50.83 70.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.696 -0.683 . . . . 1.6 112.107 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -65.18 -32.19 73.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 2.52 111.268 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -61.5 -45.14 95.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.862 -0.608 . . . . 1.64 110.366 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 50.0 t -59.88 -44.85 95.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.036 -0.529 . . . . 1.03 110.013 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.6 mt -59.92 -40.88 90.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.732 -0.667 . . . . 1.22 111.051 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.87 -41.42 98.77 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.901 -0.666 . . . . 1.03 112.016 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -68.2 -38.52 82.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 2.16 110.555 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 62.6 mt -63.78 -24.24 67.68 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.03 -0.532 . . . . 1.02 112.111 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 57.0 m -72.12 -6.27 41.41 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.934 0.716 . . . . 1.11 112.934 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 74.5 p -92.49 -11.34 34.89 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.193 0.442 . . . . 1.95 112.193 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.8 pt -107.48 16.25 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.914 0.388 . . . . 1.15 111.897 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 83.4 mt -97.42 25.87 5.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.131 0.491 . . . . 0.98 110.784 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.957 -0.565 . . . . 1.35 111.405 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 112.007 0.373 . . . . 2.03 112.007 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -91.01 2.97 55.9 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.168 -0.332 . . . . 2.82 110.804 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 84.86 61.24 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.933 1.086 . . . . 2.66 113.933 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.25 22.98 74.82 Favored Glycine 0 CA--C 1.519 0.313 0 N-CA-C 115.006 0.762 . . . . 1.28 115.006 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -83.19 116.55 22.42 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 117.498 0.649 . . . . 1.53 110.892 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.9 mt -96.07 123.26 48.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.75 110.184 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -112.92 127.47 56.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.008 0.432 . . . . 0.82 111.477 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 40.1 tp -90.13 120.35 31.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.056 -0.52 . . . . 1.05 109.748 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 5.9 p -158.63 169.55 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.505 -0.316 . . . . 0.72 110.379 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.45 133.27 34.49 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.899 -0.408 . . . . 1.68 109.899 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 18.9 mt -81.29 -29.09 34.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.485 -0.325 . . . . 0.83 111.437 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.7 154.58 35.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.051 -0.522 . . . . 1.62 111.629 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.65 116.52 4.58 Favored 'Cis proline' 0 C--O 1.237 0.432 0 C-N-CA 123.607 -1.414 . . . . 1.28 113.364 0.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.41 147.88 46.68 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.812 -0.81 . . . . 1.7 108.812 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.65 177.88 8.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.319 0.581 . . . . 1.22 112.117 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.57 -108.53 2.45 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.888 -0.672 . . . . 1.01 112.585 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -108.31 3.29 23.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.727 0.299 . . . . 2.62 111.147 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -72.4 140.21 48.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.297 -0.411 . . . . 1.28 110.05 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -68.28 142.16 55.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.669 -0.493 . . . . 1.98 109.669 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -120.1 165.85 14.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.726 0.639 . . . . 1.86 112.726 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.7 -173.11 36.45 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.44 -0.8 . . . . 0.9 112.327 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 15.6 m -96.04 123.36 39.61 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.973 -0.751 . . . . 1.11 108.973 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -157.45 155.0 26.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.705 -0.225 . . . . 2.0 110.84 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.63 133.8 35.65 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.608 2.206 . . . . 0.65 111.841 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.61 156.92 37.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.074 -0.512 . . . . 0.57 110.693 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tp -106.24 119.32 38.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.118 -0.492 . . . . 1.17 110.71 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 27.8 mt -78.36 116.83 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.317 . . . . 0.66 110.607 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 37.5 t -77.61 -37.55 24.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.025 -0.534 . . . . 0.93 111.839 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.19 142.47 87.26 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.436 -0.347 . . . . 1.1 111.74 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.68 156.09 61.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.83 2.353 . . . . 0.78 112.407 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.3 77.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.861 -0.609 . . . . 1.03 111.704 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.98 -36.74 73.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.92 0.39 . . . . 1.4 111.55 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -81.39 -40.88 22.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.112 0.482 . . . . 1.57 110.519 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -59.43 -24.84 63.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.682 -0.69 . . . . 1.92 111.899 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -89.42 -2.61 58.46 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.399 0.518 . . . . 2.93 112.399 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -108.12 -52.08 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.977 0.418 . . . . 1.09 110.282 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 1.5 m -80.87 -31.84 35.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.818 -0.628 . . . . 1.64 111.14 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? 71.01 -0.22 3.14 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.53 0.937 . . . . 2.01 113.53 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 98.4 mt -121.45 94.32 48.61 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.577 -0.527 . . . . 1.16 109.577 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.37 154.18 14.09 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.867 2.378 . . . . 0.57 113.992 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 8.8 t -95.45 123.53 47.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.901 -1.148 . . . . 1.08 107.901 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 32.3 m -113.93 147.31 17.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 113.434 0.902 . . . . 0.64 113.434 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 t -106.09 118.97 53.66 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 114.63 -1.168 . . . . 1.1 108.386 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.38 134.79 19.41 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.728 2.285 . . . . 0.73 112.557 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 44.0 t -99.01 123.62 51.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.88 -0.6 . . . . 0.9 110.46 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.44 89.89 8.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.887 -0.597 . . . . 1.24 109.579 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -82.08 67.06 7.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.855 -0.612 . . . . 2.43 111.342 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.7 31.68 7.57 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.979 -0.629 . . . . 2.22 111.636 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.35 -169.21 16.12 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.723 -0.751 . . . . 3.43 112.255 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -123.7 32.59 5.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.341 0.591 . . . . 4.91 110.577 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -69.33 -32.25 71.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.493 -0.776 . . . . 6.27 110.627 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -108.87 125.83 52.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.88 -0.6 . . . . 4.39 110.004 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.39 -49.9 6.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.141 0.496 . . . . 4.51 110.454 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.98 121.53 6.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.619 -0.719 . . . . 3.23 110.918 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.63 82.99 2.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.837 -0.619 . . . . 1.96 110.339 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.51 -87.68 0.26 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.796 -0.638 . . . . 1.14 112.676 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -109.68 -6.69 15.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.879 0.371 . . . . 3.57 110.86 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -93.04 115.13 27.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.049 -0.523 . . . . 1.08 110.845 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 23.7 t -117.05 135.99 55.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.101 -0.5 . . . . 1.34 110.013 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 88.3 p -79.42 141.59 36.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.801 0.334 . . . . 1.71 111.605 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 72.8 mt -88.76 -16.76 31.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.181 0.515 . . . . 1.02 110.751 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -73.63 147.0 44.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.718 -0.673 . . . . 1.79 111.003 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.03 -40.14 2.5 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.056 -0.593 . . . . 1.15 112.461 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 p -90.21 -17.69 7.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.111 0.412 . . . . 1.17 112.111 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.24 20.91 4.24 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.499 -0.858 . . . . 1.05 113.599 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 81.4 mt -86.64 141.31 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.772 -0.455 . . . . 1.61 109.772 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -70.9 -47.84 56.94 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.623 0.249 . . . . 2.65 110.923 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 12.2 m -60.97 99.14 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.368 0.604 . . . . 0.93 110.334 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.69 91.49 8.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.946 -0.57 . . . . 1.62 111.746 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.45 -174.0 38.81 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.709 -0.758 . . . . 0.79 111.7 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.5 m -113.71 136.31 50.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 110.211 -0.292 . . . . 0.93 110.211 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 m -80.34 135.59 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.556 -0.293 . . . . 1.38 110.92 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 16.1 mmm-85 -101.99 82.97 2.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.112 0.482 . . . . 1.52 110.829 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 2.3 m -69.32 -9.04 51.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.758 -0.655 . . . . 1.55 111.047 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -88.45 -6.21 57.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.589 -0.732 . . . . 1.1 111.771 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -126.13 55.77 14.2 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 113.0 0.741 . . . . 2.83 113.0 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.96 126.4 5.74 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.771 1.647 . . . . 0.96 112.271 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -130.38 140.39 50.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.917 0.389 . . . . 2.32 111.218 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.72 125.87 30.21 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.189 -0.671 . . . . 1.21 109.189 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 41.4 pt -128.51 151.48 35.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.521 -0.471 . . . . 1.28 111.653 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.439 ' CG ' ' HZ1' ' B' ' 83' ' ' LYS . 4.8 t70 -77.83 83.95 4.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.858 -0.61 . . . . 1.28 109.994 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 59.7 tpp -61.69 -31.66 71.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.691 -0.686 . . . . 2.7 112.274 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.439 ' HZ1' ' CG ' ' B' ' 81' ' ' ASP . 1.4 pttp -67.22 -38.91 86.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.397 0.517 . . . . 2.62 112.397 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.98 -30.18 28.41 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.108 0.41 . . . . 1.06 112.108 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -82.22 -42.46 18.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.174 0.435 . . . . 1.47 112.174 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.4 99.94 1.52 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.92 112.597 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -99.3 153.71 19.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.677 -0.773 . . . . 0.92 112.588 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.15 128.15 16.5 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.284 -0.265 . . . . 2.24 110.284 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -78.91 121.04 24.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.963 0.411 . . . . 2.99 111.339 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 89.8 mt -90.8 -68.62 0.78 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.136 -0.484 . . . . 0.76 110.666 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.61 -176.88 4.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.935 -0.575 . . . . 1.07 110.028 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.81 137.98 53.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.959 0.409 . . . . 2.71 111.198 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 53.7 t -82.86 126.72 72.2 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.854 -0.612 . . . . 1.45 109.993 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -59.59 152.5 61.86 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.656 2.237 . . . . 1.03 111.11 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -54.26 -29.69 47.78 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.461 0.541 . . . . 2.14 112.461 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.7 p -59.46 -53.83 53.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.991 0.424 . . . . 2.06 111.219 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 32.5 mm -74.84 -34.04 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.202 -0.453 . . . . 1.33 110.0 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 5.1 tpt -55.33 -45.26 76.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.706 -0.679 . . . . 2.34 110.972 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -67.55 -35.34 78.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.098 -0.501 . . . . 2.09 110.996 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.53 -44.86 89.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.97 -0.559 . . . . 1.76 111.0 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 73.9 t -60.29 -48.61 87.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.306 -0.406 . . . . 1.01 110.425 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 82.9 mt -59.68 -34.93 73.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.555 . . . . 1.29 111.048 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.45 -41.28 96.46 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.578 -0.609 . . . . 1.02 111.578 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -67.35 -33.59 75.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.898 0.38 . . . . 2.34 110.315 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 46.4 mt -65.98 -25.5 67.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.912 -0.586 . . . . 1.94 110.513 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 13.0 m -87.68 -13.94 41.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.008 -0.542 . . . . 1.16 111.161 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.13 -31.65 61.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.898 0.38 . . . . 1.85 111.361 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 14.0 pt -84.91 0.82 5.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.442 -0.345 . . . . 1.98 111.558 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.49 4.66 53.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.342 -0.39 . . . . 1.36 111.859 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.429 ' C ' HH22 ' A' ' 3' ' ' ARG . 7.0 t . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.825 -0.607 . . . . 2.71 110.206 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.432 -0.472 0 C1'-C2'-O2' 107.899 -0.9 . 0.0 '__' . 6.89 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.893 0 O4'-C1'-N19 109.57 1.37 . 0.0 OUTLIER . 3.15 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' ' A' . . . . . 0.674 ' N3 ' " H2'" ' C' ' 3' ' ' ' A' . . . . . . . . 0 C4'--C3' 1.532 0.691 0 C4'-C3'-C2' 103.935 1.235 . 0.0 OUTLIER gamma 2.89 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' ' C' . . . . . 1.016 ' O2 ' " H2'" ' C' ' 4' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.809 0 C3'-C2'-C1' 102.843 1.492 . 0.0 OUTLIER . 2.51 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O3'--C3' 1.436 0.925 0 C4'-C3'-C2' 104.572 1.872 . 0.0 OUTLIER . 5.55 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptp . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.782 0.325 . . . . 1.45 110.75 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -135.28 175.01 9.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.02 -0.536 . . . . 2.01 111.053 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.2 ttp85 -79.27 136.22 36.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.048 -0.523 . . . . 2.16 109.955 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.44 8.27 59.91 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.87 112.476 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -95.27 142.22 27.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.949 0.404 . . . . 0.99 111.138 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.7 mt -99.0 115.93 40.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.814 -0.81 . . . . 1.16 108.814 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -114.12 137.33 51.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.401 -0.363 . . . . 0.91 111.083 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.3 tp -88.81 120.76 30.51 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.392 -0.595 . . . . 0.9 109.392 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 p -147.49 169.19 4.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 120.867 0.365 . . . . 1.04 110.708 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.2 t -103.75 129.83 51.18 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.001 -0.74 . . . . 1.32 109.001 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.3 mt -88.32 -12.57 43.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.461 -0.336 . . . . 1.29 111.377 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.93 164.15 43.67 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.94 -0.573 . . . . 1.54 111.162 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.74 139.09 49.57 Favored 'Cis proline' 0 C--N 1.353 0.79 0 C-N-CA 124.324 -1.115 . . . . 1.69 112.485 -0.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 p -121.9 171.95 8.54 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.085 -0.507 . . . . 1.53 111.319 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.79 164.34 26.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 1.7 110.063 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.4 -136.87 32.34 Favored Glycine 0 CA--C 1.516 0.123 0 C-N-CA 121.16 -0.543 . . . . 1.18 113.409 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -103.74 25.46 9.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.022 -0.362 . . . . 3.12 110.022 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -76.47 175.75 8.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.212 -0.449 . . . . 1.14 111.427 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -74.23 77.38 1.81 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.607 -0.724 . . . . 2.09 110.506 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -78.03 122.89 26.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.835 -0.62 . . . . 2.44 111.726 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.71 163.45 12.27 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.272 -0.966 . . . . 1.07 113.502 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.62 148.38 25.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.743 -0.229 . . . . 1.46 110.505 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -172.71 159.87 3.83 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 110.247 -0.279 . . . . 2.01 110.247 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.65 130.3 15.72 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.448 2.099 . . . . 1.01 110.713 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 m -116.37 137.21 50.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.335 -0.393 . . . . 0.76 110.569 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.1 tp -92.32 124.39 36.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.154 -0.475 . . . . 0.7 110.948 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.6 mt -80.07 111.03 16.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.92 110.148 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 t -90.18 -27.2 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.218 -0.446 . . . . 0.95 111.75 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 p -77.6 142.25 66.08 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.603 0.594 . . . . 1.12 112.603 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.79 151.74 83.78 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.217 2.611 . . . . 1.3 111.798 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.18 -38.81 77.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.085 -0.507 . . . . 1.39 112.036 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.17 -38.3 82.81 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.024 0.44 . . . . 1.61 110.777 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -72.34 -38.73 68.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.032 -0.531 . . . . 1.77 110.166 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -64.78 -15.81 62.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.676 -0.693 . . . . 1.48 111.199 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -87.8 -24.12 23.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.562 -0.29 . . . . 3.04 110.724 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.6 t -83.1 -65.12 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 1.86 111.489 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.1 m -78.82 -33.99 45.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.337 -0.392 . . . . 2.06 110.862 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 75.14 12.64 3.35 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.724 -0.671 . . . . 4.87 111.738 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.8 mt -124.92 93.04 46.61 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.544 -0.753 . . . . 1.81 109.404 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.06 137.26 26.15 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.502 2.135 . . . . 1.05 112.798 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.8 t -83.64 111.65 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 107.972 -1.122 . . . . 1.03 107.972 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.8 m -114.54 158.74 14.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.24 0.543 . . . . 0.79 112.282 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.89 122.08 33.08 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.236 -0.893 . . . . 0.72 109.775 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.99 94.75 1.06 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.867 2.378 . . . . 1.03 112.761 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.0 m -78.68 155.86 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 1.28 110.407 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.8 m -141.01 -91.78 0.15 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.345 0.498 . . . . 2.5 112.345 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.404 ' O ' ' N1 ' ' C' ' 3' ' ' ' A' . 3.7 p -164.98 -158.11 0.38 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.839 0.745 . . . . 2.82 112.377 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -155.46 32.01 0.64 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.294 -0.722 . . . . 3.36 111.294 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.66 -126.05 7.71 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.136 -0.786 . . . . 3.83 111.136 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -80.16 -38.71 30.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.214 0.53 . . . . 5.09 110.206 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -136.84 116.15 12.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.838 -0.619 . . . . 6.24 110.063 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.77 141.28 58.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.311 -0.404 . . . . 2.61 111.277 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.78 147.68 32.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.951 -0.568 . . . . 5.23 109.478 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.0 m -69.94 100.14 1.53 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.225 0.536 . . . . 2.69 111.582 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.41 83.86 3.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.568 -0.742 . . . . 3.17 110.492 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.47 -92.89 0.28 Allowed Glycine 0 C--O 1.235 0.195 0 CA-C-N 115.562 -0.744 . . . . 1.69 112.538 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -96.08 -16.77 21.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.628 0.252 . . . . 1.56 111.03 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.02 87.37 2.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.587 -0.523 . . . . 1.25 109.587 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.3 t -66.13 121.86 16.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.276 -0.42 . . . . 1.68 110.726 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.1 t -77.56 125.94 30.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.896 0.379 . . . . 2.25 111.539 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 91.9 mt -88.35 -5.93 58.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.45 0.643 . . . . 1.35 109.427 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -80.5 108.96 14.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.264 -0.88 . . . . 2.21 109.84 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.85 -34.56 1.23 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.873 -0.679 . . . . 1.18 112.017 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.5 m -78.36 -30.7 15.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.729 0.3 . . . . 1.21 111.6 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.59 65.1 0.93 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.638 -0.791 . . . . 1.08 112.671 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.4 pt -125.24 -171.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.354 -0.609 . . . . 1.07 109.354 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -101.22 -27.66 13.09 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.739 -0.384 . . . . 4.33 111.477 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.7 m -81.41 80.71 7.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.268 0.556 . . . . 1.51 110.388 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 m -80.21 94.54 6.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.63 -0.714 . . . . 1.79 111.256 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -162.52 -178.31 36.27 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.828 -0.624 . . . . 1.18 112.137 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.3 m -105.0 138.99 27.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.821 0.31 . . . . 1.56 110.963 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.9 t -73.81 126.93 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.808 -0.633 . . . . 1.29 110.258 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.75 85.23 7.02 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.584 0.587 . . . . 2.85 112.584 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 11.0 m -83.44 -8.19 59.42 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.81 -0.811 . . . . 1.47 108.81 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -87.55 -27.97 22.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.801 -1.091 . . . . 0.89 111.14 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -130.84 64.53 73.91 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 113.984 1.105 . . . . 2.65 113.984 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -77.52 133.96 13.44 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 121.872 1.715 . . . . 0.8 109.204 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -135.19 143.06 46.22 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.683 0.623 . . . . 2.42 112.683 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.85 127.88 34.15 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.814 -1.18 . . . . 1.79 107.814 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.5 pt -126.1 173.18 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.967 0.413 . . . . 1.15 111.091 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -101.65 133.48 46.29 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.64 -0.709 . . . . 1.03 109.138 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.2 mmt -126.19 27.98 6.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.971 0.415 . . . . 1.29 111.266 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -125.3 -42.98 1.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 3.09 110.8 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.46 -37.54 9.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.728 -0.669 . . . . 1.12 109.505 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -68.69 -49.28 60.25 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.006 -0.543 . . . . 1.17 110.453 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.33 143.55 4.59 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.909 -0.587 . . . . 1.12 112.278 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.77 176.77 32.39 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.766 -0.73 . . . . 1.16 111.958 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -128.31 126.31 40.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.586 0.232 . . . . 2.87 111.171 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -74.3 132.99 42.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 2.93 110.451 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 83.1 mt -103.71 -73.23 0.68 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.362 -0.381 . . . . 1.29 110.639 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -144.83 175.4 10.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.214 -0.448 . . . . 1.15 110.626 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.6 ttp85 -120.03 144.64 47.44 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.428 -0.582 . . . . 1.57 109.428 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.9 m -103.32 145.26 30.26 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.704 0.288 . . . . 0.75 111.298 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.77 155.09 45.17 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.742 2.295 . . . . 0.95 111.751 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -67.59 -21.09 65.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.06 -0.518 . . . . 1.51 111.276 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.97 -57.46 12.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 1.62 110.994 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 pt -69.83 -23.04 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 1.31 111.509 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 40.0 mmm -67.75 -34.9 77.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 1.6 109.813 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -67.04 -30.71 70.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.583 . . . . 2.52 110.083 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -62.57 -31.16 71.92 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.781 -0.645 . . . . 1.64 110.481 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.54 -48.97 23.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.506 -0.77 . . . . 1.03 109.76 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.42 -37.08 79.73 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.966 -0.561 . . . . 1.22 111.351 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.88 -40.01 97.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.908 -0.663 . . . . 1.03 111.928 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.0 mtt85 -75.77 -38.7 58.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.947 0.403 . . . . 2.16 110.739 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 82.8 mt -59.37 -41.82 90.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.906 -0.588 . . . . 1.02 111.109 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.2 m -63.83 -20.86 66.12 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.23 0.455 . . . . 1.11 112.23 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -90.89 -35.63 14.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.812 0.339 . . . . 1.95 111.508 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.9 pt -78.04 -14.7 14.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 113.114 0.783 . . . . 1.15 113.114 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 61.8 mt -78.32 65.3 3.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.086 0.47 . . . . 0.98 110.932 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.758 -0.655 . . . . 1.35 110.632 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 121.098 0.475 . . . . 2.03 111.335 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -76.33 -34.99 58.99 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.232 -1.025 . . . . 2.82 108.232 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 68.35 140.45 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.613 -1.176 . . . . 2.66 112.853 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.53 -10.48 74.4 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.814 -0.708 . . . . 1.28 112.54 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -76.84 99.14 5.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.875 0.369 . . . . 1.53 111.536 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 20.6 mt -89.02 122.42 40.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.907 -0.588 . . . . 0.75 110.816 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -122.32 134.34 54.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.088 -0.505 . . . . 0.82 109.877 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 tt -95.14 123.06 38.43 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.66 -0.246 . . . . 1.05 110.587 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.18 154.73 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.72 110.76 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 67.8 m -76.63 126.08 30.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.439 -0.346 . . . . 1.68 111.215 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.53 -21.28 25.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.83 112.003 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.06 162.9 62.68 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.544 -0.298 . . . . 1.62 111.007 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.18 152.96 98.91 Favored 'Cis proline' 0 C--N 1.352 0.712 0 C-N-CA 123.82 -1.325 . . . . 1.28 113.214 0.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 6.2 p -123.93 145.04 49.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.576 -0.738 . . . . 1.7 110.406 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -132.79 108.32 8.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.923 0.392 . . . . 1.22 110.665 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.28 -133.96 11.73 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.897 -0.668 . . . . 1.01 111.79 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -101.32 23.79 10.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.658 0.266 . . . . 2.62 111.504 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -71.39 150.48 44.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.039 -0.528 . . . . 1.28 110.799 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -69.39 116.0 9.31 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.642 -0.503 . . . . 1.98 109.642 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -103.23 173.11 6.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.12 -0.491 . . . . 1.86 112.203 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.66 138.31 4.05 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.759 -0.655 . . . . 0.9 113.332 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 91.7 m -70.01 130.65 42.73 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.351 -0.611 . . . . 1.11 109.351 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -159.74 160.94 27.41 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.503 -0.317 . . . . 2.0 110.374 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -66.02 131.97 28.66 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.629 2.219 . . . . 0.65 110.836 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 18.4 m -125.43 157.81 34.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.388 -0.369 . . . . 0.57 110.938 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -103.88 133.18 49.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.954 -0.566 . . . . 1.17 109.942 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 54.6 mt -85.81 123.37 39.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.741 0.305 . . . . 0.66 110.958 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.69 49.44 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.496 0.665 . . . . 0.93 110.081 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 8.1 m -143.34 122.75 7.53 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.918 -0.583 . . . . 1.1 109.879 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -48.62 128.1 17.59 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.078 2.518 . . . . 0.78 112.405 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.72 -30.66 67.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.962 -0.563 . . . . 1.03 111.536 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.9 -32.83 71.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 1.4 111.211 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -94.57 -21.42 18.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.174 0.511 . . . . 1.57 110.266 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -58.71 -35.6 72.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.748 -0.66 . . . . 1.92 110.649 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.8 -20.33 65.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.265 -0.425 . . . . 2.93 111.73 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.06 -58.97 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.793 0.664 . . . . 1.09 112.793 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 1.2 p -86.51 -33.81 20.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.569 0.581 . . . . 1.64 112.569 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 67.43 24.51 8.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.309 0.576 . . . . 2.01 111.197 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.63 88.69 16.2 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.517 -0.765 . . . . 1.16 109.301 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -85.98 149.29 9.51 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.678 2.252 . . . . 0.57 113.384 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 6.1 t -86.53 124.55 40.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.555 -0.906 . . . . 1.08 108.555 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.65 154.58 22.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.237 0.458 . . . . 0.64 112.237 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 m -118.06 127.6 26.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.494 -0.775 . . . . 1.1 109.444 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.12 160.56 23.58 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.934 2.422 . . . . 0.73 113.031 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 31.5 m -115.55 145.52 21.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.943 -0.571 . . . . 0.9 110.519 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 27.9 m -95.39 124.2 39.31 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.534 -0.543 . . . . 1.24 109.534 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.87 131.55 49.84 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.569 0.581 . . . . 2.43 112.569 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.11 -171.06 13.39 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.607 -0.597 . . . . 2.22 111.607 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.21 60.59 0.56 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.551 -0.833 . . . . 3.43 112.693 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 66.58 80.1 0.22 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.206 0.527 . . . . 4.91 112.328 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -160.1 157.6 28.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.688 -0.687 . . . . 6.27 110.188 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -130.38 86.5 2.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.136 0.493 . . . . 4.39 110.758 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -126.95 97.98 5.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.047 -0.524 . . . . 4.51 110.779 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.33 70.09 9.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.053 0.454 . . . . 3.23 110.194 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.1 126.89 38.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.984 -0.553 . . . . 1.96 111.487 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.0 -114.39 6.08 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.814 -0.63 . . . . 1.14 112.497 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -116.09 16.12 16.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.925 0.393 . . . . 3.57 110.457 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.07 111.28 23.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.087 -0.506 . . . . 1.08 110.674 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 t -95.66 124.18 48.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.284 -0.416 . . . . 1.34 110.195 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.7 m -77.4 123.09 26.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.733 0.642 . . . . 1.71 112.733 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 88.2 mt -89.75 -15.62 32.05 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.185 -1.043 . . . . 1.02 108.185 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -71.48 150.42 44.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.362 -1.29 . . . . 1.79 110.499 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.79 -44.5 3.25 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.802 -0.713 . . . . 1.15 113.469 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 p -70.1 -18.82 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.949 0.404 . . . . 1.17 111.926 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.21 59.74 0.5 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.567 -0.825 . . . . 1.05 112.91 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 31.5 mm -128.61 137.24 57.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.131 -0.692 . . . . 1.61 109.131 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -65.44 -36.55 84.26 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.293 0.568 . . . . 2.65 109.874 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 11.8 m -80.0 82.17 6.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.634 -0.712 . . . . 0.93 109.946 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 23.2 p -68.48 97.52 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.861 -0.609 . . . . 1.62 111.313 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.12 -171.53 37.87 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.637 -0.792 . . . . 0.79 112.46 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 m -118.16 132.67 67.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.555 0.217 . . . . 0.93 111.24 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 30.4 t -74.78 128.78 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.434 -0.348 . . . . 1.38 110.459 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 14.0 mmm-85 -96.95 84.78 3.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.061 0.457 . . . . 1.52 110.319 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.22 -13.03 61.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.793 -0.639 . . . . 1.55 110.538 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -87.53 7.16 30.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.769 -0.65 . . . . 1.1 111.899 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -132.56 61.77 58.86 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 111.803 0.298 . . . . 2.83 111.803 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.98 119.99 4.89 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.482 2.121 . . . . 0.96 110.83 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -136.9 122.23 19.36 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 111.944 0.35 . . . . 2.32 111.944 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -84.03 139.9 32.21 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.218 -0.66 . . . . 1.21 109.218 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 8.3 pt -148.86 162.69 5.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.484 -0.325 . . . . 1.28 110.374 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -77.98 94.6 4.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.201 0.524 . . . . 1.28 110.679 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 53.0 tpp -61.11 -24.76 66.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.302 -0.863 . . . . 2.7 112.263 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.18 -49.25 11.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.76 0.314 . . . . 2.62 111.633 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.94 -41.46 82.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.379 -0.373 . . . . 1.06 111.077 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -75.68 -31.83 59.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 1.47 111.334 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.57 101.83 0.88 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.86 -0.686 . . . . 0.92 112.822 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -112.35 150.61 18.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.871 -0.68 . . . . 0.92 112.49 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -140.58 136.68 33.05 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.403 -0.221 . . . . 2.24 110.403 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -75.69 135.89 40.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.799 0.333 . . . . 2.99 110.853 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 82.7 mt -108.14 -77.99 0.59 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.301 0.482 . . . . 0.76 112.301 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.1 -178.18 4.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.495 -0.32 . . . . 1.07 111.635 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -121.5 122.67 40.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 2.71 110.778 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 57.7 t -82.91 136.19 44.57 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.934 -0.575 . . . . 1.45 110.559 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -53.66 144.57 52.57 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.837 2.358 . . . . 1.03 111.999 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -55.9 -39.95 72.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.668 -0.696 . . . . 2.14 111.916 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 14.2 t -57.53 -33.95 68.61 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.625 0.602 . . . . 2.06 112.625 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 48.2 mm -82.3 -36.57 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.218 0.532 . . . . 1.33 110.206 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 30.0 mmt -66.22 -33.27 75.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 2.34 111.047 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -60.24 -36.23 77.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.19 0.519 . . . . 2.09 110.414 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -67.67 -41.05 84.35 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.724 -0.671 . . . . 1.76 110.442 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 93.8 t -57.54 -48.3 83.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.156 -0.475 . . . . 1.01 110.248 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.79 -40.6 97.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.744 -0.662 . . . . 1.29 110.175 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.14 -46.94 89.73 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.81 -0.632 . . . . 1.02 112.342 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -60.8 -41.12 95.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.858 0.361 . . . . 2.34 110.936 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 31.8 tp -66.1 -30.67 71.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.193 -0.458 . . . . 1.94 110.714 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 49.1 m -66.33 -34.78 78.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.175 -0.466 . . . . 1.16 111.308 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -15.92 62.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.04 0.385 . . . . 1.85 112.04 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 60.2 mt -79.03 -23.16 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.297 0.57 . . . . 1.98 110.375 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 74.9 mt -93.8 48.02 1.25 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.757 -0.656 . . . . 1.36 110.779 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.661 -0.685 . . . . 2.71 110.56 179.691 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C1' 1.407 -0.579 0 C4'-C3'-C2' 103.885 1.185 . 0.0 '__' . 6.89 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.869 0 C4'-C3'-C2' 104.417 1.717 . 0.0 OUTLIER gamma 3.15 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' ' A' . . . . . 0.404 ' N1 ' ' O ' ' A' ' 47' ' ' SER . . . . . . . . 0 P--O3' 1.616 0.716 0 O4'-C1'-C2' 107.597 0.855 . 0.0 OUTLIER . 2.89 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C3'--C2' 1.536 1.04 0 C4'-C3'-C2' 105.709 3.009 OUTLIER-DELTA 0.0 OUTLIER gamma 2.51 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' ' A' . . . . . 0.459 ' N3 ' " H2'" ' C' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.887 0 O4'-C1'-C2' 107.866 1.047 . 0.0 OUTLIER . 5.55 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ptp . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.958 0.408 . . . . 1.45 110.742 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -108.66 167.15 10.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.674 -0.694 . . . . 2.01 110.231 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -69.01 129.27 39.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.287 -0.415 . . . . 2.16 109.99 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.35 -7.46 34.67 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.558 -0.83 . . . . 0.87 112.828 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -81.42 147.36 29.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.826 0.313 . . . . 0.99 111.271 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.6 mt -111.45 121.67 64.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 1.16 110.751 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -118.43 147.48 43.54 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.91 110.145 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 tp -102.91 130.09 49.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.939 -0.119 . . . . 0.9 110.717 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -169.74 154.62 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.237 0.336 . . . . 1.04 110.421 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.0 m -80.97 141.25 34.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.714 0.292 . . . . 1.32 110.435 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 53.8 mt -82.85 -7.79 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 1.29 111.03 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.45 162.45 41.79 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.412 -0.813 . . . . 1.54 110.153 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.57 141.35 64.03 Favored 'Cis proline' 0 C--O 1.236 0.385 0 C-N-CA 123.716 -1.368 . . . . 1.69 111.726 -0.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.0 p -117.58 171.77 7.79 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.224 -0.444 . . . . 1.53 110.536 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.28 137.57 39.14 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.434 -0.58 . . . . 1.7 109.434 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.54 -116.02 5.27 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.71 -0.757 . . . . 1.18 112.995 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -113.05 17.4 18.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.531 0.205 . . . . 3.12 111.136 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -59.26 137.45 57.97 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.251 -0.431 . . . . 1.14 110.004 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.76 118.39 4.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.492 -0.322 . . . . 2.09 111.204 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -124.42 164.01 20.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.169 -0.469 . . . . 2.44 110.674 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.411 ' CA ' " H2'" ' C' ' 5' ' ' ' A' . . . 112.05 150.36 11.32 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.608 -0.806 . . . . 1.07 113.595 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.402 ' H ' " H2'" ' C' ' 5' ' ' ' A' . 0.4 OUTLIER -72.47 113.9 10.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.875 0.369 . . . . 1.46 110.124 179.159 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.96 160.51 52.61 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.372 -0.376 . . . . 2.01 110.173 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.31 134.18 24.24 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.468 2.112 . . . . 1.01 111.056 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.3 m -119.28 136.08 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 110.005 -0.368 . . . . 0.76 110.005 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.8 tp -94.35 128.72 41.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.083 -0.508 . . . . 0.7 111.437 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.2 mm -73.32 114.56 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.345 -0.389 . . . . 0.92 110.127 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.2 t -90.33 -41.82 13.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.002 0.43 . . . . 0.95 111.953 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.69 147.18 96.36 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 112.04 0.385 . . . . 1.12 112.04 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.45 159.12 54.76 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.767 2.311 . . . . 1.3 111.986 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.61 70.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.982 -0.554 . . . . 1.39 112.348 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.29 94.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.846 0.355 . . . . 1.61 110.948 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -66.48 -41.2 89.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.039 -0.528 . . . . 1.77 110.482 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -67.54 -11.82 58.92 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.034 -0.53 . . . . 1.48 110.886 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.8 ttp-105 -94.79 -31.96 13.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.175 -0.466 . . . . 3.04 111.212 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.41 -49.08 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.824 0.676 . . . . 1.86 112.824 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 p -95.27 -27.05 15.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.953 0.406 . . . . 2.06 110.564 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 67.13 21.25 10.15 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.367 -0.833 . . . . 4.87 111.395 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.0 mt -125.65 98.98 33.37 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.393 -0.821 . . . . 1.81 109.027 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -88.55 134.54 2.85 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.806 2.337 . . . . 1.05 113.775 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.9 t -79.21 114.37 19.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.193 -1.41 . . . . 1.03 107.193 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.5 m -115.66 150.61 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 113.44 0.904 . . . . 0.79 113.44 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 m -117.97 129.03 25.62 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.931 -1.031 . . . . 0.72 108.96 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.35 145.44 53.77 Favored 'Trans proline' 0 CA--C 1.527 0.17 0 C-N-CA 123.186 2.591 . . . . 1.03 113.871 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.8 t -107.49 119.9 57.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.509 -0.923 . . . . 1.28 108.509 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.4 m -154.05 123.56 6.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.521 0.201 . . . . 2.5 111.172 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.2 p -111.67 -5.49 14.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.501 -0.318 . . . . 2.82 110.932 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.23 38.84 94.16 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 110.866 -0.894 . . . . 3.36 110.866 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.4 -116.51 5.1 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.571 -1.012 . . . . 3.83 110.571 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -112.27 16.0 20.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.191 0.519 . . . . 5.09 110.312 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -91.62 48.59 1.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.883 -0.599 . . . . 6.24 111.257 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.18 102.26 2.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.225 -0.443 . . . . 2.61 110.241 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.93 166.74 14.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.966 0.412 . . . . 5.23 111.846 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.17 87.78 2.77 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.758 -0.655 . . . . 2.69 109.422 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.82 113.7 18.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.984 -0.553 . . . . 3.17 110.593 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.51 -119.34 5.28 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.848 -0.691 . . . . 1.69 112.338 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -106.06 69.07 0.79 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.127 0.489 . . . . 1.56 111.328 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.19 138.45 29.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.9 -0.591 . . . . 1.25 110.03 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.7 t -116.25 118.24 58.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.601 -0.272 . . . . 1.68 110.882 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.7 118.87 20.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.609 -0.269 . . . . 2.25 111.117 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.87 -18.61 39.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.233 0.54 . . . . 1.35 110.58 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -67.37 117.04 8.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.566 -0.743 . . . . 2.21 109.954 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.78 -31.4 2.21 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.381 -0.688 . . . . 1.18 111.381 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.7 m -83.18 -17.26 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.835 0.35 . . . . 1.21 111.502 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.58 83.07 0.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.849 -0.691 . . . . 1.08 112.68 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.7 pt -138.44 169.67 17.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.838 -0.43 . . . . 1.07 109.838 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -76.5 -51.73 11.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.79 0.329 . . . . 4.33 110.586 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.9 m -85.34 75.88 10.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.269 0.557 . . . . 1.51 110.948 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.02 158.47 29.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.759 -0.655 . . . . 1.79 111.322 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 156.42 -157.34 27.83 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 121.069 -0.586 . . . . 1.18 111.744 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.6 t -130.04 126.39 61.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 110.178 -0.305 . . . . 1.56 110.178 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.7 t -72.56 118.94 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.318 -0.623 . . . . 1.29 109.318 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -92.89 96.03 9.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.241 -0.436 . . . . 2.85 110.971 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.16 -6.04 57.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.538 0.685 . . . . 1.47 109.373 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -78.98 -16.2 57.24 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.902 -1.045 . . . . 0.89 112.689 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -136.83 68.71 58.47 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 114.138 1.162 . . . . 2.65 114.138 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.79 140.73 32.63 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.289 1.993 . . . . 0.8 109.914 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.1 ptm85 -156.21 114.15 3.31 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.823 0.675 . . . . 2.42 112.823 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.8 m -82.76 109.94 17.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.154 -0.476 . . . . 1.79 110.089 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.0 pt -120.96 155.18 24.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.038 -0.528 . . . . 1.15 109.641 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.53 125.77 26.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.976 0.417 . . . . 1.03 111.5 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 40.3 tpp -103.08 9.24 38.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.094 0.473 . . . . 1.29 110.718 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -92.94 -64.21 1.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.173 -0.467 . . . . 3.09 111.854 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.58 -27.96 63.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.293 -0.412 . . . . 1.12 111.305 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -73.81 -29.86 62.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.253 -0.431 . . . . 1.17 110.502 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.32 66.94 2.09 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.896 -0.669 . . . . 1.12 112.355 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.14 151.94 51.67 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.713 -0.756 . . . . 1.16 112.27 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -113.43 122.12 46.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.31 -0.255 . . . . 2.87 110.31 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -82.18 135.28 35.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.655 0.264 . . . . 2.93 111.224 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -104.27 -64.68 1.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.134 0.492 . . . . 1.29 110.616 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -162.95 -169.07 1.93 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.791 -0.64 . . . . 1.15 109.346 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -130.77 156.48 44.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.684 0.278 . . . . 1.57 110.579 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.8 m -97.33 156.59 36.05 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.39 -0.368 . . . . 0.75 111.085 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -64.19 145.52 89.09 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.721 2.281 . . . . 0.95 111.129 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -61.19 -25.7 67.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 1.51 111.662 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -38.43 87.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.877 0.37 . . . . 1.62 110.577 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.7 mm -73.56 -46.48 48.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.96 -0.564 . . . . 1.31 109.921 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 9.8 tpt -63.03 -26.05 68.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.953 -0.567 . . . . 1.6 110.99 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.15 -48.22 79.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.673 -0.694 . . . . 2.52 111.634 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -28.41 60.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.543 -0.299 . . . . 1.64 111.55 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.2 -46.93 95.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.699 -0.482 . . . . 1.03 109.699 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 77.7 mt -61.34 -36.38 80.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.614 -0.721 . . . . 1.22 110.185 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.31 -46.18 94.95 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.479 -0.782 . . . . 1.03 112.453 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.5 mtt180 -65.4 -37.84 88.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 2.16 110.77 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.61 -18.27 65.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.757 -0.656 . . . . 1.02 112.253 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.1 m -78.82 -24.96 44.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.938 0.399 . . . . 1.11 111.164 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.75 -22.25 50.56 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.124 0.416 . . . . 1.95 112.124 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.0 pt -84.23 -9.22 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 111.96 0.356 . . . . 1.15 111.96 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.3 mt -84.2 73.03 10.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.897 0.379 . . . . 0.98 110.092 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 116.361 -0.381 . . . . 1.35 111.666 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.743 0.306 . . . . 2.03 110.881 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -82.27 -21.53 36.18 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.328 -0.619 . . . . 2.82 109.328 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 72.14 120.9 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.946 -1.024 . . . . 2.66 112.903 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.47 -26.76 21.66 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.741 -0.663 . . . . 1.28 113.679 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -71.08 97.84 1.55 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.848 0.685 . . . . 1.53 112.848 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 64.5 mt -95.26 125.91 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.851 -0.796 . . . . 0.75 108.851 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -105.78 164.78 11.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.986 0.422 . . . . 0.82 112.007 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 45.8 tp -128.87 120.04 25.51 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.05 -0.523 . . . . 1.05 109.949 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 p -159.69 169.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.251 -0.431 . . . . 0.72 110.122 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.77 135.54 39.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.779 0.323 . . . . 1.68 110.472 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 35.3 mt -86.28 -18.26 32.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.234 -0.439 . . . . 0.83 111.189 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.96 154.24 89.81 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.915 -0.584 . . . . 1.62 111.116 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.47 124.28 9.38 Favored 'Cis proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.266 -1.556 . . . . 1.28 113.041 0.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.93 166.85 13.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.554 -0.748 . . . . 1.7 109.918 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.87 -171.24 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.582 0.23 . . . . 1.22 111.069 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.96 -104.92 1.18 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 116.081 -0.508 . . . . 1.01 112.702 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -132.43 14.52 4.54 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.293 0.568 . . . . 2.62 110.285 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -78.07 143.95 36.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.735 -0.666 . . . . 1.28 110.061 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.08 105.47 2.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.763 0.316 . . . . 1.98 111.224 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -83.89 -174.73 5.45 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.112 -0.495 . . . . 1.86 110.913 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.05 -167.11 49.25 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.95 -0.568 . . . . 0.9 112.752 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 20.1 m -113.89 122.27 46.49 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.428 -0.582 . . . . 1.11 109.428 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -151.61 159.99 32.42 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.681 -0.488 . . . . 2.0 109.681 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -59.47 137.76 79.86 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.192 1.928 . . . . 0.65 110.671 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 m -128.09 128.13 68.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.989 0.424 . . . . 0.57 111.126 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 46.7 tp -94.44 121.2 35.74 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.961 -0.563 . . . . 1.17 109.605 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 51.5 mt -80.86 137.82 20.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.956 -0.387 . . . . 0.66 109.956 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.87 -29.39 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.821 0.344 . . . . 0.93 111.051 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.06 137.31 75.89 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.258 -0.428 . . . . 1.1 111.615 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.2 161.42 42.99 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.009 2.473 . . . . 0.78 112.045 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.77 -37.08 73.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.169 -0.468 . . . . 1.03 111.677 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.51 -29.99 71.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.114 0.483 . . . . 1.4 111.176 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -81.13 -40.01 24.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.033 0.444 . . . . 1.57 110.135 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -66.52 -22.32 66.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.63 -0.713 . . . . 1.92 110.725 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -79.75 -34.83 39.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 2.93 110.948 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 58.0 t -85.4 -64.21 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.156 -0.475 . . . . 1.09 111.987 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 1.3 m -67.51 -30.77 70.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.385 -0.37 . . . . 1.64 111.014 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 71.69 -9.84 0.9 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.534 0.568 . . . . 2.01 112.534 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 60.4 mt -118.62 100.93 51.09 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.681 -0.489 . . . . 1.16 109.681 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.68 158.96 9.14 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.742 2.295 . . . . 0.57 113.322 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 6.4 m -92.95 127.2 45.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 109.202 -0.666 . . . . 1.08 109.202 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.68 146.78 18.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.252 0.549 . . . . 0.64 112.148 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 43.1 t -109.84 112.91 57.87 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.944 -1.026 . . . . 1.1 109.279 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.06 119.42 6.16 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.69 2.26 . . . . 0.73 112.567 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 91.6 t -77.49 136.44 24.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.812 -0.631 . . . . 0.9 110.202 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 3.9 m -105.07 112.01 24.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.129 -0.487 . . . . 1.24 110.097 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.49 127.54 32.58 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.184 -0.462 . . . . 2.43 110.64 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.72 16.96 36.58 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.531 -0.842 . . . . 2.22 112.744 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.31 -92.89 0.33 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.977 -0.63 . . . . 3.43 111.985 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -127.83 -48.58 1.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.138 0.494 . . . . 4.91 110.293 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -85.17 93.82 8.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.063 -0.517 . . . . 6.27 110.654 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -127.83 100.52 5.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.027 -0.533 . . . . 4.39 110.579 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -115.99 -173.47 2.36 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.013 -0.539 . . . . 4.51 110.571 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 13.6 t -82.7 129.14 34.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.4 0.619 . . . . 3.23 112.605 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -116.45 64.6 0.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.469 -0.787 . . . . 1.96 109.995 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.95 -94.24 0.78 Allowed Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.77 -0.65 . . . . 1.14 112.464 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -87.72 -6.64 58.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.921 0.391 . . . . 3.57 111.096 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.36 113.91 22.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.36 -0.382 . . . . 1.08 110.392 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 t -77.79 141.29 15.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.03 -0.532 . . . . 1.34 110.335 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -90.2 124.94 35.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.54 -0.3 . . . . 1.71 110.709 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 72.4 mt -89.97 -35.68 15.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.267 -0.424 . . . . 1.02 110.868 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -82.87 -173.22 4.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 1.79 111.321 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.92 -38.46 3.17 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.162 -0.775 . . . . 1.15 111.162 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 7.0 p -94.85 -3.35 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.953 0.406 . . . . 1.17 110.679 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.88 84.29 1.68 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.789 -0.719 . . . . 1.05 112.597 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 12.0 tt -135.3 160.58 40.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.798 -0.445 . . . . 1.61 109.798 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -83.5 -45.13 13.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.864 0.364 . . . . 2.65 110.705 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 17.1 m -85.46 90.52 7.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.154 0.502 . . . . 0.93 111.643 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 52.7 m -71.46 98.1 1.77 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.804 -0.634 . . . . 1.62 111.016 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -165.05 -171.2 31.0 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.793 -0.717 . . . . 0.79 112.152 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 15.1 m -117.58 151.97 19.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.862 0.363 . . . . 0.93 111.131 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 47.3 t -87.92 121.96 39.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.904 -0.589 . . . . 1.38 110.219 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 33.3 mmm-85 -97.25 84.93 3.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.953 0.406 . . . . 1.52 111.138 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 29.6 m -73.67 -0.75 16.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.189 -0.459 . . . . 1.55 111.228 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -96.06 -2.8 45.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.977 -0.556 . . . . 1.1 111.939 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -130.16 52.45 9.42 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.538 0.94 . . . . 2.83 113.538 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.87 119.4 2.18 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.269 1.979 . . . . 0.96 111.49 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -125.61 140.34 52.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.705 0.288 . . . . 2.32 111.453 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.18 126.98 31.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.679 -0.86 . . . . 1.21 108.679 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 31.5 pt -133.8 149.54 30.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.389 0.514 . . . . 1.28 112.389 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -76.41 91.71 3.32 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.277 -0.638 . . . . 1.28 109.277 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 48.5 tpp -67.76 -16.71 64.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.976 -0.556 . . . . 2.7 111.869 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -75.91 -45.58 34.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.282 -0.417 . . . . 2.62 111.111 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.98 -31.69 25.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.236 -0.438 . . . . 1.06 111.88 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -72.61 -36.01 67.98 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.943 0.349 . . . . 1.47 111.943 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.64 80.1 1.44 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.351 -0.928 . . . . 0.92 112.108 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.55 162.0 28.93 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.746 -0.74 . . . . 0.92 112.749 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -155.96 155.37 32.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.661 -0.866 . . . . 2.24 108.661 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -99.35 142.26 31.06 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 121.083 -0.247 . . . . 2.99 111.144 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 53.5 mt -108.39 -97.06 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.95 0.352 . . . . 0.76 111.95 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -106.89 169.86 8.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.466 -0.334 . . . . 1.07 111.153 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -110.72 106.06 15.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.373 -0.376 . . . . 2.71 110.417 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 14.4 p -69.37 133.05 89.36 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.405 -0.361 . . . . 1.45 110.851 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.8 147.11 33.09 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.002 2.468 . . . . 1.03 112.52 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -60.67 -28.32 68.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.852 -0.613 . . . . 2.14 110.937 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -47.16 86.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.762 -0.654 . . . . 2.06 110.768 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 51.6 mm -74.66 -40.07 47.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.545 . . . . 1.33 110.199 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 8.8 tpt -58.56 -38.01 76.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.9 -0.591 . . . . 2.34 110.981 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -60.94 -39.35 89.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.917 0.389 . . . . 2.09 110.701 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -67.14 -27.63 67.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 1.76 111.257 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 63.3 t -70.94 -51.27 36.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.414 -0.587 . . . . 1.01 109.414 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.23 -36.59 81.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.585 -0.734 . . . . 1.29 110.821 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.23 -50.88 63.07 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.936 -0.575 . . . . 1.02 112.079 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 77.2 mtt85 -62.95 -35.89 81.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.72 0.295 . . . . 2.34 110.893 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 35.4 mt -66.03 -31.2 71.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.247 0.546 . . . . 1.94 110.115 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -80.81 -18.73 46.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.793 -0.64 . . . . 1.16 110.858 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 7.8 m -74.13 -38.88 63.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.296 -0.411 . . . . 1.85 110.841 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 34.6 pt -76.29 2.25 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 111.982 0.364 . . . . 1.98 111.982 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 86.2 mt -82.97 -13.84 55.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.345 -0.389 . . . . 1.36 111.138 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.802 -0.618 . . . . 2.71 110.273 179.65 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' ' A' . . . . . 0.705 ' N3 ' " H2'" ' C' ' 1' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.429 -0.684 0 C1'-C2'-O2' 108.238 -0.787 . 0.0 '__' . 6.89 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 O4'-C1'-C2' 104.635 -1.261 . 0.0 OUTLIER zeta-1 3.15 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' ' A' . . . . . 0.553 ' N3 ' " H2'" ' C' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.971 0 O4'-C1'-C2' 108.376 1.412 . 0.0 OUTLIER . 2.89 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C4'--C3' 1.533 0.808 0 C4'-C3'-C2' 104.18 1.48 . 0.0 OUTLIER . 2.51 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' ' A' . . . . . 0.411 " H2'" ' CA ' ' A' ' 21' ' ' GLY . . . . . . . . 0 O5'--C5' 1.428 -0.731 0 C3'-C2'-O2' 110.962 -0.806 . 0.0 OUTLIER gamma 5.55 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptp . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.887 0.375 . . . . 1.45 110.474 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -129.23 158.4 39.14 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.971 -0.559 . . . . 2.01 110.55 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -61.64 122.61 15.73 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 110.037 -0.357 . . . . 2.16 110.037 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 111.09 -8.85 29.22 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.914 -0.66 . . . . 0.87 112.055 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -85.8 145.35 27.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.88 0.371 . . . . 0.99 111.365 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.12 110.75 33.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.259 -0.645 . . . . 1.16 109.259 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -104.67 135.22 46.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.934 0.397 . . . . 0.91 111.294 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.6 tp -95.51 122.3 38.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.26 -0.427 . . . . 0.9 110.822 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 p -160.87 157.24 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 1.04 109.936 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.17 130.01 35.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.841 -0.429 . . . . 1.32 109.841 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.6 mt -78.96 -10.51 59.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.252 -0.431 . . . . 1.29 110.952 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.23 164.47 60.78 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.707 -0.679 . . . . 1.54 110.922 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.99 141.12 65.08 Favored 'Cis proline' 0 C--N 1.347 0.49 0 C-N-CA 123.815 -1.327 . . . . 1.69 112.533 0.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.0 p -120.35 151.81 38.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.296 -0.411 . . . . 1.53 111.276 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.85 125.47 11.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.931 -0.577 . . . . 1.7 109.689 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.38 -124.54 6.76 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.206 -0.758 . . . . 1.18 111.206 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -139.99 75.54 1.51 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.148 0.499 . . . . 3.12 110.948 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.86 166.79 23.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.567 -0.742 . . . . 1.14 109.414 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -63.2 128.03 34.0 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.406 0.441 . . . . 2.09 110.634 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -131.22 178.62 6.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.064 -0.516 . . . . 2.44 110.106 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.1 162.62 38.24 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.804 -0.712 . . . . 1.07 113.844 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.6 m -85.95 102.44 13.76 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.975 -0.75 . . . . 1.46 108.975 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.99 156.12 75.92 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.268 -0.423 . . . . 2.01 110.622 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.13 123.69 9.43 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.564 2.176 . . . . 1.01 110.795 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.9 m -108.93 134.22 51.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.959 0.409 . . . . 0.76 110.156 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.8 tp -86.31 122.61 30.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.849 -0.614 . . . . 0.7 111.268 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.4 mm -74.76 115.23 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.92 109.854 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.9 t -96.75 -38.78 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 112.07 0.396 . . . . 0.95 112.07 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.08 147.22 76.48 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 112.186 0.439 . . . . 1.12 112.186 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.02 156.25 65.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.853 2.368 . . . . 1.3 112.03 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.19 61.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.816 -0.629 . . . . 1.39 112.561 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.09 -46.3 90.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.745 0.307 . . . . 1.61 111.453 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -67.62 -41.2 84.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.12 0.486 . . . . 1.77 110.416 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -66.5 -18.61 65.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.712 -0.676 . . . . 1.48 111.362 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -88.99 -42.22 11.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.393 -0.367 . . . . 3.04 111.966 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 p -81.13 -44.42 20.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.032 0.753 . . . . 1.86 113.032 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 m -90.72 -24.2 20.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.83 0.348 . . . . 2.06 111.395 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? 64.25 15.79 9.64 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.915 -0.584 . . . . 4.87 111.851 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.57 87.74 55.8 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 1.81 111.045 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.66 132.12 14.24 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.207 1.938 . . . . 1.05 112.248 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.8 t -77.62 118.9 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.097 -1.445 . . . . 1.03 107.097 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.1 m -127.68 161.3 35.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.617 0.723 . . . . 0.79 112.87 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -125.06 130.74 24.09 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 114.547 -1.206 . . . . 0.72 108.292 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.7 141.73 27.98 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.528 2.152 . . . . 1.03 113.68 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 90.0 t -107.12 111.04 33.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.996 -0.742 . . . . 1.28 108.996 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.0 m -151.72 141.44 21.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.36 -0.382 . . . . 2.5 110.431 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 p -120.52 153.14 37.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.921 0.391 . . . . 2.82 111.144 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -163.65 -66.63 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.286 -1.126 . . . . 3.36 110.286 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.89 145.39 18.21 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.66 -0.976 . . . . 3.83 110.66 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -79.37 67.0 4.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.134 0.492 . . . . 5.09 111.517 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -123.84 83.38 2.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.908 -0.587 . . . . 6.24 110.113 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -96.48 122.42 39.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.969 -0.559 . . . . 2.61 109.947 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -152.93 103.11 2.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.19 -0.459 . . . . 5.23 111.042 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -27.48 67.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.177 0.513 . . . . 2.69 110.879 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.88 12.2 13.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.88 -0.6 . . . . 3.17 110.387 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -125.2 -148.58 7.33 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.665 -0.698 . . . . 1.69 111.711 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -108.81 15.2 23.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.154 0.502 . . . . 1.56 111.252 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -132.23 77.86 1.78 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.814 -0.63 . . . . 1.25 110.2 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.6 m -85.26 133.62 28.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.837 -0.62 . . . . 1.68 111.285 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.69 148.16 24.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.778 -0.646 . . . . 2.25 110.802 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.1 mt -91.64 -16.84 26.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.245 0.545 . . . . 1.35 110.175 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.21 124.95 25.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.668 -0.696 . . . . 2.21 110.614 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.4 -27.94 2.94 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.45 -0.66 . . . . 1.18 111.45 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.5 m -96.01 -13.2 8.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.667 0.27 . . . . 1.21 111.266 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.96 72.8 0.97 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.957 -0.639 . . . . 1.08 113.108 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 15.6 pt -123.25 -167.86 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.613 0.244 . . . . 1.07 111.043 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -102.95 -43.78 5.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.147 0.499 . . . . 4.33 109.781 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.2 m -64.75 109.34 2.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.514 -0.766 . . . . 1.51 111.327 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 m -102.21 127.28 49.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.06 -0.518 . . . . 1.79 111.101 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 162.31 -166.84 36.65 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.499 -1.04 . . . . 1.18 110.499 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.81 131.89 72.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.24 -0.652 . . . . 1.56 109.24 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.2 t -78.23 117.56 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.835 0.35 . . . . 1.29 110.83 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -82.85 103.39 12.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.639 -0.504 . . . . 2.85 109.639 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.19 1.96 55.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.135 0.493 . . . . 1.47 110.943 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.417 ' CG ' HO2' ' C' ' 2' ' ' ' U' . 10.7 p-10 -89.67 -16.32 30.7 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.586 -0.734 . . . . 0.89 111.341 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -125.61 72.73 68.23 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 113.49 0.922 . . . . 2.65 113.49 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -90.97 115.18 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.888 2.392 . . . . 0.8 110.014 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -138.07 165.88 25.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.163 0.506 . . . . 2.42 111.735 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.18 133.02 42.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.343 -0.984 . . . . 1.79 108.343 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.2 pt -132.21 148.35 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.788 0.328 . . . . 1.15 111.304 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -82.08 102.42 11.02 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.882 -0.414 . . . . 1.03 109.882 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.3 tpp -89.76 -10.12 46.75 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.235 -0.439 . . . . 1.29 111.108 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.1 tptp -79.69 -41.25 27.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.798 0.332 . . . . 3.09 111.274 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.09 -26.82 42.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.421 -0.354 . . . . 1.12 111.388 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 33.1 mtt-85 -84.06 -59.47 2.39 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.385 0.513 . . . . 1.17 112.385 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.78 109.29 0.3 Allowed Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.889 -0.672 . . . . 1.12 111.85 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.03 -168.66 12.5 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.649 -0.786 . . . . 1.16 112.79 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -131.36 138.97 49.4 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.063 -0.347 . . . . 2.87 110.063 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -86.2 139.8 30.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.753 0.311 . . . . 2.93 111.137 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -89.04 -55.37 3.71 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.049 -0.722 . . . . 1.29 109.049 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -170.37 -160.61 0.22 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.183 -0.917 . . . . 1.15 108.688 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -134.58 149.97 50.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.688 0.28 . . . . 1.57 110.456 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.4 m -97.73 159.82 30.07 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.26 -0.427 . . . . 0.75 111.092 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -64.87 155.87 65.28 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.713 2.276 . . . . 0.95 111.398 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -63.59 -26.94 68.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 1.51 110.753 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.34 -37.59 78.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.542 . . . . 1.62 110.573 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.5 mm -70.06 -43.69 78.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.022 -0.535 . . . . 1.31 110.12 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.7 tpt -63.7 -45.87 88.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 1.6 110.459 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -61.58 -36.69 81.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.024 -0.535 . . . . 2.52 110.716 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -63.08 -47.64 82.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.072 -0.513 . . . . 1.64 110.589 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.64 -46.02 97.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.939 -0.573 . . . . 1.03 110.336 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.55 -39.14 83.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.099 -0.501 . . . . 1.22 110.689 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.42 -43.37 99.15 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.783 -0.644 . . . . 1.03 111.644 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -65.14 -37.76 88.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 2.16 110.49 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.43 -25.06 65.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.56 . . . . 1.02 111.691 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.2 m -71.89 -11.53 60.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 1.11 111.067 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.26 -13.65 26.31 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.316 0.487 . . . . 1.95 112.316 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.1 pt -100.75 -1.24 9.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.827 0.677 . . . . 1.15 112.827 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.8 mt -81.65 73.7 8.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.753 0.311 . . . . 0.98 110.222 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.545 -0.298 . . . . 1.35 111.596 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 120.708 0.289 . . . . 2.03 110.432 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -77.39 -25.95 51.33 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.922 -0.77 . . . . 2.82 108.922 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 73.03 142.84 0.06 Allowed 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 114.96 -1.018 . . . . 2.66 111.457 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.46 -50.03 4.16 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.898 -0.668 . . . . 1.28 113.62 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -57.66 107.41 0.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.838 0.681 . . . . 1.53 112.838 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 80.6 mt -98.66 127.28 51.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.374 -0.602 . . . . 0.75 109.374 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -107.68 168.82 8.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.201 0.524 . . . . 0.82 111.805 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 33.5 tp -141.53 132.17 25.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.697 -0.683 . . . . 1.05 109.941 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 p -169.26 165.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.532 -0.544 . . . . 0.72 109.532 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 22.9 t -88.76 139.36 30.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.677 -0.49 . . . . 1.68 109.677 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 31.7 mt -87.72 -16.82 33.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.201 0.524 . . . . 0.83 110.349 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.83 162.08 75.72 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.76 -0.655 . . . . 1.62 111.283 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.28 135.56 33.92 Favored 'Cis proline' 0 C--N 1.344 0.299 0 C-N-CA 123.359 -1.517 . . . . 1.28 113.259 0.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.02 170.51 15.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.345 -0.843 . . . . 1.7 109.575 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.46 165.09 28.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.575 0.226 . . . . 1.22 110.551 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.34 -146.23 34.23 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.122 -0.561 . . . . 1.01 112.266 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -90.15 -1.72 57.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.384 -0.228 . . . . 2.62 110.384 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -57.78 154.25 12.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.906 -0.588 . . . . 1.28 112.201 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -60.94 127.35 31.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.686 -0.688 . . . . 1.98 111.383 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -142.06 -176.6 4.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.893 -0.594 . . . . 1.86 110.533 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.59 174.82 50.62 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.993 -0.622 . . . . 0.9 112.697 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 22.9 m -105.65 103.62 13.16 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.828 -0.434 . . . . 1.11 109.828 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -141.55 157.98 64.25 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.241 -0.436 . . . . 2.0 110.332 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.02 141.36 79.27 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.495 2.13 . . . . 0.65 111.411 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.4 m -131.75 131.49 62.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.379 0.609 . . . . 0.57 111.56 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 36.6 tp -101.72 123.85 46.39 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.669 -0.696 . . . . 1.17 109.527 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 34.4 mt -78.89 138.16 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.58 -0.282 . . . . 0.66 110.362 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.54 -34.92 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.406 -0.361 . . . . 0.93 110.945 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.53 140.96 68.78 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.215 -0.448 . . . . 1.1 111.634 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.76 159.83 27.93 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.767 2.311 . . . . 0.78 112.009 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.18 -29.7 58.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.212 -0.449 . . . . 1.03 111.954 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.38 -40.73 75.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.292 -0.413 . . . . 1.4 110.871 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -89.33 -37.76 14.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.058 -0.519 . . . . 1.57 110.63 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -61.69 -18.22 58.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.704 -0.68 . . . . 1.92 112.302 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -88.13 -25.88 22.76 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.694 0.257 . . . . 2.93 111.694 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -82.02 -61.84 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.963 0.411 . . . . 1.09 111.645 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.79 -28.21 36.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.186 -0.461 . . . . 1.64 111.201 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 69.9 8.23 6.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.809 -0.632 . . . . 2.01 111.819 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.64 98.06 48.28 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.968 -0.56 . . . . 1.16 109.537 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -90.62 155.23 4.28 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.789 2.326 . . . . 0.57 113.112 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 m -94.74 124.93 47.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.105 -0.702 . . . . 1.08 109.105 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.2 147.19 15.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 112.802 0.667 . . . . 0.64 112.802 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.41 118.29 49.38 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 114.752 -1.113 . . . . 1.1 108.757 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.14 142.45 30.8 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.628 2.219 . . . . 0.73 113.041 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 44.0 t -95.62 116.72 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.798 -0.637 . . . . 0.9 109.809 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.88 145.0 26.87 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.193 -0.458 . . . . 1.24 110.79 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 8.5 m -95.61 102.22 14.0 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.73 0.3 . . . . 2.43 110.745 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.3 68.25 3.34 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.129 -0.558 . . . . 2.22 112.199 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.7 -112.54 3.58 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 121.081 -0.58 . . . . 3.43 111.662 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -126.8 -51.49 1.46 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.066 0.46 . . . . 4.91 110.58 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -97.29 100.89 12.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.127 -0.488 . . . . 6.27 109.909 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.14 133.89 44.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.72 -0.673 . . . . 4.39 111.395 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.21 161.29 27.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.137 -0.483 . . . . 4.51 110.171 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.72 120.46 19.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.055 0.455 . . . . 3.23 111.44 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -108.76 -161.1 0.75 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.947 -0.57 . . . . 1.96 110.53 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.39 -61.33 5.48 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.253 -0.498 . . . . 1.14 112.54 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -114.65 0.38 13.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.283 0.563 . . . . 3.57 110.54 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -100.16 106.23 17.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.614 -0.721 . . . . 1.08 110.573 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 57.0 t -87.92 129.31 39.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.675 -0.693 . . . . 1.34 109.895 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.4 t -85.08 138.21 32.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.224 -0.444 . . . . 1.71 111.467 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 37.8 mt -106.11 5.81 30.47 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.719 -0.845 . . . . 1.02 108.719 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -101.19 144.48 30.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.239 -0.891 . . . . 1.79 110.864 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.14 -23.33 11.5 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 116.102 -0.499 . . . . 1.15 111.96 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 p -100.14 -20.52 5.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.173 0.511 . . . . 1.17 111.54 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.96 51.62 0.88 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.601 -0.809 . . . . 1.05 112.708 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 82.6 mt -109.13 147.42 13.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.446 -0.575 . . . . 1.61 109.446 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -65.53 -49.53 68.61 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.869 0.366 . . . . 2.65 110.133 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 17.8 m -67.89 101.8 1.15 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.915 -0.584 . . . . 0.93 109.866 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.17 113.97 25.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.138 -0.483 . . . . 1.62 111.253 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.98 -170.25 39.18 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.439 -0.886 . . . . 0.79 112.681 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 6.0 m -123.86 133.97 67.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.972 -0.381 . . . . 0.93 109.972 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 19.3 m -82.34 138.11 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.464 -0.334 . . . . 1.38 111.445 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 mmm-85 -94.82 85.09 4.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.376 -0.374 . . . . 1.52 110.101 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.4 m -67.85 -9.21 42.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 1.55 111.617 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -92.24 -1.86 56.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.471 . . . . 1.1 111.833 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -128.27 83.24 66.71 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 112.02 0.378 . . . . 2.83 112.02 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -92.01 144.87 2.92 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.01 2.473 . . . . 0.96 112.181 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -148.42 131.46 16.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.453 -0.34 . . . . 2.32 111.01 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.07 126.52 34.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.549 . . . . 1.21 109.567 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 23.9 pt -140.47 151.33 20.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 1.28 111.315 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -80.67 100.43 8.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 1.28 109.852 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 48.5 tpp -66.62 -16.77 64.43 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.674 0.62 . . . . 2.7 112.674 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -80.29 -54.34 5.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.931 0.396 . . . . 2.62 110.887 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.65 -28.16 67.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.125 -0.489 . . . . 1.06 111.34 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -85.44 -11.39 54.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.295 -0.411 . . . . 1.47 111.501 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.96 57.49 18.47 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 121.096 -0.573 . . . . 0.92 112.754 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.24 148.86 51.15 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.934 -0.65 . . . . 0.92 112.793 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.11 164.45 21.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.49 -0.189 . . . . 2.24 110.49 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -105.23 137.22 43.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.771 0.319 . . . . 2.99 110.399 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 23.5 mt -98.55 -69.26 0.77 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.233 -0.439 . . . . 0.76 111.908 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -154.02 -171.13 3.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.069 -0.514 . . . . 1.07 110.705 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -128.03 119.92 26.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.032 0.444 . . . . 2.71 111.262 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 2.6 p -84.58 135.06 41.2 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.687 -0.688 . . . . 1.45 109.637 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.45 145.78 27.48 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.954 2.436 . . . . 1.03 113.097 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -56.76 -29.15 62.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.757 -0.656 . . . . 2.14 111.517 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -39.14 77.53 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.326 -0.397 . . . . 2.06 111.362 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 31.5 mm -79.26 -29.8 13.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.276 0.56 . . . . 1.33 109.516 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 11.2 mmt -62.89 -32.31 73.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.59 -0.732 . . . . 2.34 110.566 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.15 -41.85 93.64 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.922 -0.581 . . . . 2.09 110.253 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -62.57 -45.04 94.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.814 -0.63 . . . . 1.76 110.024 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 38.4 t -62.66 -49.86 82.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.649 -0.705 . . . . 1.01 111.05 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 86.7 mt -55.85 -38.57 70.25 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.343 -0.389 . . . . 1.29 111.512 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.58 -44.78 97.05 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.655 -0.783 . . . . 1.02 111.34 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -68.34 -33.36 74.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.059 0.456 . . . . 2.34 110.472 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.35 -24.87 67.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.882 -0.599 . . . . 1.94 110.854 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 23.2 m -85.17 -24.16 28.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.152 -0.476 . . . . 1.16 110.882 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.35 -28.57 62.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.259 -0.428 . . . . 1.85 112.068 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 40.7 pt -68.5 -19.67 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.548 0.573 . . . . 1.98 112.548 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.31 59.45 5.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.271 0.558 . . . . 1.36 111.457 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-N 115.954 -0.566 . . . . 2.71 109.699 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.69 0 C3'-C2'-O2' 111.166 -0.736 . 0.0 '__' . 6.89 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' ' U' . . . . . 0.417 HO2' ' CG ' ' A' ' 75' ' ' ASP . . . . . . . . 0 O5'--C5' 1.422 -1.139 0 C3'-C2'-C1' 100.57 -1.034 . 0.032 2o . 3.15 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' ' A' . . . . . 0.72 ' N3 ' " H2'" ' C' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.977 0 C3'-C2'-O2' 110.849 -0.845 . 0.0 OUTLIER gamma 2.89 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.423 -1.032 0 O4'-C1'-C2' 107.972 1.123 . 0.0 OUTLIER . 2.51 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' ' A' . . . . . 0.548 ' N3 ' " H5'" ' C' ' 5' ' ' ' A' . . . . . . . . 0 O3'--C3' 1.432 0.625 0 C4'-C3'-O3' 114.039 1.323 . 0.0 OUTLIER . 5.55 . . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.415 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 23.3 ptp . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.925 0.393 . . . . 1.29 110.532 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -116.78 172.11 7.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.226 -0.443 . . . . 2.0099999999999998 111.077 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -73.19 131.06 41.54 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.196 -0.456 . . . . 1.8500000000000001 111.031 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.67 1.22 58.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.878 -0.677 . . . . 0.85999999999999999 113.116 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.419 ' OE2' ' HD2' ' A' ' 89' ' ' ARG . 35.9 mt-10 -84.61 146.86 27.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 0.98999999999999999 111.255 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.74 HD12 ' HG3' ' A' ' 91' ' ' GLU . 21.2 mt -106.52 118.91 55.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.862 -0.608 . . . . 1.1599999999999999 110.265 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -118.05 128.65 54.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.91000000000000003 111.124 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.669 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 19.9 tp -80.07 130.03 34.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.366 -0.379 . . . . 0.90000000000000002 110.621 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.444 HG11 HD11 ' A' ' 80' ' ' ILE . 9.0 p -158.28 165.17 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.415 -0.357 . . . . 1.04 110.389 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 m -104.95 139.86 39.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.848 0.356 . . . . 1.3200000000000001 110.898 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.675 HD23 HD13 ' A' ' 80' ' ' ILE . 25.3 mt -98.43 -9.17 25.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.003 0.43 . . . . 1.29 110.58 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.497 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 2.7 m-20 -78.1 165.55 49.7 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.533 -0.758 . . . . 1.54 110.672 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.497 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 73.2 Cg_endo -73.95 139.25 60.46 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.83 -1.321 . . . . 1.6899999999999999 113.073 0.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.684 ' OG1' ' HB3' ' A' ' 20' ' ' GLN . 21.5 p -111.27 157.1 20.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.502 -0.772 . . . . 1.3600000000000001 110.175 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -136.3 148.93 48.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.34 . . . . 1.7 111.075 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.88 -86.62 1.07 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.94 -0.648 . . . . 1.1799999999999999 112.176 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -160.44 45.13 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.158 0.504 . . . . 2.7799999999999998 111.258 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.677 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 29.8 mt-10 -79.43 176.63 9.52 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.737 -0.468 . . . . 1.1399999999999999 109.737 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -78.94 90.35 4.75 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.434 -0.58 . . . . 2.0899999999999999 109.434 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.684 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 1.4 pt20 -89.94 158.63 17.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.783 -0.644 . . . . 2.0899999999999999 112.059 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.9 127.72 6.18 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.684 -0.689 . . . . 1.0700000000000001 112.805 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.9 m -63.14 129.92 42.37 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.77 0.319 . . . . 1.1100000000000001 110.336 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.43 155.49 29.86 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.175 -0.466 . . . . 1.6200000000000001 110.283 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 11.7 Cg_exo -72.53 131.6 17.69 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.314 2.009 . . . . 1.01 110.824 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.655 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 20.9 m -107.38 154.12 8.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.439 -0.346 . . . . 0.76000000000000001 110.288 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.48 HD23 HG21 ' A' ' 101' ' ' VAL . 29.7 tp -100.87 133.03 45.96 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.372 -0.377 . . . . 0.69999999999999996 111.061 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.9 mm -76.51 108.96 10.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.92000000000000004 110.117 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.42 -39.59 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.94999999999999996 112.039 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.35 146.76 81.74 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 112.142 0.423 . . . . 1.1200000000000001 112.142 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 33' ' ' PHE . 41.8 Cg_endo -68.28 158.08 59.08 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.795 2.33 . . . . 1.3 112.107 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.9 -39.7 74.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.932 -0.577 . . . . 1.3899999999999999 112.065 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.73 -42.1 83.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 1.6100000000000001 111.385 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.429 ' HB2' ' HG2' ' A' ' 30' ' ' PRO . 5.9 t80 -70.39 -46.51 63.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.945 -0.57 . . . . 1.77 110.402 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -61.9 -30.31 70.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 1.48 111.197 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -68.39 -44.96 73.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.277 -0.419 . . . . 2.6200000000000001 112.101 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -86.72 -40.97 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 113.907 1.077 . . . . 1.8600000000000001 113.907 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.8 m -84.78 -33.3 23.03 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.767 0.284 . . . . 1.72 111.767 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 65.46 20.42 11.73 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.058 0.456 . . . . 4.4500000000000002 111.673 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.1 mt -134.01 91.78 23.43 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.668 -0.697 . . . . 1.8100000000000001 109.181 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -84.41 135.43 6.12 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.516 2.144 . . . . 1.05 113.339 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -79.17 124.8 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.922 -1.14 . . . . 1.03 107.922 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.655 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 23.4 m -124.33 153.74 31.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.627 0.602 . . . . 0.77000000000000002 112.627 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.42 140.74 27.74 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.352 -0.84 . . . . 0.71999999999999997 109.695 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.27 147.65 16.29 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.801 2.334 . . . . 1.03 113.897 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.604 HG22 HG22 ' A' ' 72' ' ' VAL . 84.0 t -103.76 119.74 52.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.485 -0.779 . . . . 1.28 109.269 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.319 -0.76 0 N-CA-C 109.506 -0.553 . . . . 1.9099999999999999 109.506 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 111.939 -0.464 . . . . 1.6599999999999999 111.939 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -87.94 -9.65 52.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.235 0.54 . . . . 1.5600000000000001 110.28 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.433 ' HB1' ' CG1' ' A' ' 71' ' ' VAL . . . -91.86 134.21 34.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.466 -0.788 . . . . 1.25 108.981 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 13.2 m -94.97 165.68 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.062 0.458 . . . . 1.6799999999999999 111.912 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.1 m -71.97 143.25 49.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.842 -0.617 . . . . 1.95 111.041 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.688 HD11 HG23 ' A' ' 72' ' ' VAL . 4.9 mt -136.49 -52.92 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.135 0.42 . . . . 1.23 112.135 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -66.22 116.07 6.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.129 0.49 . . . . 2.21 111.788 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.59 -27.86 0.85 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.633 -0.712 . . . . 1.1499999999999999 111.848 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.408 HG23 HG23 ' A' ' 66' ' ' ILE . 25.5 m -89.56 -10.48 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.36 0.504 . . . . 1.21 112.36 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.72 73.02 1.06 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.802 -0.713 . . . . 1.0800000000000001 112.606 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.408 HG23 HG23 ' A' ' 64' ' ' VAL . 6.9 pt -116.63 172.3 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.804 0.335 . . . . 1.0700000000000001 111.011 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.0 ttm-85 -92.68 -28.35 16.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.226 0.536 . . . . 3.5899999999999999 109.922 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.8 m -77.22 109.55 11.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.651 -0.704 . . . . 1.51 111.068 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 m -93.45 110.69 22.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.231 0.539 . . . . 1.79 110.898 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 171.18 -169.02 42.14 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.119 -0.792 . . . . 1.1799999999999999 111.119 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.433 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 4.7 t -129.24 124.87 61.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 110.192 -0.299 . . . . 1.5600000000000001 110.192 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.688 HG23 HD11 ' A' ' 61' ' ' LEU . 78.2 t -73.97 121.12 24.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.692 -0.485 . . . . 1.29 109.692 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -114.94 135.97 53.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.914 0.388 . . . . 2.23 110.721 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.4 ' SG ' HG13 ' A' ' 101' ' ' VAL . 8.1 m -113.89 32.51 5.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.907 -0.588 . . . . 1.1699999999999999 109.697 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.612 ' HB2' ' HZ ' ' B' ' 33' ' ' PHE . 20.1 p-10 -88.97 -49.63 6.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.467 -0.788 . . . . 0.89000000000000001 111.73 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.438 ' HG2' ' OD2' ' A' ' 75' ' ' ASP . 40.2 mm-40 -117.3 74.58 8.03 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.7 -0.227 . . . . 2.1299999999999999 111.587 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -96.34 163.6 1.22 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.943 2.429 . . . . 0.80000000000000004 112.495 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' B' ' 78' ' ' ARG . 1.1 ptm180 -170.24 146.11 2.87 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.297 -0.411 . . . . 2.0899999999999999 110.802 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.638 ' HB ' ' HG3' ' B' ' 76' ' ' GLN . 2.4 m -84.68 93.87 8.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.051 0.453 . . . . 1.6200000000000001 109.915 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.675 HD13 HD23 ' A' ' 11' ' ' LEU . 20.5 pt -84.36 -174.19 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.483 0.659 . . . . 1.1499999999999999 112.718 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -89.54 132.06 35.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.047 -0.979 . . . . 1.03 110.554 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 51.8 tpp -127.26 26.39 6.03 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.472 -0.936 . . . . 1.29 108.472 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -112.33 -45.92 3.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.518 -0.765 . . . . 2.6400000000000001 111.093 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.27 -26.09 16.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.179 -0.464 . . . . 1.1200000000000001 111.409 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -80.06 -43.77 21.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.236 -0.438 . . . . 1.0600000000000001 111.626 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.99 127.67 2.05 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.831 -0.7 . . . . 1.1200000000000001 112.759 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -104.05 136.74 13.17 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.849 -0.691 . . . . 1.0900000000000001 112.077 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 6.8 mptt -109.47 117.04 32.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.945 -0.391 . . . . 2.46 109.945 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.419 ' HD2' ' OE2' ' A' ' 5' ' ' GLU . 6.8 ttp85 -74.55 126.27 30.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.751 0.31 . . . . 2.4900000000000002 110.943 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.25 -73.36 0.68 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.073 0.463 . . . . 1.29 110.801 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.74 ' HG3' HD12 ' A' ' 6' ' ' ILE . 19.4 pt-20 -146.57 -164.52 2.0 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.638 -0.71 . . . . 1.1499999999999999 109.522 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 92' ' ' ARG . 3.6 ptm180 -143.18 150.66 39.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.755 0.312 . . . . 1.3200000000000001 110.746 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.669 HG13 HD11 ' A' ' 6' ' ' ILE . 16.0 m -102.5 151.96 38.29 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.217 -0.447 . . . . 0.75 110.465 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -66.16 167.22 18.74 Favored 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 122.636 2.224 . . . . 0.94999999999999996 111.644 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -60.73 -21.4 62.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.977 -0.556 . . . . 1.51 111.537 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -42.24 94.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.928 -0.578 . . . . 1.5700000000000001 110.599 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.7 mm -76.19 -33.88 24.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.841 -0.618 . . . . 1.3100000000000001 110.823 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.4 tpt -59.9 -41.36 91.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 1.6000000000000001 110.99 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -65.64 -35.08 79.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 2.2999999999999998 110.648 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 1.2 mm-40 -60.52 -48.35 82.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.934 -0.576 . . . . 1.6399999999999999 111.295 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.48 HG21 HD23 ' A' ' 26' ' ' LEU . 58.1 t -63.67 -40.78 90.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.952 -0.567 . . . . 1.03 111.226 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.2 mt -68.54 1.05 3.39 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.225 0.824 . . . . 1.22 113.225 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.12 -1.18 26.8 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.121 -1.038 . . . . 1.03 112.945 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -104.82 -20.56 13.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.9 0.381 . . . . 1.72 111.771 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.5 mt -73.73 -24.82 59.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.001 0.429 . . . . 1.02 111.707 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -28.86 62.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.839 0.352 . . . . 1.1100000000000001 111.544 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.85 -17.28 61.08 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.055 0.761 . . . . 1.5 113.055 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.1 pt -93.51 -13.62 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 111.978 0.362 . . . . 1.1499999999999999 111.978 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.2 mt -86.39 86.8 7.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.928 0.394 . . . . 0.97999999999999998 110.939 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' B' ' 30' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 116.367 -0.379 . . . . 1.3500000000000001 111.037 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.602 ' HG3' ' O ' ' B' ' 27' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.366 0.603 . . . . 2.0299999999999998 112.577 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 2' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' B' ' 31' ' ' ALA . 30.4 mt-10 -95.62 -7.47 37.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.431 -0.804 . . . . 2.8199999999999998 109.608 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? 73.42 120.71 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.22 1.193 . . . . 2.3199999999999998 114.22 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' GLY . . . . . 0.472 ' HA2' HG12 ' B' ' 93' ' ' VAL . . . 72.51 43.54 44.38 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 115.008 0.763 . . . . 1.28 115.008 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -117.55 93.74 4.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.26 0.53 . . . . 1.53 112.377 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.787 HD11 ' HB ' ' B' ' 93' ' ' VAL . 57.2 mt -100.05 102.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.442 -0.947 . . . . 0.75 108.442 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.459 ' HA ' ' HA ' ' B' ' 89' ' ' ARG . 13.8 m95 -105.79 145.84 30.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.272 0.558 . . . . 0.81000000000000005 112.4 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 22.9 tp -102.77 119.73 39.35 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.471 -0.937 . . . . 1.05 108.471 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.93 159.29 4.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.865 0.364 . . . . 0.71999999999999997 110.788 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.68 121.22 25.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.155 -0.475 . . . . 1.6299999999999999 110.519 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.493 HD21 HG11 ' B' ' 25' ' ' VAL . 88.5 mt -79.69 -20.62 46.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.147 -0.479 . . . . 0.82999999999999996 110.728 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.07 153.89 90.9 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.639 . . . . 1.6200000000000001 110.574 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -88.98 162.26 39.68 Favored 'Cis proline' 0 C--O 1.236 0.394 0 C-N-CA 123.438 -1.484 . . . . 1.28 112.053 -0.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.507 HG21 ' HB3' ' B' ' 18' ' ' GLU . 0.2 OUTLIER -150.24 160.73 43.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 1.47 110.587 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.29 142.97 37.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.783 0.325 . . . . 1.22 110.61 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.24 -155.62 34.66 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.949 -0.643 . . . . 1.01 112.433 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -85.53 50.43 1.96 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.197 0.443 . . . . 2.1800000000000002 112.197 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.507 ' HB3' HG21 ' B' ' 14' ' ' THR . 4.0 mt-10 -112.76 163.71 14.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.19 -0.459 . . . . 1.28 109.847 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.844 ' HG3' ' HG3' ' B' ' 44' ' ' PRO . 86.7 mm-40 -73.17 138.28 45.6 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.164 0.802 . . . . 1.52 113.164 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -146.65 -179.73 6.98 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.58 -0.736 . . . . 1.8600000000000001 110.419 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.24 150.88 21.57 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.125 -0.56 . . . . 0.90000000000000002 112.549 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 45.2 m -86.34 106.04 17.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.953 0.406 . . . . 0.94999999999999996 109.925 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' B' ' 23' ' ' ARG . 0.3 OUTLIER -149.65 159.95 35.11 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.159 -0.473 . . . . 1.5900000000000001 109.759 -178.798 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.72 139.8 82.59 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.347 2.031 . . . . 0.65000000000000002 111.21 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.639 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 3.3 m -137.12 152.33 27.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.39 -0.368 . . . . 0.56999999999999995 110.509 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.618 HD23 HG11 ' B' ' 101' ' ' VAL . 22.9 tp -103.05 121.66 43.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.113 -0.494 . . . . 1.1699999999999999 109.722 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ILE . . . . . 0.602 ' O ' ' HG3' ' B' ' 1' ' ' MET . 10.5 mt -74.31 148.63 8.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.432 -0.349 . . . . 0.66000000000000003 110.703 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.524 ' HB ' HG23 ' B' ' 41' ' ' VAL . 21.9 t -114.78 -34.18 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.014 0.435 . . . . 0.93000000000000005 110.988 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.29 138.43 91.85 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.059 -0.519 . . . . 0.81000000000000005 112.208 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.525 ' HB3' ' HB ' ' A' ' 110' ' ' THR . 83.5 Cg_endo -77.41 170.27 19.69 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.888 2.392 . . . . 0.78000000000000003 112.638 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.593 ' HB2' ' HG2' ' B' ' 2' ' ' GLU . . . -62.79 -30.31 71.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.852 -0.613 . . . . 1.03 110.61 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.03 -0.75 8.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.665 -0.698 . . . . 1.3999999999999999 112.3 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' PHE . . . . . 0.612 ' HZ ' ' HB2' ' A' ' 75' ' ' ASP . 7.5 t80 -135.14 -40.53 0.74 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.952 0.406 . . . . 1.5700000000000001 111.0 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -59.54 -33.05 70.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.834 -0.621 . . . . 1.6399999999999999 111.471 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -97.41 11.69 35.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.365 -0.379 . . . . 2.54 110.993 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 97.7 t -110.57 -67.03 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 1.0900000000000001 111.493 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 14.5 p -84.07 -22.83 31.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.764 0.316 . . . . 1.3300000000000001 110.979 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.44 ' HE ' ' HA ' ' B' ' 38' ' ' ARG . 1.2 mmp_? 70.35 12.87 7.57 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.596 -0.729 . . . . 1.78 111.689 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 17.1 mt -119.7 90.18 42.78 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.401 -0.962 . . . . 1.1599999999999999 108.401 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -92.45 161.78 2.98 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.737 2.291 . . . . 0.56999999999999995 114.134 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.555 HG13 HG23 ' B' ' 79' ' ' THR . 0.8 OUTLIER -98.88 130.75 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.173 -1.047 . . . . 1.0800000000000001 108.173 177.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.639 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 23.5 m -120.76 145.48 27.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 112.68 0.622 . . . . 0.64000000000000001 112.68 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 53.5 t -97.73 118.53 63.97 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.874 -1.057 . . . . 1.1000000000000001 108.451 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.844 ' HG3' ' HG3' ' B' ' 19' ' ' GLN . 50.3 Cg_endo -67.67 124.27 11.75 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.861 2.374 . . . . 0.72999999999999998 113.259 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.619 HG22 HG12 ' B' ' 72' ' ' VAL . 46.1 t -87.31 139.79 16.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.161 -0.681 . . . . 0.90000000000000002 109.161 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -120.95 116.09 24.44 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.561 -0.533 . . . . 1.1699999999999999 109.561 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 C--O 1.237 0.407 0 CA-C-N 115.934 -0.576 . . . . 1.8500000000000001 112.168 -179.587 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.227 0 CA-C-O 120.739 0.304 . . . . 1.96 111.074 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.501 ' O ' ' HD2' ' B' ' 104' ' ' ARG . . . 62.79 -110.23 3.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.136 -0.554 . . . . 1.0800000000000001 112.534 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -93.46 -14.38 26.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.976 0.417 . . . . 3.5699999999999998 110.788 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.55 110.08 10.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 1.0800000000000001 110.864 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.707 HG21 ' HA ' ' B' ' 101' ' ' VAL . 85.7 t -87.97 131.48 35.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.941 -0.572 . . . . 1.3400000000000001 109.501 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 9.3 t -88.3 119.05 28.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.409 -0.359 . . . . 1.3799999999999999 111.131 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 60.3 mt -87.9 -18.11 29.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.723 -0.843 . . . . 1.02 108.723 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -86.46 142.92 28.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.201 -0.909 . . . . 1.79 110.469 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.9 -55.12 0.76 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 121.034 -0.603 . . . . 1.1499999999999999 111.68 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 13.9 p -73.9 -27.61 22.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.949 0.404 . . . . 1.1699999999999999 111.638 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.66 68.94 0.33 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.871 -0.681 . . . . 1.05 111.977 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.457 HD11 ' HD2' ' B' ' 94' ' ' PRO . 61.0 mt -125.42 148.27 29.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.087 -0.709 . . . . 1.6100000000000001 109.087 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' B' ' 67' ' ' ARG . 1.0 OUTLIER -66.32 -50.41 63.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.958 0.409 . . . . 2.3999999999999999 109.963 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 7.2 m -67.77 94.75 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.851 -0.613 . . . . 0.93000000000000005 110.501 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 4.5 m -87.15 90.71 8.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.924 -0.58 . . . . 1.3100000000000001 110.82 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.81 -170.01 35.29 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.376 -0.916 . . . . 0.79000000000000004 112.383 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' B' ' 59' ' ' VAL . 15.6 m -123.12 145.33 30.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.791 0.329 . . . . 0.93000000000000005 110.667 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.619 HG12 HG22 ' B' ' 45' ' ' VAL . 1.3 m -91.43 136.32 24.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.821 0.343 . . . . 1.3799999999999999 111.198 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.646 ' HB2' ' HG2' ' B' ' 44' ' ' PRO . 11.9 mmm180 -86.32 82.73 7.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 1.3700000000000001 110.611 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 2.5 m -79.81 45.93 0.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.017 0.436 . . . . 1.1599999999999999 110.838 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -135.6 -32.91 0.89 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.927 -0.578 . . . . 1.1000000000000001 110.949 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' GLN . . . . . 0.638 ' HG3' ' HB ' ' A' ' 79' ' ' THR . 61.7 tt0 -125.69 79.47 67.85 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 112.455 0.539 . . . . 2.4700000000000002 112.455 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.438 ' HD2' ' OG1' ' A' ' 79' ' ' THR . 99.0 Cg_endo -89.16 143.47 4.76 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.555 2.17 . . . . 0.95999999999999996 110.647 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' ARG . . . . . 0.489 ' HA ' ' HB2' ' A' ' 78' ' ' ARG . 54.5 ttt180 -124.53 141.48 52.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.801 0.334 . . . . 1.96 111.765 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.555 HG23 HG13 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -82.75 121.23 26.62 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.482 -0.932 . . . . 1.1899999999999999 108.482 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 15.9 pt -126.96 -164.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.045 0.45 . . . . 1.28 111.41 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -115.7 143.87 44.75 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.903 -0.777 . . . . 1.28 108.903 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 11.6 ttp -126.32 31.71 5.34 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.734 0.272 . . . . 2.7000000000000002 111.734 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -137.65 -42.5 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.181 0.437 . . . . 1.96 112.181 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.21 -29.63 15.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.816 0.341 . . . . 1.0600000000000001 110.246 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -72.65 -35.73 67.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 1.47 110.628 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.22 106.74 0.99 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.922 -0.656 . . . . 0.81999999999999995 112.757 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.18 159.91 21.89 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.68 -0.772 . . . . 0.65000000000000002 112.084 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -151.59 136.12 16.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.026 -0.361 . . . . 1.8100000000000001 110.026 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' B' ' 7' ' ' TRP . 59.8 ttp180 -76.93 126.13 30.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.652 0.263 . . . . 2.4900000000000002 110.583 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 80.1 mt -82.4 -64.17 1.23 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.242 -0.435 . . . . 0.76000000000000001 110.868 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -139.85 174.17 10.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 1.0700000000000001 110.311 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -112.34 115.11 28.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.234 0.54 . . . . 2.0499999999999998 110.903 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.787 ' HB ' HD11 ' B' ' 6' ' ' ILE . 7.2 p -70.33 133.07 87.48 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.465 -0.789 . . . . 1.45 110.801 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.457 ' HD2' HD11 ' B' ' 66' ' ' ILE . 77.2 Cg_exo -53.66 147.56 39.31 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 122.94 2.427 . . . . 1.03 111.999 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.02 -33.37 67.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.996 -0.547 . . . . 2.1400000000000001 111.021 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.61 -48.97 79.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.862 -0.608 . . . . 1.78 110.799 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 21.2 mm -72.05 -34.48 50.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.771 -0.65 . . . . 1.3300000000000001 110.48 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 11.8 tpt -59.64 -38.63 81.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 2.3399999999999999 110.477 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -65.77 -35.83 81.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.889 -0.596 . . . . 1.9099999999999999 110.853 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 57.1 tt0 -63.55 -46.59 85.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 1.76 109.965 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.707 ' HA ' HG21 ' B' ' 59' ' ' VAL . 24.5 t -58.74 -48.68 85.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.116 -0.493 . . . . 1.01 110.915 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.95 -35.49 76.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.99 -0.55 . . . . 1.29 111.243 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.74 -36.43 92.27 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.259 -0.736 . . . . 1.02 111.259 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 23.9 mmt85 -73.45 -34.07 65.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.04 0.448 . . . . 1.8500000000000001 110.258 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.535 ' O ' HG12 ' B' ' 108' ' ' ILE . 78.7 mt -71.03 -11.41 60.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.893 -0.594 . . . . 1.9399999999999999 111.335 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.7 m -77.71 -8.57 58.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.88 0.371 . . . . 1.1599999999999999 111.488 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.3 m -74.22 -16.17 60.98 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.898 0.333 . . . . 1.45 111.898 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.535 HG12 ' O ' ' B' ' 105' ' ' LEU . 31.5 pt -79.69 -1.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 111.885 0.328 . . . . 1.98 111.885 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 88.8 mt -102.05 15.99 27.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.246 0.546 . . . . 1.3600000000000001 110.6 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.252 1.188 0 CA-C-N 115.769 -0.65 . . . . 2.1299999999999999 110.061 179.691 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 ptp . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.857 0.361 . . . . 1.29 110.481 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -107.66 167.0 10.27 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.103 -0.499 . . . . 2.0099999999999998 111.095 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -74.03 131.58 41.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.842 -0.617 . . . . 1.8500000000000001 109.718 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.15 -1.54 43.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 0.85999999999999999 112.986 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -93.42 149.8 20.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.95 0.375 . . . . 0.98999999999999999 110.695 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.7 pt -113.07 112.82 42.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.352 0.596 . . . . 1.1599999999999999 110.402 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.48 ' O ' HG22 ' A' ' 25' ' ' VAL . 27.8 m95 -105.48 118.23 36.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.696 -0.683 . . . . 0.91000000000000003 110.779 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 15.8 tp -67.02 117.76 9.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.36 -0.382 . . . . 0.90000000000000002 110.332 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.2 p -156.84 157.14 3.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.939 0.399 . . . . 1.04 111.073 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 1.1 t -92.43 124.17 36.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.659 -0.497 . . . . 1.3200000000000001 109.659 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 mt -76.51 -12.55 60.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.772 -0.649 . . . . 1.29 110.533 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 6.9 m-20 -74.28 164.24 62.63 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.202 -0.908 . . . . 1.54 111.314 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.56 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 39.1 Cg_exo -62.92 145.77 54.13 Favored 'Cis proline' 0 C--N 1.353 0.776 0 C-N-CA 124.337 -1.11 . . . . 1.6899999999999999 112.82 0.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.651 HG21 ' HB3' ' A' ' 20' ' ' GLN . 10.3 p -120.72 162.57 19.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.142 -0.481 . . . . 1.3600000000000001 111.829 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.41 146.21 31.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.605 -0.725 . . . . 1.7 109.378 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.15 -129.77 32.16 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.656 -0.783 . . . . 1.1799999999999999 111.998 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -107.61 14.35 25.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.773 0.32 . . . . 2.7799999999999998 111.236 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HB3' ' NH2' ' A' ' 78' ' ' ARG . 37.2 mt-10 -61.6 128.93 38.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.881 -0.414 . . . . 1.1399999999999999 109.881 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -49.09 125.77 11.27 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.052 -0.522 . . . . 2.0899999999999999 112.217 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.651 ' HB3' HG21 ' A' ' 14' ' ' THR . 28.4 pt20 -123.12 176.56 5.99 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.458 -0.792 . . . . 2.0899999999999999 111.486 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.15 140.27 8.9 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.705 -0.759 . . . . 1.0700000000000001 114.116 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 4.1 m -81.8 89.44 6.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.035 -1.098 . . . . 1.1100000000000001 108.035 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.416 HH21 ' HA ' ' A' ' 46' ' ' THR . 0.9 OUTLIER -135.26 160.42 68.15 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.822 -0.626 . . . . 1.6200000000000001 110.419 -177.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 22.4 Cg_exo -65.87 125.33 14.05 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.233 1.955 . . . . 1.01 111.387 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.755 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 22.8 m -101.42 132.03 48.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.088 -0.506 . . . . 0.76000000000000001 110.525 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.619 ' HB3' HG23 ' A' ' 43' ' ' VAL . 46.1 tp -81.98 121.24 26.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.928 -0.578 . . . . 0.69999999999999996 110.879 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.657 ' HA ' HG12 ' A' ' 42' ' ' VAL . 12.3 mm -70.55 110.04 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.256 -0.429 . . . . 0.92000000000000004 110.438 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.599 HG22 ' HE1' ' A' ' 98' ' ' MET . 38.5 t -89.16 -34.52 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.98 0.419 . . . . 0.94999999999999996 111.166 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.09 146.25 84.5 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.244 -0.434 . . . . 1.1200000000000001 111.57 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.763 ' HG2' ' HB2' ' A' ' 33' ' ' PHE . 32.8 Cg_endo -65.1 158.88 49.54 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.55 2.167 . . . . 1.3 111.812 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.39 -41.52 72.76 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.984 -0.553 . . . . 1.3899999999999999 112.333 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.49 97.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.297 -0.41 . . . . 1.6100000000000001 111.413 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.763 ' HB2' ' HG2' ' A' ' 30' ' ' PRO . 4.9 t80 -64.86 -43.9 91.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.289 -0.414 . . . . 1.77 110.834 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -59.8 -30.55 68.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.589 . . . . 1.48 110.949 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -86.74 -35.29 19.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.564 -0.744 . . . . 2.6200000000000001 112.426 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 33' ' ' PHE . 12.7 p -83.01 -45.19 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 113.274 0.842 . . . . 1.8600000000000001 113.274 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -84.17 -27.16 28.27 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.185 -0.322 . . . . 1.72 111.071 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 64.75 19.64 11.89 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.02 -0.536 . . . . 4.4500000000000002 111.304 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.2 tp -143.75 101.08 5.03 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 108.319 -0.993 . . . . 1.8100000000000001 108.319 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -90.67 150.5 4.18 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.807 2.338 . . . . 1.05 114.183 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 HG23 ' A' ' 79' ' ' THR . 56.7 t -98.96 116.73 42.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 106.704 -1.591 . . . . 1.03 106.704 177.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.755 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 19.9 m -125.46 155.38 34.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 113.386 0.884 . . . . 0.77000000000000002 113.386 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 26' ' ' LEU . 3.8 m -120.3 116.23 32.41 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.069 -0.969 . . . . 0.71999999999999997 109.443 178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.26 136.28 31.28 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.837 2.358 . . . . 1.03 113.301 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 24' ' ' PRO . 93.3 t -64.8 136.63 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.684 -0.689 . . . . 1.28 110.234 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.542 ' OG1' ' HG2' ' A' ' 73' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.661 0 CA-C-N 116.029 -0.532 . . . . 1.9099999999999999 110.806 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 N-CA-C 111.091 -0.804 . . . . 1.6599999999999999 111.091 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.544 ' HD1' ' HB2' ' A' ' 74' ' ' CYS . 46.3 m-85 -82.26 42.44 0.74 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.491 0.662 . . . . 1.5600000000000001 110.187 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -135.33 107.8 7.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.321 -0.854 . . . . 1.25 109.815 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.722 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 22.5 t -97.35 128.17 48.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.141 -0.481 . . . . 1.6799999999999999 110.26 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.64 137.38 38.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.154 -0.475 . . . . 1.95 111.389 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.544 HD13 HD11 ' A' ' 66' ' ' ILE . 74.2 mt -94.56 17.24 13.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.29 0.567 . . . . 1.23 110.903 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -81.5 137.58 35.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.626 -0.716 . . . . 2.21 110.407 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.25 -26.52 11.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.618 -0.801 . . . . 1.1499999999999999 113.066 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.596 HG11 ' HG2' ' A' ' 94' ' ' PRO . 25.8 m -93.17 -24.18 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.106 0.41 . . . . 1.21 112.106 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 68.66 63.37 3.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.795 -0.717 . . . . 1.0800000000000001 113.284 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.544 HD11 HD13 ' A' ' 61' ' ' LEU . 25.3 pt -108.93 -172.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 O-C-N 122.646 -0.326 . . . . 1.0700000000000001 110.569 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.465 ' NH2' ' HB3' ' A' ' 91' ' ' GLU . 57.1 mtm180 -93.2 -39.1 11.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.849 0.357 . . . . 3.5899999999999999 111.432 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 m -64.89 111.7 2.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.302 0.572 . . . . 1.51 111.732 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.28 79.76 2.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.804 -0.634 . . . . 1.79 110.502 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.36 -167.12 14.9 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.783 -0.722 . . . . 1.1799999999999999 112.144 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 t -118.99 139.11 47.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 110.069 -0.345 . . . . 1.5600000000000001 110.069 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.722 ' HB ' ' HB ' ' A' ' 59' ' ' VAL . 23.0 t -79.72 133.14 30.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.775 0.322 . . . . 1.29 111.136 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.549 ' HD2' ' OD1' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -94.81 154.5 17.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.119 -0.491 . . . . 2.23 110.512 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.544 ' HB2' ' HD1' ' A' ' 57' ' ' PHE . 58.8 m -141.0 2.57 1.74 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.955 0.407 . . . . 1.1699999999999999 110.768 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.549 ' OD1' ' HD2' ' A' ' 73' ' ' ARG . 11.2 p-10 -121.77 5.09 9.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.043 -0.526 . . . . 0.89000000000000001 111.163 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -122.03 74.76 38.62 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 112.964 0.727 . . . . 2.1299999999999999 112.964 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.86 119.11 3.53 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.65 2.233 . . . . 0.80000000000000004 109.908 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.495 ' NH2' ' HB3' ' A' ' 18' ' ' GLU . 21.5 mmm180 -117.72 107.24 13.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.068 0.461 . . . . 2.0899999999999999 111.747 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.673 HG23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -94.6 90.27 6.09 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.98 -0.748 . . . . 1.6200000000000001 108.98 178.591 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.9 pt -125.75 150.5 31.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.25 -0.432 . . . . 1.1499999999999999 111.275 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -75.85 124.4 27.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.854 0.359 . . . . 1.03 110.553 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 52.0 tpp -81.61 -20.77 39.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.706 -0.679 . . . . 1.29 112.062 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -65.67 -32.68 74.38 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.767 0.654 . . . . 2.6400000000000001 112.767 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.86 9.18 40.18 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.115 0.413 . . . . 1.1200000000000001 112.115 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 40.7 mtt-85 -127.86 -44.46 1.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.27 0.47 . . . . 1.0600000000000001 112.27 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.91 97.47 0.32 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.815 -0.707 . . . . 1.1200000000000001 112.38 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 8' ' ' LEU . . . -97.75 150.64 19.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.815 -0.707 . . . . 1.0900000000000001 112.296 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -113.38 113.77 25.68 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.015 -0.365 . . . . 2.46 110.015 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -71.07 118.4 13.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.603 0.24 . . . . 2.4900000000000002 111.324 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 8' ' ' LEU . 2.2 mm? -86.76 -68.56 0.74 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.43 -0.581 . . . . 1.29 109.43 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.465 ' HB3' ' NH2' ' A' ' 67' ' ' ARG . 20.3 pt-20 -151.95 -167.43 2.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.347 -0.842 . . . . 1.1499999999999999 109.433 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.9 ptm85 -132.81 142.87 49.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.788 0.327 . . . . 1.3200000000000001 110.702 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.2 m -91.08 158.76 41.07 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.191 -0.459 . . . . 0.75 110.697 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.596 ' HG2' HG11 ' A' ' 64' ' ' VAL . 46.0 Cg_exo -58.92 147.33 90.0 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.539 2.16 . . . . 0.94999999999999996 111.029 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' A' ' 95' ' ' GLU . 2.9 mm-40 -55.54 -29.32 58.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.057 -0.52 . . . . 1.51 111.945 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.66 -33.3 73.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.909 0.385 . . . . 1.5700000000000001 111.174 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.7 mm -70.67 -41.22 77.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.213 0.53 . . . . 1.3100000000000001 109.759 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.599 ' HE1' HG22 ' A' ' 28' ' ' VAL . 3.6 tpt -66.87 -37.98 85.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.56 -0.745 . . . . 1.6000000000000001 110.259 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -61.73 -34.87 76.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.905 -0.589 . . . . 2.2999999999999998 110.477 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.47 -45.52 90.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.008 -0.542 . . . . 1.6399999999999999 110.787 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 35.2 t -62.48 -44.12 98.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.044 -0.525 . . . . 1.03 110.581 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.98 -38.02 81.35 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.016 -0.538 . . . . 1.22 111.084 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.86 -41.65 98.7 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.846 -0.692 . . . . 1.03 112.072 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 104' ' ' ARG . 8.6 mmt180 -67.84 -32.85 73.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.933 0.397 . . . . 1.72 110.73 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 101' ' ' VAL . 95.4 mt -71.03 -25.57 62.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.98 -0.555 . . . . 1.02 110.844 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -74.67 -28.46 60.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.981 0.42 . . . . 1.1100000000000001 111.276 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.87 -22.22 58.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.382 0.512 . . . . 1.5 112.382 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 pt -89.84 1.83 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.739 0.644 . . . . 1.1499999999999999 112.739 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.3 mt -86.67 80.85 8.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.544 0.211 . . . . 0.97999999999999998 110.959 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 111.86 0.318 . . . . 1.3500000000000001 111.86 -179.879 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.541 ' HE1' ' HB2' ' B' ' 5' ' ' GLU . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 121.006 0.432 . . . . 2.0299999999999998 111.633 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -83.94 -14.59 50.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.816 -0.439 . . . . 2.8199999999999998 109.816 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 71.95 113.72 0.06 Allowed 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.827 1.047 . . . . 2.3199999999999998 113.827 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' B' ' 92' ' ' ARG . . . 95.04 -34.64 4.67 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.726 -0.67 . . . . 1.28 114.71 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.541 ' HB2' ' HE1' ' B' ' 1' ' ' MET . 5.5 mm-40 -61.49 106.24 0.62 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.868 0.692 . . . . 1.53 112.868 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.426 HD12 ' HG3' ' B' ' 91' ' ' GLU . 61.3 mt -98.17 128.37 49.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 109.349 -0.611 . . . . 0.75 109.349 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -111.68 153.66 26.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.085 0.469 . . . . 0.81000000000000005 111.536 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.498 ' HB2' HD11 ' B' ' 90' ' ' LEU . 23.5 tp -113.35 123.57 50.42 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.366 -0.605 . . . . 1.05 109.366 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 p -153.92 156.85 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.54 -0.3 . . . . 0.71999999999999997 110.535 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 6.8 m -89.47 129.29 35.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.497 -0.32 . . . . 1.6299999999999999 110.612 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 78.0 mt -81.13 -18.27 47.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.24 0.543 . . . . 0.82999999999999996 110.308 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ASP . . . . . 0.528 ' HA ' ' H ' ' B' ' 14' ' ' THR . 2.1 m-20 -63.25 153.59 81.27 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.215 -0.902 . . . . 1.6200000000000001 110.381 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -93.29 92.1 0.14 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.639 -1.4 . . . . 1.28 112.34 -0.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.528 ' H ' ' HA ' ' B' ' 12' ' ' ASP . 0.0 OUTLIER -79.25 173.82 12.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.182 -0.463 . . . . 1.47 110.144 179.427 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.75 168.22 23.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.577 0.227 . . . . 1.22 111.114 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.98 -130.25 30.13 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.932 -0.652 . . . . 1.01 112.024 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -90.28 -1.84 57.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.833 0.349 . . . . 2.1800000000000002 110.973 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -67.33 123.63 20.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.071 -0.715 . . . . 1.28 109.071 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -52.3 131.38 32.87 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.168 0.803 . . . . 1.52 113.168 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -113.43 139.01 49.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.579 -0.737 . . . . 1.8600000000000001 109.623 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.32 147.6 8.11 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.835 -0.698 . . . . 0.90000000000000002 112.93 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 26.9 m -76.69 124.47 27.7 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.06 -0.348 . . . . 0.94999999999999996 110.06 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.42 158.71 33.36 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.801 -0.444 . . . . 1.5900000000000001 109.801 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.23 131.55 32.71 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.219 1.946 . . . . 0.65000000000000002 110.267 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.613 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 15.7 m -124.79 142.47 41.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.134 0.492 . . . . 0.56999999999999995 111.45 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 18.7 tp -101.51 126.98 48.4 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.223 -0.658 . . . . 1.1699999999999999 109.223 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ILE . . . . . 0.408 ' O ' ' HG3' ' B' ' 1' ' ' MET . 27.7 mt -86.4 144.53 9.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.576 -0.284 . . . . 0.66000000000000003 110.339 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.488 ' HB ' HG23 ' B' ' 41' ' ' VAL . 45.4 t -108.38 -36.09 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.981 0.419 . . . . 0.93000000000000005 110.943 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' THR . . . . . 0.617 HG23 HG22 ' B' ' 41' ' ' VAL . 0.7 OUTLIER -64.64 143.79 98.69 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 0.81000000000000005 112.328 -179.096 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 22.2 Cg_exo -66.81 159.4 51.64 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.097 2.531 . . . . 0.78000000000000003 111.785 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.59 -37.6 73.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.98 -0.555 . . . . 1.03 111.403 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.65 -48.6 81.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 1.3999999999999999 111.066 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -64.18 -40.3 95.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.046 0.451 . . . . 1.5700000000000001 110.673 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' B' ' 38' ' ' ARG . 77.3 m-20 -67.09 -19.88 65.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.924 -0.58 . . . . 1.6399999999999999 111.257 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -95.32 -33.64 12.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.271 -0.422 . . . . 2.54 111.943 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 99.1 t -82.39 -71.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.612 0.244 . . . . 1.0900000000000001 111.367 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.3 -30.04 66.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.781 0.324 . . . . 1.3300000000000001 110.444 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 2.4 mmp_? 66.96 17.42 10.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.607 -0.724 . . . . 1.78 112.257 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.23 92.85 43.81 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.278 -0.638 . . . . 1.1599999999999999 109.278 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' B' ' 80' ' ' ILE . 83.1 Cg_endo -90.57 147.38 4.13 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.813 2.342 . . . . 0.56999999999999995 113.572 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.617 HG22 HG23 ' B' ' 29' ' ' THR . 5.0 m -93.9 118.02 38.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.488 -0.93 . . . . 1.0800000000000001 108.488 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.613 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 35.7 m -108.83 145.79 15.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 112.597 0.592 . . . . 0.64000000000000001 112.597 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 90.5 t -111.03 115.73 52.52 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.955 -1.02 . . . . 1.1000000000000001 108.851 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.51 ' HA ' HG12 ' B' ' 25' ' ' VAL . 7.4 Cg_exo -72.71 123.17 8.8 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.946 2.43 . . . . 0.72999999999999998 113.287 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.31 138.86 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.824 -0.806 . . . . 0.90000000000000002 108.824 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.79 168.92 9.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.544 -0.298 . . . . 1.1699999999999999 110.727 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.45 -0.341 . . . . 1.8500000000000001 111.227 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 109.893 -0.41 . . . . 1.96 109.893 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.69 -98.25 2.38 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.994 -0.622 . . . . 1.0800000000000001 112.673 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.643 ' HE1' ' HB ' ' B' ' 107' ' ' THR . 75.4 m-85 -120.54 5.25 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.016 0.436 . . . . 3.5699999999999998 111.28 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.61 107.17 18.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.921 -0.581 . . . . 1.0800000000000001 111.203 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 61.0 t -89.81 122.28 40.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.864 -0.607 . . . . 1.3400000000000001 109.796 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -82.56 123.91 29.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.298 -0.41 . . . . 1.3799999999999999 110.829 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 97.2 mt -91.16 -14.13 31.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.2 -0.455 . . . . 1.02 111.328 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ASP . . . . . 0.726 ' HB2' HG23 ' B' ' 69' ' ' THR . 10.6 t70 -81.84 142.88 32.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.07 -0.514 . . . . 1.79 111.439 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.51 -19.33 12.88 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.919 -0.658 . . . . 1.1499999999999999 112.672 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -109.62 -12.32 11.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.86 0.362 . . . . 1.1699999999999999 111.703 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.47 60.58 0.78 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.451 -0.88 . . . . 1.05 112.53 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.468 HD11 HG23 ' B' ' 93' ' ' VAL . 78.1 mt -121.12 134.79 63.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.772 -0.455 . . . . 1.6100000000000001 109.772 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -63.16 -39.28 94.21 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.073 0.463 . . . . 2.3999999999999999 109.826 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' THR . . . . . 0.414 ' N ' HG22 ' B' ' 66' ' ' ILE . 7.2 m -77.55 73.74 4.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.731 -0.668 . . . . 0.93000000000000005 109.839 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' THR . . . . . 0.726 HG23 ' HB2' ' B' ' 62' ' ' ASP . 13.3 m -73.74 105.3 4.98 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.665 -0.698 . . . . 1.3100000000000001 110.758 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -177.45 -161.21 25.51 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.784 -0.722 . . . . 0.79000000000000004 112.118 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 m -124.27 136.33 60.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.962 0.411 . . . . 0.93000000000000005 110.967 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 32.3 t -88.93 122.76 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.863 -0.608 . . . . 1.3799999999999999 110.346 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 21.9 mmm-85 -92.57 81.48 4.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.926 0.393 . . . . 1.3700000000000001 110.336 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.77 1.33 10.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.942 -0.572 . . . . 1.1599999999999999 112.089 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.09 -7.89 59.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.334 -0.394 . . . . 1.1000000000000001 111.463 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -142.53 84.34 11.18 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 113.459 0.911 . . . . 2.4700000000000002 113.459 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.46 132.93 4.42 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.049 2.499 . . . . 0.95999999999999996 110.277 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.48 127.06 45.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.244 0.461 . . . . 1.96 112.244 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.06 123.24 31.14 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.006 -0.739 . . . . 1.1899999999999999 109.006 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.404 ' O ' ' HD2' ' B' ' 40' ' ' PRO . 35.9 pt -134.61 154.11 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.545 0.212 . . . . 1.28 111.269 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.418 ' CG ' ' HZ1' ' B' ' 83' ' ' LYS . 9.5 t70 -71.45 109.59 5.52 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.262 -0.426 . . . . 1.28 110.428 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 51.7 tpp -78.44 -13.07 60.01 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.572 0.582 . . . . 2.7000000000000002 112.572 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.418 ' HZ1' ' CG ' ' B' ' 81' ' ' ASP . 6.5 mtmp? -81.64 -44.06 17.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.96 0.409 . . . . 1.96 111.188 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.66 -23.58 56.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.132 -0.485 . . . . 1.0600000000000001 111.73 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' B' ' 85' ' ' ARG . 55.8 mtt-85 -96.16 -47.96 5.84 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.365 0.505 . . . . 1.47 112.365 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.3 101.05 0.6 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.623 -0.799 . . . . 0.81999999999999995 112.398 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -97.76 142.08 15.94 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.816 -0.707 . . . . 0.65000000000000002 112.291 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -123.33 128.69 50.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.384 -0.228 . . . . 1.8100000000000001 110.384 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.524 ' HD2' ' OE1' ' B' ' 5' ' ' GLU . 3.4 ttp180 -69.56 132.61 46.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.767 0.318 . . . . 2.4900000000000002 111.005 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' B' ' 8' ' ' LEU . 93.7 mt -100.29 -69.52 0.77 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.76000000000000001 111.338 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' GLU . . . . . 0.426 ' HG3' HD12 ' B' ' 6' ' ' ILE . 18.7 pt-20 -142.4 -176.36 4.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.146 -0.479 . . . . 1.0700000000000001 110.259 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' B' ' 4' ' ' GLY . 48.9 ttt180 -125.9 118.0 24.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.79 0.329 . . . . 2.0499999999999998 111.291 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.493 HG13 ' HA2' ' B' ' 4' ' ' GLY . 2.5 p -80.11 131.36 63.09 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 1.45 110.503 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -50.2 145.47 20.32 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.239 2.626 . . . . 1.03 112.312 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -58.49 -27.51 64.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 2.1400000000000001 112.504 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.32 -38.81 84.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.193 0.52 . . . . 1.78 110.352 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 19.8 mm -86.05 -33.65 7.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.804 -0.635 . . . . 1.3300000000000001 109.72 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 11.5 tpt -63.01 -33.22 74.95 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.201 0.524 . . . . 2.3399999999999999 110.225 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -61.13 -38.47 86.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.499 -0.773 . . . . 1.9099999999999999 110.188 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.561 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 31.9 mm-40 -60.18 -41.17 92.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.916 -0.584 . . . . 1.76 110.684 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 34.2 t -60.44 -46.87 94.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.978 -0.555 . . . . 1.01 109.963 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 71.2 mt -62.49 -36.3 82.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.97 -0.559 . . . . 1.29 110.274 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.08 -43.49 97.2 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.6 -0.727 . . . . 1.02 111.801 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 7.6 mmt180 -66.23 -32.21 73.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.055 0.455 . . . . 1.8500000000000001 110.451 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 79.8 mt -71.18 -13.85 62.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.976 -0.556 . . . . 1.9399999999999999 111.232 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 10.8 m -84.04 -24.44 30.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.122 0.487 . . . . 1.1599999999999999 110.395 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.643 ' HB ' ' HE1' ' B' ' 57' ' ' PHE . 0.2 OUTLIER -72.33 -29.18 63.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 1.45 111.571 -179.539 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 49.8 pt -80.39 -3.58 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.727 0.299 . . . . 1.98 111.657 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 96.4 mt -86.04 12.8 8.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.197 0.523 . . . . 1.3600000000000001 110.669 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.246 0.901 0 N-CA-C 109.301 -0.629 . . . . 2.1299999999999999 109.301 179.766 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 ptp . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.901 0.382 . . . . 1.29 110.779 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 43.8 mt-10 -123.16 -173.63 2.76 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.685 -0.689 . . . . 2.0099999999999998 110.376 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -89.16 133.39 34.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.996 -0.547 . . . . 1.8500000000000001 110.898 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.23 13.88 52.95 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.791 -0.719 . . . . 0.85999999999999999 112.997 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 83.3 mt-10 -98.67 153.21 18.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.717 0.294 . . . . 0.98999999999999999 110.571 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.535 HD11 ' HG2' ' A' ' 91' ' ' GLU . 1.1 pt -118.46 110.17 29.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.134 -0.485 . . . . 1.1599999999999999 109.917 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.409 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 31.0 m95 -102.53 122.47 44.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.885 -0.598 . . . . 0.91000000000000003 110.831 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 17.8 tp -82.7 131.89 35.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.116 -0.493 . . . . 0.90000000000000002 111.364 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 85' ' ' ARG . 6.4 p -172.59 159.65 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.201 -0.454 . . . . 1.04 110.245 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.7 m -82.74 141.47 32.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.616 0.246 . . . . 1.3200000000000001 110.767 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.41 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . 68.3 mt -95.32 -11.44 27.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.113 0.482 . . . . 1.29 110.86 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.702 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -74.49 174.46 5.1 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.707 -0.679 . . . . 1.54 110.95 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.702 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 9.8 Cg_exo -73.12 142.47 74.87 Favored 'Cis proline' 0 C--N 1.354 0.851 0 C-N-CA 124.609 -0.996 . . . . 1.6899999999999999 112.386 -0.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.577 HG23 ' HA ' ' A' ' 12' ' ' ASP . 38.7 p -122.44 175.55 6.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 1.3600000000000001 110.993 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.01 103.49 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 1.7 110.319 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.59 -151.84 18.13 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.838 -0.696 . . . . 1.1799999999999999 111.658 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -105.98 37.15 2.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.531 0.682 . . . . 2.7799999999999998 110.374 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -79.86 -170.37 2.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.615 . . . . 1.1399999999999999 109.691 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -77.06 87.11 3.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.271 0.557 . . . . 2.0899999999999999 110.678 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.514 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 1.7 pt20 -107.07 172.9 6.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.238 -0.892 . . . . 2.0899999999999999 111.289 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.3 177.61 28.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.977 -0.63 . . . . 1.0700000000000001 113.74 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.3 m -114.12 129.49 56.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.623 -0.51 . . . . 1.1100000000000001 109.623 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.78 160.44 11.48 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.142 -0.318 . . . . 1.6200000000000001 110.142 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 10.4 Cg_exo -73.5 135.6 22.4 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.302 2.001 . . . . 1.01 110.869 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.87 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 10.7 m -108.38 136.39 44.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.219 -0.446 . . . . 0.76000000000000001 110.28 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.597 ' HB3' HG23 ' A' ' 43' ' ' VAL . 15.8 tp -86.6 125.67 33.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.363 -0.381 . . . . 0.69999999999999996 111.045 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.444 HD13 ' CG1' ' A' ' 42' ' ' VAL . 9.1 mm -74.83 117.24 18.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.318 -0.401 . . . . 0.92000000000000004 110.371 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -92.16 -37.8 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.057 -0.52 . . . . 0.94999999999999996 111.236 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.75 150.96 82.18 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.619 0.6 . . . . 1.1200000000000001 112.619 -179.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 33' ' ' PHE . 65.4 Cg_endo -74.88 158.71 42.47 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.75 2.3 . . . . 1.3 111.934 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.57 -39.85 65.13 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.563 0.579 . . . . 1.3899999999999999 112.563 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.92 99.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.356 . . . . 1.6100000000000001 111.196 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.438 ' HB2' ' HG2' ' A' ' 30' ' ' PRO . 8.0 t80 -69.17 -40.93 77.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.014 -0.539 . . . . 1.77 110.419 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -64.36 -26.13 68.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 1.48 110.773 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -78.26 -25.46 46.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.986 -0.552 . . . . 2.6200000000000001 111.873 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -96.34 -43.88 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.535 0.569 . . . . 1.8600000000000001 112.535 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 m -81.28 -25.74 36.3 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.87 0.322 . . . . 1.72 111.87 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 71.69 -2.8 2.35 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.039 0.536 . . . . 4.4500000000000002 112.217 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 81' ' ' ASP . 2.9 mt -131.33 114.47 15.96 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.379 -0.6 . . . . 1.8100000000000001 109.379 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.4 ' O ' HG23 ' A' ' 79' ' ' THR . 85.6 Cg_endo -89.14 131.56 2.17 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.802 2.335 . . . . 1.05 113.137 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.441 HG11 HD12 ' B' ' 108' ' ' ILE . 48.3 t -67.78 121.09 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.873 -1.158 . . . . 1.03 107.873 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.87 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 17.4 m -128.24 153.2 37.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 113.485 0.92 . . . . 0.77000000000000002 113.485 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.597 HG23 ' HB3' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -114.27 131.1 23.42 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 114.685 -1.143 . . . . 0.71999999999999997 108.788 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 77' ' ' PRO . 71.5 Cg_endo -73.83 114.1 3.95 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.793 2.329 . . . . 1.03 113.973 -178.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.685 HG22 HG22 ' A' ' 72' ' ' VAL . 48.3 t -79.72 99.54 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.089 -0.708 . . . . 1.28 109.089 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.566 ' HB ' ' HD3' ' A' ' 73' ' ' ARG . 2.2 m . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 116.422 -0.354 . . . . 1.9099999999999999 111.394 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.418 -0.273 . . . . 1.6599999999999999 112.418 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -95.1 -8.38 36.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.907 0.384 . . . . 1.5600000000000001 110.956 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.56 142.85 32.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.208 -0.664 . . . . 1.25 109.208 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.886 HG22 ' HB ' ' A' ' 72' ' ' VAL . 11.4 m -94.82 156.14 3.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.174 0.511 . . . . 1.6799999999999999 112.133 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.26 106.05 17.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.573 -0.74 . . . . 1.95 111.394 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 61' ' ' LEU . 4.1 mt -91.51 -32.13 15.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.179 0.514 . . . . 1.23 110.751 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -75.19 112.37 11.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.072 -0.513 . . . . 2.21 110.628 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.46 -23.01 0.75 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.599 -0.6 . . . . 1.1499999999999999 111.599 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.412 HG23 HG23 ' A' ' 66' ' ' ILE . 15.7 m -100.99 1.84 10.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 111.82 0.304 . . . . 1.21 111.82 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.59 47.41 34.4 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.958 -0.639 . . . . 1.0800000000000001 113.147 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.48 ' H ' HG13 ' A' ' 66' ' ' ILE . 1.5 pp -84.79 173.71 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.673 0.273 . . . . 1.0700000000000001 111.348 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.2 ttm105 -98.54 -55.66 2.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.556 -0.293 . . . . 3.5899999999999999 110.739 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.0 m -62.01 101.62 0.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.187 0.518 . . . . 1.51 110.822 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.73 83.27 5.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.86 -0.609 . . . . 1.79 111.339 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -143.1 158.25 27.15 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.783 -0.722 . . . . 1.1799999999999999 111.674 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.3 t -105.82 107.11 21.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.954 -0.388 . . . . 1.5600000000000001 109.954 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.886 ' HB ' HG22 ' A' ' 59' ' ' VAL . 42.3 t -61.44 116.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.39 . . . . 1.29 110.628 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.566 ' HD3' ' HB ' ' A' ' 46' ' ' THR . 74.8 mtp180 -102.78 119.34 38.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.084 -0.507 . . . . 2.23 111.686 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.8 m -103.52 5.88 37.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.429 0.633 . . . . 1.1699999999999999 109.515 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.557 ' HB2' ' CZ ' ' B' ' 33' ' ' PHE . 9.2 p-10 -81.59 -33.79 31.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.454 -0.794 . . . . 0.89000000000000001 111.574 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.55 ' HG3' ' NH2' ' A' ' 73' ' ' ARG . 11.4 mm-40 -130.38 64.02 71.41 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.677 -0.238 . . . . 2.1299999999999999 110.951 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.757 ' HD2' HG11 ' B' ' 41' ' ' VAL . 83.2 Cg_endo -80.56 164.85 20.88 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.092 1.861 . . . . 0.80000000000000004 112.237 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.635 ' HA ' ' O ' ' B' ' 77' ' ' PRO . 13.9 ptm180 -166.7 118.02 0.95 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 2.0899999999999999 110.999 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.535 ' HB ' ' HA ' ' B' ' 76' ' ' GLN . 78.3 m -72.72 109.66 6.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.383 -0.371 . . . . 1.6200000000000001 110.295 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.0 pt -103.08 165.95 2.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.704 -0.68 . . . . 1.1499999999999999 111.225 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HA ' HD23 ' A' ' 39' ' ' LEU . 8.4 t0 -82.78 136.99 34.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.644 -0.707 . . . . 1.03 109.896 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.414 ' SD ' ' HA3' ' A' ' 87' ' ' GLY . 27.6 tpp -111.46 1.59 17.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.273 -0.421 . . . . 1.29 111.216 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -91.28 -56.42 3.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.564 -0.289 . . . . 2.6400000000000001 111.768 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.4 ' HB3' ' HA2' ' B' ' 16' ' ' GLY . . . -78.84 -29.98 44.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.378 . . . . 1.1200000000000001 111.14 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.564 ' HB3' HG21 ' A' ' 9' ' ' VAL . 72.3 mtt-85 -76.35 -39.74 53.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.31 -0.405 . . . . 1.0600000000000001 110.8 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.29 82.19 0.15 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.952 -0.642 . . . . 1.1200000000000001 112.914 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.414 ' HA3' ' SD ' ' A' ' 82' ' ' MET . . . -81.93 168.0 48.55 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.807 -0.711 . . . . 1.0900000000000001 112.848 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 9.4 mptt -121.53 121.94 38.59 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.18 -0.304 . . . . 2.46 110.18 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.38 120.66 23.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.82 0.343 . . . . 2.4900000000000002 111.194 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 90' ' ' LEU . 3.3 mm? -86.71 -67.17 0.83 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.139 -0.482 . . . . 1.29 110.511 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.535 ' HG2' HD11 ' A' ' 6' ' ' ILE . 4.1 pt-20 -153.57 -174.05 4.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.946 -0.57 . . . . 1.1499999999999999 109.58 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -130.58 140.15 50.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.056 0.455 . . . . 1.3200000000000001 110.355 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.0 m -94.15 152.03 40.03 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.865 -0.607 . . . . 0.75 110.801 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.38 162.57 17.09 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.889 2.393 . . . . 0.94999999999999996 111.947 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -62.86 -24.23 67.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 1.51 111.066 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.66 -35.46 80.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 1.5700000000000001 110.702 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.4 mm -69.95 -31.02 46.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.397 -0.594 . . . . 1.3100000000000001 109.397 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.444 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 16.7 tpt -64.89 -34.16 77.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.721 -0.672 . . . . 1.6000000000000001 109.641 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -63.12 -40.39 97.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.675 -0.693 . . . . 2.2999999999999998 109.404 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.633 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 2.2 mm-40 -58.66 -49.35 77.86 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.543 -0.753 . . . . 1.6399999999999999 109.857 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.9 t -62.29 -49.11 85.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.573 -0.74 . . . . 1.03 110.901 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 98' ' ' MET . 94.5 mt -56.74 -43.31 80.57 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.271 -0.422 . . . . 1.22 111.194 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.36 -40.85 98.08 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.115 -0.564 . . . . 1.03 112.524 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.0 mmt180 -71.05 -43.07 68.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.896 0.379 . . . . 1.72 110.914 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.89 -31.4 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 1.02 111.676 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.1 m -69.03 -16.51 63.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.409 -0.359 . . . . 1.1100000000000001 111.521 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.4 m -93.85 -24.45 17.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.693 0.257 . . . . 1.5 111.693 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.7 pt -84.06 -20.9 8.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 112.08 0.4 . . . . 1.1499999999999999 112.08 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 97.3 mt -77.01 79.23 3.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.013 0.435 . . . . 0.97999999999999998 111.603 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.418 ' O ' ' HD2' ' B' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.929 -0.578 . . . . 1.3500000000000001 110.364 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.711 ' HA ' ' HA ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.288 0 N-CA-C 112.756 0.65 . . . . 2.0299999999999998 112.756 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 2' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' B' ' 3' ' ' ARG . 3.1 mp0 -71.13 -22.42 62.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.629 -0.714 . . . . 2.8199999999999998 110.848 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ARG . . . . . 0.791 ' HG3' ' HG2' ' B' ' 98' ' ' MET . 4.2 mpt_? 78.82 123.73 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.951 0.722 . . . . 2.3199999999999998 112.951 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' GLY . . . . . 0.518 ' HA2' HG12 ' B' ' 93' ' ' VAL . . . 80.09 49.22 6.07 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.478 -0.783 . . . . 1.28 113.683 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -125.37 90.38 3.21 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.473 0.546 . . . . 1.53 112.473 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.721 HD11 ' HB ' ' B' ' 93' ' ' VAL . 64.0 mt -99.86 104.39 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.184 -1.043 . . . . 0.75 108.184 178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.446 ' HA ' ' HA ' ' B' ' 89' ' ' ARG . 12.4 m95 -103.79 166.49 10.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.925 -0.579 . . . . 0.81000000000000005 111.59 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 55.4 tp -118.39 112.34 19.87 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.196 -0.668 . . . . 1.05 109.196 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 p -136.61 156.17 35.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.301 -0.409 . . . . 0.71999999999999997 110.362 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 5.8 t -90.28 127.22 36.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.402 -0.592 . . . . 1.6299999999999999 109.402 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 20.5 mt -94.67 -25.88 16.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.192 0.52 . . . . 0.82999999999999996 110.49 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.83 147.24 98.86 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.754 . . . . 1.6200000000000001 110.85 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -87.97 160.66 45.16 Favored 'Cis proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.601 -1.416 . . . . 1.28 111.978 0.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.569 ' HB ' ' HG3' ' B' ' 20' ' ' GLN . 14.0 m -156.74 124.74 5.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.377 -0.374 . . . . 1.47 110.219 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.78 164.75 14.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.388 -0.369 . . . . 1.22 110.802 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.4 ' HA2' ' HB3' ' A' ' 84' ' ' ALA . . . 87.06 -164.33 35.23 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.795 -0.717 . . . . 1.01 112.511 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -99.23 31.34 3.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.871 0.367 . . . . 2.1800000000000002 110.641 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.38 -167.7 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 1.28 111.206 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -98.85 101.21 12.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.32 -0.4 . . . . 1.52 110.832 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.569 ' HG3' ' HB ' ' B' ' 14' ' ' THR . 14.9 mp0 -102.59 -178.47 3.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.129 -0.487 . . . . 1.8600000000000001 110.148 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.53 130.64 5.33 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.89 -0.671 . . . . 0.90000000000000002 112.363 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 56.4 m -76.68 94.74 3.84 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.423 -0.584 . . . . 0.94999999999999996 109.423 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.3 165.96 32.85 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.498 -0.774 . . . . 1.5900000000000001 110.19 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.79 145.54 82.71 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.714 2.276 . . . . 0.65000000000000002 112.016 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.804 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 10.5 m -135.47 145.92 30.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.898 -0.592 . . . . 0.56999999999999995 111.138 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 48.2 tp -103.62 125.96 50.46 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.009 -0.541 . . . . 1.1699999999999999 109.573 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ILE . . . . . 0.504 HG23 ' HB2' ' B' ' 40' ' ' PRO . 23.5 mt -78.47 140.75 16.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.58 0.228 . . . . 0.66000000000000003 111.148 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.85 -31.95 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.9 0.381 . . . . 0.93000000000000005 111.621 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' THR . . . . . 0.476 HG23 HG22 ' B' ' 41' ' ' VAL . 0.2 OUTLIER -69.42 130.15 91.04 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.502 -0.317 . . . . 0.81000000000000005 111.728 -179.538 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.711 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 63.3 Cg_endo -72.74 162.29 41.58 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.013 2.475 . . . . 0.78000000000000003 112.725 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.54 -31.2 63.93 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.79 -0.641 . . . . 1.03 112.614 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.43 -18.56 40.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 1.3999999999999999 112.077 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 75' ' ' ASP . 65.7 t80 -122.4 -33.04 3.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.994 0.426 . . . . 1.5700000000000001 110.187 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -56.12 -41.49 75.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.52 -0.764 . . . . 1.6399999999999999 111.781 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -85.73 6.1 29.32 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.804 0.668 . . . . 2.54 112.804 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.05 -65.39 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.173 0.511 . . . . 1.0900000000000001 110.354 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 13.2 p -81.35 -23.83 37.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.868 -0.606 . . . . 1.3300000000000001 110.834 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.808 ' HE ' ' HA ' ' B' ' 38' ' ' ARG . 0.6 OUTLIER 67.33 16.93 10.16 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.632 -0.713 . . . . 1.78 111.432 -179.198 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 13.3 mt -128.18 94.71 35.56 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.19 -1.041 . . . . 1.1599999999999999 108.19 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' PRO . . . . . 0.504 ' HB2' HG23 ' B' ' 27' ' ' ILE . 94.6 Cg_endo -91.54 159.66 3.59 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.582 2.188 . . . . 0.56999999999999995 113.585 -178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.757 HG11 ' HD2' ' A' ' 77' ' ' PRO . 15.2 m -94.37 131.92 39.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.236 -1.024 . . . . 1.0800000000000001 108.236 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.804 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 27.6 m -124.0 153.18 29.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 113.066 0.765 . . . . 0.64000000000000001 113.066 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 42.7 t -106.63 114.2 62.16 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 114.647 -1.16 . . . . 1.1000000000000001 108.411 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.726 ' HA ' HG12 ' B' ' 25' ' ' VAL . 39.3 Cg_endo -67.62 123.39 10.71 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.69 2.26 . . . . 0.72999999999999998 112.555 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.636 HG22 HG12 ' B' ' 72' ' ' VAL . 48.9 t -77.65 123.38 34.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.348 -0.612 . . . . 0.90000000000000002 109.348 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.75 102.49 15.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.311 -0.404 . . . . 1.1699999999999999 110.44 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 116.066 -0.516 . . . . 1.8500000000000001 110.573 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.734 0.302 . . . . 1.96 111.47 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.22 -73.46 1.78 Allowed Glycine 0 CA--C 1.516 0.149 0 C-N-CA 121.005 -0.617 . . . . 1.0800000000000001 112.831 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.424 ' HB3' ' HZ ' ' A' ' 33' ' ' PHE . 26.5 p90 -88.18 -11.08 47.84 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.195 0.521 . . . . 3.5699999999999998 110.924 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' B' ' 72' ' ' VAL . . . -112.98 116.81 30.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.975 -0.557 . . . . 1.0800000000000001 110.211 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' B' ' 101' ' ' VAL . 49.5 t -90.71 135.04 27.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.295 -0.411 . . . . 1.3400000000000001 110.102 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.559 ' HA ' HG12 ' B' ' 71' ' ' VAL . 19.0 t -87.7 138.5 31.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.965 0.412 . . . . 1.3799999999999999 111.23 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.54 ' HB3' HD12 ' B' ' 66' ' ' ILE . 69.0 mt -101.63 5.34 41.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.05 -0.722 . . . . 1.02 109.05 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.09 157.41 18.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.07 -0.968 . . . . 1.79 110.638 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.51 -62.94 0.3 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.702 -0.761 . . . . 1.1499999999999999 112.92 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.96 -31.72 51.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.865 0.364 . . . . 1.1699999999999999 111.95 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.12 79.75 1.15 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.554 -0.831 . . . . 1.05 113.067 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.54 HD12 ' HB3' ' B' ' 61' ' ' LEU . 45.9 mt -123.71 152.79 29.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.737 -0.838 . . . . 1.6100000000000001 108.737 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' ARG . . . . . 0.594 ' HB3' ' OE1' ' B' ' 91' ' ' GLU . 4.1 ttt180 -63.48 -48.69 76.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.625 0.25 . . . . 2.3999999999999999 111.433 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 12.1 m -78.83 99.87 6.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.237 0.541 . . . . 0.93000000000000005 111.685 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.8 88.61 6.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.718 -0.674 . . . . 1.3100000000000001 110.751 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -163.16 -170.64 28.34 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.298 -0.953 . . . . 0.79000000000000004 112.669 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' B' ' 60' ' ' SER . 11.5 m -124.67 136.92 59.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.849 0.357 . . . . 0.93000000000000005 110.333 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.636 HG12 HG22 ' B' ' 45' ' ' VAL . 16.1 m -86.55 133.23 30.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.313 -0.403 . . . . 1.3799999999999999 111.404 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -88.75 85.74 6.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.565 -0.531 . . . . 1.3700000000000001 109.565 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 1.1 m -65.68 -15.26 62.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.355 0.598 . . . . 1.1599999999999999 111.116 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.28 -12.74 51.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.501 -0.772 . . . . 1.1000000000000001 111.12 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' GLN . . . . . 0.535 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 10.4 mt-30 -126.38 66.23 61.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 114.233 1.197 . . . . 2.4700000000000002 114.233 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.635 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 74.0 Cg_endo -79.76 142.43 15.95 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.786 1.657 . . . . 0.95999999999999996 109.159 177.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' B' ' 78' ' ' ARG . 4.9 ttt180 -138.36 144.01 40.11 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.747 -0.381 . . . . 1.96 111.882 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.511 HG21 ' HB3' ' A' ' 76' ' ' GLN . 0.1 OUTLIER -82.76 140.38 33.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.788 -0.642 . . . . 1.1899999999999999 109.714 178.683 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.96 157.8 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.935 0.397 . . . . 1.28 111.426 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' B' ' 85' ' ' ARG . 9.5 t0 -85.39 110.82 19.4 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.813 -0.81 . . . . 1.28 108.813 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 13.7 ttp -78.62 -3.52 44.32 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.44 0.904 . . . . 2.7000000000000002 113.44 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 10.3 pttt -117.63 -45.08 2.71 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.002 0.742 . . . . 1.96 113.002 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.37 -38.75 41.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.793 0.33 . . . . 1.0600000000000001 111.67 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' B' ' 81' ' ' ASP . 83.7 mtt-85 -79.89 -25.28 40.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.525 -0.307 . . . . 1.47 111.055 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.84 132.02 1.74 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.661 -0.78 . . . . 0.81999999999999995 111.849 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.39 148.15 14.42 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.157 -1.02 . . . . 0.65000000000000002 113.16 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -146.49 157.43 43.75 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.786 -0.45 . . . . 1.8100000000000001 109.786 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' B' ' 7' ' ' TRP . 53.5 ttp180 -82.45 126.0 31.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.696 0.284 . . . . 2.4900000000000002 110.601 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 50.4 mt -89.68 -51.43 5.52 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 0.76000000000000001 110.7 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' GLU . . . . . 0.594 ' OE1' ' HB3' ' B' ' 67' ' ' ARG . 12.1 pt-20 -150.16 170.55 18.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.968 -0.56 . . . . 1.0700000000000001 111.812 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.401 ' HG3' ' HA3' ' B' ' 4' ' ' GLY . 19.9 ttm180 -115.5 115.27 26.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.742 -0.663 . . . . 2.0499999999999998 110.361 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.721 ' HB ' HD11 ' B' ' 6' ' ' ILE . 11.9 p -74.08 134.5 77.53 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.966 -0.561 . . . . 1.45 110.629 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.03 148.3 48.77 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.822 2.348 . . . . 1.03 112.195 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -55.39 -34.05 64.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.805 -0.634 . . . . 2.1400000000000001 111.601 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.87 -49.03 79.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.219 0.533 . . . . 1.78 110.942 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.414 ' HB ' HG22 ' B' ' 93' ' ' VAL . 21.1 mm -74.19 -39.88 50.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.878 -0.601 . . . . 1.3300000000000001 110.491 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' MET . . . . . 0.791 ' HG2' ' HG3' ' B' ' 3' ' ' ARG . 8.3 tpt -58.54 -42.36 87.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.985 0.421 . . . . 2.3399999999999999 110.545 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -63.5 -35.36 80.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.939 -0.573 . . . . 1.9099999999999999 110.478 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 1.8 mm-40 -62.82 -42.46 99.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.023 -0.535 . . . . 1.76 110.388 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.581 ' HA ' HG21 ' B' ' 59' ' ' VAL . 39.9 t -61.53 -45.14 99.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.976 -0.556 . . . . 1.01 110.525 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.46 -38.41 87.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.017 -0.538 . . . . 1.29 110.586 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.14 -42.86 94.19 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.692 -0.686 . . . . 1.02 111.579 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 104' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 9.9 mmt180 -69.33 -29.5 67.34 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.806 0.336 . . . . 1.8500000000000001 110.72 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.521 ' O ' HG12 ' B' ' 108' ' ' ILE . 11.3 mt -66.64 -23.17 66.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 1.9399999999999999 110.535 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 24.2 m -82.76 -8.61 59.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.347 -0.388 . . . . 1.1599999999999999 111.767 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.84 -15.87 61.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 1.45 111.778 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.521 HG12 ' O ' ' B' ' 105' ' ' LEU . 37.2 pt -88.18 -1.11 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.807 0.337 . . . . 1.98 111.111 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 58.8 mt -87.42 -4.94 59.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.034 -0.53 . . . . 1.3600000000000001 111.048 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.687 -0.673 . . . . 2.1299999999999999 109.81 179.618 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.4 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 21.3 ptp . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.89 0.376 . . . . 1.29 110.783 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -123.22 168.12 12.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.886 -0.597 . . . . 2.0099999999999998 110.828 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -63.52 128.73 37.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.973 -0.558 . . . . 1.8500000000000001 110.642 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.74 -20.84 17.25 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.756 -0.735 . . . . 0.85999999999999999 113.112 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.4 ' O ' HG12 ' A' ' 27' ' ' ILE . 33.2 mt-10 -83.49 145.49 28.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.794 0.297 . . . . 0.98999999999999999 111.309 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.2 pt -112.91 130.49 66.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.879 0.371 . . . . 1.1599999999999999 110.746 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.4 m95 -116.22 117.58 30.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.152 -0.476 . . . . 0.91000000000000003 111.098 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 27.7 tp -76.07 113.44 13.59 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.791 -0.448 . . . . 0.90000000000000002 109.791 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 p -150.66 159.92 4.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.61 -0.268 . . . . 1.04 110.738 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.65 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.0 t -97.25 132.4 43.04 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.499 -0.556 . . . . 1.3200000000000001 109.499 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.4 mt -86.29 -11.65 51.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.403 -0.362 . . . . 1.29 111.509 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.486 ' CB ' ' HA ' ' A' ' 13' ' ' PRO . 3.0 m-20 -64.18 164.59 17.44 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.803 -0.635 . . . . 1.54 112.649 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.486 ' HA ' ' CB ' ' A' ' 12' ' ' ASP . 79.4 Cg_endo -83.34 111.63 2.28 Favored 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 123.553 -1.436 . . . . 1.6899999999999999 112.572 0.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -107.49 150.49 26.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.106 -0.497 . . . . 1.3600000000000001 111.298 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -130.02 167.21 18.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.002 -0.545 . . . . 1.7 110.533 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.8 -150.55 48.05 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.893 -0.883 . . . . 1.1799999999999999 110.893 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -85.62 4.14 37.62 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.093 0.446 . . . . 2.7799999999999998 111.338 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HB3' HG22 ' A' ' 14' ' ' THR . 9.3 tt0 -65.33 134.38 53.45 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.134 -0.321 . . . . 1.1399999999999999 110.134 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.428 ' HG2' ' HG3' ' A' ' 44' ' ' PRO . 7.5 tp-100 -54.77 124.45 16.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.951 -0.568 . . . . 2.0899999999999999 112.098 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.85 -178.81 4.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.722 -0.672 . . . . 2.0899999999999999 110.195 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.26 164.52 39.32 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.861 -0.685 . . . . 1.0700000000000001 113.917 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 2.2 m -91.96 124.76 36.31 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.078 -0.712 . . . . 1.1100000000000001 109.078 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.43 ' HG3' ' HB2' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -159.88 158.06 26.4 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 110.466 -0.198 . . . . 1.6200000000000001 110.466 -179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 57.6 Cg_endo -76.86 121.04 5.69 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.957 1.771 . . . . 1.01 111.335 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.557 HG21 HD11 ' A' ' 80' ' ' ILE . 24.4 m -95.59 131.07 43.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.082 -0.508 . . . . 0.76000000000000001 110.532 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HB3' HG23 ' A' ' 43' ' ' VAL . 50.8 tp -87.91 122.64 31.78 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.788 -0.642 . . . . 0.69999999999999996 110.825 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.633 ' HA ' HG12 ' A' ' 42' ' ' VAL . 19.0 mm -71.11 111.45 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.794 -0.446 . . . . 0.92000000000000004 109.794 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -92.32 -37.12 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.275 -0.42 . . . . 0.94999999999999996 111.724 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.85 148.85 82.5 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 111.719 0.266 . . . . 1.1200000000000001 111.719 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.419 ' HG3' ' OXT' ' B' ' 110' ' ' THR . 68.7 Cg_endo -71.69 161.2 45.94 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.598 2.199 . . . . 1.3 111.879 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.11 -35.79 74.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.026 -0.534 . . . . 1.3899999999999999 111.567 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.64 -43.56 89.81 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.241 -0.436 . . . . 1.6100000000000001 111.672 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.597 ' HZ ' ' HB2' ' B' ' 75' ' ' ASP . 69.9 t80 -71.94 -48.39 45.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.889 -0.596 . . . . 1.77 110.786 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -59.25 -32.68 70.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.024 -0.534 . . . . 1.48 111.123 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 35' ' ' ARG . 43.9 ttp180 -64.85 -30.08 71.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.852 -0.613 . . . . 2.6200000000000001 112.136 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 p -96.32 -47.28 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 113.575 0.954 . . . . 1.8600000000000001 113.575 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 22.1 p -78.34 -28.61 47.26 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.72 0.637 . . . . 1.72 112.72 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 37' ' ' THR . 9.4 mpt_? 74.04 -1.09 3.17 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.585 0.553 . . . . 4.4500000000000002 111.567 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.9 mt -126.05 107.3 25.02 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.317 -0.624 . . . . 1.8100000000000001 109.317 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -89.09 139.78 3.76 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.73 2.287 . . . . 1.05 113.018 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 79' ' ' THR . 62.8 t -79.79 113.66 19.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.015 -1.476 . . . . 1.03 107.015 177.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 27' ' ' ILE . 34.8 m -123.46 165.33 19.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 112.711 0.634 . . . . 0.77000000000000002 112.711 -177.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.412 HG23 ' HB3' ' A' ' 26' ' ' LEU . 4.4 m -126.54 125.92 24.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.711 -1.131 . . . . 0.71999999999999997 108.797 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.43 ' HB2' ' HG3' ' A' ' 23' ' ' ARG . 94.5 Cg_endo -80.42 131.59 8.6 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.691 2.26 . . . . 1.03 113.667 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.726 HG22 HG22 ' A' ' 72' ' ' VAL . 92.1 t -78.77 128.63 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.942 -0.762 . . . . 1.28 108.942 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 C--N 1.325 -0.46 0 C-N-CA 121.217 -0.193 . . . . 1.9099999999999999 111.388 -179.287 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.753 0 N-CA-C 111.43 -0.668 . . . . 1.6599999999999999 111.43 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -103.37 15.12 29.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.178 0.513 . . . . 1.5600000000000001 110.995 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.44 153.5 19.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.741 -0.663 . . . . 1.25 109.439 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.13 163.11 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.874 0.369 . . . . 1.6799999999999999 111.755 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.9 m -82.53 133.74 35.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.794 -0.639 . . . . 1.95 110.78 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.815 HD11 HG23 ' A' ' 72' ' ' VAL . 18.3 mt -103.48 -32.15 9.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.191 0.52 . . . . 1.23 110.775 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.78 97.9 1.87 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.369 0.604 . . . . 2.21 110.814 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.82 -8.29 4.87 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.803 -0.713 . . . . 1.1499999999999999 112.605 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 61' ' ' LEU . 28.5 m -94.33 -1.9 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.851 0.325 . . . . 1.21 111.701 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.08 54.44 5.25 Favored Glycine 0 C--O 1.236 0.228 0 C-N-CA 121.16 -0.543 . . . . 1.0800000000000001 113.937 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.639 HD11 ' HB3' ' A' ' 61' ' ' LEU . 41.6 pt -129.67 171.92 16.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 122.823 -0.222 . . . . 1.0700000000000001 110.666 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -104.82 -23.74 12.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.895 -0.409 . . . . 3.5899999999999999 109.895 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.611 ' HB ' HD12 ' A' ' 66' ' ' ILE . 21.1 m -52.74 107.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.468 -0.787 . . . . 1.51 111.378 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.73 90.71 8.34 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.589 -0.732 . . . . 1.79 111.126 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.71 -151.47 10.43 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.941 -0.864 . . . . 1.1799999999999999 110.941 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.83 131.13 37.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.986 0.422 . . . . 1.5600000000000001 110.797 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.815 HG23 HD11 ' A' ' 61' ' ' LEU . 85.1 t -97.96 142.88 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.27 -0.423 . . . . 1.29 109.922 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.407 ' HG3' ' OD2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -150.39 163.9 37.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.381 -0.372 . . . . 2.23 110.311 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.32 13.94 20.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.757 0.313 . . . . 1.1699999999999999 111.383 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.487 ' HA ' ' HZ ' ' B' ' 33' ' ' PHE . 3.3 p30 -86.95 -3.18 59.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 0.89000000000000001 112.075 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.402 ' HG2' ' OD1' ' A' ' 75' ' ' ASP . 35.4 mm-40 -129.96 64.65 72.99 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.758 -0.201 . . . . 2.1299999999999999 111.42 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -94.82 131.49 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.619 2.213 . . . . 0.80000000000000004 113.003 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' B' ' 77' ' ' PRO . 10.6 ptm180 -161.43 154.91 21.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.951 0.405 . . . . 2.0899999999999999 111.594 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.454 HG23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.85 130.02 36.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.186 -0.672 . . . . 1.6200000000000001 109.186 178.335 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.557 HD11 HG21 ' A' ' 25' ' ' VAL . 32.7 pt -131.1 157.28 43.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.961 0.41 . . . . 1.1499999999999999 111.111 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -87.84 133.19 33.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.854 -0.612 . . . . 1.03 110.596 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 43.7 tpp -120.09 21.76 11.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.128 -0.487 . . . . 1.29 110.286 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -107.31 -38.58 5.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.096 -0.502 . . . . 2.6400000000000001 110.794 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.71 -26.18 15.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.994 -0.548 . . . . 1.1200000000000001 111.203 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -76.47 -59.76 2.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.852 0.358 . . . . 1.0600000000000001 111.154 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.29 89.7 1.39 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.84 -0.695 . . . . 1.1200000000000001 111.478 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -95.97 172.29 29.42 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.666 -0.778 . . . . 1.0900000000000001 112.561 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -121.36 109.39 14.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.764 -0.458 . . . . 2.46 109.764 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.16 128.18 34.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.501 0.191 . . . . 2.4900000000000002 110.795 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.56 -89.04 0.37 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.589 -0.278 . . . . 1.29 110.881 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -122.09 -172.78 2.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.51 -0.314 . . . . 1.1499999999999999 110.409 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -140.57 133.88 29.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.94 0.4 . . . . 1.3200000000000001 110.449 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.42 155.21 66.25 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.113 -0.494 . . . . 0.75 111.411 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.54 149.38 89.98 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.47 2.114 . . . . 0.94999999999999996 111.941 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -60.77 -23.21 64.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.892 -0.595 . . . . 1.51 111.488 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -38.07 89.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.243 -0.435 . . . . 1.5700000000000001 109.851 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.7 mm -71.6 -37.92 65.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.916 -0.584 . . . . 1.3100000000000001 109.5 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 84.6 mmm -62.06 -36.9 83.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.616 -0.72 . . . . 1.6000000000000001 110.234 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -62.52 -35.98 81.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.752 -0.658 . . . . 2.2999999999999998 110.548 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -63.84 -46.63 84.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.5 -0.556 . . . . 1.6399999999999999 109.5 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.73 -47.27 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.688 -0.687 . . . . 1.03 110.446 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.3 mt -61.86 -33.84 74.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 1.22 111.121 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.95 -17.57 75.55 Favored Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.904 -0.589 . . . . 1.03 113.091 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -97.86 -24.98 15.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.973 0.416 . . . . 1.72 110.786 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.419 ' O ' HG12 ' A' ' 108' ' ' ILE . 90.6 mt -68.42 -25.45 65.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.139 -0.482 . . . . 1.02 111.398 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -16.53 64.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.835 0.35 . . . . 1.1100000000000001 111.568 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.76 -16.5 32.02 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.193 0.442 . . . . 1.5 112.193 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 105' ' ' LEU . 23.3 pt -91.9 -9.34 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.641 0.608 . . . . 1.1499999999999999 112.641 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.644 ' HA ' HG12 ' B' ' 28' ' ' VAL . 19.7 mt -87.73 82.91 7.24 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.915 -0.402 . . . . 0.97999999999999998 109.915 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.412 ' O ' ' HG3' ' B' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 N-CA-C 113.006 0.743 . . . . 1.3500000000000001 113.006 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.842 ' HA ' ' HA ' ' B' ' 30' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.326 0 N-CA-C 109.61 -0.515 . . . . 2.0299999999999998 109.61 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -77.97 -5.42 51.19 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.719 -0.474 . . . . 2.8199999999999998 109.719 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 110' ' ' THR . 7.8 mtm180 60.69 80.19 0.22 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.099 -0.955 . . . . 2.3199999999999998 112.968 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' GLY . . . . . 0.47 ' HA2' HG12 ' B' ' 93' ' ' VAL . . . 137.69 -32.69 2.35 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.092 -1.052 . . . . 1.28 113.826 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.44 ' OE2' ' HD2' ' B' ' 92' ' ' ARG . 17.6 mm-40 -64.63 109.62 2.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.062 0.458 . . . . 1.53 112.169 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.659 HD11 ' HB ' ' B' ' 93' ' ' VAL . 51.4 mt -98.8 130.7 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.371 -0.603 . . . . 0.75 109.371 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.408 ' HA ' ' HA ' ' B' ' 89' ' ' ARG . 30.2 m95 -115.44 178.32 4.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.037 0.446 . . . . 0.81000000000000005 111.316 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 tt -146.22 133.7 20.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.086 -0.506 . . . . 1.05 110.032 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.519 HG12 HG21 ' B' ' 25' ' ' VAL . 8.2 p -167.16 164.75 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.504 -0.316 . . . . 0.71999999999999997 110.182 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 6.0 t -88.83 140.56 29.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.636 0.255 . . . . 1.6299999999999999 110.661 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.517 HD11 ' HB3' ' B' ' 44' ' ' PRO . 32.1 mt -96.45 -12.25 24.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.369 0.604 . . . . 0.82999999999999996 110.15 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ASP . . . . . 0.735 ' OD1' ' HB3' ' B' ' 20' ' ' GLN . 0.1 OUTLIER -75.97 153.59 84.77 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.507 -0.769 . . . . 1.6200000000000001 110.083 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -96.23 161.73 14.48 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.823 -1.324 . . . . 1.28 112.154 -0.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.465 HG22 ' H ' ' B' ' 15' ' ' ALA . 0.2 OUTLIER -157.93 -164.65 1.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.172 -0.677 . . . . 1.47 109.172 179.108 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.465 ' H ' HG22 ' B' ' 14' ' ' THR . . . -155.41 161.57 40.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.075 -0.342 . . . . 1.22 110.075 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.47 -143.23 25.66 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.891 -0.671 . . . . 1.01 112.244 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -92.83 2.05 56.97 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.875 0.324 . . . . 2.1800000000000002 111.875 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.44 136.0 57.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.648 0.261 . . . . 1.28 110.758 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -60.31 128.33 36.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 1.52 112.097 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.735 ' HB3' ' OD1' ' B' ' 12' ' ' ASP . 71.4 mt-30 -129.55 -167.37 1.79 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.466 -0.788 . . . . 1.8600000000000001 110.874 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.22 175.7 50.89 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.962 -0.563 . . . . 0.90000000000000002 112.765 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 18.4 m -111.0 108.79 18.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.01 0.433 . . . . 0.94999999999999996 110.591 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.48 164.81 20.1 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.004 -0.544 . . . . 1.5900000000000001 109.764 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.08 147.28 91.1 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.406 2.071 . . . . 0.65000000000000002 111.078 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 9.8 m -134.99 137.2 50.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.138 0.494 . . . . 0.56999999999999995 111.753 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 33.5 tp -101.83 129.13 47.98 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.186 -0.672 . . . . 1.1699999999999999 109.186 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 55.3 mt -89.22 133.65 30.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.605 0.24 . . . . 0.66000000000000003 110.369 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 109' ' ' LEU . 21.5 t -100.5 -34.84 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.379 -0.373 . . . . 0.93000000000000005 111.913 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' THR . . . . . 0.49 HG23 HG22 ' B' ' 41' ' ' VAL . 0.7 OUTLIER -67.54 138.99 93.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 111.956 0.354 . . . . 0.81000000000000005 111.956 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.842 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 50.0 Cg_endo -68.34 162.26 41.26 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.003 2.469 . . . . 0.78000000000000003 113.02 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.06 67.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.536 -0.756 . . . . 1.03 112.208 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.07 -46.18 79.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.035 0.445 . . . . 1.3999999999999999 110.961 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' PHE . . . . . 0.487 ' HZ ' ' HA ' ' A' ' 75' ' ' ASP . 4.5 t80 -66.05 -48.13 72.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.031 -0.531 . . . . 1.5700000000000001 110.599 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -61.16 -26.88 68.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 1.6399999999999999 111.937 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -82.52 -33.98 28.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.484 -0.325 . . . . 2.54 111.262 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 89.0 t -82.99 -55.75 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.372 0.508 . . . . 1.0900000000000001 112.372 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 58.0 p -74.43 -27.81 60.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.7 0.286 . . . . 1.3300000000000001 111.33 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.416 ' HE ' ' HA ' ' B' ' 38' ' ' ARG . 2.5 mmp_? 62.84 26.22 15.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.897 -0.592 . . . . 1.78 110.061 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 30.4 mt -145.67 96.67 4.73 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.115 -0.948 . . . . 1.1599999999999999 109.57 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' PRO . . . . . 0.547 ' HD2' ' O ' ' B' ' 80' ' ' ILE . 92.5 Cg_endo -87.43 146.99 7.4 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.861 2.374 . . . . 0.56999999999999995 112.711 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.49 HG22 HG23 ' B' ' 29' ' ' THR . 4.9 m -85.52 110.68 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.327 -0.62 . . . . 1.0800000000000001 109.327 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 34.6 m -95.73 138.26 21.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.9 -0.591 . . . . 0.64000000000000001 112.035 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.491 HG13 ' O ' ' B' ' 73' ' ' ARG . 41.2 t -107.52 116.38 57.84 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.022 -0.99 . . . . 1.1000000000000001 108.91 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.517 ' HB3' HD11 ' B' ' 11' ' ' LEU . 50.0 Cg_endo -67.85 124.62 12.09 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.984 2.456 . . . . 0.72999999999999998 114.221 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -95.24 142.07 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.588 -0.893 . . . . 0.90000000000000002 108.588 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -112.63 100.56 8.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.951 0.405 . . . . 1.1699999999999999 111.181 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.774 -0.648 . . . . 1.8500000000000001 110.722 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.946 0.403 . . . . 1.96 110.988 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.34 -77.09 0.74 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.745 -0.661 . . . . 1.0800000000000001 112.869 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.491 ' HE1' ' HB ' ' B' ' 107' ' ' THR . 66.3 m-85 -104.4 -14.42 15.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.512 0.196 . . . . 3.5699999999999998 111.153 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' B' ' 72' ' ' VAL . . . -78.87 95.96 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.419 -0.355 . . . . 1.0800000000000001 110.566 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 45.0 t -85.14 125.19 40.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.11 -0.496 . . . . 1.3400000000000001 111.173 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.01 126.41 31.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.147 -0.479 . . . . 1.3799999999999999 110.993 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.418 ' HB3' HD11 ' B' ' 66' ' ' ILE . 75.9 mt -96.01 87.63 4.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 1.02 111.461 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -161.95 179.21 8.2 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.704 -0.48 . . . . 1.79 109.704 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.22 -42.47 3.16 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 121.242 -0.504 . . . . 1.1499999999999999 112.452 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.652 HG21 ' HG2' ' B' ' 94' ' ' PRO . 14.2 p -80.18 -27.28 11.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.091 0.472 . . . . 1.1699999999999999 111.111 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.65 89.51 1.07 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.717 -0.754 . . . . 1.05 112.62 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.418 HD11 ' HB3' ' B' ' 61' ' ' LEU . 4.9 pt -141.28 177.39 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.925 -0.769 . . . . 1.6100000000000001 108.925 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -83.13 -53.49 5.75 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.982 0.42 . . . . 2.3999999999999999 110.307 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 7.2 m -64.89 112.53 3.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.889 -0.596 . . . . 0.93000000000000005 109.743 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.4 131.58 53.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.888 0.375 . . . . 1.3100000000000001 111.438 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.89 -174.42 32.41 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.941 -0.647 . . . . 0.79000000000000004 111.899 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.418 ' HB ' ' HB1' ' B' ' 58' ' ' ALA . 4.0 m -102.7 124.04 56.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.045 0.45 . . . . 0.93000000000000005 111.437 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' B' ' 58' ' ' ALA . 11.0 t -86.53 118.35 32.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.801 -0.636 . . . . 1.3799999999999999 110.661 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.491 ' O ' HG13 ' B' ' 43' ' ' VAL . 9.3 mmm180 -87.3 83.9 7.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.937 0.399 . . . . 1.3700000000000001 110.315 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 2.5 m -71.17 22.97 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.233 0.827 . . . . 1.1599999999999999 113.233 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.597 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 13.3 p-10 -112.64 -4.16 14.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.661 0.267 . . . . 1.1000000000000001 110.701 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -121.26 86.22 42.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 112.497 0.554 . . . . 2.4700000000000002 112.497 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.54 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 12.8 Cg_endo -92.8 104.38 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.88 2.387 . . . . 0.95999999999999996 110.588 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -111.37 125.81 54.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.938 0.399 . . . . 1.96 111.949 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -84.04 114.11 21.5 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.427 -0.583 . . . . 1.1899999999999999 109.427 178.927 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.547 ' O ' ' HD2' ' B' ' 40' ' ' PRO . 45.0 pt -133.8 171.79 17.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.008 0.432 . . . . 1.28 111.023 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -77.47 141.87 39.46 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.643 -0.708 . . . . 1.28 109.678 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' MET . . . . . 0.708 ' SD ' ' HA3' ' B' ' 87' ' ' GLY . 49.0 tpp -115.19 -18.02 11.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.996 0.426 . . . . 2.7000000000000002 111.472 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -92.11 -42.9 9.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.373 -0.376 . . . . 1.96 111.617 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.38 -25.43 33.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.103 0.478 . . . . 1.0600000000000001 111.391 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -81.4 -13.99 57.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.263 -0.426 . . . . 1.47 111.411 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.71 43.49 35.56 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.862 -0.685 . . . . 0.81999999999999995 112.628 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' GLY . . . . . 0.708 ' HA3' ' SD ' ' B' ' 82' ' ' MET . . . -64.33 144.77 48.97 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.049 -0.596 . . . . 0.65000000000000002 112.426 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.35 146.73 51.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.455 -0.202 . . . . 1.8100000000000001 110.455 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' B' ' 7' ' ' TRP . 47.3 ttp180 -91.71 134.18 34.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.276 -0.42 . . . . 2.4900000000000002 110.108 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 94.9 mt -89.97 -63.84 1.22 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.438 -0.346 . . . . 0.76000000000000001 111.598 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -161.32 -173.84 4.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.55 -0.296 . . . . 1.0700000000000001 110.387 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' B' ' 4' ' ' GLY . 43.2 ttt85 -121.04 115.67 23.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.391 -0.368 . . . . 2.0499999999999998 110.705 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.659 ' HB ' HD11 ' B' ' 6' ' ' ILE . 9.4 p -75.03 136.69 72.91 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.939 -0.573 . . . . 1.45 109.61 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.652 ' HG2' HG21 ' B' ' 64' ' ' VAL . 90.7 Cg_exo -47.92 144.58 11.53 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.071 2.514 . . . . 1.03 112.922 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -33.32 68.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.66 -0.7 . . . . 2.1400000000000001 111.96 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -26.84 68.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.122 0.487 . . . . 1.78 111.128 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.416 ' HB ' HG22 ' B' ' 93' ' ' VAL . 30.0 mm -89.34 -37.03 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 1.3300000000000001 109.647 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 18.3 tpt -65.74 -30.34 70.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 2.3399999999999999 110.564 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -59.08 -34.14 71.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.794 -0.639 . . . . 1.9099999999999999 110.221 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.71 -44.48 90.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.939 -0.573 . . . . 1.76 109.687 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 34.9 t -59.55 -44.88 94.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.492 -0.776 . . . . 1.01 110.816 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.3 -40.35 85.93 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.117 0.484 . . . . 1.29 110.596 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.36 -39.13 94.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.934 -0.65 . . . . 1.02 111.886 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -67.55 -36.9 81.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.897 0.379 . . . . 1.8500000000000001 110.363 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.601 ' O ' HG12 ' B' ' 108' ' ' ILE . 68.5 mt -65.59 -21.59 66.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.935 -0.575 . . . . 1.9399999999999999 111.27 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 24.7 m -76.51 -14.32 60.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.008 0.433 . . . . 1.1599999999999999 111.168 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.491 ' HB ' ' HE1' ' B' ' 57' ' ' PHE . 3.0 m -93.3 -7.81 43.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.305 -0.407 . . . . 1.45 112.051 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.601 HG12 ' O ' ' B' ' 105' ' ' LEU . 13.1 pt -81.64 -21.01 10.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.959 0.409 . . . . 1.98 110.866 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 94.6 mt -94.07 47.5 1.21 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 1.3600000000000001 110.711 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.419 ' OXT' ' HG3' ' A' ' 30' ' ' PRO . 1.8 m . . . . . 0 C--O 1.255 1.372 0 CA-C-O 118.267 -0.873 . . . . 2.1299999999999999 110.235 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.417 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 8.0 ptp . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 121.337 0.589 . . . . 1.29 111.149 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -106.73 177.86 4.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.417 -0.81 . . . . 2.0099999999999998 111.039 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.496 ' NH2' ' HD3' ' A' ' 30' ' ' PRO . 9.1 ttm180 -80.93 124.33 29.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.829 -0.623 . . . . 1.8500000000000001 109.986 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.73 7.04 42.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.685 -0.769 . . . . 0.85999999999999999 112.803 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.53 ' OE2' ' HD2' ' A' ' 89' ' ' ARG . 66.4 mt-10 -94.74 151.18 19.47 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.614 -0.345 . . . . 0.98999999999999999 111.114 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.666 HD11 ' HG2' ' A' ' 91' ' ' GLU . 17.3 pt -110.35 113.92 45.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.111 0.481 . . . . 1.1599999999999999 110.191 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.439 ' C ' ' HA ' ' A' ' 24' ' ' PRO . 22.4 m95 -106.82 118.43 36.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.924 -0.58 . . . . 0.91000000000000003 111.779 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.2 tp -72.89 104.54 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.954 -0.566 . . . . 0.90000000000000002 110.47 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -144.63 161.13 14.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.304 -0.407 . . . . 1.04 110.865 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 t -96.96 130.02 44.34 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.887 -0.782 . . . . 1.3200000000000001 108.887 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.17 4.51 52.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.813 0.34 . . . . 1.29 111.17 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.494 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 6.2 m-20 -79.8 162.87 60.99 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.845 -0.616 . . . . 1.54 110.957 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 21.6 Cg_exo -66.48 144.58 68.15 Favored 'Cis proline' 0 C--N 1.351 0.7 0 C-N-CA 124.264 -1.14 . . . . 1.6899999999999999 112.588 0.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 20' ' ' GLN . 3.1 p -109.81 135.94 49.91 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.886 -0.597 . . . . 1.3600000000000001 112.045 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.64 117.45 31.94 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.044 -0.525 . . . . 1.7 110.2 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.99 -120.99 7.51 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.721 -0.752 . . . . 1.1799999999999999 112.543 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -109.73 36.52 2.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.734 0.302 . . . . 2.7799999999999998 111.393 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -68.54 173.68 4.83 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.69 -0.485 . . . . 1.1399999999999999 109.69 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.566 ' HG2' ' HB3' ' A' ' 44' ' ' PRO . 6.7 tp-100 -71.1 91.36 0.9 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.978 0.418 . . . . 2.0899999999999999 111.399 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.46 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 5.4 pt20 -94.12 152.74 18.53 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.658 -0.701 . . . . 2.0899999999999999 111.489 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.04 168.85 16.51 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.957 -0.639 . . . . 1.0700000000000001 113.234 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.7 m -111.85 112.07 23.47 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.755 -0.461 . . . . 1.1100000000000001 109.755 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.37 159.97 37.83 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.265 -0.425 . . . . 1.6200000000000001 110.348 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HB2' ' HB ' ' A' ' 6' ' ' ILE . 11.3 Cg_exo -72.34 99.27 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.496 2.13 . . . . 1.01 110.916 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.485 HG12 ' HA ' ' A' ' 44' ' ' PRO . 17.0 m -80.12 142.28 14.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.232 -0.44 . . . . 0.76000000000000001 110.345 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.539 ' HB3' HG23 ' A' ' 43' ' ' VAL . 34.6 tp -84.98 126.02 33.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.252 -0.431 . . . . 0.69999999999999996 111.17 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.42 HD13 HG12 ' A' ' 42' ' ' VAL . 17.7 mm -78.86 114.98 20.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.382 -0.599 . . . . 0.92000000000000004 109.382 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.407 HG11 HD11 ' A' ' 105' ' ' LEU . 16.8 t -92.47 -22.85 5.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.935 0.398 . . . . 0.94999999999999996 111.659 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.87 152.03 68.33 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 111.791 0.293 . . . . 1.1200000000000001 111.791 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.66 ' HG2' ' HB2' ' A' ' 33' ' ' PHE . 38.2 Cg_endo -67.28 160.86 45.66 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.805 2.337 . . . . 1.3 111.736 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.45 -38.54 66.46 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.608 0.596 . . . . 1.3899999999999999 112.608 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.454 ' O ' HG12 ' A' ' 36' ' ' VAL . . . -66.55 -44.55 82.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.415 -0.357 . . . . 1.6100000000000001 111.569 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.729 ' HZ ' ' HB2' ' B' ' 75' ' ' ASP . 5.6 t80 -60.42 -37.7 81.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.039 0.447 . . . . 1.77 111.055 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.415 ' OD1' ' HB3' ' A' ' 40' ' ' PRO . 52.5 m-20 -67.49 -9.87 46.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.669 -0.696 . . . . 1.48 111.386 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 35' ' ' ARG . 36.8 ttp180 -112.08 -51.77 2.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.298 -0.41 . . . . 2.6200000000000001 111.588 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 32' ' ' ALA . 10.4 p -65.23 -47.74 86.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.294 0.479 . . . . 1.8600000000000001 112.294 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -88.62 -29.87 19.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.637 0.256 . . . . 1.72 110.94 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.433 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 9.3 ttt180 73.96 -10.74 1.06 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.802 -0.636 . . . . 4.4500000000000002 111.962 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.3 mt -108.51 99.03 31.1 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.286 -0.415 . . . . 1.8100000000000001 110.261 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.539 ' HD2' ' O ' ' A' ' 80' ' ' ILE . 3.0 Cg_endo -87.63 135.68 3.61 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.004 2.469 . . . . 1.05 112.785 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.67 HG22 HG23 ' A' ' 79' ' ' THR . 44.2 t -80.49 113.4 19.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.018 -1.475 . . . . 1.03 107.018 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.42 HG12 HD13 ' A' ' 27' ' ' ILE . 32.1 m -116.91 152.82 18.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 112.909 0.707 . . . . 0.77000000000000002 112.909 -178.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.539 HG23 ' HB3' ' A' ' 26' ' ' LEU . 5.2 m -115.94 131.08 23.91 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 114.91 -1.041 . . . . 0.71999999999999997 108.441 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HB3' ' HG2' ' A' ' 19' ' ' GLN . 58.4 Cg_endo -71.46 172.81 13.48 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.753 2.302 . . . . 1.03 114.449 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.3 t -137.43 135.35 46.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.665 -1.152 . . . . 1.28 108.135 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 C--N 1.326 -0.436 0 N-CA-C 111.552 0.204 . . . . 1.9099999999999999 111.552 -179.528 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.319 0 N-CA-C 112.772 -0.131 . . . . 1.6599999999999999 112.772 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -103.22 -13.53 16.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.968 0.413 . . . . 1.5600000000000001 111.022 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.84 109.71 19.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.2 -0.455 . . . . 1.25 109.81 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 m -101.19 139.34 22.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.058 0.456 . . . . 1.6799999999999999 111.592 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 p -86.78 144.39 27.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.192 -0.458 . . . . 1.95 110.544 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.0 mt -84.88 -8.82 58.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 1.23 110.872 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -67.56 131.64 46.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.821 -0.627 . . . . 2.21 109.928 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.99 -39.28 1.93 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.662 -0.575 . . . . 1.1499999999999999 111.662 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -93.7 -8.13 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.758 0.313 . . . . 1.21 111.03 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.89 98.26 0.24 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.855 -0.688 . . . . 1.0800000000000001 112.765 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 13.3 pt -122.26 165.69 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.815 0.34 . . . . 1.0700000000000001 111.143 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -91.94 -44.1 9.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.093 -0.503 . . . . 3.5899999999999999 110.398 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.04 -164.1 0.42 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.136 -0.483 . . . . 1.51 112.019 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.5 m -153.0 143.37 22.53 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.18 -0.304 . . . . 1.79 110.18 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.98 166.67 11.77 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.065 -0.588 . . . . 1.1799999999999999 111.777 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.9 139.73 26.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.558 0.179 . . . . 1.5600000000000001 110.569 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -72.38 126.84 33.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.752 0.31 . . . . 1.29 110.316 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.559 ' HB2' ' HG2' ' A' ' 44' ' ' PRO . 55.8 mmm-85 -104.91 92.62 4.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.078 -0.51 . . . . 2.23 111.63 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.8 m -88.18 4.89 43.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.993 -0.549 . . . . 1.1699999999999999 110.087 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.15 -14.44 38.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.624 -0.716 . . . . 0.89000000000000001 111.967 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -129.42 64.24 70.63 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 113.295 0.85 . . . . 2.1299999999999999 113.295 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.43 134.76 23.15 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.201 1.934 . . . . 0.80000000000000004 110.035 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' B' ' 78' ' ' ARG . 2.4 ptm85 -154.74 145.68 22.6 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.109 0.781 . . . . 2.0899999999999999 113.109 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.67 HG23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -96.41 115.02 26.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.37 -0.832 . . . . 1.6200000000000001 109.502 178.424 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.539 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 1.7 pp -133.78 138.85 49.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.995 -0.372 . . . . 1.1499999999999999 109.995 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.527 ' HB3' ' HA3' ' B' ' 16' ' ' GLY . 21.1 t70 -69.08 118.38 11.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.99 0.424 . . . . 1.03 111.212 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 57.7 tpp -87.47 -13.64 42.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.861 -0.608 . . . . 1.29 111.148 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -71.18 -53.37 14.71 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.162 0.43 . . . . 2.6400000000000001 112.162 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.17 -25.12 59.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.929 0.395 . . . . 1.1200000000000001 111.888 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 65.7 mtt-85 -82.35 -48.91 10.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.226 -0.443 . . . . 1.0600000000000001 111.799 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.74 114.8 0.21 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.623 -0.798 . . . . 1.1200000000000001 112.474 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -129.61 163.25 22.74 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.812 -0.709 . . . . 1.0900000000000001 112.189 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -103.92 129.15 51.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.164 -0.31 . . . . 2.46 110.164 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.53 ' HD2' ' OE2' ' A' ' 5' ' ' GLU . 2.5 ttp180 -85.64 115.18 23.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.738 0.304 . . . . 2.4900000000000002 110.765 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -86.14 -71.84 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.415 -0.357 . . . . 1.29 110.719 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.666 ' HG2' HD11 ' A' ' 6' ' ' ILE . 3.2 pt-20 -149.29 -169.32 3.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.137 -0.483 . . . . 1.1499999999999999 109.724 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -135.04 143.01 46.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.749 0.309 . . . . 1.3200000000000001 110.444 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.3 m -83.45 153.65 65.45 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.267 -0.424 . . . . 0.75 111.305 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.39 157.94 33.7 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.753 2.302 . . . . 0.94999999999999996 111.467 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.79 -27.16 67.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.689 0.28 . . . . 1.51 111.621 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.24 -45.97 85.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.282 -0.417 . . . . 1.5700000000000001 110.575 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.8 mm -66.32 -40.75 87.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.953 -0.567 . . . . 1.3100000000000001 110.007 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 9.5 tpt -62.29 -38.82 90.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.863 -0.608 . . . . 1.6000000000000001 110.486 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -64.56 -34.22 77.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.968 -0.56 . . . . 2.2999999999999998 111.193 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.5 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 6.4 tp10 -64.12 -48.87 74.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.908 -0.587 . . . . 1.6399999999999999 110.386 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.6 t -59.28 -43.23 89.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.157 -0.474 . . . . 1.03 110.609 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.78 -34.59 78.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.846 -0.616 . . . . 1.22 111.429 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.94 -27.6 66.37 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.245 -0.502 . . . . 1.03 113.077 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 9.8 mmt180 -77.04 -33.29 57.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.125 0.488 . . . . 1.72 110.553 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 89.9 mt -66.19 -30.91 71.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.935 -0.575 . . . . 1.02 111.69 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -27.95 68.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.873 0.368 . . . . 1.1100000000000001 111.299 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 m -72.85 -31.0 64.44 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.086 0.402 . . . . 1.5 112.086 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.4 pt -86.07 -3.32 8.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.464 0.542 . . . . 1.1499999999999999 112.464 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 105' ' ' LEU . 84.3 mt -85.04 69.88 10.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.859 0.362 . . . . 0.97999999999999998 110.159 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.373 -0.376 . . . . 1.3500000000000001 111.935 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' B' ' 27' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 121.213 0.53 . . . . 2.0299999999999998 112.147 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 2' ' ' GLU . . . . . 0.52 ' HB3' ' HG3' ' B' ' 5' ' ' GLU . 3.2 mm-40 -85.46 9.69 15.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.086 0.47 . . . . 2.8199999999999998 110.198 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' B' ' 2' ' ' GLU . 0.0 OUTLIER 81.76 58.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.118 -0.946 . . . . 2.3199999999999998 113.207 179.663 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 4' ' ' GLY . . . . . 0.501 ' O ' ' HG3' ' B' ' 92' ' ' ARG . . . 69.94 57.64 6.89 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.593 -0.731 . . . . 1.28 114.321 178.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.52 ' HG3' ' HB3' ' B' ' 2' ' ' GLU . 5.5 mm-40 -115.98 117.45 30.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.863 0.331 . . . . 1.53 111.674 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.53 HD12 ' HG3' ' B' ' 91' ' ' GLU . 66.6 mt -99.78 120.06 48.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 0.75 109.798 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -114.74 144.77 42.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.428 -0.351 . . . . 0.81000000000000005 110.693 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.404 ' HB2' HD11 ' B' ' 90' ' ' LEU . 38.0 tp -105.8 117.1 33.16 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.221 -0.445 . . . . 1.05 110.0 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.408 HG22 ' H ' ' B' ' 10' ' ' SER . 9.5 p -158.89 167.54 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.71999999999999997 110.244 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' B' ' 22' ' ' THR . 7.0 m -88.88 137.64 32.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.851 0.358 . . . . 1.6299999999999999 110.54 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.605 HD21 HG11 ' B' ' 25' ' ' VAL . 55.7 mt -85.09 -21.36 29.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.323 -0.399 . . . . 0.82999999999999996 110.999 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ASP . . . . . 0.459 ' HA ' ' N ' ' B' ' 14' ' ' THR . 3.7 m-20 -60.19 153.29 58.25 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.862 -0.608 . . . . 1.6200000000000001 110.829 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.02 120.64 5.84 Favored 'Cis proline' 0 C--O 1.235 0.341 0 C-N-CA 123.534 -1.444 . . . . 1.28 113.741 0.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.459 ' N ' ' HA ' ' B' ' 12' ' ' ASP . 0.1 OUTLIER -121.11 146.68 46.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.297 -0.865 . . . . 1.47 108.95 179.063 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.07 -177.79 5.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.913 0.387 . . . . 1.22 111.979 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.527 ' HA3' ' HB3' ' A' ' 81' ' ' ASP . . . 60.79 -106.03 0.98 Allowed Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.006 -0.543 . . . . 1.01 113.34 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' HIS . . . . . 0.405 ' H ' ' HB2' ' A' ' 81' ' ' ASP . 10.2 t-160 -115.89 8.49 14.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.845 0.355 . . . . 2.1800000000000002 110.365 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.418 ' HB3' HG22 ' B' ' 14' ' ' THR . 14.7 mt-10 -71.04 148.92 47.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 1.28 110.132 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -77.73 107.24 10.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.48 -0.327 . . . . 1.52 111.013 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.457 ' HA ' ' OG1' ' B' ' 14' ' ' THR . 91.2 mt-30 -83.31 164.97 19.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.012 -0.54 . . . . 1.8600000000000001 111.675 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.72 -169.75 28.84 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.01 -0.615 . . . . 0.90000000000000002 113.625 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' B' ' 10' ' ' SER . 35.8 m -108.24 119.99 41.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.654 -0.498 . . . . 0.94999999999999996 109.654 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.446 ' HD3' HD12 ' B' ' 11' ' ' LEU . 0.1 OUTLIER -146.63 154.34 48.13 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.192 -0.458 . . . . 1.5900000000000001 110.487 -179.317 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -63.28 135.91 52.8 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.46 2.107 . . . . 0.65000000000000002 110.72 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.758 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 14.2 m -132.85 151.56 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.174 0.512 . . . . 0.56999999999999995 111.425 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 mp -109.42 122.35 47.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.682 -0.69 . . . . 1.1699999999999999 109.918 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ILE . . . . . 0.507 ' O ' ' HG2' ' B' ' 1' ' ' MET . 43.8 mt -70.08 120.23 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.697 0.284 . . . . 0.66000000000000003 110.827 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.734 ' HB ' HG23 ' B' ' 41' ' ' VAL . 18.4 t -79.33 -40.93 22.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.051 -0.522 . . . . 0.93000000000000005 111.519 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.9 146.19 95.07 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.973 -0.558 . . . . 0.81000000000000005 111.455 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.79 164.16 34.17 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.752 2.302 . . . . 0.78000000000000003 112.591 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.46 -40.57 71.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.496 -0.775 . . . . 1.03 111.807 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.01 0.84 4.02 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.702 0.63 . . . . 1.3999999999999999 112.702 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -119.31 -40.9 2.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.208 0.528 . . . . 1.5700000000000001 109.736 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.17 -32.97 70.38 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.517 -0.765 . . . . 1.6399999999999999 111.863 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.52 2.84 55.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.132 -0.485 . . . . 2.54 112.261 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 64.2 t -113.27 -46.13 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.924 0.392 . . . . 1.0900000000000001 110.421 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 10.3 m -87.09 -24.26 24.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.349 0.595 . . . . 1.3300000000000001 110.1 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.861 ' HE ' ' HA ' ' B' ' 38' ' ' ARG . 0.6 OUTLIER 75.16 -38.1 0.36 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.848 1.055 . . . . 1.78 113.848 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 89.7 mt -99.59 101.84 14.75 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.978 -0.379 . . . . 1.1599999999999999 109.978 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' B' ' 38' ' ' ARG . 90.1 Cg_endo -94.12 163.69 2.08 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.907 2.404 . . . . 0.56999999999999995 113.889 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.734 HG23 ' HB ' ' B' ' 28' ' ' VAL . 1.8 m -96.13 138.35 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.782 -0.821 . . . . 1.0800000000000001 108.782 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.758 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 17.8 m -126.09 150.12 31.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 113.205 0.817 . . . . 0.64000000000000001 113.205 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.441 HG23 HG22 ' B' ' 28' ' ' VAL . 24.4 t -97.62 111.74 59.51 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.022 -0.99 . . . . 1.1000000000000001 108.835 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.658 ' HA ' HG12 ' B' ' 25' ' ' VAL . 11.8 Cg_exo -70.93 127.83 14.17 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.9 2.4 . . . . 0.72999999999999998 112.722 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.652 HG22 HG12 ' B' ' 72' ' ' VAL . 61.8 t -99.98 133.45 42.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.055 -0.521 . . . . 0.90000000000000002 109.887 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -98.17 92.1 5.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.34 -0.391 . . . . 1.1699999999999999 110.489 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 116.011 -0.541 . . . . 1.8500000000000001 110.602 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.891 0.377 . . . . 1.96 110.411 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.64 -88.3 0.36 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.124 -0.56 . . . . 1.0800000000000001 112.732 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -104.95 -17.06 14.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.969 0.414 . . . . 3.5699999999999998 110.045 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.594 ' HB1' ' HB ' ' B' ' 71' ' ' VAL . . . -82.64 120.0 25.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.862 -0.608 . . . . 1.0800000000000001 111.566 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 t -119.8 134.55 62.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.069 -0.715 . . . . 1.3400000000000001 109.069 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 37.5 p -76.26 135.79 39.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.667 0.27 . . . . 1.3799999999999999 111.234 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 77.9 mt -89.72 -0.96 57.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.157 0.503 . . . . 1.02 110.626 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.65 148.2 28.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.958 -0.565 . . . . 1.79 111.152 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.4 -38.1 3.47 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.913 -0.66 . . . . 1.1499999999999999 112.336 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 10.8 p -81.36 -26.28 10.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.749 0.278 . . . . 1.1699999999999999 111.749 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.05 22.93 3.4 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.435 -0.888 . . . . 1.05 113.362 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 61.4 mt -90.61 138.51 19.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.541 -0.54 . . . . 1.6100000000000001 109.541 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' ARG . . . . . 0.402 ' HD2' HH11 ' B' ' 67' ' ' ARG . 28.0 ttt85 -68.31 -42.48 79.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.004 0.43 . . . . 2.3999999999999999 110.704 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 16.5 m -68.12 97.47 0.7 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.536 -0.756 . . . . 0.93000000000000005 110.957 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.6 97.61 10.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.923 -0.581 . . . . 1.3100000000000001 111.432 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.65 -179.75 46.35 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.739 -0.744 . . . . 0.79000000000000004 111.702 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.594 ' HB ' ' HB1' ' B' ' 58' ' ' ALA . 8.5 m -105.81 136.49 39.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.705 0.288 . . . . 0.93000000000000005 110.8 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.652 HG12 HG22 ' B' ' 45' ' ' VAL . 10.0 m -84.27 137.28 21.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.961 0.41 . . . . 1.3799999999999999 111.478 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 32.9 mmm-85 -113.32 85.97 2.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.191 -0.459 . . . . 1.3700000000000001 110.114 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 5.2 m -82.12 6.3 16.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.184 -0.462 . . . . 1.1599999999999999 111.266 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.729 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 10.1 p-10 -87.43 -10.47 51.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.863 -0.608 . . . . 1.1000000000000001 111.56 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -135.29 78.34 52.13 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 112.896 0.702 . . . . 2.4700000000000002 112.896 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.89 98.99 0.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.737 2.291 . . . . 0.95999999999999996 111.729 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 12.2 ttt180 -102.64 140.68 36.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.381 -0.372 . . . . 1.96 111.497 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.511 HG23 HG13 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -76.03 125.74 29.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 1.1899999999999999 109.67 178.259 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.416 ' O ' ' HD2' ' B' ' 40' ' ' PRO . 26.8 pt -131.32 -179.7 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.454 -0.339 . . . . 1.28 110.189 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.401 ' O ' ' HD2' ' B' ' 85' ' ' ARG . 7.0 t70 -97.52 139.86 32.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.368 . . . . 1.28 110.867 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' MET . . . . . 0.429 ' SD ' ' HA3' ' B' ' 87' ' ' GLY . 35.6 tpp -126.03 29.74 5.81 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.395 -0.594 . . . . 2.7000000000000002 109.395 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -121.14 -55.93 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.703 -0.68 . . . . 1.96 111.352 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.53 -33.96 15.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.133 -0.485 . . . . 1.0600000000000001 110.653 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.401 ' HD2' ' O ' ' B' ' 81' ' ' ASP . 75.3 mtt180 -63.94 -23.05 67.19 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.863 -0.608 . . . . 1.47 111.428 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.0 90.38 0.83 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.94 -0.648 . . . . 0.81999999999999995 112.623 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' GLY . . . . . 0.429 ' HA3' ' SD ' ' B' ' 82' ' ' MET . . . -96.89 133.13 11.27 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.532 -0.842 . . . . 0.65000000000000002 112.253 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -139.04 130.29 26.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.6 0.238 . . . . 1.8100000000000001 110.818 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -83.08 127.93 34.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.471 -0.332 . . . . 2.4900000000000002 110.268 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' B' ' 8' ' ' LEU . 94.3 mt -91.14 -72.62 0.57 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.188 -0.46 . . . . 0.76000000000000001 111.557 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' GLU . . . . . 0.53 ' HG3' HD12 ' B' ' 6' ' ' ILE . 16.8 pt-20 -133.42 169.93 16.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.094 -0.503 . . . . 1.0700000000000001 110.722 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' B' ' 4' ' ' GLY . 15.2 ttm180 -104.48 141.62 36.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.183 -0.462 . . . . 2.0499999999999998 110.193 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' B' ' 94' ' ' PRO . 60.3 t -83.1 132.38 50.76 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.906 -0.588 . . . . 1.45 110.68 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' B' ' 93' ' ' VAL . 31.6 Cg_exo -62.64 155.74 57.06 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.601 2.2 . . . . 1.03 110.758 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.28 -38.92 74.69 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.321 0.489 . . . . 2.1400000000000001 112.321 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.95 -39.21 88.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.974 0.416 . . . . 1.78 111.12 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 30.0 mm -82.47 -32.02 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.158 -0.474 . . . . 1.3300000000000001 110.434 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 12.7 tpt -58.66 -45.04 90.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 2.3399999999999999 110.239 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -64.57 -35.07 79.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.998 -0.546 . . . . 1.9099999999999999 110.302 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 11.1 tp10 -60.06 -44.47 94.69 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.771 -0.649 . . . . 1.76 109.959 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' B' ' 105' ' ' LEU . 55.9 t -60.99 -44.85 99.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.039 -0.528 . . . . 1.01 110.197 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.44 -42.0 90.92 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.048 -0.524 . . . . 1.29 110.559 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.79 -42.8 98.41 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.433 -0.667 . . . . 1.02 111.433 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 12.3 mmt180 -63.97 -32.74 74.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.038 0.447 . . . . 1.8500000000000001 110.793 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' B' ' 101' ' ' VAL . 93.8 mt -68.91 -20.91 64.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.021 -0.536 . . . . 1.9399999999999999 110.815 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 5.7 m -86.06 -24.73 26.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.159 -0.473 . . . . 1.1599999999999999 109.944 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.1 m -68.29 -37.41 80.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 1.45 111.214 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.44 HG21 ' HA ' ' B' ' 75' ' ' ASP . 39.2 pt -76.43 0.23 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.333 -0.394 . . . . 1.98 112.036 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 96.3 mt -91.26 10.26 27.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.922 0.391 . . . . 1.3600000000000001 110.967 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.792 -0.623 . . . . 2.1299999999999999 110.219 179.903 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.565 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 23.4 ptp . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 120.814 0.34 . . . . 1.29 110.883 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.404 ' HG2' ' HB2' ' A' ' 31' ' ' ALA . 39.6 mt-10 -124.96 169.72 11.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.106 -0.497 . . . . 2.0099999999999998 110.612 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.496 ' NH2' ' HD3' ' A' ' 30' ' ' PRO . 24.2 ttm180 -71.52 128.01 34.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.909 -0.587 . . . . 1.8500000000000001 109.671 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.409 ' HA3' ' NH2' ' A' ' 92' ' ' ARG . . . 104.11 -6.04 46.51 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.622 -0.799 . . . . 0.85999999999999999 112.492 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 57.5 mt-10 -79.92 147.68 31.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.877 0.37 . . . . 0.98999999999999999 110.782 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.469 HD12 ' HG3' ' A' ' 91' ' ' GLU . 59.5 mt -109.88 119.91 59.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.178 -0.465 . . . . 1.1599999999999999 109.86 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.415 ' CZ2' ' HB3' ' A' ' 1' ' ' MET . 21.2 m95 -114.93 149.9 36.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.012 -0.54 . . . . 0.91000000000000003 110.782 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.0 tp -106.01 118.39 36.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.776 -0.193 . . . . 0.90000000000000002 110.491 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 p -166.14 148.95 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 120.948 0.404 . . . . 1.04 110.814 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.7 OUTLIER -77.17 141.66 40.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.356 -0.384 . . . . 1.3200000000000001 110.607 179.541 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.484 HD21 HG11 ' A' ' 25' ' ' VAL . 69.2 mt -97.58 4.11 50.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.157 0.503 . . . . 1.29 111.252 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.845 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -72.08 179.9 0.92 Allowed Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.642 -0.708 . . . . 1.54 110.302 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.845 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 5.8 Cg_exo -79.65 134.89 32.76 Favored 'Cis proline' 0 C--N 1.354 0.822 0 CA-C-N 119.736 0.942 . . . . 1.6899999999999999 112.62 0.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 20' ' ' GLN . 58.2 p -108.14 155.41 20.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.663 -0.699 . . . . 1.3600000000000001 111.144 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.2 102.56 5.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.138 -0.69 . . . . 1.7 109.138 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.37 -116.21 3.87 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.505 -1.438 . . . . 1.1799999999999999 109.505 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.46 ' HB3' ' HD2' ' B' ' 83' ' ' LYS . 77.0 t60 -134.06 78.55 1.77 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.065 0.459 . . . . 2.7799999999999998 111.75 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 33.6 mt-10 -110.59 -149.32 0.44 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.791 -0.818 . . . . 1.1399999999999999 108.791 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -82.58 53.77 2.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.312 0.577 . . . . 2.0899999999999999 110.007 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.474 ' HG2' ' H ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -68.31 128.77 37.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.294 -0.866 . . . . 2.0899999999999999 112.006 -179.046 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.99 146.84 9.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.83 -0.7 . . . . 1.0700000000000001 113.445 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 21.2 m -79.31 121.1 24.68 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.715 -0.476 . . . . 1.1100000000000001 109.715 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -145.48 161.51 40.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.437 -0.347 . . . . 1.6200000000000001 110.354 -179.224 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.32 145.75 60.67 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.104 1.87 . . . . 1.01 110.289 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.729 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 15.1 m -128.75 140.12 50.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.42 -0.354 . . . . 0.76000000000000001 110.55 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.487 ' HB3' HG23 ' A' ' 43' ' ' VAL . 42.1 tp -95.04 128.64 42.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.034 -0.53 . . . . 0.69999999999999996 110.822 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.13 109.34 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.801 -0.444 . . . . 0.92000000000000004 109.801 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.59 HG11 HD11 ' A' ' 105' ' ' LEU . 17.1 t -86.95 -27.91 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 120.997 0.427 . . . . 0.94999999999999996 111.413 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.85 145.41 74.28 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.294 -0.412 . . . . 1.1200000000000001 111.411 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.496 ' HD3' ' NH2' ' A' ' 3' ' ' ARG . 58.2 Cg_endo -71.69 158.91 52.34 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.646 2.231 . . . . 1.3 112.173 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.404 ' HB2' ' HG2' ' A' ' 2' ' ' GLU . . . -53.25 -40.04 64.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.993 -0.549 . . . . 1.3899999999999999 112.206 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.31 -50.18 74.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.331 -0.395 . . . . 1.6100000000000001 111.767 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -63.93 -38.41 90.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.115 0.483 . . . . 1.77 110.885 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 85.2 m-20 -67.53 -20.84 65.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.732 -0.667 . . . . 1.48 111.051 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -91.33 -35.03 14.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.197 -0.456 . . . . 2.6200000000000001 112.003 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.57 -50.3 15.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.693 0.627 . . . . 1.8600000000000001 112.693 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 m -87.38 -31.61 20.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.855 0.359 . . . . 1.72 110.95 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.718 ' HB3' ' HE2' ' A' ' 83' ' ' LYS . 0.7 OUTLIER 66.46 23.38 10.54 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.795 -0.639 . . . . 4.4500000000000002 111.543 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.7 mt -132.35 100.43 15.31 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.442 -0.799 . . . . 1.8100000000000001 109.053 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -89.69 140.45 3.58 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.629 2.219 . . . . 1.05 114.163 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.1 t -90.36 124.37 42.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.221 -1.4 . . . . 1.03 107.221 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.729 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 31.4 m -123.43 163.97 21.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 113.542 0.942 . . . . 0.77000000000000002 113.542 -177.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -122.93 134.56 25.13 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 114.307 -1.315 . . . . 0.71999999999999997 108.686 178.45 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.11 128.86 10.91 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.927 2.418 . . . . 1.03 114.674 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.786 HG22 HG22 ' A' ' 72' ' ' VAL . 58.0 t -88.6 118.44 34.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.021 -0.733 . . . . 1.28 109.021 178.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.454 ' HB ' ' NH1' ' A' ' 73' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.478 0 N-CA-C 110.163 -0.31 . . . . 1.9099999999999999 110.163 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 CA-C-O 120.706 0.059 . . . . 1.6599999999999999 113.048 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.504 ' HE2' ' HB ' ' A' ' 107' ' ' THR . 57.8 m-85 -106.34 17.07 23.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.906 0.384 . . . . 1.5600000000000001 111.778 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . . . -81.68 137.39 35.42 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.226 -0.657 . . . . 1.25 109.226 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.609 HG22 ' HB ' ' A' ' 72' ' ' VAL . 16.5 m -88.44 161.16 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.047 0.451 . . . . 1.6799999999999999 111.731 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -84.67 93.5 8.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.988 -0.551 . . . . 1.95 111.641 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.841 HD11 HG23 ' A' ' 72' ' ' VAL . 7.2 mt -87.11 -33.79 19.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.341 -0.39 . . . . 1.23 111.923 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -68.71 114.79 7.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.023 0.439 . . . . 2.21 111.788 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.47 -10.78 5.53 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.652 -0.785 . . . . 1.1499999999999999 113.004 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 61' ' ' LEU . 19.6 m -90.61 -16.11 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 117.224 0.512 . . . . 1.21 111.49 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.88 51.77 7.56 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 121.066 -0.588 . . . . 1.0800000000000001 113.461 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.504 ' HB ' ' OE2' ' A' ' 91' ' ' GLU . 20.1 pt -103.72 -171.73 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.718 0.294 . . . . 1.0700000000000001 111.155 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 54.7 ttm-85 -102.23 -33.65 9.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.103 -0.499 . . . . 3.5899999999999999 110.28 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.487 ' HB ' HD12 ' A' ' 66' ' ' ILE . 21.8 m -55.85 117.55 3.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.412 -0.813 . . . . 1.51 111.132 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.19 109.6 21.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.973 -0.558 . . . . 1.79 110.558 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.72 -165.43 28.41 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.629 -0.795 . . . . 1.1799999999999999 112.115 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 81.6 t -132.69 129.63 58.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.797 0.332 . . . . 1.5600000000000001 110.742 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.841 HG23 HD11 ' A' ' 61' ' ' LEU . 69.9 t -72.18 110.96 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.874 -0.788 . . . . 1.29 108.874 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.597 ' HB3' ' OD2' ' A' ' 75' ' ' ASP . 12.1 mtm-85 -99.68 121.57 41.43 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.326 -0.397 . . . . 2.23 110.516 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 14.4 m -98.57 34.7 1.97 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.274 -0.421 . . . . 1.1699999999999999 110.784 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.597 ' OD2' ' HB3' ' A' ' 73' ' ' ARG . 0.5 OUTLIER -76.53 -60.96 2.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.232 -0.44 . . . . 0.89000000000000001 110.868 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.849 ' HB3' HG21 ' B' ' 79' ' ' THR . 4.3 mm100 -115.51 80.63 8.12 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.291 -0.413 . . . . 2.1299999999999999 111.4 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -84.3 156.16 12.69 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.639 2.226 . . . . 0.80000000000000004 111.118 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -168.32 166.4 12.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.056 0.455 . . . . 2.0899999999999999 111.265 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.461 ' OG1' ' HD2' ' B' ' 77' ' ' PRO . 24.2 m -92.53 145.49 24.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.625 -0.716 . . . . 1.6200000000000001 109.174 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.479 HG21 HD22 ' A' ' 11' ' ' LEU . 26.6 pt -135.3 150.79 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.684 0.278 . . . . 1.1499999999999999 110.529 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.94 142.7 47.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.043 -0.526 . . . . 1.03 110.051 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 35.4 tpp -121.55 5.61 10.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.186 0.517 . . . . 1.29 110.78 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.718 ' HE2' ' HB3' ' A' ' 38' ' ' ARG . 6.0 mptp? -93.43 -46.54 7.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.2 -0.454 . . . . 2.6400000000000001 111.043 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.704 ' HB3' ' HA2' ' B' ' 16' ' ' GLY . . . -93.02 -40.6 10.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.389 -0.369 . . . . 1.1200000000000001 110.47 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -62.31 -57.6 10.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.389 -0.368 . . . . 1.0600000000000001 110.304 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.24 84.94 0.19 Allowed Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.909 -0.662 . . . . 1.1200000000000001 113.505 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.34 172.56 47.22 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.704 -0.76 . . . . 1.0900000000000001 111.867 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -122.29 122.45 39.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.064 -0.346 . . . . 2.46 110.064 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -77.88 137.39 38.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.631 0.253 . . . . 2.4900000000000002 110.937 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 90' ' ' LEU . 2.6 mm? -112.64 -81.05 0.59 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.227 -0.442 . . . . 1.29 110.291 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.504 ' OE2' ' HB ' ' A' ' 66' ' ' ILE . 18.2 pt-20 -131.05 -163.71 1.35 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.221 -0.445 . . . . 1.1499999999999999 110.738 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.409 ' NH2' ' HA3' ' A' ' 4' ' ' GLY . 4.0 ptm180 -147.63 155.19 41.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.564 0.221 . . . . 1.3200000000000001 110.56 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.464 HG13 HD11 ' A' ' 6' ' ' ILE . 26.6 m -103.58 156.36 35.64 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.289 -0.414 . . . . 0.75 111.399 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -69.28 166.88 25.48 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.762 2.308 . . . . 0.94999999999999996 111.73 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -58.82 -24.11 61.47 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.437 -0.347 . . . . 1.51 111.769 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -40.74 87.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.285 -0.416 . . . . 1.5700000000000001 110.825 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.5 mm -71.04 -37.78 69.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 1.3100000000000001 110.186 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.7 tpt -62.0 -37.21 83.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 1.6000000000000001 110.472 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -64.16 -35.59 81.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.071 0.462 . . . . 2.2999999999999998 110.085 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 0.1 OUTLIER -64.59 -44.99 88.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.763 -0.653 . . . . 1.6399999999999999 109.62 178.79 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.5 t -64.23 -41.26 91.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.714 -0.675 . . . . 1.03 110.597 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.9 mt -55.56 -43.01 75.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.107 -0.497 . . . . 1.22 110.742 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.6 -41.95 98.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.909 -0.662 . . . . 1.03 111.897 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 19.5 mmt180 -62.05 -45.89 91.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.761 0.315 . . . . 1.72 110.529 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.59 HD11 HG11 ' A' ' 28' ' ' VAL . 93.9 mt -62.65 -40.65 97.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.037 -0.529 . . . . 1.02 111.104 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.1 m -70.78 -3.06 16.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 1.1100000000000001 111.596 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.504 ' HB ' ' HE2' ' A' ' 57' ' ' PHE . 24.7 m -105.11 -34.11 8.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.789 0.328 . . . . 1.5 110.806 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.412 ' O ' ' HD3' ' B' ' 30' ' ' PRO . 41.2 pt -79.97 -23.31 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 111.996 0.369 . . . . 1.1499999999999999 111.996 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.0 mt -76.21 81.84 3.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.97999999999999998 111.023 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.755 -0.657 . . . . 1.3500000000000001 109.835 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.609 ' HE3' ' HB ' ' B' ' 27' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.133 0 CA-C-O 121.616 0.722 . . . . 2.0299999999999998 112.736 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 2' ' ' GLU . . . . . 0.551 ' HG2' ' HB2' ' B' ' 31' ' ' ALA . 37.3 mt-10 -86.59 -19.57 29.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.259 -0.882 . . . . 2.8199999999999998 109.315 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' B' ' 2' ' ' GLU . 8.3 mpt_? 77.82 115.18 0.06 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.913 -1.039 . . . . 2.3199999999999998 112.759 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.23 49.48 4.95 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.879 -0.6 . . . . 1.28 114.128 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.465 ' HB2' ' HE3' ' B' ' 1' ' ' MET . 73.9 mm-40 -126.58 88.33 2.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.58 0.585 . . . . 1.53 112.58 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.849 HD11 ' HB ' ' B' ' 93' ' ' VAL . 60.8 mt -102.21 107.45 21.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.88 -0.785 . . . . 0.75 108.88 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -108.03 160.36 15.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.91 -0.587 . . . . 0.81000000000000005 111.198 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 42.0 tp -111.84 121.47 45.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.914 -0.772 . . . . 1.05 108.914 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.567 HG11 HD13 ' B' ' 80' ' ' ILE . 5.2 p -152.17 157.32 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 120.787 0.327 . . . . 0.71999999999999997 110.536 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 47.6 m -83.13 119.25 24.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.246 -0.433 . . . . 1.6299999999999999 110.083 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.466 HD21 HG11 ' B' ' 25' ' ' VAL . 88.8 mt -72.42 -26.31 61.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.161 -0.472 . . . . 0.82999999999999996 111.071 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.26 149.78 86.34 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.88 -0.6 . . . . 1.6200000000000001 110.497 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.07 140.78 30.95 Favored 'Cis proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.58 -1.425 . . . . 1.28 112.561 0.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.72 129.4 36.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.981 -0.554 . . . . 1.47 109.655 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.88 173.6 6.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.367 -0.379 . . . . 1.22 111.497 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 84' ' ' ALA . . . 70.41 -134.27 24.42 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.643 -0.708 . . . . 1.01 113.271 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -114.28 29.21 8.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.974 0.416 . . . . 2.1800000000000002 110.305 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -83.02 168.53 16.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.752 -0.658 . . . . 1.28 110.664 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -74.15 133.26 42.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.22 0.533 . . . . 1.52 111.962 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -125.02 -178.28 4.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.762 -0.654 . . . . 1.8600000000000001 110.809 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.71 166.92 42.75 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.235 -0.507 . . . . 0.90000000000000002 113.583 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.9 m -96.52 110.15 22.6 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.996 -0.742 . . . . 0.94999999999999996 108.996 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.85 162.97 27.7 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.466 -0.334 . . . . 1.5900000000000001 110.246 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.87 141.57 98.18 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.447 2.098 . . . . 0.65000000000000002 111.209 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.762 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 9.7 m -135.11 139.76 46.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.103 -0.498 . . . . 0.56999999999999995 110.654 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 61.3 tp -99.98 121.98 42.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.127 -0.488 . . . . 1.1699999999999999 109.837 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ILE . . . . . 0.609 ' HB ' ' HE3' ' B' ' 1' ' ' MET . 16.7 mt -72.26 145.5 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.425 -0.352 . . . . 0.66000000000000003 110.073 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.513 ' HB ' HG23 ' B' ' 41' ' ' VAL . 19.2 t -112.36 -27.72 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 120.8 0.333 . . . . 0.93000000000000005 111.525 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' THR . . . . . 0.527 HG23 HG22 ' B' ' 41' ' ' VAL . 0.2 OUTLIER -69.77 148.16 96.48 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.503 -0.317 . . . . 0.81000000000000005 111.84 -179.24 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 91.6 Cg_endo -77.62 176.17 10.37 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.962 2.441 . . . . 0.78000000000000003 113.54 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.551 ' HB2' ' HG2' ' B' ' 2' ' ' GLU . . . -66.93 -31.3 71.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.476 -0.784 . . . . 1.03 110.736 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.24 18.37 0.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.944 -0.571 . . . . 1.3999999999999999 110.946 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -137.16 -53.62 0.69 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.033 -0.53 . . . . 1.5700000000000001 110.023 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -57.12 -39.61 75.47 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.99 -0.55 . . . . 1.6399999999999999 111.953 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -92.67 8.27 39.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.23 -0.441 . . . . 2.54 111.59 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 62.7 t -116.01 -64.04 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.284 -0.416 . . . . 1.0900000000000001 111.157 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 37.1 p -78.52 -16.23 57.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.335 0.588 . . . . 1.3300000000000001 110.493 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.661 ' HB2' ' NZ ' ' B' ' 83' ' ' LYS . 0.1 OUTLIER 60.62 29.77 19.25 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.365 -0.834 . . . . 1.78 110.684 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 30.5 mt -143.24 102.74 5.14 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.35 -0.841 . . . . 1.1599999999999999 109.282 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' B' ' 80' ' ' ILE . 96.9 Cg_endo -97.18 149.35 0.94 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.778 2.319 . . . . 0.56999999999999995 113.571 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.527 HG22 HG23 ' B' ' 29' ' ' THR . 16.2 m -97.44 133.68 38.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.58 -1.267 . . . . 1.0800000000000001 107.58 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.762 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 24.9 m -127.18 153.78 36.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 113.981 1.104 . . . . 0.64000000000000001 113.981 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 54.4 t -103.61 119.36 55.0 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 114.43 -1.259 . . . . 1.1000000000000001 108.216 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.556 ' HA ' HG12 ' B' ' 25' ' ' VAL . 46.3 Cg_endo -68.51 126.23 13.88 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.889 2.393 . . . . 0.72999999999999998 113.217 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.763 HG22 HG12 ' B' ' 72' ' ' VAL . 87.8 t -88.89 135.98 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.826 -0.625 . . . . 0.90000000000000002 109.353 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -114.21 96.62 5.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.502 -0.317 . . . . 1.1699999999999999 110.378 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.026 -0.534 . . . . 1.8500000000000001 110.827 179.578 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.747 0.308 . . . . 1.96 110.469 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.78 -98.43 0.29 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.118 -0.563 . . . . 1.0800000000000001 113.099 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -86.55 -16.21 37.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.825 0.345 . . . . 3.5699999999999998 111.398 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.51 131.45 34.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.311 -0.404 . . . . 1.0800000000000001 110.523 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -113.17 144.24 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 1.3400000000000001 110.143 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -80.62 113.19 18.63 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.06 0.393 . . . . 1.3799999999999999 112.06 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 97.9 mt -88.55 -7.17 56.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.654 0.74 . . . . 1.02 109.016 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -98.07 141.24 31.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.143 -0.935 . . . . 1.79 109.767 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.91 -58.06 0.7 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.723 -0.751 . . . . 1.1499999999999999 112.125 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 p -75.7 -26.85 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.076 0.465 . . . . 1.1699999999999999 111.294 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.93 57.83 0.42 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.473 -0.87 . . . . 1.05 113.287 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 84.9 mt -104.09 143.2 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.919 -0.771 . . . . 1.6100000000000001 108.919 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -65.23 -53.43 44.5 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.81 0.338 . . . . 2.3999999999999999 110.495 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 8.8 m -71.13 101.27 2.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.18 0.514 . . . . 0.93000000000000005 110.033 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -91.85 108.8 20.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.082 -0.508 . . . . 1.3100000000000001 110.997 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.55 -160.22 25.98 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.004 -0.617 . . . . 0.79000000000000004 111.997 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 10.7 m -125.87 139.44 51.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.791 0.329 . . . . 0.93000000000000005 110.877 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.763 HG12 HG22 ' B' ' 45' ' ' VAL . 15.8 m -88.57 143.12 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.364 -0.38 . . . . 1.3799999999999999 110.887 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.536 ' HB2' ' HG2' ' B' ' 44' ' ' PRO . 35.5 mmm-85 -97.86 84.87 3.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.149 0.499 . . . . 1.3700000000000001 110.614 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.2 m -73.96 -5.87 43.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 1.1599999999999999 111.296 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -88.7 -16.15 33.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.058 -0.519 . . . . 1.1000000000000001 111.409 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' GLN . . . . . 0.437 ' N ' ' HD3' ' B' ' 77' ' ' PRO . 70.1 mt-30 -130.82 60.49 53.38 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 113.04 0.756 . . . . 2.4700000000000002 113.04 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.461 ' HD2' ' OG1' ' A' ' 79' ' ' THR . 6.9 Cg_exo -75.93 141.08 23.67 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.085 1.857 . . . . 0.95999999999999996 110.223 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -132.61 143.61 49.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.862 0.363 . . . . 1.96 111.34 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.849 HG21 ' HB3' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -78.39 135.06 37.36 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.389 -0.967 . . . . 1.1899999999999999 108.389 177.803 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.567 HD13 HG11 ' B' ' 9' ' ' VAL . 9.3 pt -118.99 154.21 21.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.93 0.395 . . . . 1.28 110.948 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' B' ' 85' ' ' ARG . 5.5 t70 -86.03 139.89 30.77 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.853 -0.612 . . . . 1.28 109.42 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 2.6 ttp -130.9 26.73 4.94 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.603 0.716 . . . . 2.7000000000000002 109.505 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.661 ' NZ ' ' HB2' ' B' ' 38' ' ' ARG . 37.9 mttm -109.86 -44.05 3.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.033 -0.985 . . . . 1.96 109.399 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.38 -28.42 8.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.421 -0.809 . . . . 1.0600000000000001 110.074 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' B' ' 81' ' ' ASP . 45.3 mtt180 -80.97 151.94 28.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.963 -0.562 . . . . 1.47 110.384 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.92 131.88 10.82 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.215 -0.754 . . . . 0.81999999999999995 111.215 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.25 148.25 18.5 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.954 -0.641 . . . . 0.65000000000000002 111.679 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -139.89 137.69 35.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.489 0.185 . . . . 1.8100000000000001 110.904 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -78.55 131.2 36.69 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.235 -0.284 . . . . 2.4900000000000002 110.235 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 82.4 mt -98.33 -58.06 2.06 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.434 0.531 . . . . 0.76000000000000001 112.434 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' GLU . . . . . 0.53 ' O ' ' HB ' ' B' ' 6' ' ' ILE . 16.0 pt-20 -149.07 158.22 44.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.412 -0.358 . . . . 1.0700000000000001 110.278 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -101.02 112.07 24.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.772 0.32 . . . . 2.0499999999999998 110.155 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.849 ' HB ' HD11 ' B' ' 6' ' ' ILE . 7.3 p -66.28 133.77 94.58 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.776 -0.647 . . . . 1.45 110.854 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.69 146.4 77.0 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.673 2.249 . . . . 1.03 111.11 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -55.06 -32.66 62.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 2.1400000000000001 111.891 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -48.39 78.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.93 -0.577 . . . . 1.78 110.953 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 40.4 mm -80.29 -34.48 14.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 1.3300000000000001 110.593 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 6.9 tpt -56.58 -47.39 79.65 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.007 -0.542 . . . . 2.3399999999999999 110.854 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -67.06 -33.71 76.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 1.9099999999999999 110.914 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.598 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 0.1 OUTLIER -60.42 -46.06 91.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 1.76 110.872 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 50.2 t -59.33 -44.09 91.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.946 0.403 . . . . 1.01 110.495 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -62.9 -36.37 83.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 1.29 110.264 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.63 -34.13 86.58 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.802 -0.635 . . . . 1.02 111.852 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 104' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 19.6 mmt85 -70.74 -28.74 64.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.035 0.445 . . . . 1.8500000000000001 110.661 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 36.5 mt -76.93 -18.54 58.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 1.9399999999999999 110.774 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 24.6 m -76.94 -6.92 54.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.212 -0.449 . . . . 1.1599999999999999 111.694 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 3.7 m -66.73 -25.04 66.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 1.45 111.366 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 46.7 pt -92.07 7.21 5.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.829 0.347 . . . . 1.98 111.675 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 59.2 mt -87.0 13.33 9.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.155 0.502 . . . . 1.3600000000000001 111.246 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.654 -0.703 . . . . 2.1299999999999999 109.436 179.806 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.469 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 23.7 ptp . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 120.658 0.266 . . . . 1.29 110.988 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -123.26 168.04 12.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.288 -0.415 . . . . 2.0099999999999998 110.442 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.49 ' NH2' ' HD3' ' A' ' 30' ' ' PRO . 36.3 ttm180 -67.64 124.67 23.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.986 -0.552 . . . . 1.8500000000000001 110.692 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.459 ' HA3' ' NH2' ' A' ' 92' ' ' ARG . . . 108.58 -2.86 32.4 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.822 -0.704 . . . . 0.85999999999999999 113.31 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.469 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 65.8 mt-10 -93.79 152.25 19.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.472 -0.428 . . . . 0.98999999999999999 110.979 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.709 HD11 ' HG2' ' A' ' 91' ' ' GLU . 21.5 pt -115.87 117.11 54.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.147 0.499 . . . . 1.1599999999999999 110.345 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.484 ' CE2' ' HB2' ' A' ' 89' ' ' ARG . 25.8 m95 -108.43 125.41 51.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.658 -0.701 . . . . 0.91000000000000003 111.097 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 14.3 tp -74.52 117.78 16.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.19 -0.459 . . . . 0.90000000000000002 110.633 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 p -162.24 153.9 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.413 -0.358 . . . . 1.04 110.122 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.0 t -84.01 140.14 32.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.961 0.41 . . . . 1.3200000000000001 110.509 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.542 HD23 HD13 ' A' ' 80' ' ' ILE . 1.3 mt -100.15 13.25 34.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.018 -0.537 . . . . 1.29 111.103 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.565 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -85.12 171.47 10.79 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.618 -0.719 . . . . 1.54 110.325 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.565 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 12.4 Cg_exo -71.82 133.2 27.77 Favored 'Cis proline' 0 C--N 1.352 0.743 0 C-N-CA 124.419 -1.075 . . . . 1.6899999999999999 112.198 -0.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 18' ' ' GLU . 21.7 p -102.25 138.52 39.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.705 -0.679 . . . . 1.3600000000000001 111.295 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -106.93 140.46 39.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.437 -0.579 . . . . 1.7 109.437 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.35 -113.27 5.23 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.645 -0.788 . . . . 1.1799999999999999 111.472 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -130.54 46.32 2.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.808 0.337 . . . . 2.7799999999999998 111.283 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 32.1 mt-10 -65.84 -174.86 0.25 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.971 -0.559 . . . . 1.1399999999999999 110.437 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.584 ' HG2' ' HG2' ' A' ' 44' ' ' PRO . 5.4 tp-100 -78.51 69.2 4.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.333 0.587 . . . . 2.0899999999999999 110.234 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.585 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 1.1 pt20 -76.13 144.61 40.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.402 -0.817 . . . . 2.0899999999999999 111.241 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.92 143.03 5.73 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.64 -0.791 . . . . 1.0700000000000001 112.843 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 10.0 m -92.9 107.17 19.01 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.263 -0.643 . . . . 1.1100000000000001 109.263 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -147.31 163.39 28.34 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.429 -0.35 . . . . 1.6200000000000001 110.582 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 16.6 Cg_exo -69.02 119.47 6.45 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.498 2.132 . . . . 1.01 111.393 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 14.2 m -97.26 142.46 14.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.126 -0.488 . . . . 0.76000000000000001 110.38 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.651 ' HB3' HG23 ' A' ' 43' ' ' VAL . 36.6 tp -83.86 121.9 27.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.44 -0.346 . . . . 0.69999999999999996 111.282 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.659 ' HA ' HG12 ' A' ' 42' ' ' VAL . 17.8 mm -71.84 112.67 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.92000000000000004 109.713 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.38 -37.51 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.346 -0.388 . . . . 0.94999999999999996 111.889 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.86 150.55 75.49 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 112.387 0.514 . . . . 1.1200000000000001 112.387 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.49 ' HD3' ' NH2' ' A' ' 3' ' ' ARG . 56.3 Cg_endo -70.1 155.91 63.7 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.766 2.311 . . . . 1.3 112.323 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.92 -38.0 64.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.843 -0.617 . . . . 1.3899999999999999 112.05 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.38 -41.4 89.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.027 0.441 . . . . 1.6100000000000001 111.227 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.639 ' HZ ' ' HB2' ' B' ' 75' ' ' ASP . 80.5 t80 -73.22 -41.95 63.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.091 -0.504 . . . . 1.77 110.777 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 60.7 m-20 -62.81 -21.13 65.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.898 -0.592 . . . . 1.48 111.345 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.404 ' HD3' HH11 ' A' ' 35' ' ' ARG . 2.7 ttp180 -93.37 -25.52 17.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 2.6200000000000001 111.93 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 33' ' ' PHE . 14.0 p -82.78 -49.24 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 112.93 0.715 . . . . 1.8600000000000001 112.93 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.5 p -94.9 -23.86 17.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 1.72 110.783 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 88.4 mtt180 68.78 18.04 8.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.478 -0.783 . . . . 4.4500000000000002 111.607 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' B' ' 17' ' ' HIS . 75.8 mt -129.11 93.28 36.91 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.349 -0.842 . . . . 1.8100000000000001 108.897 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.92 132.53 9.64 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.567 2.178 . . . . 1.05 113.521 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.413 HG22 ' OG1' ' A' ' 79' ' ' THR . 47.2 t -79.03 116.64 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.833 -1.543 . . . . 1.03 106.833 177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.659 HG12 ' HA ' ' A' ' 27' ' ' ILE . 29.5 m -124.71 156.91 33.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 113.478 0.918 . . . . 0.77000000000000002 113.478 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.651 HG23 ' HB3' ' A' ' 26' ' ' LEU . 2.6 m -118.37 118.57 33.83 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 114.806 -1.088 . . . . 0.71999999999999997 108.646 177.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.584 ' HG2' ' HG2' ' A' ' 19' ' ' GLN . 13.2 Cg_exo -69.47 156.59 63.67 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.076 2.518 . . . . 1.03 113.507 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.463 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 95.2 t -114.1 127.12 71.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.085 -0.962 . . . . 1.28 108.638 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.528 ' OG1' ' HD3' ' A' ' 73' ' ' ARG . 27.2 p . . . . . 0 C--N 1.324 -0.516 0 C-N-CA 121.105 -0.238 . . . . 1.9099999999999999 111.25 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.177 0 CA-C-O 120.702 0.057 . . . . 1.6599999999999999 112.97 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -91.32 -32.75 15.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.893 0.378 . . . . 1.5600000000000001 110.971 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.47 120.9 25.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.083 -0.508 . . . . 1.25 110.097 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.691 HG22 ' HB ' ' A' ' 72' ' ' VAL . 10.4 m -93.85 153.64 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.913 0.387 . . . . 1.6799999999999999 111.707 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.86 142.98 34.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.969 -0.559 . . . . 1.95 111.615 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.579 ' HB3' HD11 ' A' ' 66' ' ' ILE . 14.4 mt -109.94 0.57 18.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 1.23 110.927 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -91.55 -173.68 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 2.21 109.914 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.7 -47.68 3.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 1.1499999999999999 112.151 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.0 m -74.6 -28.7 22.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.889 0.376 . . . . 1.21 110.754 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.77 67.88 1.53 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.743 -0.742 . . . . 1.0800000000000001 113.619 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 61' ' ' LEU . 22.8 pt -102.97 174.69 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.624 -0.51 . . . . 1.0700000000000001 109.624 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -80.68 -44.84 18.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.956 0.407 . . . . 3.5899999999999999 110.46 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.51 149.2 49.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.8 -0.636 . . . . 1.51 111.46 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.08 91.96 3.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.836 -0.62 . . . . 1.79 110.795 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -164.85 -162.42 15.85 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.17 -0.772 . . . . 1.1799999999999999 111.17 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.34 138.63 53.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.092 -0.336 . . . . 1.5600000000000001 110.092 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.691 ' HB ' HG22 ' A' ' 59' ' ' VAL . 62.7 t -75.3 131.1 35.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.817 0.341 . . . . 1.29 110.456 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.528 ' HD3' ' OG1' ' A' ' 46' ' ' THR . 55.8 mmm-85 -100.35 91.4 4.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.127 -0.488 . . . . 2.23 112.259 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.8 m -82.67 -10.14 59.06 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.901 -0.777 . . . . 1.1699999999999999 108.901 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.407 ' C ' ' HD3' ' A' ' 77' ' ' PRO . 13.9 p-10 -86.85 -12.52 47.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.121 -0.945 . . . . 0.89000000000000001 110.943 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.401 ' N ' ' HD3' ' A' ' 77' ' ' PRO . 12.1 mm100 -129.42 62.93 65.71 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 112.195 0.443 . . . . 2.1299999999999999 112.195 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.407 ' HD3' ' C ' ' A' ' 75' ' ' ASP . 5.0 Cg_exo -77.95 144.61 21.64 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.667 2.245 . . . . 0.80000000000000004 111.024 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 78' ' ' ARG . 5.1 ptm85 -163.92 124.61 2.2 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.072 0.397 . . . . 2.0899999999999999 112.072 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.515 ' OG1' ' HD2' ' B' ' 77' ' ' PRO . 87.6 m -82.19 123.52 29.08 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.847 -0.615 . . . . 1.6200000000000001 109.597 178.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.542 HD13 HD23 ' A' ' 11' ' ' LEU . 24.3 pt -126.1 161.95 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.025 0.44 . . . . 1.1499999999999999 111.183 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.539 ' O ' ' HD2' ' A' ' 85' ' ' ARG . 2.1 t70 -76.61 145.37 38.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.62 -0.718 . . . . 1.03 110.686 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 38.2 tpp -131.91 24.66 4.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.23 0.538 . . . . 1.29 109.786 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.12 -40.42 3.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.158 -0.474 . . . . 2.6400000000000001 110.778 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.88 -35.38 10.51 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.362 -0.607 . . . . 1.1200000000000001 109.362 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 81' ' ' ASP . 77.4 mtt-85 -68.72 -57.56 5.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.471 -0.786 . . . . 1.0600000000000001 110.704 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.82 120.52 2.03 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.787 -0.72 . . . . 1.1200000000000001 113.193 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.0 171.16 21.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.939 -0.648 . . . . 1.0900000000000001 111.796 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -132.79 123.13 25.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.834 0.35 . . . . 2.46 111.482 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.484 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 45.7 ttp180 -75.41 120.39 20.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.226 -0.443 . . . . 2.4900000000000002 110.897 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.95 -53.86 4.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.925 0.393 . . . . 1.29 110.328 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.709 ' HG2' HD11 ' A' ' 6' ' ' ILE . 14.6 pt-20 -160.14 -168.44 2.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.709 -0.678 . . . . 1.1499999999999999 109.38 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.459 ' NH2' ' HA3' ' A' ' 4' ' ' GLY . 3.2 ptm180 -143.29 139.76 30.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.757 0.313 . . . . 1.3200000000000001 110.33 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.54 158.25 43.21 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.136 -0.484 . . . . 0.75 111.461 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.0 160.72 48.48 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.712 2.275 . . . . 0.94999999999999996 111.564 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -60.87 -23.04 64.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 1.51 111.93 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -37.08 74.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.483 . . . . 1.5700000000000001 110.585 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.406 ' O ' HG23 ' A' ' 101' ' ' VAL . 37.2 mm -88.55 -40.78 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.747 -0.661 . . . . 1.3100000000000001 109.99 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.7 tpt -56.63 -50.83 70.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.696 -0.683 . . . . 1.6000000000000001 112.107 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.428 ' HA ' HD12 ' A' ' 102' ' ' LEU . 58.1 m-80 -65.18 -32.19 73.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 2.2999999999999998 111.268 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 7.0 tp10 -61.5 -45.14 95.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.862 -0.608 . . . . 1.6399999999999999 110.366 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.477 HG11 HG21 ' A' ' 43' ' ' VAL . 50.0 t -59.88 -44.85 95.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.036 -0.529 . . . . 1.03 110.013 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 99' ' ' ASN . 44.6 mt -59.92 -40.88 90.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.732 -0.667 . . . . 1.22 111.051 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.87 -41.42 98.77 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.901 -0.666 . . . . 1.03 112.016 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 12.6 mmt180 -68.2 -38.52 82.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 1.72 110.555 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 62.6 mt -63.78 -24.24 67.68 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.03 -0.532 . . . . 1.02 112.111 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 57.0 m -72.12 -6.27 41.41 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.934 0.716 . . . . 1.1100000000000001 112.934 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 74.5 p -92.49 -11.34 34.89 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.193 0.442 . . . . 1.5 112.193 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.525 ' HB ' HG22 ' B' ' 29' ' ' THR . 45.8 pt -107.48 16.25 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.914 0.388 . . . . 1.1499999999999999 111.897 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 83.4 mt -97.42 25.87 5.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.131 0.491 . . . . 0.97999999999999998 110.784 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.957 -0.565 . . . . 1.3500000000000001 111.405 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.544 ' CE ' ' HG ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 112.007 0.373 . . . . 2.0299999999999998 112.007 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 2' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' B' ' 3' ' ' ARG . 24.2 mt-10 -91.01 2.97 55.9 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.168 -0.332 . . . . 2.8199999999999998 110.804 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ARG . . . . . 0.694 ' HA ' ' HE1' ' B' ' 98' ' ' MET . 0.1 OUTLIER 84.86 61.24 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.933 1.086 . . . . 2.3199999999999998 113.933 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.25 22.98 74.82 Favored Glycine 0 CA--C 1.519 0.313 0 N-CA-C 115.006 0.762 . . . . 1.28 115.006 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -83.19 116.55 22.42 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 117.498 0.649 . . . . 1.53 110.892 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.95 HD12 ' HG3' ' B' ' 91' ' ' GLU . 19.9 mt -96.07 123.26 48.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.75 110.184 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -112.92 127.47 56.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.008 0.432 . . . . 0.81000000000000005 111.477 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' B' ' 24' ' ' PRO . 40.1 tp -90.13 120.35 31.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.056 -0.52 . . . . 1.05 109.748 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.457 HG22 ' H ' ' B' ' 10' ' ' SER . 5.9 p -158.63 169.55 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.505 -0.316 . . . . 0.71999999999999997 110.379 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' B' ' 22' ' ' THR . 0.0 OUTLIER -84.45 133.27 34.49 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.899 -0.408 . . . . 1.6299999999999999 109.899 179.088 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 18.9 mt -81.29 -29.09 34.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.485 -0.325 . . . . 0.82999999999999996 111.437 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ASP . . . . . 0.417 ' HA ' ' N ' ' B' ' 14' ' ' THR . 2.5 m-20 -58.7 154.58 35.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.051 -0.522 . . . . 1.6200000000000001 111.629 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.65 116.52 4.58 Favored 'Cis proline' 0 C--O 1.237 0.432 0 C-N-CA 123.607 -1.414 . . . . 1.28 113.364 0.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' B' ' 18' ' ' GLU . 0.6 OUTLIER -123.41 147.88 46.68 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.812 -0.81 . . . . 1.47 108.812 178.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.65 177.88 8.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.319 0.581 . . . . 1.22 112.117 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.57 -108.53 2.45 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.888 -0.672 . . . . 1.01 112.585 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' HIS . . . . . 0.461 ' HB2' HD21 ' A' ' 39' ' ' LEU . 73.6 m-70 -108.31 3.29 23.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.727 0.299 . . . . 2.1800000000000002 111.147 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.44 ' HB2' ' HB ' ' B' ' 14' ' ' THR . 29.9 mt-10 -72.4 140.21 48.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.297 -0.411 . . . . 1.28 110.05 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -68.28 142.16 55.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.669 -0.493 . . . . 1.52 109.669 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -120.1 165.85 14.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.726 0.639 . . . . 1.8600000000000001 112.726 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.7 -173.11 36.45 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.44 -0.8 . . . . 0.90000000000000002 112.327 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' B' ' 10' ' ' SER . 15.6 m -96.04 123.36 39.61 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.973 -0.751 . . . . 0.94999999999999996 108.973 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.406 HH21 ' HA ' ' B' ' 46' ' ' THR . 3.9 ptm180 -157.45 155.0 26.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.705 -0.225 . . . . 1.5900000000000001 110.84 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' B' ' 8' ' ' LEU . 23.6 Cg_exo -65.63 133.8 35.65 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.608 2.206 . . . . 0.65000000000000002 111.841 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' B' ' 44' ' ' PRO . 16.9 m -126.61 156.92 37.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.074 -0.512 . . . . 0.56999999999999995 110.693 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.544 ' HG ' ' CE ' ' B' ' 1' ' ' MET . 1.5 tp -106.24 119.32 38.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.118 -0.492 . . . . 1.1699999999999999 110.71 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ILE . . . . . 0.603 HG12 HG12 ' B' ' 42' ' ' VAL . 27.8 mt -78.36 116.83 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.317 . . . . 0.66000000000000003 110.607 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' B' ' 1' ' ' MET . 37.5 t -77.61 -37.55 24.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.025 -0.534 . . . . 0.93000000000000005 111.839 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' THR . . . . . 0.525 HG22 ' HB ' ' A' ' 108' ' ' ILE . 0.8 OUTLIER -71.19 142.47 87.26 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.436 -0.347 . . . . 0.81000000000000005 111.74 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.68 156.09 61.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.83 2.353 . . . . 0.78000000000000003 112.407 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.3 77.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.861 -0.609 . . . . 1.03 111.704 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.98 -36.74 73.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.92 0.39 . . . . 1.3999999999999999 111.55 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -81.39 -40.88 22.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.112 0.482 . . . . 1.5700000000000001 110.519 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -59.43 -24.84 63.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.682 -0.69 . . . . 1.6399999999999999 111.899 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -89.42 -2.61 58.46 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.399 0.518 . . . . 2.54 112.399 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -108.12 -52.08 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.977 0.418 . . . . 1.0900000000000001 110.282 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 1.5 m -80.87 -31.84 35.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.818 -0.628 . . . . 1.3300000000000001 111.14 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.434 ' HA ' ' NE ' ' B' ' 38' ' ' ARG . 3.7 mmp_? 71.01 -0.22 3.14 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.53 0.937 . . . . 1.78 113.53 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 98.4 mt -121.45 94.32 48.61 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.577 -0.527 . . . . 1.1599999999999999 109.577 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.37 154.18 14.09 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.867 2.378 . . . . 0.56999999999999995 113.992 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.671 HG22 HG23 ' B' ' 79' ' ' THR . 8.8 t -95.45 123.53 47.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.901 -1.148 . . . . 1.0800000000000001 107.901 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.603 HG12 HG12 ' B' ' 27' ' ' ILE . 32.3 m -113.93 147.31 17.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 113.434 0.902 . . . . 0.64000000000000001 113.434 -178.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 t -106.09 118.97 53.66 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 114.63 -1.168 . . . . 1.1000000000000001 108.386 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.501 ' HA ' HG12 ' B' ' 25' ' ' VAL . 74.0 Cg_endo -74.38 134.79 19.41 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.728 2.285 . . . . 0.72999999999999998 112.557 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.697 HG22 HG12 ' B' ' 72' ' ' VAL . 44.0 t -99.01 123.62 51.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.88 -0.6 . . . . 0.90000000000000002 110.46 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' THR . . . . . 0.406 ' HA ' HH21 ' B' ' 23' ' ' ARG . 0.0 OUTLIER -89.44 89.89 8.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.887 -0.597 . . . . 1.1699999999999999 109.579 178.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.69 ' HA ' ' HA3' ' B' ' 70' ' ' GLY . 1.4 m . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 115.855 -0.612 . . . . 1.8500000000000001 111.342 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.023 0.44 . . . . 1.96 110.339 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.51 -87.68 0.26 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.796 -0.638 . . . . 1.0800000000000001 112.676 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.658 ' HE1' ' HB ' ' B' ' 107' ' ' THR . 21.0 m-85 -109.68 -6.69 15.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.879 0.371 . . . . 3.5699999999999998 110.86 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' B' ' 72' ' ' VAL . . . -93.04 115.13 27.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.049 -0.523 . . . . 1.0800000000000001 110.845 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 23.7 t -117.05 135.99 55.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.101 -0.5 . . . . 1.3400000000000001 110.013 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 88.3 p -79.42 141.59 36.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.801 0.334 . . . . 1.3799999999999999 111.605 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 72.8 mt -88.76 -16.76 31.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.181 0.515 . . . . 1.02 110.751 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -73.63 147.0 44.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.718 -0.673 . . . . 1.79 111.003 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.03 -40.14 2.5 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.056 -0.593 . . . . 1.1499999999999999 112.461 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 p -90.21 -17.69 7.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.111 0.412 . . . . 1.1699999999999999 112.111 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.24 20.91 4.24 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.499 -0.858 . . . . 1.05 113.599 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.496 HD11 ' HD2' ' B' ' 94' ' ' PRO . 81.4 mt -86.64 141.31 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.772 -0.455 . . . . 1.6100000000000001 109.772 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -70.9 -47.84 56.94 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.623 0.249 . . . . 2.3999999999999999 110.923 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 12.2 m -60.97 99.14 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.368 0.604 . . . . 0.93000000000000005 110.334 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.69 91.49 8.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.946 -0.57 . . . . 1.3100000000000001 111.746 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' B' ' 47' ' ' SER . . . -171.45 -174.0 38.81 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.709 -0.758 . . . . 0.79000000000000004 111.7 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.5 m -113.71 136.31 50.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 110.211 -0.292 . . . . 0.93000000000000005 110.211 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.697 HG12 HG22 ' B' ' 45' ' ' VAL . 11.9 m -80.34 135.59 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.556 -0.293 . . . . 1.3799999999999999 110.92 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' B' ' 73' ' ' ARG . 16.1 mmm-85 -101.99 82.97 2.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.112 0.482 . . . . 1.3700000000000001 110.829 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 2.3 m -69.32 -9.04 51.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.758 -0.655 . . . . 1.1599999999999999 111.047 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.639 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 13.7 p-10 -88.45 -6.21 57.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.589 -0.732 . . . . 1.1000000000000001 111.771 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -126.13 55.77 14.2 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 113.0 0.741 . . . . 2.4700000000000002 113.0 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.515 ' HD2' ' OG1' ' A' ' 79' ' ' THR . 90.4 Cg_endo -80.96 126.4 5.74 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.771 1.647 . . . . 0.95999999999999996 112.271 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -130.38 140.39 50.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.917 0.389 . . . . 1.96 111.218 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.671 HG23 HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -79.72 125.87 30.21 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.189 -0.671 . . . . 1.1899999999999999 109.189 178.535 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 41.4 pt -128.51 151.48 35.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.521 -0.471 . . . . 1.28 111.653 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.693 ' OD1' ' HG3' ' B' ' 83' ' ' LYS . 4.8 t70 -77.83 83.95 4.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.858 -0.61 . . . . 1.28 109.994 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 59.7 tpp -61.69 -31.66 71.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.691 -0.686 . . . . 2.7000000000000002 112.274 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.693 ' HG3' ' OD1' ' B' ' 81' ' ' ASP . 1.4 pttp -67.22 -38.91 86.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.397 0.517 . . . . 1.96 112.397 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.98 -30.18 28.41 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.108 0.41 . . . . 1.0600000000000001 112.108 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' B' ' 85' ' ' ARG . 46.1 mtt180 -82.22 -42.46 18.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.174 0.435 . . . . 1.47 112.174 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.4 99.94 1.52 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.81999999999999995 112.597 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -99.3 153.71 19.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.677 -0.773 . . . . 0.65000000000000002 112.588 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.15 128.15 16.5 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.284 -0.265 . . . . 1.8100000000000001 110.284 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' B' ' 6' ' ' ILE . 34.5 ttp180 -78.91 121.04 24.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.963 0.411 . . . . 2.4900000000000002 111.339 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 89.8 mt -90.8 -68.62 0.78 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.136 -0.484 . . . . 0.76000000000000001 110.666 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' GLU . . . . . 0.95 ' HG3' HD12 ' B' ' 6' ' ' ILE . 11.5 pt-20 -129.61 -176.88 4.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.935 -0.575 . . . . 1.0700000000000001 110.028 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.81 137.98 53.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.959 0.409 . . . . 2.0499999999999998 111.198 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.436 HG23 HD11 ' B' ' 6' ' ' ILE . 53.7 t -82.86 126.72 72.2 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.854 -0.612 . . . . 1.45 109.993 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.496 ' HD2' HD11 ' B' ' 66' ' ' ILE . 43.9 Cg_exo -59.59 152.5 61.86 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.656 2.237 . . . . 1.03 111.11 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.528 ' HA ' ' HB3' ' B' ' 98' ' ' MET . 21.8 mm-40 -54.26 -29.69 47.78 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.461 0.541 . . . . 2.1400000000000001 112.461 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.7 p -59.46 -53.83 53.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.991 0.424 . . . . 1.78 111.219 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 32.5 mm -74.84 -34.04 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.202 -0.453 . . . . 1.3300000000000001 110.0 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' MET . . . . . 0.694 ' HE1' ' HA ' ' B' ' 3' ' ' ARG . 5.1 tpt -55.33 -45.26 76.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.706 -0.679 . . . . 2.3399999999999999 110.972 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -67.55 -35.34 78.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.098 -0.501 . . . . 1.9099999999999999 110.996 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 4.5 tp10 -64.53 -44.86 89.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.97 -0.559 . . . . 1.76 111.0 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.426 HG22 HG21 ' B' ' 72' ' ' VAL . 73.9 t -60.29 -48.61 87.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.306 -0.406 . . . . 1.01 110.425 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.654 ' HA ' HD12 ' B' ' 105' ' ' LEU . 82.9 mt -59.68 -34.93 73.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.555 . . . . 1.29 111.048 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.45 -41.28 96.46 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.578 -0.609 . . . . 1.02 111.578 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 5.1 mmt180 -67.35 -33.59 75.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.898 0.38 . . . . 1.8500000000000001 110.315 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.654 HD12 ' HA ' ' B' ' 102' ' ' LEU . 46.4 mt -65.98 -25.5 67.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.912 -0.586 . . . . 1.9399999999999999 110.513 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 13.0 m -87.68 -13.94 41.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.008 -0.542 . . . . 1.1599999999999999 111.161 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.658 ' HB ' ' HE1' ' B' ' 57' ' ' PHE . 0.5 OUTLIER -75.13 -31.65 61.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.898 0.38 . . . . 1.45 111.361 -179.376 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 14.0 pt -84.91 0.82 5.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.442 -0.345 . . . . 1.98 111.558 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.49 4.66 53.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.342 -0.39 . . . . 1.3600000000000001 111.859 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.439 ' C ' HH22 ' A' ' 3' ' ' ARG . 7.0 t . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.825 -0.607 . . . . 2.1299999999999999 110.206 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptp . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.782 0.325 . . . . 1.29 110.75 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -135.28 175.01 9.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.02 -0.536 . . . . 2.0099999999999998 111.053 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.561 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 55.2 ttp85 -79.27 136.22 36.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.048 -0.523 . . . . 1.8500000000000001 109.955 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.44 8.27 59.91 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.85999999999999999 112.476 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.682 ' HG2' ' HG3' ' A' ' 92' ' ' ARG . 82.1 mt-10 -95.27 142.22 27.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.949 0.404 . . . . 0.98999999999999999 111.138 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.7 mt -99.0 115.93 40.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.814 -0.81 . . . . 1.1599999999999999 108.814 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -114.12 137.33 51.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.401 -0.363 . . . . 0.91000000000000003 111.083 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.3 tp -88.81 120.76 30.51 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.392 -0.595 . . . . 0.90000000000000002 109.392 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.454 HG22 ' H ' ' A' ' 10' ' ' SER . 4.3 p -147.49 169.19 4.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 120.867 0.365 . . . . 1.04 110.708 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.454 ' H ' HG22 ' A' ' 9' ' ' VAL . 4.2 t -103.75 129.83 51.18 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.001 -0.74 . . . . 1.3200000000000001 109.001 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.3 mt -88.32 -12.57 43.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.461 -0.336 . . . . 1.29 111.377 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.547 ' HA ' HG23 ' A' ' 14' ' ' THR . 0.2 OUTLIER -67.93 164.15 43.67 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.94 -0.573 . . . . 1.54 111.162 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.74 139.09 49.57 Favored 'Cis proline' 0 C--N 1.353 0.79 0 C-N-CA 124.324 -1.115 . . . . 1.6899999999999999 112.485 -0.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.547 HG23 ' HA ' ' A' ' 12' ' ' ASP . 14.1 p -121.9 171.95 8.54 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.085 -0.507 . . . . 1.3600000000000001 111.319 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.79 164.34 26.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 1.7 110.063 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.4 -136.87 32.34 Favored Glycine 0 CA--C 1.516 0.123 0 C-N-CA 121.16 -0.543 . . . . 1.1799999999999999 113.409 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -103.74 25.46 9.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.022 -0.362 . . . . 2.7799999999999998 110.022 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -76.47 175.75 8.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.212 -0.449 . . . . 1.1399999999999999 111.427 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.546 ' HG3' ' CZ ' ' A' ' 23' ' ' ARG . 3.3 tp-100 -74.23 77.38 1.81 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.607 -0.724 . . . . 2.0899999999999999 110.506 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.405 ' HA ' HG21 ' A' ' 14' ' ' THR . 18.3 mt-30 -78.03 122.89 26.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.835 -0.62 . . . . 2.0899999999999999 111.726 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.71 163.45 12.27 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.272 -0.966 . . . . 1.0700000000000001 113.502 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.62 148.38 25.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.743 -0.229 . . . . 1.1100000000000001 110.505 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.546 ' CZ ' ' HG3' ' A' ' 19' ' ' GLN . 8.2 ptp180 -172.71 159.87 3.83 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 110.247 -0.279 . . . . 1.6200000000000001 110.247 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.65 130.3 15.72 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.448 2.099 . . . . 1.01 110.713 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.726 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 14.2 m -116.37 137.21 50.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.335 -0.393 . . . . 0.76000000000000001 110.569 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . 53.1 tp -92.32 124.39 36.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.154 -0.475 . . . . 0.69999999999999996 110.948 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.433 ' HA ' HG12 ' A' ' 42' ' ' VAL . 56.6 mt -80.07 111.03 16.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.92000000000000004 110.148 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 t -90.18 -27.2 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.218 -0.446 . . . . 0.94999999999999996 111.75 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 1.9 p -77.6 142.25 66.08 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.603 0.594 . . . . 1.1200000000000001 112.603 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HA ' ' HB2' ' A' ' 3' ' ' ARG . 26.3 Cg_exo -63.79 151.74 83.78 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.217 2.611 . . . . 1.3 111.798 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.18 -38.81 77.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.085 -0.507 . . . . 1.3899999999999999 112.036 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.17 -38.3 82.81 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.024 0.44 . . . . 1.6100000000000001 110.777 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' B' ' 75' ' ' ASP . 83.2 t80 -72.34 -38.73 68.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.032 -0.531 . . . . 1.77 110.166 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 75.4 m-20 -64.78 -15.81 62.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.676 -0.693 . . . . 1.48 111.199 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -87.8 -24.12 23.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.562 -0.29 . . . . 2.6200000000000001 110.724 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.6 t -83.1 -65.12 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 1.8600000000000001 111.489 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.1 m -78.82 -33.99 45.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.337 -0.392 . . . . 1.72 110.862 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.616 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 21.6 mtm180 75.14 12.64 3.35 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.724 -0.671 . . . . 4.4500000000000002 111.738 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.8 mt -124.92 93.04 46.61 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.544 -0.753 . . . . 1.8100000000000001 109.404 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.478 ' HD2' ' O ' ' A' ' 80' ' ' ILE . 58.0 Cg_endo -73.06 137.26 26.15 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.502 2.135 . . . . 1.05 112.798 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.585 HG22 HG23 ' A' ' 79' ' ' THR . 51.8 t -83.64 111.65 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 107.972 -1.122 . . . . 1.03 107.972 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.726 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 35.8 m -114.54 158.74 14.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.24 0.543 . . . . 0.77000000000000002 112.282 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.438 HG21 HG13 ' A' ' 72' ' ' VAL . 17.1 m -115.89 122.08 33.08 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.236 -0.893 . . . . 0.71999999999999997 109.775 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.99 94.75 1.06 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.867 2.378 . . . . 1.03 112.761 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.783 HG12 ' HA ' ' A' ' 72' ' ' VAL . 33.0 m -78.68 155.86 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 1.28 110.407 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 112.345 0.498 . . . . 1.9099999999999999 112.345 179.106 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.195 0 N-CA-C 112.538 -0.225 . . . . 1.6599999999999999 112.538 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -96.08 -16.77 21.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.628 0.252 . . . . 1.5600000000000001 111.03 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.446 ' HB1' ' HB ' ' A' ' 71' ' ' VAL . . . -76.02 87.37 2.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.587 -0.523 . . . . 1.25 109.587 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.582 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 42.3 t -66.13 121.86 16.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.276 -0.42 . . . . 1.6799999999999999 110.726 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.1 t -77.56 125.94 30.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.896 0.379 . . . . 1.95 111.539 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.749 ' HB3' HD11 ' A' ' 66' ' ' ILE . 91.9 mt -88.35 -5.93 58.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.45 0.643 . . . . 1.23 109.427 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -80.5 108.96 14.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.264 -0.88 . . . . 2.21 109.84 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.85 -34.56 1.23 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.873 -0.679 . . . . 1.1499999999999999 112.017 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.5 m -78.36 -30.7 15.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.729 0.3 . . . . 1.21 111.6 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.59 65.1 0.93 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.638 -0.791 . . . . 1.0800000000000001 112.671 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.749 HD11 ' HB3' ' A' ' 61' ' ' LEU . 20.4 pt -125.24 -171.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.354 -0.609 . . . . 1.0700000000000001 109.354 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.534 ' HA ' ' NE ' ' A' ' 67' ' ' ARG . 5.4 mmp_? -101.22 -27.66 13.09 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.739 -0.384 . . . . 3.5899999999999999 111.477 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.7 m -81.41 80.71 7.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.268 0.556 . . . . 1.51 110.388 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 m -80.21 94.54 6.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.63 -0.714 . . . . 1.79 111.256 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -162.52 -178.31 36.27 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.828 -0.624 . . . . 1.1799999999999999 112.137 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.446 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 22.3 m -105.0 138.99 27.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.821 0.31 . . . . 1.5600000000000001 110.963 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.783 ' HA ' HG12 ' A' ' 45' ' ' VAL . 67.9 t -73.81 126.93 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.808 -0.633 . . . . 1.29 110.258 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.75 85.23 7.02 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.584 0.587 . . . . 2.23 112.584 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 11.0 m -83.44 -8.19 59.42 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.81 -0.811 . . . . 1.1699999999999999 108.81 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -87.55 -27.97 22.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.801 -1.091 . . . . 0.89000000000000001 111.14 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.424 ' HB3' HG21 ' B' ' 79' ' ' THR . 79.3 mt-30 -130.84 64.53 73.91 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 113.984 1.105 . . . . 2.1299999999999999 113.984 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -77.52 133.96 13.44 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 121.872 1.715 . . . . 0.80000000000000004 109.204 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 1.038 ' HG3' ' HG3' ' B' ' 78' ' ' ARG . 18.2 ttt180 -135.19 143.06 46.22 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.683 0.623 . . . . 2.0899999999999999 112.683 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.585 HG23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -83.85 127.88 34.15 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.814 -1.18 . . . . 1.6200000000000001 107.814 177.44 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.478 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 20.5 pt -126.1 173.18 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.967 0.413 . . . . 1.1499999999999999 111.091 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -101.65 133.48 46.29 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.64 -0.709 . . . . 1.03 109.138 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.2 mmt -126.19 27.98 6.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.971 0.415 . . . . 1.29 111.266 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -125.3 -42.98 1.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 2.6400000000000001 110.8 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.46 -37.54 9.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.728 -0.669 . . . . 1.1200000000000001 109.505 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 85' ' ' ARG . 39.3 mtt180 -68.69 -49.28 60.25 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.006 -0.543 . . . . 1.0600000000000001 110.453 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.33 143.55 4.59 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.909 -0.587 . . . . 1.1200000000000001 112.278 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.77 176.77 32.39 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.766 -0.73 . . . . 1.0900000000000001 111.958 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -128.31 126.31 40.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.586 0.232 . . . . 2.46 111.171 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -74.3 132.99 42.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 2.4900000000000002 110.451 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 83.1 mt -103.71 -73.23 0.68 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.362 -0.381 . . . . 1.29 110.639 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -144.83 175.4 10.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.214 -0.448 . . . . 1.1499999999999999 110.626 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.682 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 9.6 ttp85 -120.03 144.64 47.44 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.428 -0.582 . . . . 1.3200000000000001 109.428 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.616 ' HB ' HD11 ' A' ' 97' ' ' ILE . 29.9 m -103.32 145.26 30.26 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.704 0.288 . . . . 0.75 111.298 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.529 ' HD2' HD11 ' A' ' 97' ' ' ILE . 40.3 Cg_exo -59.77 155.09 45.17 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.742 2.295 . . . . 0.94999999999999996 111.751 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' A' ' 98' ' ' MET . 52.7 mm-40 -67.59 -21.09 65.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.06 -0.518 . . . . 1.51 111.276 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.97 -57.46 12.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 1.5700000000000001 110.994 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.616 HD11 ' HB ' ' A' ' 93' ' ' VAL . 5.2 pt -69.83 -23.04 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 1.3100000000000001 111.509 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.417 ' HB2' ' HA ' ' A' ' 95' ' ' GLU . 40.0 mmm -67.75 -34.9 77.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 1.6000000000000001 109.813 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -67.04 -30.71 70.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.583 . . . . 2.2999999999999998 110.083 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -62.57 -31.16 71.92 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.781 -0.645 . . . . 1.6399999999999999 110.481 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.54 -48.97 23.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.506 -0.77 . . . . 1.03 109.76 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.42 -37.08 79.73 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.966 -0.561 . . . . 1.22 111.351 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.88 -40.01 97.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.908 -0.663 . . . . 1.03 111.928 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.0 mtt85 -75.77 -38.7 58.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.947 0.403 . . . . 1.72 110.739 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.651 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 82.8 mt -59.37 -41.82 90.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.906 -0.588 . . . . 1.02 111.109 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.2 m -63.83 -20.86 66.12 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.23 0.455 . . . . 1.1100000000000001 112.23 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -90.89 -35.63 14.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.812 0.339 . . . . 1.5 111.508 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.474 HG12 ' HA ' ' A' ' 105' ' ' LEU . 49.9 pt -78.04 -14.7 14.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 113.114 0.783 . . . . 1.1499999999999999 113.114 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 105' ' ' LEU . 61.8 mt -78.32 65.3 3.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.086 0.47 . . . . 0.97999999999999998 110.932 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.758 -0.655 . . . . 1.3500000000000001 110.632 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 121.098 0.475 . . . . 2.0299999999999998 111.335 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -76.33 -34.99 58.99 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.232 -1.025 . . . . 2.8199999999999998 108.232 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 68.35 140.45 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.613 -1.176 . . . . 2.3199999999999998 112.853 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' B' ' 92' ' ' ARG . . . 90.53 -10.48 74.4 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.814 -0.708 . . . . 1.28 112.54 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -76.84 99.14 5.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.875 0.369 . . . . 1.53 111.536 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.505 HD12 ' HG3' ' B' ' 91' ' ' GLU . 20.6 mt -89.02 122.42 40.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.907 -0.588 . . . . 0.75 110.816 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -122.32 134.34 54.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.088 -0.505 . . . . 0.81000000000000005 109.877 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.493 ' HB2' HD11 ' B' ' 90' ' ' LEU . 4.0 tt -95.14 123.06 38.43 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.66 -0.246 . . . . 1.05 110.587 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.18 154.73 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.71999999999999997 110.76 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 67.8 m -76.63 126.08 30.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.439 -0.346 . . . . 1.6299999999999999 111.215 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.569 ' HB3' ' NH2' ' B' ' 78' ' ' ARG . 88.7 mt -87.53 -21.28 25.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.82999999999999996 112.003 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.06 162.9 62.68 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.544 -0.298 . . . . 1.6200000000000001 111.007 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.18 152.96 98.91 Favored 'Cis proline' 0 C--N 1.352 0.712 0 C-N-CA 123.82 -1.325 . . . . 1.28 113.214 0.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.538 ' OG1' ' HB3' ' B' ' 20' ' ' GLN . 6.2 p -123.93 145.04 49.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.576 -0.738 . . . . 1.47 110.406 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -132.79 108.32 8.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.923 0.392 . . . . 1.22 110.665 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.28 -133.96 11.73 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.897 -0.668 . . . . 1.01 111.79 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -101.32 23.79 10.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.658 0.266 . . . . 2.1800000000000002 111.504 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -71.39 150.48 44.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.039 -0.528 . . . . 1.28 110.799 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -69.39 116.0 9.31 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.642 -0.503 . . . . 1.52 109.642 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.538 ' HB3' ' OG1' ' B' ' 14' ' ' THR . 1.2 pt20 -103.23 173.11 6.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.12 -0.491 . . . . 1.8600000000000001 112.203 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.66 138.31 4.05 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.759 -0.655 . . . . 0.90000000000000002 113.332 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 91.7 m -70.01 130.65 42.73 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.351 -0.611 . . . . 0.94999999999999996 109.351 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -159.74 160.94 27.41 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.503 -0.317 . . . . 1.5900000000000001 110.374 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -66.02 131.97 28.66 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.629 2.219 . . . . 0.65000000000000002 110.836 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.725 HG12 ' HA ' ' B' ' 44' ' ' PRO . 18.4 m -125.43 157.81 34.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.388 -0.369 . . . . 0.56999999999999995 110.938 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -103.88 133.18 49.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.954 -0.566 . . . . 1.1699999999999999 109.942 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' B' ' 40' ' ' PRO . 54.6 mt -85.81 123.37 39.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.741 0.305 . . . . 0.66000000000000003 110.958 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.69 49.44 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.496 0.665 . . . . 0.93000000000000005 110.081 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 8.1 m -143.34 122.75 7.53 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.918 -0.583 . . . . 0.81000000000000005 109.879 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 108' ' ' ILE . 88.8 Cg_exo -48.62 128.1 17.59 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.078 2.518 . . . . 0.78000000000000003 112.405 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.72 -30.66 67.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.962 -0.563 . . . . 1.03 111.536 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.9 -32.83 71.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 1.3999999999999999 111.211 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -94.57 -21.42 18.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.174 0.511 . . . . 1.5700000000000001 110.266 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -58.71 -35.6 72.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.748 -0.66 . . . . 1.6399999999999999 110.649 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.8 -20.33 65.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.265 -0.425 . . . . 2.54 111.73 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.06 -58.97 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.793 0.664 . . . . 1.0900000000000001 112.793 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 1.2 p -86.51 -33.81 20.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.569 0.581 . . . . 1.3300000000000001 112.569 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 67.43 24.51 8.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.309 0.576 . . . . 1.78 111.197 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.63 88.69 16.2 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.517 -0.765 . . . . 1.1599999999999999 109.301 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' PRO . . . . . 0.55 ' HB2' HG23 ' B' ' 27' ' ' ILE . 90.2 Cg_endo -85.98 149.29 9.51 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.678 2.252 . . . . 0.56999999999999995 113.384 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.409 HG22 ' HB ' ' B' ' 79' ' ' THR . 6.1 t -86.53 124.55 40.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.555 -0.906 . . . . 1.0800000000000001 108.555 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.449 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 31.1 m -119.65 154.58 22.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.237 0.458 . . . . 0.64000000000000001 112.237 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 m -118.06 127.6 26.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.494 -0.775 . . . . 1.1000000000000001 109.444 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.725 ' HA ' HG12 ' B' ' 25' ' ' VAL . 94.4 Cg_endo -80.12 160.56 23.58 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.934 2.422 . . . . 0.72999999999999998 113.031 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.612 HG12 ' HA ' ' B' ' 72' ' ' VAL . 31.5 m -115.55 145.52 21.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.943 -0.571 . . . . 0.90000000000000002 110.519 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 27.9 m -95.39 124.2 39.31 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.534 -0.543 . . . . 1.1699999999999999 109.534 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 N-CA-C 112.569 0.581 . . . . 1.8500000000000001 112.569 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.378 0 CA-C-O 121.061 0.457 . . . . 1.96 111.487 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.0 -114.39 6.08 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.814 -0.63 . . . . 1.0800000000000001 112.497 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -116.09 16.12 16.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.925 0.393 . . . . 3.5699999999999998 110.457 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' B' ' 72' ' ' VAL . . . -96.07 111.28 23.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.087 -0.506 . . . . 1.0800000000000001 110.674 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 t -95.66 124.18 48.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.284 -0.416 . . . . 1.3400000000000001 110.195 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.44 ' HA ' HG12 ' B' ' 71' ' ' VAL . 4.7 m -77.4 123.09 26.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.733 0.642 . . . . 1.3799999999999999 112.733 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.445 ' O ' HG12 ' B' ' 64' ' ' VAL . 88.2 mt -89.75 -15.62 32.05 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.185 -1.043 . . . . 1.02 108.185 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ASP . . . . . 0.411 ' OD2' ' HB ' ' B' ' 69' ' ' THR . 4.0 t0 -71.48 150.42 44.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.362 -1.29 . . . . 1.79 110.499 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.79 -44.5 3.25 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.802 -0.713 . . . . 1.1499999999999999 113.469 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.502 HG11 HG13 ' B' ' 97' ' ' ILE . 3.5 p -70.1 -18.82 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.949 0.404 . . . . 1.1699999999999999 111.926 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.21 59.74 0.5 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.567 -0.825 . . . . 1.05 112.91 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' B' ' 93' ' ' VAL . 31.5 mm -128.61 137.24 57.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.131 -0.692 . . . . 1.6100000000000001 109.131 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -65.44 -36.55 84.26 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.293 0.568 . . . . 2.3999999999999999 109.874 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' THR . . . . . 0.429 ' H ' HG22 ' B' ' 66' ' ' ILE . 11.8 m -80.0 82.17 6.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.634 -0.712 . . . . 0.93000000000000005 109.946 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' THR . . . . . 0.411 ' HB ' ' OD2' ' B' ' 62' ' ' ASP . 23.2 p -68.48 97.52 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.861 -0.609 . . . . 1.3100000000000001 111.313 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.12 -171.53 37.87 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.637 -0.792 . . . . 0.79000000000000004 112.46 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' B' ' 60' ' ' SER . 11.9 m -118.16 132.67 67.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.555 0.217 . . . . 0.93000000000000005 111.24 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.612 ' HA ' HG12 ' B' ' 45' ' ' VAL . 30.4 t -74.78 128.78 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.434 -0.348 . . . . 1.3799999999999999 110.459 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' B' ' 73' ' ' ARG . 14.0 mmm-85 -96.95 84.78 3.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.061 0.457 . . . . 1.3700000000000001 110.319 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' CYS . . . . . 0.428 ' SG ' HG13 ' B' ' 101' ' ' VAL . 0.8 OUTLIER -68.22 -13.03 61.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.793 -0.639 . . . . 1.1599999999999999 110.538 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 33' ' ' PHE . 14.0 p-10 -87.53 7.16 30.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.769 -0.65 . . . . 1.1000000000000001 111.899 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' GLN . . . . . 0.419 ' N ' ' HD3' ' B' ' 77' ' ' PRO . 68.7 mt-30 -132.56 61.77 58.86 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 111.803 0.298 . . . . 2.4700000000000002 111.803 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' B' ' 76' ' ' GLN . 3.3 Cg_exo -77.98 119.99 4.89 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.482 2.121 . . . . 0.95999999999999996 110.83 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' ARG . . . . . 1.038 ' HG3' ' HG3' ' A' ' 78' ' ' ARG . 46.5 ttp180 -136.9 122.23 19.36 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 111.944 0.35 . . . . 1.96 111.944 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.424 HG21 ' HB3' ' A' ' 76' ' ' GLN . 9.8 t -84.03 139.9 32.21 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.218 -0.66 . . . . 1.1899999999999999 109.218 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 8.3 pt -148.86 162.69 5.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.484 -0.325 . . . . 1.28 110.374 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -77.98 94.6 4.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.201 0.524 . . . . 1.28 110.679 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' MET . . . . . 0.539 ' SD ' ' HA3' ' B' ' 87' ' ' GLY . 53.0 tpp -61.11 -24.76 66.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.302 -0.863 . . . . 2.7000000000000002 112.263 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.18 -49.25 11.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.76 0.314 . . . . 1.96 111.633 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.94 -41.46 82.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.379 -0.373 . . . . 1.0600000000000001 111.077 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -75.68 -31.83 59.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 1.47 111.334 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.57 101.83 0.88 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.86 -0.686 . . . . 0.81999999999999995 112.822 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' GLY . . . . . 0.539 ' HA3' ' SD ' ' B' ' 82' ' ' MET . . . -112.35 150.61 18.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.871 -0.68 . . . . 0.65000000000000002 112.49 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -140.58 136.68 33.05 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.403 -0.221 . . . . 1.8100000000000001 110.403 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' B' ' 89' ' ' ARG . 9.8 ttt180 -75.69 135.89 40.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.799 0.333 . . . . 2.4900000000000002 110.853 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' B' ' 8' ' ' LEU . 82.7 mt -108.14 -77.99 0.59 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.301 0.482 . . . . 0.76000000000000001 112.301 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' GLU . . . . . 0.505 ' HG3' HD12 ' B' ' 6' ' ' ILE . 11.0 pt-20 -133.1 -178.18 4.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.495 -0.32 . . . . 1.0700000000000001 111.635 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' B' ' 4' ' ' GLY . 5.2 tpt180 -121.5 122.67 40.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 2.0499999999999998 110.778 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.491 ' HB ' ' HA2' ' B' ' 4' ' ' GLY . 57.7 t -82.91 136.19 44.57 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.934 -0.575 . . . . 1.45 110.559 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.449 ' HD3' HD11 ' B' ' 66' ' ' ILE . 77.6 Cg_exo -53.66 144.57 52.57 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.837 2.358 . . . . 1.03 111.999 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.438 ' H ' ' HG2' ' B' ' 95' ' ' GLU . 4.3 mm-40 -55.9 -39.95 72.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.668 -0.696 . . . . 2.1400000000000001 111.916 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 14.2 t -57.53 -33.95 68.61 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.625 0.602 . . . . 1.78 112.625 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.502 HG13 HG11 ' B' ' 64' ' ' VAL . 48.2 mm -82.3 -36.57 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.218 0.532 . . . . 1.3300000000000001 110.206 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 98' ' ' MET . . . . . 0.505 ' HA ' ' HE2' ' B' ' 98' ' ' MET . 30.0 mmt -66.22 -33.27 75.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 2.3399999999999999 111.047 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -60.24 -36.23 77.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.19 0.519 . . . . 1.9099999999999999 110.414 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 3.5 mm-40 -67.67 -41.05 84.35 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.724 -0.671 . . . . 1.76 110.442 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.432 HG21 ' HE1' ' B' ' 98' ' ' MET . 93.8 t -57.54 -48.3 83.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.156 -0.475 . . . . 1.01 110.248 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.79 -40.6 97.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.744 -0.662 . . . . 1.29 110.175 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.14 -46.94 89.73 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.81 -0.632 . . . . 1.02 112.342 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 104' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 9.8 mmt180 -60.8 -41.12 95.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.858 0.361 . . . . 1.8500000000000001 110.936 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.522 HD12 HD12 ' B' ' 108' ' ' ILE . 31.8 tp -66.1 -30.67 71.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.193 -0.458 . . . . 1.9399999999999999 110.714 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 49.1 m -66.33 -34.78 78.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.175 -0.466 . . . . 1.1599999999999999 111.308 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -15.92 62.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.04 0.385 . . . . 1.45 112.04 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.522 HD12 HD12 ' B' ' 105' ' ' LEU . 60.2 mt -79.03 -23.16 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.297 0.57 . . . . 1.98 110.375 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 74.9 mt -93.8 48.02 1.25 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.757 -0.656 . . . . 1.3600000000000001 110.779 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.661 -0.685 . . . . 2.1299999999999999 110.56 179.691 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.625 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 14.2 ptp . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.958 0.408 . . . . 1.29 110.742 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.45 ' HG2' ' H ' ' A' ' 3' ' ' ARG . 14.3 tt0 -108.66 167.15 10.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.674 -0.694 . . . . 2.0099999999999998 110.231 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.45 ' H ' ' HG2' ' A' ' 2' ' ' GLU . 29.8 ttm180 -69.01 129.27 39.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.287 -0.415 . . . . 1.8500000000000001 109.99 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.35 -7.46 34.67 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.558 -0.83 . . . . 0.85999999999999999 112.828 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.625 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 31.2 mt-10 -81.42 147.36 29.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.826 0.313 . . . . 0.98999999999999999 111.271 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.542 HD11 HG13 ' A' ' 93' ' ' VAL . 32.6 mt -111.45 121.67 64.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 1.1599999999999999 110.751 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -118.43 147.48 43.54 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.91000000000000003 110.145 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 tp -102.91 130.09 49.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.939 -0.119 . . . . 0.90000000000000002 110.717 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -169.74 154.62 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.237 0.336 . . . . 1.04 110.421 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.0 m -80.97 141.25 34.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.714 0.292 . . . . 1.3200000000000001 110.435 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.574 HD11 ' HD3' ' A' ' 23' ' ' ARG . 53.8 mt -82.85 -7.79 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 1.29 111.03 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.585 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 1.6 m-20 -65.45 162.45 41.79 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.412 -0.813 . . . . 1.54 110.153 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.727 ' HB2' ' HG2' ' B' ' 13' ' ' PRO . 5.9 Cg_exo -78.57 141.35 64.03 Favored 'Cis proline' 0 C--O 1.236 0.385 0 C-N-CA 123.716 -1.368 . . . . 1.6899999999999999 111.726 -0.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.859 ' HB ' ' HB3' ' A' ' 18' ' ' GLU . 24.0 p -117.58 171.77 7.79 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.224 -0.444 . . . . 1.3600000000000001 110.536 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.28 137.57 39.14 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.434 -0.58 . . . . 1.7 109.434 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.54 -116.02 5.27 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.71 -0.757 . . . . 1.1799999999999999 112.995 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -113.05 17.4 18.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.531 0.205 . . . . 2.7799999999999998 111.136 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.859 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 18.8 tt0 -59.26 137.45 57.97 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.251 -0.431 . . . . 1.1399999999999999 110.004 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.76 118.39 4.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.492 -0.322 . . . . 2.0899999999999999 111.204 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.456 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 3.1 pt20 -124.42 164.01 20.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.169 -0.469 . . . . 2.0899999999999999 110.674 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.05 150.36 11.32 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.608 -0.806 . . . . 1.0700000000000001 113.595 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 0.4 OUTLIER -72.47 113.9 10.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.875 0.369 . . . . 1.1100000000000001 110.124 179.159 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.574 ' HD3' HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -142.96 160.51 52.61 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.372 -0.376 . . . . 1.6200000000000001 110.173 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.31 134.18 24.24 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.468 2.112 . . . . 1.01 111.056 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.795 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 15.3 m -119.28 136.08 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 110.005 -0.368 . . . . 0.76000000000000001 110.005 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.425 ' HB3' HG23 ' A' ' 43' ' ' VAL . 21.8 tp -94.35 128.72 41.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.083 -0.508 . . . . 0.69999999999999996 111.437 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.448 HD13 ' CG1' ' A' ' 42' ' ' VAL . 14.2 mm -73.32 114.56 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.345 -0.389 . . . . 0.92000000000000004 110.127 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.42 ' HA ' ' CE ' ' A' ' 98' ' ' MET . 88.2 t -90.33 -41.82 13.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.002 0.43 . . . . 0.94999999999999996 111.953 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.69 147.18 96.36 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 112.04 0.385 . . . . 1.1200000000000001 112.04 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.45 159.12 54.76 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.767 2.311 . . . . 1.3 111.986 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.61 70.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.982 -0.554 . . . . 1.3899999999999999 112.348 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.29 94.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.846 0.355 . . . . 1.6100000000000001 110.948 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -66.48 -41.2 89.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.039 -0.528 . . . . 1.77 110.482 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 66.9 m-20 -67.54 -11.82 58.92 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.034 -0.53 . . . . 1.48 110.886 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.8 ttp-105 -94.79 -31.96 13.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.175 -0.466 . . . . 2.6200000000000001 111.212 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.41 -49.08 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.824 0.676 . . . . 1.8600000000000001 112.824 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 p -95.27 -27.05 15.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.953 0.406 . . . . 1.72 110.564 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 67.13 21.25 10.15 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.367 -0.833 . . . . 4.4500000000000002 111.395 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.0 mt -125.65 98.98 33.37 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.393 -0.821 . . . . 1.8100000000000001 109.027 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.438 ' HG3' ' SD ' ' A' ' 1' ' ' MET . 90.1 Cg_endo -88.55 134.54 2.85 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.806 2.337 . . . . 1.05 113.775 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.9 t -79.21 114.37 19.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.193 -1.41 . . . . 1.03 107.193 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.795 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 31.5 m -115.66 150.61 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 113.44 0.904 . . . . 0.77000000000000002 113.44 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 26' ' ' LEU . 1.7 m -117.97 129.03 25.62 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.931 -1.031 . . . . 0.71999999999999997 108.96 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 43' ' ' VAL . 12.2 Cg_exo -70.35 145.44 53.77 Favored 'Trans proline' 0 CA--C 1.527 0.17 0 C-N-CA 123.186 2.591 . . . . 1.03 113.871 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.8 t -107.49 119.9 57.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.509 -0.923 . . . . 1.28 108.509 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.4 m . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 120.521 0.201 . . . . 1.9099999999999999 111.172 -179.258 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 112.338 -0.305 . . . . 1.6599999999999999 112.338 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.477 ' HD2' ' HB3' ' A' ' 104' ' ' ARG . 58.9 m-85 -106.06 69.07 0.79 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.127 0.489 . . . . 1.5600000000000001 111.328 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.19 138.45 29.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.9 -0.591 . . . . 1.25 110.03 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.691 HG21 HG22 ' A' ' 101' ' ' VAL . 17.7 t -116.25 118.24 58.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.601 -0.272 . . . . 1.6799999999999999 110.882 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.7 118.87 20.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.609 -0.269 . . . . 1.95 111.117 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.445 ' HB3' HD11 ' A' ' 66' ' ' ILE . 83.3 mt -82.87 -18.61 39.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.233 0.54 . . . . 1.23 110.58 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -67.37 117.04 8.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.566 -0.743 . . . . 2.21 109.954 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.78 -31.4 2.21 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.381 -0.688 . . . . 1.1499999999999999 111.381 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 61' ' ' LEU . 34.7 m -83.18 -17.26 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.835 0.35 . . . . 1.21 111.502 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.58 83.07 0.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.849 -0.691 . . . . 1.0800000000000001 112.68 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 61' ' ' LEU . 11.7 pt -138.44 169.67 17.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.838 -0.43 . . . . 1.0700000000000001 109.838 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -76.5 -51.73 11.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.79 0.329 . . . . 3.5899999999999999 110.586 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.9 m -85.34 75.88 10.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.269 0.557 . . . . 1.51 110.948 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.02 158.47 29.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.759 -0.655 . . . . 1.79 111.322 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 156.42 -157.34 27.83 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 121.069 -0.586 . . . . 1.1799999999999999 111.744 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.6 t -130.04 126.39 61.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 110.178 -0.305 . . . . 1.5600000000000001 110.178 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.7 t -72.56 118.94 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.318 -0.623 . . . . 1.29 109.318 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -92.89 96.03 9.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.241 -0.436 . . . . 2.23 110.971 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.16 -6.04 57.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.538 0.685 . . . . 1.1699999999999999 109.373 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.452 ' HA ' ' CZ ' ' B' ' 33' ' ' PHE . 3.9 p-10 -78.98 -16.2 57.24 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.902 -1.045 . . . . 0.89000000000000001 112.689 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -136.83 68.71 58.47 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 114.138 1.162 . . . . 2.1299999999999999 114.138 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.79 140.73 32.63 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.289 1.993 . . . . 0.80000000000000004 109.914 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.462 ' HD3' HD13 ' A' ' 11' ' ' LEU . 6.1 ptm85 -156.21 114.15 3.31 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.823 0.675 . . . . 2.0899999999999999 112.823 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.536 ' OG1' ' HD2' ' B' ' 77' ' ' PRO . 90.8 m -82.76 109.94 17.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.154 -0.476 . . . . 1.6200000000000001 110.089 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.0 pt -120.96 155.18 24.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.038 -0.528 . . . . 1.1499999999999999 109.641 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.53 125.77 26.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.976 0.417 . . . . 1.03 111.5 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.45 ' SD ' ' HA3' ' A' ' 87' ' ' GLY . 40.3 tpp -103.08 9.24 38.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.094 0.473 . . . . 1.29 110.718 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -92.94 -64.21 1.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.173 -0.467 . . . . 2.6400000000000001 111.854 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.58 -27.96 63.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.293 -0.412 . . . . 1.1200000000000001 111.305 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 85' ' ' ARG . 45.8 mtt180 -73.81 -29.86 62.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.253 -0.431 . . . . 1.0600000000000001 110.502 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.32 66.94 2.09 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.896 -0.669 . . . . 1.1200000000000001 112.355 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.45 ' HA3' ' SD ' ' A' ' 82' ' ' MET . . . -69.14 151.94 51.67 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.713 -0.756 . . . . 1.0900000000000001 112.27 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -113.43 122.12 46.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.31 -0.255 . . . . 2.46 110.31 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -82.18 135.28 35.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.655 0.264 . . . . 2.4900000000000002 111.224 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 90' ' ' LEU . 3.0 mm? -104.27 -64.68 1.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.134 0.492 . . . . 1.29 110.616 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -162.95 -169.07 1.93 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.791 -0.64 . . . . 1.1499999999999999 109.346 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -130.77 156.48 44.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.684 0.278 . . . . 1.3200000000000001 110.579 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.542 HG13 HD11 ' A' ' 6' ' ' ILE . 26.8 m -97.33 156.59 36.05 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.39 -0.368 . . . . 0.75 111.085 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -64.19 145.52 89.09 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.721 2.281 . . . . 0.94999999999999996 111.129 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -61.19 -25.7 67.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 1.51 111.662 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -38.43 87.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.877 0.37 . . . . 1.5700000000000001 110.577 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 101' ' ' VAL . 47.7 mm -73.56 -46.48 48.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.96 -0.564 . . . . 1.3100000000000001 109.921 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.42 ' CE ' ' HA ' ' A' ' 28' ' ' VAL . 9.8 tpt -63.03 -26.05 68.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.953 -0.567 . . . . 1.6000000000000001 110.99 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.15 -48.22 79.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.673 -0.694 . . . . 2.2999999999999998 111.634 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -28.41 60.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.543 -0.299 . . . . 1.6399999999999999 111.55 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.691 HG22 HG21 ' A' ' 59' ' ' VAL . 57.8 t -62.2 -46.93 95.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.699 -0.482 . . . . 1.03 109.699 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 77.7 mt -61.34 -36.38 80.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.614 -0.721 . . . . 1.22 110.185 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.31 -46.18 94.95 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.479 -0.782 . . . . 1.03 112.453 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.477 ' HB3' ' HD2' ' A' ' 57' ' ' PHE . 21.5 mtt180 -65.4 -37.84 88.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 1.72 110.77 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.61 -18.27 65.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.757 -0.656 . . . . 1.02 112.253 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.1 m -78.82 -24.96 44.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.938 0.399 . . . . 1.1100000000000001 111.164 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.75 -22.25 50.56 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.124 0.416 . . . . 1.5 112.124 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.0 pt -84.23 -9.22 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 111.96 0.356 . . . . 1.1499999999999999 111.96 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.3 mt -84.2 73.03 10.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.897 0.379 . . . . 0.97999999999999998 110.092 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 116.361 -0.381 . . . . 1.3500000000000001 111.666 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.882 ' HA ' ' HA ' ' B' ' 30' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.743 0.306 . . . . 2.0299999999999998 110.881 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -82.27 -21.53 36.18 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.328 -0.619 . . . . 2.8199999999999998 109.328 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' ARG . . . . . 0.713 ' HG2' ' HG2' ' B' ' 98' ' ' MET . 6.4 mtm180 72.14 120.9 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.946 -1.024 . . . . 2.3199999999999998 112.903 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' B' ' 92' ' ' ARG . . . 97.47 -26.76 21.66 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.741 -0.663 . . . . 1.28 113.679 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.427 ' OE1' ' HD2' ' B' ' 89' ' ' ARG . 6.5 mm-40 -71.08 97.84 1.55 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.848 0.685 . . . . 1.53 112.848 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.84 HD11 ' HB ' ' B' ' 93' ' ' VAL . 64.5 mt -95.26 125.91 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.851 -0.796 . . . . 0.75 108.851 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -105.78 164.78 11.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.986 0.422 . . . . 0.81000000000000005 112.007 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 45.8 tp -128.87 120.04 25.51 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.05 -0.523 . . . . 1.05 109.949 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.46 HG22 ' H ' ' B' ' 10' ' ' SER . 4.8 p -159.69 169.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.251 -0.431 . . . . 0.71999999999999997 110.122 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' SER . . . . . 0.46 ' H ' HG22 ' B' ' 9' ' ' VAL . 0.3 OUTLIER -97.77 135.54 39.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.779 0.323 . . . . 1.6299999999999999 110.472 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' B' ' 44' ' ' PRO . 35.3 mt -86.28 -18.26 32.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.234 -0.439 . . . . 0.82999999999999996 111.189 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.96 154.24 89.81 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.915 -0.584 . . . . 1.6200000000000001 111.116 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.727 ' HG2' ' HB2' ' A' ' 13' ' ' PRO . 58.5 Cg_endo -73.47 124.28 9.38 Favored 'Cis proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.266 -1.556 . . . . 1.28 113.041 0.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.489 ' HB ' ' HG2' ' B' ' 20' ' ' GLN . 0.0 OUTLIER -121.93 166.85 13.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.554 -0.748 . . . . 1.47 109.918 179.206 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.87 -171.24 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.582 0.23 . . . . 1.22 111.069 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.96 -104.92 1.18 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 116.081 -0.508 . . . . 1.01 112.702 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -132.43 14.52 4.54 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.293 0.568 . . . . 2.1800000000000002 110.285 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -78.07 143.95 36.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.735 -0.666 . . . . 1.28 110.061 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.08 105.47 2.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.763 0.316 . . . . 1.52 111.224 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.489 ' HG2' ' HB ' ' B' ' 14' ' ' THR . 6.7 mt-30 -83.89 -174.73 5.45 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.112 -0.495 . . . . 1.8600000000000001 110.913 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.05 -167.11 49.25 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.95 -0.568 . . . . 0.90000000000000002 112.752 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 20.1 m -113.89 122.27 46.49 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.428 -0.582 . . . . 0.94999999999999996 109.428 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -151.61 159.99 32.42 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.681 -0.488 . . . . 1.5900000000000001 109.681 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.674 ' HG2' HG21 ' B' ' 68' ' ' THR . 47.2 Cg_exo -59.47 137.76 79.86 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.192 1.928 . . . . 0.65000000000000002 110.671 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.863 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 4.3 m -128.09 128.13 68.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.989 0.424 . . . . 0.56999999999999995 111.126 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 46.7 tp -94.44 121.2 35.74 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.961 -0.563 . . . . 1.1699999999999999 109.605 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ILE . . . . . 0.504 HG12 HG12 ' B' ' 42' ' ' VAL . 51.5 mt -80.86 137.82 20.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.956 -0.387 . . . . 0.66000000000000003 109.956 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.87 -29.39 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.821 0.344 . . . . 0.93000000000000005 111.051 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' THR . . . . . 0.543 HG23 HG22 ' B' ' 41' ' ' VAL . 0.9 OUTLIER -74.06 137.31 75.89 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.258 -0.428 . . . . 0.81000000000000005 111.615 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.882 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 43.1 Cg_endo -67.2 161.42 42.99 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.009 2.473 . . . . 0.78000000000000003 112.045 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.77 -37.08 73.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.169 -0.468 . . . . 1.03 111.677 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.51 -29.99 71.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.114 0.483 . . . . 1.3999999999999999 111.176 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' PHE . . . . . 0.548 ' HB2' ' HG2' ' B' ' 30' ' ' PRO . 2.2 t80 -81.13 -40.01 24.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.033 0.444 . . . . 1.5700000000000001 110.135 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' B' ' 38' ' ' ARG . 44.8 m-20 -66.52 -22.32 66.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.63 -0.713 . . . . 1.6399999999999999 110.725 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -79.75 -34.83 39.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 2.54 110.948 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 58.0 t -85.4 -64.21 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.156 -0.475 . . . . 1.0900000000000001 111.987 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 1.3 m -67.51 -30.77 70.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.385 -0.37 . . . . 1.3300000000000001 111.014 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.534 ' HE ' ' HA ' ' B' ' 38' ' ' ARG . 0.7 OUTLIER 71.69 -9.84 0.9 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.534 0.568 . . . . 1.78 112.534 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 60.4 mt -118.62 100.93 51.09 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.681 -0.489 . . . . 1.1599999999999999 109.681 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' PRO . . . . . 0.46 ' HD2' ' O ' ' B' ' 80' ' ' ILE . 93.1 Cg_endo -86.68 158.96 9.14 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.742 2.295 . . . . 0.56999999999999995 113.322 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.543 HG22 HG23 ' B' ' 29' ' ' THR . 6.4 m -92.95 127.2 45.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 109.202 -0.666 . . . . 1.0800000000000001 109.202 178.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.863 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 27.8 m -114.68 146.78 18.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.252 0.549 . . . . 0.64000000000000001 112.148 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.428 HG13 ' O ' ' B' ' 73' ' ' ARG . 43.1 t -109.84 112.91 57.87 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.944 -1.026 . . . . 1.1000000000000001 109.279 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.522 ' HB3' HD11 ' B' ' 11' ' ' LEU . 56.0 Cg_endo -72.06 119.42 6.16 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.69 2.26 . . . . 0.72999999999999998 112.567 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 91.6 t -77.49 136.44 24.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.812 -0.631 . . . . 0.90000000000000002 110.202 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 3.9 m -105.07 112.01 24.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.129 -0.487 . . . . 1.1699999999999999 110.097 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 CA-C-N 116.184 -0.462 . . . . 1.8500000000000001 110.64 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.138 0.494 . . . . 1.96 109.995 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.95 -94.24 0.78 Allowed Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.77 -0.65 . . . . 1.0800000000000001 112.464 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -87.72 -6.64 58.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.921 0.391 . . . . 3.5699999999999998 111.096 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.36 113.91 22.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.36 -0.382 . . . . 1.0800000000000001 110.392 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.453 HG22 ' HD2' ' B' ' 104' ' ' ARG . 13.8 t -77.79 141.29 15.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.03 -0.532 . . . . 1.3400000000000001 110.335 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -90.2 124.94 35.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.54 -0.3 . . . . 1.3799999999999999 110.709 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.516 ' HB3' HD13 ' B' ' 66' ' ' ILE . 72.4 mt -89.97 -35.68 15.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.267 -0.424 . . . . 1.02 110.868 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -82.87 -173.22 4.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 1.79 111.321 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.92 -38.46 3.17 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.162 -0.775 . . . . 1.1499999999999999 111.162 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 7.0 p -94.85 -3.35 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.953 0.406 . . . . 1.1699999999999999 110.679 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.88 84.29 1.68 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.789 -0.719 . . . . 1.05 112.597 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.516 HD13 ' HB3' ' B' ' 61' ' ' LEU . 12.0 tt -135.3 160.58 40.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.798 -0.445 . . . . 1.6100000000000001 109.798 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -83.5 -45.13 13.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.864 0.364 . . . . 2.3999999999999999 110.705 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' THR . . . . . 0.674 HG21 ' HG2' ' B' ' 24' ' ' PRO . 17.1 m -85.46 90.52 7.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.154 0.502 . . . . 0.93000000000000005 111.643 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 52.7 m -71.46 98.1 1.77 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.804 -0.634 . . . . 1.3100000000000001 111.016 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -165.05 -171.2 31.0 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.793 -0.717 . . . . 0.79000000000000004 112.152 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 15.1 m -117.58 151.97 19.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.862 0.363 . . . . 0.93000000000000005 111.131 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.451 ' HB ' ' HB ' ' B' ' 59' ' ' VAL . 47.3 t -87.92 121.96 39.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.904 -0.589 . . . . 1.3799999999999999 110.219 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.428 ' O ' HG13 ' B' ' 43' ' ' VAL . 33.3 mmm-85 -97.25 84.93 3.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.953 0.406 . . . . 1.3700000000000001 111.138 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 29.6 m -73.67 -0.75 16.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.189 -0.459 . . . . 1.1599999999999999 111.228 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.44 ' C ' ' HD3' ' B' ' 77' ' ' PRO . 16.9 p-10 -96.06 -2.8 45.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.977 -0.556 . . . . 1.1000000000000001 111.939 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' GLN . . . . . 0.55 ' N ' ' HD3' ' B' ' 77' ' ' PRO . 39.3 mt-30 -130.16 52.45 9.42 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.538 0.94 . . . . 2.4700000000000002 113.538 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' B' ' 76' ' ' GLN . 1.0 OUTLIER -84.87 119.4 2.18 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.269 1.979 . . . . 0.95999999999999996 111.49 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -125.61 140.34 52.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.705 0.288 . . . . 1.96 111.453 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.18 126.98 31.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.679 -0.86 . . . . 1.1899999999999999 108.679 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.46 ' O ' ' HD2' ' B' ' 40' ' ' PRO . 31.5 pt -133.8 149.54 30.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.389 0.514 . . . . 1.28 112.389 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' B' ' 83' ' ' LYS . 14.1 t0 -76.41 91.71 3.32 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.277 -0.638 . . . . 1.28 109.277 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' MET . . . . . 0.451 ' SD ' ' HA3' ' B' ' 87' ' ' GLY . 48.5 tpp -67.76 -16.71 64.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.976 -0.556 . . . . 2.7000000000000002 111.869 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' B' ' 81' ' ' ASP . 5.0 mtmp? -75.91 -45.58 34.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.282 -0.417 . . . . 1.96 111.111 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.98 -31.69 25.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.236 -0.438 . . . . 1.0600000000000001 111.88 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' B' ' 85' ' ' ARG . 66.1 mtt-85 -72.61 -36.01 67.98 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.943 0.349 . . . . 1.47 111.943 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.64 80.1 1.44 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.351 -0.928 . . . . 0.81999999999999995 112.108 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' GLY . . . . . 0.451 ' HA3' ' SD ' ' B' ' 82' ' ' MET . . . -90.55 162.0 28.93 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.746 -0.74 . . . . 0.65000000000000002 112.749 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -155.96 155.37 32.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.661 -0.866 . . . . 1.8100000000000001 108.661 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ARG . . . . . 0.427 ' HD2' ' OE1' ' B' ' 5' ' ' GLU . 5.6 ttp180 -99.35 142.26 31.06 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 121.083 -0.247 . . . . 2.4900000000000002 111.144 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 53.5 mt -108.39 -97.06 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.95 0.352 . . . . 0.76000000000000001 111.95 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' GLU . . . . . 0.436 ' HG3' HD12 ' B' ' 6' ' ' ILE . 15.5 pt-20 -106.89 169.86 8.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.466 -0.334 . . . . 1.0700000000000001 111.153 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' B' ' 4' ' ' GLY . 3.7 ttt180 -110.72 106.06 15.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.373 -0.376 . . . . 2.0499999999999998 110.417 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.84 ' HB ' HD11 ' B' ' 6' ' ' ILE . 14.4 p -69.37 133.05 89.36 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.405 -0.361 . . . . 1.45 110.851 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.8 147.11 33.09 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.002 2.468 . . . . 1.03 112.52 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -60.67 -28.32 68.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.852 -0.613 . . . . 2.1400000000000001 110.937 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -47.16 86.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.762 -0.654 . . . . 1.78 110.768 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 51.6 mm -74.66 -40.07 47.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.545 . . . . 1.3300000000000001 110.199 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' MET . . . . . 0.713 ' HG2' ' HG2' ' B' ' 3' ' ' ARG . 8.8 tpt -58.56 -38.01 76.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.9 -0.591 . . . . 2.3399999999999999 110.981 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -60.94 -39.35 89.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.917 0.389 . . . . 1.9099999999999999 110.701 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -67.14 -27.63 67.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 1.76 111.257 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.444 ' HA ' HG21 ' B' ' 59' ' ' VAL . 63.3 t -70.94 -51.27 36.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.414 -0.587 . . . . 1.01 109.414 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.23 -36.59 81.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.585 -0.734 . . . . 1.29 110.821 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.23 -50.88 63.07 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.936 -0.575 . . . . 1.02 112.079 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 104' ' ' ARG . . . . . 0.453 ' HD2' HG22 ' B' ' 59' ' ' VAL . 77.2 mtt85 -62.95 -35.89 81.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.72 0.295 . . . . 1.8500000000000001 110.893 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 35.4 mt -66.03 -31.2 71.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.247 0.546 . . . . 1.9399999999999999 110.115 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -80.81 -18.73 46.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.793 -0.64 . . . . 1.1599999999999999 110.858 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 7.8 m -74.13 -38.88 63.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.296 -0.411 . . . . 1.45 110.841 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 34.6 pt -76.29 2.25 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 111.982 0.364 . . . . 1.98 111.982 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 86.2 mt -82.97 -13.84 55.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.345 -0.389 . . . . 1.3600000000000001 111.138 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.802 -0.618 . . . . 2.1299999999999999 110.273 179.65 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.578 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 24.4 ptp . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.887 0.375 . . . . 1.29 110.474 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -129.23 158.4 39.14 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.971 -0.559 . . . . 2.0099999999999998 110.55 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -61.64 122.61 15.73 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 110.037 -0.357 . . . . 1.8500000000000001 110.037 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 111.09 -8.85 29.22 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.914 -0.66 . . . . 0.85999999999999999 112.055 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.578 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 49.7 mt-10 -85.8 145.35 27.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.88 0.371 . . . . 0.98999999999999999 111.365 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.414 HD11 HG13 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -110.12 110.75 33.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.259 -0.645 . . . . 1.1599999999999999 109.259 179.083 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 89' ' ' ARG . 27.2 m95 -104.67 135.22 46.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.934 0.397 . . . . 0.91000000000000003 111.294 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.764 ' HB2' HD21 ' A' ' 90' ' ' LEU . 25.6 tp -95.51 122.3 38.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.26 -0.427 . . . . 0.90000000000000002 110.822 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 p -160.87 157.24 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 1.04 109.936 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.642 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -89.17 130.01 35.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.841 -0.429 . . . . 1.3200000000000001 109.841 179.38 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.6 mt -78.96 -10.51 59.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.252 -0.431 . . . . 1.29 110.952 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.531 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 5.1 m-20 -73.23 164.47 60.78 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.707 -0.679 . . . . 1.54 110.922 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.531 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 56.2 Cg_endo -69.99 141.12 65.08 Favored 'Cis proline' 0 C--N 1.347 0.49 0 C-N-CA 123.815 -1.327 . . . . 1.6899999999999999 112.533 0.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.522 HG23 ' HA ' ' A' ' 12' ' ' ASP . 23.0 p -120.35 151.81 38.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.296 -0.411 . . . . 1.3600000000000001 111.276 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.85 125.47 11.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.931 -0.577 . . . . 1.7 109.689 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.38 -124.54 6.76 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.206 -0.758 . . . . 1.1799999999999999 111.206 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -139.99 75.54 1.51 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.148 0.499 . . . . 2.7799999999999998 110.948 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.86 166.79 23.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.567 -0.742 . . . . 1.1399999999999999 109.414 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -63.2 128.03 34.0 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.406 0.441 . . . . 2.0899999999999999 110.634 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -131.22 178.62 6.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.064 -0.516 . . . . 2.0899999999999999 110.106 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.1 162.62 38.24 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.804 -0.712 . . . . 1.0700000000000001 113.844 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.642 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 3.6 m -85.95 102.44 13.76 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.975 -0.75 . . . . 1.1100000000000001 108.975 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.515 ' NH1' ' HB3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -136.99 156.12 75.92 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.268 -0.423 . . . . 1.6200000000000001 110.622 -179.449 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.13 123.69 9.43 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.564 2.176 . . . . 1.01 110.795 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.601 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 14.9 m -108.93 134.22 51.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.959 0.409 . . . . 0.76000000000000001 110.156 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.463 HD11 HG22 ' A' ' 93' ' ' VAL . 20.8 tp -86.31 122.61 30.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.849 -0.614 . . . . 0.69999999999999996 111.268 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.476 ' HA ' HG12 ' A' ' 42' ' ' VAL . 22.4 mm -74.76 115.23 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.92000000000000004 109.854 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.9 t -96.75 -38.78 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 112.07 0.396 . . . . 0.94999999999999996 112.07 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.08 147.22 76.48 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 112.186 0.439 . . . . 1.1200000000000001 112.186 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.02 156.25 65.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.853 2.368 . . . . 1.3 112.03 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.19 61.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.816 -0.629 . . . . 1.3899999999999999 112.561 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.09 -46.3 90.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.745 0.307 . . . . 1.6100000000000001 111.453 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -67.62 -41.2 84.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.12 0.486 . . . . 1.77 110.416 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.497 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 35.4 m-20 -66.5 -18.61 65.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.712 -0.676 . . . . 1.48 111.362 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -88.99 -42.22 11.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.393 -0.367 . . . . 2.6200000000000001 111.966 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 p -81.13 -44.42 20.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.032 0.753 . . . . 1.8600000000000001 113.032 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 m -90.72 -24.2 20.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.83 0.348 . . . . 1.72 111.395 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 5.9 mpt_? 64.25 15.79 9.64 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.915 -0.584 . . . . 4.4500000000000002 111.851 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.57 87.74 55.8 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 1.8100000000000001 111.045 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.591 ' HD2' ' O ' ' A' ' 80' ' ' ILE . 60.6 Cg_endo -75.66 132.12 14.24 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.207 1.938 . . . . 1.05 112.248 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.573 HG22 HG23 ' A' ' 79' ' ' THR . 75.8 t -77.62 118.9 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.097 -1.445 . . . . 1.03 107.097 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.601 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 35.1 m -127.68 161.3 35.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.617 0.723 . . . . 0.77000000000000002 112.87 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -125.06 130.74 24.09 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 114.547 -1.206 . . . . 0.71999999999999997 108.292 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 69.8 Cg_endo -74.7 141.73 27.98 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.528 2.152 . . . . 1.03 113.68 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.411 HG22 HG22 ' A' ' 72' ' ' VAL . 90.0 t -107.12 111.04 33.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.996 -0.742 . . . . 1.28 108.996 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 116.36 -0.382 . . . . 1.9099999999999999 110.431 -179.642 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.683 0 N-CA-C 111.711 -0.556 . . . . 1.6599999999999999 111.711 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -108.81 15.2 23.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.154 0.502 . . . . 1.5600000000000001 111.252 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -132.23 77.86 1.78 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.814 -0.63 . . . . 1.25 110.2 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.485 HG23 ' HB ' ' A' ' 72' ' ' VAL . 28.6 m -85.26 133.62 28.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.837 -0.62 . . . . 1.6799999999999999 111.285 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.69 148.16 24.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.778 -0.646 . . . . 1.95 110.802 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.9 ' HB3' HD11 ' A' ' 66' ' ' ILE . 80.1 mt -91.64 -16.84 26.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.245 0.545 . . . . 1.23 110.175 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.21 124.95 25.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.668 -0.696 . . . . 2.21 110.614 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.4 -27.94 2.94 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.45 -0.66 . . . . 1.1499999999999999 111.45 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.5 m -96.01 -13.2 8.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.667 0.27 . . . . 1.21 111.266 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.96 72.8 0.97 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.957 -0.639 . . . . 1.0800000000000001 113.108 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.9 HD11 ' HB3' ' A' ' 61' ' ' LEU . 15.6 pt -123.25 -167.86 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.613 0.244 . . . . 1.0700000000000001 111.043 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -102.95 -43.78 5.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.147 0.499 . . . . 3.5899999999999999 109.781 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.2 m -64.75 109.34 2.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.514 -0.766 . . . . 1.51 111.327 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 m -102.21 127.28 49.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.06 -0.518 . . . . 1.79 111.101 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 162.31 -166.84 36.65 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.499 -1.04 . . . . 1.1799999999999999 110.499 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.81 131.89 72.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.24 -0.652 . . . . 1.5600000000000001 109.24 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.485 ' HB ' HG23 ' A' ' 59' ' ' VAL . 47.2 t -78.23 117.56 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.835 0.35 . . . . 1.29 110.83 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 44' ' ' PRO . 19.1 mmm180 -82.85 103.39 12.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.639 -0.504 . . . . 2.23 109.639 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.19 1.96 55.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.135 0.493 . . . . 1.1699999999999999 110.943 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -89.67 -16.32 30.7 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.586 -0.734 . . . . 0.89000000000000001 111.341 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -125.61 72.73 68.23 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 113.49 0.922 . . . . 2.1299999999999999 113.49 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -90.97 115.18 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.888 2.392 . . . . 0.80000000000000004 110.014 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -138.07 165.88 25.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.163 0.506 . . . . 2.0899999999999999 111.735 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.573 HG23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -97.18 133.02 42.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.343 -0.984 . . . . 1.6200000000000001 108.343 178.661 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.591 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 20.2 pt -132.21 148.35 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.788 0.328 . . . . 1.1499999999999999 111.304 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -82.08 102.42 11.02 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.882 -0.414 . . . . 1.03 109.882 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.3 tpp -89.76 -10.12 46.75 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.235 -0.439 . . . . 1.29 111.108 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 83' ' ' LYS . 17.1 tptp -79.69 -41.25 27.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.798 0.332 . . . . 2.6400000000000001 111.274 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.09 -26.82 42.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.421 -0.354 . . . . 1.1200000000000001 111.388 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 85' ' ' ARG . 33.1 mtt-85 -84.06 -59.47 2.39 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.385 0.513 . . . . 1.0600000000000001 112.385 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.78 109.29 0.3 Allowed Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.889 -0.672 . . . . 1.1200000000000001 111.85 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.03 -168.66 12.5 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.649 -0.786 . . . . 1.0900000000000001 112.79 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -131.36 138.97 49.4 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.063 -0.347 . . . . 2.46 110.063 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 7' ' ' TRP . 17.3 ttp180 -86.2 139.8 30.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.753 0.311 . . . . 2.4900000000000002 111.137 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.764 HD21 ' HB2' ' A' ' 8' ' ' LEU . 1.9 mm? -89.04 -55.37 3.71 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.049 -0.722 . . . . 1.29 109.049 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -170.37 -160.61 0.22 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.183 -0.917 . . . . 1.1499999999999999 108.688 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -134.58 149.97 50.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.688 0.28 . . . . 1.3200000000000001 110.456 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.463 HG22 HD11 ' A' ' 26' ' ' LEU . 31.4 m -97.73 159.82 30.07 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.26 -0.427 . . . . 0.75 111.092 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -64.87 155.87 65.28 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.713 2.276 . . . . 0.94999999999999996 111.398 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -63.59 -26.94 68.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 1.51 110.753 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.34 -37.59 78.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.542 . . . . 1.5700000000000001 110.573 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.5 mm -70.06 -43.69 78.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.022 -0.535 . . . . 1.3100000000000001 110.12 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.7 tpt -63.7 -45.87 88.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 1.6000000000000001 110.459 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -61.58 -36.69 81.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.024 -0.535 . . . . 2.2999999999999998 110.716 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 5.1 tp10 -63.08 -47.64 82.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.072 -0.513 . . . . 1.6399999999999999 110.589 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.446 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 78.8 t -61.64 -46.02 97.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.939 -0.573 . . . . 1.03 110.336 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.55 -39.14 83.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.099 -0.501 . . . . 1.22 110.689 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.42 -43.37 99.15 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.783 -0.644 . . . . 1.03 111.644 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 3.2 mmt180 -65.14 -37.76 88.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 1.72 110.49 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 101' ' ' VAL . 96.7 mt -67.43 -25.06 65.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.56 . . . . 1.02 111.691 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.2 m -71.89 -11.53 60.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 1.1100000000000001 111.067 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.26 -13.65 26.31 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.316 0.487 . . . . 1.5 112.316 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.497 ' HB ' HG22 ' B' ' 29' ' ' THR . 36.1 pt -100.75 -1.24 9.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.827 0.677 . . . . 1.1499999999999999 112.827 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.8 mt -81.65 73.7 8.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.753 0.311 . . . . 0.97999999999999998 110.222 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.545 -0.298 . . . . 1.3500000000000001 111.596 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.757 ' HA ' ' HA ' ' B' ' 30' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 120.708 0.289 . . . . 2.0299999999999998 110.432 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 2' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' B' ' 3' ' ' ARG . 2.0 mp0 -77.39 -25.95 51.33 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.922 -0.77 . . . . 2.8199999999999998 108.922 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 3' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' B' ' 2' ' ' GLU . 10.7 mtm180 73.03 142.84 0.06 Allowed 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 114.96 -1.018 . . . . 2.3199999999999998 111.457 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' B' ' 92' ' ' ARG . . . 86.46 -50.03 4.16 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.898 -0.668 . . . . 1.28 113.62 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.44 ' OE2' ' HD2' ' B' ' 92' ' ' ARG . 64.7 mm-40 -57.66 107.41 0.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.838 0.681 . . . . 1.53 112.838 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.441 HD12 ' HG3' ' B' ' 91' ' ' GLU . 80.6 mt -98.66 127.28 51.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.374 -0.602 . . . . 0.75 109.374 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -107.68 168.82 8.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.201 0.524 . . . . 0.81000000000000005 111.805 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' B' ' 88' ' ' LYS . 33.5 tp -141.53 132.17 25.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.697 -0.683 . . . . 1.05 109.941 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.411 HG12 HG21 ' B' ' 25' ' ' VAL . 5.2 p -169.26 165.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.532 -0.544 . . . . 0.71999999999999997 109.532 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' B' ' 22' ' ' THR . 22.9 t -88.76 139.36 30.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.677 -0.49 . . . . 1.6299999999999999 109.677 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.714 HD13 ' HB3' ' B' ' 19' ' ' GLN . 31.7 mt -87.72 -16.82 33.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.201 0.524 . . . . 0.82999999999999996 110.349 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ASP . . . . . 0.414 ' CB ' ' HA ' ' B' ' 13' ' ' PRO . 2.1 m-20 -73.83 162.08 75.72 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.76 -0.655 . . . . 1.6200000000000001 111.283 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.414 ' HA ' ' CB ' ' B' ' 12' ' ' ASP . 98.2 Cg_endo -80.28 135.56 33.92 Favored 'Cis proline' 0 C--N 1.344 0.299 0 C-N-CA 123.359 -1.517 . . . . 1.28 113.259 0.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.02 170.51 15.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.345 -0.843 . . . . 1.47 109.575 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.46 165.09 28.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.575 0.226 . . . . 1.22 110.551 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.34 -146.23 34.23 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.122 -0.561 . . . . 1.01 112.266 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -90.15 -1.72 57.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.384 -0.228 . . . . 2.1800000000000002 110.384 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -57.78 154.25 12.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.906 -0.588 . . . . 1.28 112.201 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.714 ' HB3' HD13 ' B' ' 11' ' ' LEU . 28.9 mm-40 -60.94 127.35 31.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.686 -0.688 . . . . 1.52 111.383 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -142.06 -176.6 4.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.893 -0.594 . . . . 1.8600000000000001 110.533 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.59 174.82 50.62 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.993 -0.622 . . . . 0.90000000000000002 112.697 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' B' ' 10' ' ' SER . 22.9 m -105.65 103.62 13.16 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.828 -0.434 . . . . 0.94999999999999996 109.828 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -141.55 157.98 64.25 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.241 -0.436 . . . . 1.5900000000000001 110.332 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.02 141.36 79.27 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.495 2.13 . . . . 0.65000000000000002 111.411 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.827 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 6.4 m -131.75 131.49 62.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.379 0.609 . . . . 0.56999999999999995 111.56 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 36.6 tp -101.72 123.85 46.39 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.669 -0.696 . . . . 1.1699999999999999 109.527 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ILE . . . . . 0.422 HG12 HG12 ' B' ' 42' ' ' VAL . 34.4 mt -78.89 138.16 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.58 -0.282 . . . . 0.66000000000000003 110.362 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' B' ' 1' ' ' MET . 21.5 t -99.54 -34.92 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.406 -0.361 . . . . 0.93000000000000005 110.945 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' THR . . . . . 0.497 HG22 ' HB ' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -76.53 140.96 68.78 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.215 -0.448 . . . . 0.81000000000000005 111.634 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.757 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 95.9 Cg_endo -78.76 159.83 27.93 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.767 2.311 . . . . 0.78000000000000003 112.009 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' B' ' 34' ' ' ASN . . . -55.18 -29.7 58.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.212 -0.449 . . . . 1.03 111.954 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.38 -40.73 75.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.292 -0.413 . . . . 1.3999999999999999 110.871 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -89.33 -37.76 14.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.058 -0.519 . . . . 1.5700000000000001 110.63 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.561 ' O ' ' HA ' ' B' ' 38' ' ' ARG . 85.5 m-20 -61.69 -18.22 58.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.704 -0.68 . . . . 1.6399999999999999 112.302 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -88.13 -25.88 22.76 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.694 0.257 . . . . 2.54 111.694 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -82.02 -61.84 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.963 0.411 . . . . 1.0900000000000001 111.645 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.79 -28.21 36.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.186 -0.461 . . . . 1.3300000000000001 111.201 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 1.5 mmp_? 69.9 8.23 6.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.809 -0.632 . . . . 1.78 111.819 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.64 98.06 48.28 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.968 -0.56 . . . . 1.1599999999999999 109.537 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' B' ' 80' ' ' ILE . 85.0 Cg_endo -90.62 155.23 4.28 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.789 2.326 . . . . 0.56999999999999995 113.112 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 m -94.74 124.93 47.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.105 -0.702 . . . . 1.0800000000000001 109.105 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.827 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 28.6 m -111.2 147.19 15.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 112.802 0.667 . . . . 0.64000000000000001 112.802 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.41 118.29 49.38 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 114.752 -1.113 . . . . 1.1000000000000001 108.757 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.609 ' HG3' ' HG3' ' B' ' 19' ' ' GLN . 66.1 Cg_endo -74.14 142.45 30.8 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.628 2.219 . . . . 0.72999999999999998 113.041 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.773 HG22 HG12 ' B' ' 72' ' ' VAL . 44.0 t -95.62 116.72 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.798 -0.637 . . . . 0.90000000000000002 109.809 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.88 145.0 26.87 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.193 -0.458 . . . . 1.1699999999999999 110.79 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 C--N 1.321 -0.672 0 CA-C-O 120.73 0.3 . . . . 1.8500000000000001 110.745 179.728 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.706 ' HB3' ' HB3' ' B' ' 58' ' ' ALA . . . . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 110.53 -0.174 . . . . 1.96 110.53 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.39 -61.33 5.48 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.253 -0.498 . . . . 1.0800000000000001 112.54 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.544 ' HE1' ' HB ' ' B' ' 107' ' ' THR . 70.4 m-85 -114.65 0.38 13.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.283 0.563 . . . . 3.5699999999999998 110.54 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.706 ' HB3' ' HB3' ' B' ' 55' ' ' ALA . . . -100.16 106.23 17.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.614 -0.721 . . . . 1.0800000000000001 110.573 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.652 HG21 ' HA ' ' B' ' 101' ' ' VAL . 57.0 t -87.92 129.31 39.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.675 -0.693 . . . . 1.3400000000000001 109.895 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.4 t -85.08 138.21 32.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.224 -0.444 . . . . 1.3799999999999999 111.467 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 37.8 mt -106.11 5.81 30.47 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.719 -0.845 . . . . 1.02 108.719 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -101.19 144.48 30.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.239 -0.891 . . . . 1.79 110.864 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.14 -23.33 11.5 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 116.102 -0.499 . . . . 1.1499999999999999 111.96 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.624 HG13 HG13 ' B' ' 66' ' ' ILE . 4.2 p -100.14 -20.52 5.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.173 0.511 . . . . 1.1699999999999999 111.54 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.96 51.62 0.88 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.601 -0.809 . . . . 1.05 112.708 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.624 HG13 HG13 ' B' ' 64' ' ' VAL . 82.6 mt -109.13 147.42 13.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.446 -0.575 . . . . 1.6100000000000001 109.446 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -65.53 -49.53 68.61 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.869 0.366 . . . . 2.3999999999999999 110.133 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 17.8 m -67.89 101.8 1.15 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.915 -0.584 . . . . 0.93000000000000005 109.866 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.17 113.97 25.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.138 -0.483 . . . . 1.3100000000000001 111.253 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.98 -170.25 39.18 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.439 -0.886 . . . . 0.79000000000000004 112.681 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.623 ' HB ' ' HB1' ' B' ' 58' ' ' ALA . 6.0 m -123.86 133.97 67.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.972 -0.381 . . . . 0.93000000000000005 109.972 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.773 HG12 HG22 ' B' ' 45' ' ' VAL . 19.3 m -82.34 138.11 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.464 -0.334 . . . . 1.3799999999999999 111.445 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 mmm-85 -94.82 85.09 4.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.376 -0.374 . . . . 1.3700000000000001 110.101 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' CYS . . . . . 0.411 ' HB3' HD23 ' B' ' 105' ' ' LEU . 3.4 m -67.85 -9.21 42.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 1.1599999999999999 111.617 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -92.24 -1.86 56.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.471 . . . . 1.1000000000000001 111.833 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -128.27 83.24 66.71 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 112.02 0.378 . . . . 2.4700000000000002 112.02 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -92.01 144.87 2.92 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.01 2.473 . . . . 0.95999999999999996 112.181 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -148.42 131.46 16.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.453 -0.34 . . . . 1.96 111.01 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.07 126.52 34.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.549 . . . . 1.1899999999999999 109.567 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.532 ' O ' ' HD2' ' B' ' 40' ' ' PRO . 23.9 pt -140.47 151.33 20.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 1.28 111.315 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.522 ' CG ' ' HZ1' ' B' ' 83' ' ' LYS . 10.3 t70 -80.67 100.43 8.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 1.28 109.852 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' MET . . . . . 0.683 ' SD ' ' HA3' ' B' ' 87' ' ' GLY . 48.5 tpp -66.62 -16.77 64.43 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.674 0.62 . . . . 2.7000000000000002 112.674 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.522 ' HZ1' ' CG ' ' B' ' 81' ' ' ASP . 6.6 mtmp? -80.29 -54.34 5.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.931 0.396 . . . . 1.96 110.887 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.65 -28.16 67.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.125 -0.489 . . . . 1.0600000000000001 111.34 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -85.44 -11.39 54.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.295 -0.411 . . . . 1.47 111.501 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.96 57.49 18.47 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 121.096 -0.573 . . . . 0.81999999999999995 112.754 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' GLY . . . . . 0.683 ' HA3' ' SD ' ' B' ' 82' ' ' MET . . . -66.24 148.86 51.15 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.934 -0.65 . . . . 0.65000000000000002 112.793 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 88' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' B' ' 8' ' ' LEU . 0.1 OUTLIER -127.11 164.45 21.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.49 -0.189 . . . . 1.8100000000000001 110.49 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -105.23 137.22 43.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.771 0.319 . . . . 2.4900000000000002 110.399 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 23.5 mt -98.55 -69.26 0.77 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.233 -0.439 . . . . 0.76000000000000001 111.908 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' GLU . . . . . 0.441 ' HG3' HD12 ' B' ' 6' ' ' ILE . 16.4 pt-20 -154.02 -171.13 3.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.069 -0.514 . . . . 1.0700000000000001 110.705 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' B' ' 4' ' ' GLY . 10.6 ttt180 -128.03 119.92 26.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.032 0.444 . . . . 2.0499999999999998 111.262 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 2.6 p -84.58 135.06 41.2 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.687 -0.688 . . . . 1.45 109.637 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.45 145.78 27.48 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.954 2.436 . . . . 1.03 113.097 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' B' ' 95' ' ' GLU . 1.2 mm-40 -56.76 -29.15 62.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.757 -0.656 . . . . 2.1400000000000001 111.517 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -39.14 77.53 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.326 -0.397 . . . . 1.78 111.362 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 31.5 mm -79.26 -29.8 13.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.276 0.56 . . . . 1.3300000000000001 109.516 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 11.2 mmt -62.89 -32.31 73.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.59 -0.732 . . . . 2.3399999999999999 110.566 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.15 -41.85 93.64 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.922 -0.581 . . . . 1.9099999999999999 110.253 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 9.9 tp10 -62.57 -45.04 94.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.814 -0.63 . . . . 1.76 110.024 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.652 ' HA ' HG21 ' B' ' 59' ' ' VAL . 38.4 t -62.66 -49.86 82.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.649 -0.705 . . . . 1.01 111.05 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 86.7 mt -55.85 -38.57 70.25 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.343 -0.389 . . . . 1.29 111.512 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.58 -44.78 97.05 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.655 -0.783 . . . . 1.02 111.34 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 8.8 mmt180 -68.34 -33.36 74.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.059 0.456 . . . . 1.8500000000000001 110.472 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.455 ' O ' HG12 ' B' ' 108' ' ' ILE . 78.7 mt -64.35 -24.87 67.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.882 -0.599 . . . . 1.9399999999999999 110.854 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 23.2 m -85.17 -24.16 28.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.152 -0.476 . . . . 1.1599999999999999 110.882 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.544 ' HB ' ' HE1' ' B' ' 57' ' ' PHE . 0.5 OUTLIER -73.35 -28.57 62.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.259 -0.428 . . . . 1.45 112.068 -179.149 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.455 HG12 ' O ' ' B' ' 105' ' ' LEU . 40.7 pt -68.5 -19.67 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.548 0.573 . . . . 1.98 112.548 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.31 59.45 5.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.271 0.558 . . . . 1.3600000000000001 111.457 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-N 115.954 -0.566 . . . . 2.1299999999999999 109.699 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 23.3 ptp . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.925 0.393 . . . . 1.29 110.532 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -116.78 172.11 7.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.226 -0.443 . . . . 2.0099999999999998 111.077 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -73.19 131.06 41.54 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.196 -0.456 . . . . 1.8500000000000001 111.031 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.67 1.22 58.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.878 -0.677 . . . . 0.85999999999999999 113.116 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.419 ' OE2' ' HD2' ' A' ' 89' ' ' ARG . 35.9 mt-10 -84.61 146.86 27.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 0.98999999999999999 111.255 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.74 HD12 ' HG3' ' A' ' 91' ' ' GLU . 21.2 mt -106.52 118.91 55.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.862 -0.608 . . . . 1.1599999999999999 110.265 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -118.05 128.65 54.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.91000000000000003 111.124 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.669 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 19.9 tp -80.07 130.03 34.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.366 -0.379 . . . . 0.90000000000000002 110.621 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.444 HG11 HD11 ' A' ' 80' ' ' ILE . 9.0 p -158.28 165.17 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.415 -0.357 . . . . 1.04 110.389 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 m -104.95 139.86 39.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.848 0.356 . . . . 1.3200000000000001 110.898 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.675 HD23 HD13 ' A' ' 80' ' ' ILE . 25.3 mt -98.43 -9.17 25.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.003 0.43 . . . . 1.29 110.58 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.497 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 2.7 m-20 -78.1 165.55 49.7 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.533 -0.758 . . . . 1.54 110.672 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.497 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 73.2 Cg_endo -73.95 139.25 60.46 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.83 -1.321 . . . . 1.6899999999999999 113.073 0.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.684 ' OG1' ' HB3' ' A' ' 20' ' ' GLN . 21.5 p -111.27 157.1 20.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.502 -0.772 . . . . 1.3600000000000001 110.175 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -136.3 148.93 48.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.34 . . . . 1.7 111.075 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.88 -86.62 1.07 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.94 -0.648 . . . . 1.1799999999999999 112.176 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -160.44 45.13 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.158 0.504 . . . . 2.7799999999999998 111.258 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.677 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 29.8 mt-10 -79.43 176.63 9.52 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.737 -0.468 . . . . 1.1399999999999999 109.737 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -78.94 90.35 4.75 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.434 -0.58 . . . . 2.0899999999999999 109.434 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.684 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 1.4 pt20 -89.94 158.63 17.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.783 -0.644 . . . . 2.0899999999999999 112.059 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.9 127.72 6.18 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.684 -0.689 . . . . 1.0700000000000001 112.805 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.9 m -63.14 129.92 42.37 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.77 0.319 . . . . 1.1100000000000001 110.336 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.43 155.49 29.86 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.175 -0.466 . . . . 1.6200000000000001 110.283 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 11.7 Cg_exo -72.53 131.6 17.69 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.314 2.009 . . . . 1.01 110.824 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.655 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 20.9 m -107.38 154.12 8.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.439 -0.346 . . . . 0.76000000000000001 110.288 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.48 HD23 HG21 ' A' ' 101' ' ' VAL . 29.7 tp -100.87 133.03 45.96 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.372 -0.377 . . . . 0.69999999999999996 111.061 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.9 mm -76.51 108.96 10.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.92000000000000004 110.117 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.42 -39.59 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.94999999999999996 112.039 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.35 146.76 81.74 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 112.142 0.423 . . . . 1.1200000000000001 112.142 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 33' ' ' PHE . 41.8 Cg_endo -68.28 158.08 59.08 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.795 2.33 . . . . 1.3 112.107 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.9 -39.7 74.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.932 -0.577 . . . . 1.3899999999999999 112.065 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.73 -42.1 83.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 1.6100000000000001 111.385 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.429 ' HB2' ' HG2' ' A' ' 30' ' ' PRO . 5.9 t80 -70.39 -46.51 63.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.945 -0.57 . . . . 1.77 110.402 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -61.9 -30.31 70.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 1.48 111.197 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -68.39 -44.96 73.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.277 -0.419 . . . . 2.6200000000000001 112.101 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -86.72 -40.97 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 113.907 1.077 . . . . 1.8600000000000001 113.907 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.8 m -84.78 -33.3 23.03 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.767 0.284 . . . . 1.72 111.767 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 65.46 20.42 11.73 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.058 0.456 . . . . 4.4500000000000002 111.673 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.1 mt -134.01 91.78 23.43 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.668 -0.697 . . . . 1.8100000000000001 109.181 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -84.41 135.43 6.12 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.516 2.144 . . . . 1.05 113.339 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -79.17 124.8 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.922 -1.14 . . . . 1.03 107.922 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.655 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 23.4 m -124.33 153.74 31.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.627 0.602 . . . . 0.77000000000000002 112.627 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.42 140.74 27.74 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.352 -0.84 . . . . 0.71999999999999997 109.695 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.27 147.65 16.29 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.801 2.334 . . . . 1.03 113.897 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.604 HG22 HG22 ' A' ' 72' ' ' VAL . 84.0 t -103.76 119.74 52.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.485 -0.779 . . . . 1.28 109.269 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.61 -158.06 0.86 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.506 -0.553 . . . . 1.9099999999999999 109.506 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.72 -178.8 6.16 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.785 -0.45 . . . . 2.5299999999999998 109.785 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -131.92 -69.21 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.407 -0.901 . . . . 3.3599999999999999 110.973 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.02 -99.13 0.12 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 111.553 -0.619 . . . . 3.8300000000000001 111.553 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -86.83 -45.1 11.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.857 0.361 . . . . 4.7199999999999998 111.349 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.573 ' HB3' ' HG2' ' A' ' 53' ' ' ARG . 31.3 t80 -132.54 161.48 33.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.009 -0.541 . . . . 6.2400000000000002 110.301 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.489 ' HA ' HG22 ' A' ' 71' ' ' VAL . . . -77.89 65.56 3.36 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.322 0.582 . . . . 2.5899999999999999 110.815 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.573 ' HG2' ' HB3' ' A' ' 51' ' ' PHE . 1.4 ptm85 -136.37 -168.67 2.29 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.632 -0.713 . . . . 4.5899999999999999 110.656 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.9 121.51 10.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.045 -0.525 . . . . 2.6899999999999999 111.904 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 58' ' ' ALA . . . -137.04 70.25 1.4 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.279 0.561 . . . . 3.1699999999999999 109.803 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.525 ' HA3' ' O4 ' ' C' ' 2' ' ' ' U' . . . 72.99 -97.17 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.797 -0.638 . . . . 1.6599999999999999 111.939 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -87.94 -9.65 52.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.235 0.54 . . . . 1.5600000000000001 110.28 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -91.86 134.21 34.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.466 -0.788 . . . . 1.25 108.981 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 13.2 m -94.97 165.68 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.062 0.458 . . . . 1.6799999999999999 111.912 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 1.1 m -71.97 143.25 49.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.842 -0.617 . . . . 1.95 111.041 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.688 HD11 HG23 ' A' ' 72' ' ' VAL . 4.9 mt -136.49 -52.92 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.135 0.42 . . . . 1.23 112.135 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 9.4 t70 -66.22 116.07 6.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.129 0.49 . . . . 2.21 111.788 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.59 -27.86 0.85 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.633 -0.712 . . . . 1.1499999999999999 111.848 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.408 HG23 HG23 ' A' ' 66' ' ' ILE . 25.5 m -89.56 -10.48 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.36 0.504 . . . . 1.21 112.36 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.72 73.02 1.06 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.802 -0.713 . . . . 1.0800000000000001 112.606 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.408 HG23 HG23 ' A' ' 64' ' ' VAL . 6.9 pt -116.63 172.3 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.804 0.335 . . . . 1.0700000000000001 111.011 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.0 ttm-85 -92.68 -28.35 16.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.226 0.536 . . . . 3.5899999999999999 109.922 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.8 m -77.22 109.55 11.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.651 -0.704 . . . . 1.51 111.068 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 m -93.45 110.69 22.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.231 0.539 . . . . 1.79 110.898 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.439 ' HA3' ' N4 ' ' C' ' 4' ' ' ' C' . . . 171.18 -169.02 42.14 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.119 -0.792 . . . . 1.1799999999999999 111.119 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 52' ' ' ALA . 4.7 t -129.24 124.87 61.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 110.192 -0.299 . . . . 1.5600000000000001 110.192 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.688 HG23 HD11 ' A' ' 61' ' ' LEU . 78.2 t -73.97 121.12 24.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.692 -0.485 . . . . 1.29 109.692 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.474 ' NH1' ' C2 ' ' C' ' 3' ' ' ' A' . 19.8 mtm180 -114.94 135.97 53.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.914 0.388 . . . . 2.23 110.721 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.4 ' SG ' HG13 ' A' ' 101' ' ' VAL . 8.1 m -113.89 32.51 5.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.907 -0.588 . . . . 1.1699999999999999 109.697 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.612 ' HB2' ' HZ ' ' B' ' 33' ' ' PHE . 20.1 p-10 -88.97 -49.63 6.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.467 -0.788 . . . . 0.89000000000000001 111.73 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.438 ' HG2' ' OD2' ' A' ' 75' ' ' ASP . 40.2 mm-40 -117.3 74.58 8.03 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.7 -0.227 . . . . 2.1299999999999999 111.587 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -96.34 163.6 1.22 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.943 2.429 . . . . 0.80000000000000004 112.495 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' B' ' 78' ' ' ARG . 1.1 ptm180 -170.24 146.11 2.87 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.297 -0.411 . . . . 2.0899999999999999 110.802 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.638 ' HB ' ' HG3' ' B' ' 76' ' ' GLN . 2.4 m -84.68 93.87 8.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.051 0.453 . . . . 1.6200000000000001 109.915 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.675 HD13 HD23 ' A' ' 11' ' ' LEU . 20.5 pt -84.36 -174.19 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.483 0.659 . . . . 1.1499999999999999 112.718 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -89.54 132.06 35.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.047 -0.979 . . . . 1.03 110.554 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 51.8 tpp -127.26 26.39 6.03 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.472 -0.936 . . . . 1.29 108.472 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -112.33 -45.92 3.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.518 -0.765 . . . . 2.6400000000000001 111.093 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.27 -26.09 16.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.179 -0.464 . . . . 1.1200000000000001 111.409 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -80.06 -43.77 21.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.236 -0.438 . . . . 1.0600000000000001 111.626 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.99 127.67 2.05 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.831 -0.7 . . . . 1.1200000000000001 112.759 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -104.05 136.74 13.17 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.849 -0.691 . . . . 1.0900000000000001 112.077 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 6.8 mptt -109.47 117.04 32.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.945 -0.391 . . . . 2.46 109.945 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.419 ' HD2' ' OE2' ' A' ' 5' ' ' GLU . 6.8 ttp85 -74.55 126.27 30.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.751 0.31 . . . . 2.4900000000000002 110.943 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.25 -73.36 0.68 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.073 0.463 . . . . 1.29 110.801 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.74 ' HG3' HD12 ' A' ' 6' ' ' ILE . 19.4 pt-20 -146.57 -164.52 2.0 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.638 -0.71 . . . . 1.1499999999999999 109.522 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 92' ' ' ARG . 3.6 ptm180 -143.18 150.66 39.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.755 0.312 . . . . 1.3200000000000001 110.746 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.669 HG13 HD11 ' A' ' 6' ' ' ILE . 16.0 m -102.5 151.96 38.29 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.217 -0.447 . . . . 0.75 110.465 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -66.16 167.22 18.74 Favored 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 122.636 2.224 . . . . 0.94999999999999996 111.644 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -60.73 -21.4 62.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.977 -0.556 . . . . 1.51 111.537 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -42.24 94.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.928 -0.578 . . . . 1.5700000000000001 110.599 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.7 mm -76.19 -33.88 24.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.841 -0.618 . . . . 1.3100000000000001 110.823 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.4 tpt -59.9 -41.36 91.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 1.6000000000000001 110.99 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -65.64 -35.08 79.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 2.2999999999999998 110.648 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 1.2 mm-40 -60.52 -48.35 82.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.934 -0.576 . . . . 1.6399999999999999 111.295 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.48 HG21 HD23 ' A' ' 26' ' ' LEU . 58.1 t -63.67 -40.78 90.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.952 -0.567 . . . . 1.03 111.226 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.2 mt -68.54 1.05 3.39 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.225 0.824 . . . . 1.22 113.225 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.12 -1.18 26.8 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.121 -1.038 . . . . 1.03 112.945 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -104.82 -20.56 13.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.9 0.381 . . . . 1.72 111.771 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.5 mt -73.73 -24.82 59.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.001 0.429 . . . . 1.02 111.707 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -28.86 62.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.839 0.352 . . . . 1.1100000000000001 111.544 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.85 -17.28 61.08 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.055 0.761 . . . . 1.5 113.055 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.1 pt -93.51 -13.62 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 111.978 0.362 . . . . 1.1499999999999999 111.978 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.2 mt -86.39 86.8 7.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.928 0.394 . . . . 0.97999999999999998 110.939 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' B' ' 30' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 116.367 -0.379 . . . . 1.3500000000000001 111.037 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.602 ' HG3' ' O ' ' B' ' 27' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.366 0.603 . . . . 2.0299999999999998 112.577 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' B' ' 31' ' ' ALA . 30.4 mt-10 -95.62 -7.47 37.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.431 -0.804 . . . . 2.8199999999999998 109.608 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? 73.42 120.71 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.22 1.193 . . . . 2.3199999999999998 114.22 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.472 ' HA2' HG12 ' B' ' 93' ' ' VAL . . . 72.51 43.54 44.38 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 115.008 0.763 . . . . 1.28 115.008 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -117.55 93.74 4.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.26 0.53 . . . . 1.53 112.377 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.787 HD11 ' HB ' ' B' ' 93' ' ' VAL . 57.2 mt -100.05 102.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.442 -0.947 . . . . 0.75 108.442 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.459 ' HA ' ' HA ' ' B' ' 89' ' ' ARG . 13.8 m95 -105.79 145.84 30.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.272 0.558 . . . . 0.81000000000000005 112.4 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 22.9 tp -102.77 119.73 39.35 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.471 -0.937 . . . . 1.05 108.471 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.93 159.29 4.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.865 0.364 . . . . 0.71999999999999997 110.788 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.68 121.22 25.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.155 -0.475 . . . . 1.6299999999999999 110.519 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.493 HD21 HG11 ' B' ' 25' ' ' VAL . 88.5 mt -79.69 -20.62 46.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.147 -0.479 . . . . 0.82999999999999996 110.728 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.07 153.89 90.9 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.639 . . . . 1.6200000000000001 110.574 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -88.98 162.26 39.68 Favored 'Cis proline' 0 C--O 1.236 0.394 0 C-N-CA 123.438 -1.484 . . . . 1.28 112.053 -0.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.507 HG21 ' HB3' ' B' ' 18' ' ' GLU . 0.2 OUTLIER -150.24 160.73 43.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 1.47 110.587 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.29 142.97 37.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.783 0.325 . . . . 1.22 110.61 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.24 -155.62 34.66 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.949 -0.643 . . . . 1.01 112.433 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -85.53 50.43 1.96 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.197 0.443 . . . . 2.1800000000000002 112.197 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.507 ' HB3' HG21 ' B' ' 14' ' ' THR . 4.0 mt-10 -112.76 163.71 14.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.19 -0.459 . . . . 1.28 109.847 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.844 ' HG3' ' HG3' ' B' ' 44' ' ' PRO . 86.7 mm-40 -73.17 138.28 45.6 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.164 0.802 . . . . 1.52 113.164 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -146.65 -179.73 6.98 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.58 -0.736 . . . . 1.8600000000000001 110.419 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.24 150.88 21.57 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.125 -0.56 . . . . 0.90000000000000002 112.549 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 45.2 m -86.34 106.04 17.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.953 0.406 . . . . 0.94999999999999996 109.925 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' B' ' 23' ' ' ARG . 0.3 OUTLIER -149.65 159.95 35.11 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.159 -0.473 . . . . 1.5900000000000001 109.759 -178.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.72 139.8 82.59 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.347 2.031 . . . . 0.65000000000000002 111.21 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.639 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 3.3 m -137.12 152.33 27.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.39 -0.368 . . . . 0.56999999999999995 110.509 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.618 HD23 HG11 ' B' ' 101' ' ' VAL . 22.9 tp -103.05 121.66 43.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.113 -0.494 . . . . 1.1699999999999999 109.722 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ILE . . . . . 0.602 ' O ' ' HG3' ' B' ' 1' ' ' MET . 10.5 mt -74.31 148.63 8.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.432 -0.349 . . . . 0.66000000000000003 110.703 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.524 ' HB ' HG23 ' B' ' 41' ' ' VAL . 21.9 t -114.78 -34.18 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.014 0.435 . . . . 0.93000000000000005 110.988 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.29 138.43 91.85 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.059 -0.519 . . . . 0.81000000000000005 112.208 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.525 ' HB3' ' HB ' ' A' ' 110' ' ' THR . 83.5 Cg_endo -77.41 170.27 19.69 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.888 2.392 . . . . 0.78000000000000003 112.638 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.593 ' HB2' ' HG2' ' B' ' 2' ' ' GLU . . . -62.79 -30.31 71.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.852 -0.613 . . . . 1.03 110.61 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.03 -0.75 8.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.665 -0.698 . . . . 1.3999999999999999 112.3 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' PHE . . . . . 0.612 ' HZ ' ' HB2' ' A' ' 75' ' ' ASP . 7.5 t80 -135.14 -40.53 0.74 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.952 0.406 . . . . 1.5700000000000001 111.0 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -59.54 -33.05 70.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.834 -0.621 . . . . 1.6399999999999999 111.471 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -97.41 11.69 35.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.365 -0.379 . . . . 2.54 110.993 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 97.7 t -110.57 -67.03 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 1.0900000000000001 111.493 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' THR . . . . . 0.462 HG22 " H3'" ' C' ' 2' ' ' ' U' . 14.5 p -84.07 -22.83 31.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.764 0.316 . . . . 1.3300000000000001 110.979 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.44 ' HE ' ' HA ' ' B' ' 38' ' ' ARG . 1.2 mmp_? 70.35 12.87 7.57 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.596 -0.729 . . . . 1.78 111.689 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 17.1 mt -119.7 90.18 42.78 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.401 -0.962 . . . . 1.1599999999999999 108.401 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -92.45 161.78 2.98 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.737 2.291 . . . . 0.56999999999999995 114.134 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.555 HG13 HG23 ' B' ' 79' ' ' THR . 0.8 OUTLIER -98.88 130.75 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.173 -1.047 . . . . 1.0800000000000001 108.173 177.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.639 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 23.5 m -120.76 145.48 27.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 112.68 0.622 . . . . 0.64000000000000001 112.68 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 53.5 t -97.73 118.53 63.97 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.874 -1.057 . . . . 1.1000000000000001 108.451 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.844 ' HG3' ' HG3' ' B' ' 19' ' ' GLN . 50.3 Cg_endo -67.67 124.27 11.75 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.861 2.374 . . . . 0.72999999999999998 113.259 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.619 HG22 HG12 ' B' ' 72' ' ' VAL . 46.1 t -87.31 139.79 16.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.161 -0.681 . . . . 0.90000000000000002 109.161 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -120.95 116.09 24.44 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.561 -0.533 . . . . 1.1699999999999999 109.561 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 9.5 m -56.33 139.06 49.66 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.934 -0.576 . . . . 1.8500000000000001 112.168 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.17 -4.0 53.95 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.744 -0.662 . . . . 2.2200000000000002 111.599 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.37 -102.13 2.79 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.003 -0.618 . . . . 3.4300000000000002 111.916 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -107.66 -19.68 13.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.554 0.216 . . . . 4.6200000000000001 111.31 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -150.75 147.36 27.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.479 -0.328 . . . . 6.2699999999999996 110.255 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' B' ' 62' ' ' ASP . . . -131.93 156.45 46.14 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.441 -0.345 . . . . 4.3899999999999997 110.257 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -140.85 146.0 36.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.577 -0.283 . . . . 3.9199999999999999 110.305 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 3.9 t -78.47 137.46 37.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.385 -0.371 . . . . 2.75 110.089 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.33 115.97 2.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.497 -0.32 . . . . 1.96 111.074 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.501 ' O ' ' HD2' ' B' ' 104' ' ' ARG . . . 62.79 -110.23 3.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.136 -0.554 . . . . 1.0800000000000001 112.534 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -93.46 -14.38 26.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.976 0.417 . . . . 3.5699999999999998 110.788 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.55 110.08 10.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 1.0800000000000001 110.864 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.707 HG21 ' HA ' ' B' ' 101' ' ' VAL . 85.7 t -87.97 131.48 35.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.941 -0.572 . . . . 1.3400000000000001 109.501 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 9.3 t -88.3 119.05 28.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.409 -0.359 . . . . 1.3799999999999999 111.131 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 60.3 mt -87.9 -18.11 29.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.723 -0.843 . . . . 1.02 108.723 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ASP . . . . . 0.487 ' HB3' ' HB3' ' B' ' 52' ' ' ALA . 19.7 t0 -86.46 142.92 28.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.201 -0.909 . . . . 1.79 110.469 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.9 -55.12 0.76 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 121.034 -0.603 . . . . 1.1499999999999999 111.68 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 13.9 p -73.9 -27.61 22.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.949 0.404 . . . . 1.1699999999999999 111.638 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.66 68.94 0.33 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.871 -0.681 . . . . 1.05 111.977 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.457 HD11 ' HD2' ' B' ' 94' ' ' PRO . 61.0 mt -125.42 148.27 29.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.087 -0.709 . . . . 1.6100000000000001 109.087 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' B' ' 67' ' ' ARG . 1.0 OUTLIER -66.32 -50.41 63.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.958 0.409 . . . . 2.3999999999999999 109.963 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 7.2 m -67.77 94.75 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.851 -0.613 . . . . 0.93000000000000005 110.501 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 4.5 m -87.15 90.71 8.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.924 -0.58 . . . . 1.3100000000000001 110.82 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.81 -170.01 35.29 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.376 -0.916 . . . . 0.79000000000000004 112.383 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' B' ' 59' ' ' VAL . 15.6 m -123.12 145.33 30.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.791 0.329 . . . . 0.93000000000000005 110.667 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.619 HG12 HG22 ' B' ' 45' ' ' VAL . 1.3 m -91.43 136.32 24.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.821 0.343 . . . . 1.3799999999999999 111.198 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.646 ' HB2' ' HG2' ' B' ' 44' ' ' PRO . 11.9 mmm180 -86.32 82.73 7.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 1.3700000000000001 110.611 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 2.5 m -79.81 45.93 0.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.017 0.436 . . . . 1.1599999999999999 110.838 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -135.6 -32.91 0.89 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.927 -0.578 . . . . 1.1000000000000001 110.949 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' GLN . . . . . 0.638 ' HG3' ' HB ' ' A' ' 79' ' ' THR . 61.7 tt0 -125.69 79.47 67.85 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 112.455 0.539 . . . . 2.4700000000000002 112.455 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.438 ' HD2' ' OG1' ' A' ' 79' ' ' THR . 99.0 Cg_endo -89.16 143.47 4.76 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.555 2.17 . . . . 0.95999999999999996 110.647 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ARG . . . . . 0.489 ' HA ' ' HB2' ' A' ' 78' ' ' ARG . 54.5 ttt180 -124.53 141.48 52.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.801 0.334 . . . . 1.96 111.765 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.555 HG23 HG13 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -82.75 121.23 26.62 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.482 -0.932 . . . . 1.1899999999999999 108.482 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 15.9 pt -126.96 -164.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.045 0.45 . . . . 1.28 111.41 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -115.7 143.87 44.75 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.903 -0.777 . . . . 1.28 108.903 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 11.6 ttp -126.32 31.71 5.34 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.734 0.272 . . . . 2.7000000000000002 111.734 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -137.65 -42.5 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.181 0.437 . . . . 1.96 112.181 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.21 -29.63 15.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.816 0.341 . . . . 1.0600000000000001 110.246 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -72.65 -35.73 67.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 1.47 110.628 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.22 106.74 0.99 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.922 -0.656 . . . . 0.81999999999999995 112.757 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.18 159.91 21.89 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.68 -0.772 . . . . 0.65000000000000002 112.084 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -151.59 136.12 16.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.026 -0.361 . . . . 1.8100000000000001 110.026 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' B' ' 7' ' ' TRP . 59.8 ttp180 -76.93 126.13 30.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.652 0.263 . . . . 2.4900000000000002 110.583 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 80.1 mt -82.4 -64.17 1.23 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.242 -0.435 . . . . 0.76000000000000001 110.868 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -139.85 174.17 10.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 1.0700000000000001 110.311 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -112.34 115.11 28.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.234 0.54 . . . . 2.0499999999999998 110.903 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.787 ' HB ' HD11 ' B' ' 6' ' ' ILE . 7.2 p -70.33 133.07 87.48 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.465 -0.789 . . . . 1.45 110.801 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.457 ' HD2' HD11 ' B' ' 66' ' ' ILE . 77.2 Cg_exo -53.66 147.56 39.31 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 122.94 2.427 . . . . 1.03 111.999 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.02 -33.37 67.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.996 -0.547 . . . . 2.1400000000000001 111.021 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.61 -48.97 79.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.862 -0.608 . . . . 1.78 110.799 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 21.2 mm -72.05 -34.48 50.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.771 -0.65 . . . . 1.3300000000000001 110.48 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 11.8 tpt -59.64 -38.63 81.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 2.3399999999999999 110.477 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -65.77 -35.83 81.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.889 -0.596 . . . . 1.9099999999999999 110.853 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 57.1 tt0 -63.55 -46.59 85.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 1.76 109.965 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.707 ' HA ' HG21 ' B' ' 59' ' ' VAL . 24.5 t -58.74 -48.68 85.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.116 -0.493 . . . . 1.01 110.915 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.95 -35.49 76.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.99 -0.55 . . . . 1.29 111.243 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.74 -36.43 92.27 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.259 -0.736 . . . . 1.02 111.259 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 23.9 mmt85 -73.45 -34.07 65.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.04 0.448 . . . . 1.8500000000000001 110.258 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.535 ' O ' HG12 ' B' ' 108' ' ' ILE . 78.7 mt -71.03 -11.41 60.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.893 -0.594 . . . . 1.9399999999999999 111.335 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.7 m -77.71 -8.57 58.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.88 0.371 . . . . 1.1599999999999999 111.488 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.3 m -74.22 -16.17 60.98 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.898 0.333 . . . . 1.45 111.898 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.535 HG12 ' O ' ' B' ' 105' ' ' LEU . 31.5 pt -79.69 -1.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 111.885 0.328 . . . . 1.98 111.885 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 88.8 mt -102.05 15.99 27.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.246 0.546 . . . . 1.3600000000000001 110.6 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.252 1.188 0 CA-C-N 115.769 -0.65 . . . . 2.1299999999999999 110.061 179.691 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.431 -0.553 0 O4'-C1'-C2' 107.707 0.934 . 0.0 '__' . 6.3600000000000003 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' ' U' . . . . . 0.525 ' O4 ' ' HA3' ' A' ' 56' ' ' GLY . . . . . . . . 0 O5'--C5' 1.423 -1.058 0 C4'-C3'-C2' 105.187 2.487 OUTLIER-DELTA 0.0 OUTLIER . 2.9900000000000002 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 3' ' ' ' A' . . . . . 0.665 " H2'" ' N3 ' ' C' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.429 -0.658 0 C1'-C2'-O2' 108.498 -0.701 . 0.0 OUTLIER gamma 2.5899999999999999 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 4' ' ' ' C' . . . . . 0.439 ' N4 ' ' HA3' ' A' ' 70' ' ' GLY . . . . . . . . 0 C3'--C2' 1.541 1.475 0 C4'-C3'-C2' 105.209 2.509 . 0.0 OUTLIER . 2.5099999999999998 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 5' ' ' ' A' . . . . . 0.579 " H2'" ' HB2' ' A' ' 20' ' ' GLN . . . . . . . . 0 O5'--C5' 1.426 -0.886 0 O4'-C1'-C2' 107.82 1.014 . 0.0 OUTLIER . 4.9400000000000004 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 ptp . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.857 0.361 . . . . 1.29 110.481 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -107.66 167.0 10.27 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.103 -0.499 . . . . 2.0099999999999998 111.095 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -74.03 131.58 41.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.842 -0.617 . . . . 1.8500000000000001 109.718 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.15 -1.54 43.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 0.85999999999999999 112.986 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -93.42 149.8 20.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.95 0.375 . . . . 0.98999999999999999 110.695 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.7 pt -113.07 112.82 42.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.352 0.596 . . . . 1.1599999999999999 110.402 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.48 ' O ' HG22 ' A' ' 25' ' ' VAL . 27.8 m95 -105.48 118.23 36.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.696 -0.683 . . . . 0.91000000000000003 110.779 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 15.8 tp -67.02 117.76 9.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.36 -0.382 . . . . 0.90000000000000002 110.332 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.2 p -156.84 157.14 3.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.939 0.399 . . . . 1.04 111.073 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 1.1 t -92.43 124.17 36.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.659 -0.497 . . . . 1.3200000000000001 109.659 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 mt -76.51 -12.55 60.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.772 -0.649 . . . . 1.29 110.533 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 6.9 m-20 -74.28 164.24 62.63 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.202 -0.908 . . . . 1.54 111.314 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.56 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 39.1 Cg_exo -62.92 145.77 54.13 Favored 'Cis proline' 0 C--N 1.353 0.776 0 C-N-CA 124.337 -1.11 . . . . 1.6899999999999999 112.82 0.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.651 HG21 ' HB3' ' A' ' 20' ' ' GLN . 10.3 p -120.72 162.57 19.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.142 -0.481 . . . . 1.3600000000000001 111.829 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.41 146.21 31.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.605 -0.725 . . . . 1.7 109.378 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.15 -129.77 32.16 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.656 -0.783 . . . . 1.1799999999999999 111.998 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -107.61 14.35 25.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.773 0.32 . . . . 2.7799999999999998 111.236 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HB3' ' NH2' ' A' ' 78' ' ' ARG . 37.2 mt-10 -61.6 128.93 38.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.881 -0.414 . . . . 1.1399999999999999 109.881 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -49.09 125.77 11.27 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.052 -0.522 . . . . 2.0899999999999999 112.217 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.651 ' HB3' HG21 ' A' ' 14' ' ' THR . 28.4 pt20 -123.12 176.56 5.99 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.458 -0.792 . . . . 2.0899999999999999 111.486 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.559 ' HA2' " H2'" ' C' ' 5' ' ' ' A' . . . 109.15 140.27 8.9 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.705 -0.759 . . . . 1.0700000000000001 114.116 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 4.1 m -81.8 89.44 6.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.035 -1.098 . . . . 1.1100000000000001 108.035 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.416 HH21 ' HA ' ' A' ' 46' ' ' THR . 0.9 OUTLIER -135.26 160.42 68.15 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.822 -0.626 . . . . 1.6200000000000001 110.419 -177.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 22.4 Cg_exo -65.87 125.33 14.05 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.233 1.955 . . . . 1.01 111.387 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.755 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 22.8 m -101.42 132.03 48.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.088 -0.506 . . . . 0.76000000000000001 110.525 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.619 ' HB3' HG23 ' A' ' 43' ' ' VAL . 46.1 tp -81.98 121.24 26.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.928 -0.578 . . . . 0.69999999999999996 110.879 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.657 ' HA ' HG12 ' A' ' 42' ' ' VAL . 12.3 mm -70.55 110.04 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.256 -0.429 . . . . 0.92000000000000004 110.438 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.599 HG22 ' HE1' ' A' ' 98' ' ' MET . 38.5 t -89.16 -34.52 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.98 0.419 . . . . 0.94999999999999996 111.166 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.09 146.25 84.5 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.244 -0.434 . . . . 1.1200000000000001 111.57 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.763 ' HG2' ' HB2' ' A' ' 33' ' ' PHE . 32.8 Cg_endo -65.1 158.88 49.54 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.55 2.167 . . . . 1.3 111.812 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.39 -41.52 72.76 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.984 -0.553 . . . . 1.3899999999999999 112.333 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.49 97.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.297 -0.41 . . . . 1.6100000000000001 111.413 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.763 ' HB2' ' HG2' ' A' ' 30' ' ' PRO . 4.9 t80 -64.86 -43.9 91.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.289 -0.414 . . . . 1.77 110.834 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -59.8 -30.55 68.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.589 . . . . 1.48 110.949 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -86.74 -35.29 19.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.564 -0.744 . . . . 2.6200000000000001 112.426 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 33' ' ' PHE . 12.7 p -83.01 -45.19 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 113.274 0.842 . . . . 1.8600000000000001 113.274 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -84.17 -27.16 28.27 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.185 -0.322 . . . . 1.72 111.071 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 64.75 19.64 11.89 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.02 -0.536 . . . . 4.4500000000000002 111.304 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.2 tp -143.75 101.08 5.03 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 108.319 -0.993 . . . . 1.8100000000000001 108.319 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -90.67 150.5 4.18 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.807 2.338 . . . . 1.05 114.183 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 HG23 ' A' ' 79' ' ' THR . 56.7 t -98.96 116.73 42.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 106.704 -1.591 . . . . 1.03 106.704 177.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.755 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 19.9 m -125.46 155.38 34.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 113.386 0.884 . . . . 0.77000000000000002 113.386 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 26' ' ' LEU . 3.8 m -120.3 116.23 32.41 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.069 -0.969 . . . . 0.71999999999999997 109.443 178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.26 136.28 31.28 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.837 2.358 . . . . 1.03 113.301 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 24' ' ' PRO . 93.3 t -64.8 136.63 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.684 -0.689 . . . . 1.28 110.234 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.542 ' OG1' ' HG2' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -98.99 171.45 8.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.029 -0.532 . . . . 1.9099999999999999 110.806 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.98 135.58 41.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.165 -0.47 . . . . 2.5299999999999998 110.007 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.89 -11.4 43.45 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.483 -0.865 . . . . 3.3599999999999999 112.298 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.72 -152.64 50.71 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.874 -0.679 . . . . 3.8300000000000001 111.966 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -84.46 -39.52 18.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.044 0.45 . . . . 4.7199999999999998 110.409 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -113.24 96.29 5.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.986 -0.552 . . . . 6.2400000000000002 109.933 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.32 97.75 2.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.988 -0.551 . . . . 2.5899999999999999 110.808 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 53' ' ' ARG . 6.8 ptm180 -128.39 167.59 16.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.054 -0.521 . . . . 4.5899999999999999 110.198 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.53 140.55 48.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.428 -0.351 . . . . 2.6899999999999999 111.017 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.53 74.02 0.87 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.114 -0.493 . . . . 3.1699999999999999 110.012 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.449 ' HA3' ' O4 ' ' C' ' 2' ' ' ' U' . . . 72.35 -116.9 6.02 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.091 -0.804 . . . . 1.6599999999999999 111.091 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.544 ' HD1' ' HB2' ' A' ' 74' ' ' CYS . 46.3 m-85 -82.26 42.44 0.74 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.491 0.662 . . . . 1.5600000000000001 110.187 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -135.33 107.8 7.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.321 -0.854 . . . . 1.25 109.815 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.722 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 22.5 t -97.35 128.17 48.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.141 -0.481 . . . . 1.6799999999999999 110.26 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.64 137.38 38.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.154 -0.475 . . . . 1.95 111.389 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.544 HD13 HD11 ' A' ' 66' ' ' ILE . 74.2 mt -94.56 17.24 13.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.29 0.567 . . . . 1.23 110.903 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -81.5 137.58 35.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.626 -0.716 . . . . 2.21 110.407 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.25 -26.52 11.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.618 -0.801 . . . . 1.1499999999999999 113.066 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.596 HG11 ' HG2' ' A' ' 94' ' ' PRO . 25.8 m -93.17 -24.18 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.106 0.41 . . . . 1.21 112.106 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 68.66 63.37 3.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.795 -0.717 . . . . 1.0800000000000001 113.284 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.544 HD11 HD13 ' A' ' 61' ' ' LEU . 25.3 pt -108.93 -172.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 O-C-N 122.646 -0.326 . . . . 1.0700000000000001 110.569 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.465 ' NH2' ' HB3' ' A' ' 91' ' ' GLU . 57.1 mtm180 -93.2 -39.1 11.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.849 0.357 . . . . 3.5899999999999999 111.432 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 m -64.89 111.7 2.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.302 0.572 . . . . 1.51 111.732 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.28 79.76 2.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.804 -0.634 . . . . 1.79 110.502 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.434 ' HA3' ' H41' ' C' ' 4' ' ' ' C' . . . -152.36 -167.12 14.9 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.783 -0.722 . . . . 1.1799999999999999 112.144 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 t -118.99 139.11 47.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 110.069 -0.345 . . . . 1.5600000000000001 110.069 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.722 ' HB ' ' HB ' ' A' ' 59' ' ' VAL . 23.0 t -79.72 133.14 30.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.775 0.322 . . . . 1.29 111.136 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.549 ' HD2' ' OD1' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -94.81 154.5 17.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.119 -0.491 . . . . 2.23 110.512 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.544 ' HB2' ' HD1' ' A' ' 57' ' ' PHE . 58.8 m -141.0 2.57 1.74 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.955 0.407 . . . . 1.1699999999999999 110.768 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.549 ' OD1' ' HD2' ' A' ' 73' ' ' ARG . 11.2 p-10 -121.77 5.09 9.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.043 -0.526 . . . . 0.89000000000000001 111.163 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -122.03 74.76 38.62 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 112.964 0.727 . . . . 2.1299999999999999 112.964 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.86 119.11 3.53 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.65 2.233 . . . . 0.80000000000000004 109.908 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.495 ' NH2' ' HB3' ' A' ' 18' ' ' GLU . 21.5 mmm180 -117.72 107.24 13.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.068 0.461 . . . . 2.0899999999999999 111.747 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.673 HG23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -94.6 90.27 6.09 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.98 -0.748 . . . . 1.6200000000000001 108.98 178.591 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.9 pt -125.75 150.5 31.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.25 -0.432 . . . . 1.1499999999999999 111.275 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -75.85 124.4 27.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.854 0.359 . . . . 1.03 110.553 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 52.0 tpp -81.61 -20.77 39.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.706 -0.679 . . . . 1.29 112.062 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -65.67 -32.68 74.38 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.767 0.654 . . . . 2.6400000000000001 112.767 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.86 9.18 40.18 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.115 0.413 . . . . 1.1200000000000001 112.115 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 40.7 mtt-85 -127.86 -44.46 1.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.27 0.47 . . . . 1.0600000000000001 112.27 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.91 97.47 0.32 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.815 -0.707 . . . . 1.1200000000000001 112.38 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 8' ' ' LEU . . . -97.75 150.64 19.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.815 -0.707 . . . . 1.0900000000000001 112.296 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -113.38 113.77 25.68 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.015 -0.365 . . . . 2.46 110.015 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -71.07 118.4 13.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.603 0.24 . . . . 2.4900000000000002 111.324 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 8' ' ' LEU . 2.2 mm? -86.76 -68.56 0.74 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.43 -0.581 . . . . 1.29 109.43 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.465 ' HB3' ' NH2' ' A' ' 67' ' ' ARG . 20.3 pt-20 -151.95 -167.43 2.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.347 -0.842 . . . . 1.1499999999999999 109.433 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.9 ptm85 -132.81 142.87 49.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.788 0.327 . . . . 1.3200000000000001 110.702 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.2 m -91.08 158.76 41.07 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.191 -0.459 . . . . 0.75 110.697 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.596 ' HG2' HG11 ' A' ' 64' ' ' VAL . 46.0 Cg_exo -58.92 147.33 90.0 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.539 2.16 . . . . 0.94999999999999996 111.029 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' A' ' 95' ' ' GLU . 2.9 mm-40 -55.54 -29.32 58.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.057 -0.52 . . . . 1.51 111.945 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.66 -33.3 73.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.909 0.385 . . . . 1.5700000000000001 111.174 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.7 mm -70.67 -41.22 77.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.213 0.53 . . . . 1.3100000000000001 109.759 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.599 ' HE1' HG22 ' A' ' 28' ' ' VAL . 3.6 tpt -66.87 -37.98 85.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.56 -0.745 . . . . 1.6000000000000001 110.259 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -61.73 -34.87 76.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.905 -0.589 . . . . 2.2999999999999998 110.477 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.47 -45.52 90.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.008 -0.542 . . . . 1.6399999999999999 110.787 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 35.2 t -62.48 -44.12 98.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.044 -0.525 . . . . 1.03 110.581 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.98 -38.02 81.35 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.016 -0.538 . . . . 1.22 111.084 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.86 -41.65 98.7 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.846 -0.692 . . . . 1.03 112.072 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 104' ' ' ARG . 8.6 mmt180 -67.84 -32.85 73.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.933 0.397 . . . . 1.72 110.73 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 101' ' ' VAL . 95.4 mt -71.03 -25.57 62.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.98 -0.555 . . . . 1.02 110.844 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -74.67 -28.46 60.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.981 0.42 . . . . 1.1100000000000001 111.276 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.87 -22.22 58.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.382 0.512 . . . . 1.5 112.382 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 pt -89.84 1.83 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.739 0.644 . . . . 1.1499999999999999 112.739 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.3 mt -86.67 80.85 8.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.544 0.211 . . . . 0.97999999999999998 110.959 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 111.86 0.318 . . . . 1.3500000000000001 111.86 -179.879 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.541 ' HE1' ' HB2' ' B' ' 5' ' ' GLU . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 121.006 0.432 . . . . 2.0299999999999998 111.633 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -83.94 -14.59 50.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.816 -0.439 . . . . 2.8199999999999998 109.816 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 71.95 113.72 0.06 Allowed 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.827 1.047 . . . . 2.3199999999999998 113.827 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' B' ' 92' ' ' ARG . . . 95.04 -34.64 4.67 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.726 -0.67 . . . . 1.28 114.71 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.541 ' HB2' ' HE1' ' B' ' 1' ' ' MET . 5.5 mm-40 -61.49 106.24 0.62 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.868 0.692 . . . . 1.53 112.868 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.426 HD12 ' HG3' ' B' ' 91' ' ' GLU . 61.3 mt -98.17 128.37 49.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 109.349 -0.611 . . . . 0.75 109.349 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -111.68 153.66 26.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.085 0.469 . . . . 0.81000000000000005 111.536 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.498 ' HB2' HD11 ' B' ' 90' ' ' LEU . 23.5 tp -113.35 123.57 50.42 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.366 -0.605 . . . . 1.05 109.366 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 p -153.92 156.85 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.54 -0.3 . . . . 0.71999999999999997 110.535 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 6.8 m -89.47 129.29 35.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.497 -0.32 . . . . 1.6299999999999999 110.612 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 78.0 mt -81.13 -18.27 47.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.24 0.543 . . . . 0.82999999999999996 110.308 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ASP . . . . . 0.528 ' HA ' ' H ' ' B' ' 14' ' ' THR . 2.1 m-20 -63.25 153.59 81.27 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.215 -0.902 . . . . 1.6200000000000001 110.381 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -93.29 92.1 0.14 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.639 -1.4 . . . . 1.28 112.34 -0.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.528 ' H ' ' HA ' ' B' ' 12' ' ' ASP . 0.0 OUTLIER -79.25 173.82 12.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.182 -0.463 . . . . 1.47 110.144 179.427 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.75 168.22 23.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.577 0.227 . . . . 1.22 111.114 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.98 -130.25 30.13 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.932 -0.652 . . . . 1.01 112.024 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -90.28 -1.84 57.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.833 0.349 . . . . 2.1800000000000002 110.973 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -67.33 123.63 20.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.071 -0.715 . . . . 1.28 109.071 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -52.3 131.38 32.87 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.168 0.803 . . . . 1.52 113.168 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -113.43 139.01 49.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.579 -0.737 . . . . 1.8600000000000001 109.623 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.32 147.6 8.11 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.835 -0.698 . . . . 0.90000000000000002 112.93 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 26.9 m -76.69 124.47 27.7 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.06 -0.348 . . . . 0.94999999999999996 110.06 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.42 158.71 33.36 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.801 -0.444 . . . . 1.5900000000000001 109.801 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.23 131.55 32.71 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.219 1.946 . . . . 0.65000000000000002 110.267 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.613 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 15.7 m -124.79 142.47 41.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.134 0.492 . . . . 0.56999999999999995 111.45 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 18.7 tp -101.51 126.98 48.4 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.223 -0.658 . . . . 1.1699999999999999 109.223 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ILE . . . . . 0.408 ' O ' ' HG3' ' B' ' 1' ' ' MET . 27.7 mt -86.4 144.53 9.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.576 -0.284 . . . . 0.66000000000000003 110.339 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.488 ' HB ' HG23 ' B' ' 41' ' ' VAL . 45.4 t -108.38 -36.09 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.981 0.419 . . . . 0.93000000000000005 110.943 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' THR . . . . . 0.617 HG23 HG22 ' B' ' 41' ' ' VAL . 0.7 OUTLIER -64.64 143.79 98.69 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 0.81000000000000005 112.328 -179.096 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 22.2 Cg_exo -66.81 159.4 51.64 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.097 2.531 . . . . 0.78000000000000003 111.785 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.59 -37.6 73.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.98 -0.555 . . . . 1.03 111.403 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.65 -48.6 81.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 1.3999999999999999 111.066 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -64.18 -40.3 95.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.046 0.451 . . . . 1.5700000000000001 110.673 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' B' ' 38' ' ' ARG . 77.3 m-20 -67.09 -19.88 65.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.924 -0.58 . . . . 1.6399999999999999 111.257 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -95.32 -33.64 12.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.271 -0.422 . . . . 2.54 111.943 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 99.1 t -82.39 -71.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.612 0.244 . . . . 1.0900000000000001 111.367 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.3 -30.04 66.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.781 0.324 . . . . 1.3300000000000001 110.444 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 2.4 mmp_? 66.96 17.42 10.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.607 -0.724 . . . . 1.78 112.257 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.23 92.85 43.81 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.278 -0.638 . . . . 1.1599999999999999 109.278 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' B' ' 80' ' ' ILE . 83.1 Cg_endo -90.57 147.38 4.13 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.813 2.342 . . . . 0.56999999999999995 113.572 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.617 HG22 HG23 ' B' ' 29' ' ' THR . 5.0 m -93.9 118.02 38.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.488 -0.93 . . . . 1.0800000000000001 108.488 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.613 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 35.7 m -108.83 145.79 15.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 112.597 0.592 . . . . 0.64000000000000001 112.597 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 90.5 t -111.03 115.73 52.52 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.955 -1.02 . . . . 1.1000000000000001 108.851 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.51 ' HA ' HG12 ' B' ' 25' ' ' VAL . 7.4 Cg_exo -72.71 123.17 8.8 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.946 2.43 . . . . 0.72999999999999998 113.287 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.31 138.86 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.824 -0.806 . . . . 0.90000000000000002 108.824 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.79 168.92 9.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.544 -0.298 . . . . 1.1699999999999999 110.727 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.41 159.01 25.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.45 -0.341 . . . . 1.8500000000000001 111.227 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.0 72.63 2.25 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.838 -0.696 . . . . 2.2200000000000002 112.142 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.68 58.59 4.89 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.075 -0.583 . . . . 3.4300000000000002 112.367 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -98.79 95.27 7.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.936 0.398 . . . . 4.6200000000000001 110.191 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -79.46 -34.82 41.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.068 -0.515 . . . . 6.2699999999999996 110.633 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -130.93 -71.84 0.57 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.061 -0.518 . . . . 4.3899999999999997 110.188 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -168.25 106.97 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 3.9199999999999999 110.98 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.7 t -100.11 157.6 16.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.287 -0.415 . . . . 2.75 110.566 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.13 -155.15 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 1.96 109.893 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.69 -98.25 2.38 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.994 -0.622 . . . . 1.0800000000000001 112.673 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.643 ' HE1' ' HB ' ' B' ' 107' ' ' THR . 75.4 m-85 -120.54 5.25 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.016 0.436 . . . . 3.5699999999999998 111.28 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.61 107.17 18.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.921 -0.581 . . . . 1.0800000000000001 111.203 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 61.0 t -89.81 122.28 40.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.864 -0.607 . . . . 1.3400000000000001 109.796 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -82.56 123.91 29.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.298 -0.41 . . . . 1.3799999999999999 110.829 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 97.2 mt -91.16 -14.13 31.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.2 -0.455 . . . . 1.02 111.328 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ASP . . . . . 0.726 ' HB2' HG23 ' B' ' 69' ' ' THR . 10.6 t70 -81.84 142.88 32.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.07 -0.514 . . . . 1.79 111.439 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.51 -19.33 12.88 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.919 -0.658 . . . . 1.1499999999999999 112.672 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -109.62 -12.32 11.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.86 0.362 . . . . 1.1699999999999999 111.703 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.47 60.58 0.78 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.451 -0.88 . . . . 1.05 112.53 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.468 HD11 HG23 ' B' ' 93' ' ' VAL . 78.1 mt -121.12 134.79 63.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.772 -0.455 . . . . 1.6100000000000001 109.772 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -63.16 -39.28 94.21 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.073 0.463 . . . . 2.3999999999999999 109.826 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' THR . . . . . 0.414 ' N ' HG22 ' B' ' 66' ' ' ILE . 7.2 m -77.55 73.74 4.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.731 -0.668 . . . . 0.93000000000000005 109.839 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' THR . . . . . 0.726 HG23 ' HB2' ' B' ' 62' ' ' ASP . 13.3 m -73.74 105.3 4.98 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.665 -0.698 . . . . 1.3100000000000001 110.758 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -177.45 -161.21 25.51 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.784 -0.722 . . . . 0.79000000000000004 112.118 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 m -124.27 136.33 60.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.962 0.411 . . . . 0.93000000000000005 110.967 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 32.3 t -88.93 122.76 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.863 -0.608 . . . . 1.3799999999999999 110.346 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 21.9 mmm-85 -92.57 81.48 4.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.926 0.393 . . . . 1.3700000000000001 110.336 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.77 1.33 10.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.942 -0.572 . . . . 1.1599999999999999 112.089 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.09 -7.89 59.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.334 -0.394 . . . . 1.1000000000000001 111.463 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -142.53 84.34 11.18 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 113.459 0.911 . . . . 2.4700000000000002 113.459 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.46 132.93 4.42 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.049 2.499 . . . . 0.95999999999999996 110.277 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.48 127.06 45.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.244 0.461 . . . . 1.96 112.244 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.06 123.24 31.14 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.006 -0.739 . . . . 1.1899999999999999 109.006 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.404 ' O ' ' HD2' ' B' ' 40' ' ' PRO . 35.9 pt -134.61 154.11 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.545 0.212 . . . . 1.28 111.269 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.418 ' CG ' ' HZ1' ' B' ' 83' ' ' LYS . 9.5 t70 -71.45 109.59 5.52 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.262 -0.426 . . . . 1.28 110.428 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 51.7 tpp -78.44 -13.07 60.01 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.572 0.582 . . . . 2.7000000000000002 112.572 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.687 ' HE2' H5'' ' C' ' 1' ' ' ' A' . 6.5 mtmp? -81.64 -44.06 17.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.96 0.409 . . . . 1.96 111.188 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.66 -23.58 56.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.132 -0.485 . . . . 1.0600000000000001 111.73 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' B' ' 85' ' ' ARG . 55.8 mtt-85 -96.16 -47.96 5.84 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.365 0.505 . . . . 1.47 112.365 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.3 101.05 0.6 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.623 -0.799 . . . . 0.81999999999999995 112.398 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -97.76 142.08 15.94 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.816 -0.707 . . . . 0.65000000000000002 112.291 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -123.33 128.69 50.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.384 -0.228 . . . . 1.8100000000000001 110.384 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.524 ' HD2' ' OE1' ' B' ' 5' ' ' GLU . 3.4 ttp180 -69.56 132.61 46.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.767 0.318 . . . . 2.4900000000000002 111.005 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' B' ' 8' ' ' LEU . 93.7 mt -100.29 -69.52 0.77 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.76000000000000001 111.338 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLU . . . . . 0.426 ' HG3' HD12 ' B' ' 6' ' ' ILE . 18.7 pt-20 -142.4 -176.36 4.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.146 -0.479 . . . . 1.0700000000000001 110.259 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' B' ' 4' ' ' GLY . 48.9 ttt180 -125.9 118.0 24.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.79 0.329 . . . . 2.0499999999999998 111.291 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.493 HG13 ' HA2' ' B' ' 4' ' ' GLY . 2.5 p -80.11 131.36 63.09 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 1.45 110.503 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -50.2 145.47 20.32 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.239 2.626 . . . . 1.03 112.312 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -58.49 -27.51 64.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 2.1400000000000001 112.504 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.32 -38.81 84.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.193 0.52 . . . . 1.78 110.352 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 19.8 mm -86.05 -33.65 7.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.804 -0.635 . . . . 1.3300000000000001 109.72 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 11.5 tpt -63.01 -33.22 74.95 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.201 0.524 . . . . 2.3399999999999999 110.225 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -61.13 -38.47 86.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.499 -0.773 . . . . 1.9099999999999999 110.188 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.561 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 31.9 mm-40 -60.18 -41.17 92.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.916 -0.584 . . . . 1.76 110.684 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 34.2 t -60.44 -46.87 94.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.978 -0.555 . . . . 1.01 109.963 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 71.2 mt -62.49 -36.3 82.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.97 -0.559 . . . . 1.29 110.274 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.08 -43.49 97.2 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.6 -0.727 . . . . 1.02 111.801 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 7.6 mmt180 -66.23 -32.21 73.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.055 0.455 . . . . 1.8500000000000001 110.451 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 79.8 mt -71.18 -13.85 62.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.976 -0.556 . . . . 1.9399999999999999 111.232 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 10.8 m -84.04 -24.44 30.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.122 0.487 . . . . 1.1599999999999999 110.395 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.643 ' HB ' ' HE1' ' B' ' 57' ' ' PHE . 0.2 OUTLIER -72.33 -29.18 63.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 1.45 111.571 -179.539 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 49.8 pt -80.39 -3.58 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.727 0.299 . . . . 1.98 111.657 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 96.4 mt -86.04 12.8 8.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.197 0.523 . . . . 1.3600000000000001 110.669 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.246 0.901 0 N-CA-C 109.301 -0.629 . . . . 2.1299999999999999 109.301 179.766 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' ' A' . . . . . 0.687 H5'' ' HE2' ' B' ' 83' ' ' LYS . . . . . . . . 0 O5'--C5' 1.428 -0.761 0 C1'-C2'-O2' 108.38 -0.74 . 0.0 '__' . 6.3600000000000003 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 2' ' ' ' U' . . . . . 0.473 ' C5 ' ' HD2' ' A' ' 57' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.95 0 C3'-C2'-C1' 100.579 -1.023 . 0.0 OUTLIER beta 2.9900000000000002 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 3' ' ' ' A' . . . . . 0.722 " H2'" ' N3 ' ' C' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.856 0 C4'-C3'-C2' 103.618 0.918 . 0.0 OUTLIER gamma 2.5899999999999999 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 4' ' ' ' C' . . . . . 0.434 ' H41' ' HA3' ' A' ' 70' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.908 0 N19-C1'-C2' 115.268 1.167 . 0.0 OUTLIER . 2.5099999999999998 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 5' ' ' ' A' . . . . . 0.559 " H2'" ' HA2' ' A' ' 21' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.786 0 C4'-C3'-C2' 103.759 1.059 . 0.0 OUTLIER gamma 4.9400000000000004 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 ptp . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.901 0.382 . . . . 1.29 110.779 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 43.8 mt-10 -123.16 -173.63 2.76 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.685 -0.689 . . . . 2.0099999999999998 110.376 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -89.16 133.39 34.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.996 -0.547 . . . . 1.8500000000000001 110.898 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.23 13.88 52.95 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.791 -0.719 . . . . 0.85999999999999999 112.997 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 83.3 mt-10 -98.67 153.21 18.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.717 0.294 . . . . 0.98999999999999999 110.571 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.535 HD11 ' HG2' ' A' ' 91' ' ' GLU . 1.1 pt -118.46 110.17 29.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.134 -0.485 . . . . 1.1599999999999999 109.917 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.409 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 31.0 m95 -102.53 122.47 44.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.885 -0.598 . . . . 0.91000000000000003 110.831 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 17.8 tp -82.7 131.89 35.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.116 -0.493 . . . . 0.90000000000000002 111.364 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 85' ' ' ARG . 6.4 p -172.59 159.65 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.201 -0.454 . . . . 1.04 110.245 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.7 m -82.74 141.47 32.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.616 0.246 . . . . 1.3200000000000001 110.767 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.41 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . 68.3 mt -95.32 -11.44 27.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.113 0.482 . . . . 1.29 110.86 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.702 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -74.49 174.46 5.1 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.707 -0.679 . . . . 1.54 110.95 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.702 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 9.8 Cg_exo -73.12 142.47 74.87 Favored 'Cis proline' 0 C--N 1.354 0.851 0 C-N-CA 124.609 -0.996 . . . . 1.6899999999999999 112.386 -0.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.577 HG23 ' HA ' ' A' ' 12' ' ' ASP . 38.7 p -122.44 175.55 6.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 1.3600000000000001 110.993 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.01 103.49 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 1.7 110.319 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.59 -151.84 18.13 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.838 -0.696 . . . . 1.1799999999999999 111.658 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -105.98 37.15 2.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.531 0.682 . . . . 2.7799999999999998 110.374 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -79.86 -170.37 2.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.615 . . . . 1.1399999999999999 109.691 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -77.06 87.11 3.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.271 0.557 . . . . 2.0899999999999999 110.678 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.514 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 1.7 pt20 -107.07 172.9 6.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.238 -0.892 . . . . 2.0899999999999999 111.289 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.463 ' HA2' " H5'" ' C' ' 5' ' ' ' A' . . . 101.3 177.61 28.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.977 -0.63 . . . . 1.0700000000000001 113.74 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.3 m -114.12 129.49 56.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.623 -0.51 . . . . 1.1100000000000001 109.623 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.78 160.44 11.48 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.142 -0.318 . . . . 1.6200000000000001 110.142 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 10.4 Cg_exo -73.5 135.6 22.4 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.302 2.001 . . . . 1.01 110.869 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.87 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 10.7 m -108.38 136.39 44.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.219 -0.446 . . . . 0.76000000000000001 110.28 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.597 ' HB3' HG23 ' A' ' 43' ' ' VAL . 15.8 tp -86.6 125.67 33.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.363 -0.381 . . . . 0.69999999999999996 111.045 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.444 HD13 ' CG1' ' A' ' 42' ' ' VAL . 9.1 mm -74.83 117.24 18.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.318 -0.401 . . . . 0.92000000000000004 110.371 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -92.16 -37.8 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.057 -0.52 . . . . 0.94999999999999996 111.236 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.75 150.96 82.18 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.619 0.6 . . . . 1.1200000000000001 112.619 -179.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 33' ' ' PHE . 65.4 Cg_endo -74.88 158.71 42.47 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.75 2.3 . . . . 1.3 111.934 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.57 -39.85 65.13 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.563 0.579 . . . . 1.3899999999999999 112.563 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.92 99.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.356 . . . . 1.6100000000000001 111.196 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.438 ' HB2' ' HG2' ' A' ' 30' ' ' PRO . 8.0 t80 -69.17 -40.93 77.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.014 -0.539 . . . . 1.77 110.419 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -64.36 -26.13 68.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 1.48 110.773 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -78.26 -25.46 46.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.986 -0.552 . . . . 2.6200000000000001 111.873 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -96.34 -43.88 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.535 0.569 . . . . 1.8600000000000001 112.535 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 m -81.28 -25.74 36.3 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.87 0.322 . . . . 1.72 111.87 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 71.69 -2.8 2.35 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.039 0.536 . . . . 4.4500000000000002 112.217 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 81' ' ' ASP . 2.9 mt -131.33 114.47 15.96 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.379 -0.6 . . . . 1.8100000000000001 109.379 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.4 ' O ' HG23 ' A' ' 79' ' ' THR . 85.6 Cg_endo -89.14 131.56 2.17 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.802 2.335 . . . . 1.05 113.137 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.441 HG11 HD12 ' B' ' 108' ' ' ILE . 48.3 t -67.78 121.09 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.873 -1.158 . . . . 1.03 107.873 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.87 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 17.4 m -128.24 153.2 37.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 113.485 0.92 . . . . 0.77000000000000002 113.485 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.597 HG23 ' HB3' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -114.27 131.1 23.42 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 114.685 -1.143 . . . . 0.71999999999999997 108.788 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 77' ' ' PRO . 71.5 Cg_endo -73.83 114.1 3.95 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.793 2.329 . . . . 1.03 113.973 -178.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.685 HG22 HG22 ' A' ' 72' ' ' VAL . 48.3 t -79.72 99.54 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.089 -0.708 . . . . 1.28 109.089 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.566 ' HB ' ' HD3' ' A' ' 73' ' ' ARG . 2.2 m -120.38 -115.78 0.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.422 -0.354 . . . . 1.9099999999999999 111.394 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.579 ' O ' ' HD2' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -137.94 164.73 28.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.5 0.191 . . . . 2.5299999999999998 110.927 -179.305 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.97 74.74 0.41 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.288 -0.725 . . . . 3.3599999999999999 111.288 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.02 -71.1 3.01 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.793 -0.718 . . . . 3.8300000000000001 111.365 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -163.65 -50.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.819 0.342 . . . . 4.7199999999999998 111.081 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -86.43 143.82 27.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.328 -0.396 . . . . 6.2400000000000002 111.043 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.47 65.1 8.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.145 0.498 . . . . 2.5899999999999999 110.932 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -123.07 -169.29 1.9 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.706 -0.679 . . . . 4.5899999999999999 109.951 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.69 78.22 2.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.052 0.453 . . . . 2.6899999999999999 110.758 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.01 82.29 7.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.066 -0.515 . . . . 3.1699999999999999 110.706 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.498 ' HA3' ' O4 ' ' C' ' 2' ' ' ' U' . . . 67.55 -96.4 0.35 Allowed Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.898 -0.592 . . . . 1.6599999999999999 112.418 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -95.1 -8.38 36.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.907 0.384 . . . . 1.5600000000000001 110.956 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.56 142.85 32.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.208 -0.664 . . . . 1.25 109.208 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.886 HG22 ' HB ' ' A' ' 72' ' ' VAL . 11.4 m -94.82 156.14 3.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.174 0.511 . . . . 1.6799999999999999 112.133 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.26 106.05 17.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.573 -0.74 . . . . 1.95 111.394 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 61' ' ' LEU . 4.1 mt -91.51 -32.13 15.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.179 0.514 . . . . 1.23 110.751 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -75.19 112.37 11.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.072 -0.513 . . . . 2.21 110.628 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.46 -23.01 0.75 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.599 -0.6 . . . . 1.1499999999999999 111.599 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.412 HG23 HG23 ' A' ' 66' ' ' ILE . 15.7 m -100.99 1.84 10.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 111.82 0.304 . . . . 1.21 111.82 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.59 47.41 34.4 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.958 -0.639 . . . . 1.0800000000000001 113.147 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.48 ' H ' HG13 ' A' ' 66' ' ' ILE . 1.5 pp -84.79 173.71 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.673 0.273 . . . . 1.0700000000000001 111.348 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.2 ttm105 -98.54 -55.66 2.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.556 -0.293 . . . . 3.5899999999999999 110.739 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.0 m -62.01 101.62 0.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.187 0.518 . . . . 1.51 110.822 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.73 83.27 5.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.86 -0.609 . . . . 1.79 111.339 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.738 ' HA2' ' N4 ' ' C' ' 4' ' ' ' C' . . . -143.1 158.25 27.15 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.783 -0.722 . . . . 1.1799999999999999 111.674 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.3 t -105.82 107.11 21.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.954 -0.388 . . . . 1.5600000000000001 109.954 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.886 ' HB ' HG22 ' A' ' 59' ' ' VAL . 42.3 t -61.44 116.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.39 . . . . 1.29 110.628 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.579 ' HD2' ' O ' ' A' ' 47' ' ' SER . 74.8 mtp180 -102.78 119.34 38.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.084 -0.507 . . . . 2.23 111.686 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.8 m -103.52 5.88 37.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.429 0.633 . . . . 1.1699999999999999 109.515 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.557 ' HB2' ' CZ ' ' B' ' 33' ' ' PHE . 9.2 p-10 -81.59 -33.79 31.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.454 -0.794 . . . . 0.89000000000000001 111.574 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.55 ' HG3' ' NH2' ' A' ' 73' ' ' ARG . 11.4 mm-40 -130.38 64.02 71.41 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.677 -0.238 . . . . 2.1299999999999999 110.951 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.757 ' HD2' HG11 ' B' ' 41' ' ' VAL . 83.2 Cg_endo -80.56 164.85 20.88 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.092 1.861 . . . . 0.80000000000000004 112.237 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.635 ' HA ' ' O ' ' B' ' 77' ' ' PRO . 13.9 ptm180 -166.7 118.02 0.95 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 2.0899999999999999 110.999 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.535 ' HB ' ' HA ' ' B' ' 76' ' ' GLN . 78.3 m -72.72 109.66 6.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.383 -0.371 . . . . 1.6200000000000001 110.295 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.0 pt -103.08 165.95 2.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.704 -0.68 . . . . 1.1499999999999999 111.225 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HA ' HD23 ' A' ' 39' ' ' LEU . 8.4 t0 -82.78 136.99 34.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.644 -0.707 . . . . 1.03 109.896 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.414 ' SD ' ' HA3' ' A' ' 87' ' ' GLY . 27.6 tpp -111.46 1.59 17.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.273 -0.421 . . . . 1.29 111.216 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -91.28 -56.42 3.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.564 -0.289 . . . . 2.6400000000000001 111.768 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.4 ' HB3' ' HA2' ' B' ' 16' ' ' GLY . . . -78.84 -29.98 44.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.378 . . . . 1.1200000000000001 111.14 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.564 ' HB3' HG21 ' A' ' 9' ' ' VAL . 72.3 mtt-85 -76.35 -39.74 53.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.31 -0.405 . . . . 1.0600000000000001 110.8 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.29 82.19 0.15 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.952 -0.642 . . . . 1.1200000000000001 112.914 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.414 ' HA3' ' SD ' ' A' ' 82' ' ' MET . . . -81.93 168.0 48.55 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.807 -0.711 . . . . 1.0900000000000001 112.848 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 9.4 mptt -121.53 121.94 38.59 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.18 -0.304 . . . . 2.46 110.18 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.38 120.66 23.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.82 0.343 . . . . 2.4900000000000002 111.194 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 90' ' ' LEU . 3.3 mm? -86.71 -67.17 0.83 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.139 -0.482 . . . . 1.29 110.511 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.535 ' HG2' HD11 ' A' ' 6' ' ' ILE . 4.1 pt-20 -153.57 -174.05 4.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.946 -0.57 . . . . 1.1499999999999999 109.58 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -130.58 140.15 50.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.056 0.455 . . . . 1.3200000000000001 110.355 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.0 m -94.15 152.03 40.03 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.865 -0.607 . . . . 0.75 110.801 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.38 162.57 17.09 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.889 2.393 . . . . 0.94999999999999996 111.947 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -62.86 -24.23 67.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 1.51 111.066 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.66 -35.46 80.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 1.5700000000000001 110.702 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.4 mm -69.95 -31.02 46.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.397 -0.594 . . . . 1.3100000000000001 109.397 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.444 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 16.7 tpt -64.89 -34.16 77.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.721 -0.672 . . . . 1.6000000000000001 109.641 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -63.12 -40.39 97.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.675 -0.693 . . . . 2.2999999999999998 109.404 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.633 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 2.2 mm-40 -58.66 -49.35 77.86 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.543 -0.753 . . . . 1.6399999999999999 109.857 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.9 t -62.29 -49.11 85.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.573 -0.74 . . . . 1.03 110.901 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 98' ' ' MET . 94.5 mt -56.74 -43.31 80.57 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.271 -0.422 . . . . 1.22 111.194 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.36 -40.85 98.08 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.115 -0.564 . . . . 1.03 112.524 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.0 mmt180 -71.05 -43.07 68.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.896 0.379 . . . . 1.72 110.914 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.89 -31.4 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 1.02 111.676 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.1 m -69.03 -16.51 63.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.409 -0.359 . . . . 1.1100000000000001 111.521 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.4 m -93.85 -24.45 17.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.693 0.257 . . . . 1.5 111.693 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.7 pt -84.06 -20.9 8.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 112.08 0.4 . . . . 1.1499999999999999 112.08 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 97.3 mt -77.01 79.23 3.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.013 0.435 . . . . 0.97999999999999998 111.603 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.418 ' O ' ' HD2' ' B' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.929 -0.578 . . . . 1.3500000000000001 110.364 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.711 ' HA ' ' HA ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.288 0 N-CA-C 112.756 0.65 . . . . 2.0299999999999998 112.756 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' B' ' 3' ' ' ARG . 3.1 mp0 -71.13 -22.42 62.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.629 -0.714 . . . . 2.8199999999999998 110.848 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ARG . . . . . 0.791 ' HG3' ' HG2' ' B' ' 98' ' ' MET . 4.2 mpt_? 78.82 123.73 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.951 0.722 . . . . 2.3199999999999998 112.951 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.518 ' HA2' HG12 ' B' ' 93' ' ' VAL . . . 80.09 49.22 6.07 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.478 -0.783 . . . . 1.28 113.683 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -125.37 90.38 3.21 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.473 0.546 . . . . 1.53 112.473 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.721 HD11 ' HB ' ' B' ' 93' ' ' VAL . 64.0 mt -99.86 104.39 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.184 -1.043 . . . . 0.75 108.184 178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.446 ' HA ' ' HA ' ' B' ' 89' ' ' ARG . 12.4 m95 -103.79 166.49 10.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.925 -0.579 . . . . 0.81000000000000005 111.59 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 55.4 tp -118.39 112.34 19.87 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.196 -0.668 . . . . 1.05 109.196 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 p -136.61 156.17 35.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.301 -0.409 . . . . 0.71999999999999997 110.362 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 5.8 t -90.28 127.22 36.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.402 -0.592 . . . . 1.6299999999999999 109.402 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 20.5 mt -94.67 -25.88 16.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.192 0.52 . . . . 0.82999999999999996 110.49 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.83 147.24 98.86 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.754 . . . . 1.6200000000000001 110.85 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -87.97 160.66 45.16 Favored 'Cis proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.601 -1.416 . . . . 1.28 111.978 0.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.569 ' HB ' ' HG3' ' B' ' 20' ' ' GLN . 14.0 m -156.74 124.74 5.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.377 -0.374 . . . . 1.47 110.219 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.78 164.75 14.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.388 -0.369 . . . . 1.22 110.802 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.4 ' HA2' ' HB3' ' A' ' 84' ' ' ALA . . . 87.06 -164.33 35.23 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.795 -0.717 . . . . 1.01 112.511 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -99.23 31.34 3.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.871 0.367 . . . . 2.1800000000000002 110.641 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.38 -167.7 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 1.28 111.206 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -98.85 101.21 12.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.32 -0.4 . . . . 1.52 110.832 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.569 ' HG3' ' HB ' ' B' ' 14' ' ' THR . 14.9 mp0 -102.59 -178.47 3.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.129 -0.487 . . . . 1.8600000000000001 110.148 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.53 130.64 5.33 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.89 -0.671 . . . . 0.90000000000000002 112.363 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 56.4 m -76.68 94.74 3.84 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.423 -0.584 . . . . 0.94999999999999996 109.423 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.3 165.96 32.85 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.498 -0.774 . . . . 1.5900000000000001 110.19 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.79 145.54 82.71 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.714 2.276 . . . . 0.65000000000000002 112.016 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.804 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 10.5 m -135.47 145.92 30.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.898 -0.592 . . . . 0.56999999999999995 111.138 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 48.2 tp -103.62 125.96 50.46 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.009 -0.541 . . . . 1.1699999999999999 109.573 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ILE . . . . . 0.504 HG23 ' HB2' ' B' ' 40' ' ' PRO . 23.5 mt -78.47 140.75 16.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.58 0.228 . . . . 0.66000000000000003 111.148 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.85 -31.95 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.9 0.381 . . . . 0.93000000000000005 111.621 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' THR . . . . . 0.476 HG23 HG22 ' B' ' 41' ' ' VAL . 0.2 OUTLIER -69.42 130.15 91.04 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.502 -0.317 . . . . 0.81000000000000005 111.728 -179.538 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.711 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 63.3 Cg_endo -72.74 162.29 41.58 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.013 2.475 . . . . 0.78000000000000003 112.725 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.54 -31.2 63.93 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.79 -0.641 . . . . 1.03 112.614 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.43 -18.56 40.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 1.3999999999999999 112.077 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 75' ' ' ASP . 65.7 t80 -122.4 -33.04 3.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.994 0.426 . . . . 1.5700000000000001 110.187 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -56.12 -41.49 75.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.52 -0.764 . . . . 1.6399999999999999 111.781 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -85.73 6.1 29.32 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.804 0.668 . . . . 2.54 112.804 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.05 -65.39 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.173 0.511 . . . . 1.0900000000000001 110.354 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 13.2 p -81.35 -23.83 37.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.868 -0.606 . . . . 1.3300000000000001 110.834 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.808 ' HE ' ' HA ' ' B' ' 38' ' ' ARG . 0.6 OUTLIER 67.33 16.93 10.16 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.632 -0.713 . . . . 1.78 111.432 -179.198 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 13.3 mt -128.18 94.71 35.56 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.19 -1.041 . . . . 1.1599999999999999 108.19 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' PRO . . . . . 0.504 ' HB2' HG23 ' B' ' 27' ' ' ILE . 94.6 Cg_endo -91.54 159.66 3.59 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.582 2.188 . . . . 0.56999999999999995 113.585 -178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.757 HG11 ' HD2' ' A' ' 77' ' ' PRO . 15.2 m -94.37 131.92 39.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.236 -1.024 . . . . 1.0800000000000001 108.236 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.804 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 27.6 m -124.0 153.18 29.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 113.066 0.765 . . . . 0.64000000000000001 113.066 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 42.7 t -106.63 114.2 62.16 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 114.647 -1.16 . . . . 1.1000000000000001 108.411 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.726 ' HA ' HG12 ' B' ' 25' ' ' VAL . 39.3 Cg_endo -67.62 123.39 10.71 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.69 2.26 . . . . 0.72999999999999998 112.555 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.636 HG22 HG12 ' B' ' 72' ' ' VAL . 48.9 t -77.65 123.38 34.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.348 -0.612 . . . . 0.90000000000000002 109.348 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.75 102.49 15.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.311 -0.404 . . . . 1.1699999999999999 110.44 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.47 89.73 0.95 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.066 -0.516 . . . . 1.8500000000000001 110.573 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.8 -14.42 77.69 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.766 -0.73 . . . . 2.2200000000000002 112.104 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.92 -84.65 0.16 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.022 -0.609 . . . . 3.4300000000000002 111.597 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.62 -39.23 17.54 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.268 0.556 . . . . 4.6200000000000001 109.507 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -90.09 88.2 7.18 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.791 -0.64 . . . . 6.2699999999999996 110.806 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.59 81.49 1.88 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.554 -0.748 . . . . 4.3899999999999997 109.972 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.17 150.59 49.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.935 -0.575 . . . . 3.9199999999999999 110.386 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.19 127.54 31.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.227 -0.442 . . . . 2.75 110.433 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -127.16 46.09 2.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.47 -0.332 . . . . 1.96 111.47 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.22 -73.46 1.78 Allowed Glycine 0 CA--C 1.516 0.149 0 C-N-CA 121.005 -0.617 . . . . 1.0800000000000001 112.831 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.424 ' HB3' ' HZ ' ' A' ' 33' ' ' PHE . 26.5 p90 -88.18 -11.08 47.84 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.195 0.521 . . . . 3.5699999999999998 110.924 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' B' ' 72' ' ' VAL . . . -112.98 116.81 30.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.975 -0.557 . . . . 1.0800000000000001 110.211 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' B' ' 101' ' ' VAL . 49.5 t -90.71 135.04 27.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.295 -0.411 . . . . 1.3400000000000001 110.102 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.559 ' HA ' HG12 ' B' ' 71' ' ' VAL . 19.0 t -87.7 138.5 31.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.965 0.412 . . . . 1.3799999999999999 111.23 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.54 ' HB3' HD12 ' B' ' 66' ' ' ILE . 69.0 mt -101.63 5.34 41.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.05 -0.722 . . . . 1.02 109.05 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.09 157.41 18.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.07 -0.968 . . . . 1.79 110.638 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.51 -62.94 0.3 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.702 -0.761 . . . . 1.1499999999999999 112.92 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.96 -31.72 51.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.865 0.364 . . . . 1.1699999999999999 111.95 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.12 79.75 1.15 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.554 -0.831 . . . . 1.05 113.067 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.54 HD12 ' HB3' ' B' ' 61' ' ' LEU . 45.9 mt -123.71 152.79 29.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.737 -0.838 . . . . 1.6100000000000001 108.737 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' ARG . . . . . 0.594 ' HB3' ' OE1' ' B' ' 91' ' ' GLU . 4.1 ttt180 -63.48 -48.69 76.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.625 0.25 . . . . 2.3999999999999999 111.433 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 12.1 m -78.83 99.87 6.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.237 0.541 . . . . 0.93000000000000005 111.685 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.8 88.61 6.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.718 -0.674 . . . . 1.3100000000000001 110.751 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -163.16 -170.64 28.34 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.298 -0.953 . . . . 0.79000000000000004 112.669 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' B' ' 60' ' ' SER . 11.5 m -124.67 136.92 59.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.849 0.357 . . . . 0.93000000000000005 110.333 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.636 HG12 HG22 ' B' ' 45' ' ' VAL . 16.1 m -86.55 133.23 30.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.313 -0.403 . . . . 1.3799999999999999 111.404 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -88.75 85.74 6.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.565 -0.531 . . . . 1.3700000000000001 109.565 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 1.1 m -65.68 -15.26 62.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.355 0.598 . . . . 1.1599999999999999 111.116 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.28 -12.74 51.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.501 -0.772 . . . . 1.1000000000000001 111.12 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' GLN . . . . . 0.535 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 10.4 mt-30 -126.38 66.23 61.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 114.233 1.197 . . . . 2.4700000000000002 114.233 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.635 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 74.0 Cg_endo -79.76 142.43 15.95 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.786 1.657 . . . . 0.95999999999999996 109.159 177.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' B' ' 78' ' ' ARG . 4.9 ttt180 -138.36 144.01 40.11 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.747 -0.381 . . . . 1.96 111.882 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.511 HG21 ' HB3' ' A' ' 76' ' ' GLN . 0.1 OUTLIER -82.76 140.38 33.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.788 -0.642 . . . . 1.1899999999999999 109.714 178.683 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.96 157.8 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.935 0.397 . . . . 1.28 111.426 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' B' ' 85' ' ' ARG . 9.5 t0 -85.39 110.82 19.4 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.813 -0.81 . . . . 1.28 108.813 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 13.7 ttp -78.62 -3.52 44.32 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.44 0.904 . . . . 2.7000000000000002 113.44 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 10.3 pttt -117.63 -45.08 2.71 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.002 0.742 . . . . 1.96 113.002 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.37 -38.75 41.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.793 0.33 . . . . 1.0600000000000001 111.67 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' B' ' 81' ' ' ASP . 83.7 mtt-85 -79.89 -25.28 40.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.525 -0.307 . . . . 1.47 111.055 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.84 132.02 1.74 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.661 -0.78 . . . . 0.81999999999999995 111.849 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.39 148.15 14.42 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.157 -1.02 . . . . 0.65000000000000002 113.16 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -146.49 157.43 43.75 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.786 -0.45 . . . . 1.8100000000000001 109.786 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' B' ' 7' ' ' TRP . 53.5 ttp180 -82.45 126.0 31.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.696 0.284 . . . . 2.4900000000000002 110.601 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 50.4 mt -89.68 -51.43 5.52 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 0.76000000000000001 110.7 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLU . . . . . 0.594 ' OE1' ' HB3' ' B' ' 67' ' ' ARG . 12.1 pt-20 -150.16 170.55 18.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.968 -0.56 . . . . 1.0700000000000001 111.812 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.401 ' HG3' ' HA3' ' B' ' 4' ' ' GLY . 19.9 ttm180 -115.5 115.27 26.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.742 -0.663 . . . . 2.0499999999999998 110.361 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.721 ' HB ' HD11 ' B' ' 6' ' ' ILE . 11.9 p -74.08 134.5 77.53 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.966 -0.561 . . . . 1.45 110.629 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.03 148.3 48.77 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.822 2.348 . . . . 1.03 112.195 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -55.39 -34.05 64.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.805 -0.634 . . . . 2.1400000000000001 111.601 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.87 -49.03 79.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.219 0.533 . . . . 1.78 110.942 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.414 ' HB ' HG22 ' B' ' 93' ' ' VAL . 21.1 mm -74.19 -39.88 50.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.878 -0.601 . . . . 1.3300000000000001 110.491 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' MET . . . . . 0.791 ' HG2' ' HG3' ' B' ' 3' ' ' ARG . 8.3 tpt -58.54 -42.36 87.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.985 0.421 . . . . 2.3399999999999999 110.545 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -63.5 -35.36 80.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.939 -0.573 . . . . 1.9099999999999999 110.478 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 1.8 mm-40 -62.82 -42.46 99.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.023 -0.535 . . . . 1.76 110.388 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.581 ' HA ' HG21 ' B' ' 59' ' ' VAL . 39.9 t -61.53 -45.14 99.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.976 -0.556 . . . . 1.01 110.525 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.46 -38.41 87.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.017 -0.538 . . . . 1.29 110.586 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.14 -42.86 94.19 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.692 -0.686 . . . . 1.02 111.579 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 9.9 mmt180 -69.33 -29.5 67.34 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.806 0.336 . . . . 1.8500000000000001 110.72 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.521 ' O ' HG12 ' B' ' 108' ' ' ILE . 11.3 mt -66.64 -23.17 66.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 1.9399999999999999 110.535 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 24.2 m -82.76 -8.61 59.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.347 -0.388 . . . . 1.1599999999999999 111.767 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.84 -15.87 61.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 1.45 111.778 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.521 HG12 ' O ' ' B' ' 105' ' ' LEU . 37.2 pt -88.18 -1.11 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.807 0.337 . . . . 1.98 111.111 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 58.8 mt -87.42 -4.94 59.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.034 -0.53 . . . . 1.3600000000000001 111.048 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.687 -0.673 . . . . 2.1299999999999999 109.81 179.618 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.603 0 C3'-C2'-C1' 100.881 -0.687 . 0.0 '__' . 6.3600000000000003 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' ' U' . . . . . 0.755 " H4'" ' N7 ' ' C' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.401 -1.076 0 C4'-C3'-C2' 105.283 2.583 OUTLIER-DELTA 0.0 OUTLIER delta 2.9900000000000002 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 3' ' ' ' A' . . . . . 0.755 ' N7 ' " H4'" ' C' ' 2' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.845 0 C1'-C2'-O2' 108.292 -0.769 . 0.0 OUTLIER delta-1 2.5899999999999999 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 4' ' ' ' C' . . . . . 0.738 ' N4 ' ' HA2' ' A' ' 70' ' ' GLY . . . . . . . . 0 O5'--C5' 1.428 -0.755 0 O4'-C4'-C3' 102.527 -2.123 . 0.0 OUTLIER . 2.5099999999999998 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 5' ' ' ' A' . . . . . 0.508 ' N3 ' " H2'" ' C' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.985 0 C5'-C4'-O4' 108.054 -0.818 . 0.0 OUTLIER . 4.9400000000000004 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 21.3 ptp . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.89 0.376 . . . . 1.29 110.783 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -123.22 168.12 12.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.886 -0.597 . . . . 2.0099999999999998 110.828 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -63.52 128.73 37.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.973 -0.558 . . . . 1.8500000000000001 110.642 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.74 -20.84 17.25 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.756 -0.735 . . . . 0.85999999999999999 113.112 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.4 ' O ' HG12 ' A' ' 27' ' ' ILE . 33.2 mt-10 -83.49 145.49 28.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.794 0.297 . . . . 0.98999999999999999 111.309 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.2 pt -112.91 130.49 66.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.879 0.371 . . . . 1.1599999999999999 110.746 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.4 m95 -116.22 117.58 30.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.152 -0.476 . . . . 0.91000000000000003 111.098 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 27.7 tp -76.07 113.44 13.59 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.791 -0.448 . . . . 0.90000000000000002 109.791 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 p -150.66 159.92 4.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.61 -0.268 . . . . 1.04 110.738 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.65 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.0 t -97.25 132.4 43.04 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.499 -0.556 . . . . 1.3200000000000001 109.499 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.4 mt -86.29 -11.65 51.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.403 -0.362 . . . . 1.29 111.509 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.486 ' CB ' ' HA ' ' A' ' 13' ' ' PRO . 3.0 m-20 -64.18 164.59 17.44 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.803 -0.635 . . . . 1.54 112.649 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.486 ' HA ' ' CB ' ' A' ' 12' ' ' ASP . 79.4 Cg_endo -83.34 111.63 2.28 Favored 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 123.553 -1.436 . . . . 1.6899999999999999 112.572 0.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -107.49 150.49 26.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.106 -0.497 . . . . 1.3600000000000001 111.298 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -130.02 167.21 18.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.002 -0.545 . . . . 1.7 110.533 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.8 -150.55 48.05 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.893 -0.883 . . . . 1.1799999999999999 110.893 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -85.62 4.14 37.62 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.093 0.446 . . . . 2.7799999999999998 111.338 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HB3' HG22 ' A' ' 14' ' ' THR . 9.3 tt0 -65.33 134.38 53.45 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.134 -0.321 . . . . 1.1399999999999999 110.134 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.428 ' HG2' ' HG3' ' A' ' 44' ' ' PRO . 7.5 tp-100 -54.77 124.45 16.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.951 -0.568 . . . . 2.0899999999999999 112.098 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.85 -178.81 4.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.722 -0.672 . . . . 2.0899999999999999 110.195 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.759 ' HA2' " H2'" ' C' ' 5' ' ' ' A' . . . 91.26 164.52 39.32 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.861 -0.685 . . . . 1.0700000000000001 113.917 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 2.2 m -91.96 124.76 36.31 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.078 -0.712 . . . . 1.1100000000000001 109.078 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.43 ' HG3' ' HB2' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -159.88 158.06 26.4 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 110.466 -0.198 . . . . 1.6200000000000001 110.466 -179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 57.6 Cg_endo -76.86 121.04 5.69 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.957 1.771 . . . . 1.01 111.335 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.557 HG21 HD11 ' A' ' 80' ' ' ILE . 24.4 m -95.59 131.07 43.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.082 -0.508 . . . . 0.76000000000000001 110.532 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HB3' HG23 ' A' ' 43' ' ' VAL . 50.8 tp -87.91 122.64 31.78 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.788 -0.642 . . . . 0.69999999999999996 110.825 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.633 ' HA ' HG12 ' A' ' 42' ' ' VAL . 19.0 mm -71.11 111.45 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.794 -0.446 . . . . 0.92000000000000004 109.794 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -92.32 -37.12 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.275 -0.42 . . . . 0.94999999999999996 111.724 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.85 148.85 82.5 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 111.719 0.266 . . . . 1.1200000000000001 111.719 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.419 ' HG3' ' OXT' ' B' ' 110' ' ' THR . 68.7 Cg_endo -71.69 161.2 45.94 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.598 2.199 . . . . 1.3 111.879 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.11 -35.79 74.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.026 -0.534 . . . . 1.3899999999999999 111.567 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.64 -43.56 89.81 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.241 -0.436 . . . . 1.6100000000000001 111.672 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.597 ' HZ ' ' HB2' ' B' ' 75' ' ' ASP . 69.9 t80 -71.94 -48.39 45.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.889 -0.596 . . . . 1.77 110.786 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -59.25 -32.68 70.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.024 -0.534 . . . . 1.48 111.123 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 35' ' ' ARG . 43.9 ttp180 -64.85 -30.08 71.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.852 -0.613 . . . . 2.6200000000000001 112.136 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 p -96.32 -47.28 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 113.575 0.954 . . . . 1.8600000000000001 113.575 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 22.1 p -78.34 -28.61 47.26 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.72 0.637 . . . . 1.72 112.72 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 37' ' ' THR . 9.4 mpt_? 74.04 -1.09 3.17 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.585 0.553 . . . . 4.4500000000000002 111.567 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.9 mt -126.05 107.3 25.02 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.317 -0.624 . . . . 1.8100000000000001 109.317 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -89.09 139.78 3.76 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.73 2.287 . . . . 1.05 113.018 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 79' ' ' THR . 62.8 t -79.79 113.66 19.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.015 -1.476 . . . . 1.03 107.015 177.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 27' ' ' ILE . 34.8 m -123.46 165.33 19.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 112.711 0.634 . . . . 0.77000000000000002 112.711 -177.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.412 HG23 ' HB3' ' A' ' 26' ' ' LEU . 4.4 m -126.54 125.92 24.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.711 -1.131 . . . . 0.71999999999999997 108.797 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.43 ' HB2' ' HG3' ' A' ' 23' ' ' ARG . 94.5 Cg_endo -80.42 131.59 8.6 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.691 2.26 . . . . 1.03 113.667 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.726 HG22 HG22 ' A' ' 72' ' ' VAL . 92.1 t -78.77 128.63 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.942 -0.762 . . . . 1.28 108.942 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.549 ' HB ' " O2'" ' C' ' 3' ' ' ' A' . 16.5 p -115.9 -160.44 0.75 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.217 -0.193 . . . . 1.9099999999999999 111.388 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.402 ' H ' ' HB ' ' A' ' 46' ' ' THR . 20.1 m -111.01 153.41 25.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.769 0.318 . . . . 2.5299999999999998 111.202 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.23 19.82 3.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.491 -0.862 . . . . 3.3599999999999999 112.525 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.12 -112.75 4.34 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.597 -0.811 . . . . 3.8300000000000001 111.987 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -104.38 -52.11 2.98 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.733 -0.469 . . . . 4.7199999999999998 109.733 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -121.33 158.54 27.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.675 -0.693 . . . . 6.2400000000000002 109.623 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.514 ' HB3' ' H ' ' A' ' 61' ' ' LEU . . . -92.52 174.1 7.45 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.209 -0.293 . . . . 2.5899999999999999 110.209 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 53' ' ' ARG . 17.9 ptt85 -169.69 167.11 9.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.203 -0.453 . . . . 4.5899999999999999 109.994 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.605 ' HA ' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -75.03 67.65 1.75 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.991 0.424 . . . . 2.6899999999999999 111.72 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.54 73.22 5.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.353 0.597 . . . . 3.1699999999999999 110.13 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.587 ' HA3' ' O4 ' ' C' ' 2' ' ' ' U' . . . 81.04 -98.27 1.83 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.355 -0.839 . . . . 1.6599999999999999 111.43 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -103.37 15.12 29.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.178 0.513 . . . . 1.5600000000000001 110.995 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.605 ' O ' ' HA ' ' A' ' 54' ' ' THR . . . -101.44 153.5 19.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.741 -0.663 . . . . 1.25 109.439 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.13 163.11 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.874 0.369 . . . . 1.6799999999999999 111.755 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.416 ' OG ' ' HA ' ' A' ' 53' ' ' ARG . 70.9 m -82.53 133.74 35.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.794 -0.639 . . . . 1.95 110.78 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.815 HD11 HG23 ' A' ' 72' ' ' VAL . 18.3 mt -103.48 -32.15 9.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.191 0.52 . . . . 1.23 110.775 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.78 97.9 1.87 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.369 0.604 . . . . 2.21 110.814 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.82 -8.29 4.87 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.803 -0.713 . . . . 1.1499999999999999 112.605 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 61' ' ' LEU . 28.5 m -94.33 -1.9 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.851 0.325 . . . . 1.21 111.701 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.08 54.44 5.25 Favored Glycine 0 C--O 1.236 0.228 0 C-N-CA 121.16 -0.543 . . . . 1.0800000000000001 113.937 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.639 HD11 ' HB3' ' A' ' 61' ' ' LEU . 41.6 pt -129.67 171.92 16.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 122.823 -0.222 . . . . 1.0700000000000001 110.666 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -104.82 -23.74 12.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.895 -0.409 . . . . 3.5899999999999999 109.895 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.611 ' HB ' HD12 ' A' ' 66' ' ' ILE . 21.1 m -52.74 107.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.468 -0.787 . . . . 1.51 111.378 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.73 90.71 8.34 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.589 -0.732 . . . . 1.79 111.126 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.418 ' HA3' ' H42' ' C' ' 4' ' ' ' C' . . . 178.71 -151.47 10.43 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.941 -0.864 . . . . 1.1799999999999999 110.941 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.83 131.13 37.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.986 0.422 . . . . 1.5600000000000001 110.797 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.815 HG23 HD11 ' A' ' 61' ' ' LEU . 85.1 t -97.96 142.88 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.27 -0.423 . . . . 1.29 109.922 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.652 ' HD2' ' C2 ' ' C' ' 3' ' ' ' A' . 0.0 OUTLIER -150.39 163.9 37.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.381 -0.372 . . . . 2.23 110.311 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.32 13.94 20.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.757 0.313 . . . . 1.1699999999999999 111.383 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.487 ' HA ' ' HZ ' ' B' ' 33' ' ' PHE . 3.3 p30 -86.95 -3.18 59.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 0.89000000000000001 112.075 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.402 ' HG2' ' OD1' ' A' ' 75' ' ' ASP . 35.4 mm-40 -129.96 64.65 72.99 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.758 -0.201 . . . . 2.1299999999999999 111.42 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -94.82 131.49 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.619 2.213 . . . . 0.80000000000000004 113.003 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' B' ' 77' ' ' PRO . 10.6 ptm180 -161.43 154.91 21.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.951 0.405 . . . . 2.0899999999999999 111.594 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.454 HG23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.85 130.02 36.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.186 -0.672 . . . . 1.6200000000000001 109.186 178.335 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.557 HD11 HG21 ' A' ' 25' ' ' VAL . 32.7 pt -131.1 157.28 43.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.961 0.41 . . . . 1.1499999999999999 111.111 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -87.84 133.19 33.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.854 -0.612 . . . . 1.03 110.596 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 43.7 tpp -120.09 21.76 11.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.128 -0.487 . . . . 1.29 110.286 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -107.31 -38.58 5.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.096 -0.502 . . . . 2.6400000000000001 110.794 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.71 -26.18 15.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.994 -0.548 . . . . 1.1200000000000001 111.203 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -76.47 -59.76 2.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.852 0.358 . . . . 1.0600000000000001 111.154 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.29 89.7 1.39 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.84 -0.695 . . . . 1.1200000000000001 111.478 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -95.97 172.29 29.42 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.666 -0.778 . . . . 1.0900000000000001 112.561 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -121.36 109.39 14.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.764 -0.458 . . . . 2.46 109.764 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.16 128.18 34.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.501 0.191 . . . . 2.4900000000000002 110.795 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.56 -89.04 0.37 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.589 -0.278 . . . . 1.29 110.881 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -122.09 -172.78 2.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.51 -0.314 . . . . 1.1499999999999999 110.409 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -140.57 133.88 29.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.94 0.4 . . . . 1.3200000000000001 110.449 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.42 155.21 66.25 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.113 -0.494 . . . . 0.75 111.411 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.54 149.38 89.98 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.47 2.114 . . . . 0.94999999999999996 111.941 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -60.77 -23.21 64.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.892 -0.595 . . . . 1.51 111.488 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -38.07 89.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.243 -0.435 . . . . 1.5700000000000001 109.851 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.7 mm -71.6 -37.92 65.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.916 -0.584 . . . . 1.3100000000000001 109.5 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 84.6 mmm -62.06 -36.9 83.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.616 -0.72 . . . . 1.6000000000000001 110.234 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -62.52 -35.98 81.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.752 -0.658 . . . . 2.2999999999999998 110.548 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -63.84 -46.63 84.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.5 -0.556 . . . . 1.6399999999999999 109.5 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.73 -47.27 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.688 -0.687 . . . . 1.03 110.446 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.3 mt -61.86 -33.84 74.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 1.22 111.121 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.95 -17.57 75.55 Favored Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.904 -0.589 . . . . 1.03 113.091 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -97.86 -24.98 15.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.973 0.416 . . . . 1.72 110.786 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.419 ' O ' HG12 ' A' ' 108' ' ' ILE . 90.6 mt -68.42 -25.45 65.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.139 -0.482 . . . . 1.02 111.398 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -16.53 64.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.835 0.35 . . . . 1.1100000000000001 111.568 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.76 -16.5 32.02 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.193 0.442 . . . . 1.5 112.193 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 105' ' ' LEU . 23.3 pt -91.9 -9.34 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.641 0.608 . . . . 1.1499999999999999 112.641 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.644 ' HA ' HG12 ' B' ' 28' ' ' VAL . 19.7 mt -87.73 82.91 7.24 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.915 -0.402 . . . . 0.97999999999999998 109.915 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.412 ' O ' ' HG3' ' B' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 N-CA-C 113.006 0.743 . . . . 1.3500000000000001 113.006 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.842 ' HA ' ' HA ' ' B' ' 30' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.326 0 N-CA-C 109.61 -0.515 . . . . 2.0299999999999998 109.61 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -77.97 -5.42 51.19 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.719 -0.474 . . . . 2.8199999999999998 109.719 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 110' ' ' THR . 7.8 mtm180 60.69 80.19 0.22 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.099 -0.955 . . . . 2.3199999999999998 112.968 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.47 ' HA2' HG12 ' B' ' 93' ' ' VAL . . . 137.69 -32.69 2.35 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.092 -1.052 . . . . 1.28 113.826 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.44 ' OE2' ' HD2' ' B' ' 92' ' ' ARG . 17.6 mm-40 -64.63 109.62 2.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.062 0.458 . . . . 1.53 112.169 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.659 HD11 ' HB ' ' B' ' 93' ' ' VAL . 51.4 mt -98.8 130.7 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.371 -0.603 . . . . 0.75 109.371 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.408 ' HA ' ' HA ' ' B' ' 89' ' ' ARG . 30.2 m95 -115.44 178.32 4.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.037 0.446 . . . . 0.81000000000000005 111.316 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 tt -146.22 133.7 20.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.086 -0.506 . . . . 1.05 110.032 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.519 HG12 HG21 ' B' ' 25' ' ' VAL . 8.2 p -167.16 164.75 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.504 -0.316 . . . . 0.71999999999999997 110.182 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 6.0 t -88.83 140.56 29.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.636 0.255 . . . . 1.6299999999999999 110.661 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.517 HD11 ' HB3' ' B' ' 44' ' ' PRO . 32.1 mt -96.45 -12.25 24.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.369 0.604 . . . . 0.82999999999999996 110.15 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ASP . . . . . 0.735 ' OD1' ' HB3' ' B' ' 20' ' ' GLN . 0.1 OUTLIER -75.97 153.59 84.77 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.507 -0.769 . . . . 1.6200000000000001 110.083 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -96.23 161.73 14.48 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.823 -1.324 . . . . 1.28 112.154 -0.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.465 HG22 ' H ' ' B' ' 15' ' ' ALA . 0.2 OUTLIER -157.93 -164.65 1.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.172 -0.677 . . . . 1.47 109.172 179.108 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.465 ' H ' HG22 ' B' ' 14' ' ' THR . . . -155.41 161.57 40.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.075 -0.342 . . . . 1.22 110.075 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.47 -143.23 25.66 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.891 -0.671 . . . . 1.01 112.244 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -92.83 2.05 56.97 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.875 0.324 . . . . 2.1800000000000002 111.875 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.44 136.0 57.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.648 0.261 . . . . 1.28 110.758 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -60.31 128.33 36.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 1.52 112.097 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.735 ' HB3' ' OD1' ' B' ' 12' ' ' ASP . 71.4 mt-30 -129.55 -167.37 1.79 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.466 -0.788 . . . . 1.8600000000000001 110.874 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.22 175.7 50.89 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.962 -0.563 . . . . 0.90000000000000002 112.765 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 18.4 m -111.0 108.79 18.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.01 0.433 . . . . 0.94999999999999996 110.591 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.48 164.81 20.1 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.004 -0.544 . . . . 1.5900000000000001 109.764 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.08 147.28 91.1 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.406 2.071 . . . . 0.65000000000000002 111.078 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 9.8 m -134.99 137.2 50.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.138 0.494 . . . . 0.56999999999999995 111.753 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 33.5 tp -101.83 129.13 47.98 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.186 -0.672 . . . . 1.1699999999999999 109.186 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 55.3 mt -89.22 133.65 30.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.605 0.24 . . . . 0.66000000000000003 110.369 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 109' ' ' LEU . 21.5 t -100.5 -34.84 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.379 -0.373 . . . . 0.93000000000000005 111.913 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' THR . . . . . 0.49 HG23 HG22 ' B' ' 41' ' ' VAL . 0.7 OUTLIER -67.54 138.99 93.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 111.956 0.354 . . . . 0.81000000000000005 111.956 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.842 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 50.0 Cg_endo -68.34 162.26 41.26 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.003 2.469 . . . . 0.78000000000000003 113.02 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.06 67.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.536 -0.756 . . . . 1.03 112.208 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.07 -46.18 79.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.035 0.445 . . . . 1.3999999999999999 110.961 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' PHE . . . . . 0.487 ' HZ ' ' HA ' ' A' ' 75' ' ' ASP . 4.5 t80 -66.05 -48.13 72.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.031 -0.531 . . . . 1.5700000000000001 110.599 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -61.16 -26.88 68.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 1.6399999999999999 111.937 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -82.52 -33.98 28.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.484 -0.325 . . . . 2.54 111.262 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 89.0 t -82.99 -55.75 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.372 0.508 . . . . 1.0900000000000001 112.372 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' THR . . . . . 0.513 HG22 ' H6 ' ' C' ' 2' ' ' ' U' . 58.0 p -74.43 -27.81 60.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.7 0.286 . . . . 1.3300000000000001 111.33 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.416 ' HE ' ' HA ' ' B' ' 38' ' ' ARG . 2.5 mmp_? 62.84 26.22 15.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.897 -0.592 . . . . 1.78 110.061 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 30.4 mt -145.67 96.67 4.73 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.115 -0.948 . . . . 1.1599999999999999 109.57 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' PRO . . . . . 0.547 ' HD2' ' O ' ' B' ' 80' ' ' ILE . 92.5 Cg_endo -87.43 146.99 7.4 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.861 2.374 . . . . 0.56999999999999995 112.711 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.49 HG22 HG23 ' B' ' 29' ' ' THR . 4.9 m -85.52 110.68 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.327 -0.62 . . . . 1.0800000000000001 109.327 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 34.6 m -95.73 138.26 21.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.9 -0.591 . . . . 0.64000000000000001 112.035 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.491 HG13 ' O ' ' B' ' 73' ' ' ARG . 41.2 t -107.52 116.38 57.84 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.022 -0.99 . . . . 1.1000000000000001 108.91 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.517 ' HB3' HD11 ' B' ' 11' ' ' LEU . 50.0 Cg_endo -67.85 124.62 12.09 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.984 2.456 . . . . 0.72999999999999998 114.221 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -95.24 142.07 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.588 -0.893 . . . . 0.90000000000000002 108.588 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -112.63 100.56 8.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.951 0.405 . . . . 1.1699999999999999 111.181 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.57 157.72 26.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.774 -0.648 . . . . 1.8500000000000001 110.722 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.26 -21.98 27.87 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.476 -0.649 . . . . 2.2200000000000002 111.476 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.53 84.55 0.49 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.764 -0.732 . . . . 3.4300000000000002 111.933 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -78.03 -78.7 0.13 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.089 0.471 . . . . 4.6200000000000001 110.648 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -92.67 28.38 2.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 6.2699999999999996 110.92 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.95 148.78 45.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.724 -0.671 . . . . 4.3899999999999997 110.182 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -70.35 137.48 50.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.106 -0.331 . . . . 3.9199999999999999 110.106 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 10.4 t -64.55 120.87 13.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.47 0.652 . . . . 2.75 110.74 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.43 68.04 6.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.724 -0.671 . . . . 1.96 110.988 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.34 -77.09 0.74 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.745 -0.661 . . . . 1.0800000000000001 112.869 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.491 ' HE1' ' HB ' ' B' ' 107' ' ' THR . 66.3 m-85 -104.4 -14.42 15.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.512 0.196 . . . . 3.5699999999999998 111.153 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' B' ' 72' ' ' VAL . . . -78.87 95.96 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.419 -0.355 . . . . 1.0800000000000001 110.566 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 45.0 t -85.14 125.19 40.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.11 -0.496 . . . . 1.3400000000000001 111.173 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.01 126.41 31.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.147 -0.479 . . . . 1.3799999999999999 110.993 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.418 ' HB3' HD11 ' B' ' 66' ' ' ILE . 75.9 mt -96.01 87.63 4.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 1.02 111.461 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -161.95 179.21 8.2 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.704 -0.48 . . . . 1.79 109.704 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.22 -42.47 3.16 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 121.242 -0.504 . . . . 1.1499999999999999 112.452 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.652 HG21 ' HG2' ' B' ' 94' ' ' PRO . 14.2 p -80.18 -27.28 11.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.091 0.472 . . . . 1.1699999999999999 111.111 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.65 89.51 1.07 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.717 -0.754 . . . . 1.05 112.62 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.418 HD11 ' HB3' ' B' ' 61' ' ' LEU . 4.9 pt -141.28 177.39 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.925 -0.769 . . . . 1.6100000000000001 108.925 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -83.13 -53.49 5.75 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.982 0.42 . . . . 2.3999999999999999 110.307 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 7.2 m -64.89 112.53 3.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.889 -0.596 . . . . 0.93000000000000005 109.743 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.4 131.58 53.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.888 0.375 . . . . 1.3100000000000001 111.438 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.89 -174.42 32.41 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.941 -0.647 . . . . 0.79000000000000004 111.899 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.418 ' HB ' ' HB1' ' B' ' 58' ' ' ALA . 4.0 m -102.7 124.04 56.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.045 0.45 . . . . 0.93000000000000005 111.437 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' B' ' 58' ' ' ALA . 11.0 t -86.53 118.35 32.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.801 -0.636 . . . . 1.3799999999999999 110.661 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.491 ' O ' HG13 ' B' ' 43' ' ' VAL . 9.3 mmm180 -87.3 83.9 7.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.937 0.399 . . . . 1.3700000000000001 110.315 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 2.5 m -71.17 22.97 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.233 0.827 . . . . 1.1599999999999999 113.233 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.597 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 13.3 p-10 -112.64 -4.16 14.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.661 0.267 . . . . 1.1000000000000001 110.701 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -121.26 86.22 42.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 112.497 0.554 . . . . 2.4700000000000002 112.497 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.54 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 12.8 Cg_endo -92.8 104.38 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.88 2.387 . . . . 0.95999999999999996 110.588 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -111.37 125.81 54.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.938 0.399 . . . . 1.96 111.949 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -84.04 114.11 21.5 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.427 -0.583 . . . . 1.1899999999999999 109.427 178.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.547 ' O ' ' HD2' ' B' ' 40' ' ' PRO . 45.0 pt -133.8 171.79 17.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.008 0.432 . . . . 1.28 111.023 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -77.47 141.87 39.46 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.643 -0.708 . . . . 1.28 109.678 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' MET . . . . . 0.708 ' SD ' ' HA3' ' B' ' 87' ' ' GLY . 49.0 tpp -115.19 -18.02 11.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.996 0.426 . . . . 2.7000000000000002 111.472 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -92.11 -42.9 9.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.373 -0.376 . . . . 1.96 111.617 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.38 -25.43 33.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.103 0.478 . . . . 1.0600000000000001 111.391 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -81.4 -13.99 57.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.263 -0.426 . . . . 1.47 111.411 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.71 43.49 35.56 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.862 -0.685 . . . . 0.81999999999999995 112.628 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' GLY . . . . . 0.708 ' HA3' ' SD ' ' B' ' 82' ' ' MET . . . -64.33 144.77 48.97 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.049 -0.596 . . . . 0.65000000000000002 112.426 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.35 146.73 51.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.455 -0.202 . . . . 1.8100000000000001 110.455 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' B' ' 7' ' ' TRP . 47.3 ttp180 -91.71 134.18 34.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.276 -0.42 . . . . 2.4900000000000002 110.108 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 94.9 mt -89.97 -63.84 1.22 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.438 -0.346 . . . . 0.76000000000000001 111.598 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -161.32 -173.84 4.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.55 -0.296 . . . . 1.0700000000000001 110.387 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' B' ' 4' ' ' GLY . 43.2 ttt85 -121.04 115.67 23.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.391 -0.368 . . . . 2.0499999999999998 110.705 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.659 ' HB ' HD11 ' B' ' 6' ' ' ILE . 9.4 p -75.03 136.69 72.91 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.939 -0.573 . . . . 1.45 109.61 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.652 ' HG2' HG21 ' B' ' 64' ' ' VAL . 90.7 Cg_exo -47.92 144.58 11.53 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.071 2.514 . . . . 1.03 112.922 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -33.32 68.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.66 -0.7 . . . . 2.1400000000000001 111.96 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -26.84 68.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.122 0.487 . . . . 1.78 111.128 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.416 ' HB ' HG22 ' B' ' 93' ' ' VAL . 30.0 mm -89.34 -37.03 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 1.3300000000000001 109.647 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 18.3 tpt -65.74 -30.34 70.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 2.3399999999999999 110.564 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -59.08 -34.14 71.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.794 -0.639 . . . . 1.9099999999999999 110.221 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.71 -44.48 90.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.939 -0.573 . . . . 1.76 109.687 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 34.9 t -59.55 -44.88 94.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.492 -0.776 . . . . 1.01 110.816 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.3 -40.35 85.93 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.117 0.484 . . . . 1.29 110.596 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.36 -39.13 94.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.934 -0.65 . . . . 1.02 111.886 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -67.55 -36.9 81.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.897 0.379 . . . . 1.8500000000000001 110.363 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.601 ' O ' HG12 ' B' ' 108' ' ' ILE . 68.5 mt -65.59 -21.59 66.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.935 -0.575 . . . . 1.9399999999999999 111.27 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 24.7 m -76.51 -14.32 60.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.008 0.433 . . . . 1.1599999999999999 111.168 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.491 ' HB ' ' HE1' ' B' ' 57' ' ' PHE . 3.0 m -93.3 -7.81 43.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.305 -0.407 . . . . 1.45 112.051 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.601 HG12 ' O ' ' B' ' 105' ' ' LEU . 13.1 pt -81.64 -21.01 10.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.959 0.409 . . . . 1.98 110.866 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 94.6 mt -94.07 47.5 1.21 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 1.3600000000000001 110.711 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.419 ' OXT' ' HG3' ' A' ' 30' ' ' PRO . 1.8 m . . . . . 0 C--O 1.255 1.372 0 CA-C-O 118.267 -0.873 . . . . 2.1299999999999999 110.235 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.614 0 C3'-C2'-C1' 100.817 -0.759 . 0.0 '__' . 6.3600000000000003 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' ' U' . . . . . 0.587 ' O4 ' ' HA3' ' A' ' 56' ' ' GLY . . . . . . . . 0 O4'--C1' 1.402 -0.967 0 C4'-C3'-C2' 104.761 2.061 OUTLIER-DELTA 0.0 OUTLIER . 2.9900000000000002 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 3' ' ' ' A' . . . . . 0.652 ' C2 ' ' HD2' ' A' ' 73' ' ' ARG . . . . . . . . 0 O5'--C5' 1.428 -0.765 0 C4'-C3'-C2' 104.444 1.744 . 0.0 OUTLIER . 2.5899999999999999 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 4' ' ' ' C' . . . . . 0.862 HO2' ' H2 ' ' C' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.405 -0.787 0 C4'-C3'-C2' 104.943 2.243 OUTLIER-DELTA 0.0 OUTLIER . 2.5099999999999998 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 5' ' ' ' A' . . . . . 0.862 ' H2 ' HO2' ' C' ' 4' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.81 0 C4'-C3'-C2' 103.57 0.87 . 0.0 OUTLIER . 4.9400000000000004 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 8.0 ptp . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 121.337 0.589 . . . . 1.29 111.149 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -106.73 177.86 4.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.417 -0.81 . . . . 2.0099999999999998 111.039 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.496 ' NH2' ' HD3' ' A' ' 30' ' ' PRO . 9.1 ttm180 -80.93 124.33 29.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.829 -0.623 . . . . 1.8500000000000001 109.986 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.73 7.04 42.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.685 -0.769 . . . . 0.85999999999999999 112.803 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.53 ' OE2' ' HD2' ' A' ' 89' ' ' ARG . 66.4 mt-10 -94.74 151.18 19.47 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.614 -0.345 . . . . 0.98999999999999999 111.114 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.666 HD11 ' HG2' ' A' ' 91' ' ' GLU . 17.3 pt -110.35 113.92 45.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.111 0.481 . . . . 1.1599999999999999 110.191 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.439 ' C ' ' HA ' ' A' ' 24' ' ' PRO . 22.4 m95 -106.82 118.43 36.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.924 -0.58 . . . . 0.91000000000000003 111.779 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.2 tp -72.89 104.54 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.954 -0.566 . . . . 0.90000000000000002 110.47 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -144.63 161.13 14.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.304 -0.407 . . . . 1.04 110.865 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 t -96.96 130.02 44.34 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.887 -0.782 . . . . 1.3200000000000001 108.887 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.17 4.51 52.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.813 0.34 . . . . 1.29 111.17 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.494 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 6.2 m-20 -79.8 162.87 60.99 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.845 -0.616 . . . . 1.54 110.957 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 21.6 Cg_exo -66.48 144.58 68.15 Favored 'Cis proline' 0 C--N 1.351 0.7 0 C-N-CA 124.264 -1.14 . . . . 1.6899999999999999 112.588 0.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 20' ' ' GLN . 3.1 p -109.81 135.94 49.91 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.886 -0.597 . . . . 1.3600000000000001 112.045 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.64 117.45 31.94 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.044 -0.525 . . . . 1.7 110.2 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.99 -120.99 7.51 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.721 -0.752 . . . . 1.1799999999999999 112.543 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -109.73 36.52 2.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.734 0.302 . . . . 2.7799999999999998 111.393 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -68.54 173.68 4.83 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.69 -0.485 . . . . 1.1399999999999999 109.69 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.566 ' HG2' ' HB3' ' A' ' 44' ' ' PRO . 6.7 tp-100 -71.1 91.36 0.9 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.978 0.418 . . . . 2.0899999999999999 111.399 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.692 ' HB2' " H3'" ' C' ' 5' ' ' ' A' . 5.4 pt20 -94.12 152.74 18.53 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.658 -0.701 . . . . 2.0899999999999999 111.489 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.04 168.85 16.51 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.957 -0.639 . . . . 1.0700000000000001 113.234 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.7 m -111.85 112.07 23.47 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.755 -0.461 . . . . 1.1100000000000001 109.755 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.37 159.97 37.83 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.265 -0.425 . . . . 1.6200000000000001 110.348 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HB2' ' HB ' ' A' ' 6' ' ' ILE . 11.3 Cg_exo -72.34 99.27 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.496 2.13 . . . . 1.01 110.916 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.485 HG12 ' HA ' ' A' ' 44' ' ' PRO . 17.0 m -80.12 142.28 14.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.232 -0.44 . . . . 0.76000000000000001 110.345 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.539 ' HB3' HG23 ' A' ' 43' ' ' VAL . 34.6 tp -84.98 126.02 33.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.252 -0.431 . . . . 0.69999999999999996 111.17 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.42 HD13 HG12 ' A' ' 42' ' ' VAL . 17.7 mm -78.86 114.98 20.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.382 -0.599 . . . . 0.92000000000000004 109.382 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.407 HG11 HD11 ' A' ' 105' ' ' LEU . 16.8 t -92.47 -22.85 5.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.935 0.398 . . . . 0.94999999999999996 111.659 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.87 152.03 68.33 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 111.791 0.293 . . . . 1.1200000000000001 111.791 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.66 ' HG2' ' HB2' ' A' ' 33' ' ' PHE . 38.2 Cg_endo -67.28 160.86 45.66 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.805 2.337 . . . . 1.3 111.736 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.45 -38.54 66.46 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.608 0.596 . . . . 1.3899999999999999 112.608 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.454 ' O ' HG12 ' A' ' 36' ' ' VAL . . . -66.55 -44.55 82.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.415 -0.357 . . . . 1.6100000000000001 111.569 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.729 ' HZ ' ' HB2' ' B' ' 75' ' ' ASP . 5.6 t80 -60.42 -37.7 81.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.039 0.447 . . . . 1.77 111.055 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.415 ' OD1' ' HB3' ' A' ' 40' ' ' PRO . 52.5 m-20 -67.49 -9.87 46.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.669 -0.696 . . . . 1.48 111.386 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 35' ' ' ARG . 36.8 ttp180 -112.08 -51.77 2.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.298 -0.41 . . . . 2.6200000000000001 111.588 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 32' ' ' ALA . 10.4 p -65.23 -47.74 86.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.294 0.479 . . . . 1.8600000000000001 112.294 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -88.62 -29.87 19.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.637 0.256 . . . . 1.72 110.94 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.433 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 9.3 ttt180 73.96 -10.74 1.06 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.802 -0.636 . . . . 4.4500000000000002 111.962 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.3 mt -108.51 99.03 31.1 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.286 -0.415 . . . . 1.8100000000000001 110.261 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.539 ' HD2' ' O ' ' A' ' 80' ' ' ILE . 3.0 Cg_endo -87.63 135.68 3.61 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.004 2.469 . . . . 1.05 112.785 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.67 HG22 HG23 ' A' ' 79' ' ' THR . 44.2 t -80.49 113.4 19.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.018 -1.475 . . . . 1.03 107.018 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.42 HG12 HD13 ' A' ' 27' ' ' ILE . 32.1 m -116.91 152.82 18.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 112.909 0.707 . . . . 0.77000000000000002 112.909 -178.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.539 HG23 ' HB3' ' A' ' 26' ' ' LEU . 5.2 m -115.94 131.08 23.91 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 114.91 -1.041 . . . . 0.71999999999999997 108.441 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HB3' ' HG2' ' A' ' 19' ' ' GLN . 58.4 Cg_endo -71.46 172.81 13.48 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.753 2.302 . . . . 1.03 114.449 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.3 t -137.43 135.35 46.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.665 -1.152 . . . . 1.28 108.135 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.748 ' HB ' ' C2 ' ' C' ' 3' ' ' ' A' . 2.1 p -138.02 179.72 6.27 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.552 0.204 . . . . 1.9099999999999999 111.552 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.5 t -79.21 -85.02 0.08 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.254 -0.43 . . . . 2.5299999999999998 111.453 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.41 4.42 43.62 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.88 -0.888 . . . . 3.3599999999999999 110.88 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.47 -113.78 5.3 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.152 -0.546 . . . . 3.8300000000000001 112.342 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -96.43 -2.18 45.99 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.722 0.296 . . . . 4.7199999999999998 111.221 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -91.05 45.53 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.008 0.432 . . . . 6.2400000000000002 111.414 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.06 61.76 5.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.293 0.568 . . . . 2.5899999999999999 110.591 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.05 175.85 13.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.672 -0.694 . . . . 4.5899999999999999 110.38 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.434 HG23 HG12 ' A' ' 59' ' ' VAL . 10.6 m -67.62 122.34 17.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.931 0.396 . . . . 2.6899999999999999 111.351 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.98 101.4 3.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.733 -0.667 . . . . 3.1699999999999999 110.253 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.82 -100.91 0.73 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.052 -0.594 . . . . 1.6599999999999999 112.772 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -103.22 -13.53 16.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.968 0.413 . . . . 1.5600000000000001 111.022 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.84 109.71 19.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.2 -0.455 . . . . 1.25 109.81 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.434 HG12 HG23 ' A' ' 54' ' ' THR . 13.7 m -101.19 139.34 22.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.058 0.456 . . . . 1.6799999999999999 111.592 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 p -86.78 144.39 27.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.192 -0.458 . . . . 1.95 110.544 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.0 mt -84.88 -8.82 58.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 1.23 110.872 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -67.56 131.64 46.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.821 -0.627 . . . . 2.21 109.928 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.99 -39.28 1.93 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.662 -0.575 . . . . 1.1499999999999999 111.662 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -93.7 -8.13 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.758 0.313 . . . . 1.21 111.03 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.89 98.26 0.24 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.855 -0.688 . . . . 1.0800000000000001 112.765 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 13.3 pt -122.26 165.69 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.815 0.34 . . . . 1.0700000000000001 111.143 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -91.94 -44.1 9.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.093 -0.503 . . . . 3.5899999999999999 110.398 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.04 -164.1 0.42 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.136 -0.483 . . . . 1.51 112.019 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.5 m -153.0 143.37 22.53 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.18 -0.304 . . . . 1.79 110.18 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.98 166.67 11.77 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.065 -0.588 . . . . 1.1799999999999999 111.777 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.472 HG11 ' H61' ' C' ' 3' ' ' ' A' . 8.4 p -105.9 139.73 26.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.558 0.179 . . . . 1.5600000000000001 110.569 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -72.38 126.84 33.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.752 0.31 . . . . 1.29 110.316 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.559 ' HB2' ' HG2' ' A' ' 44' ' ' PRO . 55.8 mmm-85 -104.91 92.62 4.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.078 -0.51 . . . . 2.23 111.63 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.8 m -88.18 4.89 43.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.993 -0.549 . . . . 1.1699999999999999 110.087 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.15 -14.44 38.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.624 -0.716 . . . . 0.89000000000000001 111.967 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -129.42 64.24 70.63 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 113.295 0.85 . . . . 2.1299999999999999 113.295 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.43 134.76 23.15 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.201 1.934 . . . . 0.80000000000000004 110.035 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' B' ' 78' ' ' ARG . 2.4 ptm85 -154.74 145.68 22.6 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.109 0.781 . . . . 2.0899999999999999 113.109 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.67 HG23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -96.41 115.02 26.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.37 -0.832 . . . . 1.6200000000000001 109.502 178.424 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.539 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 1.7 pp -133.78 138.85 49.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.995 -0.372 . . . . 1.1499999999999999 109.995 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.527 ' HB3' ' HA3' ' B' ' 16' ' ' GLY . 21.1 t70 -69.08 118.38 11.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.99 0.424 . . . . 1.03 111.212 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 57.7 tpp -87.47 -13.64 42.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.861 -0.608 . . . . 1.29 111.148 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -71.18 -53.37 14.71 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.162 0.43 . . . . 2.6400000000000001 112.162 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.17 -25.12 59.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.929 0.395 . . . . 1.1200000000000001 111.888 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 65.7 mtt-85 -82.35 -48.91 10.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.226 -0.443 . . . . 1.0600000000000001 111.799 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.74 114.8 0.21 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.623 -0.798 . . . . 1.1200000000000001 112.474 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -129.61 163.25 22.74 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.812 -0.709 . . . . 1.0900000000000001 112.189 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -103.92 129.15 51.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.164 -0.31 . . . . 2.46 110.164 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.53 ' HD2' ' OE2' ' A' ' 5' ' ' GLU . 2.5 ttp180 -85.64 115.18 23.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.738 0.304 . . . . 2.4900000000000002 110.765 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -86.14 -71.84 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.415 -0.357 . . . . 1.29 110.719 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.666 ' HG2' HD11 ' A' ' 6' ' ' ILE . 3.2 pt-20 -149.29 -169.32 3.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.137 -0.483 . . . . 1.1499999999999999 109.724 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -135.04 143.01 46.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.749 0.309 . . . . 1.3200000000000001 110.444 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.3 m -83.45 153.65 65.45 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.267 -0.424 . . . . 0.75 111.305 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.39 157.94 33.7 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.753 2.302 . . . . 0.94999999999999996 111.467 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.79 -27.16 67.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.689 0.28 . . . . 1.51 111.621 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.24 -45.97 85.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.282 -0.417 . . . . 1.5700000000000001 110.575 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.8 mm -66.32 -40.75 87.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.953 -0.567 . . . . 1.3100000000000001 110.007 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 9.5 tpt -62.29 -38.82 90.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.863 -0.608 . . . . 1.6000000000000001 110.486 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -64.56 -34.22 77.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.968 -0.56 . . . . 2.2999999999999998 111.193 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.5 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 6.4 tp10 -64.12 -48.87 74.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.908 -0.587 . . . . 1.6399999999999999 110.386 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.6 t -59.28 -43.23 89.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.157 -0.474 . . . . 1.03 110.609 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.78 -34.59 78.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.846 -0.616 . . . . 1.22 111.429 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.94 -27.6 66.37 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.245 -0.502 . . . . 1.03 113.077 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 9.8 mmt180 -77.04 -33.29 57.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.125 0.488 . . . . 1.72 110.553 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 89.9 mt -66.19 -30.91 71.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.935 -0.575 . . . . 1.02 111.69 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -27.95 68.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.873 0.368 . . . . 1.1100000000000001 111.299 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 m -72.85 -31.0 64.44 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.086 0.402 . . . . 1.5 112.086 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.4 pt -86.07 -3.32 8.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.464 0.542 . . . . 1.1499999999999999 112.464 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 105' ' ' LEU . 84.3 mt -85.04 69.88 10.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.859 0.362 . . . . 0.97999999999999998 110.159 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.373 -0.376 . . . . 1.3500000000000001 111.935 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' B' ' 27' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 121.213 0.53 . . . . 2.0299999999999998 112.147 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.52 ' HB3' ' HG3' ' B' ' 5' ' ' GLU . 3.2 mm-40 -85.46 9.69 15.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.086 0.47 . . . . 2.8199999999999998 110.198 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' B' ' 2' ' ' GLU . 0.0 OUTLIER 81.76 58.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.118 -0.946 . . . . 2.3199999999999998 113.207 179.663 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.501 ' O ' ' HG3' ' B' ' 92' ' ' ARG . . . 69.94 57.64 6.89 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.593 -0.731 . . . . 1.28 114.321 178.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.52 ' HG3' ' HB3' ' B' ' 2' ' ' GLU . 5.5 mm-40 -115.98 117.45 30.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.863 0.331 . . . . 1.53 111.674 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.53 HD12 ' HG3' ' B' ' 91' ' ' GLU . 66.6 mt -99.78 120.06 48.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 0.75 109.798 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -114.74 144.77 42.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.428 -0.351 . . . . 0.81000000000000005 110.693 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.404 ' HB2' HD11 ' B' ' 90' ' ' LEU . 38.0 tp -105.8 117.1 33.16 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.221 -0.445 . . . . 1.05 110.0 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.408 HG22 ' H ' ' B' ' 10' ' ' SER . 9.5 p -158.89 167.54 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.71999999999999997 110.244 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' B' ' 22' ' ' THR . 7.0 m -88.88 137.64 32.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.851 0.358 . . . . 1.6299999999999999 110.54 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.605 HD21 HG11 ' B' ' 25' ' ' VAL . 55.7 mt -85.09 -21.36 29.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.323 -0.399 . . . . 0.82999999999999996 110.999 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ASP . . . . . 0.459 ' HA ' ' N ' ' B' ' 14' ' ' THR . 3.7 m-20 -60.19 153.29 58.25 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.862 -0.608 . . . . 1.6200000000000001 110.829 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.02 120.64 5.84 Favored 'Cis proline' 0 C--O 1.235 0.341 0 C-N-CA 123.534 -1.444 . . . . 1.28 113.741 0.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.459 ' N ' ' HA ' ' B' ' 12' ' ' ASP . 0.1 OUTLIER -121.11 146.68 46.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.297 -0.865 . . . . 1.47 108.95 179.063 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.07 -177.79 5.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.913 0.387 . . . . 1.22 111.979 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.527 ' HA3' ' HB3' ' A' ' 81' ' ' ASP . . . 60.79 -106.03 0.98 Allowed Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.006 -0.543 . . . . 1.01 113.34 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' HIS . . . . . 0.405 ' H ' ' HB2' ' A' ' 81' ' ' ASP . 10.2 t-160 -115.89 8.49 14.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.845 0.355 . . . . 2.1800000000000002 110.365 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.418 ' HB3' HG22 ' B' ' 14' ' ' THR . 14.7 mt-10 -71.04 148.92 47.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 1.28 110.132 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -77.73 107.24 10.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.48 -0.327 . . . . 1.52 111.013 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.457 ' HA ' ' OG1' ' B' ' 14' ' ' THR . 91.2 mt-30 -83.31 164.97 19.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.012 -0.54 . . . . 1.8600000000000001 111.675 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.72 -169.75 28.84 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.01 -0.615 . . . . 0.90000000000000002 113.625 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' B' ' 10' ' ' SER . 35.8 m -108.24 119.99 41.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.654 -0.498 . . . . 0.94999999999999996 109.654 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.446 ' HD3' HD12 ' B' ' 11' ' ' LEU . 0.1 OUTLIER -146.63 154.34 48.13 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.192 -0.458 . . . . 1.5900000000000001 110.487 -179.317 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -63.28 135.91 52.8 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.46 2.107 . . . . 0.65000000000000002 110.72 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.758 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 14.2 m -132.85 151.56 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.174 0.512 . . . . 0.56999999999999995 111.425 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 mp -109.42 122.35 47.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.682 -0.69 . . . . 1.1699999999999999 109.918 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ILE . . . . . 0.507 ' O ' ' HG2' ' B' ' 1' ' ' MET . 43.8 mt -70.08 120.23 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.697 0.284 . . . . 0.66000000000000003 110.827 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.734 ' HB ' HG23 ' B' ' 41' ' ' VAL . 18.4 t -79.33 -40.93 22.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.051 -0.522 . . . . 0.93000000000000005 111.519 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.9 146.19 95.07 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.973 -0.558 . . . . 0.81000000000000005 111.455 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.79 164.16 34.17 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.752 2.302 . . . . 0.78000000000000003 112.591 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.46 -40.57 71.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.496 -0.775 . . . . 1.03 111.807 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.01 0.84 4.02 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.702 0.63 . . . . 1.3999999999999999 112.702 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -119.31 -40.9 2.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.208 0.528 . . . . 1.5700000000000001 109.736 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.17 -32.97 70.38 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.517 -0.765 . . . . 1.6399999999999999 111.863 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.52 2.84 55.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.132 -0.485 . . . . 2.54 112.261 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 64.2 t -113.27 -46.13 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.924 0.392 . . . . 1.0900000000000001 110.421 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' THR . . . . . 0.642 HG23 ' C6 ' ' C' ' 2' ' ' ' U' . 10.3 m -87.09 -24.26 24.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.349 0.595 . . . . 1.3300000000000001 110.1 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.861 ' HE ' ' HA ' ' B' ' 38' ' ' ARG . 0.6 OUTLIER 75.16 -38.1 0.36 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.848 1.055 . . . . 1.78 113.848 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 89.7 mt -99.59 101.84 14.75 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.978 -0.379 . . . . 1.1599999999999999 109.978 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' B' ' 38' ' ' ARG . 90.1 Cg_endo -94.12 163.69 2.08 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.907 2.404 . . . . 0.56999999999999995 113.889 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.734 HG23 ' HB ' ' B' ' 28' ' ' VAL . 1.8 m -96.13 138.35 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.782 -0.821 . . . . 1.0800000000000001 108.782 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.758 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 17.8 m -126.09 150.12 31.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 113.205 0.817 . . . . 0.64000000000000001 113.205 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.441 HG23 HG22 ' B' ' 28' ' ' VAL . 24.4 t -97.62 111.74 59.51 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.022 -0.99 . . . . 1.1000000000000001 108.835 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.658 ' HA ' HG12 ' B' ' 25' ' ' VAL . 11.8 Cg_exo -70.93 127.83 14.17 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.9 2.4 . . . . 0.72999999999999998 112.722 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.652 HG22 HG12 ' B' ' 72' ' ' VAL . 61.8 t -99.98 133.45 42.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.055 -0.521 . . . . 0.90000000000000002 109.887 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -98.17 92.1 5.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.34 -0.391 . . . . 1.1699999999999999 110.489 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.77 152.94 26.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.011 -0.541 . . . . 1.8500000000000001 110.602 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 160.99 -59.36 0.3 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.483 -0.865 . . . . 2.2200000000000002 111.82 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.19 168.94 30.21 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.552 -0.832 . . . . 3.4300000000000002 111.692 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -111.24 26.15 10.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.128 0.489 . . . . 4.6200000000000001 110.521 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -72.92 -43.0 62.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.798 -0.637 . . . . 6.2699999999999996 110.074 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.4 113.98 24.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.873 -0.603 . . . . 4.3899999999999997 109.539 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.08 -42.32 11.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.133 0.492 . . . . 3.9199999999999999 110.875 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 1.5 t -148.47 120.95 8.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.365 0.602 . . . . 2.75 111.549 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.87 78.53 1.77 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.691 -0.686 . . . . 1.96 110.411 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.64 -88.3 0.36 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.124 -0.56 . . . . 1.0800000000000001 112.732 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -104.95 -17.06 14.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.969 0.414 . . . . 3.5699999999999998 110.045 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.594 ' HB1' ' HB ' ' B' ' 71' ' ' VAL . . . -82.64 120.0 25.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.862 -0.608 . . . . 1.0800000000000001 111.566 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 t -119.8 134.55 62.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.069 -0.715 . . . . 1.3400000000000001 109.069 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 37.5 p -76.26 135.79 39.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.667 0.27 . . . . 1.3799999999999999 111.234 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 77.9 mt -89.72 -0.96 57.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.157 0.503 . . . . 1.02 110.626 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.65 148.2 28.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.958 -0.565 . . . . 1.79 111.152 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.4 -38.1 3.47 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.913 -0.66 . . . . 1.1499999999999999 112.336 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 10.8 p -81.36 -26.28 10.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.749 0.278 . . . . 1.1699999999999999 111.749 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.05 22.93 3.4 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.435 -0.888 . . . . 1.05 113.362 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 61.4 mt -90.61 138.51 19.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.541 -0.54 . . . . 1.6100000000000001 109.541 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' ARG . . . . . 0.402 ' HD2' HH11 ' B' ' 67' ' ' ARG . 28.0 ttt85 -68.31 -42.48 79.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.004 0.43 . . . . 2.3999999999999999 110.704 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 16.5 m -68.12 97.47 0.7 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.536 -0.756 . . . . 0.93000000000000005 110.957 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.6 97.61 10.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.923 -0.581 . . . . 1.3100000000000001 111.432 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.65 -179.75 46.35 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.739 -0.744 . . . . 0.79000000000000004 111.702 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.594 ' HB ' ' HB1' ' B' ' 58' ' ' ALA . 8.5 m -105.81 136.49 39.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.705 0.288 . . . . 0.93000000000000005 110.8 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.652 HG12 HG22 ' B' ' 45' ' ' VAL . 10.0 m -84.27 137.28 21.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.961 0.41 . . . . 1.3799999999999999 111.478 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 32.9 mmm-85 -113.32 85.97 2.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.191 -0.459 . . . . 1.3700000000000001 110.114 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 5.2 m -82.12 6.3 16.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.184 -0.462 . . . . 1.1599999999999999 111.266 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.729 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 10.1 p-10 -87.43 -10.47 51.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.863 -0.608 . . . . 1.1000000000000001 111.56 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -135.29 78.34 52.13 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 112.896 0.702 . . . . 2.4700000000000002 112.896 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.89 98.99 0.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.737 2.291 . . . . 0.95999999999999996 111.729 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 12.2 ttt180 -102.64 140.68 36.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.381 -0.372 . . . . 1.96 111.497 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.511 HG23 HG13 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -76.03 125.74 29.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 1.1899999999999999 109.67 178.259 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.416 ' O ' ' HD2' ' B' ' 40' ' ' PRO . 26.8 pt -131.32 -179.7 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.454 -0.339 . . . . 1.28 110.189 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.401 ' O ' ' HD2' ' B' ' 85' ' ' ARG . 7.0 t70 -97.52 139.86 32.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.368 . . . . 1.28 110.867 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' MET . . . . . 0.429 ' SD ' ' HA3' ' B' ' 87' ' ' GLY . 35.6 tpp -126.03 29.74 5.81 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.395 -0.594 . . . . 2.7000000000000002 109.395 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -121.14 -55.93 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.703 -0.68 . . . . 1.96 111.352 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.53 -33.96 15.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.133 -0.485 . . . . 1.0600000000000001 110.653 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.401 ' HD2' ' O ' ' B' ' 81' ' ' ASP . 75.3 mtt180 -63.94 -23.05 67.19 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.863 -0.608 . . . . 1.47 111.428 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.0 90.38 0.83 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.94 -0.648 . . . . 0.81999999999999995 112.623 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' GLY . . . . . 0.429 ' HA3' ' SD ' ' B' ' 82' ' ' MET . . . -96.89 133.13 11.27 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.532 -0.842 . . . . 0.65000000000000002 112.253 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -139.04 130.29 26.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.6 0.238 . . . . 1.8100000000000001 110.818 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -83.08 127.93 34.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.471 -0.332 . . . . 2.4900000000000002 110.268 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' B' ' 8' ' ' LEU . 94.3 mt -91.14 -72.62 0.57 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.188 -0.46 . . . . 0.76000000000000001 111.557 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLU . . . . . 0.53 ' HG3' HD12 ' B' ' 6' ' ' ILE . 16.8 pt-20 -133.42 169.93 16.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.094 -0.503 . . . . 1.0700000000000001 110.722 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' B' ' 4' ' ' GLY . 15.2 ttm180 -104.48 141.62 36.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.183 -0.462 . . . . 2.0499999999999998 110.193 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' B' ' 94' ' ' PRO . 60.3 t -83.1 132.38 50.76 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.906 -0.588 . . . . 1.45 110.68 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' B' ' 93' ' ' VAL . 31.6 Cg_exo -62.64 155.74 57.06 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.601 2.2 . . . . 1.03 110.758 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.28 -38.92 74.69 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.321 0.489 . . . . 2.1400000000000001 112.321 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.95 -39.21 88.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.974 0.416 . . . . 1.78 111.12 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 30.0 mm -82.47 -32.02 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.158 -0.474 . . . . 1.3300000000000001 110.434 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 12.7 tpt -58.66 -45.04 90.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 2.3399999999999999 110.239 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -64.57 -35.07 79.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.998 -0.546 . . . . 1.9099999999999999 110.302 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 11.1 tp10 -60.06 -44.47 94.69 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.771 -0.649 . . . . 1.76 109.959 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' B' ' 105' ' ' LEU . 55.9 t -60.99 -44.85 99.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.039 -0.528 . . . . 1.01 110.197 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.44 -42.0 90.92 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.048 -0.524 . . . . 1.29 110.559 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.79 -42.8 98.41 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.433 -0.667 . . . . 1.02 111.433 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 12.3 mmt180 -63.97 -32.74 74.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.038 0.447 . . . . 1.8500000000000001 110.793 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' B' ' 101' ' ' VAL . 93.8 mt -68.91 -20.91 64.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.021 -0.536 . . . . 1.9399999999999999 110.815 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 5.7 m -86.06 -24.73 26.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.159 -0.473 . . . . 1.1599999999999999 109.944 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.1 m -68.29 -37.41 80.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 1.45 111.214 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.44 HG21 ' HA ' ' B' ' 75' ' ' ASP . 39.2 pt -76.43 0.23 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.333 -0.394 . . . . 1.98 112.036 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 96.3 mt -91.26 10.26 27.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.922 0.391 . . . . 1.3600000000000001 110.967 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.792 -0.623 . . . . 2.1299999999999999 110.219 179.903 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.699 0 C1'-C2'-O2' 108.616 -0.661 . 0.0 '__' . 6.3600000000000003 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' ' U' . . . . . 0.642 ' C6 ' HG23 ' B' ' 37' ' ' THR . . . . . . . . 0 O5'--C5' 1.426 -0.884 0 C4'-C3'-C2' 104.484 1.784 . 0.0 OUTLIER . 2.9900000000000002 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 3' ' ' ' A' . . . . . 0.748 ' C2 ' ' HB ' ' A' ' 46' ' ' THR . . . . . . . . 0 C3'--C2' 1.538 1.201 0 C4'-C3'-C2' 105.703 3.003 OUTLIER-DELTA 0.0 OUTLIER . 2.5899999999999999 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 4' ' ' ' C' . . . . . 0.41 H5'' HG22 ' A' ' 46' ' ' THR . . . . . . . . 0 O5'--C5' 1.428 -0.778 0 N19-C1'-C2' 114.955 0.972 . 0.0 OUTLIER zeta-1 2.5099999999999998 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 5' ' ' ' A' . . . . . 0.692 " H3'" ' HB2' ' A' ' 20' ' ' GLN . . . . . . . . 0 O4'--C1' 1.402 -0.985 0 C4'-C3'-C2' 104.965 2.265 . 0.0 OUTLIER gamma 4.9400000000000004 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.565 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 23.4 ptp . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 120.814 0.34 . . . . 1.29 110.883 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.404 ' HG2' ' HB2' ' A' ' 31' ' ' ALA . 39.6 mt-10 -124.96 169.72 11.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.106 -0.497 . . . . 2.0099999999999998 110.612 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.496 ' NH2' ' HD3' ' A' ' 30' ' ' PRO . 24.2 ttm180 -71.52 128.01 34.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.909 -0.587 . . . . 1.8500000000000001 109.671 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.409 ' HA3' ' NH2' ' A' ' 92' ' ' ARG . . . 104.11 -6.04 46.51 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.622 -0.799 . . . . 0.85999999999999999 112.492 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 57.5 mt-10 -79.92 147.68 31.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.877 0.37 . . . . 0.98999999999999999 110.782 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.469 HD12 ' HG3' ' A' ' 91' ' ' GLU . 59.5 mt -109.88 119.91 59.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.178 -0.465 . . . . 1.1599999999999999 109.86 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.415 ' CZ2' ' HB3' ' A' ' 1' ' ' MET . 21.2 m95 -114.93 149.9 36.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.012 -0.54 . . . . 0.91000000000000003 110.782 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.0 tp -106.01 118.39 36.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.776 -0.193 . . . . 0.90000000000000002 110.491 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 p -166.14 148.95 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 120.948 0.404 . . . . 1.04 110.814 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.7 OUTLIER -77.17 141.66 40.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.356 -0.384 . . . . 1.3200000000000001 110.607 179.541 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.484 HD21 HG11 ' A' ' 25' ' ' VAL . 69.2 mt -97.58 4.11 50.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.157 0.503 . . . . 1.29 111.252 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.845 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -72.08 179.9 0.92 Allowed Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.642 -0.708 . . . . 1.54 110.302 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.845 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 5.8 Cg_exo -79.65 134.89 32.76 Favored 'Cis proline' 0 C--N 1.354 0.822 0 CA-C-N 119.736 0.942 . . . . 1.6899999999999999 112.62 0.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 20' ' ' GLN . 58.2 p -108.14 155.41 20.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.663 -0.699 . . . . 1.3600000000000001 111.144 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.2 102.56 5.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.138 -0.69 . . . . 1.7 109.138 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.37 -116.21 3.87 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.505 -1.438 . . . . 1.1799999999999999 109.505 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.46 ' HB3' ' HD2' ' B' ' 83' ' ' LYS . 77.0 t60 -134.06 78.55 1.77 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.065 0.459 . . . . 2.7799999999999998 111.75 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 33.6 mt-10 -110.59 -149.32 0.44 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.791 -0.818 . . . . 1.1399999999999999 108.791 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -82.58 53.77 2.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.312 0.577 . . . . 2.0899999999999999 110.007 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.474 ' HG2' ' H ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -68.31 128.77 37.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.294 -0.866 . . . . 2.0899999999999999 112.006 -179.046 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.558 ' HA2' ' C8 ' ' C' ' 5' ' ' ' A' . . . 113.99 146.84 9.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.83 -0.7 . . . . 1.0700000000000001 113.445 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 21.2 m -79.31 121.1 24.68 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.715 -0.476 . . . . 1.1100000000000001 109.715 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.493 HH22 " H3'" ' C' ' 3' ' ' ' A' . 0.0 OUTLIER -145.48 161.51 40.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.437 -0.347 . . . . 1.6200000000000001 110.354 -179.224 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.32 145.75 60.67 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.104 1.87 . . . . 1.01 110.289 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.729 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 15.1 m -128.75 140.12 50.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.42 -0.354 . . . . 0.76000000000000001 110.55 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.487 ' HB3' HG23 ' A' ' 43' ' ' VAL . 42.1 tp -95.04 128.64 42.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.034 -0.53 . . . . 0.69999999999999996 110.822 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.13 109.34 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.801 -0.444 . . . . 0.92000000000000004 109.801 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.59 HG11 HD11 ' A' ' 105' ' ' LEU . 17.1 t -86.95 -27.91 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 120.997 0.427 . . . . 0.94999999999999996 111.413 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.85 145.41 74.28 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.294 -0.412 . . . . 1.1200000000000001 111.411 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.496 ' HD3' ' NH2' ' A' ' 3' ' ' ARG . 58.2 Cg_endo -71.69 158.91 52.34 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.646 2.231 . . . . 1.3 112.173 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.404 ' HB2' ' HG2' ' A' ' 2' ' ' GLU . . . -53.25 -40.04 64.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.993 -0.549 . . . . 1.3899999999999999 112.206 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.31 -50.18 74.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.331 -0.395 . . . . 1.6100000000000001 111.767 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -63.93 -38.41 90.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.115 0.483 . . . . 1.77 110.885 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 85.2 m-20 -67.53 -20.84 65.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.732 -0.667 . . . . 1.48 111.051 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -91.33 -35.03 14.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.197 -0.456 . . . . 2.6200000000000001 112.003 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.57 -50.3 15.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.693 0.627 . . . . 1.8600000000000001 112.693 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 m -87.38 -31.61 20.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.855 0.359 . . . . 1.72 110.95 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.718 ' HB3' ' HE2' ' A' ' 83' ' ' LYS . 0.7 OUTLIER 66.46 23.38 10.54 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.795 -0.639 . . . . 4.4500000000000002 111.543 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.7 mt -132.35 100.43 15.31 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.442 -0.799 . . . . 1.8100000000000001 109.053 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -89.69 140.45 3.58 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.629 2.219 . . . . 1.05 114.163 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.1 t -90.36 124.37 42.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.221 -1.4 . . . . 1.03 107.221 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.729 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 31.4 m -123.43 163.97 21.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 113.542 0.942 . . . . 0.77000000000000002 113.542 -177.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -122.93 134.56 25.13 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 114.307 -1.315 . . . . 0.71999999999999997 108.686 178.45 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.11 128.86 10.91 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.927 2.418 . . . . 1.03 114.674 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.786 HG22 HG22 ' A' ' 72' ' ' VAL . 58.0 t -88.6 118.44 34.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.021 -0.733 . . . . 1.28 109.021 178.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -147.44 -167.75 2.87 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.163 -0.31 . . . . 1.9099999999999999 110.163 -179.486 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.507 ' H ' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -80.97 156.0 26.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.47 0.176 . . . . 2.5299999999999998 110.648 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.55 69.67 0.26 Allowed Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.168 -0.773 . . . . 3.3599999999999999 111.168 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.34 -111.09 3.93 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.352 -1.099 . . . . 3.8300000000000001 110.352 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -106.84 -10.17 16.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.233 0.539 . . . . 4.7199999999999998 109.993 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -133.31 -169.25 2.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.831 -0.622 . . . . 6.2400000000000002 110.11 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.59 65.35 0.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.369 0.604 . . . . 2.5899999999999999 109.466 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 ptt85 -130.52 -177.8 4.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.712 -0.676 . . . . 4.5899999999999999 111.365 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.3 103.21 1.9 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.593 -0.731 . . . . 2.6899999999999999 110.915 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.573 ' H ' ' HB3' ' A' ' 58' ' ' ALA . . . -116.75 90.28 3.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.93 0.395 . . . . 3.1699999999999999 111.007 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.512 ' HA3' ' O4 ' ' C' ' 2' ' ' ' U' . . . 78.57 -99.33 1.6 Allowed Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.911 -0.586 . . . . 1.6599999999999999 113.048 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.504 ' HE2' ' HB ' ' A' ' 107' ' ' THR . 57.8 m-85 -106.34 17.07 23.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.906 0.384 . . . . 1.5600000000000001 111.778 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.573 ' HB3' ' H ' ' A' ' 55' ' ' ALA . . . -81.68 137.39 35.42 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.226 -0.657 . . . . 1.25 109.226 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.609 HG22 ' HB ' ' A' ' 72' ' ' VAL . 16.5 m -88.44 161.16 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.047 0.451 . . . . 1.6799999999999999 111.731 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -84.67 93.5 8.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.988 -0.551 . . . . 1.95 111.641 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.841 HD11 HG23 ' A' ' 72' ' ' VAL . 7.2 mt -87.11 -33.79 19.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.341 -0.39 . . . . 1.23 111.923 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -68.71 114.79 7.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.023 0.439 . . . . 2.21 111.788 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.47 -10.78 5.53 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.652 -0.785 . . . . 1.1499999999999999 113.004 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 61' ' ' LEU . 19.6 m -90.61 -16.11 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 117.224 0.512 . . . . 1.21 111.49 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.88 51.77 7.56 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 121.066 -0.588 . . . . 1.0800000000000001 113.461 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.504 ' HB ' ' OE2' ' A' ' 91' ' ' GLU . 20.1 pt -103.72 -171.73 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.718 0.294 . . . . 1.0700000000000001 111.155 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 54.7 ttm-85 -102.23 -33.65 9.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.103 -0.499 . . . . 3.5899999999999999 110.28 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.487 ' HB ' HD12 ' A' ' 66' ' ' ILE . 21.8 m -55.85 117.55 3.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.412 -0.813 . . . . 1.51 111.132 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.19 109.6 21.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.973 -0.558 . . . . 1.79 110.558 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.931 ' HA3' ' H42' ' C' ' 4' ' ' ' C' . . . 146.72 -165.43 28.41 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.629 -0.795 . . . . 1.1799999999999999 112.115 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 81.6 t -132.69 129.63 58.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.797 0.332 . . . . 1.5600000000000001 110.742 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.841 HG23 HD11 ' A' ' 61' ' ' LEU . 69.9 t -72.18 110.96 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.874 -0.788 . . . . 1.29 108.874 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.597 ' HB3' ' OD2' ' A' ' 75' ' ' ASP . 12.1 mtm-85 -99.68 121.57 41.43 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.326 -0.397 . . . . 2.23 110.516 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 14.4 m -98.57 34.7 1.97 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.274 -0.421 . . . . 1.1699999999999999 110.784 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.597 ' OD2' ' HB3' ' A' ' 73' ' ' ARG . 0.5 OUTLIER -76.53 -60.96 2.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.232 -0.44 . . . . 0.89000000000000001 110.868 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.849 ' HB3' HG21 ' B' ' 79' ' ' THR . 4.3 mm100 -115.51 80.63 8.12 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.291 -0.413 . . . . 2.1299999999999999 111.4 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -84.3 156.16 12.69 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.639 2.226 . . . . 0.80000000000000004 111.118 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -168.32 166.4 12.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.056 0.455 . . . . 2.0899999999999999 111.265 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.461 ' OG1' ' HD2' ' B' ' 77' ' ' PRO . 24.2 m -92.53 145.49 24.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.625 -0.716 . . . . 1.6200000000000001 109.174 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.479 HG21 HD22 ' A' ' 11' ' ' LEU . 26.6 pt -135.3 150.79 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.684 0.278 . . . . 1.1499999999999999 110.529 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.94 142.7 47.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.043 -0.526 . . . . 1.03 110.051 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 35.4 tpp -121.55 5.61 10.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.186 0.517 . . . . 1.29 110.78 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.718 ' HE2' ' HB3' ' A' ' 38' ' ' ARG . 6.0 mptp? -93.43 -46.54 7.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.2 -0.454 . . . . 2.6400000000000001 111.043 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.704 ' HB3' ' HA2' ' B' ' 16' ' ' GLY . . . -93.02 -40.6 10.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.389 -0.369 . . . . 1.1200000000000001 110.47 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -62.31 -57.6 10.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.389 -0.368 . . . . 1.0600000000000001 110.304 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.24 84.94 0.19 Allowed Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.909 -0.662 . . . . 1.1200000000000001 113.505 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.34 172.56 47.22 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.704 -0.76 . . . . 1.0900000000000001 111.867 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -122.29 122.45 39.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.064 -0.346 . . . . 2.46 110.064 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -77.88 137.39 38.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.631 0.253 . . . . 2.4900000000000002 110.937 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 90' ' ' LEU . 2.6 mm? -112.64 -81.05 0.59 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.227 -0.442 . . . . 1.29 110.291 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.504 ' OE2' ' HB ' ' A' ' 66' ' ' ILE . 18.2 pt-20 -131.05 -163.71 1.35 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.221 -0.445 . . . . 1.1499999999999999 110.738 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.409 ' NH2' ' HA3' ' A' ' 4' ' ' GLY . 4.0 ptm180 -147.63 155.19 41.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.564 0.221 . . . . 1.3200000000000001 110.56 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.464 HG13 HD11 ' A' ' 6' ' ' ILE . 26.6 m -103.58 156.36 35.64 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.289 -0.414 . . . . 0.75 111.399 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -69.28 166.88 25.48 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.762 2.308 . . . . 0.94999999999999996 111.73 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -58.82 -24.11 61.47 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.437 -0.347 . . . . 1.51 111.769 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -40.74 87.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.285 -0.416 . . . . 1.5700000000000001 110.825 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.5 mm -71.04 -37.78 69.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 1.3100000000000001 110.186 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.7 tpt -62.0 -37.21 83.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 1.6000000000000001 110.472 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -64.16 -35.59 81.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.071 0.462 . . . . 2.2999999999999998 110.085 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 0.1 OUTLIER -64.59 -44.99 88.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.763 -0.653 . . . . 1.6399999999999999 109.62 178.79 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.5 t -64.23 -41.26 91.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.714 -0.675 . . . . 1.03 110.597 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.9 mt -55.56 -43.01 75.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.107 -0.497 . . . . 1.22 110.742 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.6 -41.95 98.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.909 -0.662 . . . . 1.03 111.897 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 19.5 mmt180 -62.05 -45.89 91.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.761 0.315 . . . . 1.72 110.529 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.59 HD11 HG11 ' A' ' 28' ' ' VAL . 93.9 mt -62.65 -40.65 97.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.037 -0.529 . . . . 1.02 111.104 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.1 m -70.78 -3.06 16.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 1.1100000000000001 111.596 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.504 ' HB ' ' HE2' ' A' ' 57' ' ' PHE . 24.7 m -105.11 -34.11 8.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.789 0.328 . . . . 1.5 110.806 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.412 ' O ' ' HD3' ' B' ' 30' ' ' PRO . 41.2 pt -79.97 -23.31 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 111.996 0.369 . . . . 1.1499999999999999 111.996 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.0 mt -76.21 81.84 3.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.97999999999999998 111.023 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.755 -0.657 . . . . 1.3500000000000001 109.835 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.609 ' HE3' ' HB ' ' B' ' 27' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.133 0 CA-C-O 121.616 0.722 . . . . 2.0299999999999998 112.736 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.551 ' HG2' ' HB2' ' B' ' 31' ' ' ALA . 37.3 mt-10 -86.59 -19.57 29.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.259 -0.882 . . . . 2.8199999999999998 109.315 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' B' ' 2' ' ' GLU . 8.3 mpt_? 77.82 115.18 0.06 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.913 -1.039 . . . . 2.3199999999999998 112.759 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.23 49.48 4.95 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.879 -0.6 . . . . 1.28 114.128 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.465 ' HB2' ' HE3' ' B' ' 1' ' ' MET . 73.9 mm-40 -126.58 88.33 2.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.58 0.585 . . . . 1.53 112.58 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.849 HD11 ' HB ' ' B' ' 93' ' ' VAL . 60.8 mt -102.21 107.45 21.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.88 -0.785 . . . . 0.75 108.88 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -108.03 160.36 15.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.91 -0.587 . . . . 0.81000000000000005 111.198 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 42.0 tp -111.84 121.47 45.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.914 -0.772 . . . . 1.05 108.914 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.567 HG11 HD13 ' B' ' 80' ' ' ILE . 5.2 p -152.17 157.32 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 120.787 0.327 . . . . 0.71999999999999997 110.536 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 47.6 m -83.13 119.25 24.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.246 -0.433 . . . . 1.6299999999999999 110.083 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.466 HD21 HG11 ' B' ' 25' ' ' VAL . 88.8 mt -72.42 -26.31 61.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.161 -0.472 . . . . 0.82999999999999996 111.071 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.26 149.78 86.34 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.88 -0.6 . . . . 1.6200000000000001 110.497 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.07 140.78 30.95 Favored 'Cis proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.58 -1.425 . . . . 1.28 112.561 0.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.72 129.4 36.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.981 -0.554 . . . . 1.47 109.655 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.88 173.6 6.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.367 -0.379 . . . . 1.22 111.497 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 84' ' ' ALA . . . 70.41 -134.27 24.42 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.643 -0.708 . . . . 1.01 113.271 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -114.28 29.21 8.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.974 0.416 . . . . 2.1800000000000002 110.305 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -83.02 168.53 16.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.752 -0.658 . . . . 1.28 110.664 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -74.15 133.26 42.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.22 0.533 . . . . 1.52 111.962 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -125.02 -178.28 4.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.762 -0.654 . . . . 1.8600000000000001 110.809 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.71 166.92 42.75 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.235 -0.507 . . . . 0.90000000000000002 113.583 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.9 m -96.52 110.15 22.6 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.996 -0.742 . . . . 0.94999999999999996 108.996 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.85 162.97 27.7 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.466 -0.334 . . . . 1.5900000000000001 110.246 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.87 141.57 98.18 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.447 2.098 . . . . 0.65000000000000002 111.209 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.762 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 9.7 m -135.11 139.76 46.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.103 -0.498 . . . . 0.56999999999999995 110.654 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 61.3 tp -99.98 121.98 42.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.127 -0.488 . . . . 1.1699999999999999 109.837 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ILE . . . . . 0.609 ' HB ' ' HE3' ' B' ' 1' ' ' MET . 16.7 mt -72.26 145.5 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.425 -0.352 . . . . 0.66000000000000003 110.073 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.513 ' HB ' HG23 ' B' ' 41' ' ' VAL . 19.2 t -112.36 -27.72 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 120.8 0.333 . . . . 0.93000000000000005 111.525 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' THR . . . . . 0.527 HG23 HG22 ' B' ' 41' ' ' VAL . 0.2 OUTLIER -69.77 148.16 96.48 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.503 -0.317 . . . . 0.81000000000000005 111.84 -179.24 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 91.6 Cg_endo -77.62 176.17 10.37 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.962 2.441 . . . . 0.78000000000000003 113.54 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.551 ' HB2' ' HG2' ' B' ' 2' ' ' GLU . . . -66.93 -31.3 71.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.476 -0.784 . . . . 1.03 110.736 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.24 18.37 0.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.944 -0.571 . . . . 1.3999999999999999 110.946 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -137.16 -53.62 0.69 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.033 -0.53 . . . . 1.5700000000000001 110.023 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -57.12 -39.61 75.47 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.99 -0.55 . . . . 1.6399999999999999 111.953 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -92.67 8.27 39.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.23 -0.441 . . . . 2.54 111.59 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 62.7 t -116.01 -64.04 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.284 -0.416 . . . . 1.0900000000000001 111.157 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 37.1 p -78.52 -16.23 57.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.335 0.588 . . . . 1.3300000000000001 110.493 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.661 ' HB2' ' NZ ' ' B' ' 83' ' ' LYS . 0.1 OUTLIER 60.62 29.77 19.25 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.365 -0.834 . . . . 1.78 110.684 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.417 HD12 " H3'" ' C' ' 2' ' ' ' U' . 30.5 mt -143.24 102.74 5.14 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.35 -0.841 . . . . 1.1599999999999999 109.282 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' B' ' 80' ' ' ILE . 96.9 Cg_endo -97.18 149.35 0.94 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.778 2.319 . . . . 0.56999999999999995 113.571 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.527 HG22 HG23 ' B' ' 29' ' ' THR . 16.2 m -97.44 133.68 38.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.58 -1.267 . . . . 1.0800000000000001 107.58 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.762 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 24.9 m -127.18 153.78 36.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 113.981 1.104 . . . . 0.64000000000000001 113.981 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 54.4 t -103.61 119.36 55.0 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 114.43 -1.259 . . . . 1.1000000000000001 108.216 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.556 ' HA ' HG12 ' B' ' 25' ' ' VAL . 46.3 Cg_endo -68.51 126.23 13.88 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.889 2.393 . . . . 0.72999999999999998 113.217 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.763 HG22 HG12 ' B' ' 72' ' ' VAL . 87.8 t -88.89 135.98 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.826 -0.625 . . . . 0.90000000000000002 109.353 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -114.21 96.62 5.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.502 -0.317 . . . . 1.1699999999999999 110.378 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.1 m -68.47 119.87 13.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.026 -0.534 . . . . 1.8500000000000001 110.827 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -110.61 40.88 2.4 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.058 -0.817 . . . . 2.2200000000000002 111.058 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.31 -91.27 0.38 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.019 -0.61 . . . . 3.4300000000000002 111.676 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -131.34 6.84 4.52 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.27 0.557 . . . . 4.6200000000000001 110.611 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -100.87 119.57 38.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.656 -0.702 . . . . 6.2699999999999996 110.073 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.47 92.45 1.77 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.201 -0.454 . . . . 4.3899999999999997 110.817 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -118.22 136.78 53.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.307 -0.406 . . . . 3.9199999999999999 110.931 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 2.4 t -72.35 134.29 45.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.67 -0.695 . . . . 2.75 111.872 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.42 97.79 1.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.764 -0.653 . . . . 1.96 110.469 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.78 -98.43 0.29 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.118 -0.563 . . . . 1.0800000000000001 113.099 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -86.55 -16.21 37.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.825 0.345 . . . . 3.5699999999999998 111.398 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.51 131.45 34.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.311 -0.404 . . . . 1.0800000000000001 110.523 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -113.17 144.24 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 1.3400000000000001 110.143 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -80.62 113.19 18.63 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.06 0.393 . . . . 1.3799999999999999 112.06 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 97.9 mt -88.55 -7.17 56.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.654 0.74 . . . . 1.02 109.016 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -98.07 141.24 31.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.143 -0.935 . . . . 1.79 109.767 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.91 -58.06 0.7 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.723 -0.751 . . . . 1.1499999999999999 112.125 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 p -75.7 -26.85 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.076 0.465 . . . . 1.1699999999999999 111.294 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.93 57.83 0.42 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.473 -0.87 . . . . 1.05 113.287 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 84.9 mt -104.09 143.2 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.919 -0.771 . . . . 1.6100000000000001 108.919 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -65.23 -53.43 44.5 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.81 0.338 . . . . 2.3999999999999999 110.495 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 8.8 m -71.13 101.27 2.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.18 0.514 . . . . 0.93000000000000005 110.033 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -91.85 108.8 20.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.082 -0.508 . . . . 1.3100000000000001 110.997 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.55 -160.22 25.98 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.004 -0.617 . . . . 0.79000000000000004 111.997 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 10.7 m -125.87 139.44 51.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.791 0.329 . . . . 0.93000000000000005 110.877 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.763 HG12 HG22 ' B' ' 45' ' ' VAL . 15.8 m -88.57 143.12 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.364 -0.38 . . . . 1.3799999999999999 110.887 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.536 ' HB2' ' HG2' ' B' ' 44' ' ' PRO . 35.5 mmm-85 -97.86 84.87 3.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.149 0.499 . . . . 1.3700000000000001 110.614 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.2 m -73.96 -5.87 43.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 1.1599999999999999 111.296 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -88.7 -16.15 33.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.058 -0.519 . . . . 1.1000000000000001 111.409 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' GLN . . . . . 0.437 ' N ' ' HD3' ' B' ' 77' ' ' PRO . 70.1 mt-30 -130.82 60.49 53.38 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 113.04 0.756 . . . . 2.4700000000000002 113.04 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.461 ' HD2' ' OG1' ' A' ' 79' ' ' THR . 6.9 Cg_exo -75.93 141.08 23.67 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.085 1.857 . . . . 0.95999999999999996 110.223 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -132.61 143.61 49.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.862 0.363 . . . . 1.96 111.34 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.849 HG21 ' HB3' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -78.39 135.06 37.36 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.389 -0.967 . . . . 1.1899999999999999 108.389 177.803 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.567 HD13 HG11 ' B' ' 9' ' ' VAL . 9.3 pt -118.99 154.21 21.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.93 0.395 . . . . 1.28 110.948 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' B' ' 85' ' ' ARG . 5.5 t70 -86.03 139.89 30.77 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.853 -0.612 . . . . 1.28 109.42 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 2.6 ttp -130.9 26.73 4.94 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.603 0.716 . . . . 2.7000000000000002 109.505 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.661 ' NZ ' ' HB2' ' B' ' 38' ' ' ARG . 37.9 mttm -109.86 -44.05 3.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.033 -0.985 . . . . 1.96 109.399 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.38 -28.42 8.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.421 -0.809 . . . . 1.0600000000000001 110.074 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' B' ' 81' ' ' ASP . 45.3 mtt180 -80.97 151.94 28.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.963 -0.562 . . . . 1.47 110.384 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.92 131.88 10.82 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.215 -0.754 . . . . 0.81999999999999995 111.215 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.25 148.25 18.5 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.954 -0.641 . . . . 0.65000000000000002 111.679 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -139.89 137.69 35.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.489 0.185 . . . . 1.8100000000000001 110.904 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -78.55 131.2 36.69 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.235 -0.284 . . . . 2.4900000000000002 110.235 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 82.4 mt -98.33 -58.06 2.06 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.434 0.531 . . . . 0.76000000000000001 112.434 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLU . . . . . 0.53 ' O ' ' HB ' ' B' ' 6' ' ' ILE . 16.0 pt-20 -149.07 158.22 44.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.412 -0.358 . . . . 1.0700000000000001 110.278 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -101.02 112.07 24.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.772 0.32 . . . . 2.0499999999999998 110.155 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.849 ' HB ' HD11 ' B' ' 6' ' ' ILE . 7.3 p -66.28 133.77 94.58 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.776 -0.647 . . . . 1.45 110.854 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.69 146.4 77.0 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.673 2.249 . . . . 1.03 111.11 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -55.06 -32.66 62.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 2.1400000000000001 111.891 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -48.39 78.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.93 -0.577 . . . . 1.78 110.953 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 40.4 mm -80.29 -34.48 14.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 1.3300000000000001 110.593 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 6.9 tpt -56.58 -47.39 79.65 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.007 -0.542 . . . . 2.3399999999999999 110.854 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -67.06 -33.71 76.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 1.9099999999999999 110.914 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.598 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 0.1 OUTLIER -60.42 -46.06 91.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 1.76 110.872 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 50.2 t -59.33 -44.09 91.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.946 0.403 . . . . 1.01 110.495 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -62.9 -36.37 83.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 1.29 110.264 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.63 -34.13 86.58 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.802 -0.635 . . . . 1.02 111.852 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 19.6 mmt85 -70.74 -28.74 64.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.035 0.445 . . . . 1.8500000000000001 110.661 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 36.5 mt -76.93 -18.54 58.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 1.9399999999999999 110.774 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 24.6 m -76.94 -6.92 54.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.212 -0.449 . . . . 1.1599999999999999 111.694 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 3.7 m -66.73 -25.04 66.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 1.45 111.366 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 46.7 pt -92.07 7.21 5.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.829 0.347 . . . . 1.98 111.675 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 59.2 mt -87.0 13.33 9.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.155 0.502 . . . . 1.3600000000000001 111.246 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.654 -0.703 . . . . 2.1299999999999999 109.436 179.806 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.432 -0.477 0 C3'-C2'-C1' 100.763 -0.818 . 0.0 '__' . 6.3600000000000003 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' ' U' . . . . . 0.512 ' O4 ' ' HA3' ' A' ' 56' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.848 0 C4'-C3'-C2' 103.853 1.153 . 0.0 OUTLIER gamma 2.9900000000000002 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 3' ' ' ' A' . . . . . 0.493 " H3'" HH22 ' A' ' 23' ' ' ARG . . . . . . . . 0 O5'--C5' 1.429 -0.708 0 C3'-C2'-O2' 111.095 -0.76 . 0.0 OUTLIER gamma 2.5899999999999999 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 4' ' ' ' C' . . . . . 0.931 ' H42' ' HA3' ' A' ' 70' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.917 0 O4'-C4'-C3' 103.064 -1.74 . 0.0 OUTLIER zeta-1 2.5099999999999998 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 5' ' ' ' A' . . . . . 0.558 ' C8 ' ' HA2' ' A' ' 21' ' ' GLY . . . . . . . . 0 O5'--C5' 1.424 -0.984 0 C1'-C2'-O2' 108.393 -0.736 . 0.0 OUTLIER . 4.9400000000000004 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.469 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 23.7 ptp . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 120.658 0.266 . . . . 1.29 110.988 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -123.26 168.04 12.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.288 -0.415 . . . . 2.0099999999999998 110.442 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.49 ' NH2' ' HD3' ' A' ' 30' ' ' PRO . 36.3 ttm180 -67.64 124.67 23.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.986 -0.552 . . . . 1.8500000000000001 110.692 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.459 ' HA3' ' NH2' ' A' ' 92' ' ' ARG . . . 108.58 -2.86 32.4 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.822 -0.704 . . . . 0.85999999999999999 113.31 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.469 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 65.8 mt-10 -93.79 152.25 19.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.472 -0.428 . . . . 0.98999999999999999 110.979 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.709 HD11 ' HG2' ' A' ' 91' ' ' GLU . 21.5 pt -115.87 117.11 54.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.147 0.499 . . . . 1.1599999999999999 110.345 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.484 ' CE2' ' HB2' ' A' ' 89' ' ' ARG . 25.8 m95 -108.43 125.41 51.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.658 -0.701 . . . . 0.91000000000000003 111.097 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 14.3 tp -74.52 117.78 16.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.19 -0.459 . . . . 0.90000000000000002 110.633 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 p -162.24 153.9 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.413 -0.358 . . . . 1.04 110.122 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.0 t -84.01 140.14 32.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.961 0.41 . . . . 1.3200000000000001 110.509 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.542 HD23 HD13 ' A' ' 80' ' ' ILE . 1.3 mt -100.15 13.25 34.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.018 -0.537 . . . . 1.29 111.103 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.565 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -85.12 171.47 10.79 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.618 -0.719 . . . . 1.54 110.325 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.565 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 12.4 Cg_exo -71.82 133.2 27.77 Favored 'Cis proline' 0 C--N 1.352 0.743 0 C-N-CA 124.419 -1.075 . . . . 1.6899999999999999 112.198 -0.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 18' ' ' GLU . 21.7 p -102.25 138.52 39.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.705 -0.679 . . . . 1.3600000000000001 111.295 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -106.93 140.46 39.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.437 -0.579 . . . . 1.7 109.437 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.35 -113.27 5.23 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.645 -0.788 . . . . 1.1799999999999999 111.472 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -130.54 46.32 2.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.808 0.337 . . . . 2.7799999999999998 111.283 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 32.1 mt-10 -65.84 -174.86 0.25 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.971 -0.559 . . . . 1.1399999999999999 110.437 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.584 ' HG2' ' HG2' ' A' ' 44' ' ' PRO . 5.4 tp-100 -78.51 69.2 4.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.333 0.587 . . . . 2.0899999999999999 110.234 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.6 ' HB2' " H3'" ' C' ' 5' ' ' ' A' . 1.1 pt20 -76.13 144.61 40.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.402 -0.817 . . . . 2.0899999999999999 111.241 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.92 143.03 5.73 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.64 -0.791 . . . . 1.0700000000000001 112.843 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 10.0 m -92.9 107.17 19.01 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.263 -0.643 . . . . 1.1100000000000001 109.263 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -147.31 163.39 28.34 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.429 -0.35 . . . . 1.6200000000000001 110.582 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 16.6 Cg_exo -69.02 119.47 6.45 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.498 2.132 . . . . 1.01 111.393 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 14.2 m -97.26 142.46 14.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.126 -0.488 . . . . 0.76000000000000001 110.38 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.651 ' HB3' HG23 ' A' ' 43' ' ' VAL . 36.6 tp -83.86 121.9 27.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.44 -0.346 . . . . 0.69999999999999996 111.282 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.659 ' HA ' HG12 ' A' ' 42' ' ' VAL . 17.8 mm -71.84 112.67 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.92000000000000004 109.713 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.38 -37.51 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.346 -0.388 . . . . 0.94999999999999996 111.889 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.86 150.55 75.49 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 112.387 0.514 . . . . 1.1200000000000001 112.387 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.49 ' HD3' ' NH2' ' A' ' 3' ' ' ARG . 56.3 Cg_endo -70.1 155.91 63.7 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.766 2.311 . . . . 1.3 112.323 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.92 -38.0 64.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.843 -0.617 . . . . 1.3899999999999999 112.05 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.38 -41.4 89.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.027 0.441 . . . . 1.6100000000000001 111.227 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.639 ' HZ ' ' HB2' ' B' ' 75' ' ' ASP . 80.5 t80 -73.22 -41.95 63.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.091 -0.504 . . . . 1.77 110.777 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 60.7 m-20 -62.81 -21.13 65.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.898 -0.592 . . . . 1.48 111.345 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.404 ' HD3' HH11 ' A' ' 35' ' ' ARG . 2.7 ttp180 -93.37 -25.52 17.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 2.6200000000000001 111.93 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 33' ' ' PHE . 14.0 p -82.78 -49.24 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 112.93 0.715 . . . . 1.8600000000000001 112.93 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.5 p -94.9 -23.86 17.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 1.72 110.783 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 88.4 mtt180 68.78 18.04 8.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.478 -0.783 . . . . 4.4500000000000002 111.607 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' B' ' 17' ' ' HIS . 75.8 mt -129.11 93.28 36.91 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.349 -0.842 . . . . 1.8100000000000001 108.897 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.92 132.53 9.64 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.567 2.178 . . . . 1.05 113.521 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.413 HG22 ' OG1' ' A' ' 79' ' ' THR . 47.2 t -79.03 116.64 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.833 -1.543 . . . . 1.03 106.833 177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.659 HG12 ' HA ' ' A' ' 27' ' ' ILE . 29.5 m -124.71 156.91 33.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 113.478 0.918 . . . . 0.77000000000000002 113.478 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.651 HG23 ' HB3' ' A' ' 26' ' ' LEU . 2.6 m -118.37 118.57 33.83 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 114.806 -1.088 . . . . 0.71999999999999997 108.646 177.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.584 ' HG2' ' HG2' ' A' ' 19' ' ' GLN . 13.2 Cg_exo -69.47 156.59 63.67 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.076 2.518 . . . . 1.03 113.507 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.463 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 95.2 t -114.1 127.12 71.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.085 -0.962 . . . . 1.28 108.638 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.528 ' OG1' ' HD3' ' A' ' 73' ' ' ARG . 27.2 p -114.95 -171.71 1.99 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.105 -0.238 . . . . 1.9099999999999999 111.25 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.26 139.7 54.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.319 -0.4 . . . . 2.5299999999999998 111.384 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.26 19.04 32.57 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.638 -0.791 . . . . 3.3599999999999999 111.932 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.32 -131.87 35.61 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.841 -0.695 . . . . 3.8300000000000001 111.533 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -91.77 -43.01 9.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.042 0.448 . . . . 4.7199999999999998 109.874 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -130.43 127.81 40.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.92 -0.582 . . . . 6.2400000000000002 109.901 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.01 89.95 1.14 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 2.5899999999999999 111.128 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -108.09 153.51 23.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.864 -0.607 . . . . 4.5899999999999999 110.9 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.509 HG23 ' HA ' ' A' ' 59' ' ' VAL . 1.3 m -72.1 132.4 44.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.143 -0.48 . . . . 2.6899999999999999 110.021 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.01 69.8 1.48 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.352 -0.386 . . . . 3.1699999999999999 111.174 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.94 -83.41 0.31 Allowed Glycine 0 C--O 1.229 -0.177 0 CA-C-N 116.008 -0.542 . . . . 1.6599999999999999 112.97 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -91.32 -32.75 15.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.893 0.378 . . . . 1.5600000000000001 110.971 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.47 120.9 25.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.083 -0.508 . . . . 1.25 110.097 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.691 HG22 ' HB ' ' A' ' 72' ' ' VAL . 10.4 m -93.85 153.64 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.913 0.387 . . . . 1.6799999999999999 111.707 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.86 142.98 34.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.969 -0.559 . . . . 1.95 111.615 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.579 ' HB3' HD11 ' A' ' 66' ' ' ILE . 14.4 mt -109.94 0.57 18.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 1.23 110.927 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -91.55 -173.68 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 2.21 109.914 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.7 -47.68 3.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 1.1499999999999999 112.151 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.0 m -74.6 -28.7 22.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.889 0.376 . . . . 1.21 110.754 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.77 67.88 1.53 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.743 -0.742 . . . . 1.0800000000000001 113.619 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 61' ' ' LEU . 22.8 pt -102.97 174.69 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.624 -0.51 . . . . 1.0700000000000001 109.624 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -80.68 -44.84 18.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.956 0.407 . . . . 3.5899999999999999 110.46 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.51 149.2 49.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.8 -0.636 . . . . 1.51 111.46 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.08 91.96 3.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.836 -0.62 . . . . 1.79 110.795 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.421 ' HA3' ' H42' ' C' ' 4' ' ' ' C' . . . -164.85 -162.42 15.85 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.17 -0.772 . . . . 1.1799999999999999 111.17 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.34 138.63 53.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.092 -0.336 . . . . 1.5600000000000001 110.092 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.691 ' HB ' HG22 ' A' ' 59' ' ' VAL . 62.7 t -75.3 131.1 35.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.817 0.341 . . . . 1.29 110.456 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.528 ' HD3' ' OG1' ' A' ' 46' ' ' THR . 55.8 mmm-85 -100.35 91.4 4.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.127 -0.488 . . . . 2.23 112.259 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.8 m -82.67 -10.14 59.06 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.901 -0.777 . . . . 1.1699999999999999 108.901 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.407 ' C ' ' HD3' ' A' ' 77' ' ' PRO . 13.9 p-10 -86.85 -12.52 47.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.121 -0.945 . . . . 0.89000000000000001 110.943 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.401 ' N ' ' HD3' ' A' ' 77' ' ' PRO . 12.1 mm100 -129.42 62.93 65.71 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 112.195 0.443 . . . . 2.1299999999999999 112.195 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.407 ' HD3' ' C ' ' A' ' 75' ' ' ASP . 5.0 Cg_exo -77.95 144.61 21.64 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.667 2.245 . . . . 0.80000000000000004 111.024 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 78' ' ' ARG . 5.1 ptm85 -163.92 124.61 2.2 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.072 0.397 . . . . 2.0899999999999999 112.072 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.515 ' OG1' ' HD2' ' B' ' 77' ' ' PRO . 87.6 m -82.19 123.52 29.08 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.847 -0.615 . . . . 1.6200000000000001 109.597 178.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.542 HD13 HD23 ' A' ' 11' ' ' LEU . 24.3 pt -126.1 161.95 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.025 0.44 . . . . 1.1499999999999999 111.183 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.539 ' O ' ' HD2' ' A' ' 85' ' ' ARG . 2.1 t70 -76.61 145.37 38.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.62 -0.718 . . . . 1.03 110.686 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 38.2 tpp -131.91 24.66 4.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.23 0.538 . . . . 1.29 109.786 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.12 -40.42 3.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.158 -0.474 . . . . 2.6400000000000001 110.778 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.88 -35.38 10.51 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.362 -0.607 . . . . 1.1200000000000001 109.362 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 81' ' ' ASP . 77.4 mtt-85 -68.72 -57.56 5.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.471 -0.786 . . . . 1.0600000000000001 110.704 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.82 120.52 2.03 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.787 -0.72 . . . . 1.1200000000000001 113.193 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.0 171.16 21.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.939 -0.648 . . . . 1.0900000000000001 111.796 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -132.79 123.13 25.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.834 0.35 . . . . 2.46 111.482 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.484 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 45.7 ttp180 -75.41 120.39 20.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.226 -0.443 . . . . 2.4900000000000002 110.897 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.95 -53.86 4.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.925 0.393 . . . . 1.29 110.328 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.709 ' HG2' HD11 ' A' ' 6' ' ' ILE . 14.6 pt-20 -160.14 -168.44 2.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.709 -0.678 . . . . 1.1499999999999999 109.38 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.459 ' NH2' ' HA3' ' A' ' 4' ' ' GLY . 3.2 ptm180 -143.29 139.76 30.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.757 0.313 . . . . 1.3200000000000001 110.33 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.54 158.25 43.21 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.136 -0.484 . . . . 0.75 111.461 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.0 160.72 48.48 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.712 2.275 . . . . 0.94999999999999996 111.564 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -60.87 -23.04 64.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 1.51 111.93 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -37.08 74.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.483 . . . . 1.5700000000000001 110.585 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.406 ' O ' HG23 ' A' ' 101' ' ' VAL . 37.2 mm -88.55 -40.78 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.747 -0.661 . . . . 1.3100000000000001 109.99 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.7 tpt -56.63 -50.83 70.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.696 -0.683 . . . . 1.6000000000000001 112.107 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.428 ' HA ' HD12 ' A' ' 102' ' ' LEU . 58.1 m-80 -65.18 -32.19 73.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 2.2999999999999998 111.268 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 7.0 tp10 -61.5 -45.14 95.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.862 -0.608 . . . . 1.6399999999999999 110.366 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.477 HG11 HG21 ' A' ' 43' ' ' VAL . 50.0 t -59.88 -44.85 95.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.036 -0.529 . . . . 1.03 110.013 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 99' ' ' ASN . 44.6 mt -59.92 -40.88 90.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.732 -0.667 . . . . 1.22 111.051 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.87 -41.42 98.77 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.901 -0.666 . . . . 1.03 112.016 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 12.6 mmt180 -68.2 -38.52 82.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 1.72 110.555 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 62.6 mt -63.78 -24.24 67.68 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.03 -0.532 . . . . 1.02 112.111 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 57.0 m -72.12 -6.27 41.41 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.934 0.716 . . . . 1.1100000000000001 112.934 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 74.5 p -92.49 -11.34 34.89 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.193 0.442 . . . . 1.5 112.193 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.525 ' HB ' HG22 ' B' ' 29' ' ' THR . 45.8 pt -107.48 16.25 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.914 0.388 . . . . 1.1499999999999999 111.897 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 83.4 mt -97.42 25.87 5.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.131 0.491 . . . . 0.97999999999999998 110.784 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.957 -0.565 . . . . 1.3500000000000001 111.405 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.544 ' CE ' ' HG ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 112.007 0.373 . . . . 2.0299999999999998 112.007 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' B' ' 3' ' ' ARG . 24.2 mt-10 -91.01 2.97 55.9 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.168 -0.332 . . . . 2.8199999999999998 110.804 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ARG . . . . . 0.694 ' HA ' ' HE1' ' B' ' 98' ' ' MET . 0.1 OUTLIER 84.86 61.24 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.933 1.086 . . . . 2.3199999999999998 113.933 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.25 22.98 74.82 Favored Glycine 0 CA--C 1.519 0.313 0 N-CA-C 115.006 0.762 . . . . 1.28 115.006 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -83.19 116.55 22.42 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 117.498 0.649 . . . . 1.53 110.892 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.95 HD12 ' HG3' ' B' ' 91' ' ' GLU . 19.9 mt -96.07 123.26 48.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.75 110.184 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -112.92 127.47 56.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.008 0.432 . . . . 0.81000000000000005 111.477 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' B' ' 24' ' ' PRO . 40.1 tp -90.13 120.35 31.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.056 -0.52 . . . . 1.05 109.748 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.457 HG22 ' H ' ' B' ' 10' ' ' SER . 5.9 p -158.63 169.55 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.505 -0.316 . . . . 0.71999999999999997 110.379 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' B' ' 22' ' ' THR . 0.0 OUTLIER -84.45 133.27 34.49 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.899 -0.408 . . . . 1.6299999999999999 109.899 179.088 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 18.9 mt -81.29 -29.09 34.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.485 -0.325 . . . . 0.82999999999999996 111.437 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ASP . . . . . 0.417 ' HA ' ' N ' ' B' ' 14' ' ' THR . 2.5 m-20 -58.7 154.58 35.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.051 -0.522 . . . . 1.6200000000000001 111.629 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.65 116.52 4.58 Favored 'Cis proline' 0 C--O 1.237 0.432 0 C-N-CA 123.607 -1.414 . . . . 1.28 113.364 0.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' B' ' 18' ' ' GLU . 0.6 OUTLIER -123.41 147.88 46.68 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.812 -0.81 . . . . 1.47 108.812 178.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.65 177.88 8.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.319 0.581 . . . . 1.22 112.117 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.57 -108.53 2.45 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.888 -0.672 . . . . 1.01 112.585 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' HIS . . . . . 0.461 ' HB2' HD21 ' A' ' 39' ' ' LEU . 73.6 m-70 -108.31 3.29 23.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.727 0.299 . . . . 2.1800000000000002 111.147 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.44 ' HB2' ' HB ' ' B' ' 14' ' ' THR . 29.9 mt-10 -72.4 140.21 48.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.297 -0.411 . . . . 1.28 110.05 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -68.28 142.16 55.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.669 -0.493 . . . . 1.52 109.669 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -120.1 165.85 14.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.726 0.639 . . . . 1.8600000000000001 112.726 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.7 -173.11 36.45 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.44 -0.8 . . . . 0.90000000000000002 112.327 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' B' ' 10' ' ' SER . 15.6 m -96.04 123.36 39.61 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.973 -0.751 . . . . 0.94999999999999996 108.973 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.406 HH21 ' HA ' ' B' ' 46' ' ' THR . 3.9 ptm180 -157.45 155.0 26.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.705 -0.225 . . . . 1.5900000000000001 110.84 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' B' ' 8' ' ' LEU . 23.6 Cg_exo -65.63 133.8 35.65 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.608 2.206 . . . . 0.65000000000000002 111.841 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' B' ' 44' ' ' PRO . 16.9 m -126.61 156.92 37.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.074 -0.512 . . . . 0.56999999999999995 110.693 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.544 ' HG ' ' CE ' ' B' ' 1' ' ' MET . 1.5 tp -106.24 119.32 38.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.118 -0.492 . . . . 1.1699999999999999 110.71 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ILE . . . . . 0.603 HG12 HG12 ' B' ' 42' ' ' VAL . 27.8 mt -78.36 116.83 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.317 . . . . 0.66000000000000003 110.607 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' B' ' 1' ' ' MET . 37.5 t -77.61 -37.55 24.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.025 -0.534 . . . . 0.93000000000000005 111.839 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' THR . . . . . 0.525 HG22 ' HB ' ' A' ' 108' ' ' ILE . 0.8 OUTLIER -71.19 142.47 87.26 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.436 -0.347 . . . . 0.81000000000000005 111.74 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.68 156.09 61.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.83 2.353 . . . . 0.78000000000000003 112.407 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.3 77.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.861 -0.609 . . . . 1.03 111.704 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.98 -36.74 73.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.92 0.39 . . . . 1.3999999999999999 111.55 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -81.39 -40.88 22.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.112 0.482 . . . . 1.5700000000000001 110.519 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -59.43 -24.84 63.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.682 -0.69 . . . . 1.6399999999999999 111.899 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -89.42 -2.61 58.46 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.399 0.518 . . . . 2.54 112.399 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -108.12 -52.08 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.977 0.418 . . . . 1.0900000000000001 110.282 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' THR . . . . . 0.706 ' HA ' ' N3 ' ' C' ' 2' ' ' ' U' . 1.5 m -80.87 -31.84 35.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.818 -0.628 . . . . 1.3300000000000001 111.14 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.616 ' HG3' " O4'" ' C' ' 1' ' ' ' A' . 3.7 mmp_? 71.01 -0.22 3.14 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.53 0.937 . . . . 1.78 113.53 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 98.4 mt -121.45 94.32 48.61 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.577 -0.527 . . . . 1.1599999999999999 109.577 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.37 154.18 14.09 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.867 2.378 . . . . 0.56999999999999995 113.992 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.671 HG22 HG23 ' B' ' 79' ' ' THR . 8.8 t -95.45 123.53 47.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.901 -1.148 . . . . 1.0800000000000001 107.901 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.603 HG12 HG12 ' B' ' 27' ' ' ILE . 32.3 m -113.93 147.31 17.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 113.434 0.902 . . . . 0.64000000000000001 113.434 -178.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 t -106.09 118.97 53.66 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 114.63 -1.168 . . . . 1.1000000000000001 108.386 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.501 ' HA ' HG12 ' B' ' 25' ' ' VAL . 74.0 Cg_endo -74.38 134.79 19.41 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.728 2.285 . . . . 0.72999999999999998 112.557 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.697 HG22 HG12 ' B' ' 72' ' ' VAL . 44.0 t -99.01 123.62 51.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.88 -0.6 . . . . 0.90000000000000002 110.46 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.406 ' HA ' HH21 ' B' ' 23' ' ' ARG . 0.0 OUTLIER -89.44 89.89 8.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.887 -0.597 . . . . 1.1699999999999999 109.579 178.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.69 ' HA ' ' HA3' ' B' ' 70' ' ' GLY . 1.4 m -82.08 67.06 7.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.855 -0.612 . . . . 1.8500000000000001 111.342 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.7 31.68 7.57 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.979 -0.629 . . . . 2.2200000000000002 111.636 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.35 -169.21 16.12 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.723 -0.751 . . . . 3.4300000000000002 112.255 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -123.7 32.59 5.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.341 0.591 . . . . 4.6200000000000001 110.577 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -69.33 -32.25 71.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.493 -0.776 . . . . 6.2699999999999996 110.627 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -108.87 125.83 52.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.88 -0.6 . . . . 4.3899999999999997 110.004 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.39 -49.9 6.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.141 0.496 . . . . 3.9199999999999999 110.454 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.98 121.53 6.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.619 -0.719 . . . . 2.75 110.918 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.63 82.99 2.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.837 -0.619 . . . . 1.96 110.339 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.51 -87.68 0.26 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.796 -0.638 . . . . 1.0800000000000001 112.676 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.658 ' HE1' ' HB ' ' B' ' 107' ' ' THR . 21.0 m-85 -109.68 -6.69 15.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.879 0.371 . . . . 3.5699999999999998 110.86 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' B' ' 72' ' ' VAL . . . -93.04 115.13 27.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.049 -0.523 . . . . 1.0800000000000001 110.845 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 23.7 t -117.05 135.99 55.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.101 -0.5 . . . . 1.3400000000000001 110.013 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 88.3 p -79.42 141.59 36.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.801 0.334 . . . . 1.3799999999999999 111.605 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 72.8 mt -88.76 -16.76 31.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.181 0.515 . . . . 1.02 110.751 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -73.63 147.0 44.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.718 -0.673 . . . . 1.79 111.003 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.03 -40.14 2.5 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.056 -0.593 . . . . 1.1499999999999999 112.461 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 p -90.21 -17.69 7.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.111 0.412 . . . . 1.1699999999999999 112.111 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.24 20.91 4.24 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.499 -0.858 . . . . 1.05 113.599 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.496 HD11 ' HD2' ' B' ' 94' ' ' PRO . 81.4 mt -86.64 141.31 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.772 -0.455 . . . . 1.6100000000000001 109.772 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -70.9 -47.84 56.94 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.623 0.249 . . . . 2.3999999999999999 110.923 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 12.2 m -60.97 99.14 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.368 0.604 . . . . 0.93000000000000005 110.334 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.69 91.49 8.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.946 -0.57 . . . . 1.3100000000000001 111.746 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' B' ' 47' ' ' SER . . . -171.45 -174.0 38.81 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.709 -0.758 . . . . 0.79000000000000004 111.7 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.5 m -113.71 136.31 50.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 110.211 -0.292 . . . . 0.93000000000000005 110.211 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.697 HG12 HG22 ' B' ' 45' ' ' VAL . 11.9 m -80.34 135.59 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.556 -0.293 . . . . 1.3799999999999999 110.92 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' B' ' 73' ' ' ARG . 16.1 mmm-85 -101.99 82.97 2.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.112 0.482 . . . . 1.3700000000000001 110.829 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 2.3 m -69.32 -9.04 51.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.758 -0.655 . . . . 1.1599999999999999 111.047 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.639 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 13.7 p-10 -88.45 -6.21 57.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.589 -0.732 . . . . 1.1000000000000001 111.771 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -126.13 55.77 14.2 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 113.0 0.741 . . . . 2.4700000000000002 113.0 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.515 ' HD2' ' OG1' ' A' ' 79' ' ' THR . 90.4 Cg_endo -80.96 126.4 5.74 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.771 1.647 . . . . 0.95999999999999996 112.271 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -130.38 140.39 50.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.917 0.389 . . . . 1.96 111.218 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.671 HG23 HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -79.72 125.87 30.21 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.189 -0.671 . . . . 1.1899999999999999 109.189 178.535 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 41.4 pt -128.51 151.48 35.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.521 -0.471 . . . . 1.28 111.653 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.693 ' OD1' ' HG3' ' B' ' 83' ' ' LYS . 4.8 t70 -77.83 83.95 4.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.858 -0.61 . . . . 1.28 109.994 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 59.7 tpp -61.69 -31.66 71.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.691 -0.686 . . . . 2.7000000000000002 112.274 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.693 ' HG3' ' OD1' ' B' ' 81' ' ' ASP . 1.4 pttp -67.22 -38.91 86.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.397 0.517 . . . . 1.96 112.397 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.98 -30.18 28.41 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.108 0.41 . . . . 1.0600000000000001 112.108 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' B' ' 85' ' ' ARG . 46.1 mtt180 -82.22 -42.46 18.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.174 0.435 . . . . 1.47 112.174 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.4 99.94 1.52 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.81999999999999995 112.597 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -99.3 153.71 19.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.677 -0.773 . . . . 0.65000000000000002 112.588 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.15 128.15 16.5 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.284 -0.265 . . . . 1.8100000000000001 110.284 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' B' ' 6' ' ' ILE . 34.5 ttp180 -78.91 121.04 24.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.963 0.411 . . . . 2.4900000000000002 111.339 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 89.8 mt -90.8 -68.62 0.78 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.136 -0.484 . . . . 0.76000000000000001 110.666 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLU . . . . . 0.95 ' HG3' HD12 ' B' ' 6' ' ' ILE . 11.5 pt-20 -129.61 -176.88 4.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.935 -0.575 . . . . 1.0700000000000001 110.028 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.81 137.98 53.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.959 0.409 . . . . 2.0499999999999998 111.198 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.436 HG23 HD11 ' B' ' 6' ' ' ILE . 53.7 t -82.86 126.72 72.2 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.854 -0.612 . . . . 1.45 109.993 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.496 ' HD2' HD11 ' B' ' 66' ' ' ILE . 43.9 Cg_exo -59.59 152.5 61.86 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.656 2.237 . . . . 1.03 111.11 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.528 ' HA ' ' HB3' ' B' ' 98' ' ' MET . 21.8 mm-40 -54.26 -29.69 47.78 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.461 0.541 . . . . 2.1400000000000001 112.461 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.7 p -59.46 -53.83 53.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.991 0.424 . . . . 1.78 111.219 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 32.5 mm -74.84 -34.04 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.202 -0.453 . . . . 1.3300000000000001 110.0 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' MET . . . . . 0.694 ' HE1' ' HA ' ' B' ' 3' ' ' ARG . 5.1 tpt -55.33 -45.26 76.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.706 -0.679 . . . . 2.3399999999999999 110.972 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -67.55 -35.34 78.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.098 -0.501 . . . . 1.9099999999999999 110.996 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 4.5 tp10 -64.53 -44.86 89.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.97 -0.559 . . . . 1.76 111.0 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.426 HG22 HG21 ' B' ' 72' ' ' VAL . 73.9 t -60.29 -48.61 87.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.306 -0.406 . . . . 1.01 110.425 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.654 ' HA ' HD12 ' B' ' 105' ' ' LEU . 82.9 mt -59.68 -34.93 73.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.555 . . . . 1.29 111.048 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.45 -41.28 96.46 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.578 -0.609 . . . . 1.02 111.578 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 5.1 mmt180 -67.35 -33.59 75.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.898 0.38 . . . . 1.8500000000000001 110.315 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.654 HD12 ' HA ' ' B' ' 102' ' ' LEU . 46.4 mt -65.98 -25.5 67.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.912 -0.586 . . . . 1.9399999999999999 110.513 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 13.0 m -87.68 -13.94 41.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.008 -0.542 . . . . 1.1599999999999999 111.161 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.658 ' HB ' ' HE1' ' B' ' 57' ' ' PHE . 0.5 OUTLIER -75.13 -31.65 61.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.898 0.38 . . . . 1.45 111.361 -179.376 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 14.0 pt -84.91 0.82 5.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.442 -0.345 . . . . 1.98 111.558 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.49 4.66 53.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.342 -0.39 . . . . 1.3600000000000001 111.859 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.439 ' C ' HH22 ' A' ' 3' ' ' ARG . 7.0 t . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.825 -0.607 . . . . 2.1299999999999999 110.206 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 1' ' ' ' A' . . . . . 0.616 " O4'" ' HG3' ' B' ' 38' ' ' ARG . . . . . . . . 0 O5'--C5' 1.432 -0.472 0 C1'-C2'-O2' 107.899 -0.9 . 0.0 '__' . 6.3600000000000003 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 2' ' ' ' U' . . . . . 0.706 ' N3 ' ' HA ' ' B' ' 37' ' ' THR . . . . . . . . 0 O5'--C5' 1.426 -0.893 0 O4'-C1'-N19 109.57 1.37 . 0.0 OUTLIER . 2.9900000000000002 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 3' ' ' ' A' . . . . . 0.564 " H2'" ' N3 ' ' C' ' 3' ' ' ' A' . . . . . . . . 0 C4'--C3' 1.532 0.691 0 C4'-C3'-C2' 103.935 1.235 . 0.0 OUTLIER gamma 2.5899999999999999 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 4' ' ' ' C' . . . . . 0.971 ' O2 ' " H2'" ' C' ' 4' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.809 0 C3'-C2'-C1' 102.843 1.492 . 0.0 OUTLIER . 2.5099999999999998 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 5' ' ' ' A' . . . . . 0.6 " H3'" ' HB2' ' A' ' 20' ' ' GLN . . . . . . . . 0 O3'--C3' 1.436 0.925 0 C4'-C3'-C2' 104.572 1.872 . 0.0 OUTLIER . 4.9400000000000004 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptp . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.782 0.325 . . . . 1.29 110.75 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -135.28 175.01 9.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.02 -0.536 . . . . 2.0099999999999998 111.053 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.561 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 55.2 ttp85 -79.27 136.22 36.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.048 -0.523 . . . . 1.8500000000000001 109.955 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.44 8.27 59.91 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.85999999999999999 112.476 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.682 ' HG2' ' HG3' ' A' ' 92' ' ' ARG . 82.1 mt-10 -95.27 142.22 27.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.949 0.404 . . . . 0.98999999999999999 111.138 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.7 mt -99.0 115.93 40.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.814 -0.81 . . . . 1.1599999999999999 108.814 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -114.12 137.33 51.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.401 -0.363 . . . . 0.91000000000000003 111.083 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.3 tp -88.81 120.76 30.51 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.392 -0.595 . . . . 0.90000000000000002 109.392 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.454 HG22 ' H ' ' A' ' 10' ' ' SER . 4.3 p -147.49 169.19 4.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 120.867 0.365 . . . . 1.04 110.708 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.454 ' H ' HG22 ' A' ' 9' ' ' VAL . 4.2 t -103.75 129.83 51.18 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.001 -0.74 . . . . 1.3200000000000001 109.001 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.3 mt -88.32 -12.57 43.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.461 -0.336 . . . . 1.29 111.377 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.547 ' HA ' HG23 ' A' ' 14' ' ' THR . 0.2 OUTLIER -67.93 164.15 43.67 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.94 -0.573 . . . . 1.54 111.162 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.74 139.09 49.57 Favored 'Cis proline' 0 C--N 1.353 0.79 0 C-N-CA 124.324 -1.115 . . . . 1.6899999999999999 112.485 -0.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.547 HG23 ' HA ' ' A' ' 12' ' ' ASP . 14.1 p -121.9 171.95 8.54 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.085 -0.507 . . . . 1.3600000000000001 111.319 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.79 164.34 26.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 1.7 110.063 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.4 -136.87 32.34 Favored Glycine 0 CA--C 1.516 0.123 0 C-N-CA 121.16 -0.543 . . . . 1.1799999999999999 113.409 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -103.74 25.46 9.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.022 -0.362 . . . . 2.7799999999999998 110.022 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -76.47 175.75 8.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.212 -0.449 . . . . 1.1399999999999999 111.427 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.546 ' HG3' ' CZ ' ' A' ' 23' ' ' ARG . 3.3 tp-100 -74.23 77.38 1.81 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.607 -0.724 . . . . 2.0899999999999999 110.506 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.405 ' HA ' HG21 ' A' ' 14' ' ' THR . 18.3 mt-30 -78.03 122.89 26.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.835 -0.62 . . . . 2.0899999999999999 111.726 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.838 ' HA2' ' C5 ' ' C' ' 5' ' ' ' A' . . . 119.71 163.45 12.27 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.272 -0.966 . . . . 1.0700000000000001 113.502 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.62 148.38 25.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.743 -0.229 . . . . 1.1100000000000001 110.505 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.546 ' CZ ' ' HG3' ' A' ' 19' ' ' GLN . 8.2 ptp180 -172.71 159.87 3.83 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 110.247 -0.279 . . . . 1.6200000000000001 110.247 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.65 130.3 15.72 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.448 2.099 . . . . 1.01 110.713 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.726 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 14.2 m -116.37 137.21 50.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.335 -0.393 . . . . 0.76000000000000001 110.569 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . 53.1 tp -92.32 124.39 36.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.154 -0.475 . . . . 0.69999999999999996 110.948 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.433 ' HA ' HG12 ' A' ' 42' ' ' VAL . 56.6 mt -80.07 111.03 16.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.92000000000000004 110.148 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 t -90.18 -27.2 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.218 -0.446 . . . . 0.94999999999999996 111.75 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 1.9 p -77.6 142.25 66.08 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.603 0.594 . . . . 1.1200000000000001 112.603 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HA ' ' HB2' ' A' ' 3' ' ' ARG . 26.3 Cg_exo -63.79 151.74 83.78 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.217 2.611 . . . . 1.3 111.798 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.18 -38.81 77.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.085 -0.507 . . . . 1.3899999999999999 112.036 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.17 -38.3 82.81 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.024 0.44 . . . . 1.6100000000000001 110.777 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' B' ' 75' ' ' ASP . 83.2 t80 -72.34 -38.73 68.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.032 -0.531 . . . . 1.77 110.166 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 75.4 m-20 -64.78 -15.81 62.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.676 -0.693 . . . . 1.48 111.199 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -87.8 -24.12 23.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.562 -0.29 . . . . 2.6200000000000001 110.724 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.6 t -83.1 -65.12 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 1.8600000000000001 111.489 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.1 m -78.82 -33.99 45.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.337 -0.392 . . . . 1.72 110.862 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.616 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 21.6 mtm180 75.14 12.64 3.35 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.724 -0.671 . . . . 4.4500000000000002 111.738 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.8 mt -124.92 93.04 46.61 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.544 -0.753 . . . . 1.8100000000000001 109.404 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.478 ' HD2' ' O ' ' A' ' 80' ' ' ILE . 58.0 Cg_endo -73.06 137.26 26.15 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.502 2.135 . . . . 1.05 112.798 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.585 HG22 HG23 ' A' ' 79' ' ' THR . 51.8 t -83.64 111.65 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 107.972 -1.122 . . . . 1.03 107.972 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.726 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 35.8 m -114.54 158.74 14.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.24 0.543 . . . . 0.77000000000000002 112.282 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.438 HG21 HG13 ' A' ' 72' ' ' VAL . 17.1 m -115.89 122.08 33.08 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.236 -0.893 . . . . 0.71999999999999997 109.775 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.99 94.75 1.06 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.867 2.378 . . . . 1.03 112.761 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.783 HG12 ' HA ' ' A' ' 72' ' ' VAL . 33.0 m -78.68 155.86 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 1.28 110.407 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.728 ' HB ' ' C2 ' ' C' ' 3' ' ' ' A' . 2.8 m -141.01 -91.78 0.15 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.345 0.498 . . . . 1.9099999999999999 112.345 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.788 ' HA ' ' HA2' ' A' ' 70' ' ' GLY . 3.7 p -164.98 -158.11 0.38 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.839 0.745 . . . . 2.5299999999999998 112.377 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -155.46 32.01 0.64 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.294 -0.722 . . . . 3.3599999999999999 111.294 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.66 -126.05 7.71 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.136 -0.786 . . . . 3.8300000000000001 111.136 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -80.16 -38.71 30.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.214 0.53 . . . . 4.7199999999999998 110.206 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -136.84 116.15 12.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.838 -0.619 . . . . 6.2400000000000002 110.063 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 62' ' ' ASP . . . -64.77 141.28 58.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.311 -0.404 . . . . 2.5899999999999999 111.277 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -145.78 147.68 32.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.951 -0.568 . . . . 4.5899999999999999 109.478 179.53 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.599 HG23 ' HA ' ' A' ' 59' ' ' VAL . 26.0 m -69.94 100.14 1.53 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.225 0.536 . . . . 2.6899999999999999 111.582 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.41 83.86 3.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.568 -0.742 . . . . 3.1699999999999999 110.492 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.47 -92.89 0.28 Allowed Glycine 0 C--O 1.235 0.195 0 CA-C-N 115.562 -0.744 . . . . 1.6599999999999999 112.538 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -96.08 -16.77 21.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.628 0.252 . . . . 1.5600000000000001 111.03 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 54' ' ' THR . . . -76.02 87.37 2.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.587 -0.523 . . . . 1.25 109.587 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.599 ' HA ' HG23 ' A' ' 54' ' ' THR . 42.3 t -66.13 121.86 16.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.276 -0.42 . . . . 1.6799999999999999 110.726 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.1 t -77.56 125.94 30.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.896 0.379 . . . . 1.95 111.539 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.749 ' HB3' HD11 ' A' ' 66' ' ' ILE . 91.9 mt -88.35 -5.93 58.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.45 0.643 . . . . 1.23 109.427 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.523 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 6.4 t0 -80.5 108.96 14.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.264 -0.88 . . . . 2.21 109.84 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.85 -34.56 1.23 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.873 -0.679 . . . . 1.1499999999999999 112.017 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.5 m -78.36 -30.7 15.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.729 0.3 . . . . 1.21 111.6 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.59 65.1 0.93 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.638 -0.791 . . . . 1.0800000000000001 112.671 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.749 HD11 ' HB3' ' A' ' 61' ' ' LEU . 20.4 pt -125.24 -171.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.354 -0.609 . . . . 1.0700000000000001 109.354 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.534 ' HA ' ' NE ' ' A' ' 67' ' ' ARG . 5.4 mmp_? -101.22 -27.66 13.09 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.739 -0.384 . . . . 3.5899999999999999 111.477 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.7 m -81.41 80.71 7.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.268 0.556 . . . . 1.51 110.388 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 m -80.21 94.54 6.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.63 -0.714 . . . . 1.79 111.256 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.788 ' HA2' ' HA ' ' A' ' 47' ' ' SER . . . -162.52 -178.31 36.27 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.828 -0.624 . . . . 1.1799999999999999 112.137 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.446 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 22.3 m -105.0 138.99 27.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.821 0.31 . . . . 1.5600000000000001 110.963 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.783 ' HA ' HG12 ' A' ' 45' ' ' VAL . 67.9 t -73.81 126.93 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.808 -0.633 . . . . 1.29 110.258 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.75 85.23 7.02 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.584 0.587 . . . . 2.23 112.584 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 11.0 m -83.44 -8.19 59.42 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.81 -0.811 . . . . 1.1699999999999999 108.81 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -87.55 -27.97 22.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.801 -1.091 . . . . 0.89000000000000001 111.14 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.424 ' HB3' HG21 ' B' ' 79' ' ' THR . 79.3 mt-30 -130.84 64.53 73.91 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 113.984 1.105 . . . . 2.1299999999999999 113.984 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -77.52 133.96 13.44 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 121.872 1.715 . . . . 0.80000000000000004 109.204 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 1.038 ' HG3' ' HG3' ' B' ' 78' ' ' ARG . 18.2 ttt180 -135.19 143.06 46.22 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.683 0.623 . . . . 2.0899999999999999 112.683 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.585 HG23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -83.85 127.88 34.15 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.814 -1.18 . . . . 1.6200000000000001 107.814 177.44 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.478 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 20.5 pt -126.1 173.18 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.967 0.413 . . . . 1.1499999999999999 111.091 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -101.65 133.48 46.29 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.64 -0.709 . . . . 1.03 109.138 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.2 mmt -126.19 27.98 6.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.971 0.415 . . . . 1.29 111.266 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -125.3 -42.98 1.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 2.6400000000000001 110.8 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.46 -37.54 9.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.728 -0.669 . . . . 1.1200000000000001 109.505 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 85' ' ' ARG . 39.3 mtt180 -68.69 -49.28 60.25 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.006 -0.543 . . . . 1.0600000000000001 110.453 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.33 143.55 4.59 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.909 -0.587 . . . . 1.1200000000000001 112.278 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.77 176.77 32.39 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.766 -0.73 . . . . 1.0900000000000001 111.958 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -128.31 126.31 40.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.586 0.232 . . . . 2.46 111.171 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -74.3 132.99 42.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 2.4900000000000002 110.451 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 83.1 mt -103.71 -73.23 0.68 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.362 -0.381 . . . . 1.29 110.639 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -144.83 175.4 10.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.214 -0.448 . . . . 1.1499999999999999 110.626 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.682 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 9.6 ttp85 -120.03 144.64 47.44 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.428 -0.582 . . . . 1.3200000000000001 109.428 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.616 ' HB ' HD11 ' A' ' 97' ' ' ILE . 29.9 m -103.32 145.26 30.26 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.704 0.288 . . . . 0.75 111.298 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.529 ' HD2' HD11 ' A' ' 97' ' ' ILE . 40.3 Cg_exo -59.77 155.09 45.17 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.742 2.295 . . . . 0.94999999999999996 111.751 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' A' ' 98' ' ' MET . 52.7 mm-40 -67.59 -21.09 65.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.06 -0.518 . . . . 1.51 111.276 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.97 -57.46 12.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 1.5700000000000001 110.994 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.616 HD11 ' HB ' ' A' ' 93' ' ' VAL . 5.2 pt -69.83 -23.04 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 1.3100000000000001 111.509 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.417 ' HB2' ' HA ' ' A' ' 95' ' ' GLU . 40.0 mmm -67.75 -34.9 77.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 1.6000000000000001 109.813 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -67.04 -30.71 70.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.583 . . . . 2.2999999999999998 110.083 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -62.57 -31.16 71.92 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.781 -0.645 . . . . 1.6399999999999999 110.481 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.54 -48.97 23.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.506 -0.77 . . . . 1.03 109.76 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.42 -37.08 79.73 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.966 -0.561 . . . . 1.22 111.351 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.88 -40.01 97.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.908 -0.663 . . . . 1.03 111.928 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.0 mtt85 -75.77 -38.7 58.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.947 0.403 . . . . 1.72 110.739 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.651 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 82.8 mt -59.37 -41.82 90.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.906 -0.588 . . . . 1.02 111.109 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.2 m -63.83 -20.86 66.12 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.23 0.455 . . . . 1.1100000000000001 112.23 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -90.89 -35.63 14.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.812 0.339 . . . . 1.5 111.508 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.474 HG12 ' HA ' ' A' ' 105' ' ' LEU . 49.9 pt -78.04 -14.7 14.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 113.114 0.783 . . . . 1.1499999999999999 113.114 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 105' ' ' LEU . 61.8 mt -78.32 65.3 3.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.086 0.47 . . . . 0.97999999999999998 110.932 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.758 -0.655 . . . . 1.3500000000000001 110.632 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 121.098 0.475 . . . . 2.0299999999999998 111.335 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -76.33 -34.99 58.99 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.232 -1.025 . . . . 2.8199999999999998 108.232 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 68.35 140.45 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.613 -1.176 . . . . 2.3199999999999998 112.853 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' B' ' 92' ' ' ARG . . . 90.53 -10.48 74.4 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.814 -0.708 . . . . 1.28 112.54 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -76.84 99.14 5.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.875 0.369 . . . . 1.53 111.536 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.505 HD12 ' HG3' ' B' ' 91' ' ' GLU . 20.6 mt -89.02 122.42 40.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.907 -0.588 . . . . 0.75 110.816 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -122.32 134.34 54.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.088 -0.505 . . . . 0.81000000000000005 109.877 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.493 ' HB2' HD11 ' B' ' 90' ' ' LEU . 4.0 tt -95.14 123.06 38.43 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.66 -0.246 . . . . 1.05 110.587 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.18 154.73 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.71999999999999997 110.76 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 67.8 m -76.63 126.08 30.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.439 -0.346 . . . . 1.6299999999999999 111.215 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.569 ' HB3' ' NH2' ' B' ' 78' ' ' ARG . 88.7 mt -87.53 -21.28 25.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.82999999999999996 112.003 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.06 162.9 62.68 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.544 -0.298 . . . . 1.6200000000000001 111.007 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.18 152.96 98.91 Favored 'Cis proline' 0 C--N 1.352 0.712 0 C-N-CA 123.82 -1.325 . . . . 1.28 113.214 0.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.538 ' OG1' ' HB3' ' B' ' 20' ' ' GLN . 6.2 p -123.93 145.04 49.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.576 -0.738 . . . . 1.47 110.406 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -132.79 108.32 8.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.923 0.392 . . . . 1.22 110.665 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.28 -133.96 11.73 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.897 -0.668 . . . . 1.01 111.79 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -101.32 23.79 10.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.658 0.266 . . . . 2.1800000000000002 111.504 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -71.39 150.48 44.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.039 -0.528 . . . . 1.28 110.799 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -69.39 116.0 9.31 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.642 -0.503 . . . . 1.52 109.642 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.538 ' HB3' ' OG1' ' B' ' 14' ' ' THR . 1.2 pt20 -103.23 173.11 6.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.12 -0.491 . . . . 1.8600000000000001 112.203 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.66 138.31 4.05 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.759 -0.655 . . . . 0.90000000000000002 113.332 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 91.7 m -70.01 130.65 42.73 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.351 -0.611 . . . . 0.94999999999999996 109.351 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -159.74 160.94 27.41 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.503 -0.317 . . . . 1.5900000000000001 110.374 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -66.02 131.97 28.66 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.629 2.219 . . . . 0.65000000000000002 110.836 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.725 HG12 ' HA ' ' B' ' 44' ' ' PRO . 18.4 m -125.43 157.81 34.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.388 -0.369 . . . . 0.56999999999999995 110.938 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -103.88 133.18 49.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.954 -0.566 . . . . 1.1699999999999999 109.942 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' B' ' 40' ' ' PRO . 54.6 mt -85.81 123.37 39.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.741 0.305 . . . . 0.66000000000000003 110.958 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.69 49.44 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.496 0.665 . . . . 0.93000000000000005 110.081 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 8.1 m -143.34 122.75 7.53 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.918 -0.583 . . . . 0.81000000000000005 109.879 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 108' ' ' ILE . 88.8 Cg_exo -48.62 128.1 17.59 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.078 2.518 . . . . 0.78000000000000003 112.405 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.72 -30.66 67.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.962 -0.563 . . . . 1.03 111.536 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.9 -32.83 71.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 1.3999999999999999 111.211 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -94.57 -21.42 18.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.174 0.511 . . . . 1.5700000000000001 110.266 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -58.71 -35.6 72.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.748 -0.66 . . . . 1.6399999999999999 110.649 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.8 -20.33 65.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.265 -0.425 . . . . 2.54 111.73 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.06 -58.97 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.793 0.664 . . . . 1.0900000000000001 112.793 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 1.2 p -86.51 -33.81 20.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.569 0.581 . . . . 1.3300000000000001 112.569 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 67.43 24.51 8.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.309 0.576 . . . . 1.78 111.197 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.63 88.69 16.2 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.517 -0.765 . . . . 1.1599999999999999 109.301 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' PRO . . . . . 0.55 ' HB2' HG23 ' B' ' 27' ' ' ILE . 90.2 Cg_endo -85.98 149.29 9.51 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.678 2.252 . . . . 0.56999999999999995 113.384 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.409 HG22 ' HB ' ' B' ' 79' ' ' THR . 6.1 t -86.53 124.55 40.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.555 -0.906 . . . . 1.0800000000000001 108.555 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.449 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 31.1 m -119.65 154.58 22.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.237 0.458 . . . . 0.64000000000000001 112.237 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 m -118.06 127.6 26.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.494 -0.775 . . . . 1.1000000000000001 109.444 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.725 ' HA ' HG12 ' B' ' 25' ' ' VAL . 94.4 Cg_endo -80.12 160.56 23.58 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.934 2.422 . . . . 0.72999999999999998 113.031 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.612 HG12 ' HA ' ' B' ' 72' ' ' VAL . 31.5 m -115.55 145.52 21.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.943 -0.571 . . . . 0.90000000000000002 110.519 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 27.9 m -95.39 124.2 39.31 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.534 -0.543 . . . . 1.1699999999999999 109.534 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.87 131.55 49.84 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.569 0.581 . . . . 1.8500000000000001 112.569 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' GLY . . . . . 0.701 ' HA3' ' HE1' ' B' ' 51' ' ' PHE . . . -124.11 -171.06 13.39 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.607 -0.597 . . . . 2.2200000000000002 111.607 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.21 60.59 0.56 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.551 -0.833 . . . . 3.4300000000000002 112.693 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ASN . . . . . 0.422 ' HA ' ' CG ' ' B' ' 62' ' ' ASP . 5.1 t-20 66.58 80.1 0.22 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.206 0.527 . . . . 4.6200000000000001 112.328 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' PHE . . . . . 0.701 ' HE1' ' HA3' ' B' ' 48' ' ' GLY . 7.2 p90 -160.1 157.6 28.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.688 -0.687 . . . . 6.2699999999999996 110.188 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.458 ' O ' ' HD2' ' B' ' 53' ' ' ARG . . . -130.38 86.5 2.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.136 0.493 . . . . 4.3899999999999997 110.758 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' B' ' 52' ' ' ALA . 13.7 mmm180 -126.95 97.98 5.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.047 -0.524 . . . . 3.9199999999999999 110.779 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.33 70.09 9.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.053 0.454 . . . . 2.75 110.194 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.1 126.89 38.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.984 -0.553 . . . . 1.96 111.487 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.0 -114.39 6.08 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.814 -0.63 . . . . 1.0800000000000001 112.497 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -116.09 16.12 16.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.925 0.393 . . . . 3.5699999999999998 110.457 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' B' ' 72' ' ' VAL . . . -96.07 111.28 23.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.087 -0.506 . . . . 1.0800000000000001 110.674 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 t -95.66 124.18 48.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.284 -0.416 . . . . 1.3400000000000001 110.195 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.44 ' HA ' HG12 ' B' ' 71' ' ' VAL . 4.7 m -77.4 123.09 26.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.733 0.642 . . . . 1.3799999999999999 112.733 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.445 ' O ' HG12 ' B' ' 64' ' ' VAL . 88.2 mt -89.75 -15.62 32.05 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.185 -1.043 . . . . 1.02 108.185 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ASP . . . . . 0.422 ' CG ' ' HA ' ' B' ' 50' ' ' ASN . 4.0 t0 -71.48 150.42 44.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.362 -1.29 . . . . 1.79 110.499 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.79 -44.5 3.25 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.802 -0.713 . . . . 1.1499999999999999 113.469 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.502 HG11 HG13 ' B' ' 97' ' ' ILE . 3.5 p -70.1 -18.82 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.949 0.404 . . . . 1.1699999999999999 111.926 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.21 59.74 0.5 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.567 -0.825 . . . . 1.05 112.91 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' B' ' 93' ' ' VAL . 31.5 mm -128.61 137.24 57.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.131 -0.692 . . . . 1.6100000000000001 109.131 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -65.44 -36.55 84.26 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.293 0.568 . . . . 2.3999999999999999 109.874 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' THR . . . . . 0.429 ' H ' HG22 ' B' ' 66' ' ' ILE . 11.8 m -80.0 82.17 6.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.634 -0.712 . . . . 0.93000000000000005 109.946 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' THR . . . . . 0.411 ' HB ' ' OD2' ' B' ' 62' ' ' ASP . 23.2 p -68.48 97.52 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.861 -0.609 . . . . 1.3100000000000001 111.313 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.12 -171.53 37.87 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.637 -0.792 . . . . 0.79000000000000004 112.46 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' B' ' 60' ' ' SER . 11.9 m -118.16 132.67 67.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.555 0.217 . . . . 0.93000000000000005 111.24 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.612 ' HA ' HG12 ' B' ' 45' ' ' VAL . 30.4 t -74.78 128.78 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.434 -0.348 . . . . 1.3799999999999999 110.459 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' B' ' 73' ' ' ARG . 14.0 mmm-85 -96.95 84.78 3.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.061 0.457 . . . . 1.3700000000000001 110.319 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' CYS . . . . . 0.428 ' SG ' HG13 ' B' ' 101' ' ' VAL . 0.8 OUTLIER -68.22 -13.03 61.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.793 -0.639 . . . . 1.1599999999999999 110.538 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 33' ' ' PHE . 14.0 p-10 -87.53 7.16 30.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.769 -0.65 . . . . 1.1000000000000001 111.899 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' GLN . . . . . 0.419 ' N ' ' HD3' ' B' ' 77' ' ' PRO . 68.7 mt-30 -132.56 61.77 58.86 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 111.803 0.298 . . . . 2.4700000000000002 111.803 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' B' ' 76' ' ' GLN . 3.3 Cg_exo -77.98 119.99 4.89 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.482 2.121 . . . . 0.95999999999999996 110.83 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ARG . . . . . 1.038 ' HG3' ' HG3' ' A' ' 78' ' ' ARG . 46.5 ttp180 -136.9 122.23 19.36 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 111.944 0.35 . . . . 1.96 111.944 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.424 HG21 ' HB3' ' A' ' 76' ' ' GLN . 9.8 t -84.03 139.9 32.21 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.218 -0.66 . . . . 1.1899999999999999 109.218 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 8.3 pt -148.86 162.69 5.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.484 -0.325 . . . . 1.28 110.374 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -77.98 94.6 4.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.201 0.524 . . . . 1.28 110.679 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' MET . . . . . 0.539 ' SD ' ' HA3' ' B' ' 87' ' ' GLY . 53.0 tpp -61.11 -24.76 66.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.302 -0.863 . . . . 2.7000000000000002 112.263 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.18 -49.25 11.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.76 0.314 . . . . 1.96 111.633 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.94 -41.46 82.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.379 -0.373 . . . . 1.0600000000000001 111.077 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -75.68 -31.83 59.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 1.47 111.334 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.57 101.83 0.88 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.86 -0.686 . . . . 0.81999999999999995 112.822 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' GLY . . . . . 0.539 ' HA3' ' SD ' ' B' ' 82' ' ' MET . . . -112.35 150.61 18.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.871 -0.68 . . . . 0.65000000000000002 112.49 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -140.58 136.68 33.05 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.403 -0.221 . . . . 1.8100000000000001 110.403 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' B' ' 89' ' ' ARG . 9.8 ttt180 -75.69 135.89 40.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.799 0.333 . . . . 2.4900000000000002 110.853 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' B' ' 8' ' ' LEU . 82.7 mt -108.14 -77.99 0.59 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.301 0.482 . . . . 0.76000000000000001 112.301 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLU . . . . . 0.505 ' HG3' HD12 ' B' ' 6' ' ' ILE . 11.0 pt-20 -133.1 -178.18 4.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.495 -0.32 . . . . 1.0700000000000001 111.635 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' B' ' 4' ' ' GLY . 5.2 tpt180 -121.5 122.67 40.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 2.0499999999999998 110.778 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.491 ' HB ' ' HA2' ' B' ' 4' ' ' GLY . 57.7 t -82.91 136.19 44.57 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.934 -0.575 . . . . 1.45 110.559 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.449 ' HD3' HD11 ' B' ' 66' ' ' ILE . 77.6 Cg_exo -53.66 144.57 52.57 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.837 2.358 . . . . 1.03 111.999 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.438 ' H ' ' HG2' ' B' ' 95' ' ' GLU . 4.3 mm-40 -55.9 -39.95 72.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.668 -0.696 . . . . 2.1400000000000001 111.916 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 14.2 t -57.53 -33.95 68.61 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.625 0.602 . . . . 1.78 112.625 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.502 HG13 HG11 ' B' ' 64' ' ' VAL . 48.2 mm -82.3 -36.57 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.218 0.532 . . . . 1.3300000000000001 110.206 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' MET . . . . . 0.505 ' HA ' ' HE2' ' B' ' 98' ' ' MET . 30.0 mmt -66.22 -33.27 75.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 2.3399999999999999 111.047 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -60.24 -36.23 77.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.19 0.519 . . . . 1.9099999999999999 110.414 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 3.5 mm-40 -67.67 -41.05 84.35 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.724 -0.671 . . . . 1.76 110.442 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.432 HG21 ' HE1' ' B' ' 98' ' ' MET . 93.8 t -57.54 -48.3 83.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.156 -0.475 . . . . 1.01 110.248 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.79 -40.6 97.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.744 -0.662 . . . . 1.29 110.175 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.14 -46.94 89.73 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.81 -0.632 . . . . 1.02 112.342 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 9.8 mmt180 -60.8 -41.12 95.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.858 0.361 . . . . 1.8500000000000001 110.936 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.522 HD12 HD12 ' B' ' 108' ' ' ILE . 31.8 tp -66.1 -30.67 71.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.193 -0.458 . . . . 1.9399999999999999 110.714 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 49.1 m -66.33 -34.78 78.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.175 -0.466 . . . . 1.1599999999999999 111.308 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -15.92 62.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.04 0.385 . . . . 1.45 112.04 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.522 HD12 HD12 ' B' ' 105' ' ' LEU . 60.2 mt -79.03 -23.16 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.297 0.57 . . . . 1.98 110.375 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 74.9 mt -93.8 48.02 1.25 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.757 -0.656 . . . . 1.3600000000000001 110.779 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.661 -0.685 . . . . 2.1299999999999999 110.56 179.691 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C1' 1.407 -0.579 0 C4'-C3'-C2' 103.885 1.185 . 0.0 '__' . 6.3600000000000003 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' ' U' . . . . . 0.428 ' C2 ' ' HB2' ' A' ' 58' ' ' ALA . . . . . . . . 0 O5'--C5' 1.426 -0.869 0 C4'-C3'-C2' 104.417 1.717 . 0.0 OUTLIER gamma 2.9900000000000002 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 3' ' ' ' A' . . . . . 0.728 ' C2 ' ' HB ' ' A' ' 46' ' ' THR . . . . . . . . 0 P--O3' 1.616 0.716 0 O4'-C1'-C2' 107.597 0.855 . 0.0 OUTLIER . 2.5899999999999999 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 4' ' ' ' C' . . . . . 0.523 ' C5 ' ' HA ' ' A' ' 46' ' ' THR . . . . . . . . 0 C3'--C2' 1.536 1.04 0 C4'-C3'-C2' 105.709 3.009 OUTLIER-DELTA 0.0 OUTLIER gamma 2.5099999999999998 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 5' ' ' ' A' . . . . . 0.838 ' C5 ' ' HA2' ' A' ' 21' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.887 0 O4'-C1'-C2' 107.866 1.047 . 0.0 OUTLIER . 4.9400000000000004 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.625 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 14.2 ptp . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.958 0.408 . . . . 1.29 110.742 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.45 ' HG2' ' H ' ' A' ' 3' ' ' ARG . 14.3 tt0 -108.66 167.15 10.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.674 -0.694 . . . . 2.0099999999999998 110.231 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.45 ' H ' ' HG2' ' A' ' 2' ' ' GLU . 29.8 ttm180 -69.01 129.27 39.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.287 -0.415 . . . . 1.8500000000000001 109.99 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.35 -7.46 34.67 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.558 -0.83 . . . . 0.85999999999999999 112.828 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.625 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 31.2 mt-10 -81.42 147.36 29.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.826 0.313 . . . . 0.98999999999999999 111.271 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.542 HD11 HG13 ' A' ' 93' ' ' VAL . 32.6 mt -111.45 121.67 64.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 1.1599999999999999 110.751 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -118.43 147.48 43.54 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.91000000000000003 110.145 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 tp -102.91 130.09 49.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.939 -0.119 . . . . 0.90000000000000002 110.717 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -169.74 154.62 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.237 0.336 . . . . 1.04 110.421 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.0 m -80.97 141.25 34.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.714 0.292 . . . . 1.3200000000000001 110.435 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.574 HD11 ' HD3' ' A' ' 23' ' ' ARG . 53.8 mt -82.85 -7.79 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 1.29 111.03 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.585 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 1.6 m-20 -65.45 162.45 41.79 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.412 -0.813 . . . . 1.54 110.153 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.727 ' HB2' ' HG2' ' B' ' 13' ' ' PRO . 5.9 Cg_exo -78.57 141.35 64.03 Favored 'Cis proline' 0 C--O 1.236 0.385 0 C-N-CA 123.716 -1.368 . . . . 1.6899999999999999 111.726 -0.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.859 ' HB ' ' HB3' ' A' ' 18' ' ' GLU . 24.0 p -117.58 171.77 7.79 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.224 -0.444 . . . . 1.3600000000000001 110.536 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.28 137.57 39.14 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.434 -0.58 . . . . 1.7 109.434 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.54 -116.02 5.27 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.71 -0.757 . . . . 1.1799999999999999 112.995 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -113.05 17.4 18.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.531 0.205 . . . . 2.7799999999999998 111.136 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.859 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 18.8 tt0 -59.26 137.45 57.97 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.251 -0.431 . . . . 1.1399999999999999 110.004 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.76 118.39 4.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.492 -0.322 . . . . 2.0899999999999999 111.204 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.456 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 3.1 pt20 -124.42 164.01 20.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.169 -0.469 . . . . 2.0899999999999999 110.674 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.541 ' HA2' " H2'" ' C' ' 5' ' ' ' A' . . . 112.05 150.36 11.32 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.608 -0.806 . . . . 1.0700000000000001 113.595 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 0.4 OUTLIER -72.47 113.9 10.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.875 0.369 . . . . 1.1100000000000001 110.124 179.159 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.574 ' HD3' HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -142.96 160.51 52.61 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.372 -0.376 . . . . 1.6200000000000001 110.173 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.31 134.18 24.24 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.468 2.112 . . . . 1.01 111.056 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.795 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 15.3 m -119.28 136.08 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 110.005 -0.368 . . . . 0.76000000000000001 110.005 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.425 ' HB3' HG23 ' A' ' 43' ' ' VAL . 21.8 tp -94.35 128.72 41.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.083 -0.508 . . . . 0.69999999999999996 111.437 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.448 HD13 ' CG1' ' A' ' 42' ' ' VAL . 14.2 mm -73.32 114.56 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.345 -0.389 . . . . 0.92000000000000004 110.127 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.42 ' HA ' ' CE ' ' A' ' 98' ' ' MET . 88.2 t -90.33 -41.82 13.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.002 0.43 . . . . 0.94999999999999996 111.953 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.69 147.18 96.36 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 112.04 0.385 . . . . 1.1200000000000001 112.04 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.45 159.12 54.76 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.767 2.311 . . . . 1.3 111.986 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.61 70.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.982 -0.554 . . . . 1.3899999999999999 112.348 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.29 94.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.846 0.355 . . . . 1.6100000000000001 110.948 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -66.48 -41.2 89.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.039 -0.528 . . . . 1.77 110.482 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 66.9 m-20 -67.54 -11.82 58.92 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.034 -0.53 . . . . 1.48 110.886 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.8 ttp-105 -94.79 -31.96 13.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.175 -0.466 . . . . 2.6200000000000001 111.212 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.41 -49.08 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.824 0.676 . . . . 1.8600000000000001 112.824 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 p -95.27 -27.05 15.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.953 0.406 . . . . 1.72 110.564 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 67.13 21.25 10.15 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.367 -0.833 . . . . 4.4500000000000002 111.395 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.0 mt -125.65 98.98 33.37 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.393 -0.821 . . . . 1.8100000000000001 109.027 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.438 ' HG3' ' SD ' ' A' ' 1' ' ' MET . 90.1 Cg_endo -88.55 134.54 2.85 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.806 2.337 . . . . 1.05 113.775 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.9 t -79.21 114.37 19.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.193 -1.41 . . . . 1.03 107.193 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.795 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 31.5 m -115.66 150.61 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 113.44 0.904 . . . . 0.77000000000000002 113.44 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 26' ' ' LEU . 1.7 m -117.97 129.03 25.62 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.931 -1.031 . . . . 0.71999999999999997 108.96 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 43' ' ' VAL . 12.2 Cg_exo -70.35 145.44 53.77 Favored 'Trans proline' 0 CA--C 1.527 0.17 0 C-N-CA 123.186 2.591 . . . . 1.03 113.871 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.8 t -107.49 119.9 57.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.509 -0.923 . . . . 1.28 108.509 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.431 HG21 H5'' ' C' ' 4' ' ' ' C' . 39.4 m -154.05 123.56 6.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.521 0.201 . . . . 1.9099999999999999 111.172 -179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.542 ' HB3' HG23 ' A' ' 71' ' ' VAL . 2.2 p -111.67 -5.49 14.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.501 -0.318 . . . . 2.5299999999999998 110.932 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.701 ' HA3' " O2'" ' C' ' 3' ' ' ' A' . . . 66.23 38.84 94.16 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 110.866 -0.894 . . . . 3.3599999999999999 110.866 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.4 -116.51 5.1 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.571 -1.012 . . . . 3.8300000000000001 110.571 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -112.27 16.0 20.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.191 0.519 . . . . 4.7199999999999998 110.312 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -91.62 48.59 1.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.883 -0.599 . . . . 6.2400000000000002 111.257 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.18 102.26 2.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.225 -0.443 . . . . 2.5899999999999999 110.241 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.628 ' HG3' ' C6 ' ' C' ' 3' ' ' ' A' . 0.4 OUTLIER -122.93 166.74 14.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.966 0.412 . . . . 4.5899999999999999 111.846 -179.249 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.17 87.78 2.77 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.758 -0.655 . . . . 2.6899999999999999 109.422 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.82 113.7 18.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.984 -0.553 . . . . 3.1699999999999999 110.593 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.51 -119.34 5.28 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.848 -0.691 . . . . 1.6599999999999999 112.338 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.477 ' HD2' ' HB3' ' A' ' 104' ' ' ARG . 58.9 m-85 -106.06 69.07 0.79 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.127 0.489 . . . . 1.5600000000000001 111.328 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.19 138.45 29.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.9 -0.591 . . . . 1.25 110.03 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.691 HG21 HG22 ' A' ' 101' ' ' VAL . 17.7 t -116.25 118.24 58.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.601 -0.272 . . . . 1.6799999999999999 110.882 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.7 118.87 20.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.609 -0.269 . . . . 1.95 111.117 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.445 ' HB3' HD11 ' A' ' 66' ' ' ILE . 83.3 mt -82.87 -18.61 39.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.233 0.54 . . . . 1.23 110.58 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -67.37 117.04 8.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.566 -0.743 . . . . 2.21 109.954 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.78 -31.4 2.21 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.381 -0.688 . . . . 1.1499999999999999 111.381 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 61' ' ' LEU . 34.7 m -83.18 -17.26 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.835 0.35 . . . . 1.21 111.502 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.58 83.07 0.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.849 -0.691 . . . . 1.0800000000000001 112.68 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 61' ' ' LEU . 11.7 pt -138.44 169.67 17.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.838 -0.43 . . . . 1.0700000000000001 109.838 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -76.5 -51.73 11.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.79 0.329 . . . . 3.5899999999999999 110.586 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.9 m -85.34 75.88 10.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.269 0.557 . . . . 1.51 110.948 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.02 158.47 29.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.759 -0.655 . . . . 1.79 111.322 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 156.42 -157.34 27.83 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 121.069 -0.586 . . . . 1.1799999999999999 111.744 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.542 HG23 ' HB3' ' A' ' 47' ' ' SER . 69.6 t -130.04 126.39 61.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 110.178 -0.305 . . . . 1.5600000000000001 110.178 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.7 t -72.56 118.94 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.318 -0.623 . . . . 1.29 109.318 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -92.89 96.03 9.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.241 -0.436 . . . . 2.23 110.971 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.16 -6.04 57.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.538 0.685 . . . . 1.1699999999999999 109.373 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.452 ' HA ' ' CZ ' ' B' ' 33' ' ' PHE . 3.9 p-10 -78.98 -16.2 57.24 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.902 -1.045 . . . . 0.89000000000000001 112.689 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -136.83 68.71 58.47 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 114.138 1.162 . . . . 2.1299999999999999 114.138 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.79 140.73 32.63 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.289 1.993 . . . . 0.80000000000000004 109.914 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.462 ' HD3' HD13 ' A' ' 11' ' ' LEU . 6.1 ptm85 -156.21 114.15 3.31 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.823 0.675 . . . . 2.0899999999999999 112.823 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.536 ' OG1' ' HD2' ' B' ' 77' ' ' PRO . 90.8 m -82.76 109.94 17.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.154 -0.476 . . . . 1.6200000000000001 110.089 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.0 pt -120.96 155.18 24.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.038 -0.528 . . . . 1.1499999999999999 109.641 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.53 125.77 26.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.976 0.417 . . . . 1.03 111.5 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.45 ' SD ' ' HA3' ' A' ' 87' ' ' GLY . 40.3 tpp -103.08 9.24 38.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.094 0.473 . . . . 1.29 110.718 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -92.94 -64.21 1.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.173 -0.467 . . . . 2.6400000000000001 111.854 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.58 -27.96 63.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.293 -0.412 . . . . 1.1200000000000001 111.305 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 85' ' ' ARG . 45.8 mtt180 -73.81 -29.86 62.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.253 -0.431 . . . . 1.0600000000000001 110.502 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.32 66.94 2.09 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.896 -0.669 . . . . 1.1200000000000001 112.355 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.45 ' HA3' ' SD ' ' A' ' 82' ' ' MET . . . -69.14 151.94 51.67 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.713 -0.756 . . . . 1.0900000000000001 112.27 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -113.43 122.12 46.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.31 -0.255 . . . . 2.46 110.31 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -82.18 135.28 35.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.655 0.264 . . . . 2.4900000000000002 111.224 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 90' ' ' LEU . 3.0 mm? -104.27 -64.68 1.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.134 0.492 . . . . 1.29 110.616 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -162.95 -169.07 1.93 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.791 -0.64 . . . . 1.1499999999999999 109.346 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -130.77 156.48 44.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.684 0.278 . . . . 1.3200000000000001 110.579 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.542 HG13 HD11 ' A' ' 6' ' ' ILE . 26.8 m -97.33 156.59 36.05 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.39 -0.368 . . . . 0.75 111.085 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -64.19 145.52 89.09 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.721 2.281 . . . . 0.94999999999999996 111.129 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -61.19 -25.7 67.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 1.51 111.662 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -38.43 87.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.877 0.37 . . . . 1.5700000000000001 110.577 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 101' ' ' VAL . 47.7 mm -73.56 -46.48 48.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.96 -0.564 . . . . 1.3100000000000001 109.921 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.42 ' CE ' ' HA ' ' A' ' 28' ' ' VAL . 9.8 tpt -63.03 -26.05 68.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.953 -0.567 . . . . 1.6000000000000001 110.99 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.15 -48.22 79.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.673 -0.694 . . . . 2.2999999999999998 111.634 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -28.41 60.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.543 -0.299 . . . . 1.6399999999999999 111.55 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.691 HG22 HG21 ' A' ' 59' ' ' VAL . 57.8 t -62.2 -46.93 95.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.699 -0.482 . . . . 1.03 109.699 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 77.7 mt -61.34 -36.38 80.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.614 -0.721 . . . . 1.22 110.185 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.31 -46.18 94.95 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.479 -0.782 . . . . 1.03 112.453 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.477 ' HB3' ' HD2' ' A' ' 57' ' ' PHE . 21.5 mtt180 -65.4 -37.84 88.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 1.72 110.77 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.61 -18.27 65.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.757 -0.656 . . . . 1.02 112.253 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.1 m -78.82 -24.96 44.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.938 0.399 . . . . 1.1100000000000001 111.164 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.75 -22.25 50.56 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.124 0.416 . . . . 1.5 112.124 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.0 pt -84.23 -9.22 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 111.96 0.356 . . . . 1.1499999999999999 111.96 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.3 mt -84.2 73.03 10.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.897 0.379 . . . . 0.97999999999999998 110.092 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 116.361 -0.381 . . . . 1.3500000000000001 111.666 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.882 ' HA ' ' HA ' ' B' ' 30' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.743 0.306 . . . . 2.0299999999999998 110.881 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -82.27 -21.53 36.18 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.328 -0.619 . . . . 2.8199999999999998 109.328 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ARG . . . . . 0.713 ' HG2' ' HG2' ' B' ' 98' ' ' MET . 6.4 mtm180 72.14 120.9 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.946 -1.024 . . . . 2.3199999999999998 112.903 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' B' ' 92' ' ' ARG . . . 97.47 -26.76 21.66 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.741 -0.663 . . . . 1.28 113.679 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.427 ' OE1' ' HD2' ' B' ' 89' ' ' ARG . 6.5 mm-40 -71.08 97.84 1.55 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.848 0.685 . . . . 1.53 112.848 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.84 HD11 ' HB ' ' B' ' 93' ' ' VAL . 64.5 mt -95.26 125.91 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.851 -0.796 . . . . 0.75 108.851 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -105.78 164.78 11.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.986 0.422 . . . . 0.81000000000000005 112.007 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 45.8 tp -128.87 120.04 25.51 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.05 -0.523 . . . . 1.05 109.949 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.46 HG22 ' H ' ' B' ' 10' ' ' SER . 4.8 p -159.69 169.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.251 -0.431 . . . . 0.71999999999999997 110.122 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' SER . . . . . 0.46 ' H ' HG22 ' B' ' 9' ' ' VAL . 0.3 OUTLIER -97.77 135.54 39.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.779 0.323 . . . . 1.6299999999999999 110.472 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' B' ' 44' ' ' PRO . 35.3 mt -86.28 -18.26 32.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.234 -0.439 . . . . 0.82999999999999996 111.189 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.96 154.24 89.81 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.915 -0.584 . . . . 1.6200000000000001 111.116 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.727 ' HG2' ' HB2' ' A' ' 13' ' ' PRO . 58.5 Cg_endo -73.47 124.28 9.38 Favored 'Cis proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.266 -1.556 . . . . 1.28 113.041 0.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.489 ' HB ' ' HG2' ' B' ' 20' ' ' GLN . 0.0 OUTLIER -121.93 166.85 13.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.554 -0.748 . . . . 1.47 109.918 179.206 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.87 -171.24 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.582 0.23 . . . . 1.22 111.069 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.96 -104.92 1.18 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 116.081 -0.508 . . . . 1.01 112.702 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -132.43 14.52 4.54 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.293 0.568 . . . . 2.1800000000000002 110.285 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -78.07 143.95 36.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.735 -0.666 . . . . 1.28 110.061 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.08 105.47 2.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.763 0.316 . . . . 1.52 111.224 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.489 ' HG2' ' HB ' ' B' ' 14' ' ' THR . 6.7 mt-30 -83.89 -174.73 5.45 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.112 -0.495 . . . . 1.8600000000000001 110.913 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.05 -167.11 49.25 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.95 -0.568 . . . . 0.90000000000000002 112.752 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 20.1 m -113.89 122.27 46.49 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.428 -0.582 . . . . 0.94999999999999996 109.428 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -151.61 159.99 32.42 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.681 -0.488 . . . . 1.5900000000000001 109.681 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.674 ' HG2' HG21 ' B' ' 68' ' ' THR . 47.2 Cg_exo -59.47 137.76 79.86 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.192 1.928 . . . . 0.65000000000000002 110.671 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.863 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 4.3 m -128.09 128.13 68.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.989 0.424 . . . . 0.56999999999999995 111.126 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 46.7 tp -94.44 121.2 35.74 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.961 -0.563 . . . . 1.1699999999999999 109.605 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ILE . . . . . 0.504 HG12 HG12 ' B' ' 42' ' ' VAL . 51.5 mt -80.86 137.82 20.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.956 -0.387 . . . . 0.66000000000000003 109.956 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.87 -29.39 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.821 0.344 . . . . 0.93000000000000005 111.051 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' THR . . . . . 0.543 HG23 HG22 ' B' ' 41' ' ' VAL . 0.9 OUTLIER -74.06 137.31 75.89 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.258 -0.428 . . . . 0.81000000000000005 111.615 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.882 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 43.1 Cg_endo -67.2 161.42 42.99 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.009 2.473 . . . . 0.78000000000000003 112.045 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.77 -37.08 73.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.169 -0.468 . . . . 1.03 111.677 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.51 -29.99 71.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.114 0.483 . . . . 1.3999999999999999 111.176 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' PHE . . . . . 0.548 ' HB2' ' HG2' ' B' ' 30' ' ' PRO . 2.2 t80 -81.13 -40.01 24.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.033 0.444 . . . . 1.5700000000000001 110.135 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' B' ' 38' ' ' ARG . 44.8 m-20 -66.52 -22.32 66.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.63 -0.713 . . . . 1.6399999999999999 110.725 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -79.75 -34.83 39.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 2.54 110.948 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 58.0 t -85.4 -64.21 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.156 -0.475 . . . . 1.0900000000000001 111.987 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 1.3 m -67.51 -30.77 70.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.385 -0.37 . . . . 1.3300000000000001 111.014 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.534 ' HE ' ' HA ' ' B' ' 38' ' ' ARG . 0.7 OUTLIER 71.69 -9.84 0.9 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.534 0.568 . . . . 1.78 112.534 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 60.4 mt -118.62 100.93 51.09 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.681 -0.489 . . . . 1.1599999999999999 109.681 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' PRO . . . . . 0.46 ' HD2' ' O ' ' B' ' 80' ' ' ILE . 93.1 Cg_endo -86.68 158.96 9.14 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.742 2.295 . . . . 0.56999999999999995 113.322 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.543 HG22 HG23 ' B' ' 29' ' ' THR . 6.4 m -92.95 127.2 45.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 109.202 -0.666 . . . . 1.0800000000000001 109.202 178.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.863 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 27.8 m -114.68 146.78 18.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.252 0.549 . . . . 0.64000000000000001 112.148 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.428 HG13 ' O ' ' B' ' 73' ' ' ARG . 43.1 t -109.84 112.91 57.87 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.944 -1.026 . . . . 1.1000000000000001 109.279 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.522 ' HB3' HD11 ' B' ' 11' ' ' LEU . 56.0 Cg_endo -72.06 119.42 6.16 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.69 2.26 . . . . 0.72999999999999998 112.567 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 91.6 t -77.49 136.44 24.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.812 -0.631 . . . . 0.90000000000000002 110.202 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 3.9 m -105.07 112.01 24.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.129 -0.487 . . . . 1.1699999999999999 110.097 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.49 127.54 32.58 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.184 -0.462 . . . . 1.8500000000000001 110.64 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.72 16.96 36.58 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.531 -0.842 . . . . 2.2200000000000002 112.744 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.31 -92.89 0.33 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.977 -0.63 . . . . 3.4300000000000002 111.985 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -127.83 -48.58 1.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.138 0.494 . . . . 4.6200000000000001 110.293 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -85.17 93.82 8.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.063 -0.517 . . . . 6.2699999999999996 110.654 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -127.83 100.52 5.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.027 -0.533 . . . . 4.3899999999999997 110.579 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -115.99 -173.47 2.36 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.013 -0.539 . . . . 3.9199999999999999 110.571 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 13.6 t -82.7 129.14 34.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.4 0.619 . . . . 2.75 112.605 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -116.45 64.6 0.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.469 -0.787 . . . . 1.96 109.995 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.95 -94.24 0.78 Allowed Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.77 -0.65 . . . . 1.0800000000000001 112.464 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -87.72 -6.64 58.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.921 0.391 . . . . 3.5699999999999998 111.096 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.36 113.91 22.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.36 -0.382 . . . . 1.0800000000000001 110.392 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.453 HG22 ' HD2' ' B' ' 104' ' ' ARG . 13.8 t -77.79 141.29 15.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.03 -0.532 . . . . 1.3400000000000001 110.335 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -90.2 124.94 35.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.54 -0.3 . . . . 1.3799999999999999 110.709 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.516 ' HB3' HD13 ' B' ' 66' ' ' ILE . 72.4 mt -89.97 -35.68 15.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.267 -0.424 . . . . 1.02 110.868 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -82.87 -173.22 4.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 1.79 111.321 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.92 -38.46 3.17 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.162 -0.775 . . . . 1.1499999999999999 111.162 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 7.0 p -94.85 -3.35 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.953 0.406 . . . . 1.1699999999999999 110.679 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.88 84.29 1.68 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.789 -0.719 . . . . 1.05 112.597 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.516 HD13 ' HB3' ' B' ' 61' ' ' LEU . 12.0 tt -135.3 160.58 40.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.798 -0.445 . . . . 1.6100000000000001 109.798 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -83.5 -45.13 13.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.864 0.364 . . . . 2.3999999999999999 110.705 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' THR . . . . . 0.674 HG21 ' HG2' ' B' ' 24' ' ' PRO . 17.1 m -85.46 90.52 7.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.154 0.502 . . . . 0.93000000000000005 111.643 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 52.7 m -71.46 98.1 1.77 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.804 -0.634 . . . . 1.3100000000000001 111.016 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -165.05 -171.2 31.0 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.793 -0.717 . . . . 0.79000000000000004 112.152 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 15.1 m -117.58 151.97 19.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.862 0.363 . . . . 0.93000000000000005 111.131 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.451 ' HB ' ' HB ' ' B' ' 59' ' ' VAL . 47.3 t -87.92 121.96 39.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.904 -0.589 . . . . 1.3799999999999999 110.219 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.428 ' O ' HG13 ' B' ' 43' ' ' VAL . 33.3 mmm-85 -97.25 84.93 3.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.953 0.406 . . . . 1.3700000000000001 111.138 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 29.6 m -73.67 -0.75 16.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.189 -0.459 . . . . 1.1599999999999999 111.228 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.44 ' C ' ' HD3' ' B' ' 77' ' ' PRO . 16.9 p-10 -96.06 -2.8 45.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.977 -0.556 . . . . 1.1000000000000001 111.939 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' GLN . . . . . 0.55 ' N ' ' HD3' ' B' ' 77' ' ' PRO . 39.3 mt-30 -130.16 52.45 9.42 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.538 0.94 . . . . 2.4700000000000002 113.538 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' B' ' 76' ' ' GLN . 1.0 OUTLIER -84.87 119.4 2.18 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.269 1.979 . . . . 0.95999999999999996 111.49 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -125.61 140.34 52.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.705 0.288 . . . . 1.96 111.453 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.18 126.98 31.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.679 -0.86 . . . . 1.1899999999999999 108.679 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.46 ' O ' ' HD2' ' B' ' 40' ' ' PRO . 31.5 pt -133.8 149.54 30.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.389 0.514 . . . . 1.28 112.389 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' B' ' 83' ' ' LYS . 14.1 t0 -76.41 91.71 3.32 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.277 -0.638 . . . . 1.28 109.277 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' MET . . . . . 0.451 ' SD ' ' HA3' ' B' ' 87' ' ' GLY . 48.5 tpp -67.76 -16.71 64.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.976 -0.556 . . . . 2.7000000000000002 111.869 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' B' ' 81' ' ' ASP . 5.0 mtmp? -75.91 -45.58 34.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.282 -0.417 . . . . 1.96 111.111 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.98 -31.69 25.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.236 -0.438 . . . . 1.0600000000000001 111.88 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' B' ' 85' ' ' ARG . 66.1 mtt-85 -72.61 -36.01 67.98 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.943 0.349 . . . . 1.47 111.943 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.64 80.1 1.44 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.351 -0.928 . . . . 0.81999999999999995 112.108 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' GLY . . . . . 0.451 ' HA3' ' SD ' ' B' ' 82' ' ' MET . . . -90.55 162.0 28.93 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.746 -0.74 . . . . 0.65000000000000002 112.749 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -155.96 155.37 32.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.661 -0.866 . . . . 1.8100000000000001 108.661 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.427 ' HD2' ' OE1' ' B' ' 5' ' ' GLU . 5.6 ttp180 -99.35 142.26 31.06 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 121.083 -0.247 . . . . 2.4900000000000002 111.144 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 53.5 mt -108.39 -97.06 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.95 0.352 . . . . 0.76000000000000001 111.95 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLU . . . . . 0.436 ' HG3' HD12 ' B' ' 6' ' ' ILE . 15.5 pt-20 -106.89 169.86 8.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.466 -0.334 . . . . 1.0700000000000001 111.153 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' B' ' 4' ' ' GLY . 3.7 ttt180 -110.72 106.06 15.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.373 -0.376 . . . . 2.0499999999999998 110.417 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.84 ' HB ' HD11 ' B' ' 6' ' ' ILE . 14.4 p -69.37 133.05 89.36 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.405 -0.361 . . . . 1.45 110.851 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.8 147.11 33.09 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.002 2.468 . . . . 1.03 112.52 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -60.67 -28.32 68.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.852 -0.613 . . . . 2.1400000000000001 110.937 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -47.16 86.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.762 -0.654 . . . . 1.78 110.768 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 51.6 mm -74.66 -40.07 47.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.545 . . . . 1.3300000000000001 110.199 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' MET . . . . . 0.713 ' HG2' ' HG2' ' B' ' 3' ' ' ARG . 8.8 tpt -58.56 -38.01 76.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.9 -0.591 . . . . 2.3399999999999999 110.981 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -60.94 -39.35 89.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.917 0.389 . . . . 1.9099999999999999 110.701 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -67.14 -27.63 67.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 1.76 111.257 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.444 ' HA ' HG21 ' B' ' 59' ' ' VAL . 63.3 t -70.94 -51.27 36.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.414 -0.587 . . . . 1.01 109.414 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.23 -36.59 81.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.585 -0.734 . . . . 1.29 110.821 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.23 -50.88 63.07 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.936 -0.575 . . . . 1.02 112.079 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ARG . . . . . 0.453 ' HD2' HG22 ' B' ' 59' ' ' VAL . 77.2 mtt85 -62.95 -35.89 81.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.72 0.295 . . . . 1.8500000000000001 110.893 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 35.4 mt -66.03 -31.2 71.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.247 0.546 . . . . 1.9399999999999999 110.115 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -80.81 -18.73 46.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.793 -0.64 . . . . 1.1599999999999999 110.858 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 7.8 m -74.13 -38.88 63.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.296 -0.411 . . . . 1.45 110.841 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 34.6 pt -76.29 2.25 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 111.982 0.364 . . . . 1.98 111.982 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 86.2 mt -82.97 -13.84 55.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.345 -0.389 . . . . 1.3600000000000001 111.138 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.802 -0.618 . . . . 2.1299999999999999 110.273 179.65 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' ' A' . . . . . 0.643 ' N3 ' " H2'" ' C' ' 1' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.429 -0.684 0 C1'-C2'-O2' 108.238 -0.787 . 0.0 '__' . 6.3600000000000003 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 O4'-C1'-C2' 104.635 -1.261 . 0.0 OUTLIER zeta-1 2.9900000000000002 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' ' A' . . . . . 0.701 " O2'" ' HA3' ' A' ' 48' ' ' GLY . . . . . . . . 0 O5'--C5' 1.424 -0.971 0 O4'-C1'-C2' 108.376 1.412 . 0.0 OUTLIER . 2.5899999999999999 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 4' ' ' ' C' . . . . . 0.431 H5'' HG21 ' A' ' 46' ' ' THR . . . . . . . . 0 C4'--C3' 1.533 0.808 0 C4'-C3'-C2' 104.18 1.48 . 0.0 OUTLIER . 2.5099999999999998 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 5' ' ' ' A' . . . . . 0.541 " H2'" ' HA2' ' A' ' 21' ' ' GLY . . . . . . . . 0 O5'--C5' 1.428 -0.731 0 C3'-C2'-O2' 110.962 -0.806 . 0.0 OUTLIER gamma 4.9400000000000004 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.578 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 24.4 ptp . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.887 0.375 . . . . 1.29 110.474 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -129.23 158.4 39.14 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.971 -0.559 . . . . 2.0099999999999998 110.55 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -61.64 122.61 15.73 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 110.037 -0.357 . . . . 1.8500000000000001 110.037 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 111.09 -8.85 29.22 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.914 -0.66 . . . . 0.85999999999999999 112.055 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.578 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 49.7 mt-10 -85.8 145.35 27.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.88 0.371 . . . . 0.98999999999999999 111.365 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.414 HD11 HG13 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -110.12 110.75 33.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.259 -0.645 . . . . 1.1599999999999999 109.259 179.083 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 89' ' ' ARG . 27.2 m95 -104.67 135.22 46.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.934 0.397 . . . . 0.91000000000000003 111.294 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.764 ' HB2' HD21 ' A' ' 90' ' ' LEU . 25.6 tp -95.51 122.3 38.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.26 -0.427 . . . . 0.90000000000000002 110.822 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 p -160.87 157.24 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 1.04 109.936 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.642 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -89.17 130.01 35.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.841 -0.429 . . . . 1.3200000000000001 109.841 179.38 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.6 mt -78.96 -10.51 59.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.252 -0.431 . . . . 1.29 110.952 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.531 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 5.1 m-20 -73.23 164.47 60.78 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.707 -0.679 . . . . 1.54 110.922 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.531 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 56.2 Cg_endo -69.99 141.12 65.08 Favored 'Cis proline' 0 C--N 1.347 0.49 0 C-N-CA 123.815 -1.327 . . . . 1.6899999999999999 112.533 0.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.522 HG23 ' HA ' ' A' ' 12' ' ' ASP . 23.0 p -120.35 151.81 38.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.296 -0.411 . . . . 1.3600000000000001 111.276 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.85 125.47 11.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.931 -0.577 . . . . 1.7 109.689 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.38 -124.54 6.76 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.206 -0.758 . . . . 1.1799999999999999 111.206 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -139.99 75.54 1.51 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.148 0.499 . . . . 2.7799999999999998 110.948 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.86 166.79 23.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.567 -0.742 . . . . 1.1399999999999999 109.414 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -63.2 128.03 34.0 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.406 0.441 . . . . 2.0899999999999999 110.634 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -131.22 178.62 6.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.064 -0.516 . . . . 2.0899999999999999 110.106 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.805 ' HA2' " H2'" ' C' ' 5' ' ' ' A' . . . 91.1 162.62 38.24 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.804 -0.712 . . . . 1.0700000000000001 113.844 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.642 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 3.6 m -85.95 102.44 13.76 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.975 -0.75 . . . . 1.1100000000000001 108.975 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.515 ' NH1' ' HB3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -136.99 156.12 75.92 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.268 -0.423 . . . . 1.6200000000000001 110.622 -179.449 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.13 123.69 9.43 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.564 2.176 . . . . 1.01 110.795 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.601 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 14.9 m -108.93 134.22 51.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.959 0.409 . . . . 0.76000000000000001 110.156 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.463 HD11 HG22 ' A' ' 93' ' ' VAL . 20.8 tp -86.31 122.61 30.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.849 -0.614 . . . . 0.69999999999999996 111.268 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.476 ' HA ' HG12 ' A' ' 42' ' ' VAL . 22.4 mm -74.76 115.23 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.92000000000000004 109.854 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.9 t -96.75 -38.78 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 112.07 0.396 . . . . 0.94999999999999996 112.07 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.08 147.22 76.48 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 112.186 0.439 . . . . 1.1200000000000001 112.186 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.02 156.25 65.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.853 2.368 . . . . 1.3 112.03 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.19 61.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.816 -0.629 . . . . 1.3899999999999999 112.561 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.09 -46.3 90.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.745 0.307 . . . . 1.6100000000000001 111.453 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -67.62 -41.2 84.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.12 0.486 . . . . 1.77 110.416 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.497 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 35.4 m-20 -66.5 -18.61 65.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.712 -0.676 . . . . 1.48 111.362 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -88.99 -42.22 11.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.393 -0.367 . . . . 2.6200000000000001 111.966 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 p -81.13 -44.42 20.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.032 0.753 . . . . 1.8600000000000001 113.032 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 m -90.72 -24.2 20.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.83 0.348 . . . . 1.72 111.395 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 5.9 mpt_? 64.25 15.79 9.64 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.915 -0.584 . . . . 4.4500000000000002 111.851 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.57 87.74 55.8 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 1.8100000000000001 111.045 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.591 ' HD2' ' O ' ' A' ' 80' ' ' ILE . 60.6 Cg_endo -75.66 132.12 14.24 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.207 1.938 . . . . 1.05 112.248 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.573 HG22 HG23 ' A' ' 79' ' ' THR . 75.8 t -77.62 118.9 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.097 -1.445 . . . . 1.03 107.097 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.601 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 35.1 m -127.68 161.3 35.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.617 0.723 . . . . 0.77000000000000002 112.87 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -125.06 130.74 24.09 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 114.547 -1.206 . . . . 0.71999999999999997 108.292 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 69.8 Cg_endo -74.7 141.73 27.98 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.528 2.152 . . . . 1.03 113.68 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.411 HG22 HG22 ' A' ' 72' ' ' VAL . 90.0 t -107.12 111.04 33.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.996 -0.742 . . . . 1.28 108.996 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.0 m -151.72 141.44 21.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.36 -0.382 . . . . 1.9099999999999999 110.431 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.697 ' HB3' HG23 ' A' ' 71' ' ' VAL . 1.4 p -120.52 153.14 37.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.921 0.391 . . . . 2.5299999999999998 111.144 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.548 ' HA3' " O2'" ' C' ' 3' ' ' ' A' . . . -163.65 -66.63 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.286 -1.126 . . . . 3.3599999999999999 110.286 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.89 145.39 18.21 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.66 -0.976 . . . . 3.8300000000000001 110.66 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -79.37 67.0 4.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.134 0.492 . . . . 4.7199999999999998 111.517 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.703 ' HB2' ' N6 ' ' C' ' 3' ' ' ' A' . 83.0 m-85 -123.84 83.38 2.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.908 -0.587 . . . . 6.2400000000000002 110.113 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -96.48 122.42 39.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.969 -0.559 . . . . 2.5899999999999999 109.947 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -152.93 103.11 2.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.19 -0.459 . . . . 4.5899999999999999 111.042 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.899 ' HA ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -66.86 -27.48 67.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.177 0.513 . . . . 2.6899999999999999 110.879 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.88 12.2 13.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.88 -0.6 . . . . 3.1699999999999999 110.387 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -125.2 -148.58 7.33 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.665 -0.698 . . . . 1.6599999999999999 111.711 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -108.81 15.2 23.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.154 0.502 . . . . 1.5600000000000001 111.252 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -132.23 77.86 1.78 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.814 -0.63 . . . . 1.25 110.2 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.899 HG12 ' HA ' ' A' ' 54' ' ' THR . 28.6 m -85.26 133.62 28.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.837 -0.62 . . . . 1.6799999999999999 111.285 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.69 148.16 24.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.778 -0.646 . . . . 1.95 110.802 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.9 ' HB3' HD11 ' A' ' 66' ' ' ILE . 80.1 mt -91.64 -16.84 26.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.245 0.545 . . . . 1.23 110.175 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.21 124.95 25.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.668 -0.696 . . . . 2.21 110.614 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.4 -27.94 2.94 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.45 -0.66 . . . . 1.1499999999999999 111.45 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.5 m -96.01 -13.2 8.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.667 0.27 . . . . 1.21 111.266 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.96 72.8 0.97 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.957 -0.639 . . . . 1.0800000000000001 113.108 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.9 HD11 ' HB3' ' A' ' 61' ' ' LEU . 15.6 pt -123.25 -167.86 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.613 0.244 . . . . 1.0700000000000001 111.043 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -102.95 -43.78 5.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.147 0.499 . . . . 3.5899999999999999 109.781 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.2 m -64.75 109.34 2.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.514 -0.766 . . . . 1.51 111.327 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 m -102.21 127.28 49.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.06 -0.518 . . . . 1.79 111.101 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 162.31 -166.84 36.65 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.499 -1.04 . . . . 1.1799999999999999 110.499 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.697 HG23 ' HB3' ' A' ' 47' ' ' SER . 45.6 t -124.81 131.89 72.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.24 -0.652 . . . . 1.5600000000000001 109.24 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.485 ' HB ' HG23 ' A' ' 59' ' ' VAL . 47.2 t -78.23 117.56 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.835 0.35 . . . . 1.29 110.83 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 44' ' ' PRO . 19.1 mmm180 -82.85 103.39 12.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.639 -0.504 . . . . 2.23 109.639 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.19 1.96 55.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.135 0.493 . . . . 1.1699999999999999 110.943 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -89.67 -16.32 30.7 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.586 -0.734 . . . . 0.89000000000000001 111.341 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -125.61 72.73 68.23 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 113.49 0.922 . . . . 2.1299999999999999 113.49 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -90.97 115.18 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.888 2.392 . . . . 0.80000000000000004 110.014 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -138.07 165.88 25.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.163 0.506 . . . . 2.0899999999999999 111.735 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.573 HG23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -97.18 133.02 42.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.343 -0.984 . . . . 1.6200000000000001 108.343 178.661 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.591 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 20.2 pt -132.21 148.35 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.788 0.328 . . . . 1.1499999999999999 111.304 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -82.08 102.42 11.02 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.882 -0.414 . . . . 1.03 109.882 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.3 tpp -89.76 -10.12 46.75 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.235 -0.439 . . . . 1.29 111.108 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 83' ' ' LYS . 17.1 tptp -79.69 -41.25 27.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.798 0.332 . . . . 2.6400000000000001 111.274 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.09 -26.82 42.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.421 -0.354 . . . . 1.1200000000000001 111.388 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 85' ' ' ARG . 33.1 mtt-85 -84.06 -59.47 2.39 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.385 0.513 . . . . 1.0600000000000001 112.385 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.78 109.29 0.3 Allowed Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.889 -0.672 . . . . 1.1200000000000001 111.85 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.03 -168.66 12.5 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.649 -0.786 . . . . 1.0900000000000001 112.79 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -131.36 138.97 49.4 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.063 -0.347 . . . . 2.46 110.063 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 7' ' ' TRP . 17.3 ttp180 -86.2 139.8 30.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.753 0.311 . . . . 2.4900000000000002 111.137 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.764 HD21 ' HB2' ' A' ' 8' ' ' LEU . 1.9 mm? -89.04 -55.37 3.71 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.049 -0.722 . . . . 1.29 109.049 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -170.37 -160.61 0.22 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.183 -0.917 . . . . 1.1499999999999999 108.688 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -134.58 149.97 50.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.688 0.28 . . . . 1.3200000000000001 110.456 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.463 HG22 HD11 ' A' ' 26' ' ' LEU . 31.4 m -97.73 159.82 30.07 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.26 -0.427 . . . . 0.75 111.092 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -64.87 155.87 65.28 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.713 2.276 . . . . 0.94999999999999996 111.398 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -63.59 -26.94 68.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 1.51 110.753 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.34 -37.59 78.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.542 . . . . 1.5700000000000001 110.573 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.5 mm -70.06 -43.69 78.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.022 -0.535 . . . . 1.3100000000000001 110.12 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.7 tpt -63.7 -45.87 88.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 1.6000000000000001 110.459 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -61.58 -36.69 81.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.024 -0.535 . . . . 2.2999999999999998 110.716 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 5.1 tp10 -63.08 -47.64 82.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.072 -0.513 . . . . 1.6399999999999999 110.589 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.446 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 78.8 t -61.64 -46.02 97.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.939 -0.573 . . . . 1.03 110.336 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.55 -39.14 83.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.099 -0.501 . . . . 1.22 110.689 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.42 -43.37 99.15 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.783 -0.644 . . . . 1.03 111.644 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 3.2 mmt180 -65.14 -37.76 88.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 1.72 110.49 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 101' ' ' VAL . 96.7 mt -67.43 -25.06 65.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.56 . . . . 1.02 111.691 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.2 m -71.89 -11.53 60.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 1.1100000000000001 111.067 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.26 -13.65 26.31 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.316 0.487 . . . . 1.5 112.316 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.497 ' HB ' HG22 ' B' ' 29' ' ' THR . 36.1 pt -100.75 -1.24 9.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.827 0.677 . . . . 1.1499999999999999 112.827 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.8 mt -81.65 73.7 8.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.753 0.311 . . . . 0.97999999999999998 110.222 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.545 -0.298 . . . . 1.3500000000000001 111.596 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.757 ' HA ' ' HA ' ' B' ' 30' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 120.708 0.289 . . . . 2.0299999999999998 110.432 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' B' ' 3' ' ' ARG . 2.0 mp0 -77.39 -25.95 51.33 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.922 -0.77 . . . . 2.8199999999999998 108.922 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' B' ' 2' ' ' GLU . 10.7 mtm180 73.03 142.84 0.06 Allowed 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 114.96 -1.018 . . . . 2.3199999999999998 111.457 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' B' ' 92' ' ' ARG . . . 86.46 -50.03 4.16 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.898 -0.668 . . . . 1.28 113.62 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.44 ' OE2' ' HD2' ' B' ' 92' ' ' ARG . 64.7 mm-40 -57.66 107.41 0.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.838 0.681 . . . . 1.53 112.838 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.441 HD12 ' HG3' ' B' ' 91' ' ' GLU . 80.6 mt -98.66 127.28 51.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.374 -0.602 . . . . 0.75 109.374 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -107.68 168.82 8.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.201 0.524 . . . . 0.81000000000000005 111.805 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' B' ' 88' ' ' LYS . 33.5 tp -141.53 132.17 25.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.697 -0.683 . . . . 1.05 109.941 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.411 HG12 HG21 ' B' ' 25' ' ' VAL . 5.2 p -169.26 165.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.532 -0.544 . . . . 0.71999999999999997 109.532 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' B' ' 22' ' ' THR . 22.9 t -88.76 139.36 30.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.677 -0.49 . . . . 1.6299999999999999 109.677 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.714 HD13 ' HB3' ' B' ' 19' ' ' GLN . 31.7 mt -87.72 -16.82 33.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.201 0.524 . . . . 0.82999999999999996 110.349 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ASP . . . . . 0.414 ' CB ' ' HA ' ' B' ' 13' ' ' PRO . 2.1 m-20 -73.83 162.08 75.72 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.76 -0.655 . . . . 1.6200000000000001 111.283 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.414 ' HA ' ' CB ' ' B' ' 12' ' ' ASP . 98.2 Cg_endo -80.28 135.56 33.92 Favored 'Cis proline' 0 C--N 1.344 0.299 0 C-N-CA 123.359 -1.517 . . . . 1.28 113.259 0.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.02 170.51 15.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.345 -0.843 . . . . 1.47 109.575 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.46 165.09 28.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.575 0.226 . . . . 1.22 110.551 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.34 -146.23 34.23 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.122 -0.561 . . . . 1.01 112.266 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -90.15 -1.72 57.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.384 -0.228 . . . . 2.1800000000000002 110.384 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -57.78 154.25 12.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.906 -0.588 . . . . 1.28 112.201 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.714 ' HB3' HD13 ' B' ' 11' ' ' LEU . 28.9 mm-40 -60.94 127.35 31.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.686 -0.688 . . . . 1.52 111.383 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -142.06 -176.6 4.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.893 -0.594 . . . . 1.8600000000000001 110.533 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.59 174.82 50.62 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.993 -0.622 . . . . 0.90000000000000002 112.697 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' B' ' 10' ' ' SER . 22.9 m -105.65 103.62 13.16 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.828 -0.434 . . . . 0.94999999999999996 109.828 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -141.55 157.98 64.25 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.241 -0.436 . . . . 1.5900000000000001 110.332 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.02 141.36 79.27 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.495 2.13 . . . . 0.65000000000000002 111.411 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.827 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 6.4 m -131.75 131.49 62.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.379 0.609 . . . . 0.56999999999999995 111.56 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 36.6 tp -101.72 123.85 46.39 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.669 -0.696 . . . . 1.1699999999999999 109.527 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ILE . . . . . 0.422 HG12 HG12 ' B' ' 42' ' ' VAL . 34.4 mt -78.89 138.16 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.58 -0.282 . . . . 0.66000000000000003 110.362 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' B' ' 1' ' ' MET . 21.5 t -99.54 -34.92 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.406 -0.361 . . . . 0.93000000000000005 110.945 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' THR . . . . . 0.497 HG22 ' HB ' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -76.53 140.96 68.78 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.215 -0.448 . . . . 0.81000000000000005 111.634 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.757 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 95.9 Cg_endo -78.76 159.83 27.93 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.767 2.311 . . . . 0.78000000000000003 112.009 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' B' ' 34' ' ' ASN . . . -55.18 -29.7 58.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.212 -0.449 . . . . 1.03 111.954 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.38 -40.73 75.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.292 -0.413 . . . . 1.3999999999999999 110.871 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -89.33 -37.76 14.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.058 -0.519 . . . . 1.5700000000000001 110.63 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.561 ' O ' ' HA ' ' B' ' 38' ' ' ARG . 85.5 m-20 -61.69 -18.22 58.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.704 -0.68 . . . . 1.6399999999999999 112.302 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -88.13 -25.88 22.76 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.694 0.257 . . . . 2.54 111.694 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -82.02 -61.84 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.963 0.411 . . . . 1.0900000000000001 111.645 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.79 -28.21 36.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.186 -0.461 . . . . 1.3300000000000001 111.201 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 1.5 mmp_? 69.9 8.23 6.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.809 -0.632 . . . . 1.78 111.819 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.64 98.06 48.28 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.968 -0.56 . . . . 1.1599999999999999 109.537 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' B' ' 80' ' ' ILE . 85.0 Cg_endo -90.62 155.23 4.28 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.789 2.326 . . . . 0.56999999999999995 113.112 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 m -94.74 124.93 47.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.105 -0.702 . . . . 1.0800000000000001 109.105 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.827 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 28.6 m -111.2 147.19 15.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 112.802 0.667 . . . . 0.64000000000000001 112.802 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.41 118.29 49.38 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 114.752 -1.113 . . . . 1.1000000000000001 108.757 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.609 ' HG3' ' HG3' ' B' ' 19' ' ' GLN . 66.1 Cg_endo -74.14 142.45 30.8 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.628 2.219 . . . . 0.72999999999999998 113.041 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.773 HG22 HG12 ' B' ' 72' ' ' VAL . 44.0 t -95.62 116.72 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.798 -0.637 . . . . 0.90000000000000002 109.809 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.88 145.0 26.87 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.193 -0.458 . . . . 1.1699999999999999 110.79 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 8.5 m -95.61 102.22 14.0 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.73 0.3 . . . . 1.8500000000000001 110.745 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.3 68.25 3.34 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.129 -0.558 . . . . 2.2200000000000002 112.199 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.7 -112.54 3.58 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 121.081 -0.58 . . . . 3.4300000000000002 111.662 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -126.8 -51.49 1.46 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.066 0.46 . . . . 4.6200000000000001 110.58 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -97.29 100.89 12.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.127 -0.488 . . . . 6.2699999999999996 109.909 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.5 ' HB1' HG13 ' B' ' 71' ' ' VAL . . . -73.14 133.89 44.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.72 -0.673 . . . . 4.3899999999999997 111.395 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.21 161.29 27.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.137 -0.483 . . . . 3.9199999999999999 110.171 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.72 120.46 19.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.055 0.455 . . . . 2.75 111.44 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.706 ' HB3' ' HB3' ' B' ' 58' ' ' ALA . . . -108.76 -161.1 0.75 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.947 -0.57 . . . . 1.96 110.53 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.39 -61.33 5.48 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.253 -0.498 . . . . 1.0800000000000001 112.54 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.544 ' HE1' ' HB ' ' B' ' 107' ' ' THR . 70.4 m-85 -114.65 0.38 13.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.283 0.563 . . . . 3.5699999999999998 110.54 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.706 ' HB3' ' HB3' ' B' ' 55' ' ' ALA . . . -100.16 106.23 17.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.614 -0.721 . . . . 1.0800000000000001 110.573 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.652 HG21 ' HA ' ' B' ' 101' ' ' VAL . 57.0 t -87.92 129.31 39.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.675 -0.693 . . . . 1.3400000000000001 109.895 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.4 t -85.08 138.21 32.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.224 -0.444 . . . . 1.3799999999999999 111.467 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 37.8 mt -106.11 5.81 30.47 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.719 -0.845 . . . . 1.02 108.719 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -101.19 144.48 30.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.239 -0.891 . . . . 1.79 110.864 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.14 -23.33 11.5 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 116.102 -0.499 . . . . 1.1499999999999999 111.96 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.624 HG13 HG13 ' B' ' 66' ' ' ILE . 4.2 p -100.14 -20.52 5.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.173 0.511 . . . . 1.1699999999999999 111.54 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.96 51.62 0.88 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.601 -0.809 . . . . 1.05 112.708 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.624 HG13 HG13 ' B' ' 64' ' ' VAL . 82.6 mt -109.13 147.42 13.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.446 -0.575 . . . . 1.6100000000000001 109.446 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -65.53 -49.53 68.61 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.869 0.366 . . . . 2.3999999999999999 110.133 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 17.8 m -67.89 101.8 1.15 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.915 -0.584 . . . . 0.93000000000000005 109.866 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.17 113.97 25.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.138 -0.483 . . . . 1.3100000000000001 111.253 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.98 -170.25 39.18 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.439 -0.886 . . . . 0.79000000000000004 112.681 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.623 ' HB ' ' HB1' ' B' ' 58' ' ' ALA . 6.0 m -123.86 133.97 67.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.972 -0.381 . . . . 0.93000000000000005 109.972 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.773 HG12 HG22 ' B' ' 45' ' ' VAL . 19.3 m -82.34 138.11 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.464 -0.334 . . . . 1.3799999999999999 111.445 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 mmm-85 -94.82 85.09 4.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.376 -0.374 . . . . 1.3700000000000001 110.101 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' CYS . . . . . 0.411 ' HB3' HD23 ' B' ' 105' ' ' LEU . 3.4 m -67.85 -9.21 42.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 1.1599999999999999 111.617 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -92.24 -1.86 56.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.471 . . . . 1.1000000000000001 111.833 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -128.27 83.24 66.71 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 112.02 0.378 . . . . 2.4700000000000002 112.02 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -92.01 144.87 2.92 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.01 2.473 . . . . 0.95999999999999996 112.181 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -148.42 131.46 16.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.453 -0.34 . . . . 1.96 111.01 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.07 126.52 34.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.549 . . . . 1.1899999999999999 109.567 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.532 ' O ' ' HD2' ' B' ' 40' ' ' PRO . 23.9 pt -140.47 151.33 20.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 1.28 111.315 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.522 ' CG ' ' HZ1' ' B' ' 83' ' ' LYS . 10.3 t70 -80.67 100.43 8.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 1.28 109.852 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' MET . . . . . 0.683 ' SD ' ' HA3' ' B' ' 87' ' ' GLY . 48.5 tpp -66.62 -16.77 64.43 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.674 0.62 . . . . 2.7000000000000002 112.674 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.522 ' HZ1' ' CG ' ' B' ' 81' ' ' ASP . 6.6 mtmp? -80.29 -54.34 5.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.931 0.396 . . . . 1.96 110.887 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.65 -28.16 67.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.125 -0.489 . . . . 1.0600000000000001 111.34 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -85.44 -11.39 54.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.295 -0.411 . . . . 1.47 111.501 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.96 57.49 18.47 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 121.096 -0.573 . . . . 0.81999999999999995 112.754 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' GLY . . . . . 0.683 ' HA3' ' SD ' ' B' ' 82' ' ' MET . . . -66.24 148.86 51.15 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.934 -0.65 . . . . 0.65000000000000002 112.793 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' B' ' 8' ' ' LEU . 0.1 OUTLIER -127.11 164.45 21.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.49 -0.189 . . . . 1.8100000000000001 110.49 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -105.23 137.22 43.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.771 0.319 . . . . 2.4900000000000002 110.399 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 23.5 mt -98.55 -69.26 0.77 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.233 -0.439 . . . . 0.76000000000000001 111.908 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLU . . . . . 0.441 ' HG3' HD12 ' B' ' 6' ' ' ILE . 16.4 pt-20 -154.02 -171.13 3.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.069 -0.514 . . . . 1.0700000000000001 110.705 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' B' ' 4' ' ' GLY . 10.6 ttt180 -128.03 119.92 26.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.032 0.444 . . . . 2.0499999999999998 111.262 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 2.6 p -84.58 135.06 41.2 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.687 -0.688 . . . . 1.45 109.637 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.45 145.78 27.48 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.954 2.436 . . . . 1.03 113.097 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' B' ' 95' ' ' GLU . 1.2 mm-40 -56.76 -29.15 62.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.757 -0.656 . . . . 2.1400000000000001 111.517 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -39.14 77.53 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.326 -0.397 . . . . 1.78 111.362 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 31.5 mm -79.26 -29.8 13.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.276 0.56 . . . . 1.3300000000000001 109.516 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 11.2 mmt -62.89 -32.31 73.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.59 -0.732 . . . . 2.3399999999999999 110.566 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.15 -41.85 93.64 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.922 -0.581 . . . . 1.9099999999999999 110.253 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 9.9 tp10 -62.57 -45.04 94.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.814 -0.63 . . . . 1.76 110.024 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.652 ' HA ' HG21 ' B' ' 59' ' ' VAL . 38.4 t -62.66 -49.86 82.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.649 -0.705 . . . . 1.01 111.05 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 86.7 mt -55.85 -38.57 70.25 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.343 -0.389 . . . . 1.29 111.512 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.58 -44.78 97.05 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.655 -0.783 . . . . 1.02 111.34 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 8.8 mmt180 -68.34 -33.36 74.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.059 0.456 . . . . 1.8500000000000001 110.472 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.455 ' O ' HG12 ' B' ' 108' ' ' ILE . 78.7 mt -64.35 -24.87 67.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.882 -0.599 . . . . 1.9399999999999999 110.854 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 23.2 m -85.17 -24.16 28.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.152 -0.476 . . . . 1.1599999999999999 110.882 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.544 ' HB ' ' HE1' ' B' ' 57' ' ' PHE . 0.5 OUTLIER -73.35 -28.57 62.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.259 -0.428 . . . . 1.45 112.068 -179.149 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.455 HG12 ' O ' ' B' ' 105' ' ' LEU . 40.7 pt -68.5 -19.67 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.548 0.573 . . . . 1.98 112.548 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.31 59.45 5.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.271 0.558 . . . . 1.3600000000000001 111.457 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-N 115.954 -0.566 . . . . 2.1299999999999999 109.699 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 1' ' ' ' A' . . . . . 0.51 H5'' ' HB2' ' B' ' 38' ' ' ARG . . . . . . . . 0 O5'--C5' 1.429 -0.69 0 C3'-C2'-O2' 111.166 -0.736 . 0.0 '__' . 6.3600000000000003 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.422 -1.139 0 C3'-C2'-C1' 100.57 -1.034 . 0.032 2o . 2.9900000000000002 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 3' ' ' ' A' . . . . . 0.709 " H2'" ' N3 ' ' C' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.977 0 C3'-C2'-O2' 110.849 -0.845 . 0.0 OUTLIER gamma 2.5899999999999999 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.423 -1.032 0 O4'-C1'-C2' 107.972 1.123 . 0.0 OUTLIER . 2.5099999999999998 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' ' A' . . . . . 0.805 " H2'" ' HA2' ' A' ' 21' ' ' GLY . . . . . . . . 0 O3'--C3' 1.432 0.625 0 C4'-C3'-O3' 114.039 1.323 . 0.0 OUTLIER . 4.9400000000000004 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.415 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 23.3 ptp . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.925 0.393 . . . . 1.29 110.532 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -116.78 172.11 7.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.226 -0.443 . . . . 2.0099999999999998 111.077 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -73.19 131.06 41.54 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.196 -0.456 . . . . 1.8500000000000001 111.031 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.67 1.22 58.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.878 -0.677 . . . . 0.85999999999999999 113.116 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.419 ' OE2' ' HD2' ' A' ' 89' ' ' ARG . 35.9 mt-10 -84.61 146.86 27.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 0.98999999999999999 111.255 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.74 HD12 ' HG3' ' A' ' 91' ' ' GLU . 21.2 mt -106.52 118.91 55.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.862 -0.608 . . . . 1.1599999999999999 110.265 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -118.05 128.65 54.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.91000000000000003 111.124 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.669 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 19.9 tp -80.07 130.03 34.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.366 -0.379 . . . . 0.90000000000000002 110.621 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.444 HG11 HD11 ' A' ' 80' ' ' ILE . 9.0 p -158.28 165.17 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.415 -0.357 . . . . 1.04 110.389 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 m -104.95 139.86 39.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.848 0.356 . . . . 1.3200000000000001 110.898 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.675 HD23 HD13 ' A' ' 80' ' ' ILE . 25.3 mt -98.43 -9.17 25.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.003 0.43 . . . . 1.29 110.58 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.497 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 2.7 m-20 -78.1 165.55 49.7 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.533 -0.758 . . . . 1.54 110.672 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.497 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 73.2 Cg_endo -73.95 139.25 60.46 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.83 -1.321 . . . . 1.6899999999999999 113.073 0.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.684 ' OG1' ' HB3' ' A' ' 20' ' ' GLN . 21.5 p -111.27 157.1 20.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.502 -0.772 . . . . 1.3600000000000001 110.175 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -136.3 148.93 48.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.34 . . . . 1.7 111.075 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.88 -86.62 1.07 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.94 -0.648 . . . . 1.1799999999999999 112.176 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -160.44 45.13 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.158 0.504 . . . . 2.7799999999999998 111.258 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.677 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 29.8 mt-10 -79.43 176.63 9.52 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.737 -0.468 . . . . 1.1399999999999999 109.737 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -78.94 90.35 4.75 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.434 -0.58 . . . . 2.0899999999999999 109.434 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.684 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 1.4 pt20 -89.94 158.63 17.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.783 -0.644 . . . . 2.0899999999999999 112.059 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.9 127.72 6.18 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.684 -0.689 . . . . 1.0700000000000001 112.805 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.9 m -63.14 129.92 42.37 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.77 0.319 . . . . 1.1100000000000001 110.336 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.43 155.49 29.86 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.175 -0.466 . . . . 1.6200000000000001 110.283 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 11.7 Cg_exo -72.53 131.6 17.69 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.314 2.009 . . . . 1.01 110.824 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.655 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 20.9 m -107.38 154.12 8.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.439 -0.346 . . . . 0.76000000000000001 110.288 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.48 HD23 HG21 ' A' ' 101' ' ' VAL . 29.7 tp -100.87 133.03 45.96 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.372 -0.377 . . . . 0.69999999999999996 111.061 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.9 mm -76.51 108.96 10.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.92000000000000004 110.117 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.42 -39.59 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.94999999999999996 112.039 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.35 146.76 81.74 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 112.142 0.423 . . . . 1.1200000000000001 112.142 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 33' ' ' PHE . 41.8 Cg_endo -68.28 158.08 59.08 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.795 2.33 . . . . 1.3 112.107 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.9 -39.7 74.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.932 -0.577 . . . . 1.3899999999999999 112.065 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.73 -42.1 83.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 1.6100000000000001 111.385 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.429 ' HB2' ' HG2' ' A' ' 30' ' ' PRO . 5.9 t80 -70.39 -46.51 63.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.945 -0.57 . . . . 1.77 110.402 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -61.9 -30.31 70.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 1.48 111.197 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -68.39 -44.96 73.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.277 -0.419 . . . . 2.6200000000000001 112.101 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -86.72 -40.97 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 113.907 1.077 . . . . 1.8600000000000001 113.907 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.8 m -84.78 -33.3 23.03 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.767 0.284 . . . . 1.72 111.767 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 65.46 20.42 11.73 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.058 0.456 . . . . 4.4500000000000002 111.673 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.1 mt -134.01 91.78 23.43 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.668 -0.697 . . . . 1.8100000000000001 109.181 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -84.41 135.43 6.12 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.516 2.144 . . . . 1.05 113.339 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -79.17 124.8 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.922 -1.14 . . . . 1.03 107.922 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.655 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 23.4 m -124.33 153.74 31.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.627 0.602 . . . . 0.77000000000000002 112.627 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.42 140.74 27.74 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.352 -0.84 . . . . 0.71999999999999997 109.695 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.27 147.65 16.29 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.801 2.334 . . . . 1.03 113.897 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.604 HG22 HG22 ' A' ' 72' ' ' VAL . 84.0 t -103.76 119.74 52.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.485 -0.779 . . . . 1.28 109.269 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.319 -0.76 0 N-CA-C 109.506 -0.553 . . . . 1.9099999999999999 109.506 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 111.939 -0.464 . . . . 1.6599999999999999 111.939 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -87.94 -9.65 52.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.235 0.54 . . . . 1.5600000000000001 110.28 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.433 ' HB1' ' CG1' ' A' ' 71' ' ' VAL . . . -91.86 134.21 34.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.466 -0.788 . . . . 1.25 108.981 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 13.2 m -94.97 165.68 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.062 0.458 . . . . 1.6799999999999999 111.912 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.1 m -71.97 143.25 49.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.842 -0.617 . . . . 1.95 111.041 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.688 HD11 HG23 ' A' ' 72' ' ' VAL . 4.9 mt -136.49 -52.92 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.135 0.42 . . . . 1.23 112.135 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -66.22 116.07 6.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.129 0.49 . . . . 2.21 111.788 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.59 -27.86 0.85 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.633 -0.712 . . . . 1.1499999999999999 111.848 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.408 HG23 HG23 ' A' ' 66' ' ' ILE . 25.5 m -89.56 -10.48 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.36 0.504 . . . . 1.21 112.36 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.72 73.02 1.06 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.802 -0.713 . . . . 1.0800000000000001 112.606 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.408 HG23 HG23 ' A' ' 64' ' ' VAL . 6.9 pt -116.63 172.3 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.804 0.335 . . . . 1.0700000000000001 111.011 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.0 ttm-85 -92.68 -28.35 16.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.226 0.536 . . . . 3.5899999999999999 109.922 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.8 m -77.22 109.55 11.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.651 -0.704 . . . . 1.51 111.068 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 m -93.45 110.69 22.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.231 0.539 . . . . 1.79 110.898 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 171.18 -169.02 42.14 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.119 -0.792 . . . . 1.1799999999999999 111.119 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.433 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 4.7 t -129.24 124.87 61.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 110.192 -0.299 . . . . 1.5600000000000001 110.192 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.688 HG23 HD11 ' A' ' 61' ' ' LEU . 78.2 t -73.97 121.12 24.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.692 -0.485 . . . . 1.29 109.692 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -114.94 135.97 53.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.914 0.388 . . . . 2.23 110.721 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.4 ' SG ' HG13 ' A' ' 101' ' ' VAL . 8.1 m -113.89 32.51 5.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.907 -0.588 . . . . 1.1699999999999999 109.697 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.612 ' HB2' ' HZ ' ' B' ' 33' ' ' PHE . 20.1 p-10 -88.97 -49.63 6.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.467 -0.788 . . . . 0.89000000000000001 111.73 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.438 ' HG2' ' OD2' ' A' ' 75' ' ' ASP . 5.8 mm100 -117.3 74.58 8.03 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.7 -0.227 . . . . 2.1299999999999999 111.587 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -96.34 163.6 1.22 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.943 2.429 . . . . 0.80000000000000004 112.495 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' B' ' 78' ' ' ARG . 1.1 ptm180 -170.24 146.11 2.87 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.297 -0.411 . . . . 2.0899999999999999 110.802 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.638 ' HB ' ' HG3' ' B' ' 76' ' ' GLN . 2.4 m -84.68 93.87 8.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.051 0.453 . . . . 1.6200000000000001 109.915 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.675 HD13 HD23 ' A' ' 11' ' ' LEU . 20.5 pt -84.36 -174.19 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.483 0.659 . . . . 1.1499999999999999 112.718 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -89.54 132.06 35.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.047 -0.979 . . . . 1.03 110.554 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 51.8 tpp -127.26 26.39 6.03 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.472 -0.936 . . . . 1.29 108.472 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -112.33 -45.92 3.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.518 -0.765 . . . . 2.6400000000000001 111.093 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.27 -26.09 16.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.179 -0.464 . . . . 1.1200000000000001 111.409 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -80.06 -43.77 21.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.236 -0.438 . . . . 1.0600000000000001 111.626 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.99 127.67 2.05 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.831 -0.7 . . . . 1.1200000000000001 112.759 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -104.05 136.74 13.17 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.849 -0.691 . . . . 1.0900000000000001 112.077 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 6.8 mptt -109.47 117.04 32.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.945 -0.391 . . . . 2.46 109.945 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.419 ' HD2' ' OE2' ' A' ' 5' ' ' GLU . 6.8 ttp85 -74.55 126.27 30.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.751 0.31 . . . . 2.4900000000000002 110.943 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.25 -73.36 0.68 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.073 0.463 . . . . 1.29 110.801 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.74 ' HG3' HD12 ' A' ' 6' ' ' ILE . 19.4 pt-20 -146.57 -164.52 2.0 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.638 -0.71 . . . . 1.1499999999999999 109.522 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 92' ' ' ARG . 3.6 ptm180 -143.18 150.66 39.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.755 0.312 . . . . 1.3200000000000001 110.746 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.669 HG13 HD11 ' A' ' 6' ' ' ILE . 16.0 m -102.5 151.96 38.29 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.217 -0.447 . . . . 0.75 110.465 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -66.16 167.22 18.74 Favored 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 122.636 2.224 . . . . 0.94999999999999996 111.644 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -60.73 -21.4 62.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.977 -0.556 . . . . 1.51 111.537 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -42.24 94.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.928 -0.578 . . . . 1.5700000000000001 110.599 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.7 mm -76.19 -33.88 24.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.841 -0.618 . . . . 1.3100000000000001 110.823 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.4 tpt -59.9 -41.36 91.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 1.6000000000000001 110.99 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -65.64 -35.08 79.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 2.2999999999999998 110.648 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 1.2 mm-40 -60.52 -48.35 82.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.934 -0.576 . . . . 1.6399999999999999 111.295 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.48 HG21 HD23 ' A' ' 26' ' ' LEU . 58.1 t -63.67 -40.78 90.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.952 -0.567 . . . . 1.03 111.226 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.2 mt -68.54 1.05 3.39 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.225 0.824 . . . . 1.22 113.225 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.12 -1.18 26.8 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.121 -1.038 . . . . 1.03 112.945 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -104.82 -20.56 13.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.9 0.381 . . . . 1.72 111.771 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.5 mt -73.73 -24.82 59.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.001 0.429 . . . . 1.02 111.707 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -28.86 62.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.839 0.352 . . . . 1.1100000000000001 111.544 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.85 -17.28 61.08 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.055 0.761 . . . . 1.5 113.055 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.1 pt -93.51 -13.62 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 111.978 0.362 . . . . 1.1499999999999999 111.978 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.2 mt -86.39 86.8 7.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.928 0.394 . . . . 0.97999999999999998 110.939 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' B' ' 30' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 116.367 -0.379 . . . . 1.3500000000000001 111.037 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.602 ' HG3' ' O ' ' B' ' 27' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.366 0.603 . . . . 2.0299999999999998 112.577 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' B' ' 31' ' ' ALA . 30.4 mt-10 -95.62 -7.47 37.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.431 -0.804 . . . . 2.8199999999999998 109.608 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? 73.42 120.71 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.22 1.193 . . . . 2.3199999999999998 114.22 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . 0.472 ' HA2' HG12 ' B' ' 93' ' ' VAL . . . 72.51 43.54 44.38 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 115.008 0.763 . . . . 1.28 115.008 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -117.55 93.74 4.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.26 0.53 . . . . 1.53 112.377 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.787 HD11 ' HB ' ' B' ' 93' ' ' VAL . 57.2 mt -100.05 102.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.442 -0.947 . . . . 0.75 108.442 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.459 ' HA ' ' HA ' ' B' ' 89' ' ' ARG . 13.8 m95 -105.79 145.84 30.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.272 0.558 . . . . 0.81000000000000005 112.4 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 22.9 tp -102.77 119.73 39.35 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.471 -0.937 . . . . 1.05 108.471 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.93 159.29 4.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.865 0.364 . . . . 0.71999999999999997 110.788 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.68 121.22 25.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.155 -0.475 . . . . 1.6299999999999999 110.519 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.493 HD21 HG11 ' B' ' 25' ' ' VAL . 88.5 mt -79.69 -20.62 46.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.147 -0.479 . . . . 0.82999999999999996 110.728 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.07 153.89 90.9 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.639 . . . . 1.6200000000000001 110.574 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -88.98 162.26 39.68 Favored 'Cis proline' 0 C--O 1.236 0.394 0 C-N-CA 123.438 -1.484 . . . . 1.28 112.053 -0.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.507 HG21 ' HB3' ' B' ' 18' ' ' GLU . 0.2 OUTLIER -150.24 160.73 43.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 1.47 110.587 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.29 142.97 37.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.783 0.325 . . . . 1.22 110.61 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.24 -155.62 34.66 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.949 -0.643 . . . . 1.01 112.433 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -85.53 50.43 1.96 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.197 0.443 . . . . 2.1800000000000002 112.197 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.507 ' HB3' HG21 ' B' ' 14' ' ' THR . 4.0 mt-10 -112.76 163.71 14.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.19 -0.459 . . . . 1.28 109.847 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.844 ' HG3' ' HG3' ' B' ' 44' ' ' PRO . 86.7 mm-40 -73.17 138.28 45.6 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.164 0.802 . . . . 1.52 113.164 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -146.65 -179.73 6.98 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.58 -0.736 . . . . 1.8600000000000001 110.419 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.24 150.88 21.57 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.125 -0.56 . . . . 0.90000000000000002 112.549 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 45.2 m -86.34 106.04 17.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.953 0.406 . . . . 0.94999999999999996 109.925 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' B' ' 23' ' ' ARG . 0.3 OUTLIER -149.65 159.95 35.11 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.159 -0.473 . . . . 1.5900000000000001 109.759 -178.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.72 139.8 82.59 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.347 2.031 . . . . 0.65000000000000002 111.21 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.639 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 3.3 m -137.12 152.33 27.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.39 -0.368 . . . . 0.56999999999999995 110.509 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.618 HD23 HG11 ' B' ' 101' ' ' VAL . 22.9 tp -103.05 121.66 43.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.113 -0.494 . . . . 1.1699999999999999 109.722 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . 0.602 ' O ' ' HG3' ' B' ' 1' ' ' MET . 10.5 mt -74.31 148.63 8.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.432 -0.349 . . . . 0.66000000000000003 110.703 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.524 ' HB ' HG23 ' B' ' 41' ' ' VAL . 21.9 t -114.78 -34.18 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.014 0.435 . . . . 0.93000000000000005 110.988 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.29 138.43 91.85 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.059 -0.519 . . . . 0.81000000000000005 112.208 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.525 ' HB3' ' HB ' ' A' ' 110' ' ' THR . 83.5 Cg_endo -77.41 170.27 19.69 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.888 2.392 . . . . 0.78000000000000003 112.638 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.593 ' HB2' ' HG2' ' B' ' 2' ' ' GLU . . . -62.79 -30.31 71.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.852 -0.613 . . . . 1.03 110.61 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.03 -0.75 8.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.665 -0.698 . . . . 1.3999999999999999 112.3 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . 0.612 ' HZ ' ' HB2' ' A' ' 75' ' ' ASP . 7.5 t80 -135.14 -40.53 0.74 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.952 0.406 . . . . 1.5700000000000001 111.0 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -59.54 -33.05 70.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.834 -0.621 . . . . 1.6399999999999999 111.471 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -97.41 11.69 35.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.365 -0.379 . . . . 2.54 110.993 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 97.7 t -110.57 -67.03 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 1.0900000000000001 111.493 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 14.5 p -84.07 -22.83 31.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.764 0.316 . . . . 1.3300000000000001 110.979 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.44 ' HE ' ' HA ' ' B' ' 38' ' ' ARG . 1.2 mmp_? 70.35 12.87 7.57 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.596 -0.729 . . . . 1.78 111.689 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 17.1 mt -119.7 90.18 42.78 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.401 -0.962 . . . . 1.1599999999999999 108.401 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -92.45 161.78 2.98 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.737 2.291 . . . . 0.56999999999999995 114.134 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.555 HG13 HG23 ' B' ' 79' ' ' THR . 0.8 OUTLIER -98.88 130.75 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.173 -1.047 . . . . 1.0800000000000001 108.173 177.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.639 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 23.5 m -120.76 145.48 27.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 112.68 0.622 . . . . 0.64000000000000001 112.68 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 53.5 t -97.73 118.53 63.97 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.874 -1.057 . . . . 1.1000000000000001 108.451 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.844 ' HG3' ' HG3' ' B' ' 19' ' ' GLN . 50.3 Cg_endo -67.67 124.27 11.75 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.861 2.374 . . . . 0.72999999999999998 113.259 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.619 HG22 HG12 ' B' ' 72' ' ' VAL . 46.1 t -87.31 139.79 16.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.161 -0.681 . . . . 0.90000000000000002 109.161 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -120.95 116.09 24.44 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.561 -0.533 . . . . 1.1699999999999999 109.561 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 C--O 1.237 0.407 0 CA-C-N 115.934 -0.576 . . . . 1.8500000000000001 112.168 -179.587 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.227 0 CA-C-O 120.739 0.304 . . . . 1.96 111.074 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.501 ' O ' ' HD2' ' B' ' 104' ' ' ARG . . . 62.79 -110.23 3.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.136 -0.554 . . . . 1.0800000000000001 112.534 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -93.46 -14.38 26.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.976 0.417 . . . . 3.5699999999999998 110.788 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.55 110.08 10.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 1.0800000000000001 110.864 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.707 HG21 ' HA ' ' B' ' 101' ' ' VAL . 85.7 t -87.97 131.48 35.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.941 -0.572 . . . . 1.3400000000000001 109.501 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 9.3 t -88.3 119.05 28.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.409 -0.359 . . . . 1.3799999999999999 111.131 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 60.3 mt -87.9 -18.11 29.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.723 -0.843 . . . . 1.02 108.723 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -86.46 142.92 28.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.201 -0.909 . . . . 1.79 110.469 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.9 -55.12 0.76 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 121.034 -0.603 . . . . 1.1499999999999999 111.68 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 13.9 p -73.9 -27.61 22.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.949 0.404 . . . . 1.1699999999999999 111.638 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.66 68.94 0.33 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.871 -0.681 . . . . 1.05 111.977 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.457 HD11 ' HD2' ' B' ' 94' ' ' PRO . 61.0 mt -125.42 148.27 29.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.087 -0.709 . . . . 1.6100000000000001 109.087 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' B' ' 67' ' ' ARG . 1.0 OUTLIER -66.32 -50.41 63.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.958 0.409 . . . . 2.3999999999999999 109.963 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 7.2 m -67.77 94.75 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.851 -0.613 . . . . 0.93000000000000005 110.501 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 4.5 m -87.15 90.71 8.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.924 -0.58 . . . . 1.3100000000000001 110.82 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.81 -170.01 35.29 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.376 -0.916 . . . . 0.79000000000000004 112.383 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' B' ' 59' ' ' VAL . 15.6 m -123.12 145.33 30.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.791 0.329 . . . . 0.93000000000000005 110.667 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.619 HG12 HG22 ' B' ' 45' ' ' VAL . 1.3 m -91.43 136.32 24.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.821 0.343 . . . . 1.3799999999999999 111.198 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.646 ' HB2' ' HG2' ' B' ' 44' ' ' PRO . 11.9 mmm180 -86.32 82.73 7.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 1.3700000000000001 110.611 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 2.5 m -79.81 45.93 0.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.017 0.436 . . . . 1.1599999999999999 110.838 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -135.6 -32.91 0.89 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.927 -0.578 . . . . 1.1000000000000001 110.949 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' GLN . . . . . 0.638 ' HG3' ' HB ' ' A' ' 79' ' ' THR . 61.7 tt0 -125.69 79.47 67.85 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 112.455 0.539 . . . . 2.4700000000000002 112.455 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.438 ' HD2' ' OG1' ' A' ' 79' ' ' THR . 99.0 Cg_endo -89.16 143.47 4.76 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.555 2.17 . . . . 0.95999999999999996 110.647 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . 0.489 ' HA ' ' HB2' ' A' ' 78' ' ' ARG . 54.5 ttt180 -124.53 141.48 52.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.801 0.334 . . . . 1.96 111.765 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.555 HG23 HG13 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -82.75 121.23 26.62 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.482 -0.932 . . . . 1.1899999999999999 108.482 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 15.9 pt -126.96 -164.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.045 0.45 . . . . 1.28 111.41 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -115.7 143.87 44.75 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.903 -0.777 . . . . 1.28 108.903 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 11.6 ttp -126.32 31.71 5.34 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.734 0.272 . . . . 2.7000000000000002 111.734 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -137.65 -42.5 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.181 0.437 . . . . 1.96 112.181 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.21 -29.63 15.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.816 0.341 . . . . 1.0600000000000001 110.246 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -72.65 -35.73 67.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 1.47 110.628 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.22 106.74 0.99 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.922 -0.656 . . . . 0.81999999999999995 112.757 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.18 159.91 21.89 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.68 -0.772 . . . . 0.65000000000000002 112.084 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -151.59 136.12 16.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.026 -0.361 . . . . 1.8100000000000001 110.026 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' B' ' 7' ' ' TRP . 59.8 ttp180 -76.93 126.13 30.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.652 0.263 . . . . 2.4900000000000002 110.583 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 80.1 mt -82.4 -64.17 1.23 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.242 -0.435 . . . . 0.76000000000000001 110.868 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -139.85 174.17 10.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 1.0700000000000001 110.311 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -112.34 115.11 28.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.234 0.54 . . . . 2.0499999999999998 110.903 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.787 ' HB ' HD11 ' B' ' 6' ' ' ILE . 7.2 p -70.33 133.07 87.48 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.465 -0.789 . . . . 1.45 110.801 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.457 ' HD2' HD11 ' B' ' 66' ' ' ILE . 77.2 Cg_exo -53.66 147.56 39.31 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 122.94 2.427 . . . . 1.03 111.999 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.02 -33.37 67.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.996 -0.547 . . . . 2.1400000000000001 111.021 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.61 -48.97 79.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.862 -0.608 . . . . 1.78 110.799 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 21.2 mm -72.05 -34.48 50.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.771 -0.65 . . . . 1.3300000000000001 110.48 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 11.8 tpt -59.64 -38.63 81.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 2.3399999999999999 110.477 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -65.77 -35.83 81.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.889 -0.596 . . . . 1.9099999999999999 110.853 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 57.1 tt0 -63.55 -46.59 85.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 1.76 109.965 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.707 ' HA ' HG21 ' B' ' 59' ' ' VAL . 24.5 t -58.74 -48.68 85.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.116 -0.493 . . . . 1.01 110.915 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.95 -35.49 76.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.99 -0.55 . . . . 1.29 111.243 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.74 -36.43 92.27 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.259 -0.736 . . . . 1.02 111.259 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 23.9 mmt85 -73.45 -34.07 65.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.04 0.448 . . . . 1.8500000000000001 110.258 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.535 ' O ' HG12 ' B' ' 108' ' ' ILE . 78.7 mt -71.03 -11.41 60.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.893 -0.594 . . . . 1.9399999999999999 111.335 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.7 m -77.71 -8.57 58.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.88 0.371 . . . . 1.1599999999999999 111.488 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.3 m -74.22 -16.17 60.98 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.898 0.333 . . . . 1.45 111.898 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.535 HG12 ' O ' ' B' ' 105' ' ' LEU . 31.5 pt -79.69 -1.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 111.885 0.328 . . . . 1.98 111.885 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 88.8 mt -102.05 15.99 27.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.246 0.546 . . . . 1.3600000000000001 110.6 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.252 1.188 0 CA-C-N 115.769 -0.65 . . . . 2.1299999999999999 110.061 179.691 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 ptp . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.857 0.361 . . . . 1.29 110.481 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -107.66 167.0 10.27 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.103 -0.499 . . . . 2.0099999999999998 111.095 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -74.03 131.58 41.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.842 -0.617 . . . . 1.8500000000000001 109.718 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.15 -1.54 43.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 0.85999999999999999 112.986 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -93.42 149.8 20.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.95 0.375 . . . . 0.98999999999999999 110.695 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.7 pt -113.07 112.82 42.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.352 0.596 . . . . 1.1599999999999999 110.402 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.48 ' O ' HG22 ' A' ' 25' ' ' VAL . 27.8 m95 -105.48 118.23 36.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.696 -0.683 . . . . 0.91000000000000003 110.779 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 15.8 tp -67.02 117.76 9.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.36 -0.382 . . . . 0.90000000000000002 110.332 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.2 p -156.84 157.14 3.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.939 0.399 . . . . 1.04 111.073 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 1.1 t -92.43 124.17 36.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.659 -0.497 . . . . 1.3200000000000001 109.659 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 mt -76.51 -12.55 60.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.772 -0.649 . . . . 1.29 110.533 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 6.9 m-20 -74.28 164.24 62.63 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.202 -0.908 . . . . 1.54 111.314 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.56 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 39.1 Cg_exo -62.92 145.77 54.13 Favored 'Cis proline' 0 C--N 1.353 0.776 0 C-N-CA 124.337 -1.11 . . . . 1.6899999999999999 112.82 0.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.651 HG21 ' HB3' ' A' ' 20' ' ' GLN . 10.3 p -120.72 162.57 19.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.142 -0.481 . . . . 1.3600000000000001 111.829 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.41 146.21 31.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.605 -0.725 . . . . 1.7 109.378 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.15 -129.77 32.16 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.656 -0.783 . . . . 1.1799999999999999 111.998 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -107.61 14.35 25.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.773 0.32 . . . . 2.7799999999999998 111.236 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HB3' ' NH2' ' A' ' 78' ' ' ARG . 37.2 mt-10 -61.6 128.93 38.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.881 -0.414 . . . . 1.1399999999999999 109.881 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -49.09 125.77 11.27 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.052 -0.522 . . . . 2.0899999999999999 112.217 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.651 ' HB3' HG21 ' A' ' 14' ' ' THR . 4.4 pt20 -123.12 176.56 5.99 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.458 -0.792 . . . . 2.0899999999999999 111.486 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.15 140.27 8.9 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.705 -0.759 . . . . 1.0700000000000001 114.116 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 4.1 m -81.8 89.44 6.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.035 -1.098 . . . . 1.1100000000000001 108.035 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.416 HH21 ' HA ' ' A' ' 46' ' ' THR . 0.9 OUTLIER -135.26 160.42 68.15 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.822 -0.626 . . . . 1.6200000000000001 110.419 -177.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 22.4 Cg_exo -65.87 125.33 14.05 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.233 1.955 . . . . 1.01 111.387 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.755 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 22.8 m -101.42 132.03 48.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.088 -0.506 . . . . 0.76000000000000001 110.525 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.619 ' HB3' HG23 ' A' ' 43' ' ' VAL . 46.1 tp -81.98 121.24 26.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.928 -0.578 . . . . 0.69999999999999996 110.879 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.657 ' HA ' HG12 ' A' ' 42' ' ' VAL . 12.3 mm -70.55 110.04 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.256 -0.429 . . . . 0.92000000000000004 110.438 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.599 HG22 ' HE1' ' A' ' 98' ' ' MET . 38.5 t -89.16 -34.52 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.98 0.419 . . . . 0.94999999999999996 111.166 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.09 146.25 84.5 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.244 -0.434 . . . . 1.1200000000000001 111.57 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.763 ' HG2' ' HB2' ' A' ' 33' ' ' PHE . 32.8 Cg_endo -65.1 158.88 49.54 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.55 2.167 . . . . 1.3 111.812 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.39 -41.52 72.76 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.984 -0.553 . . . . 1.3899999999999999 112.333 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.49 97.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.297 -0.41 . . . . 1.6100000000000001 111.413 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.763 ' HB2' ' HG2' ' A' ' 30' ' ' PRO . 4.9 t80 -64.86 -43.9 91.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.289 -0.414 . . . . 1.77 110.834 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -59.8 -30.55 68.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.589 . . . . 1.48 110.949 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -86.74 -35.29 19.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.564 -0.744 . . . . 2.6200000000000001 112.426 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 33' ' ' PHE . 12.7 p -83.01 -45.19 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 113.274 0.842 . . . . 1.8600000000000001 113.274 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -84.17 -27.16 28.27 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.185 -0.322 . . . . 1.72 111.071 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 64.75 19.64 11.89 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.02 -0.536 . . . . 4.4500000000000002 111.304 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.2 tp -143.75 101.08 5.03 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 108.319 -0.993 . . . . 1.8100000000000001 108.319 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -90.67 150.5 4.18 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.807 2.338 . . . . 1.05 114.183 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 HG23 ' A' ' 79' ' ' THR . 56.7 t -98.96 116.73 42.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 106.704 -1.591 . . . . 1.03 106.704 177.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.755 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 19.9 m -125.46 155.38 34.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 113.386 0.884 . . . . 0.77000000000000002 113.386 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 26' ' ' LEU . 3.8 m -120.3 116.23 32.41 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.069 -0.969 . . . . 0.71999999999999997 109.443 178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.26 136.28 31.28 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.837 2.358 . . . . 1.03 113.301 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 24' ' ' PRO . 93.3 t -64.8 136.63 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.684 -0.689 . . . . 1.28 110.234 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.542 ' OG1' ' HG2' ' A' ' 73' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.661 0 CA-C-N 116.029 -0.532 . . . . 1.9099999999999999 110.806 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 N-CA-C 111.091 -0.804 . . . . 1.6599999999999999 111.091 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.544 ' HD1' ' HB2' ' A' ' 74' ' ' CYS . 46.3 m-85 -82.26 42.44 0.74 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.491 0.662 . . . . 1.5600000000000001 110.187 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -135.33 107.8 7.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.321 -0.854 . . . . 1.25 109.815 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.722 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 22.5 t -97.35 128.17 48.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.141 -0.481 . . . . 1.6799999999999999 110.26 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.64 137.38 38.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.154 -0.475 . . . . 1.95 111.389 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.544 HD13 HD11 ' A' ' 66' ' ' ILE . 74.2 mt -94.56 17.24 13.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.29 0.567 . . . . 1.23 110.903 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -81.5 137.58 35.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.626 -0.716 . . . . 2.21 110.407 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.25 -26.52 11.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.618 -0.801 . . . . 1.1499999999999999 113.066 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.596 HG11 ' HG2' ' A' ' 94' ' ' PRO . 25.8 m -93.17 -24.18 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.106 0.41 . . . . 1.21 112.106 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 68.66 63.37 3.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.795 -0.717 . . . . 1.0800000000000001 113.284 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.544 HD11 HD13 ' A' ' 61' ' ' LEU . 25.3 pt -108.93 -172.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 O-C-N 122.646 -0.326 . . . . 1.0700000000000001 110.569 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.465 ' NH2' ' HB3' ' A' ' 91' ' ' GLU . 57.1 mtm180 -93.2 -39.1 11.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.849 0.357 . . . . 3.5899999999999999 111.432 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 m -64.89 111.7 2.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.302 0.572 . . . . 1.51 111.732 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.28 79.76 2.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.804 -0.634 . . . . 1.79 110.502 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.36 -167.12 14.9 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.783 -0.722 . . . . 1.1799999999999999 112.144 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 t -118.99 139.11 47.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 110.069 -0.345 . . . . 1.5600000000000001 110.069 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.722 ' HB ' ' HB ' ' A' ' 59' ' ' VAL . 23.0 t -79.72 133.14 30.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.775 0.322 . . . . 1.29 111.136 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.549 ' HD2' ' OD1' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -94.81 154.5 17.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.119 -0.491 . . . . 2.23 110.512 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.544 ' HB2' ' HD1' ' A' ' 57' ' ' PHE . 58.8 m -141.0 2.57 1.74 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.955 0.407 . . . . 1.1699999999999999 110.768 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.549 ' OD1' ' HD2' ' A' ' 73' ' ' ARG . 11.2 p-10 -121.77 5.09 9.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.043 -0.526 . . . . 0.89000000000000001 111.163 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -122.03 74.76 38.62 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 112.964 0.727 . . . . 2.1299999999999999 112.964 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.86 119.11 3.53 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.65 2.233 . . . . 0.80000000000000004 109.908 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.495 ' NH2' ' HB3' ' A' ' 18' ' ' GLU . 21.5 mmm180 -117.72 107.24 13.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.068 0.461 . . . . 2.0899999999999999 111.747 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.673 HG23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -94.6 90.27 6.09 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.98 -0.748 . . . . 1.6200000000000001 108.98 178.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.9 pt -125.75 150.5 31.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.25 -0.432 . . . . 1.1499999999999999 111.275 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -75.85 124.4 27.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.854 0.359 . . . . 1.03 110.553 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 52.0 tpp -81.61 -20.77 39.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.706 -0.679 . . . . 1.29 112.062 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -65.67 -32.68 74.38 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.767 0.654 . . . . 2.6400000000000001 112.767 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.86 9.18 40.18 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.115 0.413 . . . . 1.1200000000000001 112.115 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 40.7 mtt-85 -127.86 -44.46 1.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.27 0.47 . . . . 1.0600000000000001 112.27 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.91 97.47 0.32 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.815 -0.707 . . . . 1.1200000000000001 112.38 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 8' ' ' LEU . . . -97.75 150.64 19.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.815 -0.707 . . . . 1.0900000000000001 112.296 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -113.38 113.77 25.68 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.015 -0.365 . . . . 2.46 110.015 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -71.07 118.4 13.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.603 0.24 . . . . 2.4900000000000002 111.324 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 8' ' ' LEU . 2.2 mm? -86.76 -68.56 0.74 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.43 -0.581 . . . . 1.29 109.43 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.465 ' HB3' ' NH2' ' A' ' 67' ' ' ARG . 20.3 pt-20 -151.95 -167.43 2.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.347 -0.842 . . . . 1.1499999999999999 109.433 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.9 ptm85 -132.81 142.87 49.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.788 0.327 . . . . 1.3200000000000001 110.702 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.2 m -91.08 158.76 41.07 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.191 -0.459 . . . . 0.75 110.697 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.596 ' HG2' HG11 ' A' ' 64' ' ' VAL . 46.0 Cg_exo -58.92 147.33 90.0 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.539 2.16 . . . . 0.94999999999999996 111.029 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' A' ' 95' ' ' GLU . 2.9 mm-40 -55.54 -29.32 58.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.057 -0.52 . . . . 1.51 111.945 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.66 -33.3 73.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.909 0.385 . . . . 1.5700000000000001 111.174 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.7 mm -70.67 -41.22 77.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.213 0.53 . . . . 1.3100000000000001 109.759 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.599 ' HE1' HG22 ' A' ' 28' ' ' VAL . 3.6 tpt -66.87 -37.98 85.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.56 -0.745 . . . . 1.6000000000000001 110.259 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -61.73 -34.87 76.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.905 -0.589 . . . . 2.2999999999999998 110.477 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.47 -45.52 90.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.008 -0.542 . . . . 1.6399999999999999 110.787 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 35.2 t -62.48 -44.12 98.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.044 -0.525 . . . . 1.03 110.581 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.98 -38.02 81.35 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.016 -0.538 . . . . 1.22 111.084 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.86 -41.65 98.7 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.846 -0.692 . . . . 1.03 112.072 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 104' ' ' ARG . 8.6 mmt180 -67.84 -32.85 73.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.933 0.397 . . . . 1.72 110.73 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 101' ' ' VAL . 95.4 mt -71.03 -25.57 62.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.98 -0.555 . . . . 1.02 110.844 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -74.67 -28.46 60.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.981 0.42 . . . . 1.1100000000000001 111.276 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.87 -22.22 58.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.382 0.512 . . . . 1.5 112.382 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 pt -89.84 1.83 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.739 0.644 . . . . 1.1499999999999999 112.739 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.3 mt -86.67 80.85 8.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.544 0.211 . . . . 0.97999999999999998 110.959 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 111.86 0.318 . . . . 1.3500000000000001 111.86 -179.879 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.541 ' HE1' ' HB2' ' B' ' 5' ' ' GLU . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 121.006 0.432 . . . . 2.0299999999999998 111.633 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -83.94 -14.59 50.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.816 -0.439 . . . . 2.8199999999999998 109.816 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 71.95 113.72 0.06 Allowed 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.827 1.047 . . . . 2.3199999999999998 113.827 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' B' ' 92' ' ' ARG . . . 95.04 -34.64 4.67 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.726 -0.67 . . . . 1.28 114.71 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.541 ' HB2' ' HE1' ' B' ' 1' ' ' MET . 5.5 mm-40 -61.49 106.24 0.62 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.868 0.692 . . . . 1.53 112.868 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.426 HD12 ' HG3' ' B' ' 91' ' ' GLU . 61.3 mt -98.17 128.37 49.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 109.349 -0.611 . . . . 0.75 109.349 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -111.68 153.66 26.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.085 0.469 . . . . 0.81000000000000005 111.536 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.498 ' HB2' HD11 ' B' ' 90' ' ' LEU . 23.5 tp -113.35 123.57 50.42 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.366 -0.605 . . . . 1.05 109.366 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 p -153.92 156.85 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.54 -0.3 . . . . 0.71999999999999997 110.535 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 6.8 m -89.47 129.29 35.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.497 -0.32 . . . . 1.6299999999999999 110.612 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 78.0 mt -81.13 -18.27 47.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.24 0.543 . . . . 0.82999999999999996 110.308 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . 0.528 ' HA ' ' H ' ' B' ' 14' ' ' THR . 2.1 m-20 -63.25 153.59 81.27 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.215 -0.902 . . . . 1.6200000000000001 110.381 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -93.29 92.1 0.14 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.639 -1.4 . . . . 1.28 112.34 -0.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.528 ' H ' ' HA ' ' B' ' 12' ' ' ASP . 0.0 OUTLIER -79.25 173.82 12.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.182 -0.463 . . . . 1.47 110.144 179.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.75 168.22 23.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.577 0.227 . . . . 1.22 111.114 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.98 -130.25 30.13 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.932 -0.652 . . . . 1.01 112.024 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -90.28 -1.84 57.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.833 0.349 . . . . 2.1800000000000002 110.973 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -67.33 123.63 20.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.071 -0.715 . . . . 1.28 109.071 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -52.3 131.38 32.87 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.168 0.803 . . . . 1.52 113.168 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -113.43 139.01 49.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.579 -0.737 . . . . 1.8600000000000001 109.623 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.32 147.6 8.11 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.835 -0.698 . . . . 0.90000000000000002 112.93 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 26.9 m -76.69 124.47 27.7 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.06 -0.348 . . . . 0.94999999999999996 110.06 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.42 158.71 33.36 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.801 -0.444 . . . . 1.5900000000000001 109.801 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.23 131.55 32.71 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.219 1.946 . . . . 0.65000000000000002 110.267 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.613 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 15.7 m -124.79 142.47 41.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.134 0.492 . . . . 0.56999999999999995 111.45 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 18.7 tp -101.51 126.98 48.4 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.223 -0.658 . . . . 1.1699999999999999 109.223 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . 0.408 ' O ' ' HG3' ' B' ' 1' ' ' MET . 27.7 mt -86.4 144.53 9.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.576 -0.284 . . . . 0.66000000000000003 110.339 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.488 ' HB ' HG23 ' B' ' 41' ' ' VAL . 45.4 t -108.38 -36.09 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.981 0.419 . . . . 0.93000000000000005 110.943 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' THR . . . . . 0.617 HG23 HG22 ' B' ' 41' ' ' VAL . 0.7 OUTLIER -64.64 143.79 98.69 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 0.81000000000000005 112.328 -179.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 22.2 Cg_exo -66.81 159.4 51.64 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.097 2.531 . . . . 0.78000000000000003 111.785 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.59 -37.6 73.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.98 -0.555 . . . . 1.03 111.403 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.65 -48.6 81.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 1.3999999999999999 111.066 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -64.18 -40.3 95.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.046 0.451 . . . . 1.5700000000000001 110.673 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' B' ' 38' ' ' ARG . 77.3 m-20 -67.09 -19.88 65.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.924 -0.58 . . . . 1.6399999999999999 111.257 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -95.32 -33.64 12.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.271 -0.422 . . . . 2.54 111.943 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 99.1 t -82.39 -71.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.612 0.244 . . . . 1.0900000000000001 111.367 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.3 -30.04 66.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.781 0.324 . . . . 1.3300000000000001 110.444 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 2.4 mmp_? 66.96 17.42 10.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.607 -0.724 . . . . 1.78 112.257 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.23 92.85 43.81 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.278 -0.638 . . . . 1.1599999999999999 109.278 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' B' ' 80' ' ' ILE . 83.1 Cg_endo -90.57 147.38 4.13 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.813 2.342 . . . . 0.56999999999999995 113.572 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.617 HG22 HG23 ' B' ' 29' ' ' THR . 5.0 m -93.9 118.02 38.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.488 -0.93 . . . . 1.0800000000000001 108.488 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.613 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 35.7 m -108.83 145.79 15.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 112.597 0.592 . . . . 0.64000000000000001 112.597 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 90.5 t -111.03 115.73 52.52 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.955 -1.02 . . . . 1.1000000000000001 108.851 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.51 ' HA ' HG12 ' B' ' 25' ' ' VAL . 7.4 Cg_exo -72.71 123.17 8.8 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.946 2.43 . . . . 0.72999999999999998 113.287 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.31 138.86 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.824 -0.806 . . . . 0.90000000000000002 108.824 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.79 168.92 9.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.544 -0.298 . . . . 1.1699999999999999 110.727 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.45 -0.341 . . . . 1.8500000000000001 111.227 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 109.893 -0.41 . . . . 1.96 109.893 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.69 -98.25 2.38 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.994 -0.622 . . . . 1.0800000000000001 112.673 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.643 ' HE1' ' HB ' ' B' ' 107' ' ' THR . 75.4 m-85 -120.54 5.25 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.016 0.436 . . . . 3.5699999999999998 111.28 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.61 107.17 18.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.921 -0.581 . . . . 1.0800000000000001 111.203 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 61.0 t -89.81 122.28 40.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.864 -0.607 . . . . 1.3400000000000001 109.796 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -82.56 123.91 29.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.298 -0.41 . . . . 1.3799999999999999 110.829 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 97.2 mt -91.16 -14.13 31.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.2 -0.455 . . . . 1.02 111.328 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . 0.726 ' HB2' HG23 ' B' ' 69' ' ' THR . 10.6 t70 -81.84 142.88 32.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.07 -0.514 . . . . 1.79 111.439 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.51 -19.33 12.88 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.919 -0.658 . . . . 1.1499999999999999 112.672 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -109.62 -12.32 11.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.86 0.362 . . . . 1.1699999999999999 111.703 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.47 60.58 0.78 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.451 -0.88 . . . . 1.05 112.53 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.468 HD11 HG23 ' B' ' 93' ' ' VAL . 78.1 mt -121.12 134.79 63.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.772 -0.455 . . . . 1.6100000000000001 109.772 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -63.16 -39.28 94.21 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.073 0.463 . . . . 2.3999999999999999 109.826 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . 0.414 ' N ' HG22 ' B' ' 66' ' ' ILE . 7.2 m -77.55 73.74 4.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.731 -0.668 . . . . 0.93000000000000005 109.839 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . 0.726 HG23 ' HB2' ' B' ' 62' ' ' ASP . 13.3 m -73.74 105.3 4.98 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.665 -0.698 . . . . 1.3100000000000001 110.758 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -177.45 -161.21 25.51 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.784 -0.722 . . . . 0.79000000000000004 112.118 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 m -124.27 136.33 60.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.962 0.411 . . . . 0.93000000000000005 110.967 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 32.3 t -88.93 122.76 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.863 -0.608 . . . . 1.3799999999999999 110.346 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 21.9 mmm-85 -92.57 81.48 4.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.926 0.393 . . . . 1.3700000000000001 110.336 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.77 1.33 10.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.942 -0.572 . . . . 1.1599999999999999 112.089 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.09 -7.89 59.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.334 -0.394 . . . . 1.1000000000000001 111.463 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -142.53 84.34 11.18 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 113.459 0.911 . . . . 2.4700000000000002 113.459 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.46 132.93 4.42 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.049 2.499 . . . . 0.95999999999999996 110.277 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.48 127.06 45.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.244 0.461 . . . . 1.96 112.244 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.06 123.24 31.14 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.006 -0.739 . . . . 1.1899999999999999 109.006 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.404 ' O ' ' HD2' ' B' ' 40' ' ' PRO . 35.9 pt -134.61 154.11 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.545 0.212 . . . . 1.28 111.269 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.418 ' CG ' ' HZ1' ' B' ' 83' ' ' LYS . 9.5 t70 -71.45 109.59 5.52 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.262 -0.426 . . . . 1.28 110.428 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 51.7 tpp -78.44 -13.07 60.01 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.572 0.582 . . . . 2.7000000000000002 112.572 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.418 ' HZ1' ' CG ' ' B' ' 81' ' ' ASP . 6.5 mtmp? -81.64 -44.06 17.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.96 0.409 . . . . 1.96 111.188 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.66 -23.58 56.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.132 -0.485 . . . . 1.0600000000000001 111.73 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' B' ' 85' ' ' ARG . 55.8 mtt-85 -96.16 -47.96 5.84 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.365 0.505 . . . . 1.47 112.365 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.3 101.05 0.6 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.623 -0.799 . . . . 0.81999999999999995 112.398 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -97.76 142.08 15.94 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.816 -0.707 . . . . 0.65000000000000002 112.291 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -123.33 128.69 50.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.384 -0.228 . . . . 1.8100000000000001 110.384 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.524 ' HD2' ' OE1' ' B' ' 5' ' ' GLU . 3.4 ttp180 -69.56 132.61 46.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.767 0.318 . . . . 2.4900000000000002 111.005 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' B' ' 8' ' ' LEU . 93.7 mt -100.29 -69.52 0.77 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.76000000000000001 111.338 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . 0.426 ' HG3' HD12 ' B' ' 6' ' ' ILE . 18.7 pt-20 -142.4 -176.36 4.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.146 -0.479 . . . . 1.0700000000000001 110.259 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' B' ' 4' ' ' GLY . 48.9 ttt180 -125.9 118.0 24.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.79 0.329 . . . . 2.0499999999999998 111.291 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.493 HG13 ' HA2' ' B' ' 4' ' ' GLY . 2.5 p -80.11 131.36 63.09 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 1.45 110.503 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -50.2 145.47 20.32 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.239 2.626 . . . . 1.03 112.312 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -58.49 -27.51 64.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 2.1400000000000001 112.504 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.32 -38.81 84.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.193 0.52 . . . . 1.78 110.352 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 19.8 mm -86.05 -33.65 7.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.804 -0.635 . . . . 1.3300000000000001 109.72 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 11.5 tpt -63.01 -33.22 74.95 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.201 0.524 . . . . 2.3399999999999999 110.225 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -61.13 -38.47 86.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.499 -0.773 . . . . 1.9099999999999999 110.188 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.561 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 31.9 mm-40 -60.18 -41.17 92.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.916 -0.584 . . . . 1.76 110.684 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 34.2 t -60.44 -46.87 94.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.978 -0.555 . . . . 1.01 109.963 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 71.2 mt -62.49 -36.3 82.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.97 -0.559 . . . . 1.29 110.274 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.08 -43.49 97.2 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.6 -0.727 . . . . 1.02 111.801 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 7.6 mmt180 -66.23 -32.21 73.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.055 0.455 . . . . 1.8500000000000001 110.451 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 79.8 mt -71.18 -13.85 62.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.976 -0.556 . . . . 1.9399999999999999 111.232 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 10.8 m -84.04 -24.44 30.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.122 0.487 . . . . 1.1599999999999999 110.395 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.643 ' HB ' ' HE1' ' B' ' 57' ' ' PHE . 0.2 OUTLIER -72.33 -29.18 63.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 1.45 111.571 -179.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 49.8 pt -80.39 -3.58 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.727 0.299 . . . . 1.98 111.657 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 96.4 mt -86.04 12.8 8.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.197 0.523 . . . . 1.3600000000000001 110.669 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.246 0.901 0 N-CA-C 109.301 -0.629 . . . . 2.1299999999999999 109.301 179.766 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 ptp . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.901 0.382 . . . . 1.29 110.779 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 43.8 mt-10 -123.16 -173.63 2.76 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.685 -0.689 . . . . 2.0099999999999998 110.376 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -89.16 133.39 34.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.996 -0.547 . . . . 1.8500000000000001 110.898 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.23 13.88 52.95 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.791 -0.719 . . . . 0.85999999999999999 112.997 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 83.3 mt-10 -98.67 153.21 18.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.717 0.294 . . . . 0.98999999999999999 110.571 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.535 HD11 ' HG2' ' A' ' 91' ' ' GLU . 1.1 pt -118.46 110.17 29.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.134 -0.485 . . . . 1.1599999999999999 109.917 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.409 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 31.0 m95 -102.53 122.47 44.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.885 -0.598 . . . . 0.91000000000000003 110.831 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 17.8 tp -82.7 131.89 35.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.116 -0.493 . . . . 0.90000000000000002 111.364 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 85' ' ' ARG . 6.4 p -172.59 159.65 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.201 -0.454 . . . . 1.04 110.245 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.7 m -82.74 141.47 32.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.616 0.246 . . . . 1.3200000000000001 110.767 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.41 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . 68.3 mt -95.32 -11.44 27.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.113 0.482 . . . . 1.29 110.86 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.702 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -74.49 174.46 5.1 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.707 -0.679 . . . . 1.54 110.95 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.702 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 9.8 Cg_exo -73.12 142.47 74.87 Favored 'Cis proline' 0 C--N 1.354 0.851 0 C-N-CA 124.609 -0.996 . . . . 1.6899999999999999 112.386 -0.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.577 HG23 ' HA ' ' A' ' 12' ' ' ASP . 38.7 p -122.44 175.55 6.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 1.3600000000000001 110.993 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.01 103.49 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 1.7 110.319 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.59 -151.84 18.13 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.838 -0.696 . . . . 1.1799999999999999 111.658 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.625 ' HD2' HD11 ' B' ' 39' ' ' LEU . 78.0 t60 -105.98 37.15 2.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.531 0.682 . . . . 2.7799999999999998 110.374 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -79.86 -170.37 2.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.615 . . . . 1.1399999999999999 109.691 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -77.06 87.11 3.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.271 0.557 . . . . 2.0899999999999999 110.678 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.514 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 1.7 pt20 -107.07 172.9 6.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.238 -0.892 . . . . 2.0899999999999999 111.289 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.3 177.61 28.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.977 -0.63 . . . . 1.0700000000000001 113.74 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.3 m -114.12 129.49 56.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.623 -0.51 . . . . 1.1100000000000001 109.623 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.78 160.44 11.48 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.142 -0.318 . . . . 1.6200000000000001 110.142 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 10.4 Cg_exo -73.5 135.6 22.4 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.302 2.001 . . . . 1.01 110.869 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.87 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 10.7 m -108.38 136.39 44.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.219 -0.446 . . . . 0.76000000000000001 110.28 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.597 ' HB3' HG23 ' A' ' 43' ' ' VAL . 15.8 tp -86.6 125.67 33.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.363 -0.381 . . . . 0.69999999999999996 111.045 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.444 HD13 ' CG1' ' A' ' 42' ' ' VAL . 9.1 mm -74.83 117.24 18.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.318 -0.401 . . . . 0.92000000000000004 110.371 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -92.16 -37.8 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.057 -0.52 . . . . 0.94999999999999996 111.236 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.75 150.96 82.18 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.619 0.6 . . . . 1.1200000000000001 112.619 -179.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 33' ' ' PHE . 65.4 Cg_endo -74.88 158.71 42.47 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.75 2.3 . . . . 1.3 111.934 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.57 -39.85 65.13 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.563 0.579 . . . . 1.3899999999999999 112.563 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.92 99.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.356 . . . . 1.6100000000000001 111.196 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.438 ' HB2' ' HG2' ' A' ' 30' ' ' PRO . 8.0 t80 -69.17 -40.93 77.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.014 -0.539 . . . . 1.77 110.419 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -64.36 -26.13 68.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 1.48 110.773 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -78.26 -25.46 46.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.986 -0.552 . . . . 2.6200000000000001 111.873 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -96.34 -43.88 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.535 0.569 . . . . 1.8600000000000001 112.535 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 m -81.28 -25.74 36.3 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.87 0.322 . . . . 1.72 111.87 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 71.69 -2.8 2.35 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.039 0.536 . . . . 4.4500000000000002 112.217 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 81' ' ' ASP . 2.9 mt -131.33 114.47 15.96 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.379 -0.6 . . . . 1.8100000000000001 109.379 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.4 ' O ' HG23 ' A' ' 79' ' ' THR . 85.6 Cg_endo -89.14 131.56 2.17 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.802 2.335 . . . . 1.05 113.137 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.441 HG11 HD12 ' B' ' 108' ' ' ILE . 48.3 t -67.78 121.09 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.873 -1.158 . . . . 1.03 107.873 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.87 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 17.4 m -128.24 153.2 37.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 113.485 0.92 . . . . 0.77000000000000002 113.485 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.597 HG23 ' HB3' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -114.27 131.1 23.42 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 114.685 -1.143 . . . . 0.71999999999999997 108.788 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 77' ' ' PRO . 71.5 Cg_endo -73.83 114.1 3.95 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.793 2.329 . . . . 1.03 113.973 -178.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.685 HG22 HG22 ' A' ' 72' ' ' VAL . 48.3 t -79.72 99.54 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.089 -0.708 . . . . 1.28 109.089 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.566 ' HB ' ' HD3' ' A' ' 73' ' ' ARG . 2.2 m . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 116.422 -0.354 . . . . 1.9099999999999999 111.394 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.418 -0.273 . . . . 1.6599999999999999 112.418 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -95.1 -8.38 36.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.907 0.384 . . . . 1.5600000000000001 110.956 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.56 142.85 32.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.208 -0.664 . . . . 1.25 109.208 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.886 HG22 ' HB ' ' A' ' 72' ' ' VAL . 11.4 m -94.82 156.14 3.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.174 0.511 . . . . 1.6799999999999999 112.133 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.26 106.05 17.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.573 -0.74 . . . . 1.95 111.394 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 61' ' ' LEU . 4.1 mt -91.51 -32.13 15.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.179 0.514 . . . . 1.23 110.751 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -75.19 112.37 11.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.072 -0.513 . . . . 2.21 110.628 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.46 -23.01 0.75 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.599 -0.6 . . . . 1.1499999999999999 111.599 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.412 HG23 HG23 ' A' ' 66' ' ' ILE . 15.7 m -100.99 1.84 10.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 111.82 0.304 . . . . 1.21 111.82 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.59 47.41 34.4 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.958 -0.639 . . . . 1.0800000000000001 113.147 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.48 ' H ' HG13 ' A' ' 66' ' ' ILE . 1.5 pp -84.79 173.71 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.673 0.273 . . . . 1.0700000000000001 111.348 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.2 ttm105 -98.54 -55.66 2.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.556 -0.293 . . . . 3.5899999999999999 110.739 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.0 m -62.01 101.62 0.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.187 0.518 . . . . 1.51 110.822 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.73 83.27 5.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.86 -0.609 . . . . 1.79 111.339 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -143.1 158.25 27.15 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.783 -0.722 . . . . 1.1799999999999999 111.674 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.3 t -105.82 107.11 21.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.954 -0.388 . . . . 1.5600000000000001 109.954 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.886 ' HB ' HG22 ' A' ' 59' ' ' VAL . 42.3 t -61.44 116.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.39 . . . . 1.29 110.628 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.566 ' HD3' ' HB ' ' A' ' 46' ' ' THR . 74.8 mtp180 -102.78 119.34 38.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.084 -0.507 . . . . 2.23 111.686 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.8 m -103.52 5.88 37.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.429 0.633 . . . . 1.1699999999999999 109.515 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.557 ' HB2' ' CZ ' ' B' ' 33' ' ' PHE . 9.2 p-10 -81.59 -33.79 31.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.454 -0.794 . . . . 0.89000000000000001 111.574 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.55 ' HG3' ' NH2' ' A' ' 73' ' ' ARG . 11.4 mm-40 -130.38 64.02 71.41 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.677 -0.238 . . . . 2.1299999999999999 110.951 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.757 ' HD2' HG11 ' B' ' 41' ' ' VAL . 83.2 Cg_endo -80.56 164.85 20.88 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.092 1.861 . . . . 0.80000000000000004 112.237 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.635 ' HA ' ' O ' ' B' ' 77' ' ' PRO . 13.9 ptm180 -166.7 118.02 0.95 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 2.0899999999999999 110.999 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.535 ' HB ' ' HA ' ' B' ' 76' ' ' GLN . 78.3 m -72.72 109.66 6.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.383 -0.371 . . . . 1.6200000000000001 110.295 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.0 pt -103.08 165.95 2.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.704 -0.68 . . . . 1.1499999999999999 111.225 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HA ' HD23 ' A' ' 39' ' ' LEU . 8.4 t0 -82.78 136.99 34.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.644 -0.707 . . . . 1.03 109.896 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.414 ' SD ' ' HA3' ' A' ' 87' ' ' GLY . 27.6 tpp -111.46 1.59 17.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.273 -0.421 . . . . 1.29 111.216 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -91.28 -56.42 3.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.564 -0.289 . . . . 2.6400000000000001 111.768 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.4 ' HB3' ' HA2' ' B' ' 16' ' ' GLY . . . -78.84 -29.98 44.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.378 . . . . 1.1200000000000001 111.14 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.564 ' HB3' HG21 ' A' ' 9' ' ' VAL . 72.3 mtt-85 -76.35 -39.74 53.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.31 -0.405 . . . . 1.0600000000000001 110.8 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.29 82.19 0.15 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.952 -0.642 . . . . 1.1200000000000001 112.914 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.414 ' HA3' ' SD ' ' A' ' 82' ' ' MET . . . -81.93 168.0 48.55 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.807 -0.711 . . . . 1.0900000000000001 112.848 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 9.4 mptt -121.53 121.94 38.59 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.18 -0.304 . . . . 2.46 110.18 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.38 120.66 23.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.82 0.343 . . . . 2.4900000000000002 111.194 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 90' ' ' LEU . 3.3 mm? -86.71 -67.17 0.83 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.139 -0.482 . . . . 1.29 110.511 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.535 ' HG2' HD11 ' A' ' 6' ' ' ILE . 4.1 pt-20 -153.57 -174.05 4.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.946 -0.57 . . . . 1.1499999999999999 109.58 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -130.58 140.15 50.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.056 0.455 . . . . 1.3200000000000001 110.355 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.0 m -94.15 152.03 40.03 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.865 -0.607 . . . . 0.75 110.801 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.38 162.57 17.09 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.889 2.393 . . . . 0.94999999999999996 111.947 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -62.86 -24.23 67.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 1.51 111.066 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.66 -35.46 80.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 1.5700000000000001 110.702 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.4 mm -69.95 -31.02 46.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.397 -0.594 . . . . 1.3100000000000001 109.397 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.444 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 16.7 tpt -64.89 -34.16 77.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.721 -0.672 . . . . 1.6000000000000001 109.641 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -63.12 -40.39 97.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.675 -0.693 . . . . 2.2999999999999998 109.404 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.633 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 2.2 mm-40 -58.66 -49.35 77.86 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.543 -0.753 . . . . 1.6399999999999999 109.857 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.9 t -62.29 -49.11 85.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.573 -0.74 . . . . 1.03 110.901 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 98' ' ' MET . 94.5 mt -56.74 -43.31 80.57 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.271 -0.422 . . . . 1.22 111.194 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.36 -40.85 98.08 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.115 -0.564 . . . . 1.03 112.524 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.0 mmt180 -71.05 -43.07 68.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.896 0.379 . . . . 1.72 110.914 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.89 -31.4 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 1.02 111.676 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.1 m -69.03 -16.51 63.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.409 -0.359 . . . . 1.1100000000000001 111.521 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.4 m -93.85 -24.45 17.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.693 0.257 . . . . 1.5 111.693 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.7 pt -84.06 -20.9 8.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 112.08 0.4 . . . . 1.1499999999999999 112.08 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 97.3 mt -77.01 79.23 3.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.013 0.435 . . . . 0.97999999999999998 111.603 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.418 ' O ' ' HD2' ' B' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.929 -0.578 . . . . 1.3500000000000001 110.364 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.711 ' HA ' ' HA ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.288 0 N-CA-C 112.756 0.65 . . . . 2.0299999999999998 112.756 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' B' ' 3' ' ' ARG . 3.1 mp0 -71.13 -22.42 62.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.629 -0.714 . . . . 2.8199999999999998 110.848 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . 0.791 ' HG3' ' HG2' ' B' ' 98' ' ' MET . 4.2 mpt_? 78.82 123.73 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.951 0.722 . . . . 2.3199999999999998 112.951 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . 0.518 ' HA2' HG12 ' B' ' 93' ' ' VAL . . . 80.09 49.22 6.07 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.478 -0.783 . . . . 1.28 113.683 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -125.37 90.38 3.21 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.473 0.546 . . . . 1.53 112.473 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.721 HD11 ' HB ' ' B' ' 93' ' ' VAL . 64.0 mt -99.86 104.39 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.184 -1.043 . . . . 0.75 108.184 178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.446 ' HA ' ' HA ' ' B' ' 89' ' ' ARG . 12.4 m95 -103.79 166.49 10.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.925 -0.579 . . . . 0.81000000000000005 111.59 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 55.4 tp -118.39 112.34 19.87 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.196 -0.668 . . . . 1.05 109.196 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 p -136.61 156.17 35.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.301 -0.409 . . . . 0.71999999999999997 110.362 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 5.8 t -90.28 127.22 36.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.402 -0.592 . . . . 1.6299999999999999 109.402 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 20.5 mt -94.67 -25.88 16.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.192 0.52 . . . . 0.82999999999999996 110.49 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.83 147.24 98.86 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.754 . . . . 1.6200000000000001 110.85 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -87.97 160.66 45.16 Favored 'Cis proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.601 -1.416 . . . . 1.28 111.978 0.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.569 ' HB ' ' HG3' ' B' ' 20' ' ' GLN . 14.0 m -156.74 124.74 5.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.377 -0.374 . . . . 1.47 110.219 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.78 164.75 14.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.388 -0.369 . . . . 1.22 110.802 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.4 ' HA2' ' HB3' ' A' ' 84' ' ' ALA . . . 87.06 -164.33 35.23 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.795 -0.717 . . . . 1.01 112.511 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -99.23 31.34 3.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.871 0.367 . . . . 2.1800000000000002 110.641 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.38 -167.7 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 1.28 111.206 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -98.85 101.21 12.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.32 -0.4 . . . . 1.52 110.832 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.569 ' HG3' ' HB ' ' B' ' 14' ' ' THR . 14.9 mp0 -102.59 -178.47 3.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.129 -0.487 . . . . 1.8600000000000001 110.148 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.53 130.64 5.33 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.89 -0.671 . . . . 0.90000000000000002 112.363 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 56.4 m -76.68 94.74 3.84 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.423 -0.584 . . . . 0.94999999999999996 109.423 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.3 165.96 32.85 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.498 -0.774 . . . . 1.5900000000000001 110.19 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.79 145.54 82.71 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.714 2.276 . . . . 0.65000000000000002 112.016 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.804 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 10.5 m -135.47 145.92 30.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.898 -0.592 . . . . 0.56999999999999995 111.138 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 48.2 tp -103.62 125.96 50.46 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.009 -0.541 . . . . 1.1699999999999999 109.573 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . 0.504 HG23 ' HB2' ' B' ' 40' ' ' PRO . 23.5 mt -78.47 140.75 16.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.58 0.228 . . . . 0.66000000000000003 111.148 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.85 -31.95 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.9 0.381 . . . . 0.93000000000000005 111.621 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' THR . . . . . 0.476 HG23 HG22 ' B' ' 41' ' ' VAL . 0.2 OUTLIER -69.42 130.15 91.04 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.502 -0.317 . . . . 0.81000000000000005 111.728 -179.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.711 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 63.3 Cg_endo -72.74 162.29 41.58 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.013 2.475 . . . . 0.78000000000000003 112.725 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.54 -31.2 63.93 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.79 -0.641 . . . . 1.03 112.614 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.43 -18.56 40.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 1.3999999999999999 112.077 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 75' ' ' ASP . 65.7 t80 -122.4 -33.04 3.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.994 0.426 . . . . 1.5700000000000001 110.187 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -56.12 -41.49 75.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.52 -0.764 . . . . 1.6399999999999999 111.781 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -85.73 6.1 29.32 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.804 0.668 . . . . 2.54 112.804 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.05 -65.39 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.173 0.511 . . . . 1.0900000000000001 110.354 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 13.2 p -81.35 -23.83 37.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.868 -0.606 . . . . 1.3300000000000001 110.834 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.808 ' HE ' ' HA ' ' B' ' 38' ' ' ARG . 0.6 OUTLIER 67.33 16.93 10.16 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.632 -0.713 . . . . 1.78 111.432 -179.198 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.625 HD11 ' HD2' ' A' ' 17' ' ' HIS . 13.3 mt -128.18 94.71 35.56 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.19 -1.041 . . . . 1.1599999999999999 108.19 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' PRO . . . . . 0.504 ' HB2' HG23 ' B' ' 27' ' ' ILE . 94.6 Cg_endo -91.54 159.66 3.59 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.582 2.188 . . . . 0.56999999999999995 113.585 -178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.757 HG11 ' HD2' ' A' ' 77' ' ' PRO . 15.2 m -94.37 131.92 39.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.236 -1.024 . . . . 1.0800000000000001 108.236 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.804 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 27.6 m -124.0 153.18 29.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 113.066 0.765 . . . . 0.64000000000000001 113.066 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 42.7 t -106.63 114.2 62.16 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 114.647 -1.16 . . . . 1.1000000000000001 108.411 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.726 ' HA ' HG12 ' B' ' 25' ' ' VAL . 39.3 Cg_endo -67.62 123.39 10.71 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.69 2.26 . . . . 0.72999999999999998 112.555 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.636 HG22 HG12 ' B' ' 72' ' ' VAL . 48.9 t -77.65 123.38 34.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.348 -0.612 . . . . 0.90000000000000002 109.348 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.75 102.49 15.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.311 -0.404 . . . . 1.1699999999999999 110.44 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 116.066 -0.516 . . . . 1.8500000000000001 110.573 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.734 0.302 . . . . 1.96 111.47 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.22 -73.46 1.78 Allowed Glycine 0 CA--C 1.516 0.149 0 C-N-CA 121.005 -0.617 . . . . 1.0800000000000001 112.831 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.424 ' HB3' ' HZ ' ' A' ' 33' ' ' PHE . 26.5 p90 -88.18 -11.08 47.84 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.195 0.521 . . . . 3.5699999999999998 110.924 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' B' ' 72' ' ' VAL . . . -112.98 116.81 30.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.975 -0.557 . . . . 1.0800000000000001 110.211 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' B' ' 101' ' ' VAL . 49.5 t -90.71 135.04 27.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.295 -0.411 . . . . 1.3400000000000001 110.102 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.559 ' HA ' HG12 ' B' ' 71' ' ' VAL . 19.0 t -87.7 138.5 31.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.965 0.412 . . . . 1.3799999999999999 111.23 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.54 ' HB3' HD12 ' B' ' 66' ' ' ILE . 69.0 mt -101.63 5.34 41.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.05 -0.722 . . . . 1.02 109.05 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.09 157.41 18.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.07 -0.968 . . . . 1.79 110.638 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.51 -62.94 0.3 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.702 -0.761 . . . . 1.1499999999999999 112.92 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.96 -31.72 51.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.865 0.364 . . . . 1.1699999999999999 111.95 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.12 79.75 1.15 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.554 -0.831 . . . . 1.05 113.067 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.54 HD12 ' HB3' ' B' ' 61' ' ' LEU . 45.9 mt -123.71 152.79 29.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.737 -0.838 . . . . 1.6100000000000001 108.737 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . 0.594 ' HB3' ' OE1' ' B' ' 91' ' ' GLU . 4.1 ttt180 -63.48 -48.69 76.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.625 0.25 . . . . 2.3999999999999999 111.433 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 12.1 m -78.83 99.87 6.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.237 0.541 . . . . 0.93000000000000005 111.685 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.8 88.61 6.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.718 -0.674 . . . . 1.3100000000000001 110.751 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -163.16 -170.64 28.34 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.298 -0.953 . . . . 0.79000000000000004 112.669 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' B' ' 60' ' ' SER . 11.5 m -124.67 136.92 59.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.849 0.357 . . . . 0.93000000000000005 110.333 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.636 HG12 HG22 ' B' ' 45' ' ' VAL . 16.1 m -86.55 133.23 30.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.313 -0.403 . . . . 1.3799999999999999 111.404 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -88.75 85.74 6.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.565 -0.531 . . . . 1.3700000000000001 109.565 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 1.1 m -65.68 -15.26 62.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.355 0.598 . . . . 1.1599999999999999 111.116 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.28 -12.74 51.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.501 -0.772 . . . . 1.1000000000000001 111.12 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' GLN . . . . . 0.535 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 10.4 mt-30 -126.38 66.23 61.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 114.233 1.197 . . . . 2.4700000000000002 114.233 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.635 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 74.0 Cg_endo -79.76 142.43 15.95 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.786 1.657 . . . . 0.95999999999999996 109.159 177.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' B' ' 78' ' ' ARG . 4.9 ttt180 -138.36 144.01 40.11 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.747 -0.381 . . . . 1.96 111.882 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.511 HG21 ' HB3' ' A' ' 76' ' ' GLN . 0.1 OUTLIER -82.76 140.38 33.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.788 -0.642 . . . . 1.1899999999999999 109.714 178.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.96 157.8 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.935 0.397 . . . . 1.28 111.426 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' B' ' 85' ' ' ARG . 9.5 t0 -85.39 110.82 19.4 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.813 -0.81 . . . . 1.28 108.813 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 13.7 ttp -78.62 -3.52 44.32 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.44 0.904 . . . . 2.7000000000000002 113.44 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 10.3 pttt -117.63 -45.08 2.71 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.002 0.742 . . . . 1.96 113.002 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.37 -38.75 41.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.793 0.33 . . . . 1.0600000000000001 111.67 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' B' ' 81' ' ' ASP . 83.7 mtt-85 -79.89 -25.28 40.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.525 -0.307 . . . . 1.47 111.055 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.84 132.02 1.74 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.661 -0.78 . . . . 0.81999999999999995 111.849 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.39 148.15 14.42 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.157 -1.02 . . . . 0.65000000000000002 113.16 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -146.49 157.43 43.75 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.786 -0.45 . . . . 1.8100000000000001 109.786 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' B' ' 7' ' ' TRP . 53.5 ttp180 -82.45 126.0 31.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.696 0.284 . . . . 2.4900000000000002 110.601 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 50.4 mt -89.68 -51.43 5.52 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 0.76000000000000001 110.7 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . 0.594 ' OE1' ' HB3' ' B' ' 67' ' ' ARG . 12.1 pt-20 -150.16 170.55 18.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.968 -0.56 . . . . 1.0700000000000001 111.812 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.401 ' HG3' ' HA3' ' B' ' 4' ' ' GLY . 19.9 ttm180 -115.5 115.27 26.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.742 -0.663 . . . . 2.0499999999999998 110.361 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.721 ' HB ' HD11 ' B' ' 6' ' ' ILE . 11.9 p -74.08 134.5 77.53 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.966 -0.561 . . . . 1.45 110.629 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.03 148.3 48.77 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.822 2.348 . . . . 1.03 112.195 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -55.39 -34.05 64.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.805 -0.634 . . . . 2.1400000000000001 111.601 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.87 -49.03 79.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.219 0.533 . . . . 1.78 110.942 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.414 ' HB ' HG22 ' B' ' 93' ' ' VAL . 21.1 mm -74.19 -39.88 50.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.878 -0.601 . . . . 1.3300000000000001 110.491 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' MET . . . . . 0.791 ' HG2' ' HG3' ' B' ' 3' ' ' ARG . 8.3 tpt -58.54 -42.36 87.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.985 0.421 . . . . 2.3399999999999999 110.545 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -63.5 -35.36 80.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.939 -0.573 . . . . 1.9099999999999999 110.478 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 1.8 mm-40 -62.82 -42.46 99.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.023 -0.535 . . . . 1.76 110.388 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.581 ' HA ' HG21 ' B' ' 59' ' ' VAL . 39.9 t -61.53 -45.14 99.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.976 -0.556 . . . . 1.01 110.525 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.46 -38.41 87.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.017 -0.538 . . . . 1.29 110.586 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.14 -42.86 94.19 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.692 -0.686 . . . . 1.02 111.579 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 9.9 mmt180 -69.33 -29.5 67.34 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.806 0.336 . . . . 1.8500000000000001 110.72 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.521 ' O ' HG12 ' B' ' 108' ' ' ILE . 11.3 mt -66.64 -23.17 66.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 1.9399999999999999 110.535 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 24.2 m -82.76 -8.61 59.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.347 -0.388 . . . . 1.1599999999999999 111.767 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.84 -15.87 61.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 1.45 111.778 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.521 HG12 ' O ' ' B' ' 105' ' ' LEU . 37.2 pt -88.18 -1.11 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.807 0.337 . . . . 1.98 111.111 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 58.8 mt -87.42 -4.94 59.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.034 -0.53 . . . . 1.3600000000000001 111.048 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.687 -0.673 . . . . 2.1299999999999999 109.81 179.618 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.4 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 21.3 ptp . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.89 0.376 . . . . 1.29 110.783 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -123.22 168.12 12.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.886 -0.597 . . . . 2.0099999999999998 110.828 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -63.52 128.73 37.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.973 -0.558 . . . . 1.8500000000000001 110.642 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.74 -20.84 17.25 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.756 -0.735 . . . . 0.85999999999999999 113.112 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.4 ' O ' HG12 ' A' ' 27' ' ' ILE . 33.2 mt-10 -83.49 145.49 28.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.794 0.297 . . . . 0.98999999999999999 111.309 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.2 pt -112.91 130.49 66.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.879 0.371 . . . . 1.1599999999999999 110.746 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.4 m95 -116.22 117.58 30.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.152 -0.476 . . . . 0.91000000000000003 111.098 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 27.7 tp -76.07 113.44 13.59 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.791 -0.448 . . . . 0.90000000000000002 109.791 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 p -150.66 159.92 4.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.61 -0.268 . . . . 1.04 110.738 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.65 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.0 t -97.25 132.4 43.04 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.499 -0.556 . . . . 1.3200000000000001 109.499 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.4 mt -86.29 -11.65 51.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.403 -0.362 . . . . 1.29 111.509 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.486 ' CB ' ' HA ' ' A' ' 13' ' ' PRO . 3.0 m-20 -64.18 164.59 17.44 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.803 -0.635 . . . . 1.54 112.649 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.486 ' HA ' ' CB ' ' A' ' 12' ' ' ASP . 79.4 Cg_endo -83.34 111.63 2.28 Favored 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 123.553 -1.436 . . . . 1.6899999999999999 112.572 0.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -107.49 150.49 26.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.106 -0.497 . . . . 1.3600000000000001 111.298 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -130.02 167.21 18.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.002 -0.545 . . . . 1.7 110.533 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.8 -150.55 48.05 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.893 -0.883 . . . . 1.1799999999999999 110.893 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -85.62 4.14 37.62 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.093 0.446 . . . . 2.7799999999999998 111.338 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HB3' HG22 ' A' ' 14' ' ' THR . 9.3 tt0 -65.33 134.38 53.45 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.134 -0.321 . . . . 1.1399999999999999 110.134 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.428 ' HG2' ' HG3' ' A' ' 44' ' ' PRO . 7.5 tp-100 -54.77 124.45 16.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.951 -0.568 . . . . 2.0899999999999999 112.098 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.427 HE21 ' HB2' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -127.85 -178.81 4.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.722 -0.672 . . . . 2.0899999999999999 110.195 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.26 164.52 39.32 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.861 -0.685 . . . . 1.0700000000000001 113.917 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 2.2 m -91.96 124.76 36.31 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.078 -0.712 . . . . 1.1100000000000001 109.078 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.43 ' HG3' ' HB2' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -159.88 158.06 26.4 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 110.466 -0.198 . . . . 1.6200000000000001 110.466 -179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 57.6 Cg_endo -76.86 121.04 5.69 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.957 1.771 . . . . 1.01 111.335 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.557 HG21 HD11 ' A' ' 80' ' ' ILE . 24.4 m -95.59 131.07 43.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.082 -0.508 . . . . 0.76000000000000001 110.532 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HB3' HG23 ' A' ' 43' ' ' VAL . 50.8 tp -87.91 122.64 31.78 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.788 -0.642 . . . . 0.69999999999999996 110.825 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.633 ' HA ' HG12 ' A' ' 42' ' ' VAL . 19.0 mm -71.11 111.45 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.794 -0.446 . . . . 0.92000000000000004 109.794 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -92.32 -37.12 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.275 -0.42 . . . . 0.94999999999999996 111.724 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.85 148.85 82.5 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 111.719 0.266 . . . . 1.1200000000000001 111.719 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.419 ' HG3' ' OXT' ' B' ' 110' ' ' THR . 68.7 Cg_endo -71.69 161.2 45.94 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.598 2.199 . . . . 1.3 111.879 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.11 -35.79 74.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.026 -0.534 . . . . 1.3899999999999999 111.567 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.64 -43.56 89.81 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.241 -0.436 . . . . 1.6100000000000001 111.672 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.597 ' HZ ' ' HB2' ' B' ' 75' ' ' ASP . 69.9 t80 -71.94 -48.39 45.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.889 -0.596 . . . . 1.77 110.786 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -59.25 -32.68 70.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.024 -0.534 . . . . 1.48 111.123 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 35' ' ' ARG . 43.9 ttp180 -64.85 -30.08 71.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.852 -0.613 . . . . 2.6200000000000001 112.136 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 p -96.32 -47.28 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 113.575 0.954 . . . . 1.8600000000000001 113.575 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 22.1 p -78.34 -28.61 47.26 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.72 0.637 . . . . 1.72 112.72 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 37' ' ' THR . 9.4 mpt_? 74.04 -1.09 3.17 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.585 0.553 . . . . 4.4500000000000002 111.567 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.9 mt -126.05 107.3 25.02 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.317 -0.624 . . . . 1.8100000000000001 109.317 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -89.09 139.78 3.76 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.73 2.287 . . . . 1.05 113.018 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 79' ' ' THR . 62.8 t -79.79 113.66 19.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.015 -1.476 . . . . 1.03 107.015 177.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 27' ' ' ILE . 34.8 m -123.46 165.33 19.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 112.711 0.634 . . . . 0.77000000000000002 112.711 -177.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.412 HG23 ' HB3' ' A' ' 26' ' ' LEU . 4.4 m -126.54 125.92 24.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.711 -1.131 . . . . 0.71999999999999997 108.797 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.43 ' HB2' ' HG3' ' A' ' 23' ' ' ARG . 94.5 Cg_endo -80.42 131.59 8.6 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.691 2.26 . . . . 1.03 113.667 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.726 HG22 HG22 ' A' ' 72' ' ' VAL . 92.1 t -78.77 128.63 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.942 -0.762 . . . . 1.28 108.942 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 C--N 1.325 -0.46 0 C-N-CA 121.217 -0.193 . . . . 1.9099999999999999 111.388 -179.287 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.753 0 N-CA-C 111.43 -0.668 . . . . 1.6599999999999999 111.43 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -103.37 15.12 29.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.178 0.513 . . . . 1.5600000000000001 110.995 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.44 153.5 19.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.741 -0.663 . . . . 1.25 109.439 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.13 163.11 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.874 0.369 . . . . 1.6799999999999999 111.755 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.9 m -82.53 133.74 35.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.794 -0.639 . . . . 1.95 110.78 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.815 HD11 HG23 ' A' ' 72' ' ' VAL . 18.3 mt -103.48 -32.15 9.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.191 0.52 . . . . 1.23 110.775 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.78 97.9 1.87 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.369 0.604 . . . . 2.21 110.814 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.82 -8.29 4.87 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.803 -0.713 . . . . 1.1499999999999999 112.605 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 61' ' ' LEU . 28.5 m -94.33 -1.9 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.851 0.325 . . . . 1.21 111.701 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.08 54.44 5.25 Favored Glycine 0 C--O 1.236 0.228 0 C-N-CA 121.16 -0.543 . . . . 1.0800000000000001 113.937 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.639 HD11 ' HB3' ' A' ' 61' ' ' LEU . 41.6 pt -129.67 171.92 16.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 122.823 -0.222 . . . . 1.0700000000000001 110.666 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -104.82 -23.74 12.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.895 -0.409 . . . . 3.5899999999999999 109.895 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.611 ' HB ' HD12 ' A' ' 66' ' ' ILE . 21.1 m -52.74 107.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.468 -0.787 . . . . 1.51 111.378 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.73 90.71 8.34 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.589 -0.732 . . . . 1.79 111.126 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.71 -151.47 10.43 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.941 -0.864 . . . . 1.1799999999999999 110.941 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.83 131.13 37.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.986 0.422 . . . . 1.5600000000000001 110.797 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.815 HG23 HD11 ' A' ' 61' ' ' LEU . 85.1 t -97.96 142.88 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.27 -0.423 . . . . 1.29 109.922 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.407 ' HG3' ' OD2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -150.39 163.9 37.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.381 -0.372 . . . . 2.23 110.311 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.32 13.94 20.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.757 0.313 . . . . 1.1699999999999999 111.383 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.487 ' HA ' ' HZ ' ' B' ' 33' ' ' PHE . 3.3 p30 -86.95 -3.18 59.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 0.89000000000000001 112.075 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.402 ' HG2' ' OD1' ' A' ' 75' ' ' ASP . 35.4 mm-40 -129.96 64.65 72.99 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.758 -0.201 . . . . 2.1299999999999999 111.42 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -94.82 131.49 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.619 2.213 . . . . 0.80000000000000004 113.003 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' B' ' 77' ' ' PRO . 10.6 ptm180 -161.43 154.91 21.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.951 0.405 . . . . 2.0899999999999999 111.594 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.454 HG23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.85 130.02 36.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.186 -0.672 . . . . 1.6200000000000001 109.186 178.335 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.557 HD11 HG21 ' A' ' 25' ' ' VAL . 32.7 pt -131.1 157.28 43.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.961 0.41 . . . . 1.1499999999999999 111.111 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -87.84 133.19 33.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.854 -0.612 . . . . 1.03 110.596 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 43.7 tpp -120.09 21.76 11.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.128 -0.487 . . . . 1.29 110.286 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -107.31 -38.58 5.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.096 -0.502 . . . . 2.6400000000000001 110.794 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.71 -26.18 15.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.994 -0.548 . . . . 1.1200000000000001 111.203 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -76.47 -59.76 2.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.852 0.358 . . . . 1.0600000000000001 111.154 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.29 89.7 1.39 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.84 -0.695 . . . . 1.1200000000000001 111.478 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -95.97 172.29 29.42 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.666 -0.778 . . . . 1.0900000000000001 112.561 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -121.36 109.39 14.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.764 -0.458 . . . . 2.46 109.764 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.16 128.18 34.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.501 0.191 . . . . 2.4900000000000002 110.795 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.56 -89.04 0.37 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.589 -0.278 . . . . 1.29 110.881 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -122.09 -172.78 2.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.51 -0.314 . . . . 1.1499999999999999 110.409 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -140.57 133.88 29.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.94 0.4 . . . . 1.3200000000000001 110.449 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.42 155.21 66.25 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.113 -0.494 . . . . 0.75 111.411 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.54 149.38 89.98 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.47 2.114 . . . . 0.94999999999999996 111.941 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -60.77 -23.21 64.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.892 -0.595 . . . . 1.51 111.488 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -38.07 89.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.243 -0.435 . . . . 1.5700000000000001 109.851 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.7 mm -71.6 -37.92 65.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.916 -0.584 . . . . 1.3100000000000001 109.5 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 84.6 mmm -62.06 -36.9 83.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.616 -0.72 . . . . 1.6000000000000001 110.234 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -62.52 -35.98 81.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.752 -0.658 . . . . 2.2999999999999998 110.548 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -63.84 -46.63 84.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.5 -0.556 . . . . 1.6399999999999999 109.5 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.73 -47.27 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.688 -0.687 . . . . 1.03 110.446 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.3 mt -61.86 -33.84 74.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 1.22 111.121 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.95 -17.57 75.55 Favored Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.904 -0.589 . . . . 1.03 113.091 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -97.86 -24.98 15.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.973 0.416 . . . . 1.72 110.786 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.419 ' O ' HG12 ' A' ' 108' ' ' ILE . 90.6 mt -68.42 -25.45 65.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.139 -0.482 . . . . 1.02 111.398 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -16.53 64.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.835 0.35 . . . . 1.1100000000000001 111.568 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.76 -16.5 32.02 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.193 0.442 . . . . 1.5 112.193 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 105' ' ' LEU . 23.3 pt -91.9 -9.34 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.641 0.608 . . . . 1.1499999999999999 112.641 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.644 ' HA ' HG12 ' B' ' 28' ' ' VAL . 19.7 mt -87.73 82.91 7.24 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.915 -0.402 . . . . 0.97999999999999998 109.915 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.412 ' O ' ' HG3' ' B' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 N-CA-C 113.006 0.743 . . . . 1.3500000000000001 113.006 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.842 ' HA ' ' HA ' ' B' ' 30' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.326 0 N-CA-C 109.61 -0.515 . . . . 2.0299999999999998 109.61 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -77.97 -5.42 51.19 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.719 -0.474 . . . . 2.8199999999999998 109.719 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 110' ' ' THR . 7.8 mtm180 60.69 80.19 0.22 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.099 -0.955 . . . . 2.3199999999999998 112.968 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . 0.47 ' HA2' HG12 ' B' ' 93' ' ' VAL . . . 137.69 -32.69 2.35 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.092 -1.052 . . . . 1.28 113.826 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.44 ' OE2' ' HD2' ' B' ' 92' ' ' ARG . 17.6 mm-40 -64.63 109.62 2.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.062 0.458 . . . . 1.53 112.169 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.659 HD11 ' HB ' ' B' ' 93' ' ' VAL . 51.4 mt -98.8 130.7 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.371 -0.603 . . . . 0.75 109.371 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.408 ' HA ' ' HA ' ' B' ' 89' ' ' ARG . 30.2 m95 -115.44 178.32 4.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.037 0.446 . . . . 0.81000000000000005 111.316 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 tt -146.22 133.7 20.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.086 -0.506 . . . . 1.05 110.032 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.519 HG12 HG21 ' B' ' 25' ' ' VAL . 8.2 p -167.16 164.75 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.504 -0.316 . . . . 0.71999999999999997 110.182 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 6.0 t -88.83 140.56 29.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.636 0.255 . . . . 1.6299999999999999 110.661 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.517 HD11 ' HB3' ' B' ' 44' ' ' PRO . 32.1 mt -96.45 -12.25 24.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.369 0.604 . . . . 0.82999999999999996 110.15 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . 0.735 ' OD1' ' HB3' ' B' ' 20' ' ' GLN . 0.1 OUTLIER -75.97 153.59 84.77 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.507 -0.769 . . . . 1.6200000000000001 110.083 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -96.23 161.73 14.48 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.823 -1.324 . . . . 1.28 112.154 -0.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.465 HG22 ' H ' ' B' ' 15' ' ' ALA . 0.2 OUTLIER -157.93 -164.65 1.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.172 -0.677 . . . . 1.47 109.172 179.108 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.465 ' H ' HG22 ' B' ' 14' ' ' THR . . . -155.41 161.57 40.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.075 -0.342 . . . . 1.22 110.075 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.47 -143.23 25.66 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.891 -0.671 . . . . 1.01 112.244 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -92.83 2.05 56.97 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.875 0.324 . . . . 2.1800000000000002 111.875 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.44 136.0 57.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.648 0.261 . . . . 1.28 110.758 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -60.31 128.33 36.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 1.52 112.097 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.735 ' HB3' ' OD1' ' B' ' 12' ' ' ASP . 21.7 mt-30 -129.55 -167.37 1.79 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.466 -0.788 . . . . 1.8600000000000001 110.874 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.22 175.7 50.89 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.962 -0.563 . . . . 0.90000000000000002 112.765 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 18.4 m -111.0 108.79 18.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.01 0.433 . . . . 0.94999999999999996 110.591 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.48 164.81 20.1 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.004 -0.544 . . . . 1.5900000000000001 109.764 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.08 147.28 91.1 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.406 2.071 . . . . 0.65000000000000002 111.078 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 9.8 m -134.99 137.2 50.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.138 0.494 . . . . 0.56999999999999995 111.753 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 33.5 tp -101.83 129.13 47.98 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.186 -0.672 . . . . 1.1699999999999999 109.186 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 55.3 mt -89.22 133.65 30.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.605 0.24 . . . . 0.66000000000000003 110.369 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 109' ' ' LEU . 21.5 t -100.5 -34.84 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.379 -0.373 . . . . 0.93000000000000005 111.913 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' THR . . . . . 0.49 HG23 HG22 ' B' ' 41' ' ' VAL . 0.7 OUTLIER -67.54 138.99 93.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 111.956 0.354 . . . . 0.81000000000000005 111.956 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.842 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 50.0 Cg_endo -68.34 162.26 41.26 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.003 2.469 . . . . 0.78000000000000003 113.02 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.06 67.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.536 -0.756 . . . . 1.03 112.208 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.07 -46.18 79.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.035 0.445 . . . . 1.3999999999999999 110.961 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . 0.487 ' HZ ' ' HA ' ' A' ' 75' ' ' ASP . 4.5 t80 -66.05 -48.13 72.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.031 -0.531 . . . . 1.5700000000000001 110.599 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -61.16 -26.88 68.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 1.6399999999999999 111.937 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -82.52 -33.98 28.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.484 -0.325 . . . . 2.54 111.262 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 89.0 t -82.99 -55.75 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.372 0.508 . . . . 1.0900000000000001 112.372 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 58.0 p -74.43 -27.81 60.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.7 0.286 . . . . 1.3300000000000001 111.33 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.416 ' HE ' ' HA ' ' B' ' 38' ' ' ARG . 2.5 mmp_? 62.84 26.22 15.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.897 -0.592 . . . . 1.78 110.061 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 30.4 mt -145.67 96.67 4.73 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.115 -0.948 . . . . 1.1599999999999999 109.57 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' PRO . . . . . 0.547 ' HD2' ' O ' ' B' ' 80' ' ' ILE . 92.5 Cg_endo -87.43 146.99 7.4 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.861 2.374 . . . . 0.56999999999999995 112.711 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.49 HG22 HG23 ' B' ' 29' ' ' THR . 4.9 m -85.52 110.68 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.327 -0.62 . . . . 1.0800000000000001 109.327 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 34.6 m -95.73 138.26 21.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.9 -0.591 . . . . 0.64000000000000001 112.035 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.491 HG13 ' O ' ' B' ' 73' ' ' ARG . 41.2 t -107.52 116.38 57.84 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.022 -0.99 . . . . 1.1000000000000001 108.91 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.517 ' HB3' HD11 ' B' ' 11' ' ' LEU . 50.0 Cg_endo -67.85 124.62 12.09 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.984 2.456 . . . . 0.72999999999999998 114.221 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -95.24 142.07 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.588 -0.893 . . . . 0.90000000000000002 108.588 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -112.63 100.56 8.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.951 0.405 . . . . 1.1699999999999999 111.181 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.774 -0.648 . . . . 1.8500000000000001 110.722 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.946 0.403 . . . . 1.96 110.988 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.34 -77.09 0.74 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.745 -0.661 . . . . 1.0800000000000001 112.869 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.491 ' HE1' ' HB ' ' B' ' 107' ' ' THR . 66.3 m-85 -104.4 -14.42 15.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.512 0.196 . . . . 3.5699999999999998 111.153 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' B' ' 72' ' ' VAL . . . -78.87 95.96 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.419 -0.355 . . . . 1.0800000000000001 110.566 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 45.0 t -85.14 125.19 40.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.11 -0.496 . . . . 1.3400000000000001 111.173 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.01 126.41 31.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.147 -0.479 . . . . 1.3799999999999999 110.993 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.418 ' HB3' HD11 ' B' ' 66' ' ' ILE . 75.9 mt -96.01 87.63 4.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 1.02 111.461 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -161.95 179.21 8.2 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.704 -0.48 . . . . 1.79 109.704 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.22 -42.47 3.16 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 121.242 -0.504 . . . . 1.1499999999999999 112.452 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.652 HG21 ' HG2' ' B' ' 94' ' ' PRO . 14.2 p -80.18 -27.28 11.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.091 0.472 . . . . 1.1699999999999999 111.111 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.65 89.51 1.07 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.717 -0.754 . . . . 1.05 112.62 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.418 HD11 ' HB3' ' B' ' 61' ' ' LEU . 4.9 pt -141.28 177.39 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.925 -0.769 . . . . 1.6100000000000001 108.925 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -83.13 -53.49 5.75 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.982 0.42 . . . . 2.3999999999999999 110.307 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 7.2 m -64.89 112.53 3.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.889 -0.596 . . . . 0.93000000000000005 109.743 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.4 131.58 53.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.888 0.375 . . . . 1.3100000000000001 111.438 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.89 -174.42 32.41 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.941 -0.647 . . . . 0.79000000000000004 111.899 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.418 ' HB ' ' HB1' ' B' ' 58' ' ' ALA . 4.0 m -102.7 124.04 56.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.045 0.45 . . . . 0.93000000000000005 111.437 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' B' ' 58' ' ' ALA . 11.0 t -86.53 118.35 32.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.801 -0.636 . . . . 1.3799999999999999 110.661 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.491 ' O ' HG13 ' B' ' 43' ' ' VAL . 9.3 mmm180 -87.3 83.9 7.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.937 0.399 . . . . 1.3700000000000001 110.315 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 2.5 m -71.17 22.97 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.233 0.827 . . . . 1.1599999999999999 113.233 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.597 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 13.3 p-10 -112.64 -4.16 14.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.661 0.267 . . . . 1.1000000000000001 110.701 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -121.26 86.22 42.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 112.497 0.554 . . . . 2.4700000000000002 112.497 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.54 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 12.8 Cg_endo -92.8 104.38 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.88 2.387 . . . . 0.95999999999999996 110.588 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -111.37 125.81 54.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.938 0.399 . . . . 1.96 111.949 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -84.04 114.11 21.5 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.427 -0.583 . . . . 1.1899999999999999 109.427 178.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.547 ' O ' ' HD2' ' B' ' 40' ' ' PRO . 45.0 pt -133.8 171.79 17.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.008 0.432 . . . . 1.28 111.023 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -77.47 141.87 39.46 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.643 -0.708 . . . . 1.28 109.678 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' MET . . . . . 0.708 ' SD ' ' HA3' ' B' ' 87' ' ' GLY . 49.0 tpp -115.19 -18.02 11.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.996 0.426 . . . . 2.7000000000000002 111.472 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -92.11 -42.9 9.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.373 -0.376 . . . . 1.96 111.617 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.38 -25.43 33.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.103 0.478 . . . . 1.0600000000000001 111.391 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -81.4 -13.99 57.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.263 -0.426 . . . . 1.47 111.411 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.71 43.49 35.56 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.862 -0.685 . . . . 0.81999999999999995 112.628 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . 0.708 ' HA3' ' SD ' ' B' ' 82' ' ' MET . . . -64.33 144.77 48.97 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.049 -0.596 . . . . 0.65000000000000002 112.426 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.35 146.73 51.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.455 -0.202 . . . . 1.8100000000000001 110.455 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' B' ' 7' ' ' TRP . 47.3 ttp180 -91.71 134.18 34.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.276 -0.42 . . . . 2.4900000000000002 110.108 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 94.9 mt -89.97 -63.84 1.22 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.438 -0.346 . . . . 0.76000000000000001 111.598 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -161.32 -173.84 4.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.55 -0.296 . . . . 1.0700000000000001 110.387 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' B' ' 4' ' ' GLY . 43.2 ttt85 -121.04 115.67 23.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.391 -0.368 . . . . 2.0499999999999998 110.705 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.659 ' HB ' HD11 ' B' ' 6' ' ' ILE . 9.4 p -75.03 136.69 72.91 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.939 -0.573 . . . . 1.45 109.61 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.652 ' HG2' HG21 ' B' ' 64' ' ' VAL . 90.7 Cg_exo -47.92 144.58 11.53 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.071 2.514 . . . . 1.03 112.922 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -33.32 68.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.66 -0.7 . . . . 2.1400000000000001 111.96 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -26.84 68.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.122 0.487 . . . . 1.78 111.128 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.416 ' HB ' HG22 ' B' ' 93' ' ' VAL . 30.0 mm -89.34 -37.03 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 1.3300000000000001 109.647 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 18.3 tpt -65.74 -30.34 70.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 2.3399999999999999 110.564 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -59.08 -34.14 71.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.794 -0.639 . . . . 1.9099999999999999 110.221 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.71 -44.48 90.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.939 -0.573 . . . . 1.76 109.687 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 34.9 t -59.55 -44.88 94.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.492 -0.776 . . . . 1.01 110.816 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.3 -40.35 85.93 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.117 0.484 . . . . 1.29 110.596 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.36 -39.13 94.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.934 -0.65 . . . . 1.02 111.886 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -67.55 -36.9 81.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.897 0.379 . . . . 1.8500000000000001 110.363 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.601 ' O ' HG12 ' B' ' 108' ' ' ILE . 68.5 mt -65.59 -21.59 66.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.935 -0.575 . . . . 1.9399999999999999 111.27 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 24.7 m -76.51 -14.32 60.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.008 0.433 . . . . 1.1599999999999999 111.168 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.491 ' HB ' ' HE1' ' B' ' 57' ' ' PHE . 3.0 m -93.3 -7.81 43.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.305 -0.407 . . . . 1.45 112.051 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.601 HG12 ' O ' ' B' ' 105' ' ' LEU . 13.1 pt -81.64 -21.01 10.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.959 0.409 . . . . 1.98 110.866 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 94.6 mt -94.07 47.5 1.21 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 1.3600000000000001 110.711 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.419 ' OXT' ' HG3' ' A' ' 30' ' ' PRO . 1.8 m . . . . . 0 C--O 1.255 1.372 0 CA-C-O 118.267 -0.873 . . . . 2.1299999999999999 110.235 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.417 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 8.0 ptp . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 121.337 0.589 . . . . 1.29 111.149 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -106.73 177.86 4.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.417 -0.81 . . . . 2.0099999999999998 111.039 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.496 ' NH2' ' HD3' ' A' ' 30' ' ' PRO . 9.1 ttm180 -80.93 124.33 29.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.829 -0.623 . . . . 1.8500000000000001 109.986 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.73 7.04 42.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.685 -0.769 . . . . 0.85999999999999999 112.803 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.53 ' OE2' ' HD2' ' A' ' 89' ' ' ARG . 66.4 mt-10 -94.74 151.18 19.47 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.614 -0.345 . . . . 0.98999999999999999 111.114 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.666 HD11 ' HG2' ' A' ' 91' ' ' GLU . 17.3 pt -110.35 113.92 45.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.111 0.481 . . . . 1.1599999999999999 110.191 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.439 ' C ' ' HA ' ' A' ' 24' ' ' PRO . 22.4 m95 -106.82 118.43 36.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.924 -0.58 . . . . 0.91000000000000003 111.779 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.2 tp -72.89 104.54 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.954 -0.566 . . . . 0.90000000000000002 110.47 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -144.63 161.13 14.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.304 -0.407 . . . . 1.04 110.865 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 t -96.96 130.02 44.34 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.887 -0.782 . . . . 1.3200000000000001 108.887 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.17 4.51 52.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.813 0.34 . . . . 1.29 111.17 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.494 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 6.2 m-20 -79.8 162.87 60.99 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.845 -0.616 . . . . 1.54 110.957 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 21.6 Cg_exo -66.48 144.58 68.15 Favored 'Cis proline' 0 C--N 1.351 0.7 0 C-N-CA 124.264 -1.14 . . . . 1.6899999999999999 112.588 0.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 20' ' ' GLN . 3.1 p -109.81 135.94 49.91 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.886 -0.597 . . . . 1.3600000000000001 112.045 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.64 117.45 31.94 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.044 -0.525 . . . . 1.7 110.2 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.99 -120.99 7.51 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.721 -0.752 . . . . 1.1799999999999999 112.543 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -109.73 36.52 2.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.734 0.302 . . . . 2.7799999999999998 111.393 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -68.54 173.68 4.83 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.69 -0.485 . . . . 1.1399999999999999 109.69 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.566 ' HG2' ' HB3' ' A' ' 44' ' ' PRO . 6.7 tp-100 -71.1 91.36 0.9 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.978 0.418 . . . . 2.0899999999999999 111.399 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.46 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 0.6 OUTLIER -94.12 152.74 18.53 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.658 -0.701 . . . . 2.0899999999999999 111.489 -179.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.04 168.85 16.51 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.957 -0.639 . . . . 1.0700000000000001 113.234 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.7 m -111.85 112.07 23.47 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.755 -0.461 . . . . 1.1100000000000001 109.755 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.37 159.97 37.83 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.265 -0.425 . . . . 1.6200000000000001 110.348 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HB2' ' HB ' ' A' ' 6' ' ' ILE . 11.3 Cg_exo -72.34 99.27 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.496 2.13 . . . . 1.01 110.916 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.485 HG12 ' HA ' ' A' ' 44' ' ' PRO . 17.0 m -80.12 142.28 14.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.232 -0.44 . . . . 0.76000000000000001 110.345 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.539 ' HB3' HG23 ' A' ' 43' ' ' VAL . 34.6 tp -84.98 126.02 33.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.252 -0.431 . . . . 0.69999999999999996 111.17 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.42 HD13 HG12 ' A' ' 42' ' ' VAL . 17.7 mm -78.86 114.98 20.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.382 -0.599 . . . . 0.92000000000000004 109.382 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.407 HG11 HD11 ' A' ' 105' ' ' LEU . 16.8 t -92.47 -22.85 5.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.935 0.398 . . . . 0.94999999999999996 111.659 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.87 152.03 68.33 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 111.791 0.293 . . . . 1.1200000000000001 111.791 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.66 ' HG2' ' HB2' ' A' ' 33' ' ' PHE . 38.2 Cg_endo -67.28 160.86 45.66 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.805 2.337 . . . . 1.3 111.736 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.45 -38.54 66.46 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.608 0.596 . . . . 1.3899999999999999 112.608 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.454 ' O ' HG12 ' A' ' 36' ' ' VAL . . . -66.55 -44.55 82.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.415 -0.357 . . . . 1.6100000000000001 111.569 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.729 ' HZ ' ' HB2' ' B' ' 75' ' ' ASP . 5.6 t80 -60.42 -37.7 81.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.039 0.447 . . . . 1.77 111.055 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.415 ' OD1' ' HB3' ' A' ' 40' ' ' PRO . 52.5 m-20 -67.49 -9.87 46.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.669 -0.696 . . . . 1.48 111.386 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 35' ' ' ARG . 36.8 ttp180 -112.08 -51.77 2.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.298 -0.41 . . . . 2.6200000000000001 111.588 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 32' ' ' ALA . 10.4 p -65.23 -47.74 86.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.294 0.479 . . . . 1.8600000000000001 112.294 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -88.62 -29.87 19.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.637 0.256 . . . . 1.72 110.94 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.433 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 9.3 ttt180 73.96 -10.74 1.06 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.802 -0.636 . . . . 4.4500000000000002 111.962 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.3 mt -108.51 99.03 31.1 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.286 -0.415 . . . . 1.8100000000000001 110.261 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.539 ' HD2' ' O ' ' A' ' 80' ' ' ILE . 3.0 Cg_endo -87.63 135.68 3.61 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.004 2.469 . . . . 1.05 112.785 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.67 HG22 HG23 ' A' ' 79' ' ' THR . 44.2 t -80.49 113.4 19.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.018 -1.475 . . . . 1.03 107.018 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.42 HG12 HD13 ' A' ' 27' ' ' ILE . 32.1 m -116.91 152.82 18.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 112.909 0.707 . . . . 0.77000000000000002 112.909 -178.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.539 HG23 ' HB3' ' A' ' 26' ' ' LEU . 5.2 m -115.94 131.08 23.91 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 114.91 -1.041 . . . . 0.71999999999999997 108.441 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HB3' ' HG2' ' A' ' 19' ' ' GLN . 58.4 Cg_endo -71.46 172.81 13.48 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.753 2.302 . . . . 1.03 114.449 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.3 t -137.43 135.35 46.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.665 -1.152 . . . . 1.28 108.135 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 C--N 1.326 -0.436 0 N-CA-C 111.552 0.204 . . . . 1.9099999999999999 111.552 -179.528 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.319 0 N-CA-C 112.772 -0.131 . . . . 1.6599999999999999 112.772 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -103.22 -13.53 16.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.968 0.413 . . . . 1.5600000000000001 111.022 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.84 109.71 19.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.2 -0.455 . . . . 1.25 109.81 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 m -101.19 139.34 22.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.058 0.456 . . . . 1.6799999999999999 111.592 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 p -86.78 144.39 27.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.192 -0.458 . . . . 1.95 110.544 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.0 mt -84.88 -8.82 58.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 1.23 110.872 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -67.56 131.64 46.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.821 -0.627 . . . . 2.21 109.928 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.99 -39.28 1.93 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.662 -0.575 . . . . 1.1499999999999999 111.662 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -93.7 -8.13 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.758 0.313 . . . . 1.21 111.03 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.89 98.26 0.24 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.855 -0.688 . . . . 1.0800000000000001 112.765 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 13.3 pt -122.26 165.69 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.815 0.34 . . . . 1.0700000000000001 111.143 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -91.94 -44.1 9.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.093 -0.503 . . . . 3.5899999999999999 110.398 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.04 -164.1 0.42 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.136 -0.483 . . . . 1.51 112.019 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.5 m -153.0 143.37 22.53 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.18 -0.304 . . . . 1.79 110.18 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.98 166.67 11.77 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.065 -0.588 . . . . 1.1799999999999999 111.777 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.9 139.73 26.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.558 0.179 . . . . 1.5600000000000001 110.569 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -72.38 126.84 33.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.752 0.31 . . . . 1.29 110.316 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.559 ' HB2' ' HG2' ' A' ' 44' ' ' PRO . 55.8 mmm-85 -104.91 92.62 4.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.078 -0.51 . . . . 2.23 111.63 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.8 m -88.18 4.89 43.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.993 -0.549 . . . . 1.1699999999999999 110.087 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.15 -14.44 38.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.624 -0.716 . . . . 0.89000000000000001 111.967 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -129.42 64.24 70.63 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 113.295 0.85 . . . . 2.1299999999999999 113.295 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.43 134.76 23.15 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.201 1.934 . . . . 0.80000000000000004 110.035 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' B' ' 78' ' ' ARG . 2.4 ptm85 -154.74 145.68 22.6 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.109 0.781 . . . . 2.0899999999999999 113.109 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.67 HG23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -96.41 115.02 26.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.37 -0.832 . . . . 1.6200000000000001 109.502 178.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.539 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 1.7 pp -133.78 138.85 49.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.995 -0.372 . . . . 1.1499999999999999 109.995 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.527 ' HB3' ' HA3' ' B' ' 16' ' ' GLY . 21.1 t70 -69.08 118.38 11.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.99 0.424 . . . . 1.03 111.212 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 57.7 tpp -87.47 -13.64 42.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.861 -0.608 . . . . 1.29 111.148 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -71.18 -53.37 14.71 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.162 0.43 . . . . 2.6400000000000001 112.162 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.17 -25.12 59.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.929 0.395 . . . . 1.1200000000000001 111.888 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 65.7 mtt-85 -82.35 -48.91 10.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.226 -0.443 . . . . 1.0600000000000001 111.799 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.74 114.8 0.21 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.623 -0.798 . . . . 1.1200000000000001 112.474 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -129.61 163.25 22.74 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.812 -0.709 . . . . 1.0900000000000001 112.189 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -103.92 129.15 51.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.164 -0.31 . . . . 2.46 110.164 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.53 ' HD2' ' OE2' ' A' ' 5' ' ' GLU . 2.5 ttp180 -85.64 115.18 23.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.738 0.304 . . . . 2.4900000000000002 110.765 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -86.14 -71.84 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.415 -0.357 . . . . 1.29 110.719 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.666 ' HG2' HD11 ' A' ' 6' ' ' ILE . 3.2 pt-20 -149.29 -169.32 3.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.137 -0.483 . . . . 1.1499999999999999 109.724 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -135.04 143.01 46.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.749 0.309 . . . . 1.3200000000000001 110.444 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.3 m -83.45 153.65 65.45 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.267 -0.424 . . . . 0.75 111.305 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.39 157.94 33.7 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.753 2.302 . . . . 0.94999999999999996 111.467 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.79 -27.16 67.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.689 0.28 . . . . 1.51 111.621 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.24 -45.97 85.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.282 -0.417 . . . . 1.5700000000000001 110.575 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.8 mm -66.32 -40.75 87.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.953 -0.567 . . . . 1.3100000000000001 110.007 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 9.5 tpt -62.29 -38.82 90.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.863 -0.608 . . . . 1.6000000000000001 110.486 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -64.56 -34.22 77.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.968 -0.56 . . . . 2.2999999999999998 111.193 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.5 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 6.4 tp10 -64.12 -48.87 74.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.908 -0.587 . . . . 1.6399999999999999 110.386 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.6 t -59.28 -43.23 89.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.157 -0.474 . . . . 1.03 110.609 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.78 -34.59 78.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.846 -0.616 . . . . 1.22 111.429 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.94 -27.6 66.37 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.245 -0.502 . . . . 1.03 113.077 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 9.8 mmt180 -77.04 -33.29 57.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.125 0.488 . . . . 1.72 110.553 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 89.9 mt -66.19 -30.91 71.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.935 -0.575 . . . . 1.02 111.69 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -27.95 68.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.873 0.368 . . . . 1.1100000000000001 111.299 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 m -72.85 -31.0 64.44 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.086 0.402 . . . . 1.5 112.086 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.4 pt -86.07 -3.32 8.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.464 0.542 . . . . 1.1499999999999999 112.464 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 105' ' ' LEU . 84.3 mt -85.04 69.88 10.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.859 0.362 . . . . 0.97999999999999998 110.159 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.373 -0.376 . . . . 1.3500000000000001 111.935 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' B' ' 27' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 121.213 0.53 . . . . 2.0299999999999998 112.147 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . 0.52 ' HB3' ' HG3' ' B' ' 5' ' ' GLU . 3.2 mm-40 -85.46 9.69 15.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.086 0.47 . . . . 2.8199999999999998 110.198 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' B' ' 2' ' ' GLU . 0.0 OUTLIER 81.76 58.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.118 -0.946 . . . . 2.3199999999999998 113.207 179.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . 0.501 ' O ' ' HG3' ' B' ' 92' ' ' ARG . . . 69.94 57.64 6.89 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.593 -0.731 . . . . 1.28 114.321 178.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.52 ' HG3' ' HB3' ' B' ' 2' ' ' GLU . 5.5 mm-40 -115.98 117.45 30.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.863 0.331 . . . . 1.53 111.674 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.53 HD12 ' HG3' ' B' ' 91' ' ' GLU . 66.6 mt -99.78 120.06 48.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 0.75 109.798 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -114.74 144.77 42.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.428 -0.351 . . . . 0.81000000000000005 110.693 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.404 ' HB2' HD11 ' B' ' 90' ' ' LEU . 38.0 tp -105.8 117.1 33.16 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.221 -0.445 . . . . 1.05 110.0 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.408 HG22 ' H ' ' B' ' 10' ' ' SER . 9.5 p -158.89 167.54 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.71999999999999997 110.244 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' B' ' 22' ' ' THR . 7.0 m -88.88 137.64 32.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.851 0.358 . . . . 1.6299999999999999 110.54 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.605 HD21 HG11 ' B' ' 25' ' ' VAL . 55.7 mt -85.09 -21.36 29.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.323 -0.399 . . . . 0.82999999999999996 110.999 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . 0.459 ' HA ' ' N ' ' B' ' 14' ' ' THR . 3.7 m-20 -60.19 153.29 58.25 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.862 -0.608 . . . . 1.6200000000000001 110.829 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.02 120.64 5.84 Favored 'Cis proline' 0 C--O 1.235 0.341 0 C-N-CA 123.534 -1.444 . . . . 1.28 113.741 0.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.459 ' N ' ' HA ' ' B' ' 12' ' ' ASP . 0.1 OUTLIER -121.11 146.68 46.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.297 -0.865 . . . . 1.47 108.95 179.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.07 -177.79 5.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.913 0.387 . . . . 1.22 111.979 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.527 ' HA3' ' HB3' ' A' ' 81' ' ' ASP . . . 60.79 -106.03 0.98 Allowed Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.006 -0.543 . . . . 1.01 113.34 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . 0.405 ' H ' ' HB2' ' A' ' 81' ' ' ASP . 10.2 t-160 -115.89 8.49 14.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.845 0.355 . . . . 2.1800000000000002 110.365 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.418 ' HB3' HG22 ' B' ' 14' ' ' THR . 14.7 mt-10 -71.04 148.92 47.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 1.28 110.132 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -77.73 107.24 10.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.48 -0.327 . . . . 1.52 111.013 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.457 ' HA ' ' OG1' ' B' ' 14' ' ' THR . 91.2 mt-30 -83.31 164.97 19.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.012 -0.54 . . . . 1.8600000000000001 111.675 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.72 -169.75 28.84 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.01 -0.615 . . . . 0.90000000000000002 113.625 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' B' ' 10' ' ' SER . 35.8 m -108.24 119.99 41.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.654 -0.498 . . . . 0.94999999999999996 109.654 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.446 ' HD3' HD12 ' B' ' 11' ' ' LEU . 0.1 OUTLIER -146.63 154.34 48.13 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.192 -0.458 . . . . 1.5900000000000001 110.487 -179.317 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -63.28 135.91 52.8 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.46 2.107 . . . . 0.65000000000000002 110.72 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.758 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 14.2 m -132.85 151.56 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.174 0.512 . . . . 0.56999999999999995 111.425 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 mp -109.42 122.35 47.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.682 -0.69 . . . . 1.1699999999999999 109.918 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . 0.507 ' O ' ' HG2' ' B' ' 1' ' ' MET . 43.8 mt -70.08 120.23 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.697 0.284 . . . . 0.66000000000000003 110.827 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.734 ' HB ' HG23 ' B' ' 41' ' ' VAL . 18.4 t -79.33 -40.93 22.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.051 -0.522 . . . . 0.93000000000000005 111.519 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.9 146.19 95.07 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.973 -0.558 . . . . 0.81000000000000005 111.455 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.79 164.16 34.17 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.752 2.302 . . . . 0.78000000000000003 112.591 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.46 -40.57 71.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.496 -0.775 . . . . 1.03 111.807 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.01 0.84 4.02 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.702 0.63 . . . . 1.3999999999999999 112.702 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -119.31 -40.9 2.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.208 0.528 . . . . 1.5700000000000001 109.736 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.17 -32.97 70.38 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.517 -0.765 . . . . 1.6399999999999999 111.863 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.52 2.84 55.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.132 -0.485 . . . . 2.54 112.261 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 64.2 t -113.27 -46.13 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.924 0.392 . . . . 1.0900000000000001 110.421 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 10.3 m -87.09 -24.26 24.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.349 0.595 . . . . 1.3300000000000001 110.1 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.861 ' HE ' ' HA ' ' B' ' 38' ' ' ARG . 0.6 OUTLIER 75.16 -38.1 0.36 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.848 1.055 . . . . 1.78 113.848 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 89.7 mt -99.59 101.84 14.75 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.978 -0.379 . . . . 1.1599999999999999 109.978 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' B' ' 38' ' ' ARG . 90.1 Cg_endo -94.12 163.69 2.08 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.907 2.404 . . . . 0.56999999999999995 113.889 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.734 HG23 ' HB ' ' B' ' 28' ' ' VAL . 1.8 m -96.13 138.35 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.782 -0.821 . . . . 1.0800000000000001 108.782 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.758 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 17.8 m -126.09 150.12 31.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 113.205 0.817 . . . . 0.64000000000000001 113.205 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.441 HG23 HG22 ' B' ' 28' ' ' VAL . 24.4 t -97.62 111.74 59.51 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.022 -0.99 . . . . 1.1000000000000001 108.835 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.658 ' HA ' HG12 ' B' ' 25' ' ' VAL . 11.8 Cg_exo -70.93 127.83 14.17 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.9 2.4 . . . . 0.72999999999999998 112.722 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.652 HG22 HG12 ' B' ' 72' ' ' VAL . 61.8 t -99.98 133.45 42.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.055 -0.521 . . . . 0.90000000000000002 109.887 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -98.17 92.1 5.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.34 -0.391 . . . . 1.1699999999999999 110.489 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 116.011 -0.541 . . . . 1.8500000000000001 110.602 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.891 0.377 . . . . 1.96 110.411 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.64 -88.3 0.36 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.124 -0.56 . . . . 1.0800000000000001 112.732 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -104.95 -17.06 14.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.969 0.414 . . . . 3.5699999999999998 110.045 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.594 ' HB1' ' HB ' ' B' ' 71' ' ' VAL . . . -82.64 120.0 25.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.862 -0.608 . . . . 1.0800000000000001 111.566 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 t -119.8 134.55 62.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.069 -0.715 . . . . 1.3400000000000001 109.069 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 37.5 p -76.26 135.79 39.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.667 0.27 . . . . 1.3799999999999999 111.234 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 77.9 mt -89.72 -0.96 57.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.157 0.503 . . . . 1.02 110.626 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.65 148.2 28.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.958 -0.565 . . . . 1.79 111.152 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.4 -38.1 3.47 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.913 -0.66 . . . . 1.1499999999999999 112.336 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 10.8 p -81.36 -26.28 10.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.749 0.278 . . . . 1.1699999999999999 111.749 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.05 22.93 3.4 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.435 -0.888 . . . . 1.05 113.362 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 61.4 mt -90.61 138.51 19.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.541 -0.54 . . . . 1.6100000000000001 109.541 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . 0.402 ' HD2' HH11 ' B' ' 67' ' ' ARG . 28.0 ttt85 -68.31 -42.48 79.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.004 0.43 . . . . 2.3999999999999999 110.704 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 16.5 m -68.12 97.47 0.7 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.536 -0.756 . . . . 0.93000000000000005 110.957 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.6 97.61 10.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.923 -0.581 . . . . 1.3100000000000001 111.432 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.65 -179.75 46.35 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.739 -0.744 . . . . 0.79000000000000004 111.702 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.594 ' HB ' ' HB1' ' B' ' 58' ' ' ALA . 8.5 m -105.81 136.49 39.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.705 0.288 . . . . 0.93000000000000005 110.8 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.652 HG12 HG22 ' B' ' 45' ' ' VAL . 10.0 m -84.27 137.28 21.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.961 0.41 . . . . 1.3799999999999999 111.478 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 32.9 mmm-85 -113.32 85.97 2.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.191 -0.459 . . . . 1.3700000000000001 110.114 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 5.2 m -82.12 6.3 16.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.184 -0.462 . . . . 1.1599999999999999 111.266 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.729 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 10.1 p-10 -87.43 -10.47 51.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.863 -0.608 . . . . 1.1000000000000001 111.56 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -135.29 78.34 52.13 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 112.896 0.702 . . . . 2.4700000000000002 112.896 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.89 98.99 0.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.737 2.291 . . . . 0.95999999999999996 111.729 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 12.2 ttt180 -102.64 140.68 36.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.381 -0.372 . . . . 1.96 111.497 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.511 HG23 HG13 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -76.03 125.74 29.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 1.1899999999999999 109.67 178.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.416 ' O ' ' HD2' ' B' ' 40' ' ' PRO . 26.8 pt -131.32 -179.7 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.454 -0.339 . . . . 1.28 110.189 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.401 ' O ' ' HD2' ' B' ' 85' ' ' ARG . 7.0 t70 -97.52 139.86 32.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.368 . . . . 1.28 110.867 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' MET . . . . . 0.429 ' SD ' ' HA3' ' B' ' 87' ' ' GLY . 35.6 tpp -126.03 29.74 5.81 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.395 -0.594 . . . . 2.7000000000000002 109.395 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -121.14 -55.93 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.703 -0.68 . . . . 1.96 111.352 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.53 -33.96 15.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.133 -0.485 . . . . 1.0600000000000001 110.653 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.401 ' HD2' ' O ' ' B' ' 81' ' ' ASP . 75.3 mtt180 -63.94 -23.05 67.19 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.863 -0.608 . . . . 1.47 111.428 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.0 90.38 0.83 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.94 -0.648 . . . . 0.81999999999999995 112.623 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . 0.429 ' HA3' ' SD ' ' B' ' 82' ' ' MET . . . -96.89 133.13 11.27 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.532 -0.842 . . . . 0.65000000000000002 112.253 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -139.04 130.29 26.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.6 0.238 . . . . 1.8100000000000001 110.818 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -83.08 127.93 34.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.471 -0.332 . . . . 2.4900000000000002 110.268 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' B' ' 8' ' ' LEU . 94.3 mt -91.14 -72.62 0.57 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.188 -0.46 . . . . 0.76000000000000001 111.557 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . 0.53 ' HG3' HD12 ' B' ' 6' ' ' ILE . 16.8 pt-20 -133.42 169.93 16.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.094 -0.503 . . . . 1.0700000000000001 110.722 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' B' ' 4' ' ' GLY . 15.2 ttm180 -104.48 141.62 36.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.183 -0.462 . . . . 2.0499999999999998 110.193 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' B' ' 94' ' ' PRO . 60.3 t -83.1 132.38 50.76 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.906 -0.588 . . . . 1.45 110.68 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' B' ' 93' ' ' VAL . 31.6 Cg_exo -62.64 155.74 57.06 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.601 2.2 . . . . 1.03 110.758 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.28 -38.92 74.69 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.321 0.489 . . . . 2.1400000000000001 112.321 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.95 -39.21 88.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.974 0.416 . . . . 1.78 111.12 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 30.0 mm -82.47 -32.02 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.158 -0.474 . . . . 1.3300000000000001 110.434 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 12.7 tpt -58.66 -45.04 90.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 2.3399999999999999 110.239 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -64.57 -35.07 79.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.998 -0.546 . . . . 1.9099999999999999 110.302 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 11.1 tp10 -60.06 -44.47 94.69 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.771 -0.649 . . . . 1.76 109.959 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' B' ' 105' ' ' LEU . 55.9 t -60.99 -44.85 99.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.039 -0.528 . . . . 1.01 110.197 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.44 -42.0 90.92 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.048 -0.524 . . . . 1.29 110.559 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.79 -42.8 98.41 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.433 -0.667 . . . . 1.02 111.433 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 12.3 mmt180 -63.97 -32.74 74.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.038 0.447 . . . . 1.8500000000000001 110.793 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' B' ' 101' ' ' VAL . 93.8 mt -68.91 -20.91 64.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.021 -0.536 . . . . 1.9399999999999999 110.815 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 5.7 m -86.06 -24.73 26.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.159 -0.473 . . . . 1.1599999999999999 109.944 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.1 m -68.29 -37.41 80.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 1.45 111.214 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.44 HG21 ' HA ' ' B' ' 75' ' ' ASP . 39.2 pt -76.43 0.23 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.333 -0.394 . . . . 1.98 112.036 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 96.3 mt -91.26 10.26 27.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.922 0.391 . . . . 1.3600000000000001 110.967 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.792 -0.623 . . . . 2.1299999999999999 110.219 179.903 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.565 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 23.4 ptp . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 120.814 0.34 . . . . 1.29 110.883 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.404 ' HG2' ' HB2' ' A' ' 31' ' ' ALA . 39.6 mt-10 -124.96 169.72 11.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.106 -0.497 . . . . 2.0099999999999998 110.612 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.496 ' NH2' ' HD3' ' A' ' 30' ' ' PRO . 24.2 ttm180 -71.52 128.01 34.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.909 -0.587 . . . . 1.8500000000000001 109.671 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.409 ' HA3' ' NH2' ' A' ' 92' ' ' ARG . . . 104.11 -6.04 46.51 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.622 -0.799 . . . . 0.85999999999999999 112.492 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 57.5 mt-10 -79.92 147.68 31.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.877 0.37 . . . . 0.98999999999999999 110.782 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.469 HD12 ' HG3' ' A' ' 91' ' ' GLU . 59.5 mt -109.88 119.91 59.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.178 -0.465 . . . . 1.1599999999999999 109.86 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.415 ' CZ2' ' HB3' ' A' ' 1' ' ' MET . 21.2 m95 -114.93 149.9 36.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.012 -0.54 . . . . 0.91000000000000003 110.782 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.0 tp -106.01 118.39 36.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.776 -0.193 . . . . 0.90000000000000002 110.491 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 p -166.14 148.95 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 120.948 0.404 . . . . 1.04 110.814 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.7 OUTLIER -77.17 141.66 40.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.356 -0.384 . . . . 1.3200000000000001 110.607 179.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.484 HD21 HG11 ' A' ' 25' ' ' VAL . 69.2 mt -97.58 4.11 50.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.157 0.503 . . . . 1.29 111.252 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.845 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -72.08 179.9 0.92 Allowed Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.642 -0.708 . . . . 1.54 110.302 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.845 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 5.8 Cg_exo -79.65 134.89 32.76 Favored 'Cis proline' 0 C--N 1.354 0.822 0 CA-C-N 119.736 0.942 . . . . 1.6899999999999999 112.62 0.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 20' ' ' GLN . 58.2 p -108.14 155.41 20.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.663 -0.699 . . . . 1.3600000000000001 111.144 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.2 102.56 5.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.138 -0.69 . . . . 1.7 109.138 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.37 -116.21 3.87 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.505 -1.438 . . . . 1.1799999999999999 109.505 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.46 ' HB3' ' HD2' ' B' ' 83' ' ' LYS . 77.0 t60 -134.06 78.55 1.77 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.065 0.459 . . . . 2.7799999999999998 111.75 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 33.6 mt-10 -110.59 -149.32 0.44 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.791 -0.818 . . . . 1.1399999999999999 108.791 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -82.58 53.77 2.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.312 0.577 . . . . 2.0899999999999999 110.007 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.474 ' HG2' ' H ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -68.31 128.77 37.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.294 -0.866 . . . . 2.0899999999999999 112.006 -179.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.99 146.84 9.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.83 -0.7 . . . . 1.0700000000000001 113.445 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 21.2 m -79.31 121.1 24.68 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.715 -0.476 . . . . 1.1100000000000001 109.715 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -145.48 161.51 40.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.437 -0.347 . . . . 1.6200000000000001 110.354 -179.224 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.32 145.75 60.67 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.104 1.87 . . . . 1.01 110.289 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.729 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 15.1 m -128.75 140.12 50.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.42 -0.354 . . . . 0.76000000000000001 110.55 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.487 ' HB3' HG23 ' A' ' 43' ' ' VAL . 42.1 tp -95.04 128.64 42.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.034 -0.53 . . . . 0.69999999999999996 110.822 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.13 109.34 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.801 -0.444 . . . . 0.92000000000000004 109.801 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.59 HG11 HD11 ' A' ' 105' ' ' LEU . 17.1 t -86.95 -27.91 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 120.997 0.427 . . . . 0.94999999999999996 111.413 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.85 145.41 74.28 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.294 -0.412 . . . . 1.1200000000000001 111.411 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.496 ' HD3' ' NH2' ' A' ' 3' ' ' ARG . 58.2 Cg_endo -71.69 158.91 52.34 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.646 2.231 . . . . 1.3 112.173 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.404 ' HB2' ' HG2' ' A' ' 2' ' ' GLU . . . -53.25 -40.04 64.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.993 -0.549 . . . . 1.3899999999999999 112.206 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.31 -50.18 74.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.331 -0.395 . . . . 1.6100000000000001 111.767 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -63.93 -38.41 90.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.115 0.483 . . . . 1.77 110.885 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 85.2 m-20 -67.53 -20.84 65.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.732 -0.667 . . . . 1.48 111.051 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -91.33 -35.03 14.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.197 -0.456 . . . . 2.6200000000000001 112.003 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.57 -50.3 15.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.693 0.627 . . . . 1.8600000000000001 112.693 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 m -87.38 -31.61 20.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.855 0.359 . . . . 1.72 110.95 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.718 ' HB3' ' HE2' ' A' ' 83' ' ' LYS . 0.7 OUTLIER 66.46 23.38 10.54 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.795 -0.639 . . . . 4.4500000000000002 111.543 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.7 mt -132.35 100.43 15.31 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.442 -0.799 . . . . 1.8100000000000001 109.053 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -89.69 140.45 3.58 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.629 2.219 . . . . 1.05 114.163 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.1 t -90.36 124.37 42.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.221 -1.4 . . . . 1.03 107.221 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.729 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 31.4 m -123.43 163.97 21.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 113.542 0.942 . . . . 0.77000000000000002 113.542 -177.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -122.93 134.56 25.13 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 114.307 -1.315 . . . . 0.71999999999999997 108.686 178.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.11 128.86 10.91 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.927 2.418 . . . . 1.03 114.674 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.786 HG22 HG22 ' A' ' 72' ' ' VAL . 58.0 t -88.6 118.44 34.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.021 -0.733 . . . . 1.28 109.021 178.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.454 ' HB ' ' NH1' ' A' ' 73' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.478 0 N-CA-C 110.163 -0.31 . . . . 1.9099999999999999 110.163 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 CA-C-O 120.706 0.059 . . . . 1.6599999999999999 113.048 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.504 ' HE2' ' HB ' ' A' ' 107' ' ' THR . 57.8 m-85 -106.34 17.07 23.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.906 0.384 . . . . 1.5600000000000001 111.778 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . . . -81.68 137.39 35.42 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.226 -0.657 . . . . 1.25 109.226 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.609 HG22 ' HB ' ' A' ' 72' ' ' VAL . 16.5 m -88.44 161.16 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.047 0.451 . . . . 1.6799999999999999 111.731 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -84.67 93.5 8.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.988 -0.551 . . . . 1.95 111.641 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.841 HD11 HG23 ' A' ' 72' ' ' VAL . 7.2 mt -87.11 -33.79 19.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.341 -0.39 . . . . 1.23 111.923 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -68.71 114.79 7.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.023 0.439 . . . . 2.21 111.788 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.47 -10.78 5.53 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.652 -0.785 . . . . 1.1499999999999999 113.004 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 61' ' ' LEU . 19.6 m -90.61 -16.11 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 117.224 0.512 . . . . 1.21 111.49 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.88 51.77 7.56 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 121.066 -0.588 . . . . 1.0800000000000001 113.461 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.504 ' HB ' ' OE2' ' A' ' 91' ' ' GLU . 20.1 pt -103.72 -171.73 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.718 0.294 . . . . 1.0700000000000001 111.155 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 54.7 ttm-85 -102.23 -33.65 9.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.103 -0.499 . . . . 3.5899999999999999 110.28 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.487 ' HB ' HD12 ' A' ' 66' ' ' ILE . 21.8 m -55.85 117.55 3.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.412 -0.813 . . . . 1.51 111.132 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.19 109.6 21.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.973 -0.558 . . . . 1.79 110.558 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.72 -165.43 28.41 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.629 -0.795 . . . . 1.1799999999999999 112.115 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 81.6 t -132.69 129.63 58.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.797 0.332 . . . . 1.5600000000000001 110.742 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.841 HG23 HD11 ' A' ' 61' ' ' LEU . 69.9 t -72.18 110.96 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.874 -0.788 . . . . 1.29 108.874 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.597 ' HB3' ' OD2' ' A' ' 75' ' ' ASP . 12.1 mtm-85 -99.68 121.57 41.43 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.326 -0.397 . . . . 2.23 110.516 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 14.4 m -98.57 34.7 1.97 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.274 -0.421 . . . . 1.1699999999999999 110.784 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.597 ' OD2' ' HB3' ' A' ' 73' ' ' ARG . 0.5 OUTLIER -76.53 -60.96 2.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.232 -0.44 . . . . 0.89000000000000001 110.868 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.849 ' HB3' HG21 ' B' ' 79' ' ' THR . 4.3 mm100 -115.51 80.63 8.12 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.291 -0.413 . . . . 2.1299999999999999 111.4 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -84.3 156.16 12.69 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.639 2.226 . . . . 0.80000000000000004 111.118 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -168.32 166.4 12.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.056 0.455 . . . . 2.0899999999999999 111.265 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.461 ' OG1' ' HD2' ' B' ' 77' ' ' PRO . 24.2 m -92.53 145.49 24.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.625 -0.716 . . . . 1.6200000000000001 109.174 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.479 HG21 HD22 ' A' ' 11' ' ' LEU . 26.6 pt -135.3 150.79 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.684 0.278 . . . . 1.1499999999999999 110.529 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.94 142.7 47.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.043 -0.526 . . . . 1.03 110.051 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 35.4 tpp -121.55 5.61 10.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.186 0.517 . . . . 1.29 110.78 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.718 ' HE2' ' HB3' ' A' ' 38' ' ' ARG . 6.0 mptp? -93.43 -46.54 7.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.2 -0.454 . . . . 2.6400000000000001 111.043 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.704 ' HB3' ' HA2' ' B' ' 16' ' ' GLY . . . -93.02 -40.6 10.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.389 -0.369 . . . . 1.1200000000000001 110.47 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -62.31 -57.6 10.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.389 -0.368 . . . . 1.0600000000000001 110.304 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.24 84.94 0.19 Allowed Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.909 -0.662 . . . . 1.1200000000000001 113.505 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.34 172.56 47.22 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.704 -0.76 . . . . 1.0900000000000001 111.867 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -122.29 122.45 39.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.064 -0.346 . . . . 2.46 110.064 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -77.88 137.39 38.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.631 0.253 . . . . 2.4900000000000002 110.937 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 90' ' ' LEU . 2.6 mm? -112.64 -81.05 0.59 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.227 -0.442 . . . . 1.29 110.291 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.504 ' OE2' ' HB ' ' A' ' 66' ' ' ILE . 18.2 pt-20 -131.05 -163.71 1.35 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.221 -0.445 . . . . 1.1499999999999999 110.738 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.409 ' NH2' ' HA3' ' A' ' 4' ' ' GLY . 4.0 ptm180 -147.63 155.19 41.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.564 0.221 . . . . 1.3200000000000001 110.56 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.464 HG13 HD11 ' A' ' 6' ' ' ILE . 26.6 m -103.58 156.36 35.64 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.289 -0.414 . . . . 0.75 111.399 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -69.28 166.88 25.48 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.762 2.308 . . . . 0.94999999999999996 111.73 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -58.82 -24.11 61.47 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.437 -0.347 . . . . 1.51 111.769 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -40.74 87.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.285 -0.416 . . . . 1.5700000000000001 110.825 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.5 mm -71.04 -37.78 69.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 1.3100000000000001 110.186 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.7 tpt -62.0 -37.21 83.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 1.6000000000000001 110.472 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -64.16 -35.59 81.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.071 0.462 . . . . 2.2999999999999998 110.085 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 0.1 OUTLIER -64.59 -44.99 88.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.763 -0.653 . . . . 1.6399999999999999 109.62 178.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.5 t -64.23 -41.26 91.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.714 -0.675 . . . . 1.03 110.597 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.9 mt -55.56 -43.01 75.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.107 -0.497 . . . . 1.22 110.742 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.6 -41.95 98.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.909 -0.662 . . . . 1.03 111.897 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 19.5 mmt180 -62.05 -45.89 91.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.761 0.315 . . . . 1.72 110.529 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.59 HD11 HG11 ' A' ' 28' ' ' VAL . 93.9 mt -62.65 -40.65 97.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.037 -0.529 . . . . 1.02 111.104 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.1 m -70.78 -3.06 16.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 1.1100000000000001 111.596 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.504 ' HB ' ' HE2' ' A' ' 57' ' ' PHE . 24.7 m -105.11 -34.11 8.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.789 0.328 . . . . 1.5 110.806 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.412 ' O ' ' HD3' ' B' ' 30' ' ' PRO . 41.2 pt -79.97 -23.31 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 111.996 0.369 . . . . 1.1499999999999999 111.996 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.0 mt -76.21 81.84 3.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.97999999999999998 111.023 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.755 -0.657 . . . . 1.3500000000000001 109.835 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.609 ' HE3' ' HB ' ' B' ' 27' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.133 0 CA-C-O 121.616 0.722 . . . . 2.0299999999999998 112.736 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . 0.551 ' HG2' ' HB2' ' B' ' 31' ' ' ALA . 37.3 mt-10 -86.59 -19.57 29.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.259 -0.882 . . . . 2.8199999999999998 109.315 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' B' ' 2' ' ' GLU . 8.3 mpt_? 77.82 115.18 0.06 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.913 -1.039 . . . . 2.3199999999999998 112.759 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.23 49.48 4.95 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.879 -0.6 . . . . 1.28 114.128 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.465 ' HB2' ' HE3' ' B' ' 1' ' ' MET . 73.9 mm-40 -126.58 88.33 2.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.58 0.585 . . . . 1.53 112.58 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.849 HD11 ' HB ' ' B' ' 93' ' ' VAL . 60.8 mt -102.21 107.45 21.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.88 -0.785 . . . . 0.75 108.88 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -108.03 160.36 15.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.91 -0.587 . . . . 0.81000000000000005 111.198 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 42.0 tp -111.84 121.47 45.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.914 -0.772 . . . . 1.05 108.914 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.567 HG11 HD13 ' B' ' 80' ' ' ILE . 5.2 p -152.17 157.32 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 120.787 0.327 . . . . 0.71999999999999997 110.536 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 47.6 m -83.13 119.25 24.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.246 -0.433 . . . . 1.6299999999999999 110.083 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.466 HD21 HG11 ' B' ' 25' ' ' VAL . 88.8 mt -72.42 -26.31 61.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.161 -0.472 . . . . 0.82999999999999996 111.071 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.26 149.78 86.34 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.88 -0.6 . . . . 1.6200000000000001 110.497 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.07 140.78 30.95 Favored 'Cis proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.58 -1.425 . . . . 1.28 112.561 0.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.72 129.4 36.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.981 -0.554 . . . . 1.47 109.655 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.88 173.6 6.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.367 -0.379 . . . . 1.22 111.497 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 84' ' ' ALA . . . 70.41 -134.27 24.42 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.643 -0.708 . . . . 1.01 113.271 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -114.28 29.21 8.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.974 0.416 . . . . 2.1800000000000002 110.305 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -83.02 168.53 16.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.752 -0.658 . . . . 1.28 110.664 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -74.15 133.26 42.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.22 0.533 . . . . 1.52 111.962 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -125.02 -178.28 4.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.762 -0.654 . . . . 1.8600000000000001 110.809 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.71 166.92 42.75 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.235 -0.507 . . . . 0.90000000000000002 113.583 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.9 m -96.52 110.15 22.6 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.996 -0.742 . . . . 0.94999999999999996 108.996 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.85 162.97 27.7 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.466 -0.334 . . . . 1.5900000000000001 110.246 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.87 141.57 98.18 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.447 2.098 . . . . 0.65000000000000002 111.209 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.762 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 9.7 m -135.11 139.76 46.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.103 -0.498 . . . . 0.56999999999999995 110.654 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 61.3 tp -99.98 121.98 42.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.127 -0.488 . . . . 1.1699999999999999 109.837 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . 0.609 ' HB ' ' HE3' ' B' ' 1' ' ' MET . 16.7 mt -72.26 145.5 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.425 -0.352 . . . . 0.66000000000000003 110.073 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.513 ' HB ' HG23 ' B' ' 41' ' ' VAL . 19.2 t -112.36 -27.72 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 120.8 0.333 . . . . 0.93000000000000005 111.525 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' THR . . . . . 0.527 HG23 HG22 ' B' ' 41' ' ' VAL . 0.2 OUTLIER -69.77 148.16 96.48 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.503 -0.317 . . . . 0.81000000000000005 111.84 -179.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 91.6 Cg_endo -77.62 176.17 10.37 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.962 2.441 . . . . 0.78000000000000003 113.54 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.551 ' HB2' ' HG2' ' B' ' 2' ' ' GLU . . . -66.93 -31.3 71.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.476 -0.784 . . . . 1.03 110.736 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.24 18.37 0.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.944 -0.571 . . . . 1.3999999999999999 110.946 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -137.16 -53.62 0.69 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.033 -0.53 . . . . 1.5700000000000001 110.023 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -57.12 -39.61 75.47 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.99 -0.55 . . . . 1.6399999999999999 111.953 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -92.67 8.27 39.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.23 -0.441 . . . . 2.54 111.59 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 62.7 t -116.01 -64.04 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.284 -0.416 . . . . 1.0900000000000001 111.157 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 37.1 p -78.52 -16.23 57.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.335 0.588 . . . . 1.3300000000000001 110.493 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.661 ' HB2' ' NZ ' ' B' ' 83' ' ' LYS . 0.1 OUTLIER 60.62 29.77 19.25 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.365 -0.834 . . . . 1.78 110.684 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 30.5 mt -143.24 102.74 5.14 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.35 -0.841 . . . . 1.1599999999999999 109.282 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' B' ' 80' ' ' ILE . 96.9 Cg_endo -97.18 149.35 0.94 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.778 2.319 . . . . 0.56999999999999995 113.571 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.527 HG22 HG23 ' B' ' 29' ' ' THR . 16.2 m -97.44 133.68 38.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.58 -1.267 . . . . 1.0800000000000001 107.58 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.762 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 24.9 m -127.18 153.78 36.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 113.981 1.104 . . . . 0.64000000000000001 113.981 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 54.4 t -103.61 119.36 55.0 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 114.43 -1.259 . . . . 1.1000000000000001 108.216 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.556 ' HA ' HG12 ' B' ' 25' ' ' VAL . 46.3 Cg_endo -68.51 126.23 13.88 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.889 2.393 . . . . 0.72999999999999998 113.217 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.763 HG22 HG12 ' B' ' 72' ' ' VAL . 87.8 t -88.89 135.98 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.826 -0.625 . . . . 0.90000000000000002 109.353 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -114.21 96.62 5.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.502 -0.317 . . . . 1.1699999999999999 110.378 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.026 -0.534 . . . . 1.8500000000000001 110.827 179.578 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.747 0.308 . . . . 1.96 110.469 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.78 -98.43 0.29 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.118 -0.563 . . . . 1.0800000000000001 113.099 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -86.55 -16.21 37.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.825 0.345 . . . . 3.5699999999999998 111.398 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.51 131.45 34.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.311 -0.404 . . . . 1.0800000000000001 110.523 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -113.17 144.24 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 1.3400000000000001 110.143 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -80.62 113.19 18.63 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.06 0.393 . . . . 1.3799999999999999 112.06 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 97.9 mt -88.55 -7.17 56.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.654 0.74 . . . . 1.02 109.016 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -98.07 141.24 31.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.143 -0.935 . . . . 1.79 109.767 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.91 -58.06 0.7 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.723 -0.751 . . . . 1.1499999999999999 112.125 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 p -75.7 -26.85 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.076 0.465 . . . . 1.1699999999999999 111.294 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.93 57.83 0.42 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.473 -0.87 . . . . 1.05 113.287 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 84.9 mt -104.09 143.2 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.919 -0.771 . . . . 1.6100000000000001 108.919 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -65.23 -53.43 44.5 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.81 0.338 . . . . 2.3999999999999999 110.495 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 8.8 m -71.13 101.27 2.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.18 0.514 . . . . 0.93000000000000005 110.033 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -91.85 108.8 20.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.082 -0.508 . . . . 1.3100000000000001 110.997 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.55 -160.22 25.98 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.004 -0.617 . . . . 0.79000000000000004 111.997 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 10.7 m -125.87 139.44 51.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.791 0.329 . . . . 0.93000000000000005 110.877 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.763 HG12 HG22 ' B' ' 45' ' ' VAL . 15.8 m -88.57 143.12 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.364 -0.38 . . . . 1.3799999999999999 110.887 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.536 ' HB2' ' HG2' ' B' ' 44' ' ' PRO . 35.5 mmm-85 -97.86 84.87 3.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.149 0.499 . . . . 1.3700000000000001 110.614 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.2 m -73.96 -5.87 43.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 1.1599999999999999 111.296 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -88.7 -16.15 33.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.058 -0.519 . . . . 1.1000000000000001 111.409 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' GLN . . . . . 0.437 ' N ' ' HD3' ' B' ' 77' ' ' PRO . 70.1 mt-30 -130.82 60.49 53.38 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 113.04 0.756 . . . . 2.4700000000000002 113.04 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.461 ' HD2' ' OG1' ' A' ' 79' ' ' THR . 6.9 Cg_exo -75.93 141.08 23.67 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.085 1.857 . . . . 0.95999999999999996 110.223 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -132.61 143.61 49.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.862 0.363 . . . . 1.96 111.34 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.849 HG21 ' HB3' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -78.39 135.06 37.36 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.389 -0.967 . . . . 1.1899999999999999 108.389 177.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.567 HD13 HG11 ' B' ' 9' ' ' VAL . 9.3 pt -118.99 154.21 21.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.93 0.395 . . . . 1.28 110.948 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' B' ' 85' ' ' ARG . 5.5 t70 -86.03 139.89 30.77 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.853 -0.612 . . . . 1.28 109.42 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 2.6 ttp -130.9 26.73 4.94 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.603 0.716 . . . . 2.7000000000000002 109.505 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.661 ' NZ ' ' HB2' ' B' ' 38' ' ' ARG . 37.9 mttm -109.86 -44.05 3.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.033 -0.985 . . . . 1.96 109.399 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.38 -28.42 8.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.421 -0.809 . . . . 1.0600000000000001 110.074 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' B' ' 81' ' ' ASP . 45.3 mtt180 -80.97 151.94 28.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.963 -0.562 . . . . 1.47 110.384 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.92 131.88 10.82 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.215 -0.754 . . . . 0.81999999999999995 111.215 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.25 148.25 18.5 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.954 -0.641 . . . . 0.65000000000000002 111.679 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -139.89 137.69 35.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.489 0.185 . . . . 1.8100000000000001 110.904 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -78.55 131.2 36.69 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.235 -0.284 . . . . 2.4900000000000002 110.235 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 82.4 mt -98.33 -58.06 2.06 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.434 0.531 . . . . 0.76000000000000001 112.434 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . 0.53 ' O ' ' HB ' ' B' ' 6' ' ' ILE . 16.0 pt-20 -149.07 158.22 44.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.412 -0.358 . . . . 1.0700000000000001 110.278 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -101.02 112.07 24.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.772 0.32 . . . . 2.0499999999999998 110.155 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.849 ' HB ' HD11 ' B' ' 6' ' ' ILE . 7.3 p -66.28 133.77 94.58 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.776 -0.647 . . . . 1.45 110.854 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.69 146.4 77.0 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.673 2.249 . . . . 1.03 111.11 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -55.06 -32.66 62.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 2.1400000000000001 111.891 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -48.39 78.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.93 -0.577 . . . . 1.78 110.953 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 40.4 mm -80.29 -34.48 14.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 1.3300000000000001 110.593 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 6.9 tpt -56.58 -47.39 79.65 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.007 -0.542 . . . . 2.3399999999999999 110.854 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -67.06 -33.71 76.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 1.9099999999999999 110.914 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.598 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 0.1 OUTLIER -60.42 -46.06 91.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 1.76 110.872 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 50.2 t -59.33 -44.09 91.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.946 0.403 . . . . 1.01 110.495 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -62.9 -36.37 83.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 1.29 110.264 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.63 -34.13 86.58 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.802 -0.635 . . . . 1.02 111.852 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 19.6 mmt85 -70.74 -28.74 64.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.035 0.445 . . . . 1.8500000000000001 110.661 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 36.5 mt -76.93 -18.54 58.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 1.9399999999999999 110.774 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 24.6 m -76.94 -6.92 54.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.212 -0.449 . . . . 1.1599999999999999 111.694 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 3.7 m -66.73 -25.04 66.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 1.45 111.366 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 46.7 pt -92.07 7.21 5.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.829 0.347 . . . . 1.98 111.675 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 59.2 mt -87.0 13.33 9.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.155 0.502 . . . . 1.3600000000000001 111.246 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.654 -0.703 . . . . 2.1299999999999999 109.436 179.806 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.469 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 23.7 ptp . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 120.658 0.266 . . . . 1.29 110.988 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -123.26 168.04 12.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.288 -0.415 . . . . 2.0099999999999998 110.442 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.49 ' NH2' ' HD3' ' A' ' 30' ' ' PRO . 36.3 ttm180 -67.64 124.67 23.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.986 -0.552 . . . . 1.8500000000000001 110.692 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.459 ' HA3' ' NH2' ' A' ' 92' ' ' ARG . . . 108.58 -2.86 32.4 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.822 -0.704 . . . . 0.85999999999999999 113.31 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.469 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 65.8 mt-10 -93.79 152.25 19.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.472 -0.428 . . . . 0.98999999999999999 110.979 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.709 HD11 ' HG2' ' A' ' 91' ' ' GLU . 21.5 pt -115.87 117.11 54.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.147 0.499 . . . . 1.1599999999999999 110.345 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.484 ' CE2' ' HB2' ' A' ' 89' ' ' ARG . 25.8 m95 -108.43 125.41 51.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.658 -0.701 . . . . 0.91000000000000003 111.097 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 14.3 tp -74.52 117.78 16.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.19 -0.459 . . . . 0.90000000000000002 110.633 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 p -162.24 153.9 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.413 -0.358 . . . . 1.04 110.122 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.0 t -84.01 140.14 32.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.961 0.41 . . . . 1.3200000000000001 110.509 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.542 HD23 HD13 ' A' ' 80' ' ' ILE . 1.3 mt -100.15 13.25 34.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.018 -0.537 . . . . 1.29 111.103 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.565 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -85.12 171.47 10.79 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.618 -0.719 . . . . 1.54 110.325 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.565 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 12.4 Cg_exo -71.82 133.2 27.77 Favored 'Cis proline' 0 C--N 1.352 0.743 0 C-N-CA 124.419 -1.075 . . . . 1.6899999999999999 112.198 -0.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 18' ' ' GLU . 21.7 p -102.25 138.52 39.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.705 -0.679 . . . . 1.3600000000000001 111.295 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -106.93 140.46 39.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.437 -0.579 . . . . 1.7 109.437 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.35 -113.27 5.23 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.645 -0.788 . . . . 1.1799999999999999 111.472 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -130.54 46.32 2.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.808 0.337 . . . . 2.7799999999999998 111.283 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 32.1 mt-10 -65.84 -174.86 0.25 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.971 -0.559 . . . . 1.1399999999999999 110.437 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.584 ' HG2' ' HG2' ' A' ' 44' ' ' PRO . 5.4 tp-100 -78.51 69.2 4.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.333 0.587 . . . . 2.0899999999999999 110.234 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.585 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 1.1 pt20 -76.13 144.61 40.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.402 -0.817 . . . . 2.0899999999999999 111.241 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.92 143.03 5.73 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.64 -0.791 . . . . 1.0700000000000001 112.843 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 10.0 m -92.9 107.17 19.01 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.263 -0.643 . . . . 1.1100000000000001 109.263 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -147.31 163.39 28.34 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.429 -0.35 . . . . 1.6200000000000001 110.582 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 16.6 Cg_exo -69.02 119.47 6.45 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.498 2.132 . . . . 1.01 111.393 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 14.2 m -97.26 142.46 14.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.126 -0.488 . . . . 0.76000000000000001 110.38 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.651 ' HB3' HG23 ' A' ' 43' ' ' VAL . 36.6 tp -83.86 121.9 27.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.44 -0.346 . . . . 0.69999999999999996 111.282 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.659 ' HA ' HG12 ' A' ' 42' ' ' VAL . 17.8 mm -71.84 112.67 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.92000000000000004 109.713 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.38 -37.51 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.346 -0.388 . . . . 0.94999999999999996 111.889 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.86 150.55 75.49 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 112.387 0.514 . . . . 1.1200000000000001 112.387 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.49 ' HD3' ' NH2' ' A' ' 3' ' ' ARG . 56.3 Cg_endo -70.1 155.91 63.7 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.766 2.311 . . . . 1.3 112.323 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.92 -38.0 64.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.843 -0.617 . . . . 1.3899999999999999 112.05 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.38 -41.4 89.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.027 0.441 . . . . 1.6100000000000001 111.227 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.639 ' HZ ' ' HB2' ' B' ' 75' ' ' ASP . 80.5 t80 -73.22 -41.95 63.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.091 -0.504 . . . . 1.77 110.777 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 60.7 m-20 -62.81 -21.13 65.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.898 -0.592 . . . . 1.48 111.345 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.404 ' HD3' HH11 ' A' ' 35' ' ' ARG . 2.7 ttp180 -93.37 -25.52 17.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 2.6200000000000001 111.93 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 33' ' ' PHE . 14.0 p -82.78 -49.24 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 112.93 0.715 . . . . 1.8600000000000001 112.93 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.5 p -94.9 -23.86 17.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 1.72 110.783 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 88.4 mtt180 68.78 18.04 8.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.478 -0.783 . . . . 4.4500000000000002 111.607 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' B' ' 17' ' ' HIS . 75.8 mt -129.11 93.28 36.91 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.349 -0.842 . . . . 1.8100000000000001 108.897 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.92 132.53 9.64 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.567 2.178 . . . . 1.05 113.521 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.413 HG22 ' OG1' ' A' ' 79' ' ' THR . 47.2 t -79.03 116.64 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.833 -1.543 . . . . 1.03 106.833 177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.659 HG12 ' HA ' ' A' ' 27' ' ' ILE . 29.5 m -124.71 156.91 33.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 113.478 0.918 . . . . 0.77000000000000002 113.478 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.651 HG23 ' HB3' ' A' ' 26' ' ' LEU . 2.6 m -118.37 118.57 33.83 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 114.806 -1.088 . . . . 0.71999999999999997 108.646 177.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.584 ' HG2' ' HG2' ' A' ' 19' ' ' GLN . 13.2 Cg_exo -69.47 156.59 63.67 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.076 2.518 . . . . 1.03 113.507 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.463 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 95.2 t -114.1 127.12 71.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.085 -0.962 . . . . 1.28 108.638 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.528 ' OG1' ' HD3' ' A' ' 73' ' ' ARG . 27.2 p . . . . . 0 C--N 1.324 -0.516 0 C-N-CA 121.105 -0.238 . . . . 1.9099999999999999 111.25 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.177 0 CA-C-O 120.702 0.057 . . . . 1.6599999999999999 112.97 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -91.32 -32.75 15.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.893 0.378 . . . . 1.5600000000000001 110.971 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.47 120.9 25.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.083 -0.508 . . . . 1.25 110.097 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.691 HG22 ' HB ' ' A' ' 72' ' ' VAL . 10.4 m -93.85 153.64 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.913 0.387 . . . . 1.6799999999999999 111.707 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.86 142.98 34.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.969 -0.559 . . . . 1.95 111.615 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.579 ' HB3' HD11 ' A' ' 66' ' ' ILE . 14.4 mt -109.94 0.57 18.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 1.23 110.927 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -91.55 -173.68 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 2.21 109.914 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.7 -47.68 3.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 1.1499999999999999 112.151 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.0 m -74.6 -28.7 22.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.889 0.376 . . . . 1.21 110.754 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.77 67.88 1.53 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.743 -0.742 . . . . 1.0800000000000001 113.619 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 61' ' ' LEU . 22.8 pt -102.97 174.69 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.624 -0.51 . . . . 1.0700000000000001 109.624 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -80.68 -44.84 18.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.956 0.407 . . . . 3.5899999999999999 110.46 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.51 149.2 49.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.8 -0.636 . . . . 1.51 111.46 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.08 91.96 3.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.836 -0.62 . . . . 1.79 110.795 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -164.85 -162.42 15.85 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.17 -0.772 . . . . 1.1799999999999999 111.17 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.34 138.63 53.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.092 -0.336 . . . . 1.5600000000000001 110.092 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.691 ' HB ' HG22 ' A' ' 59' ' ' VAL . 62.7 t -75.3 131.1 35.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.817 0.341 . . . . 1.29 110.456 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.528 ' HD3' ' OG1' ' A' ' 46' ' ' THR . 55.8 mmm-85 -100.35 91.4 4.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.127 -0.488 . . . . 2.23 112.259 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.8 m -82.67 -10.14 59.06 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.901 -0.777 . . . . 1.1699999999999999 108.901 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.407 ' C ' ' HD3' ' A' ' 77' ' ' PRO . 13.9 p-10 -86.85 -12.52 47.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.121 -0.945 . . . . 0.89000000000000001 110.943 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.401 ' N ' ' HD3' ' A' ' 77' ' ' PRO . 12.1 mm100 -129.42 62.93 65.71 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 112.195 0.443 . . . . 2.1299999999999999 112.195 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.407 ' HD3' ' C ' ' A' ' 75' ' ' ASP . 5.0 Cg_exo -77.95 144.61 21.64 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.667 2.245 . . . . 0.80000000000000004 111.024 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 78' ' ' ARG . 5.1 ptm85 -163.92 124.61 2.2 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.072 0.397 . . . . 2.0899999999999999 112.072 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.515 ' OG1' ' HD2' ' B' ' 77' ' ' PRO . 87.6 m -82.19 123.52 29.08 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.847 -0.615 . . . . 1.6200000000000001 109.597 178.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.542 HD13 HD23 ' A' ' 11' ' ' LEU . 24.3 pt -126.1 161.95 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.025 0.44 . . . . 1.1499999999999999 111.183 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.539 ' O ' ' HD2' ' A' ' 85' ' ' ARG . 2.1 t70 -76.61 145.37 38.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.62 -0.718 . . . . 1.03 110.686 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 38.2 tpp -131.91 24.66 4.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.23 0.538 . . . . 1.29 109.786 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.12 -40.42 3.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.158 -0.474 . . . . 2.6400000000000001 110.778 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.88 -35.38 10.51 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.362 -0.607 . . . . 1.1200000000000001 109.362 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 81' ' ' ASP . 77.4 mtt-85 -68.72 -57.56 5.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.471 -0.786 . . . . 1.0600000000000001 110.704 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.82 120.52 2.03 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.787 -0.72 . . . . 1.1200000000000001 113.193 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.0 171.16 21.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.939 -0.648 . . . . 1.0900000000000001 111.796 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -132.79 123.13 25.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.834 0.35 . . . . 2.46 111.482 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.484 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 45.7 ttp180 -75.41 120.39 20.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.226 -0.443 . . . . 2.4900000000000002 110.897 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.95 -53.86 4.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.925 0.393 . . . . 1.29 110.328 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.709 ' HG2' HD11 ' A' ' 6' ' ' ILE . 14.6 pt-20 -160.14 -168.44 2.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.709 -0.678 . . . . 1.1499999999999999 109.38 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.459 ' NH2' ' HA3' ' A' ' 4' ' ' GLY . 3.2 ptm180 -143.29 139.76 30.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.757 0.313 . . . . 1.3200000000000001 110.33 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.54 158.25 43.21 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.136 -0.484 . . . . 0.75 111.461 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.0 160.72 48.48 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.712 2.275 . . . . 0.94999999999999996 111.564 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -60.87 -23.04 64.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 1.51 111.93 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -37.08 74.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.483 . . . . 1.5700000000000001 110.585 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.406 ' O ' HG23 ' A' ' 101' ' ' VAL . 37.2 mm -88.55 -40.78 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.747 -0.661 . . . . 1.3100000000000001 109.99 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.7 tpt -56.63 -50.83 70.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.696 -0.683 . . . . 1.6000000000000001 112.107 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.428 ' HA ' HD12 ' A' ' 102' ' ' LEU . 58.1 m-80 -65.18 -32.19 73.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 2.2999999999999998 111.268 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 7.0 tp10 -61.5 -45.14 95.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.862 -0.608 . . . . 1.6399999999999999 110.366 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.477 HG11 HG21 ' A' ' 43' ' ' VAL . 50.0 t -59.88 -44.85 95.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.036 -0.529 . . . . 1.03 110.013 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 99' ' ' ASN . 44.6 mt -59.92 -40.88 90.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.732 -0.667 . . . . 1.22 111.051 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.87 -41.42 98.77 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.901 -0.666 . . . . 1.03 112.016 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 12.6 mmt180 -68.2 -38.52 82.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 1.72 110.555 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 62.6 mt -63.78 -24.24 67.68 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.03 -0.532 . . . . 1.02 112.111 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 57.0 m -72.12 -6.27 41.41 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.934 0.716 . . . . 1.1100000000000001 112.934 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 74.5 p -92.49 -11.34 34.89 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.193 0.442 . . . . 1.5 112.193 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.525 ' HB ' HG22 ' B' ' 29' ' ' THR . 45.8 pt -107.48 16.25 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.914 0.388 . . . . 1.1499999999999999 111.897 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 83.4 mt -97.42 25.87 5.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.131 0.491 . . . . 0.97999999999999998 110.784 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.957 -0.565 . . . . 1.3500000000000001 111.405 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.544 ' CE ' ' HG ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 112.007 0.373 . . . . 2.0299999999999998 112.007 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' B' ' 3' ' ' ARG . 24.2 mt-10 -91.01 2.97 55.9 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.168 -0.332 . . . . 2.8199999999999998 110.804 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . 0.694 ' HA ' ' HE1' ' B' ' 98' ' ' MET . 0.1 OUTLIER 84.86 61.24 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.933 1.086 . . . . 2.3199999999999998 113.933 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.25 22.98 74.82 Favored Glycine 0 CA--C 1.519 0.313 0 N-CA-C 115.006 0.762 . . . . 1.28 115.006 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -83.19 116.55 22.42 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 117.498 0.649 . . . . 1.53 110.892 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.95 HD12 ' HG3' ' B' ' 91' ' ' GLU . 19.9 mt -96.07 123.26 48.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.75 110.184 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -112.92 127.47 56.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.008 0.432 . . . . 0.81000000000000005 111.477 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' B' ' 24' ' ' PRO . 40.1 tp -90.13 120.35 31.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.056 -0.52 . . . . 1.05 109.748 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.457 HG22 ' H ' ' B' ' 10' ' ' SER . 5.9 p -158.63 169.55 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.505 -0.316 . . . . 0.71999999999999997 110.379 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' B' ' 22' ' ' THR . 0.0 OUTLIER -84.45 133.27 34.49 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.899 -0.408 . . . . 1.6299999999999999 109.899 179.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 18.9 mt -81.29 -29.09 34.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.485 -0.325 . . . . 0.82999999999999996 111.437 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . 0.417 ' HA ' ' N ' ' B' ' 14' ' ' THR . 2.5 m-20 -58.7 154.58 35.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.051 -0.522 . . . . 1.6200000000000001 111.629 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.65 116.52 4.58 Favored 'Cis proline' 0 C--O 1.237 0.432 0 C-N-CA 123.607 -1.414 . . . . 1.28 113.364 0.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' B' ' 18' ' ' GLU . 0.6 OUTLIER -123.41 147.88 46.68 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.812 -0.81 . . . . 1.47 108.812 178.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.65 177.88 8.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.319 0.581 . . . . 1.22 112.117 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.57 -108.53 2.45 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.888 -0.672 . . . . 1.01 112.585 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . 0.461 ' HB2' HD21 ' A' ' 39' ' ' LEU . 73.6 m-70 -108.31 3.29 23.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.727 0.299 . . . . 2.1800000000000002 111.147 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.44 ' HB2' ' HB ' ' B' ' 14' ' ' THR . 29.9 mt-10 -72.4 140.21 48.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.297 -0.411 . . . . 1.28 110.05 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -68.28 142.16 55.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.669 -0.493 . . . . 1.52 109.669 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -120.1 165.85 14.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.726 0.639 . . . . 1.8600000000000001 112.726 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.7 -173.11 36.45 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.44 -0.8 . . . . 0.90000000000000002 112.327 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' B' ' 10' ' ' SER . 15.6 m -96.04 123.36 39.61 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.973 -0.751 . . . . 0.94999999999999996 108.973 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.406 HH21 ' HA ' ' B' ' 46' ' ' THR . 3.9 ptm180 -157.45 155.0 26.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.705 -0.225 . . . . 1.5900000000000001 110.84 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' B' ' 8' ' ' LEU . 23.6 Cg_exo -65.63 133.8 35.65 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.608 2.206 . . . . 0.65000000000000002 111.841 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' B' ' 44' ' ' PRO . 16.9 m -126.61 156.92 37.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.074 -0.512 . . . . 0.56999999999999995 110.693 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.544 ' HG ' ' CE ' ' B' ' 1' ' ' MET . 1.5 tp -106.24 119.32 38.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.118 -0.492 . . . . 1.1699999999999999 110.71 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . 0.603 HG12 HG12 ' B' ' 42' ' ' VAL . 27.8 mt -78.36 116.83 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.317 . . . . 0.66000000000000003 110.607 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' B' ' 1' ' ' MET . 37.5 t -77.61 -37.55 24.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.025 -0.534 . . . . 0.93000000000000005 111.839 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' THR . . . . . 0.525 HG22 ' HB ' ' A' ' 108' ' ' ILE . 0.8 OUTLIER -71.19 142.47 87.26 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.436 -0.347 . . . . 0.81000000000000005 111.74 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.68 156.09 61.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.83 2.353 . . . . 0.78000000000000003 112.407 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.3 77.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.861 -0.609 . . . . 1.03 111.704 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.98 -36.74 73.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.92 0.39 . . . . 1.3999999999999999 111.55 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -81.39 -40.88 22.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.112 0.482 . . . . 1.5700000000000001 110.519 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -59.43 -24.84 63.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.682 -0.69 . . . . 1.6399999999999999 111.899 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -89.42 -2.61 58.46 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.399 0.518 . . . . 2.54 112.399 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -108.12 -52.08 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.977 0.418 . . . . 1.0900000000000001 110.282 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 1.5 m -80.87 -31.84 35.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.818 -0.628 . . . . 1.3300000000000001 111.14 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.434 ' HA ' ' NE ' ' B' ' 38' ' ' ARG . 3.7 mmp_? 71.01 -0.22 3.14 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.53 0.937 . . . . 1.78 113.53 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 98.4 mt -121.45 94.32 48.61 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.577 -0.527 . . . . 1.1599999999999999 109.577 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.37 154.18 14.09 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.867 2.378 . . . . 0.56999999999999995 113.992 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.671 HG22 HG23 ' B' ' 79' ' ' THR . 8.8 t -95.45 123.53 47.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.901 -1.148 . . . . 1.0800000000000001 107.901 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.603 HG12 HG12 ' B' ' 27' ' ' ILE . 32.3 m -113.93 147.31 17.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 113.434 0.902 . . . . 0.64000000000000001 113.434 -178.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 t -106.09 118.97 53.66 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 114.63 -1.168 . . . . 1.1000000000000001 108.386 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.501 ' HA ' HG12 ' B' ' 25' ' ' VAL . 74.0 Cg_endo -74.38 134.79 19.41 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.728 2.285 . . . . 0.72999999999999998 112.557 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.697 HG22 HG12 ' B' ' 72' ' ' VAL . 44.0 t -99.01 123.62 51.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.88 -0.6 . . . . 0.90000000000000002 110.46 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . 0.406 ' HA ' HH21 ' B' ' 23' ' ' ARG . 0.0 OUTLIER -89.44 89.89 8.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.887 -0.597 . . . . 1.1699999999999999 109.579 178.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.69 ' HA ' ' HA3' ' B' ' 70' ' ' GLY . 1.4 m . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 115.855 -0.612 . . . . 1.8500000000000001 111.342 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.023 0.44 . . . . 1.96 110.339 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.51 -87.68 0.26 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.796 -0.638 . . . . 1.0800000000000001 112.676 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.658 ' HE1' ' HB ' ' B' ' 107' ' ' THR . 21.0 m-85 -109.68 -6.69 15.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.879 0.371 . . . . 3.5699999999999998 110.86 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' B' ' 72' ' ' VAL . . . -93.04 115.13 27.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.049 -0.523 . . . . 1.0800000000000001 110.845 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 23.7 t -117.05 135.99 55.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.101 -0.5 . . . . 1.3400000000000001 110.013 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 88.3 p -79.42 141.59 36.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.801 0.334 . . . . 1.3799999999999999 111.605 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 72.8 mt -88.76 -16.76 31.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.181 0.515 . . . . 1.02 110.751 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -73.63 147.0 44.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.718 -0.673 . . . . 1.79 111.003 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.03 -40.14 2.5 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.056 -0.593 . . . . 1.1499999999999999 112.461 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 p -90.21 -17.69 7.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.111 0.412 . . . . 1.1699999999999999 112.111 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.24 20.91 4.24 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.499 -0.858 . . . . 1.05 113.599 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.496 HD11 ' HD2' ' B' ' 94' ' ' PRO . 81.4 mt -86.64 141.31 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.772 -0.455 . . . . 1.6100000000000001 109.772 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -70.9 -47.84 56.94 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.623 0.249 . . . . 2.3999999999999999 110.923 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 12.2 m -60.97 99.14 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.368 0.604 . . . . 0.93000000000000005 110.334 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.69 91.49 8.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.946 -0.57 . . . . 1.3100000000000001 111.746 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' B' ' 47' ' ' SER . . . -171.45 -174.0 38.81 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.709 -0.758 . . . . 0.79000000000000004 111.7 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.5 m -113.71 136.31 50.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 110.211 -0.292 . . . . 0.93000000000000005 110.211 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.697 HG12 HG22 ' B' ' 45' ' ' VAL . 11.9 m -80.34 135.59 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.556 -0.293 . . . . 1.3799999999999999 110.92 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' B' ' 73' ' ' ARG . 16.1 mmm-85 -101.99 82.97 2.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.112 0.482 . . . . 1.3700000000000001 110.829 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 2.3 m -69.32 -9.04 51.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.758 -0.655 . . . . 1.1599999999999999 111.047 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.639 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 13.7 p-10 -88.45 -6.21 57.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.589 -0.732 . . . . 1.1000000000000001 111.771 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -126.13 55.77 14.2 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 113.0 0.741 . . . . 2.4700000000000002 113.0 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.515 ' HD2' ' OG1' ' A' ' 79' ' ' THR . 90.4 Cg_endo -80.96 126.4 5.74 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.771 1.647 . . . . 0.95999999999999996 112.271 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -130.38 140.39 50.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.917 0.389 . . . . 1.96 111.218 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.671 HG23 HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -79.72 125.87 30.21 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.189 -0.671 . . . . 1.1899999999999999 109.189 178.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 41.4 pt -128.51 151.48 35.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.521 -0.471 . . . . 1.28 111.653 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.693 ' OD1' ' HG3' ' B' ' 83' ' ' LYS . 4.8 t70 -77.83 83.95 4.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.858 -0.61 . . . . 1.28 109.994 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 59.7 tpp -61.69 -31.66 71.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.691 -0.686 . . . . 2.7000000000000002 112.274 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.693 ' HG3' ' OD1' ' B' ' 81' ' ' ASP . 1.4 pttp -67.22 -38.91 86.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.397 0.517 . . . . 1.96 112.397 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.98 -30.18 28.41 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.108 0.41 . . . . 1.0600000000000001 112.108 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' B' ' 85' ' ' ARG . 46.1 mtt180 -82.22 -42.46 18.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.174 0.435 . . . . 1.47 112.174 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.4 99.94 1.52 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.81999999999999995 112.597 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -99.3 153.71 19.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.677 -0.773 . . . . 0.65000000000000002 112.588 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.15 128.15 16.5 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.284 -0.265 . . . . 1.8100000000000001 110.284 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' B' ' 6' ' ' ILE . 34.5 ttp180 -78.91 121.04 24.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.963 0.411 . . . . 2.4900000000000002 111.339 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 89.8 mt -90.8 -68.62 0.78 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.136 -0.484 . . . . 0.76000000000000001 110.666 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . 0.95 ' HG3' HD12 ' B' ' 6' ' ' ILE . 11.5 pt-20 -129.61 -176.88 4.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.935 -0.575 . . . . 1.0700000000000001 110.028 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.81 137.98 53.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.959 0.409 . . . . 2.0499999999999998 111.198 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.436 HG23 HD11 ' B' ' 6' ' ' ILE . 53.7 t -82.86 126.72 72.2 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.854 -0.612 . . . . 1.45 109.993 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.496 ' HD2' HD11 ' B' ' 66' ' ' ILE . 43.9 Cg_exo -59.59 152.5 61.86 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.656 2.237 . . . . 1.03 111.11 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.528 ' HA ' ' HB3' ' B' ' 98' ' ' MET . 21.8 mm-40 -54.26 -29.69 47.78 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.461 0.541 . . . . 2.1400000000000001 112.461 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.7 p -59.46 -53.83 53.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.991 0.424 . . . . 1.78 111.219 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 32.5 mm -74.84 -34.04 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.202 -0.453 . . . . 1.3300000000000001 110.0 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' MET . . . . . 0.694 ' HE1' ' HA ' ' B' ' 3' ' ' ARG . 5.1 tpt -55.33 -45.26 76.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.706 -0.679 . . . . 2.3399999999999999 110.972 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -67.55 -35.34 78.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.098 -0.501 . . . . 1.9099999999999999 110.996 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 4.5 tp10 -64.53 -44.86 89.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.97 -0.559 . . . . 1.76 111.0 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.426 HG22 HG21 ' B' ' 72' ' ' VAL . 73.9 t -60.29 -48.61 87.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.306 -0.406 . . . . 1.01 110.425 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.654 ' HA ' HD12 ' B' ' 105' ' ' LEU . 82.9 mt -59.68 -34.93 73.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.555 . . . . 1.29 111.048 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.45 -41.28 96.46 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.578 -0.609 . . . . 1.02 111.578 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 5.1 mmt180 -67.35 -33.59 75.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.898 0.38 . . . . 1.8500000000000001 110.315 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.654 HD12 ' HA ' ' B' ' 102' ' ' LEU . 46.4 mt -65.98 -25.5 67.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.912 -0.586 . . . . 1.9399999999999999 110.513 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 13.0 m -87.68 -13.94 41.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.008 -0.542 . . . . 1.1599999999999999 111.161 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.658 ' HB ' ' HE1' ' B' ' 57' ' ' PHE . 0.5 OUTLIER -75.13 -31.65 61.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.898 0.38 . . . . 1.45 111.361 -179.376 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 14.0 pt -84.91 0.82 5.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.442 -0.345 . . . . 1.98 111.558 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.49 4.66 53.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.342 -0.39 . . . . 1.3600000000000001 111.859 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.439 ' C ' HH22 ' A' ' 3' ' ' ARG . 7.0 t . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.825 -0.607 . . . . 2.1299999999999999 110.206 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptp . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.782 0.325 . . . . 1.29 110.75 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -135.28 175.01 9.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.02 -0.536 . . . . 2.0099999999999998 111.053 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.561 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 55.2 ttp85 -79.27 136.22 36.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.048 -0.523 . . . . 1.8500000000000001 109.955 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.44 8.27 59.91 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.85999999999999999 112.476 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.682 ' HG2' ' HG3' ' A' ' 92' ' ' ARG . 82.1 mt-10 -95.27 142.22 27.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.949 0.404 . . . . 0.98999999999999999 111.138 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.7 mt -99.0 115.93 40.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.814 -0.81 . . . . 1.1599999999999999 108.814 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -114.12 137.33 51.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.401 -0.363 . . . . 0.91000000000000003 111.083 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.3 tp -88.81 120.76 30.51 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.392 -0.595 . . . . 0.90000000000000002 109.392 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.454 HG22 ' H ' ' A' ' 10' ' ' SER . 4.3 p -147.49 169.19 4.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 120.867 0.365 . . . . 1.04 110.708 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.454 ' H ' HG22 ' A' ' 9' ' ' VAL . 4.2 t -103.75 129.83 51.18 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.001 -0.74 . . . . 1.3200000000000001 109.001 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.3 mt -88.32 -12.57 43.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.461 -0.336 . . . . 1.29 111.377 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.547 ' HA ' HG23 ' A' ' 14' ' ' THR . 0.2 OUTLIER -67.93 164.15 43.67 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.94 -0.573 . . . . 1.54 111.162 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.74 139.09 49.57 Favored 'Cis proline' 0 C--N 1.353 0.79 0 C-N-CA 124.324 -1.115 . . . . 1.6899999999999999 112.485 -0.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.547 HG23 ' HA ' ' A' ' 12' ' ' ASP . 14.1 p -121.9 171.95 8.54 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.085 -0.507 . . . . 1.3600000000000001 111.319 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.79 164.34 26.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 1.7 110.063 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.4 -136.87 32.34 Favored Glycine 0 CA--C 1.516 0.123 0 C-N-CA 121.16 -0.543 . . . . 1.1799999999999999 113.409 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -103.74 25.46 9.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.022 -0.362 . . . . 2.7799999999999998 110.022 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -76.47 175.75 8.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.212 -0.449 . . . . 1.1399999999999999 111.427 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.546 ' HG3' ' CZ ' ' A' ' 23' ' ' ARG . 3.3 tp-100 -74.23 77.38 1.81 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.607 -0.724 . . . . 2.0899999999999999 110.506 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.405 ' HA ' HG21 ' A' ' 14' ' ' THR . 18.3 mt-30 -78.03 122.89 26.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.835 -0.62 . . . . 2.0899999999999999 111.726 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.71 163.45 12.27 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.272 -0.966 . . . . 1.0700000000000001 113.502 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.62 148.38 25.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.743 -0.229 . . . . 1.1100000000000001 110.505 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.546 ' CZ ' ' HG3' ' A' ' 19' ' ' GLN . 8.2 ptp180 -172.71 159.87 3.83 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 110.247 -0.279 . . . . 1.6200000000000001 110.247 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.65 130.3 15.72 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.448 2.099 . . . . 1.01 110.713 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.726 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 14.2 m -116.37 137.21 50.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.335 -0.393 . . . . 0.76000000000000001 110.569 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . 53.1 tp -92.32 124.39 36.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.154 -0.475 . . . . 0.69999999999999996 110.948 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.433 ' HA ' HG12 ' A' ' 42' ' ' VAL . 56.6 mt -80.07 111.03 16.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.92000000000000004 110.148 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 t -90.18 -27.2 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.218 -0.446 . . . . 0.94999999999999996 111.75 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 1.9 p -77.6 142.25 66.08 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.603 0.594 . . . . 1.1200000000000001 112.603 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HA ' ' HB2' ' A' ' 3' ' ' ARG . 26.3 Cg_exo -63.79 151.74 83.78 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.217 2.611 . . . . 1.3 111.798 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.18 -38.81 77.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.085 -0.507 . . . . 1.3899999999999999 112.036 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.17 -38.3 82.81 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.024 0.44 . . . . 1.6100000000000001 110.777 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' B' ' 75' ' ' ASP . 83.2 t80 -72.34 -38.73 68.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.032 -0.531 . . . . 1.77 110.166 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 75.4 m-20 -64.78 -15.81 62.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.676 -0.693 . . . . 1.48 111.199 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -87.8 -24.12 23.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.562 -0.29 . . . . 2.6200000000000001 110.724 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.6 t -83.1 -65.12 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 1.8600000000000001 111.489 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.1 m -78.82 -33.99 45.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.337 -0.392 . . . . 1.72 110.862 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.616 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 21.6 mtm180 75.14 12.64 3.35 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.724 -0.671 . . . . 4.4500000000000002 111.738 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.8 mt -124.92 93.04 46.61 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.544 -0.753 . . . . 1.8100000000000001 109.404 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.478 ' HD2' ' O ' ' A' ' 80' ' ' ILE . 58.0 Cg_endo -73.06 137.26 26.15 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.502 2.135 . . . . 1.05 112.798 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.585 HG22 HG23 ' A' ' 79' ' ' THR . 51.8 t -83.64 111.65 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 107.972 -1.122 . . . . 1.03 107.972 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.726 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 35.8 m -114.54 158.74 14.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.24 0.543 . . . . 0.77000000000000002 112.282 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.438 HG21 HG13 ' A' ' 72' ' ' VAL . 17.1 m -115.89 122.08 33.08 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.236 -0.893 . . . . 0.71999999999999997 109.775 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.99 94.75 1.06 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.867 2.378 . . . . 1.03 112.761 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.783 HG12 ' HA ' ' A' ' 72' ' ' VAL . 33.0 m -78.68 155.86 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 1.28 110.407 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 112.345 0.498 . . . . 1.9099999999999999 112.345 179.106 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.195 0 N-CA-C 112.538 -0.225 . . . . 1.6599999999999999 112.538 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -96.08 -16.77 21.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.628 0.252 . . . . 1.5600000000000001 111.03 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.446 ' HB1' ' HB ' ' A' ' 71' ' ' VAL . . . -76.02 87.37 2.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.587 -0.523 . . . . 1.25 109.587 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.582 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 42.3 t -66.13 121.86 16.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.276 -0.42 . . . . 1.6799999999999999 110.726 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.1 t -77.56 125.94 30.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.896 0.379 . . . . 1.95 111.539 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.749 ' HB3' HD11 ' A' ' 66' ' ' ILE . 91.9 mt -88.35 -5.93 58.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.45 0.643 . . . . 1.23 109.427 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -80.5 108.96 14.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.264 -0.88 . . . . 2.21 109.84 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.85 -34.56 1.23 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.873 -0.679 . . . . 1.1499999999999999 112.017 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.5 m -78.36 -30.7 15.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.729 0.3 . . . . 1.21 111.6 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.59 65.1 0.93 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.638 -0.791 . . . . 1.0800000000000001 112.671 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.749 HD11 ' HB3' ' A' ' 61' ' ' LEU . 20.4 pt -125.24 -171.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.354 -0.609 . . . . 1.0700000000000001 109.354 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.534 ' HA ' ' NE ' ' A' ' 67' ' ' ARG . 5.4 mmp_? -101.22 -27.66 13.09 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.739 -0.384 . . . . 3.5899999999999999 111.477 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.7 m -81.41 80.71 7.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.268 0.556 . . . . 1.51 110.388 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 m -80.21 94.54 6.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.63 -0.714 . . . . 1.79 111.256 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -162.52 -178.31 36.27 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.828 -0.624 . . . . 1.1799999999999999 112.137 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.446 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 22.3 m -105.0 138.99 27.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.821 0.31 . . . . 1.5600000000000001 110.963 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.783 ' HA ' HG12 ' A' ' 45' ' ' VAL . 67.9 t -73.81 126.93 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.808 -0.633 . . . . 1.29 110.258 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.75 85.23 7.02 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.584 0.587 . . . . 2.23 112.584 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 11.0 m -83.44 -8.19 59.42 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.81 -0.811 . . . . 1.1699999999999999 108.81 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -87.55 -27.97 22.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.801 -1.091 . . . . 0.89000000000000001 111.14 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.424 ' HB3' HG21 ' B' ' 79' ' ' THR . 79.3 mt-30 -130.84 64.53 73.91 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 113.984 1.105 . . . . 2.1299999999999999 113.984 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -77.52 133.96 13.44 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 121.872 1.715 . . . . 0.80000000000000004 109.204 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 1.038 ' HG3' ' HG3' ' B' ' 78' ' ' ARG . 18.2 ttt180 -135.19 143.06 46.22 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.683 0.623 . . . . 2.0899999999999999 112.683 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.585 HG23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -83.85 127.88 34.15 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.814 -1.18 . . . . 1.6200000000000001 107.814 177.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.478 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 20.5 pt -126.1 173.18 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.967 0.413 . . . . 1.1499999999999999 111.091 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -101.65 133.48 46.29 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.64 -0.709 . . . . 1.03 109.138 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.2 mmt -126.19 27.98 6.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.971 0.415 . . . . 1.29 111.266 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -125.3 -42.98 1.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 2.6400000000000001 110.8 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.46 -37.54 9.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.728 -0.669 . . . . 1.1200000000000001 109.505 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 85' ' ' ARG . 39.3 mtt180 -68.69 -49.28 60.25 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.006 -0.543 . . . . 1.0600000000000001 110.453 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.33 143.55 4.59 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.909 -0.587 . . . . 1.1200000000000001 112.278 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.77 176.77 32.39 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.766 -0.73 . . . . 1.0900000000000001 111.958 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -128.31 126.31 40.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.586 0.232 . . . . 2.46 111.171 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -74.3 132.99 42.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 2.4900000000000002 110.451 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 83.1 mt -103.71 -73.23 0.68 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.362 -0.381 . . . . 1.29 110.639 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -144.83 175.4 10.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.214 -0.448 . . . . 1.1499999999999999 110.626 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.682 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 9.6 ttp85 -120.03 144.64 47.44 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.428 -0.582 . . . . 1.3200000000000001 109.428 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.616 ' HB ' HD11 ' A' ' 97' ' ' ILE . 29.9 m -103.32 145.26 30.26 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.704 0.288 . . . . 0.75 111.298 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.529 ' HD2' HD11 ' A' ' 97' ' ' ILE . 40.3 Cg_exo -59.77 155.09 45.17 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.742 2.295 . . . . 0.94999999999999996 111.751 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' A' ' 98' ' ' MET . 52.7 mm-40 -67.59 -21.09 65.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.06 -0.518 . . . . 1.51 111.276 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.97 -57.46 12.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 1.5700000000000001 110.994 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.616 HD11 ' HB ' ' A' ' 93' ' ' VAL . 5.2 pt -69.83 -23.04 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 1.3100000000000001 111.509 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.417 ' HB2' ' HA ' ' A' ' 95' ' ' GLU . 40.0 mmm -67.75 -34.9 77.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 1.6000000000000001 109.813 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -67.04 -30.71 70.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.583 . . . . 2.2999999999999998 110.083 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -62.57 -31.16 71.92 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.781 -0.645 . . . . 1.6399999999999999 110.481 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.54 -48.97 23.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.506 -0.77 . . . . 1.03 109.76 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.42 -37.08 79.73 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.966 -0.561 . . . . 1.22 111.351 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.88 -40.01 97.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.908 -0.663 . . . . 1.03 111.928 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.0 mtt85 -75.77 -38.7 58.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.947 0.403 . . . . 1.72 110.739 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.651 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 82.8 mt -59.37 -41.82 90.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.906 -0.588 . . . . 1.02 111.109 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.2 m -63.83 -20.86 66.12 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.23 0.455 . . . . 1.1100000000000001 112.23 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -90.89 -35.63 14.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.812 0.339 . . . . 1.5 111.508 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.474 HG12 ' HA ' ' A' ' 105' ' ' LEU . 49.9 pt -78.04 -14.7 14.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 113.114 0.783 . . . . 1.1499999999999999 113.114 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 105' ' ' LEU . 61.8 mt -78.32 65.3 3.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.086 0.47 . . . . 0.97999999999999998 110.932 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.758 -0.655 . . . . 1.3500000000000001 110.632 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 121.098 0.475 . . . . 2.0299999999999998 111.335 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -76.33 -34.99 58.99 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.232 -1.025 . . . . 2.8199999999999998 108.232 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 68.35 140.45 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.613 -1.176 . . . . 2.3199999999999998 112.853 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' B' ' 92' ' ' ARG . . . 90.53 -10.48 74.4 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.814 -0.708 . . . . 1.28 112.54 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -76.84 99.14 5.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.875 0.369 . . . . 1.53 111.536 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.505 HD12 ' HG3' ' B' ' 91' ' ' GLU . 20.6 mt -89.02 122.42 40.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.907 -0.588 . . . . 0.75 110.816 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -122.32 134.34 54.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.088 -0.505 . . . . 0.81000000000000005 109.877 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.493 ' HB2' HD11 ' B' ' 90' ' ' LEU . 4.0 tt -95.14 123.06 38.43 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.66 -0.246 . . . . 1.05 110.587 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.18 154.73 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.71999999999999997 110.76 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 67.8 m -76.63 126.08 30.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.439 -0.346 . . . . 1.6299999999999999 111.215 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.569 ' HB3' ' NH2' ' B' ' 78' ' ' ARG . 88.7 mt -87.53 -21.28 25.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.82999999999999996 112.003 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.06 162.9 62.68 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.544 -0.298 . . . . 1.6200000000000001 111.007 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.18 152.96 98.91 Favored 'Cis proline' 0 C--N 1.352 0.712 0 C-N-CA 123.82 -1.325 . . . . 1.28 113.214 0.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.538 ' OG1' ' HB3' ' B' ' 20' ' ' GLN . 6.2 p -123.93 145.04 49.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.576 -0.738 . . . . 1.47 110.406 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -132.79 108.32 8.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.923 0.392 . . . . 1.22 110.665 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.28 -133.96 11.73 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.897 -0.668 . . . . 1.01 111.79 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -101.32 23.79 10.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.658 0.266 . . . . 2.1800000000000002 111.504 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -71.39 150.48 44.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.039 -0.528 . . . . 1.28 110.799 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -69.39 116.0 9.31 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.642 -0.503 . . . . 1.52 109.642 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.538 ' HB3' ' OG1' ' B' ' 14' ' ' THR . 1.2 pt20 -103.23 173.11 6.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.12 -0.491 . . . . 1.8600000000000001 112.203 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.66 138.31 4.05 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.759 -0.655 . . . . 0.90000000000000002 113.332 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 91.7 m -70.01 130.65 42.73 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.351 -0.611 . . . . 0.94999999999999996 109.351 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -159.74 160.94 27.41 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.503 -0.317 . . . . 1.5900000000000001 110.374 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -66.02 131.97 28.66 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.629 2.219 . . . . 0.65000000000000002 110.836 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.725 HG12 ' HA ' ' B' ' 44' ' ' PRO . 18.4 m -125.43 157.81 34.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.388 -0.369 . . . . 0.56999999999999995 110.938 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -103.88 133.18 49.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.954 -0.566 . . . . 1.1699999999999999 109.942 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' B' ' 40' ' ' PRO . 54.6 mt -85.81 123.37 39.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.741 0.305 . . . . 0.66000000000000003 110.958 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.69 49.44 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.496 0.665 . . . . 0.93000000000000005 110.081 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 8.1 m -143.34 122.75 7.53 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.918 -0.583 . . . . 0.81000000000000005 109.879 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 108' ' ' ILE . 88.8 Cg_exo -48.62 128.1 17.59 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.078 2.518 . . . . 0.78000000000000003 112.405 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.72 -30.66 67.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.962 -0.563 . . . . 1.03 111.536 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.9 -32.83 71.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 1.3999999999999999 111.211 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -94.57 -21.42 18.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.174 0.511 . . . . 1.5700000000000001 110.266 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -58.71 -35.6 72.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.748 -0.66 . . . . 1.6399999999999999 110.649 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.8 -20.33 65.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.265 -0.425 . . . . 2.54 111.73 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.06 -58.97 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.793 0.664 . . . . 1.0900000000000001 112.793 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 1.2 p -86.51 -33.81 20.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.569 0.581 . . . . 1.3300000000000001 112.569 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 67.43 24.51 8.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.309 0.576 . . . . 1.78 111.197 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.63 88.69 16.2 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.517 -0.765 . . . . 1.1599999999999999 109.301 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' PRO . . . . . 0.55 ' HB2' HG23 ' B' ' 27' ' ' ILE . 90.2 Cg_endo -85.98 149.29 9.51 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.678 2.252 . . . . 0.56999999999999995 113.384 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.409 HG22 ' HB ' ' B' ' 79' ' ' THR . 6.1 t -86.53 124.55 40.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.555 -0.906 . . . . 1.0800000000000001 108.555 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.449 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 31.1 m -119.65 154.58 22.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.237 0.458 . . . . 0.64000000000000001 112.237 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 m -118.06 127.6 26.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.494 -0.775 . . . . 1.1000000000000001 109.444 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.725 ' HA ' HG12 ' B' ' 25' ' ' VAL . 94.4 Cg_endo -80.12 160.56 23.58 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.934 2.422 . . . . 0.72999999999999998 113.031 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.612 HG12 ' HA ' ' B' ' 72' ' ' VAL . 31.5 m -115.55 145.52 21.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.943 -0.571 . . . . 0.90000000000000002 110.519 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 27.9 m -95.39 124.2 39.31 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.534 -0.543 . . . . 1.1699999999999999 109.534 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 N-CA-C 112.569 0.581 . . . . 1.8500000000000001 112.569 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.378 0 CA-C-O 121.061 0.457 . . . . 1.96 111.487 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.0 -114.39 6.08 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.814 -0.63 . . . . 1.0800000000000001 112.497 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -116.09 16.12 16.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.925 0.393 . . . . 3.5699999999999998 110.457 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' B' ' 72' ' ' VAL . . . -96.07 111.28 23.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.087 -0.506 . . . . 1.0800000000000001 110.674 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 t -95.66 124.18 48.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.284 -0.416 . . . . 1.3400000000000001 110.195 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.44 ' HA ' HG12 ' B' ' 71' ' ' VAL . 4.7 m -77.4 123.09 26.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.733 0.642 . . . . 1.3799999999999999 112.733 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.445 ' O ' HG12 ' B' ' 64' ' ' VAL . 88.2 mt -89.75 -15.62 32.05 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.185 -1.043 . . . . 1.02 108.185 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . 0.411 ' OD2' ' HB ' ' B' ' 69' ' ' THR . 4.0 t0 -71.48 150.42 44.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.362 -1.29 . . . . 1.79 110.499 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.79 -44.5 3.25 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.802 -0.713 . . . . 1.1499999999999999 113.469 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.502 HG11 HG13 ' B' ' 97' ' ' ILE . 3.5 p -70.1 -18.82 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.949 0.404 . . . . 1.1699999999999999 111.926 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.21 59.74 0.5 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.567 -0.825 . . . . 1.05 112.91 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' B' ' 93' ' ' VAL . 31.5 mm -128.61 137.24 57.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.131 -0.692 . . . . 1.6100000000000001 109.131 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -65.44 -36.55 84.26 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.293 0.568 . . . . 2.3999999999999999 109.874 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . 0.429 ' H ' HG22 ' B' ' 66' ' ' ILE . 11.8 m -80.0 82.17 6.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.634 -0.712 . . . . 0.93000000000000005 109.946 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . 0.411 ' HB ' ' OD2' ' B' ' 62' ' ' ASP . 23.2 p -68.48 97.52 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.861 -0.609 . . . . 1.3100000000000001 111.313 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.12 -171.53 37.87 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.637 -0.792 . . . . 0.79000000000000004 112.46 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' B' ' 60' ' ' SER . 11.9 m -118.16 132.67 67.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.555 0.217 . . . . 0.93000000000000005 111.24 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.612 ' HA ' HG12 ' B' ' 45' ' ' VAL . 30.4 t -74.78 128.78 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.434 -0.348 . . . . 1.3799999999999999 110.459 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' B' ' 73' ' ' ARG . 14.0 mmm-85 -96.95 84.78 3.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.061 0.457 . . . . 1.3700000000000001 110.319 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . 0.428 ' SG ' HG13 ' B' ' 101' ' ' VAL . 0.8 OUTLIER -68.22 -13.03 61.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.793 -0.639 . . . . 1.1599999999999999 110.538 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 33' ' ' PHE . 14.0 p-10 -87.53 7.16 30.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.769 -0.65 . . . . 1.1000000000000001 111.899 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' GLN . . . . . 0.419 ' N ' ' HD3' ' B' ' 77' ' ' PRO . 68.7 mt-30 -132.56 61.77 58.86 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 111.803 0.298 . . . . 2.4700000000000002 111.803 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' B' ' 76' ' ' GLN . 3.3 Cg_exo -77.98 119.99 4.89 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.482 2.121 . . . . 0.95999999999999996 110.83 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . 1.038 ' HG3' ' HG3' ' A' ' 78' ' ' ARG . 46.5 ttp180 -136.9 122.23 19.36 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 111.944 0.35 . . . . 1.96 111.944 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.424 HG21 ' HB3' ' A' ' 76' ' ' GLN . 9.8 t -84.03 139.9 32.21 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.218 -0.66 . . . . 1.1899999999999999 109.218 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 8.3 pt -148.86 162.69 5.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.484 -0.325 . . . . 1.28 110.374 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -77.98 94.6 4.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.201 0.524 . . . . 1.28 110.679 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' MET . . . . . 0.539 ' SD ' ' HA3' ' B' ' 87' ' ' GLY . 53.0 tpp -61.11 -24.76 66.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.302 -0.863 . . . . 2.7000000000000002 112.263 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.18 -49.25 11.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.76 0.314 . . . . 1.96 111.633 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.94 -41.46 82.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.379 -0.373 . . . . 1.0600000000000001 111.077 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -75.68 -31.83 59.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 1.47 111.334 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.57 101.83 0.88 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.86 -0.686 . . . . 0.81999999999999995 112.822 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . 0.539 ' HA3' ' SD ' ' B' ' 82' ' ' MET . . . -112.35 150.61 18.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.871 -0.68 . . . . 0.65000000000000002 112.49 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -140.58 136.68 33.05 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.403 -0.221 . . . . 1.8100000000000001 110.403 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' B' ' 89' ' ' ARG . 9.8 ttt180 -75.69 135.89 40.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.799 0.333 . . . . 2.4900000000000002 110.853 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' B' ' 8' ' ' LEU . 82.7 mt -108.14 -77.99 0.59 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.301 0.482 . . . . 0.76000000000000001 112.301 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . 0.505 ' HG3' HD12 ' B' ' 6' ' ' ILE . 11.0 pt-20 -133.1 -178.18 4.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.495 -0.32 . . . . 1.0700000000000001 111.635 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' B' ' 4' ' ' GLY . 5.2 tpt180 -121.5 122.67 40.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 2.0499999999999998 110.778 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.491 ' HB ' ' HA2' ' B' ' 4' ' ' GLY . 57.7 t -82.91 136.19 44.57 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.934 -0.575 . . . . 1.45 110.559 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.449 ' HD3' HD11 ' B' ' 66' ' ' ILE . 77.6 Cg_exo -53.66 144.57 52.57 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.837 2.358 . . . . 1.03 111.999 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.438 ' H ' ' HG2' ' B' ' 95' ' ' GLU . 4.3 mm-40 -55.9 -39.95 72.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.668 -0.696 . . . . 2.1400000000000001 111.916 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 14.2 t -57.53 -33.95 68.61 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.625 0.602 . . . . 1.78 112.625 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.502 HG13 HG11 ' B' ' 64' ' ' VAL . 48.2 mm -82.3 -36.57 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.218 0.532 . . . . 1.3300000000000001 110.206 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' MET . . . . . 0.505 ' HA ' ' HE2' ' B' ' 98' ' ' MET . 30.0 mmt -66.22 -33.27 75.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 2.3399999999999999 111.047 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -60.24 -36.23 77.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.19 0.519 . . . . 1.9099999999999999 110.414 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 3.5 mm-40 -67.67 -41.05 84.35 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.724 -0.671 . . . . 1.76 110.442 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.432 HG21 ' HE1' ' B' ' 98' ' ' MET . 93.8 t -57.54 -48.3 83.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.156 -0.475 . . . . 1.01 110.248 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.79 -40.6 97.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.744 -0.662 . . . . 1.29 110.175 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.14 -46.94 89.73 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.81 -0.632 . . . . 1.02 112.342 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 9.8 mmt180 -60.8 -41.12 95.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.858 0.361 . . . . 1.8500000000000001 110.936 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.522 HD12 HD12 ' B' ' 108' ' ' ILE . 31.8 tp -66.1 -30.67 71.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.193 -0.458 . . . . 1.9399999999999999 110.714 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 49.1 m -66.33 -34.78 78.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.175 -0.466 . . . . 1.1599999999999999 111.308 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -15.92 62.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.04 0.385 . . . . 1.45 112.04 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.522 HD12 HD12 ' B' ' 105' ' ' LEU . 60.2 mt -79.03 -23.16 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.297 0.57 . . . . 1.98 110.375 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 74.9 mt -93.8 48.02 1.25 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.757 -0.656 . . . . 1.3600000000000001 110.779 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.661 -0.685 . . . . 2.1299999999999999 110.56 179.691 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.625 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 14.2 ptp . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.958 0.408 . . . . 1.29 110.742 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.45 ' HG2' ' H ' ' A' ' 3' ' ' ARG . 14.3 tt0 -108.66 167.15 10.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.674 -0.694 . . . . 2.0099999999999998 110.231 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.45 ' H ' ' HG2' ' A' ' 2' ' ' GLU . 29.8 ttm180 -69.01 129.27 39.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.287 -0.415 . . . . 1.8500000000000001 109.99 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.35 -7.46 34.67 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.558 -0.83 . . . . 0.85999999999999999 112.828 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.625 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 31.2 mt-10 -81.42 147.36 29.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.826 0.313 . . . . 0.98999999999999999 111.271 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.542 HD11 HG13 ' A' ' 93' ' ' VAL . 32.6 mt -111.45 121.67 64.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 1.1599999999999999 110.751 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -118.43 147.48 43.54 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.91000000000000003 110.145 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 tp -102.91 130.09 49.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.939 -0.119 . . . . 0.90000000000000002 110.717 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -169.74 154.62 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.237 0.336 . . . . 1.04 110.421 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.0 m -80.97 141.25 34.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.714 0.292 . . . . 1.3200000000000001 110.435 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.574 HD11 ' HD3' ' A' ' 23' ' ' ARG . 53.8 mt -82.85 -7.79 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 1.29 111.03 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.585 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 1.6 m-20 -65.45 162.45 41.79 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.412 -0.813 . . . . 1.54 110.153 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.727 ' HB2' ' HG2' ' B' ' 13' ' ' PRO . 5.9 Cg_exo -78.57 141.35 64.03 Favored 'Cis proline' 0 C--O 1.236 0.385 0 C-N-CA 123.716 -1.368 . . . . 1.6899999999999999 111.726 -0.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.859 ' HB ' ' HB3' ' A' ' 18' ' ' GLU . 24.0 p -117.58 171.77 7.79 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.224 -0.444 . . . . 1.3600000000000001 110.536 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.28 137.57 39.14 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.434 -0.58 . . . . 1.7 109.434 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.54 -116.02 5.27 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.71 -0.757 . . . . 1.1799999999999999 112.995 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -113.05 17.4 18.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.531 0.205 . . . . 2.7799999999999998 111.136 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.859 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 18.8 tt0 -59.26 137.45 57.97 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.251 -0.431 . . . . 1.1399999999999999 110.004 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.76 118.39 4.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.492 -0.322 . . . . 2.0899999999999999 111.204 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.456 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 3.1 pt20 -124.42 164.01 20.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.169 -0.469 . . . . 2.0899999999999999 110.674 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.05 150.36 11.32 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.608 -0.806 . . . . 1.0700000000000001 113.595 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 0.4 OUTLIER -72.47 113.9 10.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.875 0.369 . . . . 1.1100000000000001 110.124 179.159 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.574 ' HD3' HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -142.96 160.51 52.61 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.372 -0.376 . . . . 1.6200000000000001 110.173 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.31 134.18 24.24 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.468 2.112 . . . . 1.01 111.056 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.795 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 15.3 m -119.28 136.08 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 110.005 -0.368 . . . . 0.76000000000000001 110.005 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.425 ' HB3' HG23 ' A' ' 43' ' ' VAL . 21.8 tp -94.35 128.72 41.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.083 -0.508 . . . . 0.69999999999999996 111.437 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.448 HD13 ' CG1' ' A' ' 42' ' ' VAL . 14.2 mm -73.32 114.56 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.345 -0.389 . . . . 0.92000000000000004 110.127 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.42 ' HA ' ' CE ' ' A' ' 98' ' ' MET . 88.2 t -90.33 -41.82 13.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.002 0.43 . . . . 0.94999999999999996 111.953 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.69 147.18 96.36 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 112.04 0.385 . . . . 1.1200000000000001 112.04 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.45 159.12 54.76 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.767 2.311 . . . . 1.3 111.986 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.61 70.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.982 -0.554 . . . . 1.3899999999999999 112.348 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.29 94.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.846 0.355 . . . . 1.6100000000000001 110.948 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -66.48 -41.2 89.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.039 -0.528 . . . . 1.77 110.482 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 66.9 m-20 -67.54 -11.82 58.92 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.034 -0.53 . . . . 1.48 110.886 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.8 ttp-105 -94.79 -31.96 13.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.175 -0.466 . . . . 2.6200000000000001 111.212 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.41 -49.08 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.824 0.676 . . . . 1.8600000000000001 112.824 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 p -95.27 -27.05 15.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.953 0.406 . . . . 1.72 110.564 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 67.13 21.25 10.15 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.367 -0.833 . . . . 4.4500000000000002 111.395 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.0 mt -125.65 98.98 33.37 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.393 -0.821 . . . . 1.8100000000000001 109.027 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.438 ' HG3' ' SD ' ' A' ' 1' ' ' MET . 90.1 Cg_endo -88.55 134.54 2.85 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.806 2.337 . . . . 1.05 113.775 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.9 t -79.21 114.37 19.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.193 -1.41 . . . . 1.03 107.193 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.795 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 31.5 m -115.66 150.61 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 113.44 0.904 . . . . 0.77000000000000002 113.44 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 26' ' ' LEU . 1.7 m -117.97 129.03 25.62 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.931 -1.031 . . . . 0.71999999999999997 108.96 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 43' ' ' VAL . 12.2 Cg_exo -70.35 145.44 53.77 Favored 'Trans proline' 0 CA--C 1.527 0.17 0 C-N-CA 123.186 2.591 . . . . 1.03 113.871 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.8 t -107.49 119.9 57.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.509 -0.923 . . . . 1.28 108.509 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.4 m . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 120.521 0.201 . . . . 1.9099999999999999 111.172 -179.258 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 112.338 -0.305 . . . . 1.6599999999999999 112.338 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.477 ' HD2' ' HB3' ' A' ' 104' ' ' ARG . 58.9 m-85 -106.06 69.07 0.79 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.127 0.489 . . . . 1.5600000000000001 111.328 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.19 138.45 29.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.9 -0.591 . . . . 1.25 110.03 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.691 HG21 HG22 ' A' ' 101' ' ' VAL . 17.7 t -116.25 118.24 58.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.601 -0.272 . . . . 1.6799999999999999 110.882 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.7 118.87 20.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.609 -0.269 . . . . 1.95 111.117 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.445 ' HB3' HD11 ' A' ' 66' ' ' ILE . 83.3 mt -82.87 -18.61 39.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.233 0.54 . . . . 1.23 110.58 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -67.37 117.04 8.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.566 -0.743 . . . . 2.21 109.954 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.78 -31.4 2.21 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.381 -0.688 . . . . 1.1499999999999999 111.381 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 61' ' ' LEU . 34.7 m -83.18 -17.26 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.835 0.35 . . . . 1.21 111.502 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.58 83.07 0.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.849 -0.691 . . . . 1.0800000000000001 112.68 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 61' ' ' LEU . 11.7 pt -138.44 169.67 17.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.838 -0.43 . . . . 1.0700000000000001 109.838 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -76.5 -51.73 11.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.79 0.329 . . . . 3.5899999999999999 110.586 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.9 m -85.34 75.88 10.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.269 0.557 . . . . 1.51 110.948 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.02 158.47 29.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.759 -0.655 . . . . 1.79 111.322 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 156.42 -157.34 27.83 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 121.069 -0.586 . . . . 1.1799999999999999 111.744 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.6 t -130.04 126.39 61.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 110.178 -0.305 . . . . 1.5600000000000001 110.178 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.7 t -72.56 118.94 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.318 -0.623 . . . . 1.29 109.318 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -92.89 96.03 9.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.241 -0.436 . . . . 2.23 110.971 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.16 -6.04 57.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.538 0.685 . . . . 1.1699999999999999 109.373 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.452 ' HA ' ' CZ ' ' B' ' 33' ' ' PHE . 3.9 p-10 -78.98 -16.2 57.24 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.902 -1.045 . . . . 0.89000000000000001 112.689 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -136.83 68.71 58.47 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 114.138 1.162 . . . . 2.1299999999999999 114.138 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.79 140.73 32.63 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.289 1.993 . . . . 0.80000000000000004 109.914 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.462 ' HD3' HD13 ' A' ' 11' ' ' LEU . 6.1 ptm85 -156.21 114.15 3.31 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.823 0.675 . . . . 2.0899999999999999 112.823 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.536 ' OG1' ' HD2' ' B' ' 77' ' ' PRO . 90.8 m -82.76 109.94 17.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.154 -0.476 . . . . 1.6200000000000001 110.089 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.0 pt -120.96 155.18 24.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.038 -0.528 . . . . 1.1499999999999999 109.641 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.53 125.77 26.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.976 0.417 . . . . 1.03 111.5 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.45 ' SD ' ' HA3' ' A' ' 87' ' ' GLY . 40.3 tpp -103.08 9.24 38.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.094 0.473 . . . . 1.29 110.718 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -92.94 -64.21 1.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.173 -0.467 . . . . 2.6400000000000001 111.854 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.58 -27.96 63.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.293 -0.412 . . . . 1.1200000000000001 111.305 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 85' ' ' ARG . 45.8 mtt180 -73.81 -29.86 62.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.253 -0.431 . . . . 1.0600000000000001 110.502 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.32 66.94 2.09 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.896 -0.669 . . . . 1.1200000000000001 112.355 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.45 ' HA3' ' SD ' ' A' ' 82' ' ' MET . . . -69.14 151.94 51.67 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.713 -0.756 . . . . 1.0900000000000001 112.27 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -113.43 122.12 46.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.31 -0.255 . . . . 2.46 110.31 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -82.18 135.28 35.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.655 0.264 . . . . 2.4900000000000002 111.224 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 90' ' ' LEU . 3.0 mm? -104.27 -64.68 1.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.134 0.492 . . . . 1.29 110.616 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -162.95 -169.07 1.93 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.791 -0.64 . . . . 1.1499999999999999 109.346 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -130.77 156.48 44.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.684 0.278 . . . . 1.3200000000000001 110.579 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.542 HG13 HD11 ' A' ' 6' ' ' ILE . 26.8 m -97.33 156.59 36.05 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.39 -0.368 . . . . 0.75 111.085 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -64.19 145.52 89.09 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.721 2.281 . . . . 0.94999999999999996 111.129 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -61.19 -25.7 67.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 1.51 111.662 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -38.43 87.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.877 0.37 . . . . 1.5700000000000001 110.577 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 101' ' ' VAL . 47.7 mm -73.56 -46.48 48.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.96 -0.564 . . . . 1.3100000000000001 109.921 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.42 ' CE ' ' HA ' ' A' ' 28' ' ' VAL . 9.8 tpt -63.03 -26.05 68.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.953 -0.567 . . . . 1.6000000000000001 110.99 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.15 -48.22 79.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.673 -0.694 . . . . 2.2999999999999998 111.634 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -28.41 60.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.543 -0.299 . . . . 1.6399999999999999 111.55 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.691 HG22 HG21 ' A' ' 59' ' ' VAL . 57.8 t -62.2 -46.93 95.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.699 -0.482 . . . . 1.03 109.699 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 77.7 mt -61.34 -36.38 80.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.614 -0.721 . . . . 1.22 110.185 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.31 -46.18 94.95 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.479 -0.782 . . . . 1.03 112.453 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.477 ' HB3' ' HD2' ' A' ' 57' ' ' PHE . 21.5 mtt180 -65.4 -37.84 88.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 1.72 110.77 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.61 -18.27 65.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.757 -0.656 . . . . 1.02 112.253 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.1 m -78.82 -24.96 44.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.938 0.399 . . . . 1.1100000000000001 111.164 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.75 -22.25 50.56 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.124 0.416 . . . . 1.5 112.124 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.0 pt -84.23 -9.22 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 111.96 0.356 . . . . 1.1499999999999999 111.96 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.3 mt -84.2 73.03 10.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.897 0.379 . . . . 0.97999999999999998 110.092 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 116.361 -0.381 . . . . 1.3500000000000001 111.666 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.882 ' HA ' ' HA ' ' B' ' 30' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.743 0.306 . . . . 2.0299999999999998 110.881 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -82.27 -21.53 36.18 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.328 -0.619 . . . . 2.8199999999999998 109.328 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . 0.713 ' HG2' ' HG2' ' B' ' 98' ' ' MET . 6.4 mtm180 72.14 120.9 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.946 -1.024 . . . . 2.3199999999999998 112.903 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' B' ' 92' ' ' ARG . . . 97.47 -26.76 21.66 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.741 -0.663 . . . . 1.28 113.679 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.427 ' OE1' ' HD2' ' B' ' 89' ' ' ARG . 6.5 mm-40 -71.08 97.84 1.55 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.848 0.685 . . . . 1.53 112.848 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.84 HD11 ' HB ' ' B' ' 93' ' ' VAL . 64.5 mt -95.26 125.91 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.851 -0.796 . . . . 0.75 108.851 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -105.78 164.78 11.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.986 0.422 . . . . 0.81000000000000005 112.007 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 45.8 tp -128.87 120.04 25.51 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.05 -0.523 . . . . 1.05 109.949 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.46 HG22 ' H ' ' B' ' 10' ' ' SER . 4.8 p -159.69 169.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.251 -0.431 . . . . 0.71999999999999997 110.122 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . 0.46 ' H ' HG22 ' B' ' 9' ' ' VAL . 0.3 OUTLIER -97.77 135.54 39.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.779 0.323 . . . . 1.6299999999999999 110.472 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' B' ' 44' ' ' PRO . 35.3 mt -86.28 -18.26 32.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.234 -0.439 . . . . 0.82999999999999996 111.189 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.96 154.24 89.81 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.915 -0.584 . . . . 1.6200000000000001 111.116 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.727 ' HG2' ' HB2' ' A' ' 13' ' ' PRO . 58.5 Cg_endo -73.47 124.28 9.38 Favored 'Cis proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.266 -1.556 . . . . 1.28 113.041 0.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.489 ' HB ' ' HG2' ' B' ' 20' ' ' GLN . 0.0 OUTLIER -121.93 166.85 13.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.554 -0.748 . . . . 1.47 109.918 179.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.87 -171.24 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.582 0.23 . . . . 1.22 111.069 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.96 -104.92 1.18 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 116.081 -0.508 . . . . 1.01 112.702 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -132.43 14.52 4.54 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.293 0.568 . . . . 2.1800000000000002 110.285 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -78.07 143.95 36.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.735 -0.666 . . . . 1.28 110.061 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.08 105.47 2.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.763 0.316 . . . . 1.52 111.224 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.489 ' HG2' ' HB ' ' B' ' 14' ' ' THR . 6.7 mt-30 -83.89 -174.73 5.45 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.112 -0.495 . . . . 1.8600000000000001 110.913 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.05 -167.11 49.25 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.95 -0.568 . . . . 0.90000000000000002 112.752 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 20.1 m -113.89 122.27 46.49 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.428 -0.582 . . . . 0.94999999999999996 109.428 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -151.61 159.99 32.42 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.681 -0.488 . . . . 1.5900000000000001 109.681 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.674 ' HG2' HG21 ' B' ' 68' ' ' THR . 47.2 Cg_exo -59.47 137.76 79.86 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.192 1.928 . . . . 0.65000000000000002 110.671 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.863 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 4.3 m -128.09 128.13 68.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.989 0.424 . . . . 0.56999999999999995 111.126 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 46.7 tp -94.44 121.2 35.74 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.961 -0.563 . . . . 1.1699999999999999 109.605 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . 0.504 HG12 HG12 ' B' ' 42' ' ' VAL . 51.5 mt -80.86 137.82 20.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.956 -0.387 . . . . 0.66000000000000003 109.956 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.87 -29.39 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.821 0.344 . . . . 0.93000000000000005 111.051 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' THR . . . . . 0.543 HG23 HG22 ' B' ' 41' ' ' VAL . 0.9 OUTLIER -74.06 137.31 75.89 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.258 -0.428 . . . . 0.81000000000000005 111.615 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.882 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 43.1 Cg_endo -67.2 161.42 42.99 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.009 2.473 . . . . 0.78000000000000003 112.045 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.77 -37.08 73.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.169 -0.468 . . . . 1.03 111.677 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.51 -29.99 71.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.114 0.483 . . . . 1.3999999999999999 111.176 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . 0.548 ' HB2' ' HG2' ' B' ' 30' ' ' PRO . 2.2 t80 -81.13 -40.01 24.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.033 0.444 . . . . 1.5700000000000001 110.135 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' B' ' 38' ' ' ARG . 44.8 m-20 -66.52 -22.32 66.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.63 -0.713 . . . . 1.6399999999999999 110.725 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -79.75 -34.83 39.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 2.54 110.948 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 58.0 t -85.4 -64.21 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.156 -0.475 . . . . 1.0900000000000001 111.987 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 1.3 m -67.51 -30.77 70.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.385 -0.37 . . . . 1.3300000000000001 111.014 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.534 ' HE ' ' HA ' ' B' ' 38' ' ' ARG . 0.7 OUTLIER 71.69 -9.84 0.9 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.534 0.568 . . . . 1.78 112.534 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 60.4 mt -118.62 100.93 51.09 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.681 -0.489 . . . . 1.1599999999999999 109.681 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' PRO . . . . . 0.46 ' HD2' ' O ' ' B' ' 80' ' ' ILE . 93.1 Cg_endo -86.68 158.96 9.14 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.742 2.295 . . . . 0.56999999999999995 113.322 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.543 HG22 HG23 ' B' ' 29' ' ' THR . 6.4 m -92.95 127.2 45.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 109.202 -0.666 . . . . 1.0800000000000001 109.202 178.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.863 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 27.8 m -114.68 146.78 18.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.252 0.549 . . . . 0.64000000000000001 112.148 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.428 HG13 ' O ' ' B' ' 73' ' ' ARG . 43.1 t -109.84 112.91 57.87 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.944 -1.026 . . . . 1.1000000000000001 109.279 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.522 ' HB3' HD11 ' B' ' 11' ' ' LEU . 56.0 Cg_endo -72.06 119.42 6.16 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.69 2.26 . . . . 0.72999999999999998 112.567 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 91.6 t -77.49 136.44 24.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.812 -0.631 . . . . 0.90000000000000002 110.202 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 3.9 m -105.07 112.01 24.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.129 -0.487 . . . . 1.1699999999999999 110.097 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 CA-C-N 116.184 -0.462 . . . . 1.8500000000000001 110.64 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.138 0.494 . . . . 1.96 109.995 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.95 -94.24 0.78 Allowed Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.77 -0.65 . . . . 1.0800000000000001 112.464 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -87.72 -6.64 58.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.921 0.391 . . . . 3.5699999999999998 111.096 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.36 113.91 22.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.36 -0.382 . . . . 1.0800000000000001 110.392 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.453 HG22 ' HD2' ' B' ' 104' ' ' ARG . 13.8 t -77.79 141.29 15.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.03 -0.532 . . . . 1.3400000000000001 110.335 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -90.2 124.94 35.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.54 -0.3 . . . . 1.3799999999999999 110.709 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.516 ' HB3' HD13 ' B' ' 66' ' ' ILE . 72.4 mt -89.97 -35.68 15.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.267 -0.424 . . . . 1.02 110.868 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -82.87 -173.22 4.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 1.79 111.321 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.92 -38.46 3.17 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.162 -0.775 . . . . 1.1499999999999999 111.162 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 7.0 p -94.85 -3.35 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.953 0.406 . . . . 1.1699999999999999 110.679 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.88 84.29 1.68 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.789 -0.719 . . . . 1.05 112.597 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.516 HD13 ' HB3' ' B' ' 61' ' ' LEU . 12.0 tt -135.3 160.58 40.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.798 -0.445 . . . . 1.6100000000000001 109.798 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -83.5 -45.13 13.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.864 0.364 . . . . 2.3999999999999999 110.705 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . 0.674 HG21 ' HG2' ' B' ' 24' ' ' PRO . 17.1 m -85.46 90.52 7.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.154 0.502 . . . . 0.93000000000000005 111.643 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 52.7 m -71.46 98.1 1.77 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.804 -0.634 . . . . 1.3100000000000001 111.016 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -165.05 -171.2 31.0 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.793 -0.717 . . . . 0.79000000000000004 112.152 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 15.1 m -117.58 151.97 19.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.862 0.363 . . . . 0.93000000000000005 111.131 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.451 ' HB ' ' HB ' ' B' ' 59' ' ' VAL . 47.3 t -87.92 121.96 39.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.904 -0.589 . . . . 1.3799999999999999 110.219 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.428 ' O ' HG13 ' B' ' 43' ' ' VAL . 33.3 mmm-85 -97.25 84.93 3.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.953 0.406 . . . . 1.3700000000000001 111.138 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 29.6 m -73.67 -0.75 16.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.189 -0.459 . . . . 1.1599999999999999 111.228 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.44 ' C ' ' HD3' ' B' ' 77' ' ' PRO . 16.9 p-10 -96.06 -2.8 45.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.977 -0.556 . . . . 1.1000000000000001 111.939 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' GLN . . . . . 0.55 ' N ' ' HD3' ' B' ' 77' ' ' PRO . 39.3 mt-30 -130.16 52.45 9.42 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.538 0.94 . . . . 2.4700000000000002 113.538 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' B' ' 76' ' ' GLN . 1.0 OUTLIER -84.87 119.4 2.18 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.269 1.979 . . . . 0.95999999999999996 111.49 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -125.61 140.34 52.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.705 0.288 . . . . 1.96 111.453 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.18 126.98 31.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.679 -0.86 . . . . 1.1899999999999999 108.679 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.46 ' O ' ' HD2' ' B' ' 40' ' ' PRO . 31.5 pt -133.8 149.54 30.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.389 0.514 . . . . 1.28 112.389 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' B' ' 83' ' ' LYS . 14.1 t0 -76.41 91.71 3.32 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.277 -0.638 . . . . 1.28 109.277 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' MET . . . . . 0.451 ' SD ' ' HA3' ' B' ' 87' ' ' GLY . 48.5 tpp -67.76 -16.71 64.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.976 -0.556 . . . . 2.7000000000000002 111.869 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' B' ' 81' ' ' ASP . 5.0 mtmp? -75.91 -45.58 34.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.282 -0.417 . . . . 1.96 111.111 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.98 -31.69 25.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.236 -0.438 . . . . 1.0600000000000001 111.88 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' B' ' 85' ' ' ARG . 66.1 mtt-85 -72.61 -36.01 67.98 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.943 0.349 . . . . 1.47 111.943 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.64 80.1 1.44 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.351 -0.928 . . . . 0.81999999999999995 112.108 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . 0.451 ' HA3' ' SD ' ' B' ' 82' ' ' MET . . . -90.55 162.0 28.93 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.746 -0.74 . . . . 0.65000000000000002 112.749 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -155.96 155.37 32.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.661 -0.866 . . . . 1.8100000000000001 108.661 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . 0.427 ' HD2' ' OE1' ' B' ' 5' ' ' GLU . 5.6 ttp180 -99.35 142.26 31.06 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 121.083 -0.247 . . . . 2.4900000000000002 111.144 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 53.5 mt -108.39 -97.06 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.95 0.352 . . . . 0.76000000000000001 111.95 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . 0.436 ' HG3' HD12 ' B' ' 6' ' ' ILE . 15.5 pt-20 -106.89 169.86 8.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.466 -0.334 . . . . 1.0700000000000001 111.153 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' B' ' 4' ' ' GLY . 3.7 ttt180 -110.72 106.06 15.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.373 -0.376 . . . . 2.0499999999999998 110.417 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.84 ' HB ' HD11 ' B' ' 6' ' ' ILE . 14.4 p -69.37 133.05 89.36 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.405 -0.361 . . . . 1.45 110.851 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.8 147.11 33.09 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.002 2.468 . . . . 1.03 112.52 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -60.67 -28.32 68.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.852 -0.613 . . . . 2.1400000000000001 110.937 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -47.16 86.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.762 -0.654 . . . . 1.78 110.768 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 51.6 mm -74.66 -40.07 47.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.545 . . . . 1.3300000000000001 110.199 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' MET . . . . . 0.713 ' HG2' ' HG2' ' B' ' 3' ' ' ARG . 8.8 tpt -58.56 -38.01 76.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.9 -0.591 . . . . 2.3399999999999999 110.981 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -60.94 -39.35 89.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.917 0.389 . . . . 1.9099999999999999 110.701 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -67.14 -27.63 67.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 1.76 111.257 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.444 ' HA ' HG21 ' B' ' 59' ' ' VAL . 63.3 t -70.94 -51.27 36.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.414 -0.587 . . . . 1.01 109.414 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.23 -36.59 81.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.585 -0.734 . . . . 1.29 110.821 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.23 -50.88 63.07 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.936 -0.575 . . . . 1.02 112.079 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . 0.453 ' HD2' HG22 ' B' ' 59' ' ' VAL . 77.2 mtt85 -62.95 -35.89 81.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.72 0.295 . . . . 1.8500000000000001 110.893 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 35.4 mt -66.03 -31.2 71.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.247 0.546 . . . . 1.9399999999999999 110.115 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -80.81 -18.73 46.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.793 -0.64 . . . . 1.1599999999999999 110.858 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 7.8 m -74.13 -38.88 63.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.296 -0.411 . . . . 1.45 110.841 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 34.6 pt -76.29 2.25 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 111.982 0.364 . . . . 1.98 111.982 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 86.2 mt -82.97 -13.84 55.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.345 -0.389 . . . . 1.3600000000000001 111.138 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.802 -0.618 . . . . 2.1299999999999999 110.273 179.65 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.578 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 24.4 ptp . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.887 0.375 . . . . 1.29 110.474 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -129.23 158.4 39.14 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.971 -0.559 . . . . 2.0099999999999998 110.55 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -61.64 122.61 15.73 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 110.037 -0.357 . . . . 1.8500000000000001 110.037 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 111.09 -8.85 29.22 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.914 -0.66 . . . . 0.85999999999999999 112.055 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.578 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 49.7 mt-10 -85.8 145.35 27.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.88 0.371 . . . . 0.98999999999999999 111.365 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.414 HD11 HG13 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -110.12 110.75 33.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.259 -0.645 . . . . 1.1599999999999999 109.259 179.083 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 89' ' ' ARG . 27.2 m95 -104.67 135.22 46.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.934 0.397 . . . . 0.91000000000000003 111.294 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.764 ' HB2' HD21 ' A' ' 90' ' ' LEU . 25.6 tp -95.51 122.3 38.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.26 -0.427 . . . . 0.90000000000000002 110.822 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 p -160.87 157.24 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 1.04 109.936 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.642 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -89.17 130.01 35.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.841 -0.429 . . . . 1.3200000000000001 109.841 179.38 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.6 mt -78.96 -10.51 59.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.252 -0.431 . . . . 1.29 110.952 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.531 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 5.1 m-20 -73.23 164.47 60.78 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.707 -0.679 . . . . 1.54 110.922 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.531 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 56.2 Cg_endo -69.99 141.12 65.08 Favored 'Cis proline' 0 C--N 1.347 0.49 0 C-N-CA 123.815 -1.327 . . . . 1.6899999999999999 112.533 0.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.522 HG23 ' HA ' ' A' ' 12' ' ' ASP . 23.0 p -120.35 151.81 38.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.296 -0.411 . . . . 1.3600000000000001 111.276 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.85 125.47 11.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.931 -0.577 . . . . 1.7 109.689 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.38 -124.54 6.76 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.206 -0.758 . . . . 1.1799999999999999 111.206 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -139.99 75.54 1.51 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.148 0.499 . . . . 2.7799999999999998 110.948 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.86 166.79 23.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.567 -0.742 . . . . 1.1399999999999999 109.414 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -63.2 128.03 34.0 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.406 0.441 . . . . 2.0899999999999999 110.634 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.421 ' HB2' HE21 ' A' ' 20' ' ' GLN . 1.8 pt20 -131.22 178.62 6.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.064 -0.516 . . . . 2.0899999999999999 110.106 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.1 162.62 38.24 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.804 -0.712 . . . . 1.0700000000000001 113.844 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.642 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 3.6 m -85.95 102.44 13.76 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.975 -0.75 . . . . 1.1100000000000001 108.975 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.515 ' NH1' ' HB3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -136.99 156.12 75.92 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.268 -0.423 . . . . 1.6200000000000001 110.622 -179.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.13 123.69 9.43 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.564 2.176 . . . . 1.01 110.795 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.601 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 14.9 m -108.93 134.22 51.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.959 0.409 . . . . 0.76000000000000001 110.156 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.463 HD11 HG22 ' A' ' 93' ' ' VAL . 20.8 tp -86.31 122.61 30.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.849 -0.614 . . . . 0.69999999999999996 111.268 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.476 ' HA ' HG12 ' A' ' 42' ' ' VAL . 22.4 mm -74.76 115.23 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.92000000000000004 109.854 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.9 t -96.75 -38.78 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 112.07 0.396 . . . . 0.94999999999999996 112.07 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.08 147.22 76.48 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 112.186 0.439 . . . . 1.1200000000000001 112.186 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.02 156.25 65.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.853 2.368 . . . . 1.3 112.03 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.19 61.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.816 -0.629 . . . . 1.3899999999999999 112.561 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.09 -46.3 90.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.745 0.307 . . . . 1.6100000000000001 111.453 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -67.62 -41.2 84.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.12 0.486 . . . . 1.77 110.416 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.497 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 35.4 m-20 -66.5 -18.61 65.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.712 -0.676 . . . . 1.48 111.362 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -88.99 -42.22 11.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.393 -0.367 . . . . 2.6200000000000001 111.966 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 p -81.13 -44.42 20.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.032 0.753 . . . . 1.8600000000000001 113.032 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 m -90.72 -24.2 20.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.83 0.348 . . . . 1.72 111.395 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 5.9 mpt_? 64.25 15.79 9.64 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.915 -0.584 . . . . 4.4500000000000002 111.851 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.57 87.74 55.8 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 1.8100000000000001 111.045 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.591 ' HD2' ' O ' ' A' ' 80' ' ' ILE . 60.6 Cg_endo -75.66 132.12 14.24 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.207 1.938 . . . . 1.05 112.248 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.573 HG22 HG23 ' A' ' 79' ' ' THR . 75.8 t -77.62 118.9 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.097 -1.445 . . . . 1.03 107.097 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.601 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 35.1 m -127.68 161.3 35.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.617 0.723 . . . . 0.77000000000000002 112.87 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -125.06 130.74 24.09 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 114.547 -1.206 . . . . 0.71999999999999997 108.292 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 69.8 Cg_endo -74.7 141.73 27.98 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.528 2.152 . . . . 1.03 113.68 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.411 HG22 HG22 ' A' ' 72' ' ' VAL . 90.0 t -107.12 111.04 33.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.996 -0.742 . . . . 1.28 108.996 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 116.36 -0.382 . . . . 1.9099999999999999 110.431 -179.642 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.683 0 N-CA-C 111.711 -0.556 . . . . 1.6599999999999999 111.711 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -108.81 15.2 23.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.154 0.502 . . . . 1.5600000000000001 111.252 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -132.23 77.86 1.78 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.814 -0.63 . . . . 1.25 110.2 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.485 HG23 ' HB ' ' A' ' 72' ' ' VAL . 28.6 m -85.26 133.62 28.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.837 -0.62 . . . . 1.6799999999999999 111.285 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.69 148.16 24.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.778 -0.646 . . . . 1.95 110.802 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.9 ' HB3' HD11 ' A' ' 66' ' ' ILE . 80.1 mt -91.64 -16.84 26.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.245 0.545 . . . . 1.23 110.175 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.21 124.95 25.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.668 -0.696 . . . . 2.21 110.614 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.4 -27.94 2.94 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.45 -0.66 . . . . 1.1499999999999999 111.45 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.5 m -96.01 -13.2 8.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.667 0.27 . . . . 1.21 111.266 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.96 72.8 0.97 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.957 -0.639 . . . . 1.0800000000000001 113.108 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.9 HD11 ' HB3' ' A' ' 61' ' ' LEU . 15.6 pt -123.25 -167.86 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.613 0.244 . . . . 1.0700000000000001 111.043 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -102.95 -43.78 5.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.147 0.499 . . . . 3.5899999999999999 109.781 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.2 m -64.75 109.34 2.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.514 -0.766 . . . . 1.51 111.327 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 m -102.21 127.28 49.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.06 -0.518 . . . . 1.79 111.101 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 162.31 -166.84 36.65 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.499 -1.04 . . . . 1.1799999999999999 110.499 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.81 131.89 72.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.24 -0.652 . . . . 1.5600000000000001 109.24 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.485 ' HB ' HG23 ' A' ' 59' ' ' VAL . 47.2 t -78.23 117.56 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.835 0.35 . . . . 1.29 110.83 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 44' ' ' PRO . 19.1 mmm180 -82.85 103.39 12.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.639 -0.504 . . . . 2.23 109.639 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.19 1.96 55.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.135 0.493 . . . . 1.1699999999999999 110.943 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -89.67 -16.32 30.7 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.586 -0.734 . . . . 0.89000000000000001 111.341 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -125.61 72.73 68.23 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 113.49 0.922 . . . . 2.1299999999999999 113.49 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -90.97 115.18 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.888 2.392 . . . . 0.80000000000000004 110.014 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -138.07 165.88 25.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.163 0.506 . . . . 2.0899999999999999 111.735 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.573 HG23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -97.18 133.02 42.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.343 -0.984 . . . . 1.6200000000000001 108.343 178.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.591 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 20.2 pt -132.21 148.35 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.788 0.328 . . . . 1.1499999999999999 111.304 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -82.08 102.42 11.02 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.882 -0.414 . . . . 1.03 109.882 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.3 tpp -89.76 -10.12 46.75 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.235 -0.439 . . . . 1.29 111.108 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 83' ' ' LYS . 17.1 tptp -79.69 -41.25 27.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.798 0.332 . . . . 2.6400000000000001 111.274 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.09 -26.82 42.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.421 -0.354 . . . . 1.1200000000000001 111.388 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 85' ' ' ARG . 33.1 mtt-85 -84.06 -59.47 2.39 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.385 0.513 . . . . 1.0600000000000001 112.385 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.78 109.29 0.3 Allowed Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.889 -0.672 . . . . 1.1200000000000001 111.85 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.03 -168.66 12.5 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.649 -0.786 . . . . 1.0900000000000001 112.79 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -131.36 138.97 49.4 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.063 -0.347 . . . . 2.46 110.063 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 7' ' ' TRP . 17.3 ttp180 -86.2 139.8 30.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.753 0.311 . . . . 2.4900000000000002 111.137 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.764 HD21 ' HB2' ' A' ' 8' ' ' LEU . 1.9 mm? -89.04 -55.37 3.71 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.049 -0.722 . . . . 1.29 109.049 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -170.37 -160.61 0.22 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.183 -0.917 . . . . 1.1499999999999999 108.688 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -134.58 149.97 50.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.688 0.28 . . . . 1.3200000000000001 110.456 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.463 HG22 HD11 ' A' ' 26' ' ' LEU . 31.4 m -97.73 159.82 30.07 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.26 -0.427 . . . . 0.75 111.092 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -64.87 155.87 65.28 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.713 2.276 . . . . 0.94999999999999996 111.398 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -63.59 -26.94 68.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 1.51 110.753 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.34 -37.59 78.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.542 . . . . 1.5700000000000001 110.573 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.5 mm -70.06 -43.69 78.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.022 -0.535 . . . . 1.3100000000000001 110.12 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.7 tpt -63.7 -45.87 88.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 1.6000000000000001 110.459 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -61.58 -36.69 81.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.024 -0.535 . . . . 2.2999999999999998 110.716 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 5.1 tp10 -63.08 -47.64 82.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.072 -0.513 . . . . 1.6399999999999999 110.589 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.446 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 78.8 t -61.64 -46.02 97.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.939 -0.573 . . . . 1.03 110.336 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.55 -39.14 83.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.099 -0.501 . . . . 1.22 110.689 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.42 -43.37 99.15 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.783 -0.644 . . . . 1.03 111.644 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 3.2 mmt180 -65.14 -37.76 88.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 1.72 110.49 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 101' ' ' VAL . 96.7 mt -67.43 -25.06 65.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.56 . . . . 1.02 111.691 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.2 m -71.89 -11.53 60.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 1.1100000000000001 111.067 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.26 -13.65 26.31 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.316 0.487 . . . . 1.5 112.316 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.497 ' HB ' HG22 ' B' ' 29' ' ' THR . 36.1 pt -100.75 -1.24 9.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.827 0.677 . . . . 1.1499999999999999 112.827 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.8 mt -81.65 73.7 8.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.753 0.311 . . . . 0.97999999999999998 110.222 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.545 -0.298 . . . . 1.3500000000000001 111.596 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.757 ' HA ' ' HA ' ' B' ' 30' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 120.708 0.289 . . . . 2.0299999999999998 110.432 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' B' ' 3' ' ' ARG . 2.0 mp0 -77.39 -25.95 51.33 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.922 -0.77 . . . . 2.8199999999999998 108.922 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' B' ' 2' ' ' GLU . 10.7 mtm180 73.03 142.84 0.06 Allowed 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 114.96 -1.018 . . . . 2.3199999999999998 111.457 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' B' ' 92' ' ' ARG . . . 86.46 -50.03 4.16 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.898 -0.668 . . . . 1.28 113.62 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.44 ' OE2' ' HD2' ' B' ' 92' ' ' ARG . 64.7 mm-40 -57.66 107.41 0.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.838 0.681 . . . . 1.53 112.838 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.441 HD12 ' HG3' ' B' ' 91' ' ' GLU . 80.6 mt -98.66 127.28 51.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.374 -0.602 . . . . 0.75 109.374 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -107.68 168.82 8.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.201 0.524 . . . . 0.81000000000000005 111.805 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' B' ' 88' ' ' LYS . 33.5 tp -141.53 132.17 25.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.697 -0.683 . . . . 1.05 109.941 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.411 HG12 HG21 ' B' ' 25' ' ' VAL . 5.2 p -169.26 165.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.532 -0.544 . . . . 0.71999999999999997 109.532 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' B' ' 22' ' ' THR . 22.9 t -88.76 139.36 30.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.677 -0.49 . . . . 1.6299999999999999 109.677 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.714 HD13 ' HB3' ' B' ' 19' ' ' GLN . 31.7 mt -87.72 -16.82 33.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.201 0.524 . . . . 0.82999999999999996 110.349 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . 0.414 ' CB ' ' HA ' ' B' ' 13' ' ' PRO . 2.1 m-20 -73.83 162.08 75.72 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.76 -0.655 . . . . 1.6200000000000001 111.283 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.414 ' HA ' ' CB ' ' B' ' 12' ' ' ASP . 98.2 Cg_endo -80.28 135.56 33.92 Favored 'Cis proline' 0 C--N 1.344 0.299 0 C-N-CA 123.359 -1.517 . . . . 1.28 113.259 0.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.02 170.51 15.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.345 -0.843 . . . . 1.47 109.575 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.46 165.09 28.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.575 0.226 . . . . 1.22 110.551 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.34 -146.23 34.23 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.122 -0.561 . . . . 1.01 112.266 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -90.15 -1.72 57.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.384 -0.228 . . . . 2.1800000000000002 110.384 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -57.78 154.25 12.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.906 -0.588 . . . . 1.28 112.201 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.714 ' HB3' HD13 ' B' ' 11' ' ' LEU . 28.9 mm-40 -60.94 127.35 31.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.686 -0.688 . . . . 1.52 111.383 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -142.06 -176.6 4.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.893 -0.594 . . . . 1.8600000000000001 110.533 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.59 174.82 50.62 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.993 -0.622 . . . . 0.90000000000000002 112.697 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' B' ' 10' ' ' SER . 22.9 m -105.65 103.62 13.16 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.828 -0.434 . . . . 0.94999999999999996 109.828 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -141.55 157.98 64.25 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.241 -0.436 . . . . 1.5900000000000001 110.332 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.02 141.36 79.27 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.495 2.13 . . . . 0.65000000000000002 111.411 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.827 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 6.4 m -131.75 131.49 62.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.379 0.609 . . . . 0.56999999999999995 111.56 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 36.6 tp -101.72 123.85 46.39 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.669 -0.696 . . . . 1.1699999999999999 109.527 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . 0.422 HG12 HG12 ' B' ' 42' ' ' VAL . 34.4 mt -78.89 138.16 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.58 -0.282 . . . . 0.66000000000000003 110.362 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' B' ' 1' ' ' MET . 21.5 t -99.54 -34.92 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.406 -0.361 . . . . 0.93000000000000005 110.945 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' THR . . . . . 0.497 HG22 ' HB ' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -76.53 140.96 68.78 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.215 -0.448 . . . . 0.81000000000000005 111.634 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.757 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 95.9 Cg_endo -78.76 159.83 27.93 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.767 2.311 . . . . 0.78000000000000003 112.009 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' B' ' 34' ' ' ASN . . . -55.18 -29.7 58.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.212 -0.449 . . . . 1.03 111.954 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.38 -40.73 75.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.292 -0.413 . . . . 1.3999999999999999 110.871 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -89.33 -37.76 14.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.058 -0.519 . . . . 1.5700000000000001 110.63 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.561 ' O ' ' HA ' ' B' ' 38' ' ' ARG . 85.5 m-20 -61.69 -18.22 58.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.704 -0.68 . . . . 1.6399999999999999 112.302 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -88.13 -25.88 22.76 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.694 0.257 . . . . 2.54 111.694 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -82.02 -61.84 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.963 0.411 . . . . 1.0900000000000001 111.645 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.79 -28.21 36.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.186 -0.461 . . . . 1.3300000000000001 111.201 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 1.5 mmp_? 69.9 8.23 6.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.809 -0.632 . . . . 1.78 111.819 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.64 98.06 48.28 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.968 -0.56 . . . . 1.1599999999999999 109.537 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' B' ' 80' ' ' ILE . 85.0 Cg_endo -90.62 155.23 4.28 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.789 2.326 . . . . 0.56999999999999995 113.112 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 m -94.74 124.93 47.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.105 -0.702 . . . . 1.0800000000000001 109.105 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.827 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 28.6 m -111.2 147.19 15.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 112.802 0.667 . . . . 0.64000000000000001 112.802 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.41 118.29 49.38 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 114.752 -1.113 . . . . 1.1000000000000001 108.757 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.609 ' HG3' ' HG3' ' B' ' 19' ' ' GLN . 66.1 Cg_endo -74.14 142.45 30.8 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.628 2.219 . . . . 0.72999999999999998 113.041 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.773 HG22 HG12 ' B' ' 72' ' ' VAL . 44.0 t -95.62 116.72 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.798 -0.637 . . . . 0.90000000000000002 109.809 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.88 145.0 26.87 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.193 -0.458 . . . . 1.1699999999999999 110.79 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 C--N 1.321 -0.672 0 CA-C-O 120.73 0.3 . . . . 1.8500000000000001 110.745 179.728 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.706 ' HB3' ' HB3' ' B' ' 58' ' ' ALA . . . . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 110.53 -0.174 . . . . 1.96 110.53 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.39 -61.33 5.48 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.253 -0.498 . . . . 1.0800000000000001 112.54 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.544 ' HE1' ' HB ' ' B' ' 107' ' ' THR . 70.4 m-85 -114.65 0.38 13.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.283 0.563 . . . . 3.5699999999999998 110.54 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.706 ' HB3' ' HB3' ' B' ' 55' ' ' ALA . . . -100.16 106.23 17.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.614 -0.721 . . . . 1.0800000000000001 110.573 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.652 HG21 ' HA ' ' B' ' 101' ' ' VAL . 57.0 t -87.92 129.31 39.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.675 -0.693 . . . . 1.3400000000000001 109.895 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.4 t -85.08 138.21 32.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.224 -0.444 . . . . 1.3799999999999999 111.467 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 37.8 mt -106.11 5.81 30.47 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.719 -0.845 . . . . 1.02 108.719 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -101.19 144.48 30.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.239 -0.891 . . . . 1.79 110.864 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.14 -23.33 11.5 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 116.102 -0.499 . . . . 1.1499999999999999 111.96 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.624 HG13 HG13 ' B' ' 66' ' ' ILE . 4.2 p -100.14 -20.52 5.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.173 0.511 . . . . 1.1699999999999999 111.54 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.96 51.62 0.88 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.601 -0.809 . . . . 1.05 112.708 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.624 HG13 HG13 ' B' ' 64' ' ' VAL . 82.6 mt -109.13 147.42 13.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.446 -0.575 . . . . 1.6100000000000001 109.446 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -65.53 -49.53 68.61 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.869 0.366 . . . . 2.3999999999999999 110.133 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 17.8 m -67.89 101.8 1.15 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.915 -0.584 . . . . 0.93000000000000005 109.866 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.17 113.97 25.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.138 -0.483 . . . . 1.3100000000000001 111.253 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.98 -170.25 39.18 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.439 -0.886 . . . . 0.79000000000000004 112.681 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.623 ' HB ' ' HB1' ' B' ' 58' ' ' ALA . 6.0 m -123.86 133.97 67.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.972 -0.381 . . . . 0.93000000000000005 109.972 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.773 HG12 HG22 ' B' ' 45' ' ' VAL . 19.3 m -82.34 138.11 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.464 -0.334 . . . . 1.3799999999999999 111.445 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 mmm-85 -94.82 85.09 4.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.376 -0.374 . . . . 1.3700000000000001 110.101 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . 0.411 ' HB3' HD23 ' B' ' 105' ' ' LEU . 3.4 m -67.85 -9.21 42.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 1.1599999999999999 111.617 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -92.24 -1.86 56.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.471 . . . . 1.1000000000000001 111.833 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -128.27 83.24 66.71 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 112.02 0.378 . . . . 2.4700000000000002 112.02 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -92.01 144.87 2.92 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.01 2.473 . . . . 0.95999999999999996 112.181 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -148.42 131.46 16.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.453 -0.34 . . . . 1.96 111.01 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.07 126.52 34.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.549 . . . . 1.1899999999999999 109.567 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.532 ' O ' ' HD2' ' B' ' 40' ' ' PRO . 23.9 pt -140.47 151.33 20.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 1.28 111.315 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.522 ' CG ' ' HZ1' ' B' ' 83' ' ' LYS . 10.3 t70 -80.67 100.43 8.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 1.28 109.852 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' MET . . . . . 0.683 ' SD ' ' HA3' ' B' ' 87' ' ' GLY . 48.5 tpp -66.62 -16.77 64.43 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.674 0.62 . . . . 2.7000000000000002 112.674 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.522 ' HZ1' ' CG ' ' B' ' 81' ' ' ASP . 6.6 mtmp? -80.29 -54.34 5.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.931 0.396 . . . . 1.96 110.887 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.65 -28.16 67.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.125 -0.489 . . . . 1.0600000000000001 111.34 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -85.44 -11.39 54.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.295 -0.411 . . . . 1.47 111.501 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.96 57.49 18.47 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 121.096 -0.573 . . . . 0.81999999999999995 112.754 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' GLY . . . . . 0.683 ' HA3' ' SD ' ' B' ' 82' ' ' MET . . . -66.24 148.86 51.15 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.934 -0.65 . . . . 0.65000000000000002 112.793 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' B' ' 8' ' ' LEU . 0.1 OUTLIER -127.11 164.45 21.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.49 -0.189 . . . . 1.8100000000000001 110.49 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -105.23 137.22 43.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.771 0.319 . . . . 2.4900000000000002 110.399 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 23.5 mt -98.55 -69.26 0.77 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.233 -0.439 . . . . 0.76000000000000001 111.908 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . 0.441 ' HG3' HD12 ' B' ' 6' ' ' ILE . 16.4 pt-20 -154.02 -171.13 3.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.069 -0.514 . . . . 1.0700000000000001 110.705 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' B' ' 4' ' ' GLY . 10.6 ttt180 -128.03 119.92 26.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.032 0.444 . . . . 2.0499999999999998 111.262 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 2.6 p -84.58 135.06 41.2 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.687 -0.688 . . . . 1.45 109.637 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.45 145.78 27.48 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.954 2.436 . . . . 1.03 113.097 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' B' ' 95' ' ' GLU . 1.2 mm-40 -56.76 -29.15 62.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.757 -0.656 . . . . 2.1400000000000001 111.517 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -39.14 77.53 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.326 -0.397 . . . . 1.78 111.362 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 31.5 mm -79.26 -29.8 13.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.276 0.56 . . . . 1.3300000000000001 109.516 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 11.2 mmt -62.89 -32.31 73.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.59 -0.732 . . . . 2.3399999999999999 110.566 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.15 -41.85 93.64 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.922 -0.581 . . . . 1.9099999999999999 110.253 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 9.9 tp10 -62.57 -45.04 94.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.814 -0.63 . . . . 1.76 110.024 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.652 ' HA ' HG21 ' B' ' 59' ' ' VAL . 38.4 t -62.66 -49.86 82.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.649 -0.705 . . . . 1.01 111.05 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 86.7 mt -55.85 -38.57 70.25 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.343 -0.389 . . . . 1.29 111.512 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.58 -44.78 97.05 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.655 -0.783 . . . . 1.02 111.34 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 8.8 mmt180 -68.34 -33.36 74.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.059 0.456 . . . . 1.8500000000000001 110.472 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.455 ' O ' HG12 ' B' ' 108' ' ' ILE . 78.7 mt -64.35 -24.87 67.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.882 -0.599 . . . . 1.9399999999999999 110.854 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 23.2 m -85.17 -24.16 28.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.152 -0.476 . . . . 1.1599999999999999 110.882 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.544 ' HB ' ' HE1' ' B' ' 57' ' ' PHE . 0.5 OUTLIER -73.35 -28.57 62.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.259 -0.428 . . . . 1.45 112.068 -179.149 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.455 HG12 ' O ' ' B' ' 105' ' ' LEU . 40.7 pt -68.5 -19.67 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.548 0.573 . . . . 1.98 112.548 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.31 59.45 5.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.271 0.558 . . . . 1.3600000000000001 111.457 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-N 115.954 -0.566 . . . . 2.1299999999999999 109.699 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 23.3 ptp . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.925 0.393 . . . . 1.29 110.532 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -116.78 172.11 7.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.226 -0.443 . . . . 2.0099999999999998 111.077 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -73.19 131.06 41.54 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.196 -0.456 . . . . 1.8500000000000001 111.031 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.67 1.22 58.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.878 -0.677 . . . . 0.85999999999999999 113.116 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.419 ' OE2' ' HD2' ' A' ' 89' ' ' ARG . 35.9 mt-10 -84.61 146.86 27.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 0.98999999999999999 111.255 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.74 HD12 ' HG3' ' A' ' 91' ' ' GLU . 21.2 mt -106.52 118.91 55.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.862 -0.608 . . . . 1.1599999999999999 110.265 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -118.05 128.65 54.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.91000000000000003 111.124 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.669 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 19.9 tp -80.07 130.03 34.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.366 -0.379 . . . . 0.90000000000000002 110.621 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.444 HG11 HD11 ' A' ' 80' ' ' ILE . 9.0 p -158.28 165.17 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.415 -0.357 . . . . 1.04 110.389 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 m -104.95 139.86 39.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.848 0.356 . . . . 1.3200000000000001 110.898 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.675 HD23 HD13 ' A' ' 80' ' ' ILE . 25.3 mt -98.43 -9.17 25.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.003 0.43 . . . . 1.29 110.58 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.497 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 2.7 m-20 -78.1 165.55 49.7 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.533 -0.758 . . . . 1.54 110.672 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.497 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 73.2 Cg_endo -73.95 139.25 60.46 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.83 -1.321 . . . . 1.6899999999999999 113.073 0.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.684 ' OG1' ' HB3' ' A' ' 20' ' ' GLN . 21.5 p -111.27 157.1 20.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.502 -0.772 . . . . 1.3600000000000001 110.175 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -136.3 148.93 48.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.34 . . . . 1.7 111.075 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.88 -86.62 1.07 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.94 -0.648 . . . . 1.1799999999999999 112.176 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -160.44 45.13 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.158 0.504 . . . . 2.7799999999999998 111.258 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.677 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 29.8 mt-10 -79.43 176.63 9.52 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.737 -0.468 . . . . 1.1399999999999999 109.737 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -78.94 90.35 4.75 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.434 -0.58 . . . . 2.0899999999999999 109.434 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.684 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 1.4 pt20 -89.94 158.63 17.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.783 -0.644 . . . . 2.0899999999999999 112.059 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.9 127.72 6.18 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.684 -0.689 . . . . 1.0700000000000001 112.805 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.9 m -63.14 129.92 42.37 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.77 0.319 . . . . 1.1100000000000001 110.336 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.43 155.49 29.86 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.175 -0.466 . . . . 1.6200000000000001 110.283 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 11.7 Cg_exo -72.53 131.6 17.69 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.314 2.009 . . . . 1.01 110.824 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.655 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 20.9 m -107.38 154.12 8.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.439 -0.346 . . . . 0.76000000000000001 110.288 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.48 HD23 HG21 ' A' ' 101' ' ' VAL . 29.7 tp -100.87 133.03 45.96 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.372 -0.377 . . . . 0.69999999999999996 111.061 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.9 mm -76.51 108.96 10.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.92000000000000004 110.117 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.42 -39.59 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.94999999999999996 112.039 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.35 146.76 81.74 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 112.142 0.423 . . . . 1.1200000000000001 112.142 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 33' ' ' PHE . 41.8 Cg_endo -68.28 158.08 59.08 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.795 2.33 . . . . 1.3 112.107 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.9 -39.7 74.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.932 -0.577 . . . . 1.3899999999999999 112.065 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.73 -42.1 83.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 1.6100000000000001 111.385 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.429 ' HB2' ' HG2' ' A' ' 30' ' ' PRO . 5.9 t80 -70.39 -46.51 63.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.945 -0.57 . . . . 1.77 110.402 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -61.9 -30.31 70.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 1.48 111.197 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -68.39 -44.96 73.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.277 -0.419 . . . . 2.6200000000000001 112.101 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -86.72 -40.97 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 113.907 1.077 . . . . 1.8600000000000001 113.907 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.8 m -84.78 -33.3 23.03 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.767 0.284 . . . . 1.72 111.767 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 65.46 20.42 11.73 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.058 0.456 . . . . 4.4500000000000002 111.673 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.1 mt -134.01 91.78 23.43 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.668 -0.697 . . . . 1.8100000000000001 109.181 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -84.41 135.43 6.12 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.516 2.144 . . . . 1.05 113.339 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -79.17 124.8 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.922 -1.14 . . . . 1.03 107.922 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.655 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 23.4 m -124.33 153.74 31.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.627 0.602 . . . . 0.77000000000000002 112.627 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.42 140.74 27.74 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.352 -0.84 . . . . 0.71999999999999997 109.695 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.27 147.65 16.29 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.801 2.334 . . . . 1.03 113.897 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.604 HG22 HG22 ' A' ' 72' ' ' VAL . 84.0 t -103.76 119.74 52.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.485 -0.779 . . . . 1.28 109.269 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.61 -158.06 0.86 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.506 -0.553 . . . . 1.9099999999999999 109.506 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.72 -178.8 6.16 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.785 -0.45 . . . . 2.5299999999999998 109.785 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -131.92 -69.21 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.407 -0.901 . . . . 3.3599999999999999 110.973 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.02 -99.13 0.12 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 111.553 -0.619 . . . . 3.8300000000000001 111.553 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -86.83 -45.1 11.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.857 0.361 . . . . 4.7199999999999998 111.349 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.573 ' HB3' ' HG2' ' A' ' 53' ' ' ARG . 31.3 t80 -132.54 161.48 33.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.009 -0.541 . . . . 6.2400000000000002 110.301 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.489 ' HA ' HG22 ' A' ' 71' ' ' VAL . . . -77.89 65.56 3.36 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.322 0.582 . . . . 2.5899999999999999 110.815 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.573 ' HG2' ' HB3' ' A' ' 51' ' ' PHE . 1.4 ptm85 -136.37 -168.67 2.29 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.632 -0.713 . . . . 4.5899999999999999 110.656 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.9 121.51 10.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.045 -0.525 . . . . 2.6899999999999999 111.904 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 58' ' ' ALA . . . -137.04 70.25 1.4 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.279 0.561 . . . . 3.1699999999999999 109.803 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.525 ' HA3' ' O4 ' ' C' ' 2' ' ' ' U' . . . 72.99 -97.17 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.797 -0.638 . . . . 1.6599999999999999 111.939 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -87.94 -9.65 52.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.235 0.54 . . . . 1.5600000000000001 110.28 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -91.86 134.21 34.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.466 -0.788 . . . . 1.25 108.981 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 13.2 m -94.97 165.68 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.062 0.458 . . . . 1.6799999999999999 111.912 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 1.1 m -71.97 143.25 49.3 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.842 -0.617 . . . . 1.95 111.041 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.688 HD11 HG23 ' A' ' 72' ' ' VAL . 4.9 mt -136.49 -52.92 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.135 0.42 . . . . 1.23 112.135 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 9.4 t70 -66.22 116.07 6.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.129 0.49 . . . . 2.21 111.788 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.59 -27.86 0.85 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.633 -0.712 . . . . 1.1499999999999999 111.848 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.408 HG23 HG23 ' A' ' 66' ' ' ILE . 25.5 m -89.56 -10.48 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.36 0.504 . . . . 1.21 112.36 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.72 73.02 1.06 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.802 -0.713 . . . . 1.0800000000000001 112.606 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.408 HG23 HG23 ' A' ' 64' ' ' VAL . 6.9 pt -116.63 172.3 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.804 0.335 . . . . 1.0700000000000001 111.011 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.0 ttm-85 -92.68 -28.35 16.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.226 0.536 . . . . 3.5899999999999999 109.922 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.8 m -77.22 109.55 11.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.651 -0.704 . . . . 1.51 111.068 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 m -93.45 110.69 22.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.231 0.539 . . . . 1.79 110.898 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.439 ' HA3' ' N4 ' ' C' ' 4' ' ' ' C' . . . 171.18 -169.02 42.14 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.119 -0.792 . . . . 1.1799999999999999 111.119 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 52' ' ' ALA . 4.7 t -129.24 124.87 61.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 110.192 -0.299 . . . . 1.5600000000000001 110.192 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.688 HG23 HD11 ' A' ' 61' ' ' LEU . 78.2 t -73.97 121.12 24.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.692 -0.485 . . . . 1.29 109.692 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.474 ' NH1' ' C2 ' ' C' ' 3' ' ' ' A' . 19.8 mtm180 -114.94 135.97 53.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.914 0.388 . . . . 2.23 110.721 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.4 ' SG ' HG13 ' A' ' 101' ' ' VAL . 8.1 m -113.89 32.51 5.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.907 -0.588 . . . . 1.1699999999999999 109.697 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.612 ' HB2' ' HZ ' ' B' ' 33' ' ' PHE . 20.1 p-10 -88.97 -49.63 6.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.467 -0.788 . . . . 0.89000000000000001 111.73 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.438 ' HG2' ' OD2' ' A' ' 75' ' ' ASP . 5.8 mm100 -117.3 74.58 8.03 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.7 -0.227 . . . . 2.1299999999999999 111.587 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -96.34 163.6 1.22 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.943 2.429 . . . . 0.80000000000000004 112.495 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' B' ' 78' ' ' ARG . 1.1 ptm180 -170.24 146.11 2.87 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.297 -0.411 . . . . 2.0899999999999999 110.802 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.638 ' HB ' ' HG3' ' B' ' 76' ' ' GLN . 2.4 m -84.68 93.87 8.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.051 0.453 . . . . 1.6200000000000001 109.915 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.675 HD13 HD23 ' A' ' 11' ' ' LEU . 20.5 pt -84.36 -174.19 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.483 0.659 . . . . 1.1499999999999999 112.718 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -89.54 132.06 35.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.047 -0.979 . . . . 1.03 110.554 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 51.8 tpp -127.26 26.39 6.03 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.472 -0.936 . . . . 1.29 108.472 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -112.33 -45.92 3.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.518 -0.765 . . . . 2.6400000000000001 111.093 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.27 -26.09 16.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.179 -0.464 . . . . 1.1200000000000001 111.409 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -80.06 -43.77 21.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.236 -0.438 . . . . 1.0600000000000001 111.626 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.99 127.67 2.05 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.831 -0.7 . . . . 1.1200000000000001 112.759 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -104.05 136.74 13.17 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.849 -0.691 . . . . 1.0900000000000001 112.077 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 6.8 mptt -109.47 117.04 32.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.945 -0.391 . . . . 2.46 109.945 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.419 ' HD2' ' OE2' ' A' ' 5' ' ' GLU . 6.8 ttp85 -74.55 126.27 30.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.751 0.31 . . . . 2.4900000000000002 110.943 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -105.25 -73.36 0.68 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.073 0.463 . . . . 1.29 110.801 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.74 ' HG3' HD12 ' A' ' 6' ' ' ILE . 19.4 pt-20 -146.57 -164.52 2.0 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.638 -0.71 . . . . 1.1499999999999999 109.522 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 92' ' ' ARG . 3.6 ptm180 -143.18 150.66 39.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.755 0.312 . . . . 1.3200000000000001 110.746 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.669 HG13 HD11 ' A' ' 6' ' ' ILE . 16.0 m -102.5 151.96 38.29 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.217 -0.447 . . . . 0.75 110.465 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -66.16 167.22 18.74 Favored 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 122.636 2.224 . . . . 0.94999999999999996 111.644 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -60.73 -21.4 62.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.977 -0.556 . . . . 1.51 111.537 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -42.24 94.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.928 -0.578 . . . . 1.5700000000000001 110.599 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.7 mm -76.19 -33.88 24.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.841 -0.618 . . . . 1.3100000000000001 110.823 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.4 tpt -59.9 -41.36 91.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 1.6000000000000001 110.99 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -65.64 -35.08 79.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 2.2999999999999998 110.648 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . 1.2 mm-40 -60.52 -48.35 82.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.934 -0.576 . . . . 1.6399999999999999 111.295 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.48 HG21 HD23 ' A' ' 26' ' ' LEU . 58.1 t -63.67 -40.78 90.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.952 -0.567 . . . . 1.03 111.226 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.2 mt -68.54 1.05 3.39 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.225 0.824 . . . . 1.22 113.225 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.12 -1.18 26.8 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.121 -1.038 . . . . 1.03 112.945 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -104.82 -20.56 13.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.9 0.381 . . . . 1.72 111.771 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.5 mt -73.73 -24.82 59.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.001 0.429 . . . . 1.02 111.707 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -28.86 62.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.839 0.352 . . . . 1.1100000000000001 111.544 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.85 -17.28 61.08 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.055 0.761 . . . . 1.5 113.055 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.1 pt -93.51 -13.62 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 111.978 0.362 . . . . 1.1499999999999999 111.978 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.2 mt -86.39 86.8 7.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.928 0.394 . . . . 0.97999999999999998 110.939 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' B' ' 30' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 116.367 -0.379 . . . . 1.3500000000000001 111.037 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.602 ' HG3' ' O ' ' B' ' 27' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.366 0.603 . . . . 2.0299999999999998 112.577 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' B' ' 31' ' ' ALA . 30.4 mt-10 -95.62 -7.47 37.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.431 -0.804 . . . . 2.8199999999999998 109.608 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? 73.42 120.71 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.22 1.193 . . . . 2.3199999999999998 114.22 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.472 ' HA2' HG12 ' B' ' 93' ' ' VAL . . . 72.51 43.54 44.38 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 115.008 0.763 . . . . 1.28 115.008 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -117.55 93.74 4.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.26 0.53 . . . . 1.53 112.377 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.787 HD11 ' HB ' ' B' ' 93' ' ' VAL . 57.2 mt -100.05 102.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.442 -0.947 . . . . 0.75 108.442 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.459 ' HA ' ' HA ' ' B' ' 89' ' ' ARG . 13.8 m95 -105.79 145.84 30.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.272 0.558 . . . . 0.81000000000000005 112.4 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 22.9 tp -102.77 119.73 39.35 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.471 -0.937 . . . . 1.05 108.471 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.93 159.29 4.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.865 0.364 . . . . 0.71999999999999997 110.788 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.68 121.22 25.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.155 -0.475 . . . . 1.6299999999999999 110.519 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.493 HD21 HG11 ' B' ' 25' ' ' VAL . 88.5 mt -79.69 -20.62 46.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.147 -0.479 . . . . 0.82999999999999996 110.728 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.07 153.89 90.9 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.639 . . . . 1.6200000000000001 110.574 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -88.98 162.26 39.68 Favored 'Cis proline' 0 C--O 1.236 0.394 0 C-N-CA 123.438 -1.484 . . . . 1.28 112.053 -0.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.507 HG21 ' HB3' ' B' ' 18' ' ' GLU . 0.2 OUTLIER -150.24 160.73 43.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 1.47 110.587 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.29 142.97 37.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.783 0.325 . . . . 1.22 110.61 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.24 -155.62 34.66 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.949 -0.643 . . . . 1.01 112.433 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -85.53 50.43 1.96 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.197 0.443 . . . . 2.1800000000000002 112.197 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.507 ' HB3' HG21 ' B' ' 14' ' ' THR . 4.0 mt-10 -112.76 163.71 14.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.19 -0.459 . . . . 1.28 109.847 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.844 ' HG3' ' HG3' ' B' ' 44' ' ' PRO . 86.7 mm-40 -73.17 138.28 45.6 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.164 0.802 . . . . 1.52 113.164 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -146.65 -179.73 6.98 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.58 -0.736 . . . . 1.8600000000000001 110.419 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.24 150.88 21.57 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.125 -0.56 . . . . 0.90000000000000002 112.549 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 45.2 m -86.34 106.04 17.11 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.953 0.406 . . . . 0.94999999999999996 109.925 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' B' ' 23' ' ' ARG . 0.3 OUTLIER -149.65 159.95 35.11 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.159 -0.473 . . . . 1.5900000000000001 109.759 -178.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.72 139.8 82.59 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.347 2.031 . . . . 0.65000000000000002 111.21 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.639 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 3.3 m -137.12 152.33 27.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.39 -0.368 . . . . 0.56999999999999995 110.509 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.618 HD23 HG11 ' B' ' 101' ' ' VAL . 22.9 tp -103.05 121.66 43.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.113 -0.494 . . . . 1.1699999999999999 109.722 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . 0.602 ' O ' ' HG3' ' B' ' 1' ' ' MET . 10.5 mt -74.31 148.63 8.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.432 -0.349 . . . . 0.66000000000000003 110.703 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.524 ' HB ' HG23 ' B' ' 41' ' ' VAL . 21.9 t -114.78 -34.18 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.014 0.435 . . . . 0.93000000000000005 110.988 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.29 138.43 91.85 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.059 -0.519 . . . . 0.81000000000000005 112.208 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.525 ' HB3' ' HB ' ' A' ' 110' ' ' THR . 83.5 Cg_endo -77.41 170.27 19.69 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.888 2.392 . . . . 0.78000000000000003 112.638 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.593 ' HB2' ' HG2' ' B' ' 2' ' ' GLU . . . -62.79 -30.31 71.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.852 -0.613 . . . . 1.03 110.61 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.03 -0.75 8.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.665 -0.698 . . . . 1.3999999999999999 112.3 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . 0.612 ' HZ ' ' HB2' ' A' ' 75' ' ' ASP . 7.5 t80 -135.14 -40.53 0.74 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.952 0.406 . . . . 1.5700000000000001 111.0 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -59.54 -33.05 70.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.834 -0.621 . . . . 1.6399999999999999 111.471 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -97.41 11.69 35.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.365 -0.379 . . . . 2.54 110.993 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 97.7 t -110.57 -67.03 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 1.0900000000000001 111.493 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . 0.462 HG22 " H3'" ' C' ' 2' ' ' ' U' . 14.5 p -84.07 -22.83 31.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.764 0.316 . . . . 1.3300000000000001 110.979 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.44 ' HE ' ' HA ' ' B' ' 38' ' ' ARG . 1.2 mmp_? 70.35 12.87 7.57 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.596 -0.729 . . . . 1.78 111.689 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 17.1 mt -119.7 90.18 42.78 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.401 -0.962 . . . . 1.1599999999999999 108.401 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -92.45 161.78 2.98 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.737 2.291 . . . . 0.56999999999999995 114.134 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.555 HG13 HG23 ' B' ' 79' ' ' THR . 0.8 OUTLIER -98.88 130.75 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.173 -1.047 . . . . 1.0800000000000001 108.173 177.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.639 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 23.5 m -120.76 145.48 27.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 112.68 0.622 . . . . 0.64000000000000001 112.68 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 53.5 t -97.73 118.53 63.97 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.874 -1.057 . . . . 1.1000000000000001 108.451 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.844 ' HG3' ' HG3' ' B' ' 19' ' ' GLN . 50.3 Cg_endo -67.67 124.27 11.75 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.861 2.374 . . . . 0.72999999999999998 113.259 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.619 HG22 HG12 ' B' ' 72' ' ' VAL . 46.1 t -87.31 139.79 16.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.161 -0.681 . . . . 0.90000000000000002 109.161 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -120.95 116.09 24.44 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.561 -0.533 . . . . 1.1699999999999999 109.561 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 9.5 m -56.33 139.06 49.66 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.934 -0.576 . . . . 1.8500000000000001 112.168 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.17 -4.0 53.95 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.744 -0.662 . . . . 2.2200000000000002 111.599 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.37 -102.13 2.79 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.003 -0.618 . . . . 3.4300000000000002 111.916 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -107.66 -19.68 13.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.554 0.216 . . . . 4.6200000000000001 111.31 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -150.75 147.36 27.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.479 -0.328 . . . . 6.2699999999999996 110.255 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' B' ' 62' ' ' ASP . . . -131.93 156.45 46.14 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.441 -0.345 . . . . 4.3899999999999997 110.257 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -140.85 146.0 36.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.577 -0.283 . . . . 3.9199999999999999 110.305 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 3.9 t -78.47 137.46 37.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.385 -0.371 . . . . 2.75 110.089 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -159.33 115.97 2.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.497 -0.32 . . . . 1.96 111.074 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.501 ' O ' ' HD2' ' B' ' 104' ' ' ARG . . . 62.79 -110.23 3.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.136 -0.554 . . . . 1.0800000000000001 112.534 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -93.46 -14.38 26.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.976 0.417 . . . . 3.5699999999999998 110.788 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.55 110.08 10.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 1.0800000000000001 110.864 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.707 HG21 ' HA ' ' B' ' 101' ' ' VAL . 85.7 t -87.97 131.48 35.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.941 -0.572 . . . . 1.3400000000000001 109.501 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 9.3 t -88.3 119.05 28.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.409 -0.359 . . . . 1.3799999999999999 111.131 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 60.3 mt -87.9 -18.11 29.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.723 -0.843 . . . . 1.02 108.723 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . 0.487 ' HB3' ' HB3' ' B' ' 52' ' ' ALA . 19.7 t0 -86.46 142.92 28.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.201 -0.909 . . . . 1.79 110.469 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.9 -55.12 0.76 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 121.034 -0.603 . . . . 1.1499999999999999 111.68 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 13.9 p -73.9 -27.61 22.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.949 0.404 . . . . 1.1699999999999999 111.638 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.66 68.94 0.33 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.871 -0.681 . . . . 1.05 111.977 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.457 HD11 ' HD2' ' B' ' 94' ' ' PRO . 61.0 mt -125.42 148.27 29.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.087 -0.709 . . . . 1.6100000000000001 109.087 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' B' ' 67' ' ' ARG . 1.0 OUTLIER -66.32 -50.41 63.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.958 0.409 . . . . 2.3999999999999999 109.963 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 7.2 m -67.77 94.75 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.851 -0.613 . . . . 0.93000000000000005 110.501 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 4.5 m -87.15 90.71 8.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.924 -0.58 . . . . 1.3100000000000001 110.82 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.81 -170.01 35.29 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.376 -0.916 . . . . 0.79000000000000004 112.383 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' B' ' 59' ' ' VAL . 15.6 m -123.12 145.33 30.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.791 0.329 . . . . 0.93000000000000005 110.667 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.619 HG12 HG22 ' B' ' 45' ' ' VAL . 1.3 m -91.43 136.32 24.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.821 0.343 . . . . 1.3799999999999999 111.198 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.646 ' HB2' ' HG2' ' B' ' 44' ' ' PRO . 11.9 mmm180 -86.32 82.73 7.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 1.3700000000000001 110.611 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 2.5 m -79.81 45.93 0.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.017 0.436 . . . . 1.1599999999999999 110.838 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -135.6 -32.91 0.89 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.927 -0.578 . . . . 1.1000000000000001 110.949 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . 0.638 ' HG3' ' HB ' ' A' ' 79' ' ' THR . 61.7 tt0 -125.69 79.47 67.85 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 112.455 0.539 . . . . 2.4700000000000002 112.455 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.438 ' HD2' ' OG1' ' A' ' 79' ' ' THR . 99.0 Cg_endo -89.16 143.47 4.76 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.555 2.17 . . . . 0.95999999999999996 110.647 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . 0.489 ' HA ' ' HB2' ' A' ' 78' ' ' ARG . 54.5 ttt180 -124.53 141.48 52.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.801 0.334 . . . . 1.96 111.765 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.555 HG23 HG13 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -82.75 121.23 26.62 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.482 -0.932 . . . . 1.1899999999999999 108.482 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 15.9 pt -126.96 -164.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.045 0.45 . . . . 1.28 111.41 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -115.7 143.87 44.75 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.903 -0.777 . . . . 1.28 108.903 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 11.6 ttp -126.32 31.71 5.34 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.734 0.272 . . . . 2.7000000000000002 111.734 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -137.65 -42.5 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.181 0.437 . . . . 1.96 112.181 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.21 -29.63 15.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.816 0.341 . . . . 1.0600000000000001 110.246 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -72.65 -35.73 67.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 1.47 110.628 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.22 106.74 0.99 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.922 -0.656 . . . . 0.81999999999999995 112.757 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.18 159.91 21.89 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.68 -0.772 . . . . 0.65000000000000002 112.084 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -151.59 136.12 16.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.026 -0.361 . . . . 1.8100000000000001 110.026 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' B' ' 7' ' ' TRP . 59.8 ttp180 -76.93 126.13 30.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.652 0.263 . . . . 2.4900000000000002 110.583 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 80.1 mt -82.4 -64.17 1.23 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.242 -0.435 . . . . 0.76000000000000001 110.868 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -139.85 174.17 10.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 1.0700000000000001 110.311 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -112.34 115.11 28.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.234 0.54 . . . . 2.0499999999999998 110.903 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.787 ' HB ' HD11 ' B' ' 6' ' ' ILE . 7.2 p -70.33 133.07 87.48 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.465 -0.789 . . . . 1.45 110.801 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.457 ' HD2' HD11 ' B' ' 66' ' ' ILE . 77.2 Cg_exo -53.66 147.56 39.31 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 122.94 2.427 . . . . 1.03 111.999 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.02 -33.37 67.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.996 -0.547 . . . . 2.1400000000000001 111.021 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.61 -48.97 79.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.862 -0.608 . . . . 1.78 110.799 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 21.2 mm -72.05 -34.48 50.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.771 -0.65 . . . . 1.3300000000000001 110.48 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 11.8 tpt -59.64 -38.63 81.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 2.3399999999999999 110.477 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -65.77 -35.83 81.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.889 -0.596 . . . . 1.9099999999999999 110.853 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 57.1 tt0 -63.55 -46.59 85.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 1.76 109.965 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.707 ' HA ' HG21 ' B' ' 59' ' ' VAL . 24.5 t -58.74 -48.68 85.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.116 -0.493 . . . . 1.01 110.915 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.95 -35.49 76.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.99 -0.55 . . . . 1.29 111.243 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.74 -36.43 92.27 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.259 -0.736 . . . . 1.02 111.259 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 23.9 mmt85 -73.45 -34.07 65.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.04 0.448 . . . . 1.8500000000000001 110.258 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.535 ' O ' HG12 ' B' ' 108' ' ' ILE . 78.7 mt -71.03 -11.41 60.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.893 -0.594 . . . . 1.9399999999999999 111.335 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.7 m -77.71 -8.57 58.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.88 0.371 . . . . 1.1599999999999999 111.488 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.3 m -74.22 -16.17 60.98 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.898 0.333 . . . . 1.45 111.898 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.535 HG12 ' O ' ' B' ' 105' ' ' LEU . 31.5 pt -79.69 -1.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 111.885 0.328 . . . . 1.98 111.885 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 88.8 mt -102.05 15.99 27.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.246 0.546 . . . . 1.3600000000000001 110.6 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.252 1.188 0 CA-C-N 115.769 -0.65 . . . . 2.1299999999999999 110.061 179.691 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.431 -0.553 0 O4'-C1'-C2' 107.707 0.934 . 0.0 '__' . 6.3600000000000003 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' ' U' . . . . . 0.525 ' O4 ' ' HA3' ' A' ' 56' ' ' GLY . . . . . . . . 0 O5'--C5' 1.423 -1.058 0 C4'-C3'-C2' 105.187 2.487 OUTLIER-DELTA 0.0 OUTLIER . 2.9900000000000002 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' ' A' . . . . . 0.665 " H2'" ' N3 ' ' C' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.429 -0.658 0 C1'-C2'-O2' 108.498 -0.701 . 0.0 OUTLIER gamma 2.5899999999999999 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' ' C' . . . . . 0.439 ' N4 ' ' HA3' ' A' ' 70' ' ' GLY . . . . . . . . 0 C3'--C2' 1.541 1.475 0 C4'-C3'-C2' 105.209 2.509 . 0.0 OUTLIER . 2.5099999999999998 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' ' A' . . . . . 0.579 " H2'" ' HB2' ' A' ' 20' ' ' GLN . . . . . . . . 0 O5'--C5' 1.426 -0.886 0 O4'-C1'-C2' 107.82 1.014 . 0.0 OUTLIER . 4.9400000000000004 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 ptp . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.857 0.361 . . . . 1.29 110.481 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -107.66 167.0 10.27 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.103 -0.499 . . . . 2.0099999999999998 111.095 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -74.03 131.58 41.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.842 -0.617 . . . . 1.8500000000000001 109.718 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.15 -1.54 43.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 0.85999999999999999 112.986 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -93.42 149.8 20.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.95 0.375 . . . . 0.98999999999999999 110.695 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.7 pt -113.07 112.82 42.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.352 0.596 . . . . 1.1599999999999999 110.402 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.48 ' O ' HG22 ' A' ' 25' ' ' VAL . 27.8 m95 -105.48 118.23 36.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.696 -0.683 . . . . 0.91000000000000003 110.779 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 15.8 tp -67.02 117.76 9.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.36 -0.382 . . . . 0.90000000000000002 110.332 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.2 p -156.84 157.14 3.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.939 0.399 . . . . 1.04 111.073 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 1.1 t -92.43 124.17 36.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.659 -0.497 . . . . 1.3200000000000001 109.659 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 mt -76.51 -12.55 60.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.772 -0.649 . . . . 1.29 110.533 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 6.9 m-20 -74.28 164.24 62.63 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.202 -0.908 . . . . 1.54 111.314 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.56 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 39.1 Cg_exo -62.92 145.77 54.13 Favored 'Cis proline' 0 C--N 1.353 0.776 0 C-N-CA 124.337 -1.11 . . . . 1.6899999999999999 112.82 0.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.651 HG21 ' HB3' ' A' ' 20' ' ' GLN . 10.3 p -120.72 162.57 19.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.142 -0.481 . . . . 1.3600000000000001 111.829 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.41 146.21 31.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.605 -0.725 . . . . 1.7 109.378 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.15 -129.77 32.16 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.656 -0.783 . . . . 1.1799999999999999 111.998 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -107.61 14.35 25.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.773 0.32 . . . . 2.7799999999999998 111.236 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HB3' ' NH2' ' A' ' 78' ' ' ARG . 37.2 mt-10 -61.6 128.93 38.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.881 -0.414 . . . . 1.1399999999999999 109.881 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -49.09 125.77 11.27 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.052 -0.522 . . . . 2.0899999999999999 112.217 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.651 ' HB3' HG21 ' A' ' 14' ' ' THR . 4.4 pt20 -123.12 176.56 5.99 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.458 -0.792 . . . . 2.0899999999999999 111.486 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.559 ' HA2' " H2'" ' C' ' 5' ' ' ' A' . . . 109.15 140.27 8.9 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.705 -0.759 . . . . 1.0700000000000001 114.116 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 4.1 m -81.8 89.44 6.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.035 -1.098 . . . . 1.1100000000000001 108.035 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.416 HH21 ' HA ' ' A' ' 46' ' ' THR . 0.9 OUTLIER -135.26 160.42 68.15 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.822 -0.626 . . . . 1.6200000000000001 110.419 -177.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 22.4 Cg_exo -65.87 125.33 14.05 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.233 1.955 . . . . 1.01 111.387 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.755 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 22.8 m -101.42 132.03 48.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.088 -0.506 . . . . 0.76000000000000001 110.525 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.619 ' HB3' HG23 ' A' ' 43' ' ' VAL . 46.1 tp -81.98 121.24 26.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.928 -0.578 . . . . 0.69999999999999996 110.879 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.657 ' HA ' HG12 ' A' ' 42' ' ' VAL . 12.3 mm -70.55 110.04 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.256 -0.429 . . . . 0.92000000000000004 110.438 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.599 HG22 ' HE1' ' A' ' 98' ' ' MET . 38.5 t -89.16 -34.52 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.98 0.419 . . . . 0.94999999999999996 111.166 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.09 146.25 84.5 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.244 -0.434 . . . . 1.1200000000000001 111.57 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.763 ' HG2' ' HB2' ' A' ' 33' ' ' PHE . 32.8 Cg_endo -65.1 158.88 49.54 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.55 2.167 . . . . 1.3 111.812 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.39 -41.52 72.76 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.984 -0.553 . . . . 1.3899999999999999 112.333 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.49 97.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.297 -0.41 . . . . 1.6100000000000001 111.413 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.763 ' HB2' ' HG2' ' A' ' 30' ' ' PRO . 4.9 t80 -64.86 -43.9 91.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.289 -0.414 . . . . 1.77 110.834 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -59.8 -30.55 68.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.589 . . . . 1.48 110.949 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -86.74 -35.29 19.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.564 -0.744 . . . . 2.6200000000000001 112.426 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 33' ' ' PHE . 12.7 p -83.01 -45.19 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 113.274 0.842 . . . . 1.8600000000000001 113.274 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -84.17 -27.16 28.27 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.185 -0.322 . . . . 1.72 111.071 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 64.75 19.64 11.89 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.02 -0.536 . . . . 4.4500000000000002 111.304 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.2 tp -143.75 101.08 5.03 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 108.319 -0.993 . . . . 1.8100000000000001 108.319 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -90.67 150.5 4.18 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.807 2.338 . . . . 1.05 114.183 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 HG23 ' A' ' 79' ' ' THR . 56.7 t -98.96 116.73 42.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 106.704 -1.591 . . . . 1.03 106.704 177.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.755 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 19.9 m -125.46 155.38 34.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 113.386 0.884 . . . . 0.77000000000000002 113.386 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 26' ' ' LEU . 3.8 m -120.3 116.23 32.41 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.069 -0.969 . . . . 0.71999999999999997 109.443 178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.26 136.28 31.28 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.837 2.358 . . . . 1.03 113.301 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 24' ' ' PRO . 93.3 t -64.8 136.63 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.684 -0.689 . . . . 1.28 110.234 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.542 ' OG1' ' HG2' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -98.99 171.45 8.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.029 -0.532 . . . . 1.9099999999999999 110.806 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.98 135.58 41.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.165 -0.47 . . . . 2.5299999999999998 110.007 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.89 -11.4 43.45 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.483 -0.865 . . . . 3.3599999999999999 112.298 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.72 -152.64 50.71 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.874 -0.679 . . . . 3.8300000000000001 111.966 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -84.46 -39.52 18.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.044 0.45 . . . . 4.7199999999999998 110.409 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -113.24 96.29 5.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.986 -0.552 . . . . 6.2400000000000002 109.933 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.32 97.75 2.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.988 -0.551 . . . . 2.5899999999999999 110.808 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 53' ' ' ARG . 6.8 ptm180 -128.39 167.59 16.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.054 -0.521 . . . . 4.5899999999999999 110.198 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.53 140.55 48.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.428 -0.351 . . . . 2.6899999999999999 111.017 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.53 74.02 0.87 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.114 -0.493 . . . . 3.1699999999999999 110.012 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.449 ' HA3' ' O4 ' ' C' ' 2' ' ' ' U' . . . 72.35 -116.9 6.02 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.091 -0.804 . . . . 1.6599999999999999 111.091 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.544 ' HD1' ' HB2' ' A' ' 74' ' ' CYS . 46.3 m-85 -82.26 42.44 0.74 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.491 0.662 . . . . 1.5600000000000001 110.187 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -135.33 107.8 7.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.321 -0.854 . . . . 1.25 109.815 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.722 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 22.5 t -97.35 128.17 48.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.141 -0.481 . . . . 1.6799999999999999 110.26 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.64 137.38 38.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.154 -0.475 . . . . 1.95 111.389 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.544 HD13 HD11 ' A' ' 66' ' ' ILE . 74.2 mt -94.56 17.24 13.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.29 0.567 . . . . 1.23 110.903 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -81.5 137.58 35.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.626 -0.716 . . . . 2.21 110.407 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.25 -26.52 11.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.618 -0.801 . . . . 1.1499999999999999 113.066 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.596 HG11 ' HG2' ' A' ' 94' ' ' PRO . 25.8 m -93.17 -24.18 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.106 0.41 . . . . 1.21 112.106 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 68.66 63.37 3.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.795 -0.717 . . . . 1.0800000000000001 113.284 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.544 HD11 HD13 ' A' ' 61' ' ' LEU . 25.3 pt -108.93 -172.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 O-C-N 122.646 -0.326 . . . . 1.0700000000000001 110.569 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.465 ' NH2' ' HB3' ' A' ' 91' ' ' GLU . 57.1 mtm180 -93.2 -39.1 11.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.849 0.357 . . . . 3.5899999999999999 111.432 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 m -64.89 111.7 2.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.302 0.572 . . . . 1.51 111.732 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.28 79.76 2.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.804 -0.634 . . . . 1.79 110.502 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.434 ' HA3' ' H41' ' C' ' 4' ' ' ' C' . . . -152.36 -167.12 14.9 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.783 -0.722 . . . . 1.1799999999999999 112.144 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 t -118.99 139.11 47.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 110.069 -0.345 . . . . 1.5600000000000001 110.069 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.722 ' HB ' ' HB ' ' A' ' 59' ' ' VAL . 23.0 t -79.72 133.14 30.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.775 0.322 . . . . 1.29 111.136 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.549 ' HD2' ' OD1' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -94.81 154.5 17.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.119 -0.491 . . . . 2.23 110.512 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.544 ' HB2' ' HD1' ' A' ' 57' ' ' PHE . 58.8 m -141.0 2.57 1.74 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.955 0.407 . . . . 1.1699999999999999 110.768 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.549 ' OD1' ' HD2' ' A' ' 73' ' ' ARG . 11.2 p-10 -121.77 5.09 9.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.043 -0.526 . . . . 0.89000000000000001 111.163 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -122.03 74.76 38.62 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 112.964 0.727 . . . . 2.1299999999999999 112.964 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.86 119.11 3.53 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.65 2.233 . . . . 0.80000000000000004 109.908 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.495 ' NH2' ' HB3' ' A' ' 18' ' ' GLU . 21.5 mmm180 -117.72 107.24 13.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.068 0.461 . . . . 2.0899999999999999 111.747 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.673 HG23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -94.6 90.27 6.09 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.98 -0.748 . . . . 1.6200000000000001 108.98 178.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.9 pt -125.75 150.5 31.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.25 -0.432 . . . . 1.1499999999999999 111.275 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -75.85 124.4 27.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.854 0.359 . . . . 1.03 110.553 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 52.0 tpp -81.61 -20.77 39.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.706 -0.679 . . . . 1.29 112.062 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -65.67 -32.68 74.38 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.767 0.654 . . . . 2.6400000000000001 112.767 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.86 9.18 40.18 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.115 0.413 . . . . 1.1200000000000001 112.115 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 40.7 mtt-85 -127.86 -44.46 1.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.27 0.47 . . . . 1.0600000000000001 112.27 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.91 97.47 0.32 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.815 -0.707 . . . . 1.1200000000000001 112.38 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 8' ' ' LEU . . . -97.75 150.64 19.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.815 -0.707 . . . . 1.0900000000000001 112.296 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -113.38 113.77 25.68 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.015 -0.365 . . . . 2.46 110.015 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -71.07 118.4 13.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.603 0.24 . . . . 2.4900000000000002 111.324 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 8' ' ' LEU . 2.2 mm? -86.76 -68.56 0.74 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.43 -0.581 . . . . 1.29 109.43 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.465 ' HB3' ' NH2' ' A' ' 67' ' ' ARG . 20.3 pt-20 -151.95 -167.43 2.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.347 -0.842 . . . . 1.1499999999999999 109.433 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.9 ptm85 -132.81 142.87 49.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.788 0.327 . . . . 1.3200000000000001 110.702 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.2 m -91.08 158.76 41.07 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.191 -0.459 . . . . 0.75 110.697 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.596 ' HG2' HG11 ' A' ' 64' ' ' VAL . 46.0 Cg_exo -58.92 147.33 90.0 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.539 2.16 . . . . 0.94999999999999996 111.029 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' A' ' 95' ' ' GLU . 2.9 mm-40 -55.54 -29.32 58.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.057 -0.52 . . . . 1.51 111.945 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.66 -33.3 73.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.909 0.385 . . . . 1.5700000000000001 111.174 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.7 mm -70.67 -41.22 77.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.213 0.53 . . . . 1.3100000000000001 109.759 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.599 ' HE1' HG22 ' A' ' 28' ' ' VAL . 3.6 tpt -66.87 -37.98 85.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.56 -0.745 . . . . 1.6000000000000001 110.259 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -61.73 -34.87 76.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.905 -0.589 . . . . 2.2999999999999998 110.477 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.47 -45.52 90.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.008 -0.542 . . . . 1.6399999999999999 110.787 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 35.2 t -62.48 -44.12 98.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.044 -0.525 . . . . 1.03 110.581 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.98 -38.02 81.35 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.016 -0.538 . . . . 1.22 111.084 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.86 -41.65 98.7 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.846 -0.692 . . . . 1.03 112.072 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 104' ' ' ARG . 8.6 mmt180 -67.84 -32.85 73.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.933 0.397 . . . . 1.72 110.73 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 101' ' ' VAL . 95.4 mt -71.03 -25.57 62.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.98 -0.555 . . . . 1.02 110.844 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -74.67 -28.46 60.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.981 0.42 . . . . 1.1100000000000001 111.276 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.87 -22.22 58.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.382 0.512 . . . . 1.5 112.382 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 pt -89.84 1.83 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.739 0.644 . . . . 1.1499999999999999 112.739 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.3 mt -86.67 80.85 8.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.544 0.211 . . . . 0.97999999999999998 110.959 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 111.86 0.318 . . . . 1.3500000000000001 111.86 -179.879 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.541 ' HE1' ' HB2' ' B' ' 5' ' ' GLU . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 121.006 0.432 . . . . 2.0299999999999998 111.633 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -83.94 -14.59 50.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.816 -0.439 . . . . 2.8199999999999998 109.816 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 71.95 113.72 0.06 Allowed 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.827 1.047 . . . . 2.3199999999999998 113.827 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' B' ' 92' ' ' ARG . . . 95.04 -34.64 4.67 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.726 -0.67 . . . . 1.28 114.71 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.541 ' HB2' ' HE1' ' B' ' 1' ' ' MET . 5.5 mm-40 -61.49 106.24 0.62 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.868 0.692 . . . . 1.53 112.868 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.426 HD12 ' HG3' ' B' ' 91' ' ' GLU . 61.3 mt -98.17 128.37 49.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 109.349 -0.611 . . . . 0.75 109.349 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -111.68 153.66 26.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.085 0.469 . . . . 0.81000000000000005 111.536 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.498 ' HB2' HD11 ' B' ' 90' ' ' LEU . 23.5 tp -113.35 123.57 50.42 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.366 -0.605 . . . . 1.05 109.366 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 p -153.92 156.85 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.54 -0.3 . . . . 0.71999999999999997 110.535 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 6.8 m -89.47 129.29 35.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.497 -0.32 . . . . 1.6299999999999999 110.612 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 78.0 mt -81.13 -18.27 47.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.24 0.543 . . . . 0.82999999999999996 110.308 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . 0.528 ' HA ' ' H ' ' B' ' 14' ' ' THR . 2.1 m-20 -63.25 153.59 81.27 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.215 -0.902 . . . . 1.6200000000000001 110.381 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -93.29 92.1 0.14 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.639 -1.4 . . . . 1.28 112.34 -0.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.528 ' H ' ' HA ' ' B' ' 12' ' ' ASP . 0.0 OUTLIER -79.25 173.82 12.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.182 -0.463 . . . . 1.47 110.144 179.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.75 168.22 23.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.577 0.227 . . . . 1.22 111.114 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.98 -130.25 30.13 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.932 -0.652 . . . . 1.01 112.024 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -90.28 -1.84 57.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.833 0.349 . . . . 2.1800000000000002 110.973 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -67.33 123.63 20.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.071 -0.715 . . . . 1.28 109.071 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -52.3 131.38 32.87 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.168 0.803 . . . . 1.52 113.168 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -113.43 139.01 49.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.579 -0.737 . . . . 1.8600000000000001 109.623 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.32 147.6 8.11 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.835 -0.698 . . . . 0.90000000000000002 112.93 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 26.9 m -76.69 124.47 27.7 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.06 -0.348 . . . . 0.94999999999999996 110.06 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.42 158.71 33.36 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.801 -0.444 . . . . 1.5900000000000001 109.801 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.23 131.55 32.71 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.219 1.946 . . . . 0.65000000000000002 110.267 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.613 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 15.7 m -124.79 142.47 41.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.134 0.492 . . . . 0.56999999999999995 111.45 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 18.7 tp -101.51 126.98 48.4 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.223 -0.658 . . . . 1.1699999999999999 109.223 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . 0.408 ' O ' ' HG3' ' B' ' 1' ' ' MET . 27.7 mt -86.4 144.53 9.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.576 -0.284 . . . . 0.66000000000000003 110.339 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.488 ' HB ' HG23 ' B' ' 41' ' ' VAL . 45.4 t -108.38 -36.09 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.981 0.419 . . . . 0.93000000000000005 110.943 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' THR . . . . . 0.617 HG23 HG22 ' B' ' 41' ' ' VAL . 0.7 OUTLIER -64.64 143.79 98.69 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 0.81000000000000005 112.328 -179.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 22.2 Cg_exo -66.81 159.4 51.64 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.097 2.531 . . . . 0.78000000000000003 111.785 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.59 -37.6 73.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.98 -0.555 . . . . 1.03 111.403 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.65 -48.6 81.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 1.3999999999999999 111.066 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -64.18 -40.3 95.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.046 0.451 . . . . 1.5700000000000001 110.673 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' B' ' 38' ' ' ARG . 77.3 m-20 -67.09 -19.88 65.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.924 -0.58 . . . . 1.6399999999999999 111.257 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -95.32 -33.64 12.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.271 -0.422 . . . . 2.54 111.943 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 99.1 t -82.39 -71.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.612 0.244 . . . . 1.0900000000000001 111.367 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.3 -30.04 66.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.781 0.324 . . . . 1.3300000000000001 110.444 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 2.4 mmp_? 66.96 17.42 10.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.607 -0.724 . . . . 1.78 112.257 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.23 92.85 43.81 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.278 -0.638 . . . . 1.1599999999999999 109.278 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' B' ' 80' ' ' ILE . 83.1 Cg_endo -90.57 147.38 4.13 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.813 2.342 . . . . 0.56999999999999995 113.572 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.617 HG22 HG23 ' B' ' 29' ' ' THR . 5.0 m -93.9 118.02 38.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.488 -0.93 . . . . 1.0800000000000001 108.488 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.613 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 35.7 m -108.83 145.79 15.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 112.597 0.592 . . . . 0.64000000000000001 112.597 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 90.5 t -111.03 115.73 52.52 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.955 -1.02 . . . . 1.1000000000000001 108.851 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.51 ' HA ' HG12 ' B' ' 25' ' ' VAL . 7.4 Cg_exo -72.71 123.17 8.8 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.946 2.43 . . . . 0.72999999999999998 113.287 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.31 138.86 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.824 -0.806 . . . . 0.90000000000000002 108.824 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.79 168.92 9.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.544 -0.298 . . . . 1.1699999999999999 110.727 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.41 159.01 25.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.45 -0.341 . . . . 1.8500000000000001 111.227 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.0 72.63 2.25 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.838 -0.696 . . . . 2.2200000000000002 112.142 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.68 58.59 4.89 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.075 -0.583 . . . . 3.4300000000000002 112.367 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -98.79 95.27 7.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.936 0.398 . . . . 4.6200000000000001 110.191 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -79.46 -34.82 41.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.068 -0.515 . . . . 6.2699999999999996 110.633 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -130.93 -71.84 0.57 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.061 -0.518 . . . . 4.3899999999999997 110.188 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -168.25 106.97 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 3.9199999999999999 110.98 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.7 t -100.11 157.6 16.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.287 -0.415 . . . . 2.75 110.566 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.13 -155.15 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 1.96 109.893 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.69 -98.25 2.38 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.994 -0.622 . . . . 1.0800000000000001 112.673 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.643 ' HE1' ' HB ' ' B' ' 107' ' ' THR . 75.4 m-85 -120.54 5.25 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.016 0.436 . . . . 3.5699999999999998 111.28 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.61 107.17 18.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.921 -0.581 . . . . 1.0800000000000001 111.203 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 61.0 t -89.81 122.28 40.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.864 -0.607 . . . . 1.3400000000000001 109.796 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -82.56 123.91 29.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.298 -0.41 . . . . 1.3799999999999999 110.829 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 97.2 mt -91.16 -14.13 31.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.2 -0.455 . . . . 1.02 111.328 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . 0.726 ' HB2' HG23 ' B' ' 69' ' ' THR . 10.6 t70 -81.84 142.88 32.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.07 -0.514 . . . . 1.79 111.439 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.51 -19.33 12.88 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.919 -0.658 . . . . 1.1499999999999999 112.672 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -109.62 -12.32 11.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.86 0.362 . . . . 1.1699999999999999 111.703 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.47 60.58 0.78 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.451 -0.88 . . . . 1.05 112.53 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.468 HD11 HG23 ' B' ' 93' ' ' VAL . 78.1 mt -121.12 134.79 63.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.772 -0.455 . . . . 1.6100000000000001 109.772 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -63.16 -39.28 94.21 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.073 0.463 . . . . 2.3999999999999999 109.826 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . 0.414 ' N ' HG22 ' B' ' 66' ' ' ILE . 7.2 m -77.55 73.74 4.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.731 -0.668 . . . . 0.93000000000000005 109.839 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . 0.726 HG23 ' HB2' ' B' ' 62' ' ' ASP . 13.3 m -73.74 105.3 4.98 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.665 -0.698 . . . . 1.3100000000000001 110.758 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -177.45 -161.21 25.51 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.784 -0.722 . . . . 0.79000000000000004 112.118 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 m -124.27 136.33 60.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.962 0.411 . . . . 0.93000000000000005 110.967 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 32.3 t -88.93 122.76 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.863 -0.608 . . . . 1.3799999999999999 110.346 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 21.9 mmm-85 -92.57 81.48 4.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.926 0.393 . . . . 1.3700000000000001 110.336 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.77 1.33 10.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.942 -0.572 . . . . 1.1599999999999999 112.089 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.09 -7.89 59.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.334 -0.394 . . . . 1.1000000000000001 111.463 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -142.53 84.34 11.18 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 113.459 0.911 . . . . 2.4700000000000002 113.459 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.46 132.93 4.42 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.049 2.499 . . . . 0.95999999999999996 110.277 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.48 127.06 45.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.244 0.461 . . . . 1.96 112.244 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.06 123.24 31.14 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.006 -0.739 . . . . 1.1899999999999999 109.006 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.404 ' O ' ' HD2' ' B' ' 40' ' ' PRO . 35.9 pt -134.61 154.11 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.545 0.212 . . . . 1.28 111.269 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.418 ' CG ' ' HZ1' ' B' ' 83' ' ' LYS . 9.5 t70 -71.45 109.59 5.52 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.262 -0.426 . . . . 1.28 110.428 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 51.7 tpp -78.44 -13.07 60.01 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.572 0.582 . . . . 2.7000000000000002 112.572 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.687 ' HE2' H5'' ' C' ' 1' ' ' ' A' . 6.5 mtmp? -81.64 -44.06 17.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.96 0.409 . . . . 1.96 111.188 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.66 -23.58 56.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.132 -0.485 . . . . 1.0600000000000001 111.73 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' B' ' 85' ' ' ARG . 55.8 mtt-85 -96.16 -47.96 5.84 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.365 0.505 . . . . 1.47 112.365 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.3 101.05 0.6 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.623 -0.799 . . . . 0.81999999999999995 112.398 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -97.76 142.08 15.94 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.816 -0.707 . . . . 0.65000000000000002 112.291 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -123.33 128.69 50.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.384 -0.228 . . . . 1.8100000000000001 110.384 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.524 ' HD2' ' OE1' ' B' ' 5' ' ' GLU . 3.4 ttp180 -69.56 132.61 46.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.767 0.318 . . . . 2.4900000000000002 111.005 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' B' ' 8' ' ' LEU . 93.7 mt -100.29 -69.52 0.77 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.76000000000000001 111.338 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . 0.426 ' HG3' HD12 ' B' ' 6' ' ' ILE . 18.7 pt-20 -142.4 -176.36 4.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.146 -0.479 . . . . 1.0700000000000001 110.259 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' B' ' 4' ' ' GLY . 48.9 ttt180 -125.9 118.0 24.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.79 0.329 . . . . 2.0499999999999998 111.291 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.493 HG13 ' HA2' ' B' ' 4' ' ' GLY . 2.5 p -80.11 131.36 63.09 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 1.45 110.503 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -50.2 145.47 20.32 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.239 2.626 . . . . 1.03 112.312 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -58.49 -27.51 64.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 2.1400000000000001 112.504 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.32 -38.81 84.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.193 0.52 . . . . 1.78 110.352 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 19.8 mm -86.05 -33.65 7.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.804 -0.635 . . . . 1.3300000000000001 109.72 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 11.5 tpt -63.01 -33.22 74.95 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.201 0.524 . . . . 2.3399999999999999 110.225 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -61.13 -38.47 86.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.499 -0.773 . . . . 1.9099999999999999 110.188 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.561 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 31.9 mm-40 -60.18 -41.17 92.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.916 -0.584 . . . . 1.76 110.684 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 34.2 t -60.44 -46.87 94.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.978 -0.555 . . . . 1.01 109.963 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 71.2 mt -62.49 -36.3 82.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.97 -0.559 . . . . 1.29 110.274 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.08 -43.49 97.2 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.6 -0.727 . . . . 1.02 111.801 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 7.6 mmt180 -66.23 -32.21 73.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.055 0.455 . . . . 1.8500000000000001 110.451 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 79.8 mt -71.18 -13.85 62.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.976 -0.556 . . . . 1.9399999999999999 111.232 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 10.8 m -84.04 -24.44 30.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.122 0.487 . . . . 1.1599999999999999 110.395 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.643 ' HB ' ' HE1' ' B' ' 57' ' ' PHE . 0.2 OUTLIER -72.33 -29.18 63.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 1.45 111.571 -179.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 49.8 pt -80.39 -3.58 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.727 0.299 . . . . 1.98 111.657 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 96.4 mt -86.04 12.8 8.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.197 0.523 . . . . 1.3600000000000001 110.669 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.246 0.901 0 N-CA-C 109.301 -0.629 . . . . 2.1299999999999999 109.301 179.766 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' ' A' . . . . . 0.687 H5'' ' HE2' ' B' ' 83' ' ' LYS . . . . . . . . 0 O5'--C5' 1.428 -0.761 0 C1'-C2'-O2' 108.38 -0.74 . 0.0 '__' . 6.3600000000000003 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' ' U' . . . . . 0.473 ' C5 ' ' HD2' ' A' ' 57' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.95 0 C3'-C2'-C1' 100.579 -1.023 . 0.0 OUTLIER beta 2.9900000000000002 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' ' A' . . . . . 0.722 " H2'" ' N3 ' ' C' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.856 0 C4'-C3'-C2' 103.618 0.918 . 0.0 OUTLIER gamma 2.5899999999999999 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' ' C' . . . . . 0.434 ' H41' ' HA3' ' A' ' 70' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.908 0 N19-C1'-C2' 115.268 1.167 . 0.0 OUTLIER . 2.5099999999999998 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' ' A' . . . . . 0.559 " H2'" ' HA2' ' A' ' 21' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.786 0 C4'-C3'-C2' 103.759 1.059 . 0.0 OUTLIER gamma 4.9400000000000004 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 ptp . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.901 0.382 . . . . 1.29 110.779 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 43.8 mt-10 -123.16 -173.63 2.76 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.685 -0.689 . . . . 2.0099999999999998 110.376 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -89.16 133.39 34.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.996 -0.547 . . . . 1.8500000000000001 110.898 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.23 13.88 52.95 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.791 -0.719 . . . . 0.85999999999999999 112.997 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 83.3 mt-10 -98.67 153.21 18.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.717 0.294 . . . . 0.98999999999999999 110.571 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.535 HD11 ' HG2' ' A' ' 91' ' ' GLU . 1.1 pt -118.46 110.17 29.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.134 -0.485 . . . . 1.1599999999999999 109.917 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.409 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 31.0 m95 -102.53 122.47 44.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.885 -0.598 . . . . 0.91000000000000003 110.831 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 17.8 tp -82.7 131.89 35.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.116 -0.493 . . . . 0.90000000000000002 111.364 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 85' ' ' ARG . 6.4 p -172.59 159.65 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.201 -0.454 . . . . 1.04 110.245 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.7 m -82.74 141.47 32.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.616 0.246 . . . . 1.3200000000000001 110.767 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.41 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . 68.3 mt -95.32 -11.44 27.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.113 0.482 . . . . 1.29 110.86 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.702 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -74.49 174.46 5.1 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.707 -0.679 . . . . 1.54 110.95 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.702 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 9.8 Cg_exo -73.12 142.47 74.87 Favored 'Cis proline' 0 C--N 1.354 0.851 0 C-N-CA 124.609 -0.996 . . . . 1.6899999999999999 112.386 -0.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.577 HG23 ' HA ' ' A' ' 12' ' ' ASP . 38.7 p -122.44 175.55 6.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 1.3600000000000001 110.993 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.01 103.49 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 1.7 110.319 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.59 -151.84 18.13 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.838 -0.696 . . . . 1.1799999999999999 111.658 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.625 ' HD2' HD11 ' B' ' 39' ' ' LEU . 78.0 t60 -105.98 37.15 2.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.531 0.682 . . . . 2.7799999999999998 110.374 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -79.86 -170.37 2.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.615 . . . . 1.1399999999999999 109.691 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -77.06 87.11 3.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.271 0.557 . . . . 2.0899999999999999 110.678 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.514 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 1.7 pt20 -107.07 172.9 6.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.238 -0.892 . . . . 2.0899999999999999 111.289 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.463 ' HA2' " H5'" ' C' ' 5' ' ' ' A' . . . 101.3 177.61 28.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.977 -0.63 . . . . 1.0700000000000001 113.74 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.3 m -114.12 129.49 56.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.623 -0.51 . . . . 1.1100000000000001 109.623 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.78 160.44 11.48 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.142 -0.318 . . . . 1.6200000000000001 110.142 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 10.4 Cg_exo -73.5 135.6 22.4 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.302 2.001 . . . . 1.01 110.869 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.87 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 10.7 m -108.38 136.39 44.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.219 -0.446 . . . . 0.76000000000000001 110.28 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.597 ' HB3' HG23 ' A' ' 43' ' ' VAL . 15.8 tp -86.6 125.67 33.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.363 -0.381 . . . . 0.69999999999999996 111.045 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.444 HD13 ' CG1' ' A' ' 42' ' ' VAL . 9.1 mm -74.83 117.24 18.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.318 -0.401 . . . . 0.92000000000000004 110.371 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -92.16 -37.8 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.057 -0.52 . . . . 0.94999999999999996 111.236 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.75 150.96 82.18 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.619 0.6 . . . . 1.1200000000000001 112.619 -179.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 33' ' ' PHE . 65.4 Cg_endo -74.88 158.71 42.47 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.75 2.3 . . . . 1.3 111.934 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.57 -39.85 65.13 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.563 0.579 . . . . 1.3899999999999999 112.563 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.92 99.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.356 . . . . 1.6100000000000001 111.196 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.438 ' HB2' ' HG2' ' A' ' 30' ' ' PRO . 8.0 t80 -69.17 -40.93 77.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.014 -0.539 . . . . 1.77 110.419 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -64.36 -26.13 68.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 1.48 110.773 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -78.26 -25.46 46.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.986 -0.552 . . . . 2.6200000000000001 111.873 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -96.34 -43.88 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.535 0.569 . . . . 1.8600000000000001 112.535 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 m -81.28 -25.74 36.3 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.87 0.322 . . . . 1.72 111.87 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 71.69 -2.8 2.35 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.039 0.536 . . . . 4.4500000000000002 112.217 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 81' ' ' ASP . 2.9 mt -131.33 114.47 15.96 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.379 -0.6 . . . . 1.8100000000000001 109.379 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.4 ' O ' HG23 ' A' ' 79' ' ' THR . 85.6 Cg_endo -89.14 131.56 2.17 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.802 2.335 . . . . 1.05 113.137 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.441 HG11 HD12 ' B' ' 108' ' ' ILE . 48.3 t -67.78 121.09 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.873 -1.158 . . . . 1.03 107.873 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.87 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 17.4 m -128.24 153.2 37.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 113.485 0.92 . . . . 0.77000000000000002 113.485 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.597 HG23 ' HB3' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -114.27 131.1 23.42 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 114.685 -1.143 . . . . 0.71999999999999997 108.788 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 77' ' ' PRO . 71.5 Cg_endo -73.83 114.1 3.95 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.793 2.329 . . . . 1.03 113.973 -178.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.685 HG22 HG22 ' A' ' 72' ' ' VAL . 48.3 t -79.72 99.54 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.089 -0.708 . . . . 1.28 109.089 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.566 ' HB ' ' HD3' ' A' ' 73' ' ' ARG . 2.2 m -120.38 -115.78 0.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.422 -0.354 . . . . 1.9099999999999999 111.394 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.579 ' O ' ' HD2' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -137.94 164.73 28.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.5 0.191 . . . . 2.5299999999999998 110.927 -179.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.97 74.74 0.41 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.288 -0.725 . . . . 3.3599999999999999 111.288 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.02 -71.1 3.01 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.793 -0.718 . . . . 3.8300000000000001 111.365 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -163.65 -50.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.819 0.342 . . . . 4.7199999999999998 111.081 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -86.43 143.82 27.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.328 -0.396 . . . . 6.2400000000000002 111.043 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.47 65.1 8.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.145 0.498 . . . . 2.5899999999999999 110.932 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -123.07 -169.29 1.9 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.706 -0.679 . . . . 4.5899999999999999 109.951 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.69 78.22 2.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.052 0.453 . . . . 2.6899999999999999 110.758 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.01 82.29 7.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.066 -0.515 . . . . 3.1699999999999999 110.706 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.498 ' HA3' ' O4 ' ' C' ' 2' ' ' ' U' . . . 67.55 -96.4 0.35 Allowed Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.898 -0.592 . . . . 1.6599999999999999 112.418 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -95.1 -8.38 36.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.907 0.384 . . . . 1.5600000000000001 110.956 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.56 142.85 32.45 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.208 -0.664 . . . . 1.25 109.208 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.886 HG22 ' HB ' ' A' ' 72' ' ' VAL . 11.4 m -94.82 156.14 3.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.174 0.511 . . . . 1.6799999999999999 112.133 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.26 106.05 17.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.573 -0.74 . . . . 1.95 111.394 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 61' ' ' LEU . 4.1 mt -91.51 -32.13 15.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.179 0.514 . . . . 1.23 110.751 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -75.19 112.37 11.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.072 -0.513 . . . . 2.21 110.628 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.46 -23.01 0.75 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.599 -0.6 . . . . 1.1499999999999999 111.599 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.412 HG23 HG23 ' A' ' 66' ' ' ILE . 15.7 m -100.99 1.84 10.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 111.82 0.304 . . . . 1.21 111.82 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.59 47.41 34.4 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.958 -0.639 . . . . 1.0800000000000001 113.147 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.48 ' H ' HG13 ' A' ' 66' ' ' ILE . 1.5 pp -84.79 173.71 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.673 0.273 . . . . 1.0700000000000001 111.348 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.2 ttm105 -98.54 -55.66 2.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.556 -0.293 . . . . 3.5899999999999999 110.739 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.0 m -62.01 101.62 0.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.187 0.518 . . . . 1.51 110.822 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.73 83.27 5.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.86 -0.609 . . . . 1.79 111.339 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.738 ' HA2' ' N4 ' ' C' ' 4' ' ' ' C' . . . -143.1 158.25 27.15 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.783 -0.722 . . . . 1.1799999999999999 111.674 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.3 t -105.82 107.11 21.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.954 -0.388 . . . . 1.5600000000000001 109.954 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.886 ' HB ' HG22 ' A' ' 59' ' ' VAL . 42.3 t -61.44 116.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.39 . . . . 1.29 110.628 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.579 ' HD2' ' O ' ' A' ' 47' ' ' SER . 74.8 mtp180 -102.78 119.34 38.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.084 -0.507 . . . . 2.23 111.686 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.8 m -103.52 5.88 37.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.429 0.633 . . . . 1.1699999999999999 109.515 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.557 ' HB2' ' CZ ' ' B' ' 33' ' ' PHE . 9.2 p-10 -81.59 -33.79 31.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.454 -0.794 . . . . 0.89000000000000001 111.574 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.55 ' HG3' ' NH2' ' A' ' 73' ' ' ARG . 11.4 mm-40 -130.38 64.02 71.41 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.677 -0.238 . . . . 2.1299999999999999 110.951 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.757 ' HD2' HG11 ' B' ' 41' ' ' VAL . 83.2 Cg_endo -80.56 164.85 20.88 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.092 1.861 . . . . 0.80000000000000004 112.237 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.635 ' HA ' ' O ' ' B' ' 77' ' ' PRO . 13.9 ptm180 -166.7 118.02 0.95 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 2.0899999999999999 110.999 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.535 ' HB ' ' HA ' ' B' ' 76' ' ' GLN . 78.3 m -72.72 109.66 6.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.383 -0.371 . . . . 1.6200000000000001 110.295 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.0 pt -103.08 165.95 2.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.704 -0.68 . . . . 1.1499999999999999 111.225 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HA ' HD23 ' A' ' 39' ' ' LEU . 8.4 t0 -82.78 136.99 34.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.644 -0.707 . . . . 1.03 109.896 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.414 ' SD ' ' HA3' ' A' ' 87' ' ' GLY . 27.6 tpp -111.46 1.59 17.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.273 -0.421 . . . . 1.29 111.216 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -91.28 -56.42 3.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.564 -0.289 . . . . 2.6400000000000001 111.768 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.4 ' HB3' ' HA2' ' B' ' 16' ' ' GLY . . . -78.84 -29.98 44.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.378 . . . . 1.1200000000000001 111.14 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.564 ' HB3' HG21 ' A' ' 9' ' ' VAL . 72.3 mtt-85 -76.35 -39.74 53.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.31 -0.405 . . . . 1.0600000000000001 110.8 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.29 82.19 0.15 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.952 -0.642 . . . . 1.1200000000000001 112.914 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.414 ' HA3' ' SD ' ' A' ' 82' ' ' MET . . . -81.93 168.0 48.55 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.807 -0.711 . . . . 1.0900000000000001 112.848 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 7' ' ' TRP . 9.4 mptt -121.53 121.94 38.59 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.18 -0.304 . . . . 2.46 110.18 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.38 120.66 23.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.82 0.343 . . . . 2.4900000000000002 111.194 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 90' ' ' LEU . 3.3 mm? -86.71 -67.17 0.83 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.139 -0.482 . . . . 1.29 110.511 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.535 ' HG2' HD11 ' A' ' 6' ' ' ILE . 4.1 pt-20 -153.57 -174.05 4.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.946 -0.57 . . . . 1.1499999999999999 109.58 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -130.58 140.15 50.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.056 0.455 . . . . 1.3200000000000001 110.355 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.0 m -94.15 152.03 40.03 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.865 -0.607 . . . . 0.75 110.801 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.38 162.57 17.09 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.889 2.393 . . . . 0.94999999999999996 111.947 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -62.86 -24.23 67.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 1.51 111.066 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.66 -35.46 80.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 1.5700000000000001 110.702 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.4 mm -69.95 -31.02 46.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.397 -0.594 . . . . 1.3100000000000001 109.397 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.444 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 16.7 tpt -64.89 -34.16 77.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.721 -0.672 . . . . 1.6000000000000001 109.641 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -63.12 -40.39 97.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.675 -0.693 . . . . 2.2999999999999998 109.404 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.633 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 2.2 mm-40 -58.66 -49.35 77.86 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.543 -0.753 . . . . 1.6399999999999999 109.857 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.9 t -62.29 -49.11 85.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.573 -0.74 . . . . 1.03 110.901 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 98' ' ' MET . 94.5 mt -56.74 -43.31 80.57 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.271 -0.422 . . . . 1.22 111.194 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.36 -40.85 98.08 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.115 -0.564 . . . . 1.03 112.524 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 13.0 mmt180 -71.05 -43.07 68.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.896 0.379 . . . . 1.72 110.914 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.89 -31.4 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 1.02 111.676 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.1 m -69.03 -16.51 63.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.409 -0.359 . . . . 1.1100000000000001 111.521 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.4 m -93.85 -24.45 17.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.693 0.257 . . . . 1.5 111.693 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.7 pt -84.06 -20.9 8.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 112.08 0.4 . . . . 1.1499999999999999 112.08 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 97.3 mt -77.01 79.23 3.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.013 0.435 . . . . 0.97999999999999998 111.603 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.418 ' O ' ' HD2' ' B' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.929 -0.578 . . . . 1.3500000000000001 110.364 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.711 ' HA ' ' HA ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.288 0 N-CA-C 112.756 0.65 . . . . 2.0299999999999998 112.756 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' B' ' 3' ' ' ARG . 3.1 mp0 -71.13 -22.42 62.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.629 -0.714 . . . . 2.8199999999999998 110.848 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . 0.791 ' HG3' ' HG2' ' B' ' 98' ' ' MET . 4.2 mpt_? 78.82 123.73 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.951 0.722 . . . . 2.3199999999999998 112.951 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.518 ' HA2' HG12 ' B' ' 93' ' ' VAL . . . 80.09 49.22 6.07 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.478 -0.783 . . . . 1.28 113.683 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -125.37 90.38 3.21 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.473 0.546 . . . . 1.53 112.473 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.721 HD11 ' HB ' ' B' ' 93' ' ' VAL . 64.0 mt -99.86 104.39 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.184 -1.043 . . . . 0.75 108.184 178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.446 ' HA ' ' HA ' ' B' ' 89' ' ' ARG . 12.4 m95 -103.79 166.49 10.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.925 -0.579 . . . . 0.81000000000000005 111.59 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 55.4 tp -118.39 112.34 19.87 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.196 -0.668 . . . . 1.05 109.196 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 p -136.61 156.17 35.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.301 -0.409 . . . . 0.71999999999999997 110.362 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 5.8 t -90.28 127.22 36.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.402 -0.592 . . . . 1.6299999999999999 109.402 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 20.5 mt -94.67 -25.88 16.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.192 0.52 . . . . 0.82999999999999996 110.49 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.83 147.24 98.86 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.754 . . . . 1.6200000000000001 110.85 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -87.97 160.66 45.16 Favored 'Cis proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.601 -1.416 . . . . 1.28 111.978 0.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.569 ' HB ' ' HG3' ' B' ' 20' ' ' GLN . 14.0 m -156.74 124.74 5.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.377 -0.374 . . . . 1.47 110.219 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.78 164.75 14.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.388 -0.369 . . . . 1.22 110.802 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.4 ' HA2' ' HB3' ' A' ' 84' ' ' ALA . . . 87.06 -164.33 35.23 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.795 -0.717 . . . . 1.01 112.511 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -99.23 31.34 3.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.871 0.367 . . . . 2.1800000000000002 110.641 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.38 -167.7 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 1.28 111.206 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -98.85 101.21 12.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.32 -0.4 . . . . 1.52 110.832 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.569 ' HG3' ' HB ' ' B' ' 14' ' ' THR . 14.9 mp0 -102.59 -178.47 3.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.129 -0.487 . . . . 1.8600000000000001 110.148 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.53 130.64 5.33 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.89 -0.671 . . . . 0.90000000000000002 112.363 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 56.4 m -76.68 94.74 3.84 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.423 -0.584 . . . . 0.94999999999999996 109.423 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.3 165.96 32.85 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.498 -0.774 . . . . 1.5900000000000001 110.19 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.79 145.54 82.71 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.714 2.276 . . . . 0.65000000000000002 112.016 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.804 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 10.5 m -135.47 145.92 30.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.898 -0.592 . . . . 0.56999999999999995 111.138 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 48.2 tp -103.62 125.96 50.46 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.009 -0.541 . . . . 1.1699999999999999 109.573 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . 0.504 HG23 ' HB2' ' B' ' 40' ' ' PRO . 23.5 mt -78.47 140.75 16.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.58 0.228 . . . . 0.66000000000000003 111.148 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.85 -31.95 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.9 0.381 . . . . 0.93000000000000005 111.621 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' THR . . . . . 0.476 HG23 HG22 ' B' ' 41' ' ' VAL . 0.2 OUTLIER -69.42 130.15 91.04 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.502 -0.317 . . . . 0.81000000000000005 111.728 -179.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.711 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 63.3 Cg_endo -72.74 162.29 41.58 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.013 2.475 . . . . 0.78000000000000003 112.725 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.54 -31.2 63.93 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.79 -0.641 . . . . 1.03 112.614 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.43 -18.56 40.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 1.3999999999999999 112.077 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 75' ' ' ASP . 65.7 t80 -122.4 -33.04 3.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.994 0.426 . . . . 1.5700000000000001 110.187 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -56.12 -41.49 75.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.52 -0.764 . . . . 1.6399999999999999 111.781 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -85.73 6.1 29.32 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.804 0.668 . . . . 2.54 112.804 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.05 -65.39 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.173 0.511 . . . . 1.0900000000000001 110.354 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 13.2 p -81.35 -23.83 37.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.868 -0.606 . . . . 1.3300000000000001 110.834 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.808 ' HE ' ' HA ' ' B' ' 38' ' ' ARG . 0.6 OUTLIER 67.33 16.93 10.16 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.632 -0.713 . . . . 1.78 111.432 -179.198 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.625 HD11 ' HD2' ' A' ' 17' ' ' HIS . 13.3 mt -128.18 94.71 35.56 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.19 -1.041 . . . . 1.1599999999999999 108.19 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' PRO . . . . . 0.504 ' HB2' HG23 ' B' ' 27' ' ' ILE . 94.6 Cg_endo -91.54 159.66 3.59 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.582 2.188 . . . . 0.56999999999999995 113.585 -178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.757 HG11 ' HD2' ' A' ' 77' ' ' PRO . 15.2 m -94.37 131.92 39.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.236 -1.024 . . . . 1.0800000000000001 108.236 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.804 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 27.6 m -124.0 153.18 29.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 113.066 0.765 . . . . 0.64000000000000001 113.066 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 42.7 t -106.63 114.2 62.16 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 114.647 -1.16 . . . . 1.1000000000000001 108.411 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.726 ' HA ' HG12 ' B' ' 25' ' ' VAL . 39.3 Cg_endo -67.62 123.39 10.71 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.69 2.26 . . . . 0.72999999999999998 112.555 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.636 HG22 HG12 ' B' ' 72' ' ' VAL . 48.9 t -77.65 123.38 34.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.348 -0.612 . . . . 0.90000000000000002 109.348 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.75 102.49 15.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.311 -0.404 . . . . 1.1699999999999999 110.44 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.47 89.73 0.95 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.066 -0.516 . . . . 1.8500000000000001 110.573 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.8 -14.42 77.69 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.766 -0.73 . . . . 2.2200000000000002 112.104 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.92 -84.65 0.16 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.022 -0.609 . . . . 3.4300000000000002 111.597 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.62 -39.23 17.54 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.268 0.556 . . . . 4.6200000000000001 109.507 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -90.09 88.2 7.18 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.791 -0.64 . . . . 6.2699999999999996 110.806 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.59 81.49 1.88 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.554 -0.748 . . . . 4.3899999999999997 109.972 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.17 150.59 49.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.935 -0.575 . . . . 3.9199999999999999 110.386 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.19 127.54 31.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.227 -0.442 . . . . 2.75 110.433 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -127.16 46.09 2.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.47 -0.332 . . . . 1.96 111.47 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.22 -73.46 1.78 Allowed Glycine 0 CA--C 1.516 0.149 0 C-N-CA 121.005 -0.617 . . . . 1.0800000000000001 112.831 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.424 ' HB3' ' HZ ' ' A' ' 33' ' ' PHE . 26.5 p90 -88.18 -11.08 47.84 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.195 0.521 . . . . 3.5699999999999998 110.924 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' B' ' 72' ' ' VAL . . . -112.98 116.81 30.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.975 -0.557 . . . . 1.0800000000000001 110.211 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' B' ' 101' ' ' VAL . 49.5 t -90.71 135.04 27.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.295 -0.411 . . . . 1.3400000000000001 110.102 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.559 ' HA ' HG12 ' B' ' 71' ' ' VAL . 19.0 t -87.7 138.5 31.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.965 0.412 . . . . 1.3799999999999999 111.23 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.54 ' HB3' HD12 ' B' ' 66' ' ' ILE . 69.0 mt -101.63 5.34 41.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.05 -0.722 . . . . 1.02 109.05 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.09 157.41 18.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.07 -0.968 . . . . 1.79 110.638 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.51 -62.94 0.3 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.702 -0.761 . . . . 1.1499999999999999 112.92 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.96 -31.72 51.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.865 0.364 . . . . 1.1699999999999999 111.95 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.12 79.75 1.15 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.554 -0.831 . . . . 1.05 113.067 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.54 HD12 ' HB3' ' B' ' 61' ' ' LEU . 45.9 mt -123.71 152.79 29.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.737 -0.838 . . . . 1.6100000000000001 108.737 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . 0.594 ' HB3' ' OE1' ' B' ' 91' ' ' GLU . 4.1 ttt180 -63.48 -48.69 76.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.625 0.25 . . . . 2.3999999999999999 111.433 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 12.1 m -78.83 99.87 6.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.237 0.541 . . . . 0.93000000000000005 111.685 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.8 88.61 6.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.718 -0.674 . . . . 1.3100000000000001 110.751 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -163.16 -170.64 28.34 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.298 -0.953 . . . . 0.79000000000000004 112.669 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' B' ' 60' ' ' SER . 11.5 m -124.67 136.92 59.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.849 0.357 . . . . 0.93000000000000005 110.333 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.636 HG12 HG22 ' B' ' 45' ' ' VAL . 16.1 m -86.55 133.23 30.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.313 -0.403 . . . . 1.3799999999999999 111.404 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -88.75 85.74 6.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.565 -0.531 . . . . 1.3700000000000001 109.565 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 1.1 m -65.68 -15.26 62.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.355 0.598 . . . . 1.1599999999999999 111.116 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.28 -12.74 51.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.501 -0.772 . . . . 1.1000000000000001 111.12 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . 0.535 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 10.4 mt-30 -126.38 66.23 61.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 114.233 1.197 . . . . 2.4700000000000002 114.233 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.635 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 74.0 Cg_endo -79.76 142.43 15.95 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.786 1.657 . . . . 0.95999999999999996 109.159 177.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' B' ' 78' ' ' ARG . 4.9 ttt180 -138.36 144.01 40.11 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.747 -0.381 . . . . 1.96 111.882 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.511 HG21 ' HB3' ' A' ' 76' ' ' GLN . 0.1 OUTLIER -82.76 140.38 33.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.788 -0.642 . . . . 1.1899999999999999 109.714 178.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.96 157.8 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.935 0.397 . . . . 1.28 111.426 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' B' ' 85' ' ' ARG . 9.5 t0 -85.39 110.82 19.4 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.813 -0.81 . . . . 1.28 108.813 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 13.7 ttp -78.62 -3.52 44.32 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.44 0.904 . . . . 2.7000000000000002 113.44 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 10.3 pttt -117.63 -45.08 2.71 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.002 0.742 . . . . 1.96 113.002 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.37 -38.75 41.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.793 0.33 . . . . 1.0600000000000001 111.67 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' B' ' 81' ' ' ASP . 83.7 mtt-85 -79.89 -25.28 40.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.525 -0.307 . . . . 1.47 111.055 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.84 132.02 1.74 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.661 -0.78 . . . . 0.81999999999999995 111.849 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.39 148.15 14.42 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.157 -1.02 . . . . 0.65000000000000002 113.16 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -146.49 157.43 43.75 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.786 -0.45 . . . . 1.8100000000000001 109.786 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' B' ' 7' ' ' TRP . 53.5 ttp180 -82.45 126.0 31.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.696 0.284 . . . . 2.4900000000000002 110.601 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 50.4 mt -89.68 -51.43 5.52 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 0.76000000000000001 110.7 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . 0.594 ' OE1' ' HB3' ' B' ' 67' ' ' ARG . 12.1 pt-20 -150.16 170.55 18.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.968 -0.56 . . . . 1.0700000000000001 111.812 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.401 ' HG3' ' HA3' ' B' ' 4' ' ' GLY . 19.9 ttm180 -115.5 115.27 26.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.742 -0.663 . . . . 2.0499999999999998 110.361 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.721 ' HB ' HD11 ' B' ' 6' ' ' ILE . 11.9 p -74.08 134.5 77.53 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.966 -0.561 . . . . 1.45 110.629 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.03 148.3 48.77 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.822 2.348 . . . . 1.03 112.195 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -55.39 -34.05 64.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.805 -0.634 . . . . 2.1400000000000001 111.601 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.87 -49.03 79.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.219 0.533 . . . . 1.78 110.942 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.414 ' HB ' HG22 ' B' ' 93' ' ' VAL . 21.1 mm -74.19 -39.88 50.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.878 -0.601 . . . . 1.3300000000000001 110.491 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' MET . . . . . 0.791 ' HG2' ' HG3' ' B' ' 3' ' ' ARG . 8.3 tpt -58.54 -42.36 87.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.985 0.421 . . . . 2.3399999999999999 110.545 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -63.5 -35.36 80.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.939 -0.573 . . . . 1.9099999999999999 110.478 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 1.8 mm-40 -62.82 -42.46 99.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.023 -0.535 . . . . 1.76 110.388 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.581 ' HA ' HG21 ' B' ' 59' ' ' VAL . 39.9 t -61.53 -45.14 99.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.976 -0.556 . . . . 1.01 110.525 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.46 -38.41 87.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.017 -0.538 . . . . 1.29 110.586 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.14 -42.86 94.19 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.692 -0.686 . . . . 1.02 111.579 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 9.9 mmt180 -69.33 -29.5 67.34 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.806 0.336 . . . . 1.8500000000000001 110.72 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.521 ' O ' HG12 ' B' ' 108' ' ' ILE . 11.3 mt -66.64 -23.17 66.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 1.9399999999999999 110.535 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 24.2 m -82.76 -8.61 59.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.347 -0.388 . . . . 1.1599999999999999 111.767 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.84 -15.87 61.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 1.45 111.778 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.521 HG12 ' O ' ' B' ' 105' ' ' LEU . 37.2 pt -88.18 -1.11 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.807 0.337 . . . . 1.98 111.111 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 58.8 mt -87.42 -4.94 59.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.034 -0.53 . . . . 1.3600000000000001 111.048 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.687 -0.673 . . . . 2.1299999999999999 109.81 179.618 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.603 0 C3'-C2'-C1' 100.881 -0.687 . 0.0 '__' . 6.3600000000000003 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' ' U' . . . . . 0.755 " H4'" ' N7 ' ' C' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.401 -1.076 0 C4'-C3'-C2' 105.283 2.583 OUTLIER-DELTA 0.0 OUTLIER delta 2.9900000000000002 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' ' A' . . . . . 0.755 ' N7 ' " H4'" ' C' ' 2' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.845 0 C1'-C2'-O2' 108.292 -0.769 . 0.0 OUTLIER delta-1 2.5899999999999999 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' ' C' . . . . . 0.738 ' N4 ' ' HA2' ' A' ' 70' ' ' GLY . . . . . . . . 0 O5'--C5' 1.428 -0.755 0 O4'-C4'-C3' 102.527 -2.123 . 0.0 OUTLIER . 2.5099999999999998 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' ' A' . . . . . 0.508 ' N3 ' " H2'" ' C' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.985 0 C5'-C4'-O4' 108.054 -0.818 . 0.0 OUTLIER . 4.9400000000000004 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 21.3 ptp . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.89 0.376 . . . . 1.29 110.783 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -123.22 168.12 12.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.886 -0.597 . . . . 2.0099999999999998 110.828 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -63.52 128.73 37.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.973 -0.558 . . . . 1.8500000000000001 110.642 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.74 -20.84 17.25 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.756 -0.735 . . . . 0.85999999999999999 113.112 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.4 ' O ' HG12 ' A' ' 27' ' ' ILE . 33.2 mt-10 -83.49 145.49 28.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.794 0.297 . . . . 0.98999999999999999 111.309 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.2 pt -112.91 130.49 66.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.879 0.371 . . . . 1.1599999999999999 110.746 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.4 m95 -116.22 117.58 30.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.152 -0.476 . . . . 0.91000000000000003 111.098 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 27.7 tp -76.07 113.44 13.59 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.791 -0.448 . . . . 0.90000000000000002 109.791 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 p -150.66 159.92 4.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.61 -0.268 . . . . 1.04 110.738 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.65 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.0 t -97.25 132.4 43.04 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.499 -0.556 . . . . 1.3200000000000001 109.499 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.4 mt -86.29 -11.65 51.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.403 -0.362 . . . . 1.29 111.509 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.486 ' CB ' ' HA ' ' A' ' 13' ' ' PRO . 3.0 m-20 -64.18 164.59 17.44 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.803 -0.635 . . . . 1.54 112.649 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.486 ' HA ' ' CB ' ' A' ' 12' ' ' ASP . 79.4 Cg_endo -83.34 111.63 2.28 Favored 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 123.553 -1.436 . . . . 1.6899999999999999 112.572 0.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -107.49 150.49 26.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.106 -0.497 . . . . 1.3600000000000001 111.298 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -130.02 167.21 18.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.002 -0.545 . . . . 1.7 110.533 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.8 -150.55 48.05 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.893 -0.883 . . . . 1.1799999999999999 110.893 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -85.62 4.14 37.62 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.093 0.446 . . . . 2.7799999999999998 111.338 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HB3' HG22 ' A' ' 14' ' ' THR . 9.3 tt0 -65.33 134.38 53.45 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.134 -0.321 . . . . 1.1399999999999999 110.134 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.428 ' HG2' ' HG3' ' A' ' 44' ' ' PRO . 7.5 tp-100 -54.77 124.45 16.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.951 -0.568 . . . . 2.0899999999999999 112.098 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.427 HE21 ' HB2' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -127.85 -178.81 4.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.722 -0.672 . . . . 2.0899999999999999 110.195 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.759 ' HA2' " H2'" ' C' ' 5' ' ' ' A' . . . 91.26 164.52 39.32 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.861 -0.685 . . . . 1.0700000000000001 113.917 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 2.2 m -91.96 124.76 36.31 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.078 -0.712 . . . . 1.1100000000000001 109.078 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.43 ' HG3' ' HB2' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -159.88 158.06 26.4 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 110.466 -0.198 . . . . 1.6200000000000001 110.466 -179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 57.6 Cg_endo -76.86 121.04 5.69 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.957 1.771 . . . . 1.01 111.335 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.557 HG21 HD11 ' A' ' 80' ' ' ILE . 24.4 m -95.59 131.07 43.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.082 -0.508 . . . . 0.76000000000000001 110.532 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HB3' HG23 ' A' ' 43' ' ' VAL . 50.8 tp -87.91 122.64 31.78 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.788 -0.642 . . . . 0.69999999999999996 110.825 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.633 ' HA ' HG12 ' A' ' 42' ' ' VAL . 19.0 mm -71.11 111.45 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.794 -0.446 . . . . 0.92000000000000004 109.794 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.1 t -92.32 -37.12 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.275 -0.42 . . . . 0.94999999999999996 111.724 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.85 148.85 82.5 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 111.719 0.266 . . . . 1.1200000000000001 111.719 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.419 ' HG3' ' OXT' ' B' ' 110' ' ' THR . 68.7 Cg_endo -71.69 161.2 45.94 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.598 2.199 . . . . 1.3 111.879 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.11 -35.79 74.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.026 -0.534 . . . . 1.3899999999999999 111.567 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.64 -43.56 89.81 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.241 -0.436 . . . . 1.6100000000000001 111.672 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.597 ' HZ ' ' HB2' ' B' ' 75' ' ' ASP . 69.9 t80 -71.94 -48.39 45.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.889 -0.596 . . . . 1.77 110.786 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -59.25 -32.68 70.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.024 -0.534 . . . . 1.48 111.123 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 35' ' ' ARG . 43.9 ttp180 -64.85 -30.08 71.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.852 -0.613 . . . . 2.6200000000000001 112.136 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 p -96.32 -47.28 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 113.575 0.954 . . . . 1.8600000000000001 113.575 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 22.1 p -78.34 -28.61 47.26 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.72 0.637 . . . . 1.72 112.72 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 37' ' ' THR . 9.4 mpt_? 74.04 -1.09 3.17 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.585 0.553 . . . . 4.4500000000000002 111.567 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.9 mt -126.05 107.3 25.02 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.317 -0.624 . . . . 1.8100000000000001 109.317 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -89.09 139.78 3.76 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.73 2.287 . . . . 1.05 113.018 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 79' ' ' THR . 62.8 t -79.79 113.66 19.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.015 -1.476 . . . . 1.03 107.015 177.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 27' ' ' ILE . 34.8 m -123.46 165.33 19.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 112.711 0.634 . . . . 0.77000000000000002 112.711 -177.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.412 HG23 ' HB3' ' A' ' 26' ' ' LEU . 4.4 m -126.54 125.92 24.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.711 -1.131 . . . . 0.71999999999999997 108.797 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.43 ' HB2' ' HG3' ' A' ' 23' ' ' ARG . 94.5 Cg_endo -80.42 131.59 8.6 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.691 2.26 . . . . 1.03 113.667 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.726 HG22 HG22 ' A' ' 72' ' ' VAL . 92.1 t -78.77 128.63 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.942 -0.762 . . . . 1.28 108.942 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.549 ' HB ' " O2'" ' C' ' 3' ' ' ' A' . 16.5 p -115.9 -160.44 0.75 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.217 -0.193 . . . . 1.9099999999999999 111.388 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.402 ' H ' ' HB ' ' A' ' 46' ' ' THR . 20.1 m -111.01 153.41 25.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.769 0.318 . . . . 2.5299999999999998 111.202 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.23 19.82 3.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.491 -0.862 . . . . 3.3599999999999999 112.525 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.12 -112.75 4.34 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.597 -0.811 . . . . 3.8300000000000001 111.987 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -104.38 -52.11 2.98 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.733 -0.469 . . . . 4.7199999999999998 109.733 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -121.33 158.54 27.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.675 -0.693 . . . . 6.2400000000000002 109.623 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.514 ' HB3' ' H ' ' A' ' 61' ' ' LEU . . . -92.52 174.1 7.45 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.209 -0.293 . . . . 2.5899999999999999 110.209 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 53' ' ' ARG . 17.9 ptt85 -169.69 167.11 9.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.203 -0.453 . . . . 4.5899999999999999 109.994 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.605 ' HA ' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -75.03 67.65 1.75 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.991 0.424 . . . . 2.6899999999999999 111.72 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.54 73.22 5.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.353 0.597 . . . . 3.1699999999999999 110.13 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.587 ' HA3' ' O4 ' ' C' ' 2' ' ' ' U' . . . 81.04 -98.27 1.83 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.355 -0.839 . . . . 1.6599999999999999 111.43 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -103.37 15.12 29.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.178 0.513 . . . . 1.5600000000000001 110.995 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.605 ' O ' ' HA ' ' A' ' 54' ' ' THR . . . -101.44 153.5 19.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.741 -0.663 . . . . 1.25 109.439 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.13 163.11 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.874 0.369 . . . . 1.6799999999999999 111.755 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.416 ' OG ' ' HA ' ' A' ' 53' ' ' ARG . 70.9 m -82.53 133.74 35.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.794 -0.639 . . . . 1.95 110.78 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.815 HD11 HG23 ' A' ' 72' ' ' VAL . 18.3 mt -103.48 -32.15 9.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.191 0.52 . . . . 1.23 110.775 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.78 97.9 1.87 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.369 0.604 . . . . 2.21 110.814 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.82 -8.29 4.87 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.803 -0.713 . . . . 1.1499999999999999 112.605 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 61' ' ' LEU . 28.5 m -94.33 -1.9 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.851 0.325 . . . . 1.21 111.701 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.08 54.44 5.25 Favored Glycine 0 C--O 1.236 0.228 0 C-N-CA 121.16 -0.543 . . . . 1.0800000000000001 113.937 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.639 HD11 ' HB3' ' A' ' 61' ' ' LEU . 41.6 pt -129.67 171.92 16.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 122.823 -0.222 . . . . 1.0700000000000001 110.666 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -104.82 -23.74 12.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.895 -0.409 . . . . 3.5899999999999999 109.895 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.611 ' HB ' HD12 ' A' ' 66' ' ' ILE . 21.1 m -52.74 107.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.468 -0.787 . . . . 1.51 111.378 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.73 90.71 8.34 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.589 -0.732 . . . . 1.79 111.126 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.418 ' HA3' ' H42' ' C' ' 4' ' ' ' C' . . . 178.71 -151.47 10.43 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.941 -0.864 . . . . 1.1799999999999999 110.941 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.83 131.13 37.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.986 0.422 . . . . 1.5600000000000001 110.797 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.815 HG23 HD11 ' A' ' 61' ' ' LEU . 85.1 t -97.96 142.88 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.27 -0.423 . . . . 1.29 109.922 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.652 ' HD2' ' C2 ' ' C' ' 3' ' ' ' A' . 0.0 OUTLIER -150.39 163.9 37.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.381 -0.372 . . . . 2.23 110.311 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.32 13.94 20.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.757 0.313 . . . . 1.1699999999999999 111.383 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.487 ' HA ' ' HZ ' ' B' ' 33' ' ' PHE . 3.3 p30 -86.95 -3.18 59.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 0.89000000000000001 112.075 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.402 ' HG2' ' OD1' ' A' ' 75' ' ' ASP . 35.4 mm-40 -129.96 64.65 72.99 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.758 -0.201 . . . . 2.1299999999999999 111.42 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -94.82 131.49 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.619 2.213 . . . . 0.80000000000000004 113.003 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' B' ' 77' ' ' PRO . 10.6 ptm180 -161.43 154.91 21.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.951 0.405 . . . . 2.0899999999999999 111.594 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.454 HG23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.85 130.02 36.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.186 -0.672 . . . . 1.6200000000000001 109.186 178.335 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.557 HD11 HG21 ' A' ' 25' ' ' VAL . 32.7 pt -131.1 157.28 43.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.961 0.41 . . . . 1.1499999999999999 111.111 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -87.84 133.19 33.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.854 -0.612 . . . . 1.03 110.596 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 43.7 tpp -120.09 21.76 11.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.128 -0.487 . . . . 1.29 110.286 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -107.31 -38.58 5.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.096 -0.502 . . . . 2.6400000000000001 110.794 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.71 -26.18 15.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.994 -0.548 . . . . 1.1200000000000001 111.203 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -76.47 -59.76 2.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.852 0.358 . . . . 1.0600000000000001 111.154 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.29 89.7 1.39 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.84 -0.695 . . . . 1.1200000000000001 111.478 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -95.97 172.29 29.42 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.666 -0.778 . . . . 1.0900000000000001 112.561 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -121.36 109.39 14.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.764 -0.458 . . . . 2.46 109.764 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.16 128.18 34.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.501 0.191 . . . . 2.4900000000000002 110.795 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.56 -89.04 0.37 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.589 -0.278 . . . . 1.29 110.881 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -122.09 -172.78 2.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.51 -0.314 . . . . 1.1499999999999999 110.409 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -140.57 133.88 29.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.94 0.4 . . . . 1.3200000000000001 110.449 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.42 155.21 66.25 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.113 -0.494 . . . . 0.75 111.411 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.54 149.38 89.98 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.47 2.114 . . . . 0.94999999999999996 111.941 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -60.77 -23.21 64.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.892 -0.595 . . . . 1.51 111.488 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -38.07 89.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.243 -0.435 . . . . 1.5700000000000001 109.851 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.7 mm -71.6 -37.92 65.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.916 -0.584 . . . . 1.3100000000000001 109.5 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 84.6 mmm -62.06 -36.9 83.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.616 -0.72 . . . . 1.6000000000000001 110.234 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -62.52 -35.98 81.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.752 -0.658 . . . . 2.2999999999999998 110.548 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -63.84 -46.63 84.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.5 -0.556 . . . . 1.6399999999999999 109.5 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.73 -47.27 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.688 -0.687 . . . . 1.03 110.446 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.3 mt -61.86 -33.84 74.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 1.22 111.121 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.95 -17.57 75.55 Favored Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.904 -0.589 . . . . 1.03 113.091 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -97.86 -24.98 15.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.973 0.416 . . . . 1.72 110.786 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.419 ' O ' HG12 ' A' ' 108' ' ' ILE . 90.6 mt -68.42 -25.45 65.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.139 -0.482 . . . . 1.02 111.398 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -16.53 64.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.835 0.35 . . . . 1.1100000000000001 111.568 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.76 -16.5 32.02 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.193 0.442 . . . . 1.5 112.193 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 105' ' ' LEU . 23.3 pt -91.9 -9.34 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.641 0.608 . . . . 1.1499999999999999 112.641 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.644 ' HA ' HG12 ' B' ' 28' ' ' VAL . 19.7 mt -87.73 82.91 7.24 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.915 -0.402 . . . . 0.97999999999999998 109.915 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.412 ' O ' ' HG3' ' B' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 N-CA-C 113.006 0.743 . . . . 1.3500000000000001 113.006 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.842 ' HA ' ' HA ' ' B' ' 30' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.326 0 N-CA-C 109.61 -0.515 . . . . 2.0299999999999998 109.61 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -77.97 -5.42 51.19 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.719 -0.474 . . . . 2.8199999999999998 109.719 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 110' ' ' THR . 7.8 mtm180 60.69 80.19 0.22 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.099 -0.955 . . . . 2.3199999999999998 112.968 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.47 ' HA2' HG12 ' B' ' 93' ' ' VAL . . . 137.69 -32.69 2.35 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.092 -1.052 . . . . 1.28 113.826 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.44 ' OE2' ' HD2' ' B' ' 92' ' ' ARG . 17.6 mm-40 -64.63 109.62 2.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.062 0.458 . . . . 1.53 112.169 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.659 HD11 ' HB ' ' B' ' 93' ' ' VAL . 51.4 mt -98.8 130.7 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.371 -0.603 . . . . 0.75 109.371 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.408 ' HA ' ' HA ' ' B' ' 89' ' ' ARG . 30.2 m95 -115.44 178.32 4.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.037 0.446 . . . . 0.81000000000000005 111.316 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 tt -146.22 133.7 20.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.086 -0.506 . . . . 1.05 110.032 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.519 HG12 HG21 ' B' ' 25' ' ' VAL . 8.2 p -167.16 164.75 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.504 -0.316 . . . . 0.71999999999999997 110.182 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 6.0 t -88.83 140.56 29.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.636 0.255 . . . . 1.6299999999999999 110.661 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.517 HD11 ' HB3' ' B' ' 44' ' ' PRO . 32.1 mt -96.45 -12.25 24.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.369 0.604 . . . . 0.82999999999999996 110.15 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . 0.735 ' OD1' ' HB3' ' B' ' 20' ' ' GLN . 0.1 OUTLIER -75.97 153.59 84.77 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.507 -0.769 . . . . 1.6200000000000001 110.083 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -96.23 161.73 14.48 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.823 -1.324 . . . . 1.28 112.154 -0.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.465 HG22 ' H ' ' B' ' 15' ' ' ALA . 0.2 OUTLIER -157.93 -164.65 1.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.172 -0.677 . . . . 1.47 109.172 179.108 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.465 ' H ' HG22 ' B' ' 14' ' ' THR . . . -155.41 161.57 40.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.075 -0.342 . . . . 1.22 110.075 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.47 -143.23 25.66 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.891 -0.671 . . . . 1.01 112.244 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -92.83 2.05 56.97 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.875 0.324 . . . . 2.1800000000000002 111.875 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.44 136.0 57.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.648 0.261 . . . . 1.28 110.758 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -60.31 128.33 36.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 1.52 112.097 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.735 ' HB3' ' OD1' ' B' ' 12' ' ' ASP . 21.7 mt-30 -129.55 -167.37 1.79 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.466 -0.788 . . . . 1.8600000000000001 110.874 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.22 175.7 50.89 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.962 -0.563 . . . . 0.90000000000000002 112.765 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 18.4 m -111.0 108.79 18.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.01 0.433 . . . . 0.94999999999999996 110.591 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.48 164.81 20.1 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.004 -0.544 . . . . 1.5900000000000001 109.764 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.08 147.28 91.1 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.406 2.071 . . . . 0.65000000000000002 111.078 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 9.8 m -134.99 137.2 50.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.138 0.494 . . . . 0.56999999999999995 111.753 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 33.5 tp -101.83 129.13 47.98 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.186 -0.672 . . . . 1.1699999999999999 109.186 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 55.3 mt -89.22 133.65 30.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.605 0.24 . . . . 0.66000000000000003 110.369 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 109' ' ' LEU . 21.5 t -100.5 -34.84 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.379 -0.373 . . . . 0.93000000000000005 111.913 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' THR . . . . . 0.49 HG23 HG22 ' B' ' 41' ' ' VAL . 0.7 OUTLIER -67.54 138.99 93.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 111.956 0.354 . . . . 0.81000000000000005 111.956 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.842 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 50.0 Cg_endo -68.34 162.26 41.26 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.003 2.469 . . . . 0.78000000000000003 113.02 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.06 67.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.536 -0.756 . . . . 1.03 112.208 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.07 -46.18 79.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.035 0.445 . . . . 1.3999999999999999 110.961 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . 0.487 ' HZ ' ' HA ' ' A' ' 75' ' ' ASP . 4.5 t80 -66.05 -48.13 72.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.031 -0.531 . . . . 1.5700000000000001 110.599 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -61.16 -26.88 68.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 1.6399999999999999 111.937 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -82.52 -33.98 28.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.484 -0.325 . . . . 2.54 111.262 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 89.0 t -82.99 -55.75 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.372 0.508 . . . . 1.0900000000000001 112.372 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . 0.513 HG22 ' H6 ' ' C' ' 2' ' ' ' U' . 58.0 p -74.43 -27.81 60.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.7 0.286 . . . . 1.3300000000000001 111.33 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.416 ' HE ' ' HA ' ' B' ' 38' ' ' ARG . 2.5 mmp_? 62.84 26.22 15.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.897 -0.592 . . . . 1.78 110.061 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 30.4 mt -145.67 96.67 4.73 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.115 -0.948 . . . . 1.1599999999999999 109.57 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' PRO . . . . . 0.547 ' HD2' ' O ' ' B' ' 80' ' ' ILE . 92.5 Cg_endo -87.43 146.99 7.4 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.861 2.374 . . . . 0.56999999999999995 112.711 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.49 HG22 HG23 ' B' ' 29' ' ' THR . 4.9 m -85.52 110.68 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.327 -0.62 . . . . 1.0800000000000001 109.327 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 34.6 m -95.73 138.26 21.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.9 -0.591 . . . . 0.64000000000000001 112.035 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.491 HG13 ' O ' ' B' ' 73' ' ' ARG . 41.2 t -107.52 116.38 57.84 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.022 -0.99 . . . . 1.1000000000000001 108.91 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.517 ' HB3' HD11 ' B' ' 11' ' ' LEU . 50.0 Cg_endo -67.85 124.62 12.09 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.984 2.456 . . . . 0.72999999999999998 114.221 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -95.24 142.07 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.588 -0.893 . . . . 0.90000000000000002 108.588 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -112.63 100.56 8.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.951 0.405 . . . . 1.1699999999999999 111.181 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.57 157.72 26.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.774 -0.648 . . . . 1.8500000000000001 110.722 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.26 -21.98 27.87 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.476 -0.649 . . . . 2.2200000000000002 111.476 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.53 84.55 0.49 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.764 -0.732 . . . . 3.4300000000000002 111.933 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -78.03 -78.7 0.13 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.089 0.471 . . . . 4.6200000000000001 110.648 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -92.67 28.38 2.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 6.2699999999999996 110.92 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.95 148.78 45.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.724 -0.671 . . . . 4.3899999999999997 110.182 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -70.35 137.48 50.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.106 -0.331 . . . . 3.9199999999999999 110.106 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 10.4 t -64.55 120.87 13.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.47 0.652 . . . . 2.75 110.74 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.43 68.04 6.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.724 -0.671 . . . . 1.96 110.988 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.34 -77.09 0.74 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.745 -0.661 . . . . 1.0800000000000001 112.869 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.491 ' HE1' ' HB ' ' B' ' 107' ' ' THR . 66.3 m-85 -104.4 -14.42 15.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.512 0.196 . . . . 3.5699999999999998 111.153 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' B' ' 72' ' ' VAL . . . -78.87 95.96 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.419 -0.355 . . . . 1.0800000000000001 110.566 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 45.0 t -85.14 125.19 40.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.11 -0.496 . . . . 1.3400000000000001 111.173 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.01 126.41 31.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.147 -0.479 . . . . 1.3799999999999999 110.993 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.418 ' HB3' HD11 ' B' ' 66' ' ' ILE . 75.9 mt -96.01 87.63 4.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 1.02 111.461 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -161.95 179.21 8.2 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.704 -0.48 . . . . 1.79 109.704 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.22 -42.47 3.16 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 121.242 -0.504 . . . . 1.1499999999999999 112.452 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.652 HG21 ' HG2' ' B' ' 94' ' ' PRO . 14.2 p -80.18 -27.28 11.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.091 0.472 . . . . 1.1699999999999999 111.111 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.65 89.51 1.07 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.717 -0.754 . . . . 1.05 112.62 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.418 HD11 ' HB3' ' B' ' 61' ' ' LEU . 4.9 pt -141.28 177.39 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.925 -0.769 . . . . 1.6100000000000001 108.925 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -83.13 -53.49 5.75 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.982 0.42 . . . . 2.3999999999999999 110.307 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 7.2 m -64.89 112.53 3.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.889 -0.596 . . . . 0.93000000000000005 109.743 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.4 131.58 53.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.888 0.375 . . . . 1.3100000000000001 111.438 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.89 -174.42 32.41 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.941 -0.647 . . . . 0.79000000000000004 111.899 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.418 ' HB ' ' HB1' ' B' ' 58' ' ' ALA . 4.0 m -102.7 124.04 56.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.045 0.45 . . . . 0.93000000000000005 111.437 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' B' ' 58' ' ' ALA . 11.0 t -86.53 118.35 32.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.801 -0.636 . . . . 1.3799999999999999 110.661 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.491 ' O ' HG13 ' B' ' 43' ' ' VAL . 9.3 mmm180 -87.3 83.9 7.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.937 0.399 . . . . 1.3700000000000001 110.315 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 2.5 m -71.17 22.97 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.233 0.827 . . . . 1.1599999999999999 113.233 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.597 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 13.3 p-10 -112.64 -4.16 14.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.661 0.267 . . . . 1.1000000000000001 110.701 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -121.26 86.22 42.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 112.497 0.554 . . . . 2.4700000000000002 112.497 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.54 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 12.8 Cg_endo -92.8 104.38 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.88 2.387 . . . . 0.95999999999999996 110.588 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -111.37 125.81 54.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.938 0.399 . . . . 1.96 111.949 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -84.04 114.11 21.5 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.427 -0.583 . . . . 1.1899999999999999 109.427 178.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.547 ' O ' ' HD2' ' B' ' 40' ' ' PRO . 45.0 pt -133.8 171.79 17.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.008 0.432 . . . . 1.28 111.023 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -77.47 141.87 39.46 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.643 -0.708 . . . . 1.28 109.678 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' MET . . . . . 0.708 ' SD ' ' HA3' ' B' ' 87' ' ' GLY . 49.0 tpp -115.19 -18.02 11.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.996 0.426 . . . . 2.7000000000000002 111.472 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -92.11 -42.9 9.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.373 -0.376 . . . . 1.96 111.617 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.38 -25.43 33.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.103 0.478 . . . . 1.0600000000000001 111.391 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -81.4 -13.99 57.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.263 -0.426 . . . . 1.47 111.411 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.71 43.49 35.56 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.862 -0.685 . . . . 0.81999999999999995 112.628 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . 0.708 ' HA3' ' SD ' ' B' ' 82' ' ' MET . . . -64.33 144.77 48.97 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.049 -0.596 . . . . 0.65000000000000002 112.426 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.35 146.73 51.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.455 -0.202 . . . . 1.8100000000000001 110.455 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' B' ' 7' ' ' TRP . 47.3 ttp180 -91.71 134.18 34.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.276 -0.42 . . . . 2.4900000000000002 110.108 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 94.9 mt -89.97 -63.84 1.22 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.438 -0.346 . . . . 0.76000000000000001 111.598 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -161.32 -173.84 4.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.55 -0.296 . . . . 1.0700000000000001 110.387 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' B' ' 4' ' ' GLY . 43.2 ttt85 -121.04 115.67 23.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.391 -0.368 . . . . 2.0499999999999998 110.705 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.659 ' HB ' HD11 ' B' ' 6' ' ' ILE . 9.4 p -75.03 136.69 72.91 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.939 -0.573 . . . . 1.45 109.61 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.652 ' HG2' HG21 ' B' ' 64' ' ' VAL . 90.7 Cg_exo -47.92 144.58 11.53 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.071 2.514 . . . . 1.03 112.922 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -33.32 68.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.66 -0.7 . . . . 2.1400000000000001 111.96 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -26.84 68.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.122 0.487 . . . . 1.78 111.128 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.416 ' HB ' HG22 ' B' ' 93' ' ' VAL . 30.0 mm -89.34 -37.03 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 1.3300000000000001 109.647 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 18.3 tpt -65.74 -30.34 70.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 2.3399999999999999 110.564 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -59.08 -34.14 71.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.794 -0.639 . . . . 1.9099999999999999 110.221 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.71 -44.48 90.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.939 -0.573 . . . . 1.76 109.687 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 34.9 t -59.55 -44.88 94.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.492 -0.776 . . . . 1.01 110.816 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.3 -40.35 85.93 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.117 0.484 . . . . 1.29 110.596 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.36 -39.13 94.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.934 -0.65 . . . . 1.02 111.886 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -67.55 -36.9 81.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.897 0.379 . . . . 1.8500000000000001 110.363 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.601 ' O ' HG12 ' B' ' 108' ' ' ILE . 68.5 mt -65.59 -21.59 66.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.935 -0.575 . . . . 1.9399999999999999 111.27 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 24.7 m -76.51 -14.32 60.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.008 0.433 . . . . 1.1599999999999999 111.168 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.491 ' HB ' ' HE1' ' B' ' 57' ' ' PHE . 3.0 m -93.3 -7.81 43.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.305 -0.407 . . . . 1.45 112.051 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.601 HG12 ' O ' ' B' ' 105' ' ' LEU . 13.1 pt -81.64 -21.01 10.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.959 0.409 . . . . 1.98 110.866 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 94.6 mt -94.07 47.5 1.21 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 1.3600000000000001 110.711 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.419 ' OXT' ' HG3' ' A' ' 30' ' ' PRO . 1.8 m . . . . . 0 C--O 1.255 1.372 0 CA-C-O 118.267 -0.873 . . . . 2.1299999999999999 110.235 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.614 0 C3'-C2'-C1' 100.817 -0.759 . 0.0 '__' . 6.3600000000000003 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' ' U' . . . . . 0.587 ' O4 ' ' HA3' ' A' ' 56' ' ' GLY . . . . . . . . 0 O4'--C1' 1.402 -0.967 0 C4'-C3'-C2' 104.761 2.061 OUTLIER-DELTA 0.0 OUTLIER . 2.9900000000000002 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' ' A' . . . . . 0.652 ' C2 ' ' HD2' ' A' ' 73' ' ' ARG . . . . . . . . 0 O5'--C5' 1.428 -0.765 0 C4'-C3'-C2' 104.444 1.744 . 0.0 OUTLIER . 2.5899999999999999 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' ' C' . . . . . 0.862 HO2' ' H2 ' ' C' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.405 -0.787 0 C4'-C3'-C2' 104.943 2.243 OUTLIER-DELTA 0.0 OUTLIER . 2.5099999999999998 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' ' A' . . . . . 0.862 ' H2 ' HO2' ' C' ' 4' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.81 0 C4'-C3'-C2' 103.57 0.87 . 0.0 OUTLIER . 4.9400000000000004 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 8.0 ptp . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 121.337 0.589 . . . . 1.29 111.149 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -106.73 177.86 4.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.417 -0.81 . . . . 2.0099999999999998 111.039 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.496 ' NH2' ' HD3' ' A' ' 30' ' ' PRO . 9.1 ttm180 -80.93 124.33 29.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.829 -0.623 . . . . 1.8500000000000001 109.986 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.73 7.04 42.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.685 -0.769 . . . . 0.85999999999999999 112.803 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.53 ' OE2' ' HD2' ' A' ' 89' ' ' ARG . 66.4 mt-10 -94.74 151.18 19.47 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.614 -0.345 . . . . 0.98999999999999999 111.114 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.666 HD11 ' HG2' ' A' ' 91' ' ' GLU . 17.3 pt -110.35 113.92 45.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.111 0.481 . . . . 1.1599999999999999 110.191 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.439 ' C ' ' HA ' ' A' ' 24' ' ' PRO . 22.4 m95 -106.82 118.43 36.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.924 -0.58 . . . . 0.91000000000000003 111.779 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.2 tp -72.89 104.54 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.954 -0.566 . . . . 0.90000000000000002 110.47 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -144.63 161.13 14.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.304 -0.407 . . . . 1.04 110.865 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.3 t -96.96 130.02 44.34 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.887 -0.782 . . . . 1.3200000000000001 108.887 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.17 4.51 52.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.813 0.34 . . . . 1.29 111.17 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.494 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 6.2 m-20 -79.8 162.87 60.99 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.845 -0.616 . . . . 1.54 110.957 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 21.6 Cg_exo -66.48 144.58 68.15 Favored 'Cis proline' 0 C--N 1.351 0.7 0 C-N-CA 124.264 -1.14 . . . . 1.6899999999999999 112.588 0.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 20' ' ' GLN . 3.1 p -109.81 135.94 49.91 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.886 -0.597 . . . . 1.3600000000000001 112.045 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.64 117.45 31.94 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.044 -0.525 . . . . 1.7 110.2 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.99 -120.99 7.51 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.721 -0.752 . . . . 1.1799999999999999 112.543 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -109.73 36.52 2.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.734 0.302 . . . . 2.7799999999999998 111.393 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -68.54 173.68 4.83 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.69 -0.485 . . . . 1.1399999999999999 109.69 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.566 ' HG2' ' HB3' ' A' ' 44' ' ' PRO . 6.7 tp-100 -71.1 91.36 0.9 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.978 0.418 . . . . 2.0899999999999999 111.399 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.692 ' HB2' " H3'" ' C' ' 5' ' ' ' A' . 0.6 OUTLIER -94.12 152.74 18.53 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.658 -0.701 . . . . 2.0899999999999999 111.489 -179.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.04 168.85 16.51 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.957 -0.639 . . . . 1.0700000000000001 113.234 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.7 m -111.85 112.07 23.47 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.755 -0.461 . . . . 1.1100000000000001 109.755 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.37 159.97 37.83 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.265 -0.425 . . . . 1.6200000000000001 110.348 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HB2' ' HB ' ' A' ' 6' ' ' ILE . 11.3 Cg_exo -72.34 99.27 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.496 2.13 . . . . 1.01 110.916 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.485 HG12 ' HA ' ' A' ' 44' ' ' PRO . 17.0 m -80.12 142.28 14.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.232 -0.44 . . . . 0.76000000000000001 110.345 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.539 ' HB3' HG23 ' A' ' 43' ' ' VAL . 34.6 tp -84.98 126.02 33.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.252 -0.431 . . . . 0.69999999999999996 111.17 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.42 HD13 HG12 ' A' ' 42' ' ' VAL . 17.7 mm -78.86 114.98 20.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.382 -0.599 . . . . 0.92000000000000004 109.382 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.407 HG11 HD11 ' A' ' 105' ' ' LEU . 16.8 t -92.47 -22.85 5.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.935 0.398 . . . . 0.94999999999999996 111.659 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.87 152.03 68.33 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 111.791 0.293 . . . . 1.1200000000000001 111.791 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.66 ' HG2' ' HB2' ' A' ' 33' ' ' PHE . 38.2 Cg_endo -67.28 160.86 45.66 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.805 2.337 . . . . 1.3 111.736 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.45 -38.54 66.46 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.608 0.596 . . . . 1.3899999999999999 112.608 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.454 ' O ' HG12 ' A' ' 36' ' ' VAL . . . -66.55 -44.55 82.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.415 -0.357 . . . . 1.6100000000000001 111.569 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.729 ' HZ ' ' HB2' ' B' ' 75' ' ' ASP . 5.6 t80 -60.42 -37.7 81.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.039 0.447 . . . . 1.77 111.055 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.415 ' OD1' ' HB3' ' A' ' 40' ' ' PRO . 52.5 m-20 -67.49 -9.87 46.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.669 -0.696 . . . . 1.48 111.386 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 35' ' ' ARG . 36.8 ttp180 -112.08 -51.77 2.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.298 -0.41 . . . . 2.6200000000000001 111.588 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 32' ' ' ALA . 10.4 p -65.23 -47.74 86.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.294 0.479 . . . . 1.8600000000000001 112.294 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -88.62 -29.87 19.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.637 0.256 . . . . 1.72 110.94 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.433 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 9.3 ttt180 73.96 -10.74 1.06 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.802 -0.636 . . . . 4.4500000000000002 111.962 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.3 mt -108.51 99.03 31.1 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.286 -0.415 . . . . 1.8100000000000001 110.261 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.539 ' HD2' ' O ' ' A' ' 80' ' ' ILE . 3.0 Cg_endo -87.63 135.68 3.61 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.004 2.469 . . . . 1.05 112.785 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.67 HG22 HG23 ' A' ' 79' ' ' THR . 44.2 t -80.49 113.4 19.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.018 -1.475 . . . . 1.03 107.018 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.42 HG12 HD13 ' A' ' 27' ' ' ILE . 32.1 m -116.91 152.82 18.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 112.909 0.707 . . . . 0.77000000000000002 112.909 -178.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.539 HG23 ' HB3' ' A' ' 26' ' ' LEU . 5.2 m -115.94 131.08 23.91 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 114.91 -1.041 . . . . 0.71999999999999997 108.441 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HB3' ' HG2' ' A' ' 19' ' ' GLN . 58.4 Cg_endo -71.46 172.81 13.48 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.753 2.302 . . . . 1.03 114.449 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.3 t -137.43 135.35 46.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 114.665 -1.152 . . . . 1.28 108.135 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.748 ' HB ' ' C2 ' ' C' ' 3' ' ' ' A' . 2.1 p -138.02 179.72 6.27 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.552 0.204 . . . . 1.9099999999999999 111.552 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.5 t -79.21 -85.02 0.08 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.254 -0.43 . . . . 2.5299999999999998 111.453 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.41 4.42 43.62 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.88 -0.888 . . . . 3.3599999999999999 110.88 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.47 -113.78 5.3 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.152 -0.546 . . . . 3.8300000000000001 112.342 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -96.43 -2.18 45.99 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.722 0.296 . . . . 4.7199999999999998 111.221 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -91.05 45.53 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.008 0.432 . . . . 6.2400000000000002 111.414 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.06 61.76 5.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.293 0.568 . . . . 2.5899999999999999 110.591 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.05 175.85 13.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.672 -0.694 . . . . 4.5899999999999999 110.38 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.434 HG23 HG12 ' A' ' 59' ' ' VAL . 10.6 m -67.62 122.34 17.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.931 0.396 . . . . 2.6899999999999999 111.351 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -141.98 101.4 3.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.733 -0.667 . . . . 3.1699999999999999 110.253 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.82 -100.91 0.73 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.052 -0.594 . . . . 1.6599999999999999 112.772 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -103.22 -13.53 16.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.968 0.413 . . . . 1.5600000000000001 111.022 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.84 109.71 19.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.2 -0.455 . . . . 1.25 109.81 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.434 HG12 HG23 ' A' ' 54' ' ' THR . 13.7 m -101.19 139.34 22.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.058 0.456 . . . . 1.6799999999999999 111.592 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 p -86.78 144.39 27.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.192 -0.458 . . . . 1.95 110.544 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.0 mt -84.88 -8.82 58.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 1.23 110.872 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -67.56 131.64 46.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.821 -0.627 . . . . 2.21 109.928 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.99 -39.28 1.93 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.662 -0.575 . . . . 1.1499999999999999 111.662 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -93.7 -8.13 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.758 0.313 . . . . 1.21 111.03 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.89 98.26 0.24 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.855 -0.688 . . . . 1.0800000000000001 112.765 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 13.3 pt -122.26 165.69 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.815 0.34 . . . . 1.0700000000000001 111.143 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -91.94 -44.1 9.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.093 -0.503 . . . . 3.5899999999999999 110.398 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.04 -164.1 0.42 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.136 -0.483 . . . . 1.51 112.019 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.5 m -153.0 143.37 22.53 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.18 -0.304 . . . . 1.79 110.18 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.98 166.67 11.77 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.065 -0.588 . . . . 1.1799999999999999 111.777 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.472 HG11 ' H61' ' C' ' 3' ' ' ' A' . 8.4 p -105.9 139.73 26.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.558 0.179 . . . . 1.5600000000000001 110.569 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -72.38 126.84 33.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.752 0.31 . . . . 1.29 110.316 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.559 ' HB2' ' HG2' ' A' ' 44' ' ' PRO . 55.8 mmm-85 -104.91 92.62 4.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.078 -0.51 . . . . 2.23 111.63 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.8 m -88.18 4.89 43.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.993 -0.549 . . . . 1.1699999999999999 110.087 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.15 -14.44 38.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.624 -0.716 . . . . 0.89000000000000001 111.967 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -129.42 64.24 70.63 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 113.295 0.85 . . . . 2.1299999999999999 113.295 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.43 134.76 23.15 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.201 1.934 . . . . 0.80000000000000004 110.035 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' B' ' 78' ' ' ARG . 2.4 ptm85 -154.74 145.68 22.6 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.109 0.781 . . . . 2.0899999999999999 113.109 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.67 HG23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -96.41 115.02 26.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.37 -0.832 . . . . 1.6200000000000001 109.502 178.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.539 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 1.7 pp -133.78 138.85 49.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.995 -0.372 . . . . 1.1499999999999999 109.995 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.527 ' HB3' ' HA3' ' B' ' 16' ' ' GLY . 21.1 t70 -69.08 118.38 11.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.99 0.424 . . . . 1.03 111.212 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 57.7 tpp -87.47 -13.64 42.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.861 -0.608 . . . . 1.29 111.148 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -71.18 -53.37 14.71 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.162 0.43 . . . . 2.6400000000000001 112.162 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.17 -25.12 59.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.929 0.395 . . . . 1.1200000000000001 111.888 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 65.7 mtt-85 -82.35 -48.91 10.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.226 -0.443 . . . . 1.0600000000000001 111.799 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.74 114.8 0.21 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.623 -0.798 . . . . 1.1200000000000001 112.474 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -129.61 163.25 22.74 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.812 -0.709 . . . . 1.0900000000000001 112.189 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -103.92 129.15 51.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.164 -0.31 . . . . 2.46 110.164 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.53 ' HD2' ' OE2' ' A' ' 5' ' ' GLU . 2.5 ttp180 -85.64 115.18 23.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.738 0.304 . . . . 2.4900000000000002 110.765 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -86.14 -71.84 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.415 -0.357 . . . . 1.29 110.719 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.666 ' HG2' HD11 ' A' ' 6' ' ' ILE . 3.2 pt-20 -149.29 -169.32 3.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.137 -0.483 . . . . 1.1499999999999999 109.724 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -135.04 143.01 46.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.749 0.309 . . . . 1.3200000000000001 110.444 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.3 m -83.45 153.65 65.45 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.267 -0.424 . . . . 0.75 111.305 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.39 157.94 33.7 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.753 2.302 . . . . 0.94999999999999996 111.467 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.79 -27.16 67.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.689 0.28 . . . . 1.51 111.621 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.24 -45.97 85.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.282 -0.417 . . . . 1.5700000000000001 110.575 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.8 mm -66.32 -40.75 87.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.953 -0.567 . . . . 1.3100000000000001 110.007 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 9.5 tpt -62.29 -38.82 90.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.863 -0.608 . . . . 1.6000000000000001 110.486 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -64.56 -34.22 77.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.968 -0.56 . . . . 2.2999999999999998 111.193 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.5 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 6.4 tp10 -64.12 -48.87 74.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.908 -0.587 . . . . 1.6399999999999999 110.386 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.6 t -59.28 -43.23 89.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.157 -0.474 . . . . 1.03 110.609 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.78 -34.59 78.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.846 -0.616 . . . . 1.22 111.429 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.94 -27.6 66.37 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.245 -0.502 . . . . 1.03 113.077 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 9.8 mmt180 -77.04 -33.29 57.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.125 0.488 . . . . 1.72 110.553 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 89.9 mt -66.19 -30.91 71.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.935 -0.575 . . . . 1.02 111.69 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -27.95 68.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.873 0.368 . . . . 1.1100000000000001 111.299 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 m -72.85 -31.0 64.44 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.086 0.402 . . . . 1.5 112.086 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.4 pt -86.07 -3.32 8.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.464 0.542 . . . . 1.1499999999999999 112.464 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 105' ' ' LEU . 84.3 mt -85.04 69.88 10.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.859 0.362 . . . . 0.97999999999999998 110.159 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.373 -0.376 . . . . 1.3500000000000001 111.935 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' B' ' 27' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 121.213 0.53 . . . . 2.0299999999999998 112.147 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.52 ' HB3' ' HG3' ' B' ' 5' ' ' GLU . 3.2 mm-40 -85.46 9.69 15.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.086 0.47 . . . . 2.8199999999999998 110.198 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' B' ' 2' ' ' GLU . 0.0 OUTLIER 81.76 58.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.118 -0.946 . . . . 2.3199999999999998 113.207 179.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.501 ' O ' ' HG3' ' B' ' 92' ' ' ARG . . . 69.94 57.64 6.89 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.593 -0.731 . . . . 1.28 114.321 178.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.52 ' HG3' ' HB3' ' B' ' 2' ' ' GLU . 5.5 mm-40 -115.98 117.45 30.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.863 0.331 . . . . 1.53 111.674 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.53 HD12 ' HG3' ' B' ' 91' ' ' GLU . 66.6 mt -99.78 120.06 48.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 0.75 109.798 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -114.74 144.77 42.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.428 -0.351 . . . . 0.81000000000000005 110.693 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.404 ' HB2' HD11 ' B' ' 90' ' ' LEU . 38.0 tp -105.8 117.1 33.16 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.221 -0.445 . . . . 1.05 110.0 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.408 HG22 ' H ' ' B' ' 10' ' ' SER . 9.5 p -158.89 167.54 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.71999999999999997 110.244 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' B' ' 22' ' ' THR . 7.0 m -88.88 137.64 32.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.851 0.358 . . . . 1.6299999999999999 110.54 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.605 HD21 HG11 ' B' ' 25' ' ' VAL . 55.7 mt -85.09 -21.36 29.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.323 -0.399 . . . . 0.82999999999999996 110.999 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . 0.459 ' HA ' ' N ' ' B' ' 14' ' ' THR . 3.7 m-20 -60.19 153.29 58.25 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.862 -0.608 . . . . 1.6200000000000001 110.829 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.02 120.64 5.84 Favored 'Cis proline' 0 C--O 1.235 0.341 0 C-N-CA 123.534 -1.444 . . . . 1.28 113.741 0.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.459 ' N ' ' HA ' ' B' ' 12' ' ' ASP . 0.1 OUTLIER -121.11 146.68 46.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.297 -0.865 . . . . 1.47 108.95 179.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.07 -177.79 5.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.913 0.387 . . . . 1.22 111.979 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.527 ' HA3' ' HB3' ' A' ' 81' ' ' ASP . . . 60.79 -106.03 0.98 Allowed Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.006 -0.543 . . . . 1.01 113.34 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . 0.405 ' H ' ' HB2' ' A' ' 81' ' ' ASP . 10.2 t-160 -115.89 8.49 14.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.845 0.355 . . . . 2.1800000000000002 110.365 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.418 ' HB3' HG22 ' B' ' 14' ' ' THR . 14.7 mt-10 -71.04 148.92 47.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 1.28 110.132 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -77.73 107.24 10.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.48 -0.327 . . . . 1.52 111.013 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.457 ' HA ' ' OG1' ' B' ' 14' ' ' THR . 91.2 mt-30 -83.31 164.97 19.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.012 -0.54 . . . . 1.8600000000000001 111.675 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.72 -169.75 28.84 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.01 -0.615 . . . . 0.90000000000000002 113.625 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' B' ' 10' ' ' SER . 35.8 m -108.24 119.99 41.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.654 -0.498 . . . . 0.94999999999999996 109.654 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.446 ' HD3' HD12 ' B' ' 11' ' ' LEU . 0.1 OUTLIER -146.63 154.34 48.13 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.192 -0.458 . . . . 1.5900000000000001 110.487 -179.317 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -63.28 135.91 52.8 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.46 2.107 . . . . 0.65000000000000002 110.72 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.758 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 14.2 m -132.85 151.56 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.174 0.512 . . . . 0.56999999999999995 111.425 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 mp -109.42 122.35 47.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.682 -0.69 . . . . 1.1699999999999999 109.918 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . 0.507 ' O ' ' HG2' ' B' ' 1' ' ' MET . 43.8 mt -70.08 120.23 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.697 0.284 . . . . 0.66000000000000003 110.827 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.734 ' HB ' HG23 ' B' ' 41' ' ' VAL . 18.4 t -79.33 -40.93 22.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.051 -0.522 . . . . 0.93000000000000005 111.519 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.9 146.19 95.07 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.973 -0.558 . . . . 0.81000000000000005 111.455 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.79 164.16 34.17 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.752 2.302 . . . . 0.78000000000000003 112.591 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.46 -40.57 71.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.496 -0.775 . . . . 1.03 111.807 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.01 0.84 4.02 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.702 0.63 . . . . 1.3999999999999999 112.702 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -119.31 -40.9 2.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.208 0.528 . . . . 1.5700000000000001 109.736 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.17 -32.97 70.38 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.517 -0.765 . . . . 1.6399999999999999 111.863 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.52 2.84 55.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.132 -0.485 . . . . 2.54 112.261 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 64.2 t -113.27 -46.13 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.924 0.392 . . . . 1.0900000000000001 110.421 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . 0.642 HG23 ' C6 ' ' C' ' 2' ' ' ' U' . 10.3 m -87.09 -24.26 24.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.349 0.595 . . . . 1.3300000000000001 110.1 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.861 ' HE ' ' HA ' ' B' ' 38' ' ' ARG . 0.6 OUTLIER 75.16 -38.1 0.36 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.848 1.055 . . . . 1.78 113.848 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 89.7 mt -99.59 101.84 14.75 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.978 -0.379 . . . . 1.1599999999999999 109.978 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' B' ' 38' ' ' ARG . 90.1 Cg_endo -94.12 163.69 2.08 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.907 2.404 . . . . 0.56999999999999995 113.889 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.734 HG23 ' HB ' ' B' ' 28' ' ' VAL . 1.8 m -96.13 138.35 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.782 -0.821 . . . . 1.0800000000000001 108.782 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.758 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 17.8 m -126.09 150.12 31.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 113.205 0.817 . . . . 0.64000000000000001 113.205 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.441 HG23 HG22 ' B' ' 28' ' ' VAL . 24.4 t -97.62 111.74 59.51 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.022 -0.99 . . . . 1.1000000000000001 108.835 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.658 ' HA ' HG12 ' B' ' 25' ' ' VAL . 11.8 Cg_exo -70.93 127.83 14.17 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.9 2.4 . . . . 0.72999999999999998 112.722 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.652 HG22 HG12 ' B' ' 72' ' ' VAL . 61.8 t -99.98 133.45 42.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.055 -0.521 . . . . 0.90000000000000002 109.887 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -98.17 92.1 5.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.34 -0.391 . . . . 1.1699999999999999 110.489 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.77 152.94 26.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.011 -0.541 . . . . 1.8500000000000001 110.602 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 160.99 -59.36 0.3 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.483 -0.865 . . . . 2.2200000000000002 111.82 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.19 168.94 30.21 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.552 -0.832 . . . . 3.4300000000000002 111.692 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -111.24 26.15 10.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.128 0.489 . . . . 4.6200000000000001 110.521 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -72.92 -43.0 62.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.798 -0.637 . . . . 6.2699999999999996 110.074 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.4 113.98 24.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.873 -0.603 . . . . 4.3899999999999997 109.539 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.08 -42.32 11.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.133 0.492 . . . . 3.9199999999999999 110.875 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 1.5 t -148.47 120.95 8.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.365 0.602 . . . . 2.75 111.549 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.87 78.53 1.77 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.691 -0.686 . . . . 1.96 110.411 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.64 -88.3 0.36 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.124 -0.56 . . . . 1.0800000000000001 112.732 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -104.95 -17.06 14.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.969 0.414 . . . . 3.5699999999999998 110.045 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.594 ' HB1' ' HB ' ' B' ' 71' ' ' VAL . . . -82.64 120.0 25.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.862 -0.608 . . . . 1.0800000000000001 111.566 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 t -119.8 134.55 62.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.069 -0.715 . . . . 1.3400000000000001 109.069 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 37.5 p -76.26 135.79 39.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.667 0.27 . . . . 1.3799999999999999 111.234 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 77.9 mt -89.72 -0.96 57.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.157 0.503 . . . . 1.02 110.626 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.65 148.2 28.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.958 -0.565 . . . . 1.79 111.152 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.4 -38.1 3.47 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.913 -0.66 . . . . 1.1499999999999999 112.336 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 10.8 p -81.36 -26.28 10.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.749 0.278 . . . . 1.1699999999999999 111.749 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.05 22.93 3.4 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.435 -0.888 . . . . 1.05 113.362 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 61.4 mt -90.61 138.51 19.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.541 -0.54 . . . . 1.6100000000000001 109.541 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . 0.402 ' HD2' HH11 ' B' ' 67' ' ' ARG . 28.0 ttt85 -68.31 -42.48 79.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.004 0.43 . . . . 2.3999999999999999 110.704 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 16.5 m -68.12 97.47 0.7 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.536 -0.756 . . . . 0.93000000000000005 110.957 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.6 97.61 10.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.923 -0.581 . . . . 1.3100000000000001 111.432 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.65 -179.75 46.35 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.739 -0.744 . . . . 0.79000000000000004 111.702 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.594 ' HB ' ' HB1' ' B' ' 58' ' ' ALA . 8.5 m -105.81 136.49 39.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.705 0.288 . . . . 0.93000000000000005 110.8 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.652 HG12 HG22 ' B' ' 45' ' ' VAL . 10.0 m -84.27 137.28 21.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.961 0.41 . . . . 1.3799999999999999 111.478 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 32.9 mmm-85 -113.32 85.97 2.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.191 -0.459 . . . . 1.3700000000000001 110.114 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 5.2 m -82.12 6.3 16.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.184 -0.462 . . . . 1.1599999999999999 111.266 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.729 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 10.1 p-10 -87.43 -10.47 51.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.863 -0.608 . . . . 1.1000000000000001 111.56 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -135.29 78.34 52.13 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 112.896 0.702 . . . . 2.4700000000000002 112.896 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.89 98.99 0.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.737 2.291 . . . . 0.95999999999999996 111.729 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 12.2 ttt180 -102.64 140.68 36.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.381 -0.372 . . . . 1.96 111.497 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.511 HG23 HG13 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -76.03 125.74 29.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 1.1899999999999999 109.67 178.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.416 ' O ' ' HD2' ' B' ' 40' ' ' PRO . 26.8 pt -131.32 -179.7 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.454 -0.339 . . . . 1.28 110.189 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.401 ' O ' ' HD2' ' B' ' 85' ' ' ARG . 7.0 t70 -97.52 139.86 32.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.368 . . . . 1.28 110.867 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' MET . . . . . 0.429 ' SD ' ' HA3' ' B' ' 87' ' ' GLY . 35.6 tpp -126.03 29.74 5.81 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.395 -0.594 . . . . 2.7000000000000002 109.395 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -121.14 -55.93 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.703 -0.68 . . . . 1.96 111.352 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.53 -33.96 15.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.133 -0.485 . . . . 1.0600000000000001 110.653 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.401 ' HD2' ' O ' ' B' ' 81' ' ' ASP . 75.3 mtt180 -63.94 -23.05 67.19 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.863 -0.608 . . . . 1.47 111.428 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.0 90.38 0.83 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.94 -0.648 . . . . 0.81999999999999995 112.623 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . 0.429 ' HA3' ' SD ' ' B' ' 82' ' ' MET . . . -96.89 133.13 11.27 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.532 -0.842 . . . . 0.65000000000000002 112.253 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -139.04 130.29 26.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.6 0.238 . . . . 1.8100000000000001 110.818 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -83.08 127.93 34.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.471 -0.332 . . . . 2.4900000000000002 110.268 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' B' ' 8' ' ' LEU . 94.3 mt -91.14 -72.62 0.57 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.188 -0.46 . . . . 0.76000000000000001 111.557 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . 0.53 ' HG3' HD12 ' B' ' 6' ' ' ILE . 16.8 pt-20 -133.42 169.93 16.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.094 -0.503 . . . . 1.0700000000000001 110.722 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' B' ' 4' ' ' GLY . 15.2 ttm180 -104.48 141.62 36.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.183 -0.462 . . . . 2.0499999999999998 110.193 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' B' ' 94' ' ' PRO . 60.3 t -83.1 132.38 50.76 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.906 -0.588 . . . . 1.45 110.68 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' B' ' 93' ' ' VAL . 31.6 Cg_exo -62.64 155.74 57.06 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.601 2.2 . . . . 1.03 110.758 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.28 -38.92 74.69 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.321 0.489 . . . . 2.1400000000000001 112.321 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.95 -39.21 88.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.974 0.416 . . . . 1.78 111.12 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 30.0 mm -82.47 -32.02 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.158 -0.474 . . . . 1.3300000000000001 110.434 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 12.7 tpt -58.66 -45.04 90.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 2.3399999999999999 110.239 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -64.57 -35.07 79.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.998 -0.546 . . . . 1.9099999999999999 110.302 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 11.1 tp10 -60.06 -44.47 94.69 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.771 -0.649 . . . . 1.76 109.959 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' B' ' 105' ' ' LEU . 55.9 t -60.99 -44.85 99.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.039 -0.528 . . . . 1.01 110.197 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.44 -42.0 90.92 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.048 -0.524 . . . . 1.29 110.559 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.79 -42.8 98.41 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.433 -0.667 . . . . 1.02 111.433 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 12.3 mmt180 -63.97 -32.74 74.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.038 0.447 . . . . 1.8500000000000001 110.793 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' B' ' 101' ' ' VAL . 93.8 mt -68.91 -20.91 64.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.021 -0.536 . . . . 1.9399999999999999 110.815 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 5.7 m -86.06 -24.73 26.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.159 -0.473 . . . . 1.1599999999999999 109.944 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.1 m -68.29 -37.41 80.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 1.45 111.214 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.44 HG21 ' HA ' ' B' ' 75' ' ' ASP . 39.2 pt -76.43 0.23 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.333 -0.394 . . . . 1.98 112.036 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 96.3 mt -91.26 10.26 27.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.922 0.391 . . . . 1.3600000000000001 110.967 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.792 -0.623 . . . . 2.1299999999999999 110.219 179.903 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.699 0 C1'-C2'-O2' 108.616 -0.661 . 0.0 '__' . 6.3600000000000003 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' ' U' . . . . . 0.642 ' C6 ' HG23 ' B' ' 37' ' ' THR . . . . . . . . 0 O5'--C5' 1.426 -0.884 0 C4'-C3'-C2' 104.484 1.784 . 0.0 OUTLIER . 2.9900000000000002 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' ' A' . . . . . 0.748 ' C2 ' ' HB ' ' A' ' 46' ' ' THR . . . . . . . . 0 C3'--C2' 1.538 1.201 0 C4'-C3'-C2' 105.703 3.003 OUTLIER-DELTA 0.0 OUTLIER . 2.5899999999999999 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' ' C' . . . . . 0.41 H5'' HG22 ' A' ' 46' ' ' THR . . . . . . . . 0 O5'--C5' 1.428 -0.778 0 N19-C1'-C2' 114.955 0.972 . 0.0 OUTLIER zeta-1 2.5099999999999998 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' ' A' . . . . . 0.692 " H3'" ' HB2' ' A' ' 20' ' ' GLN . . . . . . . . 0 O4'--C1' 1.402 -0.985 0 C4'-C3'-C2' 104.965 2.265 . 0.0 OUTLIER gamma 4.9400000000000004 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.565 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 23.4 ptp . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 120.814 0.34 . . . . 1.29 110.883 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.404 ' HG2' ' HB2' ' A' ' 31' ' ' ALA . 39.6 mt-10 -124.96 169.72 11.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.106 -0.497 . . . . 2.0099999999999998 110.612 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.496 ' NH2' ' HD3' ' A' ' 30' ' ' PRO . 24.2 ttm180 -71.52 128.01 34.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.909 -0.587 . . . . 1.8500000000000001 109.671 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.409 ' HA3' ' NH2' ' A' ' 92' ' ' ARG . . . 104.11 -6.04 46.51 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.622 -0.799 . . . . 0.85999999999999999 112.492 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 57.5 mt-10 -79.92 147.68 31.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.877 0.37 . . . . 0.98999999999999999 110.782 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.469 HD12 ' HG3' ' A' ' 91' ' ' GLU . 59.5 mt -109.88 119.91 59.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.178 -0.465 . . . . 1.1599999999999999 109.86 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.415 ' CZ2' ' HB3' ' A' ' 1' ' ' MET . 21.2 m95 -114.93 149.9 36.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.012 -0.54 . . . . 0.91000000000000003 110.782 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.0 tp -106.01 118.39 36.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.776 -0.193 . . . . 0.90000000000000002 110.491 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 p -166.14 148.95 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 120.948 0.404 . . . . 1.04 110.814 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.7 OUTLIER -77.17 141.66 40.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.356 -0.384 . . . . 1.3200000000000001 110.607 179.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.484 HD21 HG11 ' A' ' 25' ' ' VAL . 69.2 mt -97.58 4.11 50.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.157 0.503 . . . . 1.29 111.252 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.845 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -72.08 179.9 0.92 Allowed Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.642 -0.708 . . . . 1.54 110.302 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.845 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 5.8 Cg_exo -79.65 134.89 32.76 Favored 'Cis proline' 0 C--N 1.354 0.822 0 CA-C-N 119.736 0.942 . . . . 1.6899999999999999 112.62 0.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 20' ' ' GLN . 58.2 p -108.14 155.41 20.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.663 -0.699 . . . . 1.3600000000000001 111.144 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.2 102.56 5.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.138 -0.69 . . . . 1.7 109.138 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.37 -116.21 3.87 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.505 -1.438 . . . . 1.1799999999999999 109.505 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.46 ' HB3' ' HD2' ' B' ' 83' ' ' LYS . 77.0 t60 -134.06 78.55 1.77 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.065 0.459 . . . . 2.7799999999999998 111.75 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 33.6 mt-10 -110.59 -149.32 0.44 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.791 -0.818 . . . . 1.1399999999999999 108.791 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -82.58 53.77 2.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.312 0.577 . . . . 2.0899999999999999 110.007 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.474 ' HG2' ' H ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -68.31 128.77 37.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.294 -0.866 . . . . 2.0899999999999999 112.006 -179.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.558 ' HA2' ' C8 ' ' C' ' 5' ' ' ' A' . . . 113.99 146.84 9.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.83 -0.7 . . . . 1.0700000000000001 113.445 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 21.2 m -79.31 121.1 24.68 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.715 -0.476 . . . . 1.1100000000000001 109.715 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.493 HH22 " H3'" ' C' ' 3' ' ' ' A' . 0.0 OUTLIER -145.48 161.51 40.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.437 -0.347 . . . . 1.6200000000000001 110.354 -179.224 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.32 145.75 60.67 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.104 1.87 . . . . 1.01 110.289 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.729 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 15.1 m -128.75 140.12 50.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.42 -0.354 . . . . 0.76000000000000001 110.55 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.487 ' HB3' HG23 ' A' ' 43' ' ' VAL . 42.1 tp -95.04 128.64 42.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.034 -0.53 . . . . 0.69999999999999996 110.822 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.13 109.34 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.801 -0.444 . . . . 0.92000000000000004 109.801 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.59 HG11 HD11 ' A' ' 105' ' ' LEU . 17.1 t -86.95 -27.91 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 120.997 0.427 . . . . 0.94999999999999996 111.413 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.85 145.41 74.28 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.294 -0.412 . . . . 1.1200000000000001 111.411 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.496 ' HD3' ' NH2' ' A' ' 3' ' ' ARG . 58.2 Cg_endo -71.69 158.91 52.34 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.646 2.231 . . . . 1.3 112.173 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.404 ' HB2' ' HG2' ' A' ' 2' ' ' GLU . . . -53.25 -40.04 64.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.993 -0.549 . . . . 1.3899999999999999 112.206 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.31 -50.18 74.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.331 -0.395 . . . . 1.6100000000000001 111.767 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -63.93 -38.41 90.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.115 0.483 . . . . 1.77 110.885 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 85.2 m-20 -67.53 -20.84 65.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.732 -0.667 . . . . 1.48 111.051 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -91.33 -35.03 14.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.197 -0.456 . . . . 2.6200000000000001 112.003 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.57 -50.3 15.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.693 0.627 . . . . 1.8600000000000001 112.693 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 m -87.38 -31.61 20.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.855 0.359 . . . . 1.72 110.95 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.718 ' HB3' ' HE2' ' A' ' 83' ' ' LYS . 0.7 OUTLIER 66.46 23.38 10.54 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.795 -0.639 . . . . 4.4500000000000002 111.543 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.7 mt -132.35 100.43 15.31 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.442 -0.799 . . . . 1.8100000000000001 109.053 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -89.69 140.45 3.58 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.629 2.219 . . . . 1.05 114.163 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.1 t -90.36 124.37 42.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.221 -1.4 . . . . 1.03 107.221 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.729 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 31.4 m -123.43 163.97 21.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 113.542 0.942 . . . . 0.77000000000000002 113.542 -177.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -122.93 134.56 25.13 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 114.307 -1.315 . . . . 0.71999999999999997 108.686 178.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.11 128.86 10.91 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.927 2.418 . . . . 1.03 114.674 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.786 HG22 HG22 ' A' ' 72' ' ' VAL . 58.0 t -88.6 118.44 34.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.021 -0.733 . . . . 1.28 109.021 178.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -147.44 -167.75 2.87 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.163 -0.31 . . . . 1.9099999999999999 110.163 -179.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.507 ' H ' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -80.97 156.0 26.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.47 0.176 . . . . 2.5299999999999998 110.648 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.55 69.67 0.26 Allowed Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.168 -0.773 . . . . 3.3599999999999999 111.168 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.34 -111.09 3.93 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.352 -1.099 . . . . 3.8300000000000001 110.352 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -106.84 -10.17 16.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.233 0.539 . . . . 4.7199999999999998 109.993 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -133.31 -169.25 2.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.831 -0.622 . . . . 6.2400000000000002 110.11 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.59 65.35 0.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.369 0.604 . . . . 2.5899999999999999 109.466 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 ptt85 -130.52 -177.8 4.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.712 -0.676 . . . . 4.5899999999999999 111.365 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.3 103.21 1.9 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.593 -0.731 . . . . 2.6899999999999999 110.915 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.573 ' H ' ' HB3' ' A' ' 58' ' ' ALA . . . -116.75 90.28 3.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.93 0.395 . . . . 3.1699999999999999 111.007 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.512 ' HA3' ' O4 ' ' C' ' 2' ' ' ' U' . . . 78.57 -99.33 1.6 Allowed Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.911 -0.586 . . . . 1.6599999999999999 113.048 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.504 ' HE2' ' HB ' ' A' ' 107' ' ' THR . 57.8 m-85 -106.34 17.07 23.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.906 0.384 . . . . 1.5600000000000001 111.778 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.573 ' HB3' ' H ' ' A' ' 55' ' ' ALA . . . -81.68 137.39 35.42 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.226 -0.657 . . . . 1.25 109.226 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.609 HG22 ' HB ' ' A' ' 72' ' ' VAL . 16.5 m -88.44 161.16 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.047 0.451 . . . . 1.6799999999999999 111.731 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -84.67 93.5 8.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.988 -0.551 . . . . 1.95 111.641 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.841 HD11 HG23 ' A' ' 72' ' ' VAL . 7.2 mt -87.11 -33.79 19.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.341 -0.39 . . . . 1.23 111.923 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -68.71 114.79 7.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.023 0.439 . . . . 2.21 111.788 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.47 -10.78 5.53 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.652 -0.785 . . . . 1.1499999999999999 113.004 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 61' ' ' LEU . 19.6 m -90.61 -16.11 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 117.224 0.512 . . . . 1.21 111.49 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.88 51.77 7.56 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 121.066 -0.588 . . . . 1.0800000000000001 113.461 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.504 ' HB ' ' OE2' ' A' ' 91' ' ' GLU . 20.1 pt -103.72 -171.73 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.718 0.294 . . . . 1.0700000000000001 111.155 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 54.7 ttm-85 -102.23 -33.65 9.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.103 -0.499 . . . . 3.5899999999999999 110.28 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.487 ' HB ' HD12 ' A' ' 66' ' ' ILE . 21.8 m -55.85 117.55 3.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.412 -0.813 . . . . 1.51 111.132 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.19 109.6 21.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.973 -0.558 . . . . 1.79 110.558 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.931 ' HA3' ' H42' ' C' ' 4' ' ' ' C' . . . 146.72 -165.43 28.41 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.629 -0.795 . . . . 1.1799999999999999 112.115 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 81.6 t -132.69 129.63 58.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.797 0.332 . . . . 1.5600000000000001 110.742 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.841 HG23 HD11 ' A' ' 61' ' ' LEU . 69.9 t -72.18 110.96 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.874 -0.788 . . . . 1.29 108.874 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.597 ' HB3' ' OD2' ' A' ' 75' ' ' ASP . 12.1 mtm-85 -99.68 121.57 41.43 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.326 -0.397 . . . . 2.23 110.516 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 14.4 m -98.57 34.7 1.97 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.274 -0.421 . . . . 1.1699999999999999 110.784 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.597 ' OD2' ' HB3' ' A' ' 73' ' ' ARG . 0.5 OUTLIER -76.53 -60.96 2.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.232 -0.44 . . . . 0.89000000000000001 110.868 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.849 ' HB3' HG21 ' B' ' 79' ' ' THR . 4.3 mm100 -115.51 80.63 8.12 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.291 -0.413 . . . . 2.1299999999999999 111.4 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -84.3 156.16 12.69 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.639 2.226 . . . . 0.80000000000000004 111.118 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -168.32 166.4 12.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.056 0.455 . . . . 2.0899999999999999 111.265 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.461 ' OG1' ' HD2' ' B' ' 77' ' ' PRO . 24.2 m -92.53 145.49 24.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.625 -0.716 . . . . 1.6200000000000001 109.174 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.479 HG21 HD22 ' A' ' 11' ' ' LEU . 26.6 pt -135.3 150.79 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.684 0.278 . . . . 1.1499999999999999 110.529 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.94 142.7 47.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.043 -0.526 . . . . 1.03 110.051 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 35.4 tpp -121.55 5.61 10.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.186 0.517 . . . . 1.29 110.78 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.718 ' HE2' ' HB3' ' A' ' 38' ' ' ARG . 6.0 mptp? -93.43 -46.54 7.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.2 -0.454 . . . . 2.6400000000000001 111.043 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.704 ' HB3' ' HA2' ' B' ' 16' ' ' GLY . . . -93.02 -40.6 10.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.389 -0.369 . . . . 1.1200000000000001 110.47 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -62.31 -57.6 10.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.389 -0.368 . . . . 1.0600000000000001 110.304 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.24 84.94 0.19 Allowed Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.909 -0.662 . . . . 1.1200000000000001 113.505 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.34 172.56 47.22 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.704 -0.76 . . . . 1.0900000000000001 111.867 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -122.29 122.45 39.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.064 -0.346 . . . . 2.46 110.064 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -77.88 137.39 38.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.631 0.253 . . . . 2.4900000000000002 110.937 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 90' ' ' LEU . 2.6 mm? -112.64 -81.05 0.59 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.227 -0.442 . . . . 1.29 110.291 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.504 ' OE2' ' HB ' ' A' ' 66' ' ' ILE . 18.2 pt-20 -131.05 -163.71 1.35 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.221 -0.445 . . . . 1.1499999999999999 110.738 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.409 ' NH2' ' HA3' ' A' ' 4' ' ' GLY . 4.0 ptm180 -147.63 155.19 41.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.564 0.221 . . . . 1.3200000000000001 110.56 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.464 HG13 HD11 ' A' ' 6' ' ' ILE . 26.6 m -103.58 156.36 35.64 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.289 -0.414 . . . . 0.75 111.399 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -69.28 166.88 25.48 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.762 2.308 . . . . 0.94999999999999996 111.73 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -58.82 -24.11 61.47 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.437 -0.347 . . . . 1.51 111.769 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -40.74 87.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.285 -0.416 . . . . 1.5700000000000001 110.825 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.5 mm -71.04 -37.78 69.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 1.3100000000000001 110.186 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.7 tpt -62.0 -37.21 83.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 1.6000000000000001 110.472 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -64.16 -35.59 81.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.071 0.462 . . . . 2.2999999999999998 110.085 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 0.1 OUTLIER -64.59 -44.99 88.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.763 -0.653 . . . . 1.6399999999999999 109.62 178.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.5 t -64.23 -41.26 91.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.714 -0.675 . . . . 1.03 110.597 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.9 mt -55.56 -43.01 75.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.107 -0.497 . . . . 1.22 110.742 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.6 -41.95 98.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.909 -0.662 . . . . 1.03 111.897 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 19.5 mmt180 -62.05 -45.89 91.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.761 0.315 . . . . 1.72 110.529 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.59 HD11 HG11 ' A' ' 28' ' ' VAL . 93.9 mt -62.65 -40.65 97.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.037 -0.529 . . . . 1.02 111.104 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.1 m -70.78 -3.06 16.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 1.1100000000000001 111.596 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.504 ' HB ' ' HE2' ' A' ' 57' ' ' PHE . 24.7 m -105.11 -34.11 8.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.789 0.328 . . . . 1.5 110.806 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.412 ' O ' ' HD3' ' B' ' 30' ' ' PRO . 41.2 pt -79.97 -23.31 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 111.996 0.369 . . . . 1.1499999999999999 111.996 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.0 mt -76.21 81.84 3.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.97999999999999998 111.023 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.755 -0.657 . . . . 1.3500000000000001 109.835 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.609 ' HE3' ' HB ' ' B' ' 27' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.133 0 CA-C-O 121.616 0.722 . . . . 2.0299999999999998 112.736 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.551 ' HG2' ' HB2' ' B' ' 31' ' ' ALA . 37.3 mt-10 -86.59 -19.57 29.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.259 -0.882 . . . . 2.8199999999999998 109.315 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' B' ' 2' ' ' GLU . 8.3 mpt_? 77.82 115.18 0.06 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.913 -1.039 . . . . 2.3199999999999998 112.759 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.23 49.48 4.95 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.879 -0.6 . . . . 1.28 114.128 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.465 ' HB2' ' HE3' ' B' ' 1' ' ' MET . 73.9 mm-40 -126.58 88.33 2.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.58 0.585 . . . . 1.53 112.58 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.849 HD11 ' HB ' ' B' ' 93' ' ' VAL . 60.8 mt -102.21 107.45 21.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.88 -0.785 . . . . 0.75 108.88 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -108.03 160.36 15.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.91 -0.587 . . . . 0.81000000000000005 111.198 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 42.0 tp -111.84 121.47 45.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.914 -0.772 . . . . 1.05 108.914 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.567 HG11 HD13 ' B' ' 80' ' ' ILE . 5.2 p -152.17 157.32 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 120.787 0.327 . . . . 0.71999999999999997 110.536 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 47.6 m -83.13 119.25 24.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.246 -0.433 . . . . 1.6299999999999999 110.083 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.466 HD21 HG11 ' B' ' 25' ' ' VAL . 88.8 mt -72.42 -26.31 61.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.161 -0.472 . . . . 0.82999999999999996 111.071 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.26 149.78 86.34 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.88 -0.6 . . . . 1.6200000000000001 110.497 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.07 140.78 30.95 Favored 'Cis proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.58 -1.425 . . . . 1.28 112.561 0.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.72 129.4 36.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.981 -0.554 . . . . 1.47 109.655 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.88 173.6 6.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.367 -0.379 . . . . 1.22 111.497 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 84' ' ' ALA . . . 70.41 -134.27 24.42 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.643 -0.708 . . . . 1.01 113.271 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -114.28 29.21 8.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.974 0.416 . . . . 2.1800000000000002 110.305 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -83.02 168.53 16.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.752 -0.658 . . . . 1.28 110.664 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -74.15 133.26 42.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.22 0.533 . . . . 1.52 111.962 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -125.02 -178.28 4.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.762 -0.654 . . . . 1.8600000000000001 110.809 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.71 166.92 42.75 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.235 -0.507 . . . . 0.90000000000000002 113.583 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 28.9 m -96.52 110.15 22.6 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.996 -0.742 . . . . 0.94999999999999996 108.996 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.85 162.97 27.7 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.466 -0.334 . . . . 1.5900000000000001 110.246 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.87 141.57 98.18 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.447 2.098 . . . . 0.65000000000000002 111.209 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.762 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 9.7 m -135.11 139.76 46.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.103 -0.498 . . . . 0.56999999999999995 110.654 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 61.3 tp -99.98 121.98 42.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.127 -0.488 . . . . 1.1699999999999999 109.837 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . 0.609 ' HB ' ' HE3' ' B' ' 1' ' ' MET . 16.7 mt -72.26 145.5 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.425 -0.352 . . . . 0.66000000000000003 110.073 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.513 ' HB ' HG23 ' B' ' 41' ' ' VAL . 19.2 t -112.36 -27.72 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 120.8 0.333 . . . . 0.93000000000000005 111.525 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' THR . . . . . 0.527 HG23 HG22 ' B' ' 41' ' ' VAL . 0.2 OUTLIER -69.77 148.16 96.48 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.503 -0.317 . . . . 0.81000000000000005 111.84 -179.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 91.6 Cg_endo -77.62 176.17 10.37 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.962 2.441 . . . . 0.78000000000000003 113.54 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.551 ' HB2' ' HG2' ' B' ' 2' ' ' GLU . . . -66.93 -31.3 71.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.476 -0.784 . . . . 1.03 110.736 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.24 18.37 0.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.944 -0.571 . . . . 1.3999999999999999 110.946 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -137.16 -53.62 0.69 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.033 -0.53 . . . . 1.5700000000000001 110.023 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -57.12 -39.61 75.47 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.99 -0.55 . . . . 1.6399999999999999 111.953 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -92.67 8.27 39.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.23 -0.441 . . . . 2.54 111.59 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 62.7 t -116.01 -64.04 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.284 -0.416 . . . . 1.0900000000000001 111.157 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 37.1 p -78.52 -16.23 57.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.335 0.588 . . . . 1.3300000000000001 110.493 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.661 ' HB2' ' NZ ' ' B' ' 83' ' ' LYS . 0.1 OUTLIER 60.62 29.77 19.25 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.365 -0.834 . . . . 1.78 110.684 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.417 HD12 " H3'" ' C' ' 2' ' ' ' U' . 30.5 mt -143.24 102.74 5.14 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.35 -0.841 . . . . 1.1599999999999999 109.282 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' B' ' 80' ' ' ILE . 96.9 Cg_endo -97.18 149.35 0.94 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.778 2.319 . . . . 0.56999999999999995 113.571 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.527 HG22 HG23 ' B' ' 29' ' ' THR . 16.2 m -97.44 133.68 38.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.58 -1.267 . . . . 1.0800000000000001 107.58 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.762 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 24.9 m -127.18 153.78 36.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 113.981 1.104 . . . . 0.64000000000000001 113.981 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 54.4 t -103.61 119.36 55.0 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 114.43 -1.259 . . . . 1.1000000000000001 108.216 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.556 ' HA ' HG12 ' B' ' 25' ' ' VAL . 46.3 Cg_endo -68.51 126.23 13.88 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.889 2.393 . . . . 0.72999999999999998 113.217 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.763 HG22 HG12 ' B' ' 72' ' ' VAL . 87.8 t -88.89 135.98 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.826 -0.625 . . . . 0.90000000000000002 109.353 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -114.21 96.62 5.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.502 -0.317 . . . . 1.1699999999999999 110.378 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.1 m -68.47 119.87 13.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.026 -0.534 . . . . 1.8500000000000001 110.827 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -110.61 40.88 2.4 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.058 -0.817 . . . . 2.2200000000000002 111.058 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.31 -91.27 0.38 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.019 -0.61 . . . . 3.4300000000000002 111.676 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -131.34 6.84 4.52 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.27 0.557 . . . . 4.6200000000000001 110.611 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -100.87 119.57 38.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.656 -0.702 . . . . 6.2699999999999996 110.073 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.47 92.45 1.77 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.201 -0.454 . . . . 4.3899999999999997 110.817 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' B' ' 53' ' ' ARG . 0.0 OUTLIER -118.22 136.78 53.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.307 -0.406 . . . . 3.9199999999999999 110.931 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 2.4 t -72.35 134.29 45.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.67 -0.695 . . . . 2.75 111.872 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.42 97.79 1.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.764 -0.653 . . . . 1.96 110.469 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.78 -98.43 0.29 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.118 -0.563 . . . . 1.0800000000000001 113.099 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -86.55 -16.21 37.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.825 0.345 . . . . 3.5699999999999998 111.398 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.51 131.45 34.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.311 -0.404 . . . . 1.0800000000000001 110.523 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -113.17 144.24 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 1.3400000000000001 110.143 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -80.62 113.19 18.63 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.06 0.393 . . . . 1.3799999999999999 112.06 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 97.9 mt -88.55 -7.17 56.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.654 0.74 . . . . 1.02 109.016 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -98.07 141.24 31.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.143 -0.935 . . . . 1.79 109.767 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.91 -58.06 0.7 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.723 -0.751 . . . . 1.1499999999999999 112.125 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 p -75.7 -26.85 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.076 0.465 . . . . 1.1699999999999999 111.294 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.93 57.83 0.42 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.473 -0.87 . . . . 1.05 113.287 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 84.9 mt -104.09 143.2 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.919 -0.771 . . . . 1.6100000000000001 108.919 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -65.23 -53.43 44.5 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.81 0.338 . . . . 2.3999999999999999 110.495 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 8.8 m -71.13 101.27 2.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.18 0.514 . . . . 0.93000000000000005 110.033 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -91.85 108.8 20.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.082 -0.508 . . . . 1.3100000000000001 110.997 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.55 -160.22 25.98 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.004 -0.617 . . . . 0.79000000000000004 111.997 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 10.7 m -125.87 139.44 51.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.791 0.329 . . . . 0.93000000000000005 110.877 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.763 HG12 HG22 ' B' ' 45' ' ' VAL . 15.8 m -88.57 143.12 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.364 -0.38 . . . . 1.3799999999999999 110.887 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.536 ' HB2' ' HG2' ' B' ' 44' ' ' PRO . 35.5 mmm-85 -97.86 84.87 3.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.149 0.499 . . . . 1.3700000000000001 110.614 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.2 m -73.96 -5.87 43.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 1.1599999999999999 111.296 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -88.7 -16.15 33.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.058 -0.519 . . . . 1.1000000000000001 111.409 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . 0.437 ' N ' ' HD3' ' B' ' 77' ' ' PRO . 70.1 mt-30 -130.82 60.49 53.38 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 113.04 0.756 . . . . 2.4700000000000002 113.04 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.461 ' HD2' ' OG1' ' A' ' 79' ' ' THR . 6.9 Cg_exo -75.93 141.08 23.67 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.085 1.857 . . . . 0.95999999999999996 110.223 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -132.61 143.61 49.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.862 0.363 . . . . 1.96 111.34 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.849 HG21 ' HB3' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -78.39 135.06 37.36 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.389 -0.967 . . . . 1.1899999999999999 108.389 177.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.567 HD13 HG11 ' B' ' 9' ' ' VAL . 9.3 pt -118.99 154.21 21.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.93 0.395 . . . . 1.28 110.948 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' B' ' 85' ' ' ARG . 5.5 t70 -86.03 139.89 30.77 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.853 -0.612 . . . . 1.28 109.42 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 2.6 ttp -130.9 26.73 4.94 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.603 0.716 . . . . 2.7000000000000002 109.505 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.661 ' NZ ' ' HB2' ' B' ' 38' ' ' ARG . 37.9 mttm -109.86 -44.05 3.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.033 -0.985 . . . . 1.96 109.399 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.38 -28.42 8.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.421 -0.809 . . . . 1.0600000000000001 110.074 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' B' ' 81' ' ' ASP . 45.3 mtt180 -80.97 151.94 28.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.963 -0.562 . . . . 1.47 110.384 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.92 131.88 10.82 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.215 -0.754 . . . . 0.81999999999999995 111.215 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.25 148.25 18.5 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.954 -0.641 . . . . 0.65000000000000002 111.679 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -139.89 137.69 35.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.489 0.185 . . . . 1.8100000000000001 110.904 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -78.55 131.2 36.69 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.235 -0.284 . . . . 2.4900000000000002 110.235 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 82.4 mt -98.33 -58.06 2.06 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.434 0.531 . . . . 0.76000000000000001 112.434 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . 0.53 ' O ' ' HB ' ' B' ' 6' ' ' ILE . 16.0 pt-20 -149.07 158.22 44.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.412 -0.358 . . . . 1.0700000000000001 110.278 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -101.02 112.07 24.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.772 0.32 . . . . 2.0499999999999998 110.155 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.849 ' HB ' HD11 ' B' ' 6' ' ' ILE . 7.3 p -66.28 133.77 94.58 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.776 -0.647 . . . . 1.45 110.854 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.69 146.4 77.0 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.673 2.249 . . . . 1.03 111.11 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -55.06 -32.66 62.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 2.1400000000000001 111.891 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -48.39 78.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.93 -0.577 . . . . 1.78 110.953 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 40.4 mm -80.29 -34.48 14.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 1.3300000000000001 110.593 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 6.9 tpt -56.58 -47.39 79.65 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.007 -0.542 . . . . 2.3399999999999999 110.854 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -67.06 -33.71 76.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 1.9099999999999999 110.914 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.598 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 0.1 OUTLIER -60.42 -46.06 91.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 1.76 110.872 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 50.2 t -59.33 -44.09 91.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.946 0.403 . . . . 1.01 110.495 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -62.9 -36.37 83.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 1.29 110.264 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.63 -34.13 86.58 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.802 -0.635 . . . . 1.02 111.852 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 19.6 mmt85 -70.74 -28.74 64.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.035 0.445 . . . . 1.8500000000000001 110.661 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 36.5 mt -76.93 -18.54 58.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 1.9399999999999999 110.774 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 24.6 m -76.94 -6.92 54.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.212 -0.449 . . . . 1.1599999999999999 111.694 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 3.7 m -66.73 -25.04 66.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 1.45 111.366 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 46.7 pt -92.07 7.21 5.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.829 0.347 . . . . 1.98 111.675 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 59.2 mt -87.0 13.33 9.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.155 0.502 . . . . 1.3600000000000001 111.246 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.654 -0.703 . . . . 2.1299999999999999 109.436 179.806 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.432 -0.477 0 C3'-C2'-C1' 100.763 -0.818 . 0.0 '__' . 6.3600000000000003 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' ' U' . . . . . 0.512 ' O4 ' ' HA3' ' A' ' 56' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.848 0 C4'-C3'-C2' 103.853 1.153 . 0.0 OUTLIER gamma 2.9900000000000002 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' ' A' . . . . . 0.493 " H3'" HH22 ' A' ' 23' ' ' ARG . . . . . . . . 0 O5'--C5' 1.429 -0.708 0 C3'-C2'-O2' 111.095 -0.76 . 0.0 OUTLIER gamma 2.5899999999999999 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' ' C' . . . . . 0.931 ' H42' ' HA3' ' A' ' 70' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.917 0 O4'-C4'-C3' 103.064 -1.74 . 0.0 OUTLIER zeta-1 2.5099999999999998 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' ' A' . . . . . 0.558 ' C8 ' ' HA2' ' A' ' 21' ' ' GLY . . . . . . . . 0 O5'--C5' 1.424 -0.984 0 C1'-C2'-O2' 108.393 -0.736 . 0.0 OUTLIER . 4.9400000000000004 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.469 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 23.7 ptp . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 120.658 0.266 . . . . 1.29 110.988 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -123.26 168.04 12.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.288 -0.415 . . . . 2.0099999999999998 110.442 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.49 ' NH2' ' HD3' ' A' ' 30' ' ' PRO . 36.3 ttm180 -67.64 124.67 23.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.986 -0.552 . . . . 1.8500000000000001 110.692 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.459 ' HA3' ' NH2' ' A' ' 92' ' ' ARG . . . 108.58 -2.86 32.4 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.822 -0.704 . . . . 0.85999999999999999 113.31 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.469 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 65.8 mt-10 -93.79 152.25 19.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.472 -0.428 . . . . 0.98999999999999999 110.979 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.709 HD11 ' HG2' ' A' ' 91' ' ' GLU . 21.5 pt -115.87 117.11 54.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.147 0.499 . . . . 1.1599999999999999 110.345 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.484 ' CE2' ' HB2' ' A' ' 89' ' ' ARG . 25.8 m95 -108.43 125.41 51.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.658 -0.701 . . . . 0.91000000000000003 111.097 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 14.3 tp -74.52 117.78 16.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.19 -0.459 . . . . 0.90000000000000002 110.633 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 p -162.24 153.9 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.413 -0.358 . . . . 1.04 110.122 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.0 t -84.01 140.14 32.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.961 0.41 . . . . 1.3200000000000001 110.509 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.542 HD23 HD13 ' A' ' 80' ' ' ILE . 1.3 mt -100.15 13.25 34.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.018 -0.537 . . . . 1.29 111.103 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.565 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -85.12 171.47 10.79 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.618 -0.719 . . . . 1.54 110.325 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.565 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 12.4 Cg_exo -71.82 133.2 27.77 Favored 'Cis proline' 0 C--N 1.352 0.743 0 C-N-CA 124.419 -1.075 . . . . 1.6899999999999999 112.198 -0.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 18' ' ' GLU . 21.7 p -102.25 138.52 39.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.705 -0.679 . . . . 1.3600000000000001 111.295 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -106.93 140.46 39.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.437 -0.579 . . . . 1.7 109.437 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.35 -113.27 5.23 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.645 -0.788 . . . . 1.1799999999999999 111.472 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -130.54 46.32 2.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.808 0.337 . . . . 2.7799999999999998 111.283 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 32.1 mt-10 -65.84 -174.86 0.25 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.971 -0.559 . . . . 1.1399999999999999 110.437 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.584 ' HG2' ' HG2' ' A' ' 44' ' ' PRO . 5.4 tp-100 -78.51 69.2 4.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.333 0.587 . . . . 2.0899999999999999 110.234 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.6 ' HB2' " H3'" ' C' ' 5' ' ' ' A' . 1.1 pt20 -76.13 144.61 40.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.402 -0.817 . . . . 2.0899999999999999 111.241 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.92 143.03 5.73 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.64 -0.791 . . . . 1.0700000000000001 112.843 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 10.0 m -92.9 107.17 19.01 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.263 -0.643 . . . . 1.1100000000000001 109.263 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -147.31 163.39 28.34 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.429 -0.35 . . . . 1.6200000000000001 110.582 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 16.6 Cg_exo -69.02 119.47 6.45 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.498 2.132 . . . . 1.01 111.393 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 14.2 m -97.26 142.46 14.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.126 -0.488 . . . . 0.76000000000000001 110.38 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.651 ' HB3' HG23 ' A' ' 43' ' ' VAL . 36.6 tp -83.86 121.9 27.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.44 -0.346 . . . . 0.69999999999999996 111.282 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.659 ' HA ' HG12 ' A' ' 42' ' ' VAL . 17.8 mm -71.84 112.67 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.92000000000000004 109.713 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.38 -37.51 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.346 -0.388 . . . . 0.94999999999999996 111.889 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.86 150.55 75.49 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 112.387 0.514 . . . . 1.1200000000000001 112.387 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.49 ' HD3' ' NH2' ' A' ' 3' ' ' ARG . 56.3 Cg_endo -70.1 155.91 63.7 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.766 2.311 . . . . 1.3 112.323 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.92 -38.0 64.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.843 -0.617 . . . . 1.3899999999999999 112.05 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.38 -41.4 89.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.027 0.441 . . . . 1.6100000000000001 111.227 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.639 ' HZ ' ' HB2' ' B' ' 75' ' ' ASP . 80.5 t80 -73.22 -41.95 63.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.091 -0.504 . . . . 1.77 110.777 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 60.7 m-20 -62.81 -21.13 65.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.898 -0.592 . . . . 1.48 111.345 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.404 ' HD3' HH11 ' A' ' 35' ' ' ARG . 2.7 ttp180 -93.37 -25.52 17.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 2.6200000000000001 111.93 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 33' ' ' PHE . 14.0 p -82.78 -49.24 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 112.93 0.715 . . . . 1.8600000000000001 112.93 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.5 p -94.9 -23.86 17.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 1.72 110.783 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 88.4 mtt180 68.78 18.04 8.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.478 -0.783 . . . . 4.4500000000000002 111.607 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' B' ' 17' ' ' HIS . 75.8 mt -129.11 93.28 36.91 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.349 -0.842 . . . . 1.8100000000000001 108.897 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.92 132.53 9.64 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.567 2.178 . . . . 1.05 113.521 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.413 HG22 ' OG1' ' A' ' 79' ' ' THR . 47.2 t -79.03 116.64 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.833 -1.543 . . . . 1.03 106.833 177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.659 HG12 ' HA ' ' A' ' 27' ' ' ILE . 29.5 m -124.71 156.91 33.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 113.478 0.918 . . . . 0.77000000000000002 113.478 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.651 HG23 ' HB3' ' A' ' 26' ' ' LEU . 2.6 m -118.37 118.57 33.83 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 114.806 -1.088 . . . . 0.71999999999999997 108.646 177.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.584 ' HG2' ' HG2' ' A' ' 19' ' ' GLN . 13.2 Cg_exo -69.47 156.59 63.67 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.076 2.518 . . . . 1.03 113.507 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.463 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 95.2 t -114.1 127.12 71.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.085 -0.962 . . . . 1.28 108.638 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.528 ' OG1' ' HD3' ' A' ' 73' ' ' ARG . 27.2 p -114.95 -171.71 1.99 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.105 -0.238 . . . . 1.9099999999999999 111.25 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.26 139.7 54.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.319 -0.4 . . . . 2.5299999999999998 111.384 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.26 19.04 32.57 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.638 -0.791 . . . . 3.3599999999999999 111.932 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.32 -131.87 35.61 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.841 -0.695 . . . . 3.8300000000000001 111.533 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -91.77 -43.01 9.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.042 0.448 . . . . 4.7199999999999998 109.874 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -130.43 127.81 40.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.92 -0.582 . . . . 6.2400000000000002 109.901 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.01 89.95 1.14 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 2.5899999999999999 111.128 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -108.09 153.51 23.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.864 -0.607 . . . . 4.5899999999999999 110.9 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.509 HG23 ' HA ' ' A' ' 59' ' ' VAL . 1.3 m -72.1 132.4 44.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.143 -0.48 . . . . 2.6899999999999999 110.021 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.01 69.8 1.48 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.352 -0.386 . . . . 3.1699999999999999 111.174 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.94 -83.41 0.31 Allowed Glycine 0 C--O 1.229 -0.177 0 CA-C-N 116.008 -0.542 . . . . 1.6599999999999999 112.97 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -91.32 -32.75 15.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.893 0.378 . . . . 1.5600000000000001 110.971 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.47 120.9 25.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.083 -0.508 . . . . 1.25 110.097 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.691 HG22 ' HB ' ' A' ' 72' ' ' VAL . 10.4 m -93.85 153.64 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.913 0.387 . . . . 1.6799999999999999 111.707 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.86 142.98 34.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.969 -0.559 . . . . 1.95 111.615 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.579 ' HB3' HD11 ' A' ' 66' ' ' ILE . 14.4 mt -109.94 0.57 18.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 1.23 110.927 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -91.55 -173.68 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 2.21 109.914 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.7 -47.68 3.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 1.1499999999999999 112.151 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.0 m -74.6 -28.7 22.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.889 0.376 . . . . 1.21 110.754 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.77 67.88 1.53 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.743 -0.742 . . . . 1.0800000000000001 113.619 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 61' ' ' LEU . 22.8 pt -102.97 174.69 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.624 -0.51 . . . . 1.0700000000000001 109.624 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -80.68 -44.84 18.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.956 0.407 . . . . 3.5899999999999999 110.46 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.51 149.2 49.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.8 -0.636 . . . . 1.51 111.46 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.08 91.96 3.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.836 -0.62 . . . . 1.79 110.795 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.421 ' HA3' ' H42' ' C' ' 4' ' ' ' C' . . . -164.85 -162.42 15.85 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.17 -0.772 . . . . 1.1799999999999999 111.17 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.34 138.63 53.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.092 -0.336 . . . . 1.5600000000000001 110.092 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.691 ' HB ' HG22 ' A' ' 59' ' ' VAL . 62.7 t -75.3 131.1 35.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.817 0.341 . . . . 1.29 110.456 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.528 ' HD3' ' OG1' ' A' ' 46' ' ' THR . 55.8 mmm-85 -100.35 91.4 4.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.127 -0.488 . . . . 2.23 112.259 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.8 m -82.67 -10.14 59.06 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.901 -0.777 . . . . 1.1699999999999999 108.901 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.407 ' C ' ' HD3' ' A' ' 77' ' ' PRO . 13.9 p-10 -86.85 -12.52 47.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.121 -0.945 . . . . 0.89000000000000001 110.943 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.401 ' N ' ' HD3' ' A' ' 77' ' ' PRO . 12.1 mm100 -129.42 62.93 65.71 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 112.195 0.443 . . . . 2.1299999999999999 112.195 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.407 ' HD3' ' C ' ' A' ' 75' ' ' ASP . 5.0 Cg_exo -77.95 144.61 21.64 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.667 2.245 . . . . 0.80000000000000004 111.024 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 78' ' ' ARG . 5.1 ptm85 -163.92 124.61 2.2 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.072 0.397 . . . . 2.0899999999999999 112.072 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.515 ' OG1' ' HD2' ' B' ' 77' ' ' PRO . 87.6 m -82.19 123.52 29.08 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.847 -0.615 . . . . 1.6200000000000001 109.597 178.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.542 HD13 HD23 ' A' ' 11' ' ' LEU . 24.3 pt -126.1 161.95 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.025 0.44 . . . . 1.1499999999999999 111.183 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.539 ' O ' ' HD2' ' A' ' 85' ' ' ARG . 2.1 t70 -76.61 145.37 38.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.62 -0.718 . . . . 1.03 110.686 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 38.2 tpp -131.91 24.66 4.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.23 0.538 . . . . 1.29 109.786 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.12 -40.42 3.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.158 -0.474 . . . . 2.6400000000000001 110.778 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.88 -35.38 10.51 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.362 -0.607 . . . . 1.1200000000000001 109.362 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 81' ' ' ASP . 77.4 mtt-85 -68.72 -57.56 5.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.471 -0.786 . . . . 1.0600000000000001 110.704 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.82 120.52 2.03 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.787 -0.72 . . . . 1.1200000000000001 113.193 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.0 171.16 21.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.939 -0.648 . . . . 1.0900000000000001 111.796 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -132.79 123.13 25.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.834 0.35 . . . . 2.46 111.482 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.484 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 45.7 ttp180 -75.41 120.39 20.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.226 -0.443 . . . . 2.4900000000000002 110.897 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.95 -53.86 4.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.925 0.393 . . . . 1.29 110.328 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.709 ' HG2' HD11 ' A' ' 6' ' ' ILE . 14.6 pt-20 -160.14 -168.44 2.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.709 -0.678 . . . . 1.1499999999999999 109.38 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.459 ' NH2' ' HA3' ' A' ' 4' ' ' GLY . 3.2 ptm180 -143.29 139.76 30.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.757 0.313 . . . . 1.3200000000000001 110.33 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.54 158.25 43.21 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.136 -0.484 . . . . 0.75 111.461 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.0 160.72 48.48 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.712 2.275 . . . . 0.94999999999999996 111.564 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -60.87 -23.04 64.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 1.51 111.93 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -37.08 74.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.483 . . . . 1.5700000000000001 110.585 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.406 ' O ' HG23 ' A' ' 101' ' ' VAL . 37.2 mm -88.55 -40.78 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.747 -0.661 . . . . 1.3100000000000001 109.99 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.7 tpt -56.63 -50.83 70.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.696 -0.683 . . . . 1.6000000000000001 112.107 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.428 ' HA ' HD12 ' A' ' 102' ' ' LEU . 58.1 m-80 -65.18 -32.19 73.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 2.2999999999999998 111.268 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 7.0 tp10 -61.5 -45.14 95.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.862 -0.608 . . . . 1.6399999999999999 110.366 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.477 HG11 HG21 ' A' ' 43' ' ' VAL . 50.0 t -59.88 -44.85 95.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.036 -0.529 . . . . 1.03 110.013 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 99' ' ' ASN . 44.6 mt -59.92 -40.88 90.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.732 -0.667 . . . . 1.22 111.051 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.87 -41.42 98.77 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.901 -0.666 . . . . 1.03 112.016 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 12.6 mmt180 -68.2 -38.52 82.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 1.72 110.555 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 62.6 mt -63.78 -24.24 67.68 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.03 -0.532 . . . . 1.02 112.111 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 57.0 m -72.12 -6.27 41.41 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.934 0.716 . . . . 1.1100000000000001 112.934 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 74.5 p -92.49 -11.34 34.89 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.193 0.442 . . . . 1.5 112.193 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.525 ' HB ' HG22 ' B' ' 29' ' ' THR . 45.8 pt -107.48 16.25 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.914 0.388 . . . . 1.1499999999999999 111.897 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 83.4 mt -97.42 25.87 5.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.131 0.491 . . . . 0.97999999999999998 110.784 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.957 -0.565 . . . . 1.3500000000000001 111.405 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.544 ' CE ' ' HG ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 112.007 0.373 . . . . 2.0299999999999998 112.007 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' B' ' 3' ' ' ARG . 24.2 mt-10 -91.01 2.97 55.9 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.168 -0.332 . . . . 2.8199999999999998 110.804 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . 0.694 ' HA ' ' HE1' ' B' ' 98' ' ' MET . 0.1 OUTLIER 84.86 61.24 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.933 1.086 . . . . 2.3199999999999998 113.933 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.25 22.98 74.82 Favored Glycine 0 CA--C 1.519 0.313 0 N-CA-C 115.006 0.762 . . . . 1.28 115.006 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -83.19 116.55 22.42 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 117.498 0.649 . . . . 1.53 110.892 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.95 HD12 ' HG3' ' B' ' 91' ' ' GLU . 19.9 mt -96.07 123.26 48.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.75 110.184 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -112.92 127.47 56.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.008 0.432 . . . . 0.81000000000000005 111.477 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' B' ' 24' ' ' PRO . 40.1 tp -90.13 120.35 31.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.056 -0.52 . . . . 1.05 109.748 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.457 HG22 ' H ' ' B' ' 10' ' ' SER . 5.9 p -158.63 169.55 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.505 -0.316 . . . . 0.71999999999999997 110.379 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' B' ' 22' ' ' THR . 0.0 OUTLIER -84.45 133.27 34.49 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.899 -0.408 . . . . 1.6299999999999999 109.899 179.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 18.9 mt -81.29 -29.09 34.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.485 -0.325 . . . . 0.82999999999999996 111.437 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . 0.417 ' HA ' ' N ' ' B' ' 14' ' ' THR . 2.5 m-20 -58.7 154.58 35.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.051 -0.522 . . . . 1.6200000000000001 111.629 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.65 116.52 4.58 Favored 'Cis proline' 0 C--O 1.237 0.432 0 C-N-CA 123.607 -1.414 . . . . 1.28 113.364 0.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' B' ' 18' ' ' GLU . 0.6 OUTLIER -123.41 147.88 46.68 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.812 -0.81 . . . . 1.47 108.812 178.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.65 177.88 8.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.319 0.581 . . . . 1.22 112.117 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.57 -108.53 2.45 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.888 -0.672 . . . . 1.01 112.585 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . 0.461 ' HB2' HD21 ' A' ' 39' ' ' LEU . 73.6 m-70 -108.31 3.29 23.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.727 0.299 . . . . 2.1800000000000002 111.147 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.44 ' HB2' ' HB ' ' B' ' 14' ' ' THR . 29.9 mt-10 -72.4 140.21 48.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.297 -0.411 . . . . 1.28 110.05 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -68.28 142.16 55.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.669 -0.493 . . . . 1.52 109.669 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -120.1 165.85 14.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.726 0.639 . . . . 1.8600000000000001 112.726 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.7 -173.11 36.45 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.44 -0.8 . . . . 0.90000000000000002 112.327 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' B' ' 10' ' ' SER . 15.6 m -96.04 123.36 39.61 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.973 -0.751 . . . . 0.94999999999999996 108.973 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.406 HH21 ' HA ' ' B' ' 46' ' ' THR . 3.9 ptm180 -157.45 155.0 26.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.705 -0.225 . . . . 1.5900000000000001 110.84 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' B' ' 8' ' ' LEU . 23.6 Cg_exo -65.63 133.8 35.65 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.608 2.206 . . . . 0.65000000000000002 111.841 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' B' ' 44' ' ' PRO . 16.9 m -126.61 156.92 37.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.074 -0.512 . . . . 0.56999999999999995 110.693 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.544 ' HG ' ' CE ' ' B' ' 1' ' ' MET . 1.5 tp -106.24 119.32 38.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.118 -0.492 . . . . 1.1699999999999999 110.71 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . 0.603 HG12 HG12 ' B' ' 42' ' ' VAL . 27.8 mt -78.36 116.83 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.317 . . . . 0.66000000000000003 110.607 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' B' ' 1' ' ' MET . 37.5 t -77.61 -37.55 24.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.025 -0.534 . . . . 0.93000000000000005 111.839 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' THR . . . . . 0.525 HG22 ' HB ' ' A' ' 108' ' ' ILE . 0.8 OUTLIER -71.19 142.47 87.26 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.436 -0.347 . . . . 0.81000000000000005 111.74 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.68 156.09 61.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.83 2.353 . . . . 0.78000000000000003 112.407 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.3 77.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.861 -0.609 . . . . 1.03 111.704 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.98 -36.74 73.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.92 0.39 . . . . 1.3999999999999999 111.55 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -81.39 -40.88 22.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.112 0.482 . . . . 1.5700000000000001 110.519 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -59.43 -24.84 63.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.682 -0.69 . . . . 1.6399999999999999 111.899 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -89.42 -2.61 58.46 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.399 0.518 . . . . 2.54 112.399 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -108.12 -52.08 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.977 0.418 . . . . 1.0900000000000001 110.282 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . 0.706 ' HA ' ' N3 ' ' C' ' 2' ' ' ' U' . 1.5 m -80.87 -31.84 35.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.818 -0.628 . . . . 1.3300000000000001 111.14 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.616 ' HG3' " O4'" ' C' ' 1' ' ' ' A' . 3.7 mmp_? 71.01 -0.22 3.14 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.53 0.937 . . . . 1.78 113.53 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 98.4 mt -121.45 94.32 48.61 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.577 -0.527 . . . . 1.1599999999999999 109.577 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.37 154.18 14.09 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.867 2.378 . . . . 0.56999999999999995 113.992 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.671 HG22 HG23 ' B' ' 79' ' ' THR . 8.8 t -95.45 123.53 47.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.901 -1.148 . . . . 1.0800000000000001 107.901 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.603 HG12 HG12 ' B' ' 27' ' ' ILE . 32.3 m -113.93 147.31 17.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 113.434 0.902 . . . . 0.64000000000000001 113.434 -178.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 t -106.09 118.97 53.66 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 114.63 -1.168 . . . . 1.1000000000000001 108.386 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.501 ' HA ' HG12 ' B' ' 25' ' ' VAL . 74.0 Cg_endo -74.38 134.79 19.41 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.728 2.285 . . . . 0.72999999999999998 112.557 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.697 HG22 HG12 ' B' ' 72' ' ' VAL . 44.0 t -99.01 123.62 51.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.88 -0.6 . . . . 0.90000000000000002 110.46 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.406 ' HA ' HH21 ' B' ' 23' ' ' ARG . 0.0 OUTLIER -89.44 89.89 8.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.887 -0.597 . . . . 1.1699999999999999 109.579 178.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.69 ' HA ' ' HA3' ' B' ' 70' ' ' GLY . 1.4 m -82.08 67.06 7.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.855 -0.612 . . . . 1.8500000000000001 111.342 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.7 31.68 7.57 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.979 -0.629 . . . . 2.2200000000000002 111.636 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.35 -169.21 16.12 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.723 -0.751 . . . . 3.4300000000000002 112.255 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -123.7 32.59 5.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.341 0.591 . . . . 4.6200000000000001 110.577 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -69.33 -32.25 71.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.493 -0.776 . . . . 6.2699999999999996 110.627 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -108.87 125.83 52.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.88 -0.6 . . . . 4.3899999999999997 110.004 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.39 -49.9 6.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.141 0.496 . . . . 3.9199999999999999 110.454 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.98 121.53 6.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.619 -0.719 . . . . 2.75 110.918 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.63 82.99 2.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.837 -0.619 . . . . 1.96 110.339 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.51 -87.68 0.26 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.796 -0.638 . . . . 1.0800000000000001 112.676 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.658 ' HE1' ' HB ' ' B' ' 107' ' ' THR . 21.0 m-85 -109.68 -6.69 15.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.879 0.371 . . . . 3.5699999999999998 110.86 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' B' ' 72' ' ' VAL . . . -93.04 115.13 27.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.049 -0.523 . . . . 1.0800000000000001 110.845 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 23.7 t -117.05 135.99 55.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.101 -0.5 . . . . 1.3400000000000001 110.013 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 88.3 p -79.42 141.59 36.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.801 0.334 . . . . 1.3799999999999999 111.605 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 72.8 mt -88.76 -16.76 31.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.181 0.515 . . . . 1.02 110.751 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -73.63 147.0 44.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.718 -0.673 . . . . 1.79 111.003 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.03 -40.14 2.5 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.056 -0.593 . . . . 1.1499999999999999 112.461 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 p -90.21 -17.69 7.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.111 0.412 . . . . 1.1699999999999999 112.111 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.24 20.91 4.24 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.499 -0.858 . . . . 1.05 113.599 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.496 HD11 ' HD2' ' B' ' 94' ' ' PRO . 81.4 mt -86.64 141.31 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.772 -0.455 . . . . 1.6100000000000001 109.772 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -70.9 -47.84 56.94 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.623 0.249 . . . . 2.3999999999999999 110.923 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 12.2 m -60.97 99.14 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.368 0.604 . . . . 0.93000000000000005 110.334 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.69 91.49 8.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.946 -0.57 . . . . 1.3100000000000001 111.746 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' B' ' 47' ' ' SER . . . -171.45 -174.0 38.81 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.709 -0.758 . . . . 0.79000000000000004 111.7 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.5 m -113.71 136.31 50.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 110.211 -0.292 . . . . 0.93000000000000005 110.211 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.697 HG12 HG22 ' B' ' 45' ' ' VAL . 11.9 m -80.34 135.59 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.556 -0.293 . . . . 1.3799999999999999 110.92 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' B' ' 73' ' ' ARG . 16.1 mmm-85 -101.99 82.97 2.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.112 0.482 . . . . 1.3700000000000001 110.829 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 2.3 m -69.32 -9.04 51.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.758 -0.655 . . . . 1.1599999999999999 111.047 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.639 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 13.7 p-10 -88.45 -6.21 57.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.589 -0.732 . . . . 1.1000000000000001 111.771 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -126.13 55.77 14.2 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 113.0 0.741 . . . . 2.4700000000000002 113.0 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.515 ' HD2' ' OG1' ' A' ' 79' ' ' THR . 90.4 Cg_endo -80.96 126.4 5.74 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.771 1.647 . . . . 0.95999999999999996 112.271 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -130.38 140.39 50.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.917 0.389 . . . . 1.96 111.218 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.671 HG23 HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -79.72 125.87 30.21 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.189 -0.671 . . . . 1.1899999999999999 109.189 178.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 41.4 pt -128.51 151.48 35.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.521 -0.471 . . . . 1.28 111.653 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.693 ' OD1' ' HG3' ' B' ' 83' ' ' LYS . 4.8 t70 -77.83 83.95 4.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.858 -0.61 . . . . 1.28 109.994 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' MET . . . . . . . . . . . . . 59.7 tpp -61.69 -31.66 71.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.691 -0.686 . . . . 2.7000000000000002 112.274 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.693 ' HG3' ' OD1' ' B' ' 81' ' ' ASP . 1.4 pttp -67.22 -38.91 86.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.397 0.517 . . . . 1.96 112.397 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.98 -30.18 28.41 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.108 0.41 . . . . 1.0600000000000001 112.108 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' B' ' 85' ' ' ARG . 46.1 mtt180 -82.22 -42.46 18.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.174 0.435 . . . . 1.47 112.174 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.4 99.94 1.52 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.81999999999999995 112.597 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . . . . . . . . . . . -99.3 153.71 19.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.677 -0.773 . . . . 0.65000000000000002 112.588 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.15 128.15 16.5 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.284 -0.265 . . . . 1.8100000000000001 110.284 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' B' ' 6' ' ' ILE . 34.5 ttp180 -78.91 121.04 24.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.963 0.411 . . . . 2.4900000000000002 111.339 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 89.8 mt -90.8 -68.62 0.78 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.136 -0.484 . . . . 0.76000000000000001 110.666 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . 0.95 ' HG3' HD12 ' B' ' 6' ' ' ILE . 11.5 pt-20 -129.61 -176.88 4.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.935 -0.575 . . . . 1.0700000000000001 110.028 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.81 137.98 53.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.959 0.409 . . . . 2.0499999999999998 111.198 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.436 HG23 HD11 ' B' ' 6' ' ' ILE . 53.7 t -82.86 126.72 72.2 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.854 -0.612 . . . . 1.45 109.993 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.496 ' HD2' HD11 ' B' ' 66' ' ' ILE . 43.9 Cg_exo -59.59 152.5 61.86 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.656 2.237 . . . . 1.03 111.11 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.528 ' HA ' ' HB3' ' B' ' 98' ' ' MET . 21.8 mm-40 -54.26 -29.69 47.78 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.461 0.541 . . . . 2.1400000000000001 112.461 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.7 p -59.46 -53.83 53.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.991 0.424 . . . . 1.78 111.219 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 32.5 mm -74.84 -34.04 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.202 -0.453 . . . . 1.3300000000000001 110.0 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' MET . . . . . 0.694 ' HE1' ' HA ' ' B' ' 3' ' ' ARG . 5.1 tpt -55.33 -45.26 76.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.706 -0.679 . . . . 2.3399999999999999 110.972 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -67.55 -35.34 78.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.098 -0.501 . . . . 1.9099999999999999 110.996 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 4.5 tp10 -64.53 -44.86 89.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.97 -0.559 . . . . 1.76 111.0 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.426 HG22 HG21 ' B' ' 72' ' ' VAL . 73.9 t -60.29 -48.61 87.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.306 -0.406 . . . . 1.01 110.425 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.654 ' HA ' HD12 ' B' ' 105' ' ' LEU . 82.9 mt -59.68 -34.93 73.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.555 . . . . 1.29 111.048 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.45 -41.28 96.46 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.578 -0.609 . . . . 1.02 111.578 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 5.1 mmt180 -67.35 -33.59 75.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.898 0.38 . . . . 1.8500000000000001 110.315 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.654 HD12 ' HA ' ' B' ' 102' ' ' LEU . 46.4 mt -65.98 -25.5 67.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.912 -0.586 . . . . 1.9399999999999999 110.513 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 13.0 m -87.68 -13.94 41.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.008 -0.542 . . . . 1.1599999999999999 111.161 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.658 ' HB ' ' HE1' ' B' ' 57' ' ' PHE . 0.5 OUTLIER -75.13 -31.65 61.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.898 0.38 . . . . 1.45 111.361 -179.376 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 14.0 pt -84.91 0.82 5.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.442 -0.345 . . . . 1.98 111.558 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.49 4.66 53.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.342 -0.39 . . . . 1.3600000000000001 111.859 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.439 ' C ' HH22 ' A' ' 3' ' ' ARG . 7.0 t . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.825 -0.607 . . . . 2.1299999999999999 110.206 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' ' A' . . . . . 0.616 " O4'" ' HG3' ' B' ' 38' ' ' ARG . . . . . . . . 0 O5'--C5' 1.432 -0.472 0 C1'-C2'-O2' 107.899 -0.9 . 0.0 '__' . 6.3600000000000003 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' ' U' . . . . . 0.706 ' N3 ' ' HA ' ' B' ' 37' ' ' THR . . . . . . . . 0 O5'--C5' 1.426 -0.893 0 O4'-C1'-N19 109.57 1.37 . 0.0 OUTLIER . 2.9900000000000002 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' ' A' . . . . . 0.564 " H2'" ' N3 ' ' C' ' 3' ' ' ' A' . . . . . . . . 0 C4'--C3' 1.532 0.691 0 C4'-C3'-C2' 103.935 1.235 . 0.0 OUTLIER gamma 2.5899999999999999 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' ' C' . . . . . 0.971 ' O2 ' " H2'" ' C' ' 4' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.809 0 C3'-C2'-C1' 102.843 1.492 . 0.0 OUTLIER . 2.5099999999999998 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' ' A' . . . . . 0.6 " H3'" ' HB2' ' A' ' 20' ' ' GLN . . . . . . . . 0 O3'--C3' 1.436 0.925 0 C4'-C3'-C2' 104.572 1.872 . 0.0 OUTLIER . 4.9400000000000004 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptp . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.782 0.325 . . . . 1.29 110.75 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -135.28 175.01 9.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.02 -0.536 . . . . 2.0099999999999998 111.053 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.561 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 55.2 ttp85 -79.27 136.22 36.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.048 -0.523 . . . . 1.8500000000000001 109.955 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.44 8.27 59.91 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.85999999999999999 112.476 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.682 ' HG2' ' HG3' ' A' ' 92' ' ' ARG . 82.1 mt-10 -95.27 142.22 27.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.949 0.404 . . . . 0.98999999999999999 111.138 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.7 mt -99.0 115.93 40.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.814 -0.81 . . . . 1.1599999999999999 108.814 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -114.12 137.33 51.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.401 -0.363 . . . . 0.91000000000000003 111.083 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.3 tp -88.81 120.76 30.51 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.392 -0.595 . . . . 0.90000000000000002 109.392 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.454 HG22 ' H ' ' A' ' 10' ' ' SER . 4.3 p -147.49 169.19 4.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 120.867 0.365 . . . . 1.04 110.708 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.454 ' H ' HG22 ' A' ' 9' ' ' VAL . 4.2 t -103.75 129.83 51.18 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.001 -0.74 . . . . 1.3200000000000001 109.001 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.3 mt -88.32 -12.57 43.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.461 -0.336 . . . . 1.29 111.377 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.547 ' HA ' HG23 ' A' ' 14' ' ' THR . 0.2 OUTLIER -67.93 164.15 43.67 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.94 -0.573 . . . . 1.54 111.162 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.74 139.09 49.57 Favored 'Cis proline' 0 C--N 1.353 0.79 0 C-N-CA 124.324 -1.115 . . . . 1.6899999999999999 112.485 -0.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.547 HG23 ' HA ' ' A' ' 12' ' ' ASP . 14.1 p -121.9 171.95 8.54 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.085 -0.507 . . . . 1.3600000000000001 111.319 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.79 164.34 26.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 1.7 110.063 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.4 -136.87 32.34 Favored Glycine 0 CA--C 1.516 0.123 0 C-N-CA 121.16 -0.543 . . . . 1.1799999999999999 113.409 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -103.74 25.46 9.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.022 -0.362 . . . . 2.7799999999999998 110.022 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -76.47 175.75 8.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.212 -0.449 . . . . 1.1399999999999999 111.427 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.546 ' HG3' ' CZ ' ' A' ' 23' ' ' ARG . 3.3 tp-100 -74.23 77.38 1.81 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.607 -0.724 . . . . 2.0899999999999999 110.506 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.405 ' HA ' HG21 ' A' ' 14' ' ' THR . 18.3 mt-30 -78.03 122.89 26.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.835 -0.62 . . . . 2.0899999999999999 111.726 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.838 ' HA2' ' C5 ' ' C' ' 5' ' ' ' A' . . . 119.71 163.45 12.27 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.272 -0.966 . . . . 1.0700000000000001 113.502 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.62 148.38 25.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.743 -0.229 . . . . 1.1100000000000001 110.505 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.546 ' CZ ' ' HG3' ' A' ' 19' ' ' GLN . 8.2 ptp180 -172.71 159.87 3.83 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 110.247 -0.279 . . . . 1.6200000000000001 110.247 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.65 130.3 15.72 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.448 2.099 . . . . 1.01 110.713 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.726 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 14.2 m -116.37 137.21 50.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.335 -0.393 . . . . 0.76000000000000001 110.569 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . 53.1 tp -92.32 124.39 36.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.154 -0.475 . . . . 0.69999999999999996 110.948 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.433 ' HA ' HG12 ' A' ' 42' ' ' VAL . 56.6 mt -80.07 111.03 16.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 0.92000000000000004 110.148 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 t -90.18 -27.2 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.218 -0.446 . . . . 0.94999999999999996 111.75 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 1.9 p -77.6 142.25 66.08 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.603 0.594 . . . . 1.1200000000000001 112.603 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HA ' ' HB2' ' A' ' 3' ' ' ARG . 26.3 Cg_exo -63.79 151.74 83.78 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.217 2.611 . . . . 1.3 111.798 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.18 -38.81 77.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.085 -0.507 . . . . 1.3899999999999999 112.036 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.17 -38.3 82.81 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.024 0.44 . . . . 1.6100000000000001 110.777 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' B' ' 75' ' ' ASP . 83.2 t80 -72.34 -38.73 68.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.032 -0.531 . . . . 1.77 110.166 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 75.4 m-20 -64.78 -15.81 62.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.676 -0.693 . . . . 1.48 111.199 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -87.8 -24.12 23.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.562 -0.29 . . . . 2.6200000000000001 110.724 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.6 t -83.1 -65.12 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 1.8600000000000001 111.489 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.1 m -78.82 -33.99 45.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.337 -0.392 . . . . 1.72 110.862 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.616 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 21.6 mtm180 75.14 12.64 3.35 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.724 -0.671 . . . . 4.4500000000000002 111.738 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.8 mt -124.92 93.04 46.61 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.544 -0.753 . . . . 1.8100000000000001 109.404 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.478 ' HD2' ' O ' ' A' ' 80' ' ' ILE . 58.0 Cg_endo -73.06 137.26 26.15 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.502 2.135 . . . . 1.05 112.798 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.585 HG22 HG23 ' A' ' 79' ' ' THR . 51.8 t -83.64 111.65 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 107.972 -1.122 . . . . 1.03 107.972 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.726 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 35.8 m -114.54 158.74 14.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.24 0.543 . . . . 0.77000000000000002 112.282 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.438 HG21 HG13 ' A' ' 72' ' ' VAL . 17.1 m -115.89 122.08 33.08 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.236 -0.893 . . . . 0.71999999999999997 109.775 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.99 94.75 1.06 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.867 2.378 . . . . 1.03 112.761 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.783 HG12 ' HA ' ' A' ' 72' ' ' VAL . 33.0 m -78.68 155.86 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 1.28 110.407 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.728 ' HB ' ' C2 ' ' C' ' 3' ' ' ' A' . 2.8 m -141.01 -91.78 0.15 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.345 0.498 . . . . 1.9099999999999999 112.345 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.788 ' HA ' ' HA2' ' A' ' 70' ' ' GLY . 3.7 p -164.98 -158.11 0.38 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.839 0.745 . . . . 2.5299999999999998 112.377 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -155.46 32.01 0.64 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.294 -0.722 . . . . 3.3599999999999999 111.294 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.66 -126.05 7.71 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.136 -0.786 . . . . 3.8300000000000001 111.136 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -80.16 -38.71 30.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.214 0.53 . . . . 4.7199999999999998 110.206 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -136.84 116.15 12.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.838 -0.619 . . . . 6.2400000000000002 110.063 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 62' ' ' ASP . . . -64.77 141.28 58.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.311 -0.404 . . . . 2.5899999999999999 111.277 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -145.78 147.68 32.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.951 -0.568 . . . . 4.5899999999999999 109.478 179.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.599 HG23 ' HA ' ' A' ' 59' ' ' VAL . 26.0 m -69.94 100.14 1.53 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.225 0.536 . . . . 2.6899999999999999 111.582 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.41 83.86 3.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.568 -0.742 . . . . 3.1699999999999999 110.492 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.47 -92.89 0.28 Allowed Glycine 0 C--O 1.235 0.195 0 CA-C-N 115.562 -0.744 . . . . 1.6599999999999999 112.538 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -96.08 -16.77 21.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.628 0.252 . . . . 1.5600000000000001 111.03 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 54' ' ' THR . . . -76.02 87.37 2.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.587 -0.523 . . . . 1.25 109.587 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.599 ' HA ' HG23 ' A' ' 54' ' ' THR . 42.3 t -66.13 121.86 16.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.276 -0.42 . . . . 1.6799999999999999 110.726 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.1 t -77.56 125.94 30.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.896 0.379 . . . . 1.95 111.539 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.749 ' HB3' HD11 ' A' ' 66' ' ' ILE . 91.9 mt -88.35 -5.93 58.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.45 0.643 . . . . 1.23 109.427 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.523 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 6.4 t0 -80.5 108.96 14.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.264 -0.88 . . . . 2.21 109.84 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.85 -34.56 1.23 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.873 -0.679 . . . . 1.1499999999999999 112.017 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.5 m -78.36 -30.7 15.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.729 0.3 . . . . 1.21 111.6 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.59 65.1 0.93 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.638 -0.791 . . . . 1.0800000000000001 112.671 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.749 HD11 ' HB3' ' A' ' 61' ' ' LEU . 20.4 pt -125.24 -171.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.354 -0.609 . . . . 1.0700000000000001 109.354 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.534 ' HA ' ' NE ' ' A' ' 67' ' ' ARG . 5.4 mmp_? -101.22 -27.66 13.09 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.739 -0.384 . . . . 3.5899999999999999 111.477 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.7 m -81.41 80.71 7.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.268 0.556 . . . . 1.51 110.388 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.0 m -80.21 94.54 6.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.63 -0.714 . . . . 1.79 111.256 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.788 ' HA2' ' HA ' ' A' ' 47' ' ' SER . . . -162.52 -178.31 36.27 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.828 -0.624 . . . . 1.1799999999999999 112.137 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.446 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 22.3 m -105.0 138.99 27.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.821 0.31 . . . . 1.5600000000000001 110.963 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.783 ' HA ' HG12 ' A' ' 45' ' ' VAL . 67.9 t -73.81 126.93 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.808 -0.633 . . . . 1.29 110.258 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.75 85.23 7.02 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.584 0.587 . . . . 2.23 112.584 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 11.0 m -83.44 -8.19 59.42 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.81 -0.811 . . . . 1.1699999999999999 108.81 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -87.55 -27.97 22.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.801 -1.091 . . . . 0.89000000000000001 111.14 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.424 ' HB3' HG21 ' B' ' 79' ' ' THR . 79.3 mt-30 -130.84 64.53 73.91 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 113.984 1.105 . . . . 2.1299999999999999 113.984 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -77.52 133.96 13.44 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 121.872 1.715 . . . . 0.80000000000000004 109.204 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 1.038 ' HG3' ' HG3' ' B' ' 78' ' ' ARG . 18.2 ttt180 -135.19 143.06 46.22 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.683 0.623 . . . . 2.0899999999999999 112.683 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.585 HG23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -83.85 127.88 34.15 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.814 -1.18 . . . . 1.6200000000000001 107.814 177.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.478 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 20.5 pt -126.1 173.18 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.967 0.413 . . . . 1.1499999999999999 111.091 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -101.65 133.48 46.29 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.64 -0.709 . . . . 1.03 109.138 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.2 mmt -126.19 27.98 6.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.971 0.415 . . . . 1.29 111.266 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -125.3 -42.98 1.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 2.6400000000000001 110.8 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.46 -37.54 9.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.728 -0.669 . . . . 1.1200000000000001 109.505 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 85' ' ' ARG . 39.3 mtt180 -68.69 -49.28 60.25 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.006 -0.543 . . . . 1.0600000000000001 110.453 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.33 143.55 4.59 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.909 -0.587 . . . . 1.1200000000000001 112.278 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.77 176.77 32.39 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.766 -0.73 . . . . 1.0900000000000001 111.958 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -128.31 126.31 40.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.586 0.232 . . . . 2.46 111.171 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -74.3 132.99 42.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 2.4900000000000002 110.451 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 83.1 mt -103.71 -73.23 0.68 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.362 -0.381 . . . . 1.29 110.639 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -144.83 175.4 10.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.214 -0.448 . . . . 1.1499999999999999 110.626 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.682 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 9.6 ttp85 -120.03 144.64 47.44 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.428 -0.582 . . . . 1.3200000000000001 109.428 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.616 ' HB ' HD11 ' A' ' 97' ' ' ILE . 29.9 m -103.32 145.26 30.26 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.704 0.288 . . . . 0.75 111.298 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.529 ' HD2' HD11 ' A' ' 97' ' ' ILE . 40.3 Cg_exo -59.77 155.09 45.17 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.742 2.295 . . . . 0.94999999999999996 111.751 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' A' ' 98' ' ' MET . 52.7 mm-40 -67.59 -21.09 65.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.06 -0.518 . . . . 1.51 111.276 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.97 -57.46 12.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 1.5700000000000001 110.994 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.616 HD11 ' HB ' ' A' ' 93' ' ' VAL . 5.2 pt -69.83 -23.04 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 1.3100000000000001 111.509 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.417 ' HB2' ' HA ' ' A' ' 95' ' ' GLU . 40.0 mmm -67.75 -34.9 77.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 1.6000000000000001 109.813 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -67.04 -30.71 70.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.583 . . . . 2.2999999999999998 110.083 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -62.57 -31.16 71.92 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.781 -0.645 . . . . 1.6399999999999999 110.481 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.54 -48.97 23.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.506 -0.77 . . . . 1.03 109.76 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.42 -37.08 79.73 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.966 -0.561 . . . . 1.22 111.351 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.88 -40.01 97.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.908 -0.663 . . . . 1.03 111.928 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.0 mtt85 -75.77 -38.7 58.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.947 0.403 . . . . 1.72 110.739 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.651 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 82.8 mt -59.37 -41.82 90.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.906 -0.588 . . . . 1.02 111.109 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.2 m -63.83 -20.86 66.12 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.23 0.455 . . . . 1.1100000000000001 112.23 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -90.89 -35.63 14.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.812 0.339 . . . . 1.5 111.508 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.474 HG12 ' HA ' ' A' ' 105' ' ' LEU . 49.9 pt -78.04 -14.7 14.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 113.114 0.783 . . . . 1.1499999999999999 113.114 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 105' ' ' LEU . 61.8 mt -78.32 65.3 3.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.086 0.47 . . . . 0.97999999999999998 110.932 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.758 -0.655 . . . . 1.3500000000000001 110.632 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 121.098 0.475 . . . . 2.0299999999999998 111.335 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -76.33 -34.99 58.99 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.232 -1.025 . . . . 2.8199999999999998 108.232 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 68.35 140.45 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.613 -1.176 . . . . 2.3199999999999998 112.853 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' B' ' 92' ' ' ARG . . . 90.53 -10.48 74.4 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.814 -0.708 . . . . 1.28 112.54 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -76.84 99.14 5.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.875 0.369 . . . . 1.53 111.536 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.505 HD12 ' HG3' ' B' ' 91' ' ' GLU . 20.6 mt -89.02 122.42 40.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.907 -0.588 . . . . 0.75 110.816 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -122.32 134.34 54.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.088 -0.505 . . . . 0.81000000000000005 109.877 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.493 ' HB2' HD11 ' B' ' 90' ' ' LEU . 4.0 tt -95.14 123.06 38.43 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.66 -0.246 . . . . 1.05 110.587 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.18 154.73 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.71999999999999997 110.76 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 67.8 m -76.63 126.08 30.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.439 -0.346 . . . . 1.6299999999999999 111.215 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.569 ' HB3' ' NH2' ' B' ' 78' ' ' ARG . 88.7 mt -87.53 -21.28 25.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.82999999999999996 112.003 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.06 162.9 62.68 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.544 -0.298 . . . . 1.6200000000000001 111.007 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.18 152.96 98.91 Favored 'Cis proline' 0 C--N 1.352 0.712 0 C-N-CA 123.82 -1.325 . . . . 1.28 113.214 0.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.538 ' OG1' ' HB3' ' B' ' 20' ' ' GLN . 6.2 p -123.93 145.04 49.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.576 -0.738 . . . . 1.47 110.406 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -132.79 108.32 8.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.923 0.392 . . . . 1.22 110.665 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.28 -133.96 11.73 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.897 -0.668 . . . . 1.01 111.79 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -101.32 23.79 10.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.658 0.266 . . . . 2.1800000000000002 111.504 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -71.39 150.48 44.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.039 -0.528 . . . . 1.28 110.799 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -69.39 116.0 9.31 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.642 -0.503 . . . . 1.52 109.642 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.538 ' HB3' ' OG1' ' B' ' 14' ' ' THR . 1.2 pt20 -103.23 173.11 6.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.12 -0.491 . . . . 1.8600000000000001 112.203 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.66 138.31 4.05 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.759 -0.655 . . . . 0.90000000000000002 113.332 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 91.7 m -70.01 130.65 42.73 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.351 -0.611 . . . . 0.94999999999999996 109.351 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -159.74 160.94 27.41 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.503 -0.317 . . . . 1.5900000000000001 110.374 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -66.02 131.97 28.66 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.629 2.219 . . . . 0.65000000000000002 110.836 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.725 HG12 ' HA ' ' B' ' 44' ' ' PRO . 18.4 m -125.43 157.81 34.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.388 -0.369 . . . . 0.56999999999999995 110.938 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -103.88 133.18 49.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.954 -0.566 . . . . 1.1699999999999999 109.942 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' B' ' 40' ' ' PRO . 54.6 mt -85.81 123.37 39.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.741 0.305 . . . . 0.66000000000000003 110.958 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.69 49.44 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.496 0.665 . . . . 0.93000000000000005 110.081 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' THR . . . . . . . . . . . . . 8.1 m -143.34 122.75 7.53 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.918 -0.583 . . . . 0.81000000000000005 109.879 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 108' ' ' ILE . 88.8 Cg_exo -48.62 128.1 17.59 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.078 2.518 . . . . 0.78000000000000003 112.405 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.72 -30.66 67.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.962 -0.563 . . . . 1.03 111.536 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.9 -32.83 71.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 1.3999999999999999 111.211 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -94.57 -21.42 18.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.174 0.511 . . . . 1.5700000000000001 110.266 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -58.71 -35.6 72.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.748 -0.66 . . . . 1.6399999999999999 110.649 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.8 -20.33 65.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.265 -0.425 . . . . 2.54 111.73 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.06 -58.97 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.793 0.664 . . . . 1.0900000000000001 112.793 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 1.2 p -86.51 -33.81 20.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.569 0.581 . . . . 1.3300000000000001 112.569 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 67.43 24.51 8.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.309 0.576 . . . . 1.78 111.197 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.63 88.69 16.2 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.517 -0.765 . . . . 1.1599999999999999 109.301 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' PRO . . . . . 0.55 ' HB2' HG23 ' B' ' 27' ' ' ILE . 90.2 Cg_endo -85.98 149.29 9.51 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.678 2.252 . . . . 0.56999999999999995 113.384 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.409 HG22 ' HB ' ' B' ' 79' ' ' THR . 6.1 t -86.53 124.55 40.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.555 -0.906 . . . . 1.0800000000000001 108.555 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.449 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 31.1 m -119.65 154.58 22.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.237 0.458 . . . . 0.64000000000000001 112.237 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 m -118.06 127.6 26.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.494 -0.775 . . . . 1.1000000000000001 109.444 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.725 ' HA ' HG12 ' B' ' 25' ' ' VAL . 94.4 Cg_endo -80.12 160.56 23.58 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.934 2.422 . . . . 0.72999999999999998 113.031 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.612 HG12 ' HA ' ' B' ' 72' ' ' VAL . 31.5 m -115.55 145.52 21.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.943 -0.571 . . . . 0.90000000000000002 110.519 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 27.9 m -95.39 124.2 39.31 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.534 -0.543 . . . . 1.1699999999999999 109.534 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.87 131.55 49.84 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.569 0.581 . . . . 1.8500000000000001 112.569 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . 0.701 ' HA3' ' HE1' ' B' ' 51' ' ' PHE . . . -124.11 -171.06 13.39 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.607 -0.597 . . . . 2.2200000000000002 111.607 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.21 60.59 0.56 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.551 -0.833 . . . . 3.4300000000000002 112.693 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . 0.422 ' HA ' ' CG ' ' B' ' 62' ' ' ASP . 5.1 t-20 66.58 80.1 0.22 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.206 0.527 . . . . 4.6200000000000001 112.328 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . 0.701 ' HE1' ' HA3' ' B' ' 48' ' ' GLY . 7.2 p90 -160.1 157.6 28.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.688 -0.687 . . . . 6.2699999999999996 110.188 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.458 ' O ' ' HD2' ' B' ' 53' ' ' ARG . . . -130.38 86.5 2.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.136 0.493 . . . . 4.3899999999999997 110.758 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' B' ' 52' ' ' ALA . 13.7 mmm180 -126.95 97.98 5.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.047 -0.524 . . . . 3.9199999999999999 110.779 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.33 70.09 9.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.053 0.454 . . . . 2.75 110.194 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.1 126.89 38.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.984 -0.553 . . . . 1.96 111.487 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.0 -114.39 6.08 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.814 -0.63 . . . . 1.0800000000000001 112.497 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -116.09 16.12 16.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.925 0.393 . . . . 3.5699999999999998 110.457 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' B' ' 72' ' ' VAL . . . -96.07 111.28 23.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.087 -0.506 . . . . 1.0800000000000001 110.674 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 t -95.66 124.18 48.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.284 -0.416 . . . . 1.3400000000000001 110.195 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.44 ' HA ' HG12 ' B' ' 71' ' ' VAL . 4.7 m -77.4 123.09 26.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.733 0.642 . . . . 1.3799999999999999 112.733 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.445 ' O ' HG12 ' B' ' 64' ' ' VAL . 88.2 mt -89.75 -15.62 32.05 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.185 -1.043 . . . . 1.02 108.185 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . 0.422 ' CG ' ' HA ' ' B' ' 50' ' ' ASN . 4.0 t0 -71.48 150.42 44.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.362 -1.29 . . . . 1.79 110.499 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.79 -44.5 3.25 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.802 -0.713 . . . . 1.1499999999999999 113.469 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.502 HG11 HG13 ' B' ' 97' ' ' ILE . 3.5 p -70.1 -18.82 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.949 0.404 . . . . 1.1699999999999999 111.926 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.21 59.74 0.5 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.567 -0.825 . . . . 1.05 112.91 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' B' ' 93' ' ' VAL . 31.5 mm -128.61 137.24 57.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.131 -0.692 . . . . 1.6100000000000001 109.131 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -65.44 -36.55 84.26 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.293 0.568 . . . . 2.3999999999999999 109.874 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . 0.429 ' H ' HG22 ' B' ' 66' ' ' ILE . 11.8 m -80.0 82.17 6.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.634 -0.712 . . . . 0.93000000000000005 109.946 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . 0.411 ' HB ' ' OD2' ' B' ' 62' ' ' ASP . 23.2 p -68.48 97.52 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.861 -0.609 . . . . 1.3100000000000001 111.313 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.12 -171.53 37.87 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.637 -0.792 . . . . 0.79000000000000004 112.46 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' B' ' 60' ' ' SER . 11.9 m -118.16 132.67 67.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.555 0.217 . . . . 0.93000000000000005 111.24 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.612 ' HA ' HG12 ' B' ' 45' ' ' VAL . 30.4 t -74.78 128.78 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.434 -0.348 . . . . 1.3799999999999999 110.459 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' B' ' 73' ' ' ARG . 14.0 mmm-85 -96.95 84.78 3.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.061 0.457 . . . . 1.3700000000000001 110.319 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . 0.428 ' SG ' HG13 ' B' ' 101' ' ' VAL . 0.8 OUTLIER -68.22 -13.03 61.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.793 -0.639 . . . . 1.1599999999999999 110.538 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 33' ' ' PHE . 14.0 p-10 -87.53 7.16 30.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.769 -0.65 . . . . 1.1000000000000001 111.899 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . 0.419 ' N ' ' HD3' ' B' ' 77' ' ' PRO . 68.7 mt-30 -132.56 61.77 58.86 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 111.803 0.298 . . . . 2.4700000000000002 111.803 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' B' ' 76' ' ' GLN . 3.3 Cg_exo -77.98 119.99 4.89 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.482 2.121 . . . . 0.95999999999999996 110.83 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . 1.038 ' HG3' ' HG3' ' A' ' 78' ' ' ARG . 46.5 ttp180 -136.9 122.23 19.36 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 111.944 0.35 . . . . 1.96 111.944 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.424 HG21 ' HB3' ' A' ' 76' ' ' GLN . 9.8 t -84.03 139.9 32.21 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.218 -0.66 . . . . 1.1899999999999999 109.218 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 8.3 pt -148.86 162.69 5.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.484 -0.325 . . . . 1.28 110.374 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -77.98 94.6 4.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.201 0.524 . . . . 1.28 110.679 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' MET . . . . . 0.539 ' SD ' ' HA3' ' B' ' 87' ' ' GLY . 53.0 tpp -61.11 -24.76 66.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.302 -0.863 . . . . 2.7000000000000002 112.263 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.18 -49.25 11.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.76 0.314 . . . . 1.96 111.633 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.94 -41.46 82.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.379 -0.373 . . . . 1.0600000000000001 111.077 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -75.68 -31.83 59.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 1.47 111.334 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.57 101.83 0.88 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.86 -0.686 . . . . 0.81999999999999995 112.822 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . 0.539 ' HA3' ' SD ' ' B' ' 82' ' ' MET . . . -112.35 150.61 18.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.871 -0.68 . . . . 0.65000000000000002 112.49 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -140.58 136.68 33.05 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.403 -0.221 . . . . 1.8100000000000001 110.403 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' B' ' 89' ' ' ARG . 9.8 ttt180 -75.69 135.89 40.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.799 0.333 . . . . 2.4900000000000002 110.853 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' B' ' 8' ' ' LEU . 82.7 mt -108.14 -77.99 0.59 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.301 0.482 . . . . 0.76000000000000001 112.301 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . 0.505 ' HG3' HD12 ' B' ' 6' ' ' ILE . 11.0 pt-20 -133.1 -178.18 4.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.495 -0.32 . . . . 1.0700000000000001 111.635 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' B' ' 4' ' ' GLY . 5.2 tpt180 -121.5 122.67 40.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 2.0499999999999998 110.778 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.491 ' HB ' ' HA2' ' B' ' 4' ' ' GLY . 57.7 t -82.91 136.19 44.57 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.934 -0.575 . . . . 1.45 110.559 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.449 ' HD3' HD11 ' B' ' 66' ' ' ILE . 77.6 Cg_exo -53.66 144.57 52.57 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.837 2.358 . . . . 1.03 111.999 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.438 ' H ' ' HG2' ' B' ' 95' ' ' GLU . 4.3 mm-40 -55.9 -39.95 72.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.668 -0.696 . . . . 2.1400000000000001 111.916 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 14.2 t -57.53 -33.95 68.61 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.625 0.602 . . . . 1.78 112.625 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.502 HG13 HG11 ' B' ' 64' ' ' VAL . 48.2 mm -82.3 -36.57 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.218 0.532 . . . . 1.3300000000000001 110.206 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' MET . . . . . 0.505 ' HA ' ' HE2' ' B' ' 98' ' ' MET . 30.0 mmt -66.22 -33.27 75.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 2.3399999999999999 111.047 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -60.24 -36.23 77.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.19 0.519 . . . . 1.9099999999999999 110.414 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 3.5 mm-40 -67.67 -41.05 84.35 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.724 -0.671 . . . . 1.76 110.442 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.432 HG21 ' HE1' ' B' ' 98' ' ' MET . 93.8 t -57.54 -48.3 83.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.156 -0.475 . . . . 1.01 110.248 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.79 -40.6 97.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.744 -0.662 . . . . 1.29 110.175 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.14 -46.94 89.73 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.81 -0.632 . . . . 1.02 112.342 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 9.8 mmt180 -60.8 -41.12 95.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.858 0.361 . . . . 1.8500000000000001 110.936 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.522 HD12 HD12 ' B' ' 108' ' ' ILE . 31.8 tp -66.1 -30.67 71.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.193 -0.458 . . . . 1.9399999999999999 110.714 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 49.1 m -66.33 -34.78 78.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.175 -0.466 . . . . 1.1599999999999999 111.308 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -15.92 62.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.04 0.385 . . . . 1.45 112.04 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.522 HD12 HD12 ' B' ' 105' ' ' LEU . 60.2 mt -79.03 -23.16 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.297 0.57 . . . . 1.98 110.375 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 74.9 mt -93.8 48.02 1.25 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.757 -0.656 . . . . 1.3600000000000001 110.779 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.661 -0.685 . . . . 2.1299999999999999 110.56 179.691 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C1' 1.407 -0.579 0 C4'-C3'-C2' 103.885 1.185 . 0.0 '__' . 6.3600000000000003 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' ' U' . . . . . 0.428 ' C2 ' ' HB2' ' A' ' 58' ' ' ALA . . . . . . . . 0 O5'--C5' 1.426 -0.869 0 C4'-C3'-C2' 104.417 1.717 . 0.0 OUTLIER gamma 2.9900000000000002 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' ' A' . . . . . 0.728 ' C2 ' ' HB ' ' A' ' 46' ' ' THR . . . . . . . . 0 P--O3' 1.616 0.716 0 O4'-C1'-C2' 107.597 0.855 . 0.0 OUTLIER . 2.5899999999999999 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' ' C' . . . . . 0.523 ' C5 ' ' HA ' ' A' ' 46' ' ' THR . . . . . . . . 0 C3'--C2' 1.536 1.04 0 C4'-C3'-C2' 105.709 3.009 OUTLIER-DELTA 0.0 OUTLIER gamma 2.5099999999999998 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' ' A' . . . . . 0.838 ' C5 ' ' HA2' ' A' ' 21' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.887 0 O4'-C1'-C2' 107.866 1.047 . 0.0 OUTLIER . 4.9400000000000004 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.625 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 14.2 ptp . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.958 0.408 . . . . 1.29 110.742 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.45 ' HG2' ' H ' ' A' ' 3' ' ' ARG . 14.3 tt0 -108.66 167.15 10.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.674 -0.694 . . . . 2.0099999999999998 110.231 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.45 ' H ' ' HG2' ' A' ' 2' ' ' GLU . 29.8 ttm180 -69.01 129.27 39.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.287 -0.415 . . . . 1.8500000000000001 109.99 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.35 -7.46 34.67 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.558 -0.83 . . . . 0.85999999999999999 112.828 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.625 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 31.2 mt-10 -81.42 147.36 29.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.826 0.313 . . . . 0.98999999999999999 111.271 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.542 HD11 HG13 ' A' ' 93' ' ' VAL . 32.6 mt -111.45 121.67 64.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 1.1599999999999999 110.751 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -118.43 147.48 43.54 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.91000000000000003 110.145 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 tp -102.91 130.09 49.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.939 -0.119 . . . . 0.90000000000000002 110.717 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -169.74 154.62 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.237 0.336 . . . . 1.04 110.421 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.0 m -80.97 141.25 34.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.714 0.292 . . . . 1.3200000000000001 110.435 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.574 HD11 ' HD3' ' A' ' 23' ' ' ARG . 53.8 mt -82.85 -7.79 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 1.29 111.03 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.585 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 1.6 m-20 -65.45 162.45 41.79 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.412 -0.813 . . . . 1.54 110.153 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.727 ' HB2' ' HG2' ' B' ' 13' ' ' PRO . 5.9 Cg_exo -78.57 141.35 64.03 Favored 'Cis proline' 0 C--O 1.236 0.385 0 C-N-CA 123.716 -1.368 . . . . 1.6899999999999999 111.726 -0.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.859 ' HB ' ' HB3' ' A' ' 18' ' ' GLU . 24.0 p -117.58 171.77 7.79 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.224 -0.444 . . . . 1.3600000000000001 110.536 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.28 137.57 39.14 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.434 -0.58 . . . . 1.7 109.434 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.54 -116.02 5.27 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.71 -0.757 . . . . 1.1799999999999999 112.995 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -113.05 17.4 18.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.531 0.205 . . . . 2.7799999999999998 111.136 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.859 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 18.8 tt0 -59.26 137.45 57.97 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.251 -0.431 . . . . 1.1399999999999999 110.004 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.76 118.39 4.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.492 -0.322 . . . . 2.0899999999999999 111.204 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.456 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 3.1 pt20 -124.42 164.01 20.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.169 -0.469 . . . . 2.0899999999999999 110.674 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.541 ' HA2' " H2'" ' C' ' 5' ' ' ' A' . . . 112.05 150.36 11.32 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.608 -0.806 . . . . 1.0700000000000001 113.595 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 0.4 OUTLIER -72.47 113.9 10.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.875 0.369 . . . . 1.1100000000000001 110.124 179.159 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.574 ' HD3' HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -142.96 160.51 52.61 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.372 -0.376 . . . . 1.6200000000000001 110.173 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.31 134.18 24.24 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.468 2.112 . . . . 1.01 111.056 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.795 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 15.3 m -119.28 136.08 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 110.005 -0.368 . . . . 0.76000000000000001 110.005 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.425 ' HB3' HG23 ' A' ' 43' ' ' VAL . 21.8 tp -94.35 128.72 41.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.083 -0.508 . . . . 0.69999999999999996 111.437 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.448 HD13 ' CG1' ' A' ' 42' ' ' VAL . 14.2 mm -73.32 114.56 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.345 -0.389 . . . . 0.92000000000000004 110.127 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.42 ' HA ' ' CE ' ' A' ' 98' ' ' MET . 88.2 t -90.33 -41.82 13.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.002 0.43 . . . . 0.94999999999999996 111.953 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.69 147.18 96.36 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 112.04 0.385 . . . . 1.1200000000000001 112.04 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.45 159.12 54.76 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.767 2.311 . . . . 1.3 111.986 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.61 70.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.982 -0.554 . . . . 1.3899999999999999 112.348 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.29 94.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.846 0.355 . . . . 1.6100000000000001 110.948 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -66.48 -41.2 89.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.039 -0.528 . . . . 1.77 110.482 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 66.9 m-20 -67.54 -11.82 58.92 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.034 -0.53 . . . . 1.48 110.886 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.8 ttp-105 -94.79 -31.96 13.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.175 -0.466 . . . . 2.6200000000000001 111.212 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.41 -49.08 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.824 0.676 . . . . 1.8600000000000001 112.824 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 p -95.27 -27.05 15.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.953 0.406 . . . . 1.72 110.564 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 67.13 21.25 10.15 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.367 -0.833 . . . . 4.4500000000000002 111.395 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.0 mt -125.65 98.98 33.37 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.393 -0.821 . . . . 1.8100000000000001 109.027 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.438 ' HG3' ' SD ' ' A' ' 1' ' ' MET . 90.1 Cg_endo -88.55 134.54 2.85 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.806 2.337 . . . . 1.05 113.775 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.9 t -79.21 114.37 19.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.193 -1.41 . . . . 1.03 107.193 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.795 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 31.5 m -115.66 150.61 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 113.44 0.904 . . . . 0.77000000000000002 113.44 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 26' ' ' LEU . 1.7 m -117.97 129.03 25.62 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.931 -1.031 . . . . 0.71999999999999997 108.96 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 43' ' ' VAL . 12.2 Cg_exo -70.35 145.44 53.77 Favored 'Trans proline' 0 CA--C 1.527 0.17 0 C-N-CA 123.186 2.591 . . . . 1.03 113.871 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.8 t -107.49 119.9 57.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.509 -0.923 . . . . 1.28 108.509 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.431 HG21 H5'' ' C' ' 4' ' ' ' C' . 39.4 m -154.05 123.56 6.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.521 0.201 . . . . 1.9099999999999999 111.172 -179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.542 ' HB3' HG23 ' A' ' 71' ' ' VAL . 2.2 p -111.67 -5.49 14.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.501 -0.318 . . . . 2.5299999999999998 110.932 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.701 ' HA3' " O2'" ' C' ' 3' ' ' ' A' . . . 66.23 38.84 94.16 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 110.866 -0.894 . . . . 3.3599999999999999 110.866 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.4 -116.51 5.1 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.571 -1.012 . . . . 3.8300000000000001 110.571 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -112.27 16.0 20.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.191 0.519 . . . . 4.7199999999999998 110.312 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -91.62 48.59 1.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.883 -0.599 . . . . 6.2400000000000002 111.257 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.18 102.26 2.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.225 -0.443 . . . . 2.5899999999999999 110.241 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.628 ' HG3' ' C6 ' ' C' ' 3' ' ' ' A' . 0.4 OUTLIER -122.93 166.74 14.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.966 0.412 . . . . 4.5899999999999999 111.846 -179.249 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.17 87.78 2.77 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.758 -0.655 . . . . 2.6899999999999999 109.422 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.82 113.7 18.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.984 -0.553 . . . . 3.1699999999999999 110.593 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.51 -119.34 5.28 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.848 -0.691 . . . . 1.6599999999999999 112.338 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.477 ' HD2' ' HB3' ' A' ' 104' ' ' ARG . 58.9 m-85 -106.06 69.07 0.79 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.127 0.489 . . . . 1.5600000000000001 111.328 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.19 138.45 29.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.9 -0.591 . . . . 1.25 110.03 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.691 HG21 HG22 ' A' ' 101' ' ' VAL . 17.7 t -116.25 118.24 58.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.601 -0.272 . . . . 1.6799999999999999 110.882 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.7 118.87 20.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.609 -0.269 . . . . 1.95 111.117 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.445 ' HB3' HD11 ' A' ' 66' ' ' ILE . 83.3 mt -82.87 -18.61 39.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.233 0.54 . . . . 1.23 110.58 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -67.37 117.04 8.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.566 -0.743 . . . . 2.21 109.954 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.78 -31.4 2.21 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.381 -0.688 . . . . 1.1499999999999999 111.381 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 61' ' ' LEU . 34.7 m -83.18 -17.26 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.835 0.35 . . . . 1.21 111.502 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.58 83.07 0.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.849 -0.691 . . . . 1.0800000000000001 112.68 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 61' ' ' LEU . 11.7 pt -138.44 169.67 17.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.838 -0.43 . . . . 1.0700000000000001 109.838 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -76.5 -51.73 11.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.79 0.329 . . . . 3.5899999999999999 110.586 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.9 m -85.34 75.88 10.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.269 0.557 . . . . 1.51 110.948 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.02 158.47 29.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.759 -0.655 . . . . 1.79 111.322 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 156.42 -157.34 27.83 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 121.069 -0.586 . . . . 1.1799999999999999 111.744 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.542 HG23 ' HB3' ' A' ' 47' ' ' SER . 69.6 t -130.04 126.39 61.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 110.178 -0.305 . . . . 1.5600000000000001 110.178 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.7 t -72.56 118.94 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.318 -0.623 . . . . 1.29 109.318 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -92.89 96.03 9.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.241 -0.436 . . . . 2.23 110.971 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.16 -6.04 57.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.538 0.685 . . . . 1.1699999999999999 109.373 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.452 ' HA ' ' CZ ' ' B' ' 33' ' ' PHE . 3.9 p-10 -78.98 -16.2 57.24 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.902 -1.045 . . . . 0.89000000000000001 112.689 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -136.83 68.71 58.47 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 114.138 1.162 . . . . 2.1299999999999999 114.138 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.79 140.73 32.63 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.289 1.993 . . . . 0.80000000000000004 109.914 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.462 ' HD3' HD13 ' A' ' 11' ' ' LEU . 6.1 ptm85 -156.21 114.15 3.31 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.823 0.675 . . . . 2.0899999999999999 112.823 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.536 ' OG1' ' HD2' ' B' ' 77' ' ' PRO . 90.8 m -82.76 109.94 17.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.154 -0.476 . . . . 1.6200000000000001 110.089 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.0 pt -120.96 155.18 24.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.038 -0.528 . . . . 1.1499999999999999 109.641 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.53 125.77 26.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.976 0.417 . . . . 1.03 111.5 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.45 ' SD ' ' HA3' ' A' ' 87' ' ' GLY . 40.3 tpp -103.08 9.24 38.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.094 0.473 . . . . 1.29 110.718 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -92.94 -64.21 1.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.173 -0.467 . . . . 2.6400000000000001 111.854 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.58 -27.96 63.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.293 -0.412 . . . . 1.1200000000000001 111.305 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 85' ' ' ARG . 45.8 mtt180 -73.81 -29.86 62.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.253 -0.431 . . . . 1.0600000000000001 110.502 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.32 66.94 2.09 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.896 -0.669 . . . . 1.1200000000000001 112.355 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.45 ' HA3' ' SD ' ' A' ' 82' ' ' MET . . . -69.14 151.94 51.67 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.713 -0.756 . . . . 1.0900000000000001 112.27 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -113.43 122.12 46.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.31 -0.255 . . . . 2.46 110.31 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -82.18 135.28 35.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.655 0.264 . . . . 2.4900000000000002 111.224 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 90' ' ' LEU . 3.0 mm? -104.27 -64.68 1.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.134 0.492 . . . . 1.29 110.616 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -162.95 -169.07 1.93 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.791 -0.64 . . . . 1.1499999999999999 109.346 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -130.77 156.48 44.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.684 0.278 . . . . 1.3200000000000001 110.579 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.542 HG13 HD11 ' A' ' 6' ' ' ILE . 26.8 m -97.33 156.59 36.05 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.39 -0.368 . . . . 0.75 111.085 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -64.19 145.52 89.09 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.721 2.281 . . . . 0.94999999999999996 111.129 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -61.19 -25.7 67.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 1.51 111.662 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -38.43 87.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.877 0.37 . . . . 1.5700000000000001 110.577 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 101' ' ' VAL . 47.7 mm -73.56 -46.48 48.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.96 -0.564 . . . . 1.3100000000000001 109.921 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.42 ' CE ' ' HA ' ' A' ' 28' ' ' VAL . 9.8 tpt -63.03 -26.05 68.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.953 -0.567 . . . . 1.6000000000000001 110.99 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.15 -48.22 79.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.673 -0.694 . . . . 2.2999999999999998 111.634 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -28.41 60.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.543 -0.299 . . . . 1.6399999999999999 111.55 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.691 HG22 HG21 ' A' ' 59' ' ' VAL . 57.8 t -62.2 -46.93 95.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.699 -0.482 . . . . 1.03 109.699 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 77.7 mt -61.34 -36.38 80.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.614 -0.721 . . . . 1.22 110.185 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.31 -46.18 94.95 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.479 -0.782 . . . . 1.03 112.453 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.477 ' HB3' ' HD2' ' A' ' 57' ' ' PHE . 21.5 mtt180 -65.4 -37.84 88.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 1.72 110.77 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.61 -18.27 65.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.757 -0.656 . . . . 1.02 112.253 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.1 m -78.82 -24.96 44.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.938 0.399 . . . . 1.1100000000000001 111.164 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.75 -22.25 50.56 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.124 0.416 . . . . 1.5 112.124 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.0 pt -84.23 -9.22 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 111.96 0.356 . . . . 1.1499999999999999 111.96 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.3 mt -84.2 73.03 10.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.897 0.379 . . . . 0.97999999999999998 110.092 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 116.361 -0.381 . . . . 1.3500000000000001 111.666 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.882 ' HA ' ' HA ' ' B' ' 30' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.743 0.306 . . . . 2.0299999999999998 110.881 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -82.27 -21.53 36.18 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.328 -0.619 . . . . 2.8199999999999998 109.328 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . 0.713 ' HG2' ' HG2' ' B' ' 98' ' ' MET . 6.4 mtm180 72.14 120.9 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.946 -1.024 . . . . 2.3199999999999998 112.903 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' B' ' 92' ' ' ARG . . . 97.47 -26.76 21.66 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.741 -0.663 . . . . 1.28 113.679 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.427 ' OE1' ' HD2' ' B' ' 89' ' ' ARG . 6.5 mm-40 -71.08 97.84 1.55 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.848 0.685 . . . . 1.53 112.848 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.84 HD11 ' HB ' ' B' ' 93' ' ' VAL . 64.5 mt -95.26 125.91 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.851 -0.796 . . . . 0.75 108.851 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -105.78 164.78 11.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.986 0.422 . . . . 0.81000000000000005 112.007 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 45.8 tp -128.87 120.04 25.51 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.05 -0.523 . . . . 1.05 109.949 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.46 HG22 ' H ' ' B' ' 10' ' ' SER . 4.8 p -159.69 169.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.251 -0.431 . . . . 0.71999999999999997 110.122 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . 0.46 ' H ' HG22 ' B' ' 9' ' ' VAL . 0.3 OUTLIER -97.77 135.54 39.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.779 0.323 . . . . 1.6299999999999999 110.472 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' B' ' 44' ' ' PRO . 35.3 mt -86.28 -18.26 32.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.234 -0.439 . . . . 0.82999999999999996 111.189 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.96 154.24 89.81 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.915 -0.584 . . . . 1.6200000000000001 111.116 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.727 ' HG2' ' HB2' ' A' ' 13' ' ' PRO . 58.5 Cg_endo -73.47 124.28 9.38 Favored 'Cis proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.266 -1.556 . . . . 1.28 113.041 0.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.489 ' HB ' ' HG2' ' B' ' 20' ' ' GLN . 0.0 OUTLIER -121.93 166.85 13.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.554 -0.748 . . . . 1.47 109.918 179.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.87 -171.24 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.582 0.23 . . . . 1.22 111.069 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 66.96 -104.92 1.18 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 116.081 -0.508 . . . . 1.01 112.702 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -132.43 14.52 4.54 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.293 0.568 . . . . 2.1800000000000002 110.285 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -78.07 143.95 36.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.735 -0.666 . . . . 1.28 110.061 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.08 105.47 2.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.763 0.316 . . . . 1.52 111.224 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.489 ' HG2' ' HB ' ' B' ' 14' ' ' THR . 6.7 mt-30 -83.89 -174.73 5.45 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.112 -0.495 . . . . 1.8600000000000001 110.913 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.05 -167.11 49.25 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.95 -0.568 . . . . 0.90000000000000002 112.752 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 20.1 m -113.89 122.27 46.49 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.428 -0.582 . . . . 0.94999999999999996 109.428 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -151.61 159.99 32.42 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.681 -0.488 . . . . 1.5900000000000001 109.681 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.674 ' HG2' HG21 ' B' ' 68' ' ' THR . 47.2 Cg_exo -59.47 137.76 79.86 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.192 1.928 . . . . 0.65000000000000002 110.671 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.863 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 4.3 m -128.09 128.13 68.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.989 0.424 . . . . 0.56999999999999995 111.126 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 46.7 tp -94.44 121.2 35.74 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.961 -0.563 . . . . 1.1699999999999999 109.605 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . 0.504 HG12 HG12 ' B' ' 42' ' ' VAL . 51.5 mt -80.86 137.82 20.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.956 -0.387 . . . . 0.66000000000000003 109.956 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.87 -29.39 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.821 0.344 . . . . 0.93000000000000005 111.051 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' THR . . . . . 0.543 HG23 HG22 ' B' ' 41' ' ' VAL . 0.9 OUTLIER -74.06 137.31 75.89 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.258 -0.428 . . . . 0.81000000000000005 111.615 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.882 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 43.1 Cg_endo -67.2 161.42 42.99 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.009 2.473 . . . . 0.78000000000000003 112.045 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.77 -37.08 73.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.169 -0.468 . . . . 1.03 111.677 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.51 -29.99 71.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.114 0.483 . . . . 1.3999999999999999 111.176 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . 0.548 ' HB2' ' HG2' ' B' ' 30' ' ' PRO . 2.2 t80 -81.13 -40.01 24.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.033 0.444 . . . . 1.5700000000000001 110.135 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' B' ' 38' ' ' ARG . 44.8 m-20 -66.52 -22.32 66.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.63 -0.713 . . . . 1.6399999999999999 110.725 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -79.75 -34.83 39.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 2.54 110.948 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 58.0 t -85.4 -64.21 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.156 -0.475 . . . . 1.0900000000000001 111.987 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 1.3 m -67.51 -30.77 70.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.385 -0.37 . . . . 1.3300000000000001 111.014 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.534 ' HE ' ' HA ' ' B' ' 38' ' ' ARG . 0.7 OUTLIER 71.69 -9.84 0.9 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.534 0.568 . . . . 1.78 112.534 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 60.4 mt -118.62 100.93 51.09 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.681 -0.489 . . . . 1.1599999999999999 109.681 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' PRO . . . . . 0.46 ' HD2' ' O ' ' B' ' 80' ' ' ILE . 93.1 Cg_endo -86.68 158.96 9.14 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.742 2.295 . . . . 0.56999999999999995 113.322 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.543 HG22 HG23 ' B' ' 29' ' ' THR . 6.4 m -92.95 127.2 45.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 109.202 -0.666 . . . . 1.0800000000000001 109.202 178.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.863 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 27.8 m -114.68 146.78 18.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.252 0.549 . . . . 0.64000000000000001 112.148 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.428 HG13 ' O ' ' B' ' 73' ' ' ARG . 43.1 t -109.84 112.91 57.87 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.944 -1.026 . . . . 1.1000000000000001 109.279 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.522 ' HB3' HD11 ' B' ' 11' ' ' LEU . 56.0 Cg_endo -72.06 119.42 6.16 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.69 2.26 . . . . 0.72999999999999998 112.567 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 91.6 t -77.49 136.44 24.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.812 -0.631 . . . . 0.90000000000000002 110.202 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 3.9 m -105.07 112.01 24.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.129 -0.487 . . . . 1.1699999999999999 110.097 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.49 127.54 32.58 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.184 -0.462 . . . . 1.8500000000000001 110.64 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.72 16.96 36.58 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.531 -0.842 . . . . 2.2200000000000002 112.744 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.31 -92.89 0.33 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.977 -0.63 . . . . 3.4300000000000002 111.985 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -127.83 -48.58 1.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.138 0.494 . . . . 4.6200000000000001 110.293 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -85.17 93.82 8.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.063 -0.517 . . . . 6.2699999999999996 110.654 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -127.83 100.52 5.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.027 -0.533 . . . . 4.3899999999999997 110.579 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -115.99 -173.47 2.36 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.013 -0.539 . . . . 3.9199999999999999 110.571 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 13.6 t -82.7 129.14 34.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.4 0.619 . . . . 2.75 112.605 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -116.45 64.6 0.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.469 -0.787 . . . . 1.96 109.995 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.95 -94.24 0.78 Allowed Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.77 -0.65 . . . . 1.0800000000000001 112.464 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -87.72 -6.64 58.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.921 0.391 . . . . 3.5699999999999998 111.096 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.36 113.91 22.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.36 -0.382 . . . . 1.0800000000000001 110.392 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.453 HG22 ' HD2' ' B' ' 104' ' ' ARG . 13.8 t -77.79 141.29 15.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.03 -0.532 . . . . 1.3400000000000001 110.335 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -90.2 124.94 35.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.54 -0.3 . . . . 1.3799999999999999 110.709 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.516 ' HB3' HD13 ' B' ' 66' ' ' ILE . 72.4 mt -89.97 -35.68 15.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.267 -0.424 . . . . 1.02 110.868 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -82.87 -173.22 4.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 1.79 111.321 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.92 -38.46 3.17 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.162 -0.775 . . . . 1.1499999999999999 111.162 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 7.0 p -94.85 -3.35 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.953 0.406 . . . . 1.1699999999999999 110.679 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.88 84.29 1.68 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.789 -0.719 . . . . 1.05 112.597 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.516 HD13 ' HB3' ' B' ' 61' ' ' LEU . 12.0 tt -135.3 160.58 40.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.798 -0.445 . . . . 1.6100000000000001 109.798 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -83.5 -45.13 13.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.864 0.364 . . . . 2.3999999999999999 110.705 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . 0.674 HG21 ' HG2' ' B' ' 24' ' ' PRO . 17.1 m -85.46 90.52 7.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.154 0.502 . . . . 0.93000000000000005 111.643 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 52.7 m -71.46 98.1 1.77 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.804 -0.634 . . . . 1.3100000000000001 111.016 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -165.05 -171.2 31.0 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.793 -0.717 . . . . 0.79000000000000004 112.152 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 15.1 m -117.58 151.97 19.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.862 0.363 . . . . 0.93000000000000005 111.131 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.451 ' HB ' ' HB ' ' B' ' 59' ' ' VAL . 47.3 t -87.92 121.96 39.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.904 -0.589 . . . . 1.3799999999999999 110.219 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.428 ' O ' HG13 ' B' ' 43' ' ' VAL . 33.3 mmm-85 -97.25 84.93 3.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.953 0.406 . . . . 1.3700000000000001 111.138 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 29.6 m -73.67 -0.75 16.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.189 -0.459 . . . . 1.1599999999999999 111.228 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.44 ' C ' ' HD3' ' B' ' 77' ' ' PRO . 16.9 p-10 -96.06 -2.8 45.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.977 -0.556 . . . . 1.1000000000000001 111.939 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . 0.55 ' N ' ' HD3' ' B' ' 77' ' ' PRO . 39.3 mt-30 -130.16 52.45 9.42 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.538 0.94 . . . . 2.4700000000000002 113.538 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' B' ' 76' ' ' GLN . 1.0 OUTLIER -84.87 119.4 2.18 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.269 1.979 . . . . 0.95999999999999996 111.49 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -125.61 140.34 52.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.705 0.288 . . . . 1.96 111.453 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.18 126.98 31.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.679 -0.86 . . . . 1.1899999999999999 108.679 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.46 ' O ' ' HD2' ' B' ' 40' ' ' PRO . 31.5 pt -133.8 149.54 30.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.389 0.514 . . . . 1.28 112.389 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' B' ' 83' ' ' LYS . 14.1 t0 -76.41 91.71 3.32 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.277 -0.638 . . . . 1.28 109.277 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' MET . . . . . 0.451 ' SD ' ' HA3' ' B' ' 87' ' ' GLY . 48.5 tpp -67.76 -16.71 64.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.976 -0.556 . . . . 2.7000000000000002 111.869 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' B' ' 81' ' ' ASP . 5.0 mtmp? -75.91 -45.58 34.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.282 -0.417 . . . . 1.96 111.111 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.98 -31.69 25.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.236 -0.438 . . . . 1.0600000000000001 111.88 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' B' ' 85' ' ' ARG . 66.1 mtt-85 -72.61 -36.01 67.98 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.943 0.349 . . . . 1.47 111.943 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.64 80.1 1.44 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.351 -0.928 . . . . 0.81999999999999995 112.108 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . 0.451 ' HA3' ' SD ' ' B' ' 82' ' ' MET . . . -90.55 162.0 28.93 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.746 -0.74 . . . . 0.65000000000000002 112.749 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -155.96 155.37 32.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.661 -0.866 . . . . 1.8100000000000001 108.661 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.427 ' HD2' ' OE1' ' B' ' 5' ' ' GLU . 5.6 ttp180 -99.35 142.26 31.06 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 121.083 -0.247 . . . . 2.4900000000000002 111.144 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 53.5 mt -108.39 -97.06 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.95 0.352 . . . . 0.76000000000000001 111.95 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . 0.436 ' HG3' HD12 ' B' ' 6' ' ' ILE . 15.5 pt-20 -106.89 169.86 8.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.466 -0.334 . . . . 1.0700000000000001 111.153 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' B' ' 4' ' ' GLY . 3.7 ttt180 -110.72 106.06 15.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.373 -0.376 . . . . 2.0499999999999998 110.417 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.84 ' HB ' HD11 ' B' ' 6' ' ' ILE . 14.4 p -69.37 133.05 89.36 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.405 -0.361 . . . . 1.45 110.851 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.8 147.11 33.09 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.002 2.468 . . . . 1.03 112.52 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -60.67 -28.32 68.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.852 -0.613 . . . . 2.1400000000000001 110.937 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -47.16 86.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.762 -0.654 . . . . 1.78 110.768 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 51.6 mm -74.66 -40.07 47.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.545 . . . . 1.3300000000000001 110.199 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' MET . . . . . 0.713 ' HG2' ' HG2' ' B' ' 3' ' ' ARG . 8.8 tpt -58.56 -38.01 76.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.9 -0.591 . . . . 2.3399999999999999 110.981 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -60.94 -39.35 89.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.917 0.389 . . . . 1.9099999999999999 110.701 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -67.14 -27.63 67.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 1.76 111.257 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.444 ' HA ' HG21 ' B' ' 59' ' ' VAL . 63.3 t -70.94 -51.27 36.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.414 -0.587 . . . . 1.01 109.414 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.23 -36.59 81.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.585 -0.734 . . . . 1.29 110.821 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.23 -50.88 63.07 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.936 -0.575 . . . . 1.02 112.079 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . 0.453 ' HD2' HG22 ' B' ' 59' ' ' VAL . 77.2 mtt85 -62.95 -35.89 81.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.72 0.295 . . . . 1.8500000000000001 110.893 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 35.4 mt -66.03 -31.2 71.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.247 0.546 . . . . 1.9399999999999999 110.115 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -80.81 -18.73 46.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.793 -0.64 . . . . 1.1599999999999999 110.858 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 7.8 m -74.13 -38.88 63.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.296 -0.411 . . . . 1.45 110.841 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 34.6 pt -76.29 2.25 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 111.982 0.364 . . . . 1.98 111.982 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 86.2 mt -82.97 -13.84 55.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.345 -0.389 . . . . 1.3600000000000001 111.138 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.802 -0.618 . . . . 2.1299999999999999 110.273 179.65 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' ' A' . . . . . 0.643 ' N3 ' " H2'" ' C' ' 1' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.429 -0.684 0 C1'-C2'-O2' 108.238 -0.787 . 0.0 '__' . 6.3600000000000003 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 O4'-C1'-C2' 104.635 -1.261 . 0.0 OUTLIER zeta-1 2.9900000000000002 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' ' A' . . . . . 0.701 " O2'" ' HA3' ' A' ' 48' ' ' GLY . . . . . . . . 0 O5'--C5' 1.424 -0.971 0 O4'-C1'-C2' 108.376 1.412 . 0.0 OUTLIER . 2.5899999999999999 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' ' C' . . . . . 0.431 H5'' HG21 ' A' ' 46' ' ' THR . . . . . . . . 0 C4'--C3' 1.533 0.808 0 C4'-C3'-C2' 104.18 1.48 . 0.0 OUTLIER . 2.5099999999999998 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' ' A' . . . . . 0.541 " H2'" ' HA2' ' A' ' 21' ' ' GLY . . . . . . . . 0 O5'--C5' 1.428 -0.731 0 C3'-C2'-O2' 110.962 -0.806 . 0.0 OUTLIER gamma 4.9400000000000004 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.578 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 24.4 ptp . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.887 0.375 . . . . 1.29 110.474 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -129.23 158.4 39.14 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.971 -0.559 . . . . 2.0099999999999998 110.55 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -61.64 122.61 15.73 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 110.037 -0.357 . . . . 1.8500000000000001 110.037 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 111.09 -8.85 29.22 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.914 -0.66 . . . . 0.85999999999999999 112.055 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.578 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 49.7 mt-10 -85.8 145.35 27.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.88 0.371 . . . . 0.98999999999999999 111.365 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.414 HD11 HG13 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -110.12 110.75 33.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.259 -0.645 . . . . 1.1599999999999999 109.259 179.083 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 89' ' ' ARG . 27.2 m95 -104.67 135.22 46.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.934 0.397 . . . . 0.91000000000000003 111.294 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.764 ' HB2' HD21 ' A' ' 90' ' ' LEU . 25.6 tp -95.51 122.3 38.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.26 -0.427 . . . . 0.90000000000000002 110.822 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 p -160.87 157.24 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 1.04 109.936 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.642 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -89.17 130.01 35.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.841 -0.429 . . . . 1.3200000000000001 109.841 179.38 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.6 mt -78.96 -10.51 59.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.252 -0.431 . . . . 1.29 110.952 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.531 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 5.1 m-20 -73.23 164.47 60.78 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.707 -0.679 . . . . 1.54 110.922 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.531 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 56.2 Cg_endo -69.99 141.12 65.08 Favored 'Cis proline' 0 C--N 1.347 0.49 0 C-N-CA 123.815 -1.327 . . . . 1.6899999999999999 112.533 0.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.522 HG23 ' HA ' ' A' ' 12' ' ' ASP . 23.0 p -120.35 151.81 38.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.296 -0.411 . . . . 1.3600000000000001 111.276 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.85 125.47 11.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.931 -0.577 . . . . 1.7 109.689 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.38 -124.54 6.76 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.206 -0.758 . . . . 1.1799999999999999 111.206 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -139.99 75.54 1.51 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.148 0.499 . . . . 2.7799999999999998 110.948 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.86 166.79 23.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.567 -0.742 . . . . 1.1399999999999999 109.414 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -63.2 128.03 34.0 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.406 0.441 . . . . 2.0899999999999999 110.634 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.421 ' HB2' HE21 ' A' ' 20' ' ' GLN . 1.8 pt20 -131.22 178.62 6.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.064 -0.516 . . . . 2.0899999999999999 110.106 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.805 ' HA2' " H2'" ' C' ' 5' ' ' ' A' . . . 91.1 162.62 38.24 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.804 -0.712 . . . . 1.0700000000000001 113.844 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.642 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 3.6 m -85.95 102.44 13.76 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.975 -0.75 . . . . 1.1100000000000001 108.975 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.515 ' NH1' ' HB3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -136.99 156.12 75.92 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.268 -0.423 . . . . 1.6200000000000001 110.622 -179.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.13 123.69 9.43 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.564 2.176 . . . . 1.01 110.795 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.601 ' HB ' ' HB ' ' A' ' 42' ' ' VAL . 14.9 m -108.93 134.22 51.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.959 0.409 . . . . 0.76000000000000001 110.156 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.463 HD11 HG22 ' A' ' 93' ' ' VAL . 20.8 tp -86.31 122.61 30.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.849 -0.614 . . . . 0.69999999999999996 111.268 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.476 ' HA ' HG12 ' A' ' 42' ' ' VAL . 22.4 mm -74.76 115.23 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.92000000000000004 109.854 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.9 t -96.75 -38.78 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 112.07 0.396 . . . . 0.94999999999999996 112.07 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.08 147.22 76.48 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 112.186 0.439 . . . . 1.1200000000000001 112.186 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.02 156.25 65.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.853 2.368 . . . . 1.3 112.03 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.19 61.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.816 -0.629 . . . . 1.3899999999999999 112.561 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.09 -46.3 90.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.745 0.307 . . . . 1.6100000000000001 111.453 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -67.62 -41.2 84.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.12 0.486 . . . . 1.77 110.416 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.497 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 35.4 m-20 -66.5 -18.61 65.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.712 -0.676 . . . . 1.48 111.362 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -88.99 -42.22 11.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.393 -0.367 . . . . 2.6200000000000001 111.966 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 p -81.13 -44.42 20.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.032 0.753 . . . . 1.8600000000000001 113.032 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 m -90.72 -24.2 20.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.83 0.348 . . . . 1.72 111.395 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 5.9 mpt_? 64.25 15.79 9.64 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.915 -0.584 . . . . 4.4500000000000002 111.851 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.57 87.74 55.8 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 1.8100000000000001 111.045 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.591 ' HD2' ' O ' ' A' ' 80' ' ' ILE . 60.6 Cg_endo -75.66 132.12 14.24 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.207 1.938 . . . . 1.05 112.248 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.573 HG22 HG23 ' A' ' 79' ' ' THR . 75.8 t -77.62 118.9 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.097 -1.445 . . . . 1.03 107.097 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.601 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 35.1 m -127.68 161.3 35.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.617 0.723 . . . . 0.77000000000000002 112.87 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -125.06 130.74 24.09 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 114.547 -1.206 . . . . 0.71999999999999997 108.292 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 69.8 Cg_endo -74.7 141.73 27.98 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.528 2.152 . . . . 1.03 113.68 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.411 HG22 HG22 ' A' ' 72' ' ' VAL . 90.0 t -107.12 111.04 33.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.996 -0.742 . . . . 1.28 108.996 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.0 m -151.72 141.44 21.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.36 -0.382 . . . . 1.9099999999999999 110.431 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.697 ' HB3' HG23 ' A' ' 71' ' ' VAL . 1.4 p -120.52 153.14 37.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.921 0.391 . . . . 2.5299999999999998 111.144 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.548 ' HA3' " O2'" ' C' ' 3' ' ' ' A' . . . -163.65 -66.63 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.286 -1.126 . . . . 3.3599999999999999 110.286 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.89 145.39 18.21 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.66 -0.976 . . . . 3.8300000000000001 110.66 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -79.37 67.0 4.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.134 0.492 . . . . 4.7199999999999998 111.517 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.703 ' HB2' ' N6 ' ' C' ' 3' ' ' ' A' . 83.0 m-85 -123.84 83.38 2.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.908 -0.587 . . . . 6.2400000000000002 110.113 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -96.48 122.42 39.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.969 -0.559 . . . . 2.5899999999999999 109.947 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -152.93 103.11 2.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.19 -0.459 . . . . 4.5899999999999999 111.042 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.899 ' HA ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -66.86 -27.48 67.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.177 0.513 . . . . 2.6899999999999999 110.879 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.88 12.2 13.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.88 -0.6 . . . . 3.1699999999999999 110.387 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -125.2 -148.58 7.33 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.665 -0.698 . . . . 1.6599999999999999 111.711 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -108.81 15.2 23.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.154 0.502 . . . . 1.5600000000000001 111.252 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -132.23 77.86 1.78 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.814 -0.63 . . . . 1.25 110.2 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.899 HG12 ' HA ' ' A' ' 54' ' ' THR . 28.6 m -85.26 133.62 28.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.837 -0.62 . . . . 1.6799999999999999 111.285 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.69 148.16 24.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.778 -0.646 . . . . 1.95 110.802 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.9 ' HB3' HD11 ' A' ' 66' ' ' ILE . 80.1 mt -91.64 -16.84 26.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.245 0.545 . . . . 1.23 110.175 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.21 124.95 25.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.668 -0.696 . . . . 2.21 110.614 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.4 -27.94 2.94 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.45 -0.66 . . . . 1.1499999999999999 111.45 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.5 m -96.01 -13.2 8.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.667 0.27 . . . . 1.21 111.266 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.96 72.8 0.97 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.957 -0.639 . . . . 1.0800000000000001 113.108 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.9 HD11 ' HB3' ' A' ' 61' ' ' LEU . 15.6 pt -123.25 -167.86 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.613 0.244 . . . . 1.0700000000000001 111.043 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -102.95 -43.78 5.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.147 0.499 . . . . 3.5899999999999999 109.781 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.2 m -64.75 109.34 2.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.514 -0.766 . . . . 1.51 111.327 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.7 m -102.21 127.28 49.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.06 -0.518 . . . . 1.79 111.101 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 162.31 -166.84 36.65 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.499 -1.04 . . . . 1.1799999999999999 110.499 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.697 HG23 ' HB3' ' A' ' 47' ' ' SER . 45.6 t -124.81 131.89 72.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.24 -0.652 . . . . 1.5600000000000001 109.24 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.485 ' HB ' HG23 ' A' ' 59' ' ' VAL . 47.2 t -78.23 117.56 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.835 0.35 . . . . 1.29 110.83 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 44' ' ' PRO . 19.1 mmm180 -82.85 103.39 12.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.639 -0.504 . . . . 2.23 109.639 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.5 m -90.19 1.96 55.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.135 0.493 . . . . 1.1699999999999999 110.943 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -89.67 -16.32 30.7 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.586 -0.734 . . . . 0.89000000000000001 111.341 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -125.61 72.73 68.23 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 113.49 0.922 . . . . 2.1299999999999999 113.49 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -90.97 115.18 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.888 2.392 . . . . 0.80000000000000004 110.014 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -138.07 165.88 25.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.163 0.506 . . . . 2.0899999999999999 111.735 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.573 HG23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -97.18 133.02 42.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.343 -0.984 . . . . 1.6200000000000001 108.343 178.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.591 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 20.2 pt -132.21 148.35 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.788 0.328 . . . . 1.1499999999999999 111.304 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -82.08 102.42 11.02 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.882 -0.414 . . . . 1.03 109.882 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.3 tpp -89.76 -10.12 46.75 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.235 -0.439 . . . . 1.29 111.108 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 83' ' ' LYS . 17.1 tptp -79.69 -41.25 27.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.798 0.332 . . . . 2.6400000000000001 111.274 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.09 -26.82 42.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.421 -0.354 . . . . 1.1200000000000001 111.388 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 85' ' ' ARG . 33.1 mtt-85 -84.06 -59.47 2.39 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.385 0.513 . . . . 1.0600000000000001 112.385 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.78 109.29 0.3 Allowed Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.889 -0.672 . . . . 1.1200000000000001 111.85 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.03 -168.66 12.5 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.649 -0.786 . . . . 1.0900000000000001 112.79 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -131.36 138.97 49.4 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.063 -0.347 . . . . 2.46 110.063 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 7' ' ' TRP . 17.3 ttp180 -86.2 139.8 30.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.753 0.311 . . . . 2.4900000000000002 111.137 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.764 HD21 ' HB2' ' A' ' 8' ' ' LEU . 1.9 mm? -89.04 -55.37 3.71 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.049 -0.722 . . . . 1.29 109.049 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -170.37 -160.61 0.22 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.183 -0.917 . . . . 1.1499999999999999 108.688 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -134.58 149.97 50.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.688 0.28 . . . . 1.3200000000000001 110.456 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.463 HG22 HD11 ' A' ' 26' ' ' LEU . 31.4 m -97.73 159.82 30.07 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.26 -0.427 . . . . 0.75 111.092 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -64.87 155.87 65.28 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.713 2.276 . . . . 0.94999999999999996 111.398 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -63.59 -26.94 68.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 1.51 110.753 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.34 -37.59 78.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.542 . . . . 1.5700000000000001 110.573 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.5 mm -70.06 -43.69 78.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.022 -0.535 . . . . 1.3100000000000001 110.12 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.7 tpt -63.7 -45.87 88.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 1.6000000000000001 110.459 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -61.58 -36.69 81.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.024 -0.535 . . . . 2.2999999999999998 110.716 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 104' ' ' ARG . 5.1 tp10 -63.08 -47.64 82.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.072 -0.513 . . . . 1.6399999999999999 110.589 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.446 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 78.8 t -61.64 -46.02 97.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.939 -0.573 . . . . 1.03 110.336 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.55 -39.14 83.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.099 -0.501 . . . . 1.22 110.689 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.42 -43.37 99.15 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.783 -0.644 . . . . 1.03 111.644 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 3.2 mmt180 -65.14 -37.76 88.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 1.72 110.49 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 101' ' ' VAL . 96.7 mt -67.43 -25.06 65.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.56 . . . . 1.02 111.691 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.2 m -71.89 -11.53 60.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 1.1100000000000001 111.067 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.26 -13.65 26.31 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.316 0.487 . . . . 1.5 112.316 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.497 ' HB ' HG22 ' B' ' 29' ' ' THR . 36.1 pt -100.75 -1.24 9.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.827 0.677 . . . . 1.1499999999999999 112.827 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.8 mt -81.65 73.7 8.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.753 0.311 . . . . 0.97999999999999998 110.222 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.545 -0.298 . . . . 1.3500000000000001 111.596 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.757 ' HA ' ' HA ' ' B' ' 30' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 120.708 0.289 . . . . 2.0299999999999998 110.432 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' B' ' 3' ' ' ARG . 2.0 mp0 -77.39 -25.95 51.33 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.922 -0.77 . . . . 2.8199999999999998 108.922 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' B' ' 2' ' ' GLU . 10.7 mtm180 73.03 142.84 0.06 Allowed 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 114.96 -1.018 . . . . 2.3199999999999998 111.457 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' B' ' 92' ' ' ARG . . . 86.46 -50.03 4.16 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.898 -0.668 . . . . 1.28 113.62 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.44 ' OE2' ' HD2' ' B' ' 92' ' ' ARG . 64.7 mm-40 -57.66 107.41 0.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.838 0.681 . . . . 1.53 112.838 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.441 HD12 ' HG3' ' B' ' 91' ' ' GLU . 80.6 mt -98.66 127.28 51.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.374 -0.602 . . . . 0.75 109.374 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -107.68 168.82 8.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.201 0.524 . . . . 0.81000000000000005 111.805 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' B' ' 88' ' ' LYS . 33.5 tp -141.53 132.17 25.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.697 -0.683 . . . . 1.05 109.941 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.411 HG12 HG21 ' B' ' 25' ' ' VAL . 5.2 p -169.26 165.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.532 -0.544 . . . . 0.71999999999999997 109.532 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' B' ' 22' ' ' THR . 22.9 t -88.76 139.36 30.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.677 -0.49 . . . . 1.6299999999999999 109.677 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.714 HD13 ' HB3' ' B' ' 19' ' ' GLN . 31.7 mt -87.72 -16.82 33.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.201 0.524 . . . . 0.82999999999999996 110.349 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . 0.414 ' CB ' ' HA ' ' B' ' 13' ' ' PRO . 2.1 m-20 -73.83 162.08 75.72 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.76 -0.655 . . . . 1.6200000000000001 111.283 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.414 ' HA ' ' CB ' ' B' ' 12' ' ' ASP . 98.2 Cg_endo -80.28 135.56 33.92 Favored 'Cis proline' 0 C--N 1.344 0.299 0 C-N-CA 123.359 -1.517 . . . . 1.28 113.259 0.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.02 170.51 15.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.345 -0.843 . . . . 1.47 109.575 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.46 165.09 28.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.575 0.226 . . . . 1.22 110.551 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.34 -146.23 34.23 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.122 -0.561 . . . . 1.01 112.266 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -90.15 -1.72 57.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.384 -0.228 . . . . 2.1800000000000002 110.384 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -57.78 154.25 12.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.906 -0.588 . . . . 1.28 112.201 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.714 ' HB3' HD13 ' B' ' 11' ' ' LEU . 28.9 mm-40 -60.94 127.35 31.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.686 -0.688 . . . . 1.52 111.383 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -142.06 -176.6 4.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.893 -0.594 . . . . 1.8600000000000001 110.533 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.59 174.82 50.62 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.993 -0.622 . . . . 0.90000000000000002 112.697 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' B' ' 10' ' ' SER . 22.9 m -105.65 103.62 13.16 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.828 -0.434 . . . . 0.94999999999999996 109.828 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -141.55 157.98 64.25 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.241 -0.436 . . . . 1.5900000000000001 110.332 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.02 141.36 79.27 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.495 2.13 . . . . 0.65000000000000002 111.411 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.827 ' HB ' ' HB ' ' B' ' 42' ' ' VAL . 6.4 m -131.75 131.49 62.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.379 0.609 . . . . 0.56999999999999995 111.56 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 36.6 tp -101.72 123.85 46.39 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.669 -0.696 . . . . 1.1699999999999999 109.527 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . 0.422 HG12 HG12 ' B' ' 42' ' ' VAL . 34.4 mt -78.89 138.16 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.58 -0.282 . . . . 0.66000000000000003 110.362 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' B' ' 1' ' ' MET . 21.5 t -99.54 -34.92 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.406 -0.361 . . . . 0.93000000000000005 110.945 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' THR . . . . . 0.497 HG22 ' HB ' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -76.53 140.96 68.78 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.215 -0.448 . . . . 0.81000000000000005 111.634 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.757 ' HA ' ' HA ' ' B' ' 1' ' ' MET . 95.9 Cg_endo -78.76 159.83 27.93 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.767 2.311 . . . . 0.78000000000000003 112.009 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' B' ' 34' ' ' ASN . . . -55.18 -29.7 58.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.212 -0.449 . . . . 1.03 111.954 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.38 -40.73 75.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.292 -0.413 . . . . 1.3999999999999999 110.871 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -89.33 -37.76 14.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.058 -0.519 . . . . 1.5700000000000001 110.63 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.561 ' O ' ' HA ' ' B' ' 38' ' ' ARG . 85.5 m-20 -61.69 -18.22 58.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.704 -0.68 . . . . 1.6399999999999999 112.302 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -88.13 -25.88 22.76 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.694 0.257 . . . . 2.54 111.694 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -82.02 -61.84 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.963 0.411 . . . . 1.0900000000000001 111.645 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.79 -28.21 36.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.186 -0.461 . . . . 1.3300000000000001 111.201 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 1.5 mmp_? 69.9 8.23 6.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.809 -0.632 . . . . 1.78 111.819 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.64 98.06 48.28 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.968 -0.56 . . . . 1.1599999999999999 109.537 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' B' ' 80' ' ' ILE . 85.0 Cg_endo -90.62 155.23 4.28 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.789 2.326 . . . . 0.56999999999999995 113.112 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 m -94.74 124.93 47.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.105 -0.702 . . . . 1.0800000000000001 109.105 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.827 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 28.6 m -111.2 147.19 15.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 112.802 0.667 . . . . 0.64000000000000001 112.802 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.41 118.29 49.38 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 114.752 -1.113 . . . . 1.1000000000000001 108.757 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.609 ' HG3' ' HG3' ' B' ' 19' ' ' GLN . 66.1 Cg_endo -74.14 142.45 30.8 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.628 2.219 . . . . 0.72999999999999998 113.041 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.773 HG22 HG12 ' B' ' 72' ' ' VAL . 44.0 t -95.62 116.72 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.798 -0.637 . . . . 0.90000000000000002 109.809 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.88 145.0 26.87 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.193 -0.458 . . . . 1.1699999999999999 110.79 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 8.5 m -95.61 102.22 14.0 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.73 0.3 . . . . 1.8500000000000001 110.745 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.3 68.25 3.34 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.129 -0.558 . . . . 2.2200000000000002 112.199 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.7 -112.54 3.58 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 121.081 -0.58 . . . . 3.4300000000000002 111.662 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -126.8 -51.49 1.46 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.066 0.46 . . . . 4.6200000000000001 110.58 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -97.29 100.89 12.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.127 -0.488 . . . . 6.2699999999999996 109.909 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.5 ' HB1' HG13 ' B' ' 71' ' ' VAL . . . -73.14 133.89 44.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.72 -0.673 . . . . 4.3899999999999997 111.395 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.21 161.29 27.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.137 -0.483 . . . . 3.9199999999999999 110.171 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.72 120.46 19.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.055 0.455 . . . . 2.75 111.44 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.706 ' HB3' ' HB3' ' B' ' 58' ' ' ALA . . . -108.76 -161.1 0.75 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.947 -0.57 . . . . 1.96 110.53 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.39 -61.33 5.48 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.253 -0.498 . . . . 1.0800000000000001 112.54 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.544 ' HE1' ' HB ' ' B' ' 107' ' ' THR . 70.4 m-85 -114.65 0.38 13.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.283 0.563 . . . . 3.5699999999999998 110.54 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.706 ' HB3' ' HB3' ' B' ' 55' ' ' ALA . . . -100.16 106.23 17.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.614 -0.721 . . . . 1.0800000000000001 110.573 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.652 HG21 ' HA ' ' B' ' 101' ' ' VAL . 57.0 t -87.92 129.31 39.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.675 -0.693 . . . . 1.3400000000000001 109.895 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.4 t -85.08 138.21 32.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.224 -0.444 . . . . 1.3799999999999999 111.467 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 37.8 mt -106.11 5.81 30.47 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.719 -0.845 . . . . 1.02 108.719 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -101.19 144.48 30.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.239 -0.891 . . . . 1.79 110.864 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.14 -23.33 11.5 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 116.102 -0.499 . . . . 1.1499999999999999 111.96 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.624 HG13 HG13 ' B' ' 66' ' ' ILE . 4.2 p -100.14 -20.52 5.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.173 0.511 . . . . 1.1699999999999999 111.54 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.96 51.62 0.88 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.601 -0.809 . . . . 1.05 112.708 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.624 HG13 HG13 ' B' ' 64' ' ' VAL . 82.6 mt -109.13 147.42 13.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.446 -0.575 . . . . 1.6100000000000001 109.446 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -65.53 -49.53 68.61 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.869 0.366 . . . . 2.3999999999999999 110.133 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 17.8 m -67.89 101.8 1.15 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.915 -0.584 . . . . 0.93000000000000005 109.866 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.17 113.97 25.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.138 -0.483 . . . . 1.3100000000000001 111.253 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.98 -170.25 39.18 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.439 -0.886 . . . . 0.79000000000000004 112.681 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.623 ' HB ' ' HB1' ' B' ' 58' ' ' ALA . 6.0 m -123.86 133.97 67.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.972 -0.381 . . . . 0.93000000000000005 109.972 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.773 HG12 HG22 ' B' ' 45' ' ' VAL . 19.3 m -82.34 138.11 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.464 -0.334 . . . . 1.3799999999999999 111.445 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 mmm-85 -94.82 85.09 4.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.376 -0.374 . . . . 1.3700000000000001 110.101 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . 0.411 ' HB3' HD23 ' B' ' 105' ' ' LEU . 3.4 m -67.85 -9.21 42.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 1.1599999999999999 111.617 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -92.24 -1.86 56.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.471 . . . . 1.1000000000000001 111.833 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -128.27 83.24 66.71 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 112.02 0.378 . . . . 2.4700000000000002 112.02 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -92.01 144.87 2.92 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.01 2.473 . . . . 0.95999999999999996 112.181 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -148.42 131.46 16.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.453 -0.34 . . . . 1.96 111.01 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.07 126.52 34.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.549 . . . . 1.1899999999999999 109.567 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.532 ' O ' ' HD2' ' B' ' 40' ' ' PRO . 23.9 pt -140.47 151.33 20.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 1.28 111.315 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.522 ' CG ' ' HZ1' ' B' ' 83' ' ' LYS . 10.3 t70 -80.67 100.43 8.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 1.28 109.852 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' MET . . . . . 0.683 ' SD ' ' HA3' ' B' ' 87' ' ' GLY . 48.5 tpp -66.62 -16.77 64.43 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.674 0.62 . . . . 2.7000000000000002 112.674 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.522 ' HZ1' ' CG ' ' B' ' 81' ' ' ASP . 6.6 mtmp? -80.29 -54.34 5.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.931 0.396 . . . . 1.96 110.887 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.65 -28.16 67.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.125 -0.489 . . . . 1.0600000000000001 111.34 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -85.44 -11.39 54.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.295 -0.411 . . . . 1.47 111.501 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.96 57.49 18.47 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 121.096 -0.573 . . . . 0.81999999999999995 112.754 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' GLY . . . . . 0.683 ' HA3' ' SD ' ' B' ' 82' ' ' MET . . . -66.24 148.86 51.15 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.934 -0.65 . . . . 0.65000000000000002 112.793 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' B' ' 8' ' ' LEU . 0.1 OUTLIER -127.11 164.45 21.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.49 -0.189 . . . . 1.8100000000000001 110.49 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -105.23 137.22 43.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.771 0.319 . . . . 2.4900000000000002 110.399 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 23.5 mt -98.55 -69.26 0.77 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.233 -0.439 . . . . 0.76000000000000001 111.908 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . 0.441 ' HG3' HD12 ' B' ' 6' ' ' ILE . 16.4 pt-20 -154.02 -171.13 3.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.069 -0.514 . . . . 1.0700000000000001 110.705 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' B' ' 4' ' ' GLY . 10.6 ttt180 -128.03 119.92 26.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.032 0.444 . . . . 2.0499999999999998 111.262 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 2.6 p -84.58 135.06 41.2 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.687 -0.688 . . . . 1.45 109.637 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.45 145.78 27.48 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.954 2.436 . . . . 1.03 113.097 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' B' ' 95' ' ' GLU . 1.2 mm-40 -56.76 -29.15 62.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.757 -0.656 . . . . 2.1400000000000001 111.517 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -39.14 77.53 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.326 -0.397 . . . . 1.78 111.362 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 31.5 mm -79.26 -29.8 13.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.276 0.56 . . . . 1.3300000000000001 109.516 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' MET . . . . . . . . . . . . . 11.2 mmt -62.89 -32.31 73.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.59 -0.732 . . . . 2.3399999999999999 110.566 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.15 -41.85 93.64 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.922 -0.581 . . . . 1.9099999999999999 110.253 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' B' ' 104' ' ' ARG . 9.9 tp10 -62.57 -45.04 94.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.814 -0.63 . . . . 1.76 110.024 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.652 ' HA ' HG21 ' B' ' 59' ' ' VAL . 38.4 t -62.66 -49.86 82.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.649 -0.705 . . . . 1.01 111.05 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 86.7 mt -55.85 -38.57 70.25 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.343 -0.389 . . . . 1.29 111.512 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.58 -44.78 97.05 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.655 -0.783 . . . . 1.02 111.34 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' B' ' 100' ' ' GLU . 8.8 mmt180 -68.34 -33.36 74.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.059 0.456 . . . . 1.8500000000000001 110.472 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.455 ' O ' HG12 ' B' ' 108' ' ' ILE . 78.7 mt -64.35 -24.87 67.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.882 -0.599 . . . . 1.9399999999999999 110.854 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 23.2 m -85.17 -24.16 28.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.152 -0.476 . . . . 1.1599999999999999 110.882 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.544 ' HB ' ' HE1' ' B' ' 57' ' ' PHE . 0.5 OUTLIER -73.35 -28.57 62.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.259 -0.428 . . . . 1.45 112.068 -179.149 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.455 HG12 ' O ' ' B' ' 105' ' ' LEU . 40.7 pt -68.5 -19.67 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.548 0.573 . . . . 1.98 112.548 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.31 59.45 5.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.271 0.558 . . . . 1.3600000000000001 111.457 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-N 115.954 -0.566 . . . . 2.1299999999999999 109.699 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' ' A' . . . . . 0.51 H5'' ' HB2' ' B' ' 38' ' ' ARG . . . . . . . . 0 O5'--C5' 1.429 -0.69 0 C3'-C2'-O2' 111.166 -0.736 . 0.0 '__' . 6.3600000000000003 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.422 -1.139 0 C3'-C2'-C1' 100.57 -1.034 . 0.032 2o . 2.9900000000000002 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' ' A' . . . . . 0.709 " H2'" ' N3 ' ' C' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.977 0 C3'-C2'-O2' 110.849 -0.845 . 0.0 OUTLIER gamma 2.5899999999999999 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.423 -1.032 0 O4'-C1'-C2' 107.972 1.123 . 0.0 OUTLIER . 2.5099999999999998 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' ' A' . . . . . 0.805 " H2'" ' HA2' ' A' ' 21' ' ' GLY . . . . . . . . 0 O3'--C3' 1.432 0.625 0 C4'-C3'-O3' 114.039 1.323 . 0.0 OUTLIER . 4.9400000000000004 . . . . . . . . . . 2 2 . 1 stop_ save_